Citrus Sinensis ID: 007290
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 609 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGT1 | 613 | Probable LRR receptor-lik | yes | no | 0.998 | 0.991 | 0.796 | 0.0 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.990 | 0.993 | 0.779 | 0.0 | |
| Q8W4S5 | 614 | Probable LRR receptor-lik | no | no | 0.932 | 0.925 | 0.567 | 0.0 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.985 | 0.96 | 0.550 | 0.0 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.922 | 0.913 | 0.549 | 1e-170 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.898 | 0.882 | 0.554 | 1e-159 | |
| Q8LPS5 | 601 | Somatic embryogenesis rec | no | no | 0.878 | 0.890 | 0.545 | 1e-157 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.939 | 0.900 | 0.498 | 1e-157 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.945 | 0.902 | 0.495 | 1e-152 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.949 | 0.914 | 0.483 | 1e-148 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 973 bits (2515), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/608 (79%), Positives = 533/608 (87%)
Query: 2 MKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVI 61
++ + + + CL D QGDALFALR SLR NQL DWNQNQVNPCTWS VI
Sbjct: 6 LQKMAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVI 65
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
CD+ N V S+TLS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL
Sbjct: 66 CDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDL 125
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
++N+L G+IP ++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP
Sbjct: 126 EDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQS 185
Query: 182 LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF 241
LF+IPKYNFT NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF
Sbjct: 186 LFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFL 245
Query: 242 LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVY 301
CK RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY
Sbjct: 246 FCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVY 305
Query: 302 RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361
+GVL D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYP
Sbjct: 306 KGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 365
Query: 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 421
FMQNLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLL
Sbjct: 366 FMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLL 425
Query: 422 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 481
DEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE
Sbjct: 426 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 485
Query: 482 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL 541
LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALL
Sbjct: 486 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALL 545
Query: 542 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQE 601
CTQ SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+
Sbjct: 546 CTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQD 605
Query: 602 AIELSGGR 609
AIELSGGR
Sbjct: 606 AIELSGGR 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/604 (77%), Positives = 528/604 (87%), Gaps = 1/604 (0%)
Query: 7 LVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSN 66
L++ A++ L D QGDALFALR+SLR QL DWNQNQV+PCTWS VICD+
Sbjct: 4 LIITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPCTWSQVICDDKK 63
Query: 67 NVASVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
+V SVTLS MNFS GTLS IG+L TL TLTLKGNGI G IPE +GNLSSLTSLDL++N
Sbjct: 64 HVTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLEDNH 123
Query: 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 185
L +IP +LGNLK LQFLTLS+NN +G+IPDSLT LS LI+I LDSNNLSG+IP LF+I
Sbjct: 124 LTDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQSLFKI 183
Query: 186 PKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKG 245
PKYNFT NNL+CG T P C + S+ SG S K GII G+V G+ V++ G FF CK
Sbjct: 184 PKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKTGIIAGVVSGIAVILLGFFFFFFCKD 243
Query: 246 RHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL 305
+HKGYKR+VFVDVAGEVDRRIAFGQL+R++WRELQLATD FSEKNVLGQGGFGKVY+G+L
Sbjct: 244 KHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWRELQLATDEFSEKNVLGQGGFGKVYKGLL 303
Query: 306 ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365
+DGTKVAVKRLTDFE PGGD AFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQN
Sbjct: 304 SDGTKVAVKRLTDFERPGGDEAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQN 363
Query: 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425
LSVAY LREIKPG+PVLDW RK++ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF
Sbjct: 364 LSVAYCLREIKPGDPVLDWFRRKQIALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 423
Query: 426 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
EAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPE +STGKSSE+TDVFGYGIMLLELVTG
Sbjct: 424 EAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPECISTGKSSEKTDVFGYGIMLLELVTG 483
Query: 486 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQA 545
QRAIDFSRLEEEDDVLLLDHVKKLEREKRL+ IVD+ L+++Y +EVE MIQVALLCTQA
Sbjct: 484 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIVDKKLDEDYIKEEVEMMIQVALLCTQA 543
Query: 546 SPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIEL 605
+PE+RPAMSEVVRMLEGEGLAERWEEWQ++EVTR++E++RLQRRFDWGEDS+ NQ+AIEL
Sbjct: 544 APEERPAMSEVVRMLEGEGLAERWEEWQNLEVTRQEEFQRLQRRFDWGEDSINNQDAIEL 603
Query: 606 SGGR 609
SGGR
Sbjct: 604 SGGR 607
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/615 (56%), Positives = 436/615 (70%), Gaps = 47/615 (7%)
Query: 12 IILDCLHYLAL---------SDYQGDALFALRTSLRVPNNQLRDWNQNQVNPC-TWSNVI 61
+IL C LA D +G AL LR SL +N+L+ W ++ V+PC +WS V
Sbjct: 30 LILQCFMALAFVGITSSTTQPDIEGGALLQLRDSLNDSSNRLK-WTRDFVSPCYSWSYVT 88
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
C +V ++ L+S F+GTLSP I L+ L TL +L
Sbjct: 89 C-RGQSVVALNLASSGFTGTLSPAITKLKFLVTL------------------------EL 123
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
NN L G +P SLGN+ LQ L LS N+FSG+IP S + LS+L + L SNNL+G IP
Sbjct: 124 QNNSLSGALPDSLGNMVNLQTLNLSVNSFSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQ 183
Query: 182 LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPK---IGIIVGIVGGLIVLISGGL 238
F IP ++F+G L CGK+L C SSS +S K K I + V +I+ + +
Sbjct: 184 FFSIPTFDFSGTQLICGKSLNQPCSSSSRLPVTSSKKKLRDITLTASCVASIILFLGAMV 243
Query: 239 LFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFG 298
++ + R Y ++F DVAGE DR+I+FGQLKR+S RE+QLATD+F+E N++GQGGFG
Sbjct: 244 MYHHHRVRRTKY--DIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFG 301
Query: 299 KVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358
KVYRG+L D TKVAVKRL D+ SPGG+AAFQRE+++ISVAVH+NLLRLIGFCTT +ER+L
Sbjct: 302 KVYRGLLPDKTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERIL 361
Query: 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418
VYP+M+NLSVAYRLR++K GE LDW TRKRVA G+A GLEYLHEHCNPKIIHRD+KAAN
Sbjct: 362 VYPYMENLSVAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAAN 421
Query: 419 VLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM 478
+LLD +FE V+GDFGLAKLVD T+VTTQVRGTMGHIAPEYL TGKSSE+TDVFGYGI
Sbjct: 422 ILLDNNFEPVLGDFGLAKLVDTSLTHVTTQVRGTMGHIAPEYLCTGKSSEKTDVFGYGIT 481
Query: 479 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQV 538
LLELVTGQRAIDFSRLEEE+++LLLDH+KKL RE+RL IVD NL Y+ +EVET++QV
Sbjct: 482 LLELVTGQRAIDFSRLEEEENILLLDHIKKLLREQRLRDIVDSNLT-TYDSKEVETIVQV 540
Query: 539 ALLCTQASPEDRPAMSEVVRMLEGE-GLAERWEEWQHVEVTRRQE---YERLQRRFDWGE 594
ALLCTQ SPEDRPAMSEVV+ML+G GLAE+W EW+ +E R +E L +D E
Sbjct: 541 ALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKWTEWEQLEEVRNKEALLLPTLPATWD-EE 599
Query: 595 DSVYNQEAIELSGGR 609
++ +QE+I LS R
Sbjct: 600 ETTVDQESIRLSTAR 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 634 bits (1634), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/625 (55%), Positives = 424/625 (67%), Gaps = 25/625 (4%)
Query: 5 VKLVLVAIILDCLH--YLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVIC 62
V +L+++IL H +LA ++ +GDAL LR +L PNN L+ W+ VNPCTW +V C
Sbjct: 6 VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65
Query: 63 DNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 122
+N N+V V L + SG L P +GVL+ L L L N ITG IP LGNL++L SLDL
Sbjct: 66 NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125
Query: 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--- 179
N G IP SLG L KL+FL L+ N+ +G+IP SLT +++L + L +N LSG +P
Sbjct: 126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185
Query: 180 -VHLFQIPKYNFTGNNLN-CGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGG 237
LF + NNL+ CG H C S S + + G I G
Sbjct: 186 SFSLFTPISF---ANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAG 242
Query: 238 LLF-------------FLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATD 284
+ F R K ++F DV E D + GQLKR+S RELQ+A+D
Sbjct: 243 GVAAGAALLFAAPAIAFAWWRRRKPL--DIFFDVPAEEDPEVHLGQLKRFSLRELQVASD 300
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
FS KN+LG+GGFGKVY+G LADGT VAVKRL + +PGG+ FQ EVEMIS+AVHRNLL
Sbjct: 301 GFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 360
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
RL GFC TPTERLLVYP+M N SVA LRE P +P LDW TRKR+ALG+ARGL YLH+H
Sbjct: 361 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDH 420
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 464
C+PKIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTG
Sbjct: 421 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG 480
Query: 465 KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524
KSSE+TDVFGYGIMLLEL+TGQRA D +RL +DDV+LLD VK L +EK+L+ +VD +L
Sbjct: 481 KSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQ 540
Query: 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYE 584
NY +E+E +IQVALLCTQ SP +RP MSEVVRMLEG+GLAE+W+EWQ VE+ R +
Sbjct: 541 TNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAEKWDEWQKVEILREEIDL 600
Query: 585 RLQRRFDWGEDSVYNQEAIELSGGR 609
DW DS YN A+ELSG R
Sbjct: 601 SPNPNSDWILDSTYNLHAVELSGPR 625
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 600 bits (1546), Expect = e-170, Method: Compositional matrix adjust.
Identities = 322/586 (54%), Positives = 403/586 (68%), Gaps = 24/586 (4%)
Query: 12 IILDCLHYLAL---------SDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVIC 62
+++ C +L L + +GDAL AL+ SL PN L+ W+ V PCTW +V C
Sbjct: 5 LMIPCFFWLILVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTC 64
Query: 63 DNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 122
++ N+V V L + N SG L ++G L L L L N ITG IPE+LGNL+ L SLDL
Sbjct: 65 NSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLY 124
Query: 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH- 181
N L G IP +LG LKKL+FL L+ N+ SG IP SLT + +L + L +N L+G IPV+
Sbjct: 125 LNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNG 184
Query: 182 ---LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGL 238
LF + T P + + +GS++ + V L
Sbjct: 185 SFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNR-------ITGAIAGGVAAGAAL 237
Query: 239 LFFLCKGRHKGYKR----EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQ 294
LF + ++R + F DV E D + GQLKR+S RELQ+A+DNFS KN+LG+
Sbjct: 238 LFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGR 297
Query: 295 GGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354
GGFGKVY+G LADGT VAVKRL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPT
Sbjct: 298 GGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 357
Query: 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 414
ERLLVYP+M N SVA LRE +P LDW R+R+ALG+ARGL YLH+HC+PKIIHRDV
Sbjct: 358 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDV 417
Query: 415 KAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFG 474
KAAN+LLDE+FEAVVGDFGLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFG
Sbjct: 418 KAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG 477
Query: 475 YGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVET 534
YG+MLLEL+TGQRA D +RL +DDV+LLD VK L +EK+L+A+VD +L NY +EVE
Sbjct: 478 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQ 537
Query: 535 MIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR 580
+IQVALLCTQ+SP +RP MSEVVRMLEG+GLAERWEEWQ E+ R+
Sbjct: 538 LIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 583
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 562 bits (1448), Expect = e-159, Method: Compositional matrix adjust.
Identities = 310/559 (55%), Positives = 384/559 (68%), Gaps = 12/559 (2%)
Query: 26 QGDALFALRTSLRV---PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTL 82
+GDAL L+ SL NN L+ W+ V PCTW +V C+ N V V L + SG L
Sbjct: 32 EGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSGKL 91
Query: 83 SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142
P +G L L L L N ITGEIPEELG+L L SLDL N + G IP SLG L KL+F
Sbjct: 92 VPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRF 151
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH----LFQIPKYNFTGNNLNCG 198
L L+ N+ SG IP +LT++ L + + +N LSG IPV+ LF +F N+L
Sbjct: 152 LRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFT--PISFANNSLTDL 208
Query: 199 KTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDV 258
P + S + S + I G+ G +L + + F R K ++ F DV
Sbjct: 209 PEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRK--PQDHFFDV 266
Query: 259 AGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD 318
E D + GQLKR++ REL +ATDNFS KNVLG+GGFGKVY+G LADG VAVKRL +
Sbjct: 267 PAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKE 326
Query: 319 FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG 378
+ GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE G
Sbjct: 327 ERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEG 386
Query: 379 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438
P LDW RK +ALG+ARGL YLH+HC+ KIIHRDVKAAN+LLDE+FEAVVGDFGLAKL+
Sbjct: 387 NPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 446
Query: 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 498
+ ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +RL +D
Sbjct: 447 NYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDD 506
Query: 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
D++LLD VK++ +EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MSEVVR
Sbjct: 507 DIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVR 566
Query: 559 MLEGEGLAERWEEWQHVEV 577
MLEG+GLAERWEEWQ E+
Sbjct: 567 MLEGDGLAERWEEWQKEEM 585
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 555 bits (1431), Expect = e-157, Method: Compositional matrix adjust.
Identities = 304/557 (54%), Positives = 379/557 (68%), Gaps = 22/557 (3%)
Query: 26 QGDALFALRTSLRV---PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTL 82
Q DAL ALR+SL NN L+ WN V PC+W +V C+ N+V + L S N SG L
Sbjct: 27 QVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNTENSVTRLDLGSANLSGEL 86
Query: 83 SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142
P++ L L L L N ITGEIPEELG+L L SLDL N + G IP SLG L KL+F
Sbjct: 87 VPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKLGKLRF 146
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKYNFTGNNLNCGKT 200
L L N+ SG IP SLT L L + + +N LSG IPV+ Q +F N L
Sbjct: 147 LRLYNNSLSGEIPRSLTALP-LDVLDISNNRLSGDIPVNGSFSQFTSMSFANNKLR---- 201
Query: 201 LPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAG 260
++ S S I+VG+ G +L + + + +G+ F+DV
Sbjct: 202 -----PRPASPSPSPSGTSAAIVVGVAAGAALLFALAWW---LRRKLQGH----FLDVPA 249
Query: 261 EVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE 320
E D + GQ KR+S REL +AT+ FS++NVLG+G FG +Y+G LAD T VAVKRL +
Sbjct: 250 EEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEER 309
Query: 321 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 380
+ GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE G P
Sbjct: 310 TKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNP 369
Query: 381 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
LDW RK +ALG+ARGL YLH+HC+ KIIH DVKAAN+LLDE+FEAVVGDFGLAKL++
Sbjct: 370 ALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNY 429
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500
++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +RL +DD+
Sbjct: 430 NDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDI 489
Query: 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+LLD VK++ +EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MSEVVRML
Sbjct: 490 MLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRML 549
Query: 561 EGEGLAERWEEWQHVEV 577
EG+GLAERWEEWQ E+
Sbjct: 550 EGDGLAERWEEWQKEEM 566
|
Serine/threonine-kinase of unknown function. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 554 bits (1427), Expect = e-157, Method: Compositional matrix adjust.
Identities = 299/600 (49%), Positives = 394/600 (65%), Gaps = 28/600 (4%)
Query: 29 ALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV 88
AL +++SL P+ L +W+ V+PC+W+ + C + V + S N SGTLS IG
Sbjct: 45 ALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCSDGF-VIRLEAPSQNLSGTLSSSIGN 103
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L T+ L+ N ITG IP E+G L L +LDL N G+IP +L K LQ+L ++ N
Sbjct: 104 LTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVNNN 163
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCE-- 206
+ +GTIP SL ++ L + L NNLSG +P L + +N GN+ C C
Sbjct: 164 SLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKT--FNVMGNSQICPTGTEKDCNGT 221
Query: 207 ----------SSSNDS--GSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREV 254
SS N S G +K KI ++ G+ + L+ G F L R + K+ +
Sbjct: 222 QPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLW-WRRRHNKQVL 280
Query: 255 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 314
F D+ + + G L+R++++ELQ AT NFS KN++G+GGFG VY+G L DG+ +AVK
Sbjct: 281 FFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVK 340
Query: 315 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 374
RL D + GG+ FQ E+EMIS+AVHRNLLRL GFCTT +ERLLVYP+M N SVA RL+
Sbjct: 341 RLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK- 399
Query: 375 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434
+PVLDW TRKR+ALGA RGL YLHE C+PKIIHRDVKAAN+LLD+ FEAVVGDFGL
Sbjct: 400 ---AKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGL 456
Query: 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494
AKL+D +++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +
Sbjct: 457 AKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKA 516
Query: 495 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
+ +LD VKKL++EK+L+ IVD++L NY+ EVE M+QVALLCTQ P RP MS
Sbjct: 517 ANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMS 575
Query: 555 EVVRMLEGEGLAERWE-EWQHVEVTRR----QEYERLQRRFDWGEDSVYNQEAIELSGGR 609
EVVRMLEG+GL E+WE Q E R E+ +R D +DS +A+ELSG R
Sbjct: 576 EVVRMLEGDGLVEKWEASSQRAETNRSYSKPNEFSSSERYSDLTDDSSVLVQAMELSGPR 635
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 540 bits (1391), Expect = e-152, Method: Compositional matrix adjust.
Identities = 302/610 (49%), Positives = 401/610 (65%), Gaps = 34/610 (5%)
Query: 24 DYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLS 83
+++ AL ++ SL P+ L +W+++ V+PC+W+ V C + N V + S N SGTLS
Sbjct: 39 NFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQNLSGTLS 98
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
P I L L + L+ N I G+IP E+G L+ L +LDL +N G+IP S+G L+ LQ+L
Sbjct: 99 PSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYL 158
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC------ 197
L+ N+ SG P SL+ ++ L + L NNLSG PV F ++ GN L C
Sbjct: 159 RLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSG--PVPRFAAKTFSIVGNPLICPTGTEP 216
Query: 198 ---GKTL-PHSCESSSND----SGSSKKPKIGIIVGIVGGLIVLISGGL-LFFLCKGRHK 248
G TL P S + +G S+ K+ I VG G + LI + LF + RH
Sbjct: 217 DCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQRHN 276
Query: 249 GYKREVFVDVA-GEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD 307
+ F DV G ++ G L+R+ +RELQ+AT+NFS KN+LG+GG+G VY+G+L D
Sbjct: 277 ---QNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGD 333
Query: 308 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367
T VAVKRL D + GG+ FQ EVEMIS+AVHRNLLRL GFC T TE+LLVYP+M N S
Sbjct: 334 STVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGS 393
Query: 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427
VA R++ +PVLDW RKR+A+GAARGL YLHE C+PKIIHRDVKAAN+LLD+ EA
Sbjct: 394 VASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEA 449
Query: 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
VVGDFGLAKL+D + ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLELVTGQR
Sbjct: 450 VVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQR 509
Query: 488 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL--NKNYNIQEVETMIQVALLCTQA 545
A +F + + V +LD VKK+ +EK+L+ +VD+ L K+Y+ E++ M++VALLCTQ
Sbjct: 510 AFEFGKAANQKGV-MLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQY 568
Query: 546 SPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVT-----RRQEYERLQRRF-DWGEDSVYN 599
P RP MSEVVRMLEG+GLAE+WE Q + R E R+ D +DS
Sbjct: 569 LPGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLL 628
Query: 600 QEAIELSGGR 609
+A+ELSG R
Sbjct: 629 VQAMELSGPR 638
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1355), Expect = e-148, Method: Compositional matrix adjust.
Identities = 294/608 (48%), Positives = 392/608 (64%), Gaps = 30/608 (4%)
Query: 24 DYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLS 83
+Y+ AL A++ L P L +W+ N V+PC+W V C + V+S+ L S + SGTLS
Sbjct: 33 NYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCTDGY-VSSLDLPSQSLSGTLS 91
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
PRIG L L ++ L+ N ITG IPE +G L L SLDL NN G+IP SLG LK L +L
Sbjct: 92 PRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYL 151
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGK---- 199
L+ N+ GT P+SL+ + L + + NNLSG +P + GN L CG
Sbjct: 152 RLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPK--VSARTFKVIGNALICGPKAVS 209
Query: 200 ---------TLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGRHKGY 250
TLP S + + V + G+ + R+K
Sbjct: 210 NCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNK-- 267
Query: 251 KREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTK 310
++F DV + D ++ G LKRY+++EL+ AT++F+ KN+LG+GG+G VY+G L DGT
Sbjct: 268 --QIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTL 325
Query: 311 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 370
VAVKRL D GG+ FQ EVE IS+A+HRNLLRL GFC++ ER+LVYP+M N SVA
Sbjct: 326 VAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVAS 385
Query: 371 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 430
RL++ GEP LDW RK++A+G ARGL YLHE C+PKIIHRDVKAAN+LLDEDFEAVVG
Sbjct: 386 RLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 445
Query: 431 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490
DFGLAKL+D R ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TGQ+A+D
Sbjct: 446 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALD 505
Query: 491 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 550
F R + V +LD VKKL +E +L ++D++LN ++ E+E ++QVALLCTQ +P R
Sbjct: 506 FGRSAHQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHR 564
Query: 551 PAMSEVVRMLEGEGLAERWEEWQHVEVTRR---------QEYERLQRRFDWGEDSVYNQE 601
P MSEV++MLEG+GLAERWE Q+ + R++ D+ ++S E
Sbjct: 565 PKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSLVVE 624
Query: 602 AIELSGGR 609
AIELSG R
Sbjct: 625 AIELSGPR 632
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 609 | ||||||
| 224093748 | 611 | predicted protein [Populus trichocarpa] | 1.0 | 0.996 | 0.840 | 0.0 | |
| 356525465 | 610 | PREDICTED: probable LRR receptor-like se | 1.0 | 0.998 | 0.821 | 0.0 | |
| 118486735 | 611 | unknown [Populus trichocarpa] | 1.0 | 0.996 | 0.839 | 0.0 | |
| 356512695 | 610 | PREDICTED: probable LRR receptor-like se | 1.0 | 0.998 | 0.821 | 0.0 | |
| 224081132 | 606 | predicted protein [Populus trichocarpa] | 0.993 | 0.998 | 0.846 | 0.0 | |
| 449458289 | 612 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.991 | 0.806 | 0.0 | |
| 297811131 | 613 | leucine-rich repeat family protein [Arab | 0.998 | 0.991 | 0.794 | 0.0 | |
| 22326703 | 613 | putative LRR receptor-like serine/threon | 0.998 | 0.991 | 0.796 | 0.0 | |
| 8953410 | 605 | protein serine/threonine kinase-like pro | 0.993 | 1.0 | 0.8 | 0.0 | |
| 20260260 | 613 | protein serine/threonine kinase-like pro | 0.998 | 0.991 | 0.794 | 0.0 |
| >gi|224093748|ref|XP_002309974.1| predicted protein [Populus trichocarpa] gi|222852877|gb|EEE90424.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1043 bits (2696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/610 (84%), Positives = 552/610 (90%), Gaps = 1/610 (0%)
Query: 1 MMKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNV 60
M ++LVL A++L L LS+ QGDAL AL+ S+ VP+NQL+DWN NQV PCTW+NV
Sbjct: 2 MSLKMELVLAALVLAYLQSFVLSNLQGDALSALKLSMNVPDNQLKDWNPNQVTPCTWTNV 61
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
ICD++ +V SVTLS +N SGTLSP+IGVL+TL+TLTLKGNGITG IP+E GNL+SLTSLD
Sbjct: 62 ICDSNEHVISVTLSGINCSGTLSPKIGVLKTLNTLTLKGNGITGGIPKEFGNLTSLTSLD 121
Query: 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
L+NNRL G+IP SLGNLK+LQFLTL QNN SG IP+SL L +LI+I LDSNNLSGQIP
Sbjct: 122 LENNRLSGEIPSSLGNLKRLQFLTLGQNNLSGAIPESLAGLQNLINILLDSNNLSGQIPD 181
Query: 181 HLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLF 240
HLFQ+PKYNFTGN+LNC HSCES ++DSG S K K GII+G+VGG VL G L
Sbjct: 182 HLFQVPKYNFTGNHLNCSGPNLHSCESHNSDSGGSHKSKTGIIIGVVGGFTVLFLFGGLL 241
Query: 241 F-LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGK 299
F +CKGRHKGYKREVFVDVAGEVD+RIAFGQLKR+SWRELQLATDNFSEKN+LGQGGFGK
Sbjct: 242 FFVCKGRHKGYKREVFVDVAGEVDQRIAFGQLKRFSWRELQLATDNFSEKNILGQGGFGK 301
Query: 300 VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359
VY+GVLAD TK+AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLV
Sbjct: 302 VYKGVLADNTKIAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLV 361
Query: 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419
YPFMQNLSVAY LRE KP EPVLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV
Sbjct: 362 YPFMQNLSVAYCLRERKPEEPVLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 421
Query: 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML
Sbjct: 422 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 481
Query: 480 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVA 539
LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MIQVA
Sbjct: 482 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIQVA 541
Query: 540 LLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYN 599
LLCTQASPE+RPAMSEVVRMLEGEGLAERWEEWQHVEVTR QEYERLQRRFDWGEDSVYN
Sbjct: 542 LLCTQASPENRPAMSEVVRMLEGEGLAERWEEWQHVEVTRMQEYERLQRRFDWGEDSVYN 601
Query: 600 QEAIELSGGR 609
Q+AIELSGGR
Sbjct: 602 QDAIELSGGR 611
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356525465|ref|XP_003531345.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/610 (82%), Positives = 547/610 (89%), Gaps = 1/610 (0%)
Query: 1 MMKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNV 60
M + + V ++L CL L D QGDALFAL+ SL +QL DWNQNQVNPCTWS V
Sbjct: 1 MPVEMDFIFVLLLLGCLCSFVLPDTQGDALFALKISLNASAHQLTDWNQNQVNPCTWSRV 60
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
CD++NNV V+L+ M F+G L+PRIGVL+ L+ L+L+GNGITG IP+ELGNL+SL+ LD
Sbjct: 61 YCDSNNNVMQVSLAYMGFTGYLNPRIGVLKYLTALSLQGNGITGNIPKELGNLTSLSRLD 120
Query: 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
L+ N+L G+IP SLGNLKKLQFLTLSQNN SGTIP+SL +L LI++ LDSNNLSGQIP
Sbjct: 121 LEGNKLTGEIPSSLGNLKKLQFLTLSQNNLSGTIPESLASLPILINVLLDSNNLSGQIPE 180
Query: 181 HLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIV-LISGGLL 239
LF++PKYNFTGNNL+CG + CE+ + D GSS KPK G+IVGIV GL+V L GGL+
Sbjct: 181 QLFKVPKYNFTGNNLSCGASYHQPCETDNADQGSSHKPKTGLIVGIVIGLVVILFLGGLM 240
Query: 240 FFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGK 299
FF CKGRHKGY+REVFVDVAGEVDRRIAFGQL+R++WRELQ+ATDNFSEKNVLGQGGFGK
Sbjct: 241 FFGCKGRHKGYRREVFVDVAGEVDRRIAFGQLRRFAWRELQIATDNFSEKNVLGQGGFGK 300
Query: 300 VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359
VY+GVLAD TKVAVKRLTD+ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV
Sbjct: 301 VYKGVLADNTKVAVKRLTDYESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 360
Query: 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419
YPFMQNLSVAYRLREIKPGEPVLDW TRK+VALG ARGLEYLHEHCNPKIIHRDVKAANV
Sbjct: 361 YPFMQNLSVAYRLREIKPGEPVLDWPTRKQVALGTARGLEYLHEHCNPKIIHRDVKAANV 420
Query: 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML
Sbjct: 421 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 480
Query: 480 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVA 539
LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD NLNKNYNIQEVE MI+VA
Sbjct: 481 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDHNLNKNYNIQEVEMMIKVA 540
Query: 540 LLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYN 599
LLCTQA+PEDRP MSEVVRMLEGEGLAERWEEWQHVEV RRQEYERLQRRFDWGEDSVYN
Sbjct: 541 LLCTQATPEDRPPMSEVVRMLEGEGLAERWEEWQHVEVNRRQEYERLQRRFDWGEDSVYN 600
Query: 600 QEAIELSGGR 609
Q+AIELSGGR
Sbjct: 601 QDAIELSGGR 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118486735|gb|ABK95203.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/610 (83%), Positives = 551/610 (90%), Gaps = 1/610 (0%)
Query: 1 MMKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNV 60
M ++LVL A++L L LS+ QGDAL AL+ S+ VP+NQL+DWN NQV PCTW+NV
Sbjct: 2 MSLKMELVLAALVLAYLQSFVLSNLQGDALSALKLSMNVPDNQLKDWNPNQVTPCTWTNV 61
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
ICD++ +V SVTLS +N SGTLSP+IGVL+TL+TLTLKGNGITG IP+E GNL+SLTSLD
Sbjct: 62 ICDSNEHVISVTLSGINCSGTLSPKIGVLKTLNTLTLKGNGITGGIPKEFGNLTSLTSLD 121
Query: 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
L+NNRL G+IP SLGNLK+LQFLTL QNN SG IP+SL L +LI+I LDSNNLSGQIP
Sbjct: 122 LENNRLSGEIPSSLGNLKRLQFLTLGQNNLSGAIPESLAGLQNLINILLDSNNLSGQIPD 181
Query: 181 HLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLF 240
HLFQ+PKYNFTGN+LNC HSCES ++DSG S K K GII+G+VGG VL G L
Sbjct: 182 HLFQVPKYNFTGNHLNCSGPNLHSCESHNSDSGGSHKSKTGIIIGVVGGFTVLFLFGGLL 241
Query: 241 F-LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGK 299
F +CKGRHKGYKREVFVDVAGEVD+RIAFGQLKR+SWRELQLATDNFSEKN+LGQGGFGK
Sbjct: 242 FFVCKGRHKGYKREVFVDVAGEVDQRIAFGQLKRFSWRELQLATDNFSEKNILGQGGFGK 301
Query: 300 VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359
VY+GVLAD TK+AVKRLTD ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLV
Sbjct: 302 VYKGVLADNTKIAVKRLTDVESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLV 361
Query: 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419
YPFMQNLSVAY LRE KP EPVLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV
Sbjct: 362 YPFMQNLSVAYCLRERKPEEPVLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 421
Query: 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML
Sbjct: 422 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 481
Query: 480 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVA 539
LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MIQVA
Sbjct: 482 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIQVA 541
Query: 540 LLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYN 599
LLCTQASPE+RPAMSEVVRMLEGEGLAERWEEWQHVEVTR QEYERLQRRFDWGEDSVYN
Sbjct: 542 LLCTQASPENRPAMSEVVRMLEGEGLAERWEEWQHVEVTRMQEYERLQRRFDWGEDSVYN 601
Query: 600 QEAIELSGGR 609
Q+AIELSGGR
Sbjct: 602 QDAIELSGGR 611
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356512695|ref|XP_003525052.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/610 (82%), Positives = 547/610 (89%), Gaps = 1/610 (0%)
Query: 1 MMKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNV 60
M + + V ++L CL L D QGDALFAL+ SL +QL DWNQNQVNPCTWS V
Sbjct: 1 MPVEMDFIFVLLLLGCLCSFVLPDTQGDALFALKISLNASAHQLTDWNQNQVNPCTWSRV 60
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
CD++NNV V+L+ M F+G L+P IGVL+ L+ L+L+GNGITG IP+ELGNL+SL+ LD
Sbjct: 61 YCDSNNNVMQVSLAYMGFTGYLTPIIGVLKYLTALSLQGNGITGNIPKELGNLTSLSRLD 120
Query: 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
L++N+L G+IP SLGNLK+LQFLTLSQNN SGTIP+SL +L LI++ LDSNNLSGQIP
Sbjct: 121 LESNKLTGEIPSSLGNLKRLQFLTLSQNNLSGTIPESLASLPILINVLLDSNNLSGQIPE 180
Query: 181 HLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIV-LISGGLL 239
LF++PKYNFTGNNLNCG + CE+ + D GSS KPK G+IVGIV GL+V L GGLL
Sbjct: 181 QLFKVPKYNFTGNNLNCGASYHQPCETDNADQGSSHKPKTGLIVGIVIGLVVILFLGGLL 240
Query: 240 FFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGK 299
FF CKGRHK Y+REVFVDVAGEVDRRIAFGQL+R++WRELQ+ATDNFSEKNVLGQGGFGK
Sbjct: 241 FFWCKGRHKSYRREVFVDVAGEVDRRIAFGQLRRFAWRELQIATDNFSEKNVLGQGGFGK 300
Query: 300 VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359
VY+GVLAD TKVAVKRLTD+ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV
Sbjct: 301 VYKGVLADNTKVAVKRLTDYESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 360
Query: 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419
YPFMQNLSVAYRLRE+KPGEPVLDW TRKRVALG ARGLEYLHEHCNPKIIHRDVKAANV
Sbjct: 361 YPFMQNLSVAYRLRELKPGEPVLDWPTRKRVALGTARGLEYLHEHCNPKIIHRDVKAANV 420
Query: 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML
Sbjct: 421 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 480
Query: 480 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVA 539
LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL+AIVDRNLNKNYNIQEVE MIQVA
Sbjct: 481 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEAIVDRNLNKNYNIQEVEMMIQVA 540
Query: 540 LLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYN 599
LLCTQA+PEDRP MSEVVRMLEGEGLAERWEEWQHVEV RRQEYERLQRRFDWGEDSVYN
Sbjct: 541 LLCTQATPEDRPPMSEVVRMLEGEGLAERWEEWQHVEVNRRQEYERLQRRFDWGEDSVYN 600
Query: 600 QEAIELSGGR 609
Q+AIELSGGR
Sbjct: 601 QDAIELSGGR 610
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081132|ref|XP_002306304.1| predicted protein [Populus trichocarpa] gi|222855753|gb|EEE93300.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2592), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/606 (84%), Positives = 551/606 (90%), Gaps = 1/606 (0%)
Query: 5 VKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDN 64
++++ A+IL L LSD QGDAL+AL+ S+ +PNNQL DWNQNQVNPCTW+NVICD
Sbjct: 1 MEMIFAALILAFLQSFVLSDPQGDALYALKLSMNIPNNQLTDWNQNQVNPCTWTNVICDK 60
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124
SNNV SVTLS +N SG LSP IG LRTL+TLTLKGNGITG IP+E GNLSSLTSLDL+NN
Sbjct: 61 SNNVVSVTLSDINCSGILSPMIGALRTLTTLTLKGNGITGGIPKEFGNLSSLTSLDLENN 120
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
RL G+IP SLG+LKKLQFLTLSQNN SG IP+SL +L SLI+I LDSNNLSGQ+P HLFQ
Sbjct: 121 RLSGEIPSSLGDLKKLQFLTLSQNNLSGAIPESLASLESLINILLDSNNLSGQVPNHLFQ 180
Query: 185 IPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF-LC 243
IPKYNFTGN+LNCG H CES S DSG S K KIGIIVG+VGG ++L G L F +C
Sbjct: 181 IPKYNFTGNHLNCGGLNLHLCESYSGDSGGSHKSKIGIIVGVVGGFVILFLLGGLLFFVC 240
Query: 244 KGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRG 303
KGR KGY+RE+FVDVAGEVDRRIAFGQLKR++WRELQLATDNFSE+N+LGQGGFGKVY+G
Sbjct: 241 KGRRKGYRREIFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEENILGQGGFGKVYKG 300
Query: 304 VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363
VLAD TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFM
Sbjct: 301 VLADNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTTTERLLVYPFM 360
Query: 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 423
QNLSVAYRLRE KP EPVLDW TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE
Sbjct: 361 QNLSVAYRLRERKPEEPVLDWTTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 420
Query: 424 DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483
DFEAVVGDFGLAKL+DVRKTNVTTQVRGTMGHIAPEYLSTGKSS RTDVFGYGIMLLELV
Sbjct: 421 DFEAVVGDFGLAKLMDVRKTNVTTQVRGTMGHIAPEYLSTGKSSGRTDVFGYGIMLLELV 480
Query: 484 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCT 543
TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE MI+VALLCT
Sbjct: 481 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVEMMIKVALLCT 540
Query: 544 QASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAI 603
QASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR+EY RLQRRFD+GEDS+YNQ+AI
Sbjct: 541 QASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRREEYSRLQRRFDFGEDSLYNQDAI 600
Query: 604 ELSGGR 609
ELSGGR
Sbjct: 601 ELSGGR 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458289|ref|XP_004146880.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Cucumis sativus] gi|449519138|ref|XP_004166592.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g10290-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2591), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/610 (80%), Positives = 549/610 (90%), Gaps = 3/610 (0%)
Query: 1 MMKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNV 60
+++ ++ L+ ++L C +YLALSD+QGDAL+ALRT+L NQL DWN NQVNPCTWSNV
Sbjct: 5 LVRMGEVYLLILVLACYNYLALSDFQGDALYALRTTLNATANQLTDWNPNQVNPCTWSNV 64
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
IC N+V SV+LS+M F+GTLSPRIG +++LSTL L+GN I+GEIP++ GNL++L SLD
Sbjct: 65 IC-RGNSVISVSLSTMGFTGTLSPRIGSIKSLSTLILQGNYISGEIPKDFGNLTNLVSLD 123
Query: 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
L NN L G+IP SLGNLKKLQFLTLSQN +GTIPDSL+TL SLI++ LDSN+LSG IP
Sbjct: 124 LGNNSLTGQIPSSLGNLKKLQFLTLSQNRLTGTIPDSLSTLPSLINLLLDSNDLSGPIPQ 183
Query: 181 HLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIV-LISGGLL 239
LFQ+PK+NF+ N LNCG H+C S S +SGSS KPK+G+IVGI+ G V L+ G+L
Sbjct: 184 QLFQVPKFNFSANKLNCGGKSLHACASDSTNSGSSNKPKVGLIVGIIAGFTVALLLVGVL 243
Query: 240 FFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGK 299
FFL KGR+K YKREVFVDVAGEVDRRIAFGQLKR++WRELQLAT+NFSEKNVLGQGGFGK
Sbjct: 244 FFLSKGRYKSYKREVFVDVAGEVDRRIAFGQLKRFAWRELQLATENFSEKNVLGQGGFGK 303
Query: 300 VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359
VY+GVLADGTKVAVKRLTD+ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLV
Sbjct: 304 VYKGVLADGTKVAVKRLTDYESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLV 363
Query: 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419
YPFMQNLSVAYRLRE+KPGE VLDW TRKRVALG ARGLEYLHEHCNPKIIHRDVKAANV
Sbjct: 364 YPFMQNLSVAYRLRELKPGEAVLDWPTRKRVALGTARGLEYLHEHCNPKIIHRDVKAANV 423
Query: 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
LLDEDFEAVVGDFGLAKLVDVRKTNVTTQ+RGTMGHIAPEYLSTGKSSERTDVFGYGIML
Sbjct: 424 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQIRGTMGHIAPEYLSTGKSSERTDVFGYGIML 483
Query: 480 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVA 539
LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN NYNIQEVE MIQVA
Sbjct: 484 LELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-NYNIQEVEMMIQVA 542
Query: 540 LLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYN 599
LLCTQ +DRPAMS+VVRMLEGEGLAERWEEWQH+EVTRRQEYERLQRRF+WGEDS++
Sbjct: 543 LLCTQPCSDDRPAMSQVVRMLEGEGLAERWEEWQHLEVTRRQEYERLQRRFEWGEDSIHR 602
Query: 600 QEAIELSGGR 609
Q+AI+LSGGR
Sbjct: 603 QDAIQLSGGR 612
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811131|ref|XP_002873449.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297319286|gb|EFH49708.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2544), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/608 (79%), Positives = 531/608 (87%)
Query: 2 MKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVI 61
++ + + ++ L D QGDALFALR SLR NQL DWNQNQVNPCTWS VI
Sbjct: 6 LQKMAMAFTVLVFASLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVI 65
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
CD+ N V S+TLS MNFSGTLS RIG+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL
Sbjct: 66 CDDKNFVTSLTLSDMNFSGTLSSRIGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDL 125
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
++N+L G+IP ++GNLKKLQFLTLS+N +GTIP SLT L +L+++ LDSN+LSGQIP
Sbjct: 126 EDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPQSLTGLPNLLNLLLDSNSLSGQIPQS 185
Query: 182 LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF 241
LF+IPKYNFT NNL CG PH C S+ SG S KPK GII G+V G+ V++ G LLF
Sbjct: 186 LFEIPKYNFTANNLTCGGGQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVILFGILLFL 245
Query: 242 LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVY 301
CK RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY
Sbjct: 246 FCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVY 305
Query: 302 RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361
+GVL D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYP
Sbjct: 306 KGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 365
Query: 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 421
FMQNLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLL
Sbjct: 366 FMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLL 425
Query: 422 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 481
DEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE
Sbjct: 426 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 485
Query: 482 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL 541
LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALL
Sbjct: 486 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALL 545
Query: 542 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQE 601
CTQ SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+
Sbjct: 546 CTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQD 605
Query: 602 AIELSGGR 609
AIELSGGR
Sbjct: 606 AIELSGGR 613
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22326703|ref|NP_196591.2| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|264664527|sp|C0LGT1.1|Y5129_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g10290; Flags: Precursor gi|224589669|gb|ACN59366.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332004134|gb|AED91517.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2515), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/608 (79%), Positives = 533/608 (87%)
Query: 2 MKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVI 61
++ + + + CL D QGDALFALR SLR NQL DWNQNQVNPCTWS VI
Sbjct: 6 LQKMAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVI 65
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
CD+ N V S+TLS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL
Sbjct: 66 CDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDL 125
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
++N+L G+IP ++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP
Sbjct: 126 EDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQS 185
Query: 182 LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF 241
LF+IPKYNFT NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF
Sbjct: 186 LFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFL 245
Query: 242 LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVY 301
CK RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY
Sbjct: 246 FCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVY 305
Query: 302 RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361
+GVL D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYP
Sbjct: 306 KGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 365
Query: 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 421
FMQNLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLL
Sbjct: 366 FMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLL 425
Query: 422 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 481
DEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE
Sbjct: 426 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 485
Query: 482 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL 541
LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALL
Sbjct: 486 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALL 545
Query: 542 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQE 601
CTQ SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+
Sbjct: 546 CTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQD 605
Query: 602 AIELSGGR 609
AIELSGGR
Sbjct: 606 AIELSGGR 613
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|8953410|emb|CAB96685.1| protein serine/threonine kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 970 bits (2508), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/605 (80%), Positives = 531/605 (87%)
Query: 5 VKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDN 64
+ + + CL D QGDALFALR SLR NQL DWNQNQVNPCTWS VICD+
Sbjct: 1 MAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDD 60
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124
N V S+TLS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL++N
Sbjct: 61 KNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDN 120
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+L G+IP ++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP LF+
Sbjct: 121 QLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQSLFE 180
Query: 185 IPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCK 244
IPKYNFT NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF CK
Sbjct: 181 IPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFLFCK 240
Query: 245 GRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV 304
RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY+GV
Sbjct: 241 DRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGV 300
Query: 305 LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 364
L D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYPFMQ
Sbjct: 301 LPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQ 360
Query: 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424
NLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLLDED
Sbjct: 361 NLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDED 420
Query: 425 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
FEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT
Sbjct: 421 FEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 480
Query: 485 GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQ 544
GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EVE MIQVALLCTQ
Sbjct: 481 GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALLCTQ 540
Query: 545 ASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIE 604
SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+AIE
Sbjct: 541 GSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQDAIE 600
Query: 605 LSGGR 609
LSGGR
Sbjct: 601 LSGGR 605
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|20260260|gb|AAM13028.1| protein serine/threonine kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2506), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/608 (79%), Positives = 532/608 (87%)
Query: 2 MKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVI 61
++ + + + CL D QGDALFALR SLR NQL DWNQNQVNPCTWS VI
Sbjct: 6 LQKMAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVI 65
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
CD+ N V S+TLS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+ GNL+SLTSLDL
Sbjct: 66 CDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDL 125
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
++N+L G+IP ++GNLKKLQFLTLS+N +GTIP+SLT L +L+++ LDSN+LSGQIP
Sbjct: 126 EDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQS 185
Query: 182 LFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFF 241
LF+IPKYNFT NNLNCG PH C S+ SG S KPK GII G+V G+ V++ G LLF
Sbjct: 186 LFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFL 245
Query: 242 LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVY 301
CK RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY
Sbjct: 246 FCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVY 305
Query: 302 RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361
+GVL D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYP
Sbjct: 306 KGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 365
Query: 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 421
FMQNLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLL
Sbjct: 366 FMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLL 425
Query: 422 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 481
DEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE
Sbjct: 426 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 485
Query: 482 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL 541
LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL AIVD+NL+ Y +EV MIQVALL
Sbjct: 486 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVGMMIQVALL 545
Query: 542 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQE 601
CTQ SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+
Sbjct: 546 CTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQD 605
Query: 602 AIELSGGR 609
AIELSGGR
Sbjct: 606 AIELSGGR 613
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 609 | ||||||
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.998 | 0.991 | 0.700 | 5.8e-224 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.586 | 0.571 | 0.652 | 3.1e-151 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.586 | 0.568 | 0.649 | 1.1e-146 | |
| TAIR|locus:2160644 | 614 | AT5G63710 [Arabidopsis thalian | 0.852 | 0.845 | 0.538 | 1.9e-138 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.530 | 0.520 | 0.653 | 7.6e-133 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.530 | 0.537 | 0.631 | 1.1e-129 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.589 | 0.568 | 0.552 | 5.6e-126 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.582 | 0.556 | 0.563 | 1.7e-122 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.490 | 0.471 | 0.605 | 1.4e-116 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.919 | 0.864 | 0.424 | 8.4e-113 |
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2162 (766.1 bits), Expect = 5.8e-224, P = 5.8e-224
Identities = 426/608 (70%), Positives = 460/608 (75%)
Query: 2 MKSVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVI 61
++ + + + CL D QGDALFALR SLR NQL DWNQNQVNPCTWS VI
Sbjct: 6 LQKMAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVI 65
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEXXXXXXXXXXXX 121
CD+ N V S+TLS MNFSGTLS R+G+L L TLTLKGNGITGEIPE+
Sbjct: 66 CDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDL 125
Query: 122 XXXXXVGKIPPSLGNLKKLQFLTLSQNNFSGTIPXXXXXXXXXXXXXXXXXXXXGQIPVH 181
G+IP ++GNLKKLQFLTLS+N +GTIP GQIP
Sbjct: 126 EDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQS 185
Query: 182 LFQIPKYNFTGNNLNCGKTLPHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFF 241
LF+IPKYNFT NNLNCG PH F
Sbjct: 186 LFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFGILLFL 245
Query: 242 LCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVY 301
CK RHKGY+R+VFVDVAGEVDRRIAFGQLKR++WRELQLATDNFSEKNVLGQGGFGKVY
Sbjct: 246 FCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVY 305
Query: 302 RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361
+GVL D TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT TERLLVYP
Sbjct: 306 KGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYP 365
Query: 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 421
FMQNLS+A+RLREIK G+PVLDW TRKR+ALGAARG EYLHEHCNPKIIHRDVKAANVLL
Sbjct: 366 FMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLL 425
Query: 422 DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 481
DEDFEAVVGDFGLAKLVDVR+TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE
Sbjct: 426 DEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLE 485
Query: 482 LVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALL 541
LVTGQRAIDFSR REKRL AIVD+NL+ Y +EVE MIQVALL
Sbjct: 486 LVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVALL 545
Query: 542 CTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQE 601
CTQ SPEDRP MSEVVRMLEGEGLAERWEEWQ+VEVTRR E+ERLQRRFDWGEDS++NQ+
Sbjct: 546 CTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDSMHNQD 605
Query: 602 AIELSGGR 609
AIELSGGR
Sbjct: 606 AIELSGGR 613
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 3.1e-151, Sum P(2) = 3.1e-151
Identities = 233/357 (65%), Positives = 276/357 (77%)
Query: 253 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVA 312
++F DV E D + GQLKR+S RELQ+A+D FS KN+LG+GGFGKVY+G LADGT VA
Sbjct: 269 DIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVA 328
Query: 313 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL 372
VKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA L
Sbjct: 329 VKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 388
Query: 373 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432
RE P +P LDW TRKR+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDF
Sbjct: 389 RERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 448
Query: 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 492
GLAKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D +
Sbjct: 449 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLA 508
Query: 493 RXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 552
R +EK+L+ +VD +L NY +E+E +IQVALLCTQ SP +RP
Sbjct: 509 RLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPK 568
Query: 553 MSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRRFDWGEDSVYNQEAIELSGGR 609
MSEVVRMLEG+GLAE+W+EWQ VE+ R + DW DS YN A+ELSG R
Sbjct: 569 MSEVVRMLEGDGLAEKWDEWQKVEILREEIDLSPNPNSDWILDSTYNLHAVELSGPR 625
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 1.1e-146, Sum P(2) = 1.1e-146
Identities = 233/359 (64%), Positives = 275/359 (76%)
Query: 252 REVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV 311
+E F DV E D + GQLKR+S RELQ+ATD+FS KN+LG+GGFGKVY+G LADGT V
Sbjct: 271 QEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLV 330
Query: 312 AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYR 371
AVKRL + +PGG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA
Sbjct: 331 AVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 390
Query: 372 LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431
LRE P + L W R+++ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGD
Sbjct: 391 LRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 450
Query: 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 491
FGLA+L+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYGIMLLEL+TGQRA D
Sbjct: 451 FGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDL 510
Query: 492 SRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 551
+R +EK+L+ +VD +L NY EVE +IQVALLCTQ+SP +RP
Sbjct: 511 ARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERP 570
Query: 552 AMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQR-RFDWGEDSVYNQEAIELSGGR 609
MSEVVRMLEG+GLAE+W+EWQ VEV R QE E DW DS N A+ELSG R
Sbjct: 571 KMSEVVRMLEGDGLAEKWDEWQKVEVLR-QEVELSSHPTSDWILDSTDNLHAMELSGPR 628
|
|
| TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
Identities = 282/524 (53%), Positives = 342/524 (65%)
Query: 90 RTLSTLTLKGNGITGEIPEEXXXXXXXXXXXXXXXXXVGKIPPSLGNLKKLQFLTLSQNN 149
+++ L L +G TG + G +P SLGN+ LQ L LS N+
Sbjct: 92 QSVVALNLASSGFTGTLSPAITKLKFLVTLELQNNSLSGALPDSLGNMVNLQTLNLSVNS 151
Query: 150 FSGTIPXXXXXXXXXXXXXXXXXXXXGQIPVHLFQIPKYNFTGNNLNCGKTLPHXXXXXX 209
FSG+IP G IP F IP ++F+G L CGK+L
Sbjct: 152 FSGSIPASWSQLSNLKHLDLSSNNLTGSIPTQFFSIPTFDFSGTQLICGKSLNQPCSSSS 211
Query: 210 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFFLCKG-RHKGYKREVFVDVAGEVDRRIAF 268
+ R + K ++F DVAGE DR+I+F
Sbjct: 212 RLPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISF 271
Query: 269 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF 328
GQLKR+S RE+QLATD+F+E N++GQGGFGKVYRG+L D TKVAVKRL D+ SPGG+AAF
Sbjct: 272 GQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAF 331
Query: 329 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 388
QRE+++ISVAVH+NLLRLIGFCTT +ER+LVYP+M+NLSVAYRLR++K GE LDW TRK
Sbjct: 332 QREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRK 391
Query: 389 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
RVA G+A GLEYLHEHCNPKIIHRD+KAAN+LLD +FE V+GDFGLAKLVD T+VTTQ
Sbjct: 392 RVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQ 451
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXX 508
VRGTMGHIAPEYL TGKSSE+TDVFGYGI LLELVTGQRAIDFSR
Sbjct: 452 VRGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKK 511
Query: 509 XXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG-LAE 567
RE+RL IVD NL Y+ +EVET++QVALLCTQ SPEDRPAMSEVV+ML+G G LAE
Sbjct: 512 LLREQRLRDIVDSNLT-TYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAE 570
Query: 568 RWEEWQHVEVTRRQEYERLQRR-FDWGED-SVYNQEAIELSGGR 609
+W EW+ +E R +E L W E+ + +QE+I LS R
Sbjct: 571 KWTEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 7.6e-133, Sum P(2) = 7.6e-133
Identities = 211/323 (65%), Positives = 249/323 (77%)
Query: 255 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 314
F DV E D + GQLKR++ REL +ATDNFS KNVLG+GGFGKVY+G LADG VAVK
Sbjct: 263 FFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVK 322
Query: 315 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 374
RL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 323 RLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 382
Query: 375 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434
G P LDW RK +ALG+ARGL YLH+HC+ KIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 383 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGL 442
Query: 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 494
AKL++ ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +R
Sbjct: 443 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 502
Query: 495 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
+EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MS
Sbjct: 503 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 562
Query: 555 EVVRMLEGEGLAERWEEWQHVEV 577
EVVRMLEG+GLAERWEEWQ E+
Sbjct: 563 EVVRMLEGDGLAERWEEWQKEEM 585
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 1.1e-129, Sum P(2) = 1.1e-129
Identities = 204/323 (63%), Positives = 246/323 (76%)
Query: 255 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 314
F+DV E D + GQ KR+S REL +AT+ FS++NVLG+G FG +Y+G LAD T VAVK
Sbjct: 244 FLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVK 303
Query: 315 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 374
RL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 304 RLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 363
Query: 375 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434
G P LDW RK +ALG+ARGL YLH+HC+ KIIH DVKAAN+LLDE+FEAVVGDFGL
Sbjct: 364 RPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGL 423
Query: 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRX 494
AKL++ ++VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQ+A D +R
Sbjct: 424 AKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARL 483
Query: 495 XXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
+EK+L+++VD L Y EVE +IQ+ALLCTQ+S +RP MS
Sbjct: 484 ANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMS 543
Query: 555 EVVRMLEGEGLAERWEEWQHVEV 577
EVVRMLEG+GLAERWEEWQ E+
Sbjct: 544 EVVRMLEGDGLAERWEEWQKEEM 566
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 5.6e-126, Sum P(2) = 5.6e-126
Identities = 205/371 (55%), Positives = 269/371 (72%)
Query: 250 YKR--EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD 307
Y+R ++F DV + D ++ G LKRY+++EL+ AT++F+ KN+LG+GG+G VY+G L D
Sbjct: 263 YRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHLND 322
Query: 308 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367
GT VAVKRL D GG+ FQ EVE IS+A+HRNLLRL GFC++ ER+LVYP+M N S
Sbjct: 323 GTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGS 382
Query: 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427
VA RL++ GEP LDW RK++A+G ARGL YLHE C+PKIIHRDVKAAN+LLDEDFEA
Sbjct: 383 VASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEA 442
Query: 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
VVGDFGLAKL+D R ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TGQ+
Sbjct: 443 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502
Query: 488 AIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASP 547
A+DF R +E +L ++D++LN ++ E+E ++QVALLCTQ +P
Sbjct: 503 ALDFGRSAHQKGVMLDWVKKLH-QEGKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNP 561
Query: 548 EDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR---------QEYERLQRRFDWGEDSVY 598
RP MSEV++MLEG+GLAERWE Q+ + R++ D+ ++S
Sbjct: 562 SHRPKMSEVMKMLEGDGLAERWEATQNGTGEHQPPPLPPGMVSSSPRVRYYSDYIQESSL 621
Query: 599 NQEAIELSGGR 609
EAIELSG R
Sbjct: 622 VVEAIELSGPR 632
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 208/369 (56%), Positives = 264/369 (71%)
Query: 250 YKREVFVDVA-GEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADG 308
+ + F DV G ++ G L+R+ +RELQ+AT+NFS KN+LG+GG+G VY+G+L D
Sbjct: 275 HNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDS 334
Query: 309 TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368
T VAVKRL D + GG+ FQ EVEMIS+AVHRNLLRL GFC T TE+LLVYP+M N SV
Sbjct: 335 TVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSV 394
Query: 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428
A R++ +PVLDW RKR+A+GAARGL YLHE C+PKIIHRDVKAAN+LLD+ EAV
Sbjct: 395 ASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAV 450
Query: 429 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 488
VGDFGLAKL+D + ++VTT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLELVTGQRA
Sbjct: 451 VGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRA 510
Query: 489 IDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNL--NKNYNIQEVETMIQVALLCTQAS 546
+F + +EK+L+ +VD+ L K+Y+ E++ M++VALLCTQ
Sbjct: 511 FEFGKAANQKGVMLDWVKKIH-QEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYL 569
Query: 547 PEDRPAMSEVVRMLEGEGLAERWEEWQHVEVT-----RRQEYERLQRRF-DWGEDSVYNQ 600
P RP MSEVVRMLEG+GLAE+WE Q + R E R+ D +DS
Sbjct: 570 PGHRPKMSEVVRMLEGDGLAEKWEASQRSDSVSKCSNRINELMSSSDRYSDLTDDSSLLV 629
Query: 601 EAIELSGGR 609
+A+ELSG R
Sbjct: 630 QAMELSGPR 638
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
Identities = 184/304 (60%), Positives = 230/304 (75%)
Query: 266 IAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD 325
+ G L+ +++REL +ATD FS K++LG GGFG VYRG DGT VAVKRL D G+
Sbjct: 279 LGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGN 338
Query: 326 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 385
+ F+ E+EMIS+AVHRNLLRLIG+C + +ERLLVYP+M N SVA RL+ +P LDW
Sbjct: 339 SQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWN 394
Query: 386 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445
TRK++A+GAARGL YLHE C+PKIIHRDVKAAN+LLDE FEAVVGDFGLAKL++ ++V
Sbjct: 395 TRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHV 454
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXX 505
TT VRGT+GHIAPEYLSTG+SSE+TDVFG+GI+LLEL+TG RA++F +
Sbjct: 455 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWV 514
Query: 506 XXXXXREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 565
+E +++ +VDR L Y+ EV M+QVALLCTQ P RP MSEVV+MLEG+GL
Sbjct: 515 RKLH-KEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGL 573
Query: 566 AERW 569
AERW
Sbjct: 574 AERW 577
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
Identities = 247/582 (42%), Positives = 330/582 (56%)
Query: 3 KSVKL---VLVAIILDCLHYLALSDY----QGDALFALRTSLRVPNNQLRDWNQNQVNPC 55
K++K+ +L + + C L LS + +AL ++R +L P+ L +W++ V+PC
Sbjct: 7 KTMKIQIHLLYSFLFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPC 66
Query: 56 TWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEXXXXXX 115
+W+ + C N V + S + SG LS IG L L ++L+ N I+G+IP E
Sbjct: 67 SWAMITCSPDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPK 126
Query: 116 XXXXXXXXXXXVGKIPPSLGNLKKLQFLTLSQNNFSGTIPXXXXXXXXXXXXXXXXXXXX 175
G IP S+ L LQ+L L+ N+ SG P
Sbjct: 127 LQTLDLSNNRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLS 186
Query: 176 GQIPVHLFQIPKYNFTGNNLNCGKTLPHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 235
G +P F +N GN L C P
Sbjct: 187 GPVPK--FPARTFNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRRSNRLAIALSV 244
Query: 236 XXXX---FFLCKGRHKGYKRE----VFVDVAGEVDRRI-AFGQLKRYSWRELQLATDNFS 287
L G Y+++ + +++ + + + G L+ +++REL + TD FS
Sbjct: 245 SLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFS 304
Query: 288 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
KN+LG GGFG VYRG L DGT VAVKRL D GD+ F+ E+EMIS+AVH+NLLRLI
Sbjct: 305 SKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLI 364
Query: 348 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
G+C T ERLLVYP+M N SVA +L+ +P LDW RKR+A+GAARGL YLHE C+P
Sbjct: 365 GYCATSGERLLVYPYMPNGSVASKLKS----KPALDWNMRKRIAIGAARGLLYLHEQCDP 420
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 467
KIIHRDVKAAN+LLDE FEAVVGDFGLAKL++ ++VTT VRGT+GHIAPEYLSTG+SS
Sbjct: 421 KIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSS 480
Query: 468 ERTDVFGYGIMLLELVTGQRAIDFSRXXXXXXXXXXXXXXXXXREKRLDAIVDRNLNKNY 527
E+TDVFG+GI+LLEL+TG RA++F + E +++ ++DR L NY
Sbjct: 481 EKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEWVRKLH-EEMKVEELLDRELGTNY 539
Query: 528 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERW 569
+ EV M+QVALLCTQ P RP MSEVV MLEG+GLAERW
Sbjct: 540 DKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGDGLAERW 581
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGX1 | Y5524_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7798 | 0.9901 | 0.9934 | no | no |
| C0LGT1 | Y5129_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7960 | 0.9983 | 0.9918 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_VII0470 | SubName- Full=Putative uncharacterized protein; (611 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 609 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-45
Identities = 82/288 (28%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 290 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LG+G FG+VY+G L T+VAVK L + S F +E ++ H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 346 LIGFCTTPTERLLVYPFMQN---LSV--AYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
L+G CT LV +M+ L R P + L A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---A 457
L K +HRD+ A N L+ ED + DFGL++ V G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK---LEREK 513
PE L G + ++DV+ +G++L E+ T G + + +L++++K L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGA-----TPYPGLSNEEVLEYLRKGYRLPKPE 230
Query: 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + ++ L C Q PEDRP SE+V LE
Sbjct: 231 YCP----------------DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 78/276 (28%), Positives = 126/276 (45%), Gaps = 29/276 (10%)
Query: 291 VLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LG+G FG+VY+G L +VAVK L + S F RE ++ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
L+G CT ++V +M + LR K L AL ARG+EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 465
IHRD+ A N L+ E+ + DFGL++ + + + +APE L GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 466 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524
+ ++DV+ +G++L E+ T G+ + + + +L+++KK R +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEE--PYPGMSNAE---VLEYLKKGYRLPKPPNCPPE--- 232
Query: 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+ ++ L C PEDRP SE+V +L
Sbjct: 233 ----------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 6e-44
Identities = 138/531 (25%), Positives = 237/531 (44%), Gaps = 89/531 (16%)
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124
S + ++ LS FSG + ++G L L L L N ++GEIP+EL + L SLDL +N
Sbjct: 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HL 182
+L G+IP S + L L LSQN SG IP +L + SL+ + + N+L G +P
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593
Query: 183 FQIPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKKP---------KIGIIVGIVGGLIVL 233
I GN CG D+ S P I +G +VL
Sbjct: 594 LAINASAVAGNIDLCG-----------GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVL 642
Query: 234 ISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRY-----SWRELQLATDNFS- 287
F +GR+ +LKR +W ELQ S
Sbjct: 643 ALVAFGFVFIRGRNNL--------------------ELKRVENEDGTW-ELQFFDSKVSK 681
Query: 288 ------------EKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFES-PGGDAAFQREVE 333
E+NV+ +G G Y+G + +G + VK + D S P + A +++
Sbjct: 682 SITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ 741
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
H N+++LIG C + L++ +++ +++ LR L W R+++A+G
Sbjct: 742 ------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIG 788
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
A+ L +LH C+P ++ ++ +++D E + L L+ +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS----- 842
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513
++APE T +E++D++G+G++L+EL+TG+ D E +++ + +
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDC 899
Query: 514 RLDAIVDRNLNKNYNIQE---VETMIQVALLCTQASPEDRPAMSEVVRMLE 561
LD +D ++ + ++ + VE M +AL CT P RP ++V++ LE
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 289 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
LG+G FG+VY+G L +VAVK L + S F RE ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLH 402
++L+G CT +V +M+ L ++ P L AL ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGD----LLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APE 459
IHRD+ A N L+ E+ + DFGL++ + RG I APE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR---KRGGKLPIRWMAPE 173
Query: 460 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
L GK + ++DV+ +G++L E+ T G++ + + E+ +L+++K R +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQ--PYPGMSNEE---VLEYLKNGYRLPQPPNC 228
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+ + L C PEDRP SE+V +L
Sbjct: 229 PPE-------------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 9e-43
Identities = 71/199 (35%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG G FG VY+ G VAVK L E D +RE+ ++ H N++RLI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
LV + + + L L K++AL RGLEYLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS 467
IIHRD+K N+LLDE+ + DFGLAK + +++TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 468 ERTDVFGYGIMLLELVTGQ 486
+ DV+ G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 89/284 (31%), Positives = 132/284 (46%), Gaps = 45/284 (15%)
Query: 291 VLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LG+G FG+VY+G L TKVAVK L + S F E ++ H N++R
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
L+G CT +V +M + LR K GE L ++AL A+G+EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEK-LTLKDLLQMALQIAKGMEYLESK- 121
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLS 462
+HRD+ A N L+ E+ + DFGL++ D+ + + + G I APE L
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 463 TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
GK + ++DV+ +G++L E+ T G+ + + E +VL + LE RL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGE--QPYPGMSNE-EVL-----ELLEDGYRLPR---- 225
Query: 522 NLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+N Y + M L C PEDRP SE+V L
Sbjct: 226 --PENCPDELYEL-----M----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 66/194 (34%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
LG+GGFG VY G KVA+K + +S RE+E++ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
LV + + S+ L+E + L R+ L GLEYLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 411 HRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSSE 468
HRD+K N+LLD D + + DFGL+KL+ ++ + GT ++APE L G SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 469 RTDVFGYGIMLLEL 482
++D++ G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 286 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
+ LG+G FGKVY G VA+K + + RE++++ H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
RL + LV + + + L++ L + LEYLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSK 116
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 464
I+HRD+K N+LLDED + DFGLA+ +D +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 465 KSSERTDVFGYGIMLLELVTGQ 486
+ D++ G++L EL+TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 290 NVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
+LG+G FG VY + D G +AVK + +S A +RE+ ++S H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 348 GFCTTPTER-LLVY-PFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEH 404
G + L ++ ++ S++ L++ EPV+ ++ GL YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKYTRQILEGLAYLHSN 120
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVRGTMGHIAPEYLST 463
I+HRD+K AN+L+D D + DFG AK + D+ T VRGT +APE +
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 464 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 502
+ D++ G ++E+ TG+ +S L L
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 286 FSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
F +G+GGFG+VY+ G +VA+K + ES E++++ H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHE 403
+ G E +V F S L+++ K L V +GLEYLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
+ IIHRD+KAAN+LL D E + DFGL+ + K T GT +APE ++
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVING 171
Query: 464 GKSSERTDVFGYGIMLLELVTGQ 486
+ D++ GI +EL G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 37/277 (13%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G+G FG V G G KVAVK L D +S A F E +++ H NL++L+G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQA-FLAEASVMTTLRHPNLVQLLG 67
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+V +M S+ LR G V+ + AL G+EYL E
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
+HRD+ A NVL+ ED A V DFGLAK + + V+ T APE L K S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528
++DV+ +GI+L E+ + R + R+ +D ++ HV+ K Y
Sbjct: 179 KSDVWSFGILLWEIYSFGRV-PYPRIPLKD---VVPHVE-----------------KGYR 217
Query: 529 IQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 561
++ E + +V C + P RP ++ L
Sbjct: 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 73/218 (33%), Positives = 100/218 (45%), Gaps = 55/218 (25%)
Query: 30 LFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASV------------------ 71
L + ++S+ P L +WN + + C W + C+NS+ V S+
Sbjct: 34 LLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRL 92
Query: 72 -------------------------------TLSSMNFSGTLSPRIGVLRTLSTLTLKGN 100
LS+ NF+G++ PR G + L TL L N
Sbjct: 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI-PR-GSIPNLETLDLSNN 150
Query: 101 GITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 160
++GEIP ++G+ SSL LDL N LVGKIP SL NL L+FLTL+ N G IP L
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 161 LSSLISIQLDSNNLSGQIPVHLFQIPKYN---FTGNNL 195
+ SL I L NNLSG+IP + + N NNL
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
|
Length = 968 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 89/284 (31%), Positives = 135/284 (47%), Gaps = 39/284 (13%)
Query: 290 NVLGQGGFGKVYRGVLADG----TKVAVK---RLTDFESPGGDAAFQREVEMISVAVHRN 342
V+G+G FG VY G L D AVK R+TD E F +E ++ H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV---EQFLKEGIIMKDFSHPN 57
Query: 343 LLRLIGFCTTPTE--RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
+L L+G C P+E L+V P+M++ + +R V D + L A+G+EY
Sbjct: 58 VLSLLGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEY 113
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHIA 457
L + K +HRD+ A N +LDE F V DFGLA+ + + + T + + +A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
E L T K + ++DV+ +G++L EL+T + A + DV D L + +RL
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYP------DVDSFDITVYLLQGRRL-- 221
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L Y + + +V L C PE RP SE+V +E
Sbjct: 222 -----LQPEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 60/133 (45%), Positives = 79/133 (59%), Gaps = 14/133 (10%)
Query: 71 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI 130
+TL+S G + +G +++L + L N ++GEIP E+G L+SL LDL N L G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 131 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP----------- 179
P SLGNLK LQ+L L QN SG IP S+ +L LIS+ L N+LSG+IP
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 180 VHLFQIPKYNFTG 192
+HLF NFTG
Sbjct: 313 LHLFS---NNFTG 322
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 24/285 (8%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAA-FQREVE-MISVAVHR 341
++ LG+G FG+VY D VA+K L ES + F RE++ + S+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N+++L F LV ++ S+ L++I P+ + + LEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILAQILSALEYL 117
Query: 402 HEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVR-----GTMGH 455
H IIHRD+K N+LLD D + DFGLAKL+ + + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 456 IAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512
+APE L S +S +D++ GI L EL+TG + + L + +L
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTP 233
Query: 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557
L+ + + + P++R + S +
Sbjct: 234 SLA-----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 40/283 (14%)
Query: 290 NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
V+G G FG+V RG L K VA+K L S F E ++ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
L G T +++ +M+N S+ LRE + + G A G++YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-----VRGTMGHIAPEY 460
+HRD+ A N+L++ + V DFGL++ ++ + TT+ +R T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 461 LSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
++ K + +DV+ +GI++ E+++ G+R D S DV+ K +E RL
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS----NQDVI-----KAVEDGYRLPPP 230
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+D + Q+ L C Q +RP S++V L+
Sbjct: 231 MDCP----------SALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 75/291 (25%), Positives = 137/291 (47%), Gaps = 38/291 (13%)
Query: 290 NVLGQGGFGKVYRG---VLADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
LG+G FGKV L D T +VAVK L + F+RE+E++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 345 RLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+ G C P R L+ ++ + S+ L+ + ++ + +G++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLG 126
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHIAPEY 460
+ IHRD+ A N+L++ + + DFGLAK++ K + G + APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAI-----DFSRL--EEEDDVLLLDHVKKLEREK 513
L T K S +DV+ +G+ L EL T +F R+ + +++ ++ L+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 514 RL---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
RL + D EV +++ LC +A P+DRP+ ++++ +++
Sbjct: 244 RLPRPPSCPD----------EVYDLMK---LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 43/240 (17%)
Query: 291 VLGQGGFGKVYRGV---LADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
VLG G FG VY+GV + K VA+K L + SP + E +++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA----------A 395
L+G C + L+ M P +LD+V + +G+ A
Sbjct: 74 LLGICLSSQ-VQLITQLM-------------PLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
+G+ YL E +++HRD+ A NVL+ + DFGLAKL+DV + G
Sbjct: 120 KGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVP 174
Query: 456 I---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 511
I A E + + ++DV+ YG+ + EL+T G + + E + D ++K ER
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G FG VY+GVL T+VAVK R T P F +E E++ H N+++LIG
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
C +V + S+ LR+ K V + +++L AA G+EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL---QMSLDAAAGMEYLESKN---C 114
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTG 464
IHRD+ A N L+ E+ + DFG+++ + V + I APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 465 KSSERTDVFGYGIMLLELVTG 485
+ + +DV+ YGI+L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 51/285 (17%)
Query: 292 LGQGGFGKVYRGV--LADGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
LG G FG V +GV + G +VAVK L G F RE +++ H ++RLI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 348 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------VALGAARGL 398
G C P M + E+ P P+L ++ ++R +A A G+
Sbjct: 63 GVCKGE-------PLML-------VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVRGTMGHI 456
YL +HRD+ A NVLL +A + DFG+++ + TT R +
Sbjct: 109 AYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
APE ++ GK S ++DV+ YG+ L E + G + + ++ + + +L+ ++L R +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPRPEEC 223
Query: 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+ + + L C + PEDRP SE+
Sbjct: 224 P----------------QEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 75/286 (26%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 292 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LGQG FG VY G+ T+VA+K + + S F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE---PVLDWVTRKRV---ALGAARGLE 399
L+G +T L+V M + LR +P P L T ++ A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI--- 456
YL K +HRD+ A N ++ ED +GDFG+ + D+ +T+ + + +
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWM 188
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
APE L G + ++DV+ +G++L E+ T L E+ + L E+ L
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQP-------YQGLSNEEVLK 232
Query: 517 AIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++D L+ N + ++++ +C Q +P+ RP E+V L+
Sbjct: 233 FVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLL 344
F+ + LG G FG+V+ G+ + +VA+K L +D D FQ+EV+ + H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
L C+ ++ M+ S+ LR P VL + +A A G+ YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTT-QVRGTMGHIAPEYL 461
IHRD+ A N+L+ ED V DFGLA+L+ DV ++ + T APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176
Query: 462 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
S G S ++DV+ +GI+L E+ T GQ + + + + + ++ + +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQ--VPYPGMNNHEVYDQITAGYRMPCPAKCPQEI- 233
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRP 551
Y I L C A PEDRP
Sbjct: 234 ------YKIM---------LECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRN 342
N+ +++G+G FG VY+G+ L G VA+K+++ + + +E++++ H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-----VLDWVTRKRVALGAARG 397
+++ IG T ++ + +N S+ + IK P V +V + +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLR---QIIKKFGPFPESLVAVYVYQ------VLQG 111
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHI 456
L YLHE +IHRD+KAAN+L +D + DFG+A KL DV K V GT +
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
APE + +S +D++ G ++EL+TG
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 290 NVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
N +G G FGKVY V L G +AVK R+ D P E++++ + H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
G R VY FM+ S L E+ +LD + L GL YLH H
Sbjct: 65 YG---VEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG---HIAPEYLST 463
I+HRD+K AN+ LD + +GDFG A + T + +V+ G ++APE ++
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 464 GKSSER---TDVFGYGIMLLELVTGQRAIDFSRLEEE 497
GK D++ G ++LE+ TG+R +S L+ E
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 87/295 (29%), Positives = 136/295 (46%), Gaps = 52/295 (17%)
Query: 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQ-- 329
WR+ +L LG G FG VY G+ L DG AVK L D G +A Q
Sbjct: 1 RWRKGEL----------LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE 50
Query: 330 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLREIKP-GEPVLDWV 385
+E+ ++S H N+++ +G T E +Y F++ + S+A L++ EPV+
Sbjct: 51 QEIALLSKLQHPNIVQYLG---TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY 107
Query: 386 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445
TR+ + GLEYLH + +HRD+K AN+L+D + + DFG+AK V
Sbjct: 108 TRQILL-----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFS 156
Query: 446 TTQ-VRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503
+ +G+ +APE + G D++ G +LE+ TG+ +S+LE V
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVF-- 212
Query: 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
K+ R K L I D ++ + L C Q P RP +E++
Sbjct: 213 ----KIGRSKELPPIPDHLSDEAKDF---------ILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-22
Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 42/228 (18%)
Query: 29 ALFALRTSLRVPNNQLR-DWNQNQVNPCT-----WSNVICDNSNNVASVTLSSMNFSGTL 82
AL L++SL +P LR WN + PC WS C F T
Sbjct: 376 ALQTLKSSLGLP---LRFGWNGD---PCVPQQHPWSGADC--------------QFDSTK 415
Query: 83 SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142
+ L L G+ G IP ++ L L S++L N + G IPPSLG++ L+
Sbjct: 416 GKWF-----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP----KYNFTGNNLNCG 198
L LS N+F+G+IP+SL L+SL + L+ N+LSG++P L +NFT N CG
Sbjct: 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
Query: 199 KTLPHSCESSSNDSGSSKKPKIGIIVGIVGGLIVLISGGLLFFLCKGR 246
+C S KIGI G+ + L+ + K R
Sbjct: 531 IPGLRACGPH-----LSVGAKIGIAFGVSVAFLFLVICAM--CWWKRR 571
|
Length = 623 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 8e-22
Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 39/281 (13%)
Query: 289 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
K+ LG G +G+VY GV VAVK L + + F +E ++ H NL++L+
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68
Query: 348 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
G CT ++ FM ++ LRE ++ V +A + +EYL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK--- 123
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 464
IHRD+ A N L+ E+ V DFGL++L+ + T G I APE L+
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 465 KSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
K S ++DV+ +G++L E+ T G ID S++ E LL+ ++ER + V
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKGYRMERPEGCPPKV- 234
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E M C Q +P DRP+ +E+ + E
Sbjct: 235 -----------YELMRA----CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 61/166 (36%), Positives = 82/166 (49%), Gaps = 17/166 (10%)
Query: 21 ALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVIC----DNSNNVASVTLSSM 76
LS D +F +SLR N N N ++ D SNN+
Sbjct: 104 QLSGPIPDDIFTTSSSLRYLNLS----NNNFTGSIPRGSIPNLETLDLSNNM-------- 151
Query: 77 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 136
SG + IG +L L L GN + G+IP L NL+SL L L +N+LVG+IP LG
Sbjct: 152 -LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 137 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
+K L+++ L NN SG IP + L+SL + L NNL+G IP L
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISV 337
D K LG+G FGKV+ G D VAVK L + S F+RE E+++
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE--------IKPGEPV--LDWVTR 387
H N+++ G CT ++V+ +M++ + LR P P+ L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 388 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
++A+ A G+ YL +HRD+ N L+ D +GDFG+++ DV T+
Sbjct: 125 LQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDY-Y 178
Query: 448 QVRG-TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 484
+V G TM I PE + K + +DV+ +G++L E+ T
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 349
LG G FG+V+ G TKVAVK L PG AF +E +++ H L++L
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 350 CTTPTERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGA--ARGLEYLHEH 404
C+ +V +M S+ L+ K P L V + A A G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-------VDMAAQIAEGMAYLESR 122
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 464
IHRD+ A N+L+ E+ + DFGLA+L++ + + + APE + G
Sbjct: 123 ---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG 179
Query: 465 KSSERTDVFGYGIMLLELVT 484
+ + ++DV+ +GI+L E+VT
Sbjct: 180 RFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 291 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
VLGQG G VY+ G A+K++ RE++ + +++ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
E +V +M S+A L+++ EPVL ++ R+ +GL+YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQ-----ILKGLDYLHT--KRH 120
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
IIHRD+K +N+L++ E + DFG++K+++ T V GT+ +++PE + S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 469 RTDVFGYGIMLLELVTGQ 486
D++ G+ LLE G+
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 7e-21
Identities = 66/292 (22%), Positives = 128/292 (43%), Gaps = 54/292 (18%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAVHR 341
+ +G+G FGKVY +DG +K L++ + A EV+++ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHP 59
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEP-----VLDWVTRKRVALGAA 395
N+++ + +V + ++ ++++ K G+P +LDW + + L
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA-- 115
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
L+YLH KI+HRD+K N+ L + +GDFG++K++ ++ V GT +
Sbjct: 116 --LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYY 169
Query: 456 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 512
++PE L K + ++D++ G +L EL T + + L E L + K +
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKGQYPPI 223
Query: 513 -----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
L +V L K+ PE+RP+++++++
Sbjct: 224 PSQYSSELRNLVSSLLQKD--------------------PEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-20
Identities = 51/111 (45%), Positives = 69/111 (62%)
Query: 77 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 136
N SG + IG L +L+ L L N +TG IP LGNL +L L L N+L G IPPS+ +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 137 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
L+KL L LS N+ SG IP+ + L +L + L SNN +G+IPV L +P+
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 349
LG G FG+V+ G+ + T VAVK L PG F E +++ H L++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
CT +V M+ S+ L+ L +A A G+ YL
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGR--ALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 469
IHRD+ A NVL+ E+ V DFGLA+++ + + APE + S +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 470 TDVFGYGIMLLELVT 484
+DV+ +GI+L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 69/293 (23%)
Query: 291 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+LG+G FG+V++G L D T VAVK + F E ++ H N+++LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK----------RVALGAARGLEY 400
T+R +Y M E+ PG L ++ +K + AL AA G+ Y
Sbjct: 62 ---TQRQPIYIVM----------ELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY 108
Query: 401 LH-EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIA 457
L ++C IHRD+ A N L+ E+ + DFG+++ D + ++ Q+ + A
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTA 162
Query: 458 PEYLSTGKSSERTDVFGYGIMLLEL----------VTGQRAIDFSRLEEEDDVLLLDHVK 507
PE L+ G+ S +DV+ YGI+L E +T Q+A
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------------------- 203
Query: 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
RE+ V++ + + + + +V C PE+RP SE+ + L
Sbjct: 204 ---REQ-----VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 290 NVLGQGGFGKVYRGV-LADGTKVAVKRL------TDFESPGGDAAFQREVEMISVAVHRN 342
V+G G VY + L + KVA+KR+ T + ++EV+ +S H N
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE------LRKEVQAMSQCNHPN 60
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+++ E LV P++ S+ ++ P LD V +GLEYLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH 119
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAP 458
+ IHRD+KA N+LL ED + DFG LA D + T V GT +AP
Sbjct: 120 SN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAP 175
Query: 459 EYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL---DHVKKLEREKR 514
E + + D++ +GI +EL TG A +S+ VL+L + LE
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATG--AAPYSKYPPM-KVLMLTLQNDPPSLETGAD 232
Query: 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
K Y+ + MI LC Q P RP E+++
Sbjct: 233 ---------YKKYS-KSFRKMIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 82/294 (27%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 292 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 344
LG+G FG+V + + VAVK L D + + E+EM+ + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 345 RLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGE---PVLDWVTRKRV--------A 391
L+G CT P ++ Y NL R R PGE P + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR-PPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQ 448
ARG+E+L K IHRD+ A NVL+ ED + DFGLA+ D+ + TT
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTN 193
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 507
R + +APE L + ++DV+ +G++L E+ T G +EE L +K
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----LFKLLK 248
Query: 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ R +++ N QE+ ++ C P RP ++V L+
Sbjct: 249 EGYR-------MEKPQNCT---QELYHLM---RDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
+G G FG V+ G + KVA+K T E + F E +++ H L++L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 411
+ LV+ FM++ ++ LR + T + L G+ YL +IH
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 412 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTD 471
RD+ A N L+ E+ V DFG+ + V + +T + + +PE S K S ++D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 472 VFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQE 531
V+ +G+++ E+ FS K E R ++ V +N + + +
Sbjct: 184 VWSFGVLMWEV--------FSE-------------GKTPYENRSNSEVVETINAGFRLYK 222
Query: 532 ----VETMIQVALLCTQASPEDRPAMSEVVRML 560
+++ ++ C + PEDRP+ S ++ L
Sbjct: 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 18/197 (9%)
Query: 292 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+G+G FG+V+ G L AD T VAVK + P A F +E ++ H N++RLIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKI 409
T++ +Y M+ + L ++ P L ++ AA G+EYL +HC
Sbjct: 63 ---TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APEYLSTG 464
IHRD+ A N L+ E + DFG+++ + + G M I APE L+ G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 465 KSSERTDVFGYGIMLLE 481
+ S +DV+ +GI+L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G +G+VY+ G VA+K++ + E G RE++++ H N++RL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 350 CTTPTER--LLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
T+ + +V+ +M + L+ E+K E + K GL+YLH +
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI-----KCYMKQLLEGLQYLHSN-- 119
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STG 464
I+HRD+K +N+L++ D + DFGLA+ R + T T+ + PE L +T
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT- 177
Query: 465 KSSERTDVFGYGIMLLELVTG 485
+ D++ G +L EL G
Sbjct: 178 RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA------FQREVEMISVAVHRNL 343
VLG+G +G VY G+ G +AVK++ + ++ AA Q EV+++ H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLH 402
++ +G C + F+ S++ L P EPV T++ + G+ YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLH 119
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIA 457
+C ++HRD+K NV+L + + DFG A+ + +N+ + GT +A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
PE ++ ++D++ G + E+ TG+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 40/278 (14%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 349
LG G FG+V+ G + TKVAVK L PG + AF E ++ H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 407
T ++ +M S+ L+ + G+ +L K + A A G+ Y+
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMAYIERK--- 122
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 467
IHRD++AANVL+ E + DFGLA++++ + + + APE ++ G +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 468 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 527
++DV+ +GI+L E+VT K+ ++ V L + Y
Sbjct: 183 IKSDVWSFGILLYEIVT---------------------YGKIPYPGMSNSDVMSALQRGY 221
Query: 528 NIQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 561
+ +E + + C + E+RP + +L+
Sbjct: 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 37/275 (13%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
LG G FG V+ G VA+K + E + F E +++ H NL++L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR--EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 352 TPTERLLVYPFMQNLSVAYRLREIK---PGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+V +M N + LRE K E +LD + +EYL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNG--- 120
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
IHRD+ A N L+ ED V DFGLA+ V + + + + PE + S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK---KLEREKRLDAIVDRNLNK 525
++DV+ +G+++ E+ + + + + R + +++ V +L R K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-MPYERFSNSE---VVESVSAGYRLYRPK------------ 224
Query: 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+ + C PEDRPA +++ L
Sbjct: 225 ----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 39/298 (13%)
Query: 280 QLATDNFSEKNVLGQGGFGKVY----RGVLADGTK--VAVKRLTDFESPGGDAAFQREVE 333
++ D+ + LG G FG+VY RG D + VAVK L + S ++ F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP--GEP-VLDWVTRKRV 390
++S H+N++RLIG R ++ M + LRE +P P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTT 447
A A+G +YL E+ IHRD+ A N LL A + DFG+A+ D+ + +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYR 176
Query: 448 QVRGTMGHIA---PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504
+ M I PE G + +TDV+ +G++L E+ + R +E V+
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEF- 233
Query: 505 HVKKLEREKRLDAIVDRNL-NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ RLD + Y I M C Q +PEDRP + ++ ++
Sbjct: 234 ----VTGGGRLDP--PKGCPGPVYRI-----MTD----CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 45/106 (42%), Positives = 64/106 (60%)
Query: 77 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 136
N +G + +G L+ L L L N ++G IP + +L L SLDL +N L G+IP +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 137 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
L+ L+ L L NNF+G IP +LT+L L +QL SN SG+IP +L
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 71/277 (25%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
LG G FG+V+ G TKVA+K L + AF E ++ H L+RL T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK--QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 352 T-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNPK 408
P ++ +M+N S+ L+ + K + + A A G+ ++
Sbjct: 72 QEPI--YIITEYMENGSLVDFLKT----PEGIKLTINKLIDMAAQIAEGMAFIERK---N 122
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
IHRD++AAN+L+ E + DFGLA+L++ + + + APE ++ G +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528
++DV+ +GI+L E+VT R I + + + V +NL + Y
Sbjct: 183 KSDVWSFGILLTEIVTYGR-IPYPGMTNPE--------------------VIQNLERGYR 221
Query: 529 IQEVET----MIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + + ++ LC + PE+RP + +LE
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 292 LGQGGFGKVYRGVLADGTKV-AVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+GGFG+V + K+ A K+L + G+ E +++ R ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHC 405
T + LV M + Y + + GEP R AA+ GLE+LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFP---EARAIFYAAQIICGLEHLHQR- 114
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 465
+I++RD+K NVLLD+ + D GLA V+++ GT G++APE L
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 466 SSERTDVFGYGIMLLELVTGQ 486
D F G L E++ G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+F V+G+G FGKV D K+ A+K + Q+ VE SV RN+
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK----------QKCVEKGSV---RNV 47
Query: 344 LRLIGFCTTPTERLLV----YPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVA 391
L ER ++ +PF+ NL +++ E + G+ L + ++V
Sbjct: 48 LN---------ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD--LRYHLSQKVK 96
Query: 392 LGAAR----------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
+ LEYLH IIHRD+K N+LLDE + DF +A V
Sbjct: 97 FSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA--TKVT 151
Query: 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501
+TT GT G++APE L S D + G+ E + G+R D +
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 286 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNL 343
F+ +G+G FG+VY+ + VA+K + D E + Q+E++ +S +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
+ G ++ ++ + S L+ K E + ++ R+ + GLEYLHE
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHE 116
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPE 459
IHRD+KAAN+LL E+ + + DFG L + R T V GT +APE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPE 168
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTG 485
+ E+ D++ GI +EL G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 291 VLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
++G+G FG V +G G KVAVK + D + AF E +++ H+NL+RL+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLG- 66
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
+V M ++ LR G ++ + + +L A G+EYL + K+
Sbjct: 67 VILHNGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLE---SKKL 121
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 469
+HRD+ A N+L+ ED A V DFGLA++ + N V+ T APE L K S +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177
Query: 470 TDVFGYGIMLLELVTGQRA 488
+DV+ YG++L E+ + RA
Sbjct: 178 SDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 84/296 (28%), Positives = 136/296 (45%), Gaps = 56/296 (18%)
Query: 291 VLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFESPGGDAAFQREVE-MISVAV------ 339
+LG+G FG V G L+ DG+ KVAVK + D E+E +S A
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK------LDIHTYSEIEEFLSEAACMKDFD 59
Query: 340 HRNLLRLIGFCTTPTER------LLVYPFMQNLSV-AYRLREIKPGEPV-LDWVTRKRVA 391
H N+++LIG C + +++ PFM++ + ++ L G P L T +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV----DVRKTNVTT 447
+ A G+EYL N IHRD+ A N +L ED V DFGL+K + R+ +
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA- 175
Query: 448 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506
+ + IA E L+ + ++DV+ +G+ + E+ T GQ + +E + L H
Sbjct: 176 --KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHEIYDYLRHG 231
Query: 507 KKLER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+L++ E LD + D M C +A P+DRP +++ +LE
Sbjct: 232 NRLKQPEDCLDELYD-------------LMYS----CWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 35/284 (12%)
Query: 287 SEKNVLGQGGFGKVYRGVL-ADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+++ V+G G FG+V+RG+L G K VA+K L + F E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYL 401
++RL G T +++ +M+N ++ LR+ GE V R G A G++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLR---GIAAGMKYL 123
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPE 459
+ +HRD+ A N+L++ + E V DFGL++++ D T T+ + + APE
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 460 YLSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDA 517
++ K + +DV+ +GI++ E+++ G+R D S E +K + RL A
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---------MKAINDGFRLPA 231
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+D + Q+ L C Q RP ++V +L+
Sbjct: 232 PMDCP----------SAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 78/276 (28%), Positives = 118/276 (42%), Gaps = 30/276 (10%)
Query: 292 LGQGGFGKVYRG----VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
LG G FG V RG VAVK L + F +E ++ H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 348 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
G T ++V S+ RLR K T A+ A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEYLSTGK 465
+ IHRD+ A N+LL D + +GDFGL + + + + + ++ APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 466 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524
S +DV+ +G+ L E+ T G+ ++ L + +D K+ ER +R +A
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILKKID--KEGERLERPEACPQD--- 229
Query: 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
YN+ M+Q C +P DRP + + L
Sbjct: 230 -IYNV-----MLQ----CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 49/291 (16%)
Query: 292 LGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LGQG FG VY G D T+VAVK + + S F E ++ +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLE 399
L+G + L+V M + + LR ++P G P ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-------VRGT 452
YL+ K +HRD+ A N ++ DF +GDFG+ + D+ +T+ + VR
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW- 187
Query: 453 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512
+APE L G + +D++ +G++L E+ + L E+ + L E
Sbjct: 188 ---MAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQP-------YQGLSNE 228
Query: 513 KRLDAIVDRN-LNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ L ++D L++ N E V +++ +C Q +P+ RP E+V +L+
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 48/126 (38%), Positives = 66/126 (52%), Gaps = 3/126 (2%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L S NF+G + + L L L L N +GEIP+ LG ++LT LDL N L G+IP
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNF-- 190
L + L L L N+ G IP SL SL ++L N+ SG++P ++P F
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 191 -TGNNL 195
+ NNL
Sbjct: 435 ISNNNL 440
|
Length = 968 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
+ + +G+G G+VY+ A G +VA+K++ + E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR--EIKPGEPVLDWVTRKRVALGAARGLE 399
N++ E +V +M S+ + ++ EP + +V R+ + +GLE
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLE 130
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
YLH +IHRD+K+ N+LL +D + DFG A + K+ + V GT +APE
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + D++ GIM +E+ G+
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 73/231 (31%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 291 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA---AFQREVEMISVAVHRNLLRLI 347
+G+G FG V G G KVAVK + + DA AF E +++ H NL++L+
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 348 GFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
G L +V +M S+ LR G VL + +L +EYL +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 466
+HRD+ A NVL+ ED A V DFGL K + V+ T APE L K
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 467 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
S ++DV+ +GI+L E+ + R + + R+ L D V ++E+ ++DA
Sbjct: 177 STKSDVWSFGILLWEIYSFGR-VPYPRIP------LKDVVPRVEKGYKMDA 220
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 20/221 (9%)
Query: 291 VLGQGGFGKVYRGV-LADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
VLG G FG VY+G+ + +G V A+K L + P + F E +++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 346 LIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
L+G C +PT +L+ + P L + ++ + +L+W + A+G+ YL E
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 461
+++HRD+ A NVL+ + DFGLA+L+ D ++ N + + +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG-KMPIKWMALECI 183
Query: 462 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 501
K + ++DV+ YG+ + EL+T G + D E D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 32/228 (14%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQRE 331
E+ L+ F E+ LG+G FGKVY+G L T VA+K L + P F++E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 332 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---------- 381
E++S H N++ L+G CT +++ ++ + + L P V
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 382 --LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 438
LD +A+ A G+EYL H +HRD+ A N L+ E + DFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 439 --DVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 482
D + + VR + PE + GK + +D++ +G++L E+
Sbjct: 176 SADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 291 VLGQGGFGKVYRGVLAD-GTKVAVKR--LTDFESPGGD-------AAFQREVEMISVAVH 340
++G+G +G+VY + G +AVK+ L + D A + E+E + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARG 397
N+++ +GF TT + ++ S+ LR G E ++ + T + + G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVL-----EG 120
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVRGTMGHI 456
L YLH + I+HRD+KA N+L+D D + DFG++K D+ + ++G++ +
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 457 APEYLSTGKS--SERTDVFGYGIMLLELVTGQRAIDFSRLE 495
APE + + S + D++ G ++LE+ G+R +S E
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGD---AAFQREVEMISVAV 339
N+ +LGQG FG+VY D G ++AVK++ D +SP A + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 397
H R++ + + + FM+ + ++K + + VTRK R L G
Sbjct: 63 HE---RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EG 116
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 455
+EYLH + I+HRD+K AN+L D +GDFG +K + ++ T V GT
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVT 484
++PE +S + DV+ G ++E++T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 49/297 (16%)
Query: 292 LGQGGFGKVYR----GVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
+GQG FG+V++ G+L T VAVK L + S A FQRE +++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 346 LIGFCTTPTERLLVYPFM----------------QNLSVAYRLREIKPGEPVLDWVTRKR 389
L+G C L++ +M Q K G L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 390 VALGA--ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTN 444
+ + A G+ YL E K +HRD+ N L+ E+ + DFGL++ D K +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504
+ + + PE + + + +DV+ YG++L E+ + + EE
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE------- 240
Query: 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
V R+ + + D + YN+ LC P DRP+ + + R+L+
Sbjct: 241 -VIYYVRDGNVLSCPDNCPLELYNLMR---------LCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 286 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
F LG+G +G VY+ + G VA+K + +E+ ++ ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
+ G T+ +V M+ +K L + +GLEYLH +
Sbjct: 62 KYYGSYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVRGTMGHIAPEYLS 462
K IHRD+KA N+LL+E+ +A + DFG++ +L D + K N V GT +APE +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN---TVIGTPFWMAPEVIQ 172
Query: 463 TGKSSERTDVFGYGIMLLELVTG 485
+ + D++ GI +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 7e-17
Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLRLIGF 349
LG G FG+V+ TKVAVK + PG + AF E ++ H L++L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 68
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--ARGLEYLHEHCNP 407
T ++ FM S+ L+ + + L K + A A G+ ++ +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQIAEGMAFIEQR--- 121
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 467
IHRD++AAN+L+ + DFGLA++++ + + + APE ++ G +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 468 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 527
++DV+ +GI+L+E+VT R I + + + + L+ ++ R +
Sbjct: 182 IKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALERGYRMPRPENCP----------- 229
Query: 528 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E + + + C + PE+RP + +L+
Sbjct: 230 -----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 291 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDA-----------AFQREVEMISVA 338
++G G FG VY G+ A G +AVK++ E P A A RE+ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQV---ELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 339 VHRNLLRLIGFCTTPTERLLVY-PFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAAR 396
H N+++ +G + + L ++ ++ SVA L E ++ R+ + +
Sbjct: 64 QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----K 117
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-----VRG 451
GL YLH N IIHRD+K AN+L+D + DFG++K ++ + T ++G
Sbjct: 118 GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 452 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
++ +APE + + + D++ G +++E++TG
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 42/294 (14%)
Query: 285 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 338
N E LG+G FG+V+ T V VK L + + F+RE++M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 339 VHRNLLRLIGFC--TTPTERLLVYPFMQNLS---VAYRLREIKPGEPVLDWVTRKRVALG 393
H+N++RL+G C P +L Y + +L A + ++ K P L + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
A G+++L N + +HRD+ A N L+ E V L+K V + +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 512
+APE + S ++DV+ +G+++ E+ T Q + F L +E +VL KLE
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE-EVLNRLQAGKLELPV 240
Query: 513 -----KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
RL ++ R C +P+DRP+ SE+V L
Sbjct: 241 PEGCPSRLYKLMTR--------------------CWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 78/283 (27%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 291 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
V+G G FG+V RG L K VA+K L + F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
G T +++ FM+N ++ LR+ V+ V R G A G++YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHI-----APEY 460
+HRD+ A N+L++ + V DFGL++ ++ ++ T T G G I APE
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEA 182
Query: 461 LSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
++ K + +DV+ YGI++ E+++ G+R D S D + +E++ RL
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------QDVINAIEQDYRLPPP 233
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+D + Q+ L C Q RP ++V L+
Sbjct: 234 MDCP----------TALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 31/273 (11%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 349
LG G FG+V+ G TKVAVK L PG +F E +++ H L++L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGE-PVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ +Y + +S L +K GE L +A A G+ Y+ E N
Sbjct: 70 VS----EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN-- 122
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
IHRD+++AN+L+ + + DFGLA+L++ + + + APE G+ +
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528
++DV+ +GI+L ELVT R + + + +VL +++ER R+ D ++ +
Sbjct: 183 KSDVWSFGILLTELVTKGR-VPYPGMNNR-EVL-----EQVERGYRMPCPQDCPISLH-- 233
Query: 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E M+Q C + PE+RP + LE
Sbjct: 234 ----ELMLQ----CWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 33/275 (12%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH---RNLLR 345
++G+G +G VYRG + G VA+K + + ++P D + QREV ++S N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
G ++ + + SV ++ E + + R+ + L+Y+H+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV- 120
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 465
+IHRD+KAAN+L+ + DFG+A L++ + +T V GT +APE ++ GK
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 466 SSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524
+ + D++ GI + E+ TG +S ++ ++L+ K RL+ D +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKP----PRLE---DNGYS 228
Query: 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
K + + C P++R + E+++
Sbjct: 229 K--------LLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 292 LGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAFQREVEMIS-VAV 339
LG+G FG+V V+A+ VAVK L D + + E+EM+ +
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 340 HRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG-----------EPVLDWVT 386
H+N++ L+G CT P L+ Y NL R R PG E L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLPEEQLTFKD 135
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNV 445
A ARG+EYL + K IHRD+ A NVL+ ED + DFGLA+ V ++
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
TT R + +APE L + ++DV+ +G++L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 290 NVLGQGGFGKVYRG----VLADGT---KVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
N LG G FG+VY G +L G+ +VAVK L + F +E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 343 LLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
+++L+G C + ++ M+ LS R + G P+L + L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 400 YLHEHCNPKIIHRDVKAANVLLDE---DFEAVV--GDFGLAKLVDVRKTNVTTQVRGT-- 452
YL + IHRD+ A N L+ E D + VV GDFGLA+ D+ K++ + G
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYY-RKEGEGL 174
Query: 453 --MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+ +APE L GK + ++DV+ +G+++ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 79/315 (25%), Positives = 144/315 (45%), Gaps = 67/315 (21%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRG-VLADGTKV--AVKRLTDFESPGGDAAFQREV 332
W +++ ++V+G+G FG+V + + DG ++ A+KR+ ++ S F E+
Sbjct: 6 WNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 333 EMI-SVAVHRNLLRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKR 389
E++ + H N++ L+G C L + NL R + +P
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 390 VALGA----------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
L + ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE 175
Query: 440 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELV----TGQRAID 490
V V+ TMG + A E L+ + +DV+ YG++L E+V T +
Sbjct: 176 V-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
Query: 491 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 550
+ L E KL + RL ++ LN + EV +++ C + P +R
Sbjct: 229 CAELYE-----------KLPQGYRL----EKPLNCD---DEVYDLMR---QCWREKPYER 267
Query: 551 PAMSEVV----RMLE 561
P+ ++++ RMLE
Sbjct: 268 PSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 35/275 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 349
LGQG FG+V+ G T+VA+K L PG AF +E +++ H L++L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 350 CTTPTERL-LVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAARGLEYLHEHCN 406
E + +V +M S L + GE L +A A G+ Y+ E N
Sbjct: 68 AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS 466
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE G+
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 467 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526
+ ++DV+ +GI+L EL T R + E +LD V ER R+ +
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV---ERGYRMPCPPECP---- 229
Query: 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E++ + C + PE+RP + LE
Sbjct: 230 ------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 74/285 (25%), Positives = 136/285 (47%), Gaps = 45/285 (15%)
Query: 292 LGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
LGQG FG VY G+ A G T+VA+K + + S F E ++ +++
Sbjct: 14 LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGA---ARGL 398
RL+G + L++ M + LR ++P PV + K++ A A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG---- 454
YL+ + K +HRD+ A N ++ EDF +GDFG+ + D+ +T+ +G G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLPV 185
Query: 455 -HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513
++PE L G + +DV+ +G++L E+ T L E+ + + E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQP-------YQGMSNEQ 229
Query: 514 RLDAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557
L +++ L+K N ++ + ++ +C Q +P+ RP+ E++
Sbjct: 230 VLRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 292 LGQGGFGKVYRGVLA------DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLL 344
LG+G FGKV+ D VAVK L + ES D FQRE E+++V H++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA---------- 394
R G CT L+V+ +M++ + LR P +L + VA G
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA--GGEDVAPGQLTLGQMLAIA 128
Query: 395 ---ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
A G+ YL + +HRD+ N L+ + +GDFG+++ D+ T+
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGR 183
Query: 452 TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 484
TM I PE + K + +D++ +G++L E+ T
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 42/232 (18%)
Query: 291 VLGQGGFGKVYRGV-LADGTK----VAVKRLTDFESPGGDAAFQREVE-MISVAV--HRN 342
+LG G FG V++G+ + +G VA+K + D G FQ + M+++ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAY 70
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA-------- 394
++RL+G C + +L+ ++ P +LD V + R +L
Sbjct: 71 IVRLLGICPGASLQLVT--------------QLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 395 --ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVR 450
A+G+ YL EH ++HR++ A N+LL D + DFG+A L+ D +K ++ +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY-FYSEHK 172
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 501
+ +A E + G+ + ++DV+ YG+ + E+++ G R E D+L
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 4e-16
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 292 LGQGGFGKVYRGV--LADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLI 347
LG+G FGKV V G A+K L + E ++S H +++L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 348 -GFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLH 402
F T E+L LV + + L + E +R AA LEYLH
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYLH 110
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 462
II+RD+K N+LLD D + DFGLAK + + T GT ++APE L
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLL 166
Query: 463 TGKSSERTDVFGYGIMLLELVTGQ 486
+ D + G++L E++TG+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 52/284 (18%)
Query: 291 VLGQGGFGKVYRGVLA-DGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
VLG G FG VY+G+ DG VA+K L + SP + E +++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA----------A 395
L+G C T T +L+ ++ P +LD+V + +G+ A
Sbjct: 74 LLGICLTSTVQLVT--------------QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA 119
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTMG 454
+G+ YL E +++HRD+ A NVL+ + DFGLA+L+D+ +T + +
Sbjct: 120 KGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 513
+A E + + + ++DV+ YG+ + EL+T G + D E D+L +K ER
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-----EKGER-- 229
Query: 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557
L + MI V C E RP E+V
Sbjct: 230 ---------LPQPPICTIDVYMIMVK--CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAF-QREVEMISVAV 339
+++ +G G +G VY+ +A G VA+K +L PG D Q+E+ M+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECR 58
Query: 340 HRNLLRLIGFCTTPTERLLVYPFM--QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
H N++ G + +V + +L Y++ E + +V R+ +G
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKG 113
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTM 453
L YLHE IHRD+K AN+LL ED + + DFG++ + RK+ + GT
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTP 165
Query: 454 GHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQ 486
+APE G + D++ GI +EL Q
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 40/111 (36%), Positives = 66/111 (59%), Gaps = 14/111 (12%)
Query: 378 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-K 436
E +L ++A+ +GL YLHE KIIHRDVK +N+L++ + + DFG++ +
Sbjct: 98 PERIL-----GKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150
Query: 437 LVD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
LV+ + KT V GT ++APE + S ++D++ G+ L+EL TG+
Sbjct: 151 LVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 281 LATDNFSEKNVLGQGGFGKVYRGV-LADGTK----VAVKRLTDFESPGGDAAFQREVEMI 335
L F + VLG G FG VY+G+ + +G K VA+K L + SP + E ++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 336 SVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
+ + ++ RL+G C T T +L+ + PF L ++ + +L+W +
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGT 452
A+G+ YL E +++HRD+ A NVL+ + DFGLAKL+ K +
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 453 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+ +A E + + ++DV+ YG+ + EL+T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 64/209 (30%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 291 VLGQGGFGKV--YRGVLA-DGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
VLG+G FGKV Y A DGT VAVK L + +++E+ ++ H N+++
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--------ARG 397
G C+ + L + E P + D++ + ++ L G
Sbjct: 71 YKGCCSEQGGKGLQL-----------IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEG 119
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVRGTMGH 455
+ YLH IHRD+ A NVLLD D +GDFGLAK V V +
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVT 484
A E L K S +DV+ +G+ L EL+T
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 51/292 (17%)
Query: 292 LGQGGFGKVYRGVLADGT---KVAVKRL-------TDFESPGGDAAFQREVEMISVAVHR 341
LG+G FG V G L KVAVK + ++ E +A +E + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD------HP 60
Query: 342 NLLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA- 394
N++RLIG C E +++ PFM++ + L + G+ T+ V
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 395 -ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVR 450
A G+EYL + IHRD+ A N +L+E+ V DFGL+K + D + ++
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM- 176
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 509
+ IA E L+ + ++DV+ +G+ + E+ T GQ + +E + + D++++
Sbjct: 177 -PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE---IYDYLRQG 230
Query: 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
R K+ +D + + C +P+DRP+ + LE
Sbjct: 231 NRLKQPPDCLD-------------GLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 44/116 (37%), Positives = 63/116 (54%)
Query: 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 126
+ S+ LS + SG + + L+ L L L N TG+IP L +L L L L +N+
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 127 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
G+IP +LG L L LS NN +G IP+ L + +L + L SN+L G+IP L
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 292 LGQGGFGKVYR----GVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRN 342
LG+G FG+V R G+ VAVK L D + A E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRK-----------RV 390
++ L+G CT ++ + ++ LR +P P + +T+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQV 449
A ARG+EYL + IHRD+ A NVL+ ED + DFGLA+ V D+ T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
R + +APE L + ++DV+ +GI++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 57/230 (24%)
Query: 289 KNVLGQGGFGKVYRGVL-ADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLL 344
++V+G+G FG+V R ++ DG K+ A+K L +F S F E+E++ + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-------------- 390
L+G C +N Y E P +LD++ + RV
Sbjct: 67 NLLGAC-------------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 391 -----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
A A G++YL E + IHRD+ A NVL+ E+ + + DFGL++ +
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE 170
Query: 440 VRKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 484
V V+ TMG + A E L+ + ++DV+ +G++L E+V+
Sbjct: 171 V-------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 47/298 (15%)
Query: 291 VLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
LG+G FGKV + A T VAVK L + S E ++ H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--------------------PGEPVLDW 384
+L G C+ LL+ + + S+ LRE + P E L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 385 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444
A +RG++YL E K++HRD+ A NVL+ E + + DFGL++ V +
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 445 VT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503
V ++ R + +A E L + ++DV+ +G++L E+VT + + E LL
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPERLFNLL 242
Query: 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++ER + E M + L C + P+ RP +++ + LE
Sbjct: 243 KTGYRMERPENCS----------------EEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G +G VY+ G VA+K++ FES G RE++++ H N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 350 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ LV+ FM +L + IK + L K +GL + H H
Sbjct: 67 FRHKGDLYLVFEFMDTDL-----YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-S 467
I+HRD+K N+L++ + + DFGLA+ T V T + APE L K S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177
Query: 468 ERTDVFGYGIMLLELVTGQ 486
D++ G + EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADG-----------TKVAVKRLTDFESPGGDAAF 328
++ D LG+G FG+V V+A+ TKVAVK L + +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL 70
Query: 329 QREVEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPG------- 378
E+EM+ + H+N++ L+G CT P ++ Y NL R R PG
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYCYNP 129
Query: 379 --EPVLDWVTRKRV--ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434
P + V A ARG+EYL + K IHRD+ A NVL+ ED + DFGL
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 186
Query: 435 AK---LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
A+ +D K TT R + +APE L + ++DV+ +G++L E+ T
Sbjct: 187 ARDIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGD---AAFQREVEMISVAV 339
N+ +LGQG FG+VY AD G ++AVK++ D ESP A + E++++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 397
H +++ G P ER L FM+++ ++K + + VTRK R L G
Sbjct: 63 HERIVQYYGCLRDPMERTLSI-FMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL---EG 118
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 455
+ YLH + I+HRD+K AN+L D +GDFG +K + + T V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVT 484
++PE +S + D++ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRLIGF 349
LGQG FG+V+ G TKVA+K L PG AF +E +++ H L+ L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67
Query: 350 CTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
E + +V FM S+ L+E L + +A A G+ Y+ E N
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD--MAAQIADGMAYI-ERMN-- 122
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
IHRD++AAN+L+ ++ + DFGLA+L++ + + + APE G+ +
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528
++DV+ +GI+L ELVT R + E LE+ V+R
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNRE----------VLEQ-------VERGYRMPCP 225
Query: 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E++ ++ LC + P++RP + LE
Sbjct: 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 43/114 (37%), Positives = 63/114 (55%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L S FSG + +G L+ L L N +TGEIPE L + +L L L +N L G+IP
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 186
SLG + L+ + L N+FSG +P T L + + + +NNL G+I + +P
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
|
Length = 968 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 74/284 (26%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 292 LGQGGFGKVYRGVLADGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G G FGKV G G A VK L +P F +EV+ H N+L+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 349 FCTTPTERLLVYPF--MQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
C LLV F + +L R R + +R+A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA--QKDVLQRMACEVASGLLWLHQA- 119
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT--QVRGTMGHIAPEY--- 460
IH D+ N L D +GD+GLA L + T + +APE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 461 ----LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
L +++++++ G+ + EL T + L +E +L V + E++ +L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAA-DQPYPDLSDEQ---VLKQVVR-EQDIKLP 231
Query: 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
L+ Y+ + E M L PE RP EV +L
Sbjct: 232 ---KPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ----REVEMISVAVH 340
+F N +G+G FG V++ V +V + D + + E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDS 58
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRVALGAARG 397
++R + +V + +N + L+ + G P+ + W R + G
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVW----RFFIQILLG 113
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
L +LH KI+HRD+K+ N+ LD +GD G+AKL+ TN + GT +++
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLS 169
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490
PE +E++DV+ G++L E TG+ D
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 31/278 (11%)
Query: 291 VLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
V+G G FG+V G L K VA+K L + F E ++ H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
G T ++V +M+N S+ LR+ V+ V R G A G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDM-- 125
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYLSTG 464
+HRD+ A N+L++ + V DFGL++++ D T + + APE ++
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 465 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523
K + +DV+ YGI++ E+++ G+R + + + D +K +E RL A +D
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP--YWEMSNQ------DVIKAIEEGYRLPAPMDCPA 236
Query: 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Q+ L C Q +RP ++V +L+
Sbjct: 237 ----------ALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 344
F++ +G+G FG+V++G+ KV ++ D E + Q+E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
+ G T+ ++ M+ L L ++PG LD + +GL+YLH
Sbjct: 66 KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVR-----GTMGHIAP 458
K IHRD+KAANVLL E E + DFG+A +L D TQ++ GT +AP
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAP 170
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVTGQ 486
E + + D++ GI +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 54/297 (18%)
Query: 292 LGQGGFGKV----YRGVLADGTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LG+G FG V Y L D T VAVK+L + F+RE+E++ H N+++
Sbjct: 12 LGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQH-STAEHLRDFEREIEILKSLQHDNIVK 69
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR-------- 396
G C + R L RL E P + D++ + R L +
Sbjct: 70 YKGVCYSAGRRNL------------RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 397 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-- 452
G+EYL + +HRD+ N+L++ + +GDFGL K++ K + G
Sbjct: 118 CKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 453 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-----GQRAIDFSRL--EEEDDVLLLDH 505
+ APE L+ K S +DV+ +G++L EL T +F R+ ++ +++ H
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234
Query: 506 -VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++ L+ RL A E+ ++ C P RP+ SE+ +E
Sbjct: 235 LIELLKNNGRLPAPPGCP-------AEIYAIM---KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 35/275 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
LG G FG V G VA+K + E + F E +++ H L++L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 352 TPTERLLVYPFMQNLSVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
+V +M N + LRE +P K V G+ YL + I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC----EGMAYLESK---QFI 122
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQ--VRGTMGHIAPEYLSTGKS 466
HRD+ A N L+D+ V DFGL++ V D ++V ++ VR + PE L K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKF 178
Query: 467 SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526
S ++DV+ +G+++ E+ + + + + R + V + +L R
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQGLRLYRPH------------- 224
Query: 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E + + C E+RP +++ +E
Sbjct: 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 45/129 (34%), Positives = 66/129 (51%), Gaps = 4/129 (3%)
Query: 71 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI 130
V L +FSG L L + L + N + G I ++ SL L L N+ G +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 131 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK--- 187
P S G+ K+L+ L LS+N FSG +P L +LS L+ ++L N LSG+IP L K
Sbjct: 469 PDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 188 YNFTGNNLN 196
+ + N L+
Sbjct: 528 LDLSHNQLS 536
|
Length = 968 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 57/229 (24%)
Query: 290 NVLGQGGFGKVYRGVL-ADGTKV--AVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLR 345
+V+G+G FG+V + + DG ++ A+KR+ ++ S F E+E++ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV--------------- 390
L+G C ++ Y E P +LD++ + RV
Sbjct: 61 LLGAC-------------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 107
Query: 391 ----------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
A ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +V
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164
Query: 441 RKTNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT 484
V+ TMG + A E L+ + +DV+ YG++L E+V+
Sbjct: 165 -------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREV 332
EL L+ F E+ LG+ FGK+Y+G L VA+K L D +P FQ+E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 333 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV----------- 381
+++ H N++ L+G T +++ ++ + L P V
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 382 --LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LV 438
LD +A+ A G+EYL H +H+D+ A N+L+ E + D GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
V + + + PE + GK S +D++ +G++L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 34/224 (15%)
Query: 286 FSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRL-------TDFESPGGDAAFQREVEM 334
F+ +LG+G FG V L DG+ KVAVK L +D E +AA +E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD- 59
Query: 335 ISVAVHRNLLRLIGFC--TTPTERL----LVYPFMQNLSVAYRLREIKPGE-PV-LDWVT 386
H N+++LIG + RL ++ PFM++ + L + GE P L T
Sbjct: 60 -----HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKT 443
R + A G+EYL + IHRD+ A N +L+E+ V DFGL+K + D +
Sbjct: 115 LVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQ 486
+++ + +A E L+ + +DV+ +G+ + E++T GQ
Sbjct: 172 GCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 344
F++ +G+G FG+VY+G+ +V ++ D E + Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYL 401
R G T+ ++ M+ L L +KPG E + + R+ + +GL+YL
Sbjct: 66 RYYGSYLKGTKLWII---MEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYL 117
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVR-KTNVTTQVRGTMGHIAPE 459
H + IHRD+KAANVLL E + + DFG+A +L D + K N GT +APE
Sbjct: 118 HSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPE 171
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + D++ GI +EL G+
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 282 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMI-SVAV 339
T F V+G+G +GKVY+ G VA+K + D + + E ++ +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDII-EDEEEEIKEEYNILRKYSN 61
Query: 340 HRNLLRLIG--FCTTPT----ERLLVYPFMQNLSV-----AYRLREIKPGEPVLDWVTRK 388
H N+ G P + LV SV R + + E + ++ R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR- 120
Query: 389 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD--VRKTNVT 446
RGL YLHE+ K+IHRD+K N+LL ++ E + DFG++ +D + + N
Sbjct: 121 ----ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 447 TQVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 486
GT +APE ++ + + R+DV+ GI +EL G+
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+ E + LG+G G V + L + + A+K +T +P RE+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 343 LLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKP-----GEPVLDWVTRKRVALGAA 395
+++ G + + + + S+ +++K GE VL ++A
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMG 454
+GL YLH KIIHRD+K +N+LL + + DFG++ +LV+ T GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
++APE + S +DV+ G+ LLE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYR----GVLADGTK----VAVKRLTDFESPGGDAAFQRE 331
+ + D + LG+G FG+V G+ D K VAVK L D + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 332 VEMIS-VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIK-----------P 377
+EM+ + H+N++ L+G CT P ++ Y NL R R P
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 378 GEPVL--DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435
E + D V+ ARG+EYL + K IHRD+ A NVL+ E+ + DFGLA
Sbjct: 131 DEQMTFKDLVS---CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 436 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+ V ++ TT R + +APE L + ++DV+ +G+++ E+ T
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 48/283 (16%)
Query: 291 VLGQGGFGK--VYRGVLADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
VLG+G FG+ +YR D + V K LT A E+ ++S+ H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAY 64
Query: 347 IG-FCTTPTERLLV---YPFMQNLS--VAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
F T LL+ Y L + + ++ E VL ++ + A+ Y
Sbjct: 65 YNHFMDDNT--LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS------Y 116
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
+H+ I+HRD+K N+ L + +GDFG++K++ + T V GT +++PE
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPEL 172
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
K + ++D++ G +L EL+T +R D + +V
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------------------LVV 211
Query: 521 RNLNKNYN-IQEVET--MIQVALLCTQASPEDRPAMSEVVRML 560
+ + NY + V + +I + Q PE RP EV+
Sbjct: 212 KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
LG G FGKVY+ + A ++ ES F E++++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 352 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
+ ++ F ++ + E++ G EP + +V R+ + L +LH H K+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH---KV 124
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGL-AKLVDVRKTNVTTQVR----GTMGHIAPEYLSTG 464
IHRD+KA N+LL D + + DFG+ AK T Q R GT +APE ++
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKS------TLQKRDTFIGTPYWMAPEVVACE 178
Query: 465 KSSE-----RTDVFGYGIMLLEL 482
+ + D++ GI L+EL
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 286 FSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVH 340
F++ +G G FG VY R V + VA+K+++ + + +Q +EV + H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEV-VAIKKMS-YSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGL 398
N + G LV + L A + E+ KP L V + GA +GL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYC--LGSASDILEVHKKP----LQEVEIAAICHGALQGL 128
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
YLH H IHRD+KA N+LL E + DFG A LV + V GT +AP
Sbjct: 129 AYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAP 180
Query: 459 EY---LSTGKSSERTDVFGYGIMLLEL 482
E + G+ + DV+ GI +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 33/273 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
LG G FG V+ G KVA+K + E + F E +++ H L++L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN--EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----GLEYLHEHCNP 407
+V FM+N + LR+ + G K + L + G+EYL +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ-RQG------KLSKDMLLSMCQDVCEGMEYLERN--- 119
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 467
IHRD+ A N L+ V DFG+ + V + ++ + + PE + K S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 468 ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 527
++DV+ +G+++ E+ T + + F + + V ++ +L R K V
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK-MPFEKKSNYEVVEMISRGFRLYRPKLASMTV-------- 230
Query: 528 NIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+V C PE RP +E++R +
Sbjct: 231 --------YEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGT-----KVAVKRLTDFESPGGDAAFQREVEMISVA 338
D + ++L +G FG+++ G+L D +V VK + D S +E ++
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 339 VHRNLLRLIGFCTTPTERLLV-YPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGA- 394
H+N+L ++ C E V YP+M NL + + + T++ V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 395 -ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---------LVDVRKTN 444
A G+ YLH+ +IH+D+ A N ++DE+ + + D L++ L D N
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----N 178
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
V+ +A E L + S +DV+ +G++L EL+T
Sbjct: 179 ENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 24/189 (12%)
Query: 286 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGG-DAAFQREVEM---ISVAVH 340
+ E +G+G +G VY+ L G VA+K++ S G + RE+ + + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 341 RNLLRLIGFCTTP-TER----LLVYPFM-QNLSVAYRLREIKPG--EPVLDWVTRKRVAL 392
N++RL+ C P T+R LV+ + Q+L+ Y + KPG + + R+ +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT-YLSKCPKPGLPPETIKDLMRQLL-- 117
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 452
RG+++LH H I+HRD+K N+L+ D + + DFGLA++ + +T+ V T
Sbjct: 118 ---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-T 169
Query: 453 MGHIAPEYL 461
+ + APE L
Sbjct: 170 LWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 285 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDA-----AFQREVEMISV 337
+ + LG G F Y R V GT +AVK++T + + A ++E+ +++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAAR 396
H +++R++G + L +M SV++ L + E V+ T + R
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-----LLR 114
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNV---TTQVRGT 452
GL YLHE+ +IIHRDVK AN+L+D + + + DFG A + + T Q+ GT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 453 MGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQ 486
+ +APE L G+S DV+ G +++E+ T +
Sbjct: 172 IAFMAPEVLRGEQYGRSC---DVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAF----QREV 332
E + D E+ VLG+G +G VY L+ ++A+K E P D+ + E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEI 56
Query: 333 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL---SVAYRLRE----IKPGEPVLDWV 385
+ S HRN+++ +G + E FM+ + S++ LR +K E + +
Sbjct: 57 ALHSYLKHRNIVQYLGSDS---ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113
Query: 386 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKT 443
T++ + GL+YLH++ +I+HRD+K NVL++ + VV DFG +K +
Sbjct: 114 TKQIL-----EGLKYLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL-AGIN 163
Query: 444 NVTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQ 486
T GT+ ++APE + G D++ G ++E+ TG+
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 48/222 (21%)
Query: 289 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRNLLR 345
+G G +G V V G KVA+K++++ DA RE++++ H N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIG 63
Query: 346 LIGFCTTPTERL------LVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRV------AL 392
L+ P +V M+ +L +++ IK +P+ T + L
Sbjct: 64 LLDI-LRPPSPEDFNDVYIVTELMETDL---HKV--IKSPQPL----TDDHIQYFLYQIL 113
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQV 449
RGL+YLH N +IHRD+K +N+L++ + + + DFGLA+ VD K +T V
Sbjct: 114 ---RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 450 -----RGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTG 485
R APE LS+ + ++ D++ G + EL+T
Sbjct: 168 VTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 285 NFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA 338
N K LG+G FGKV+ D VAVK L D S F RE E+++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNL 64
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRK--R 389
H ++++ G C ++V+ +M++ + LR P G + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 449
+A A G+ YL + +HRD+ N L+ E+ +GDFG+++ DV T+
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVG 179
Query: 450 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT 484
TM I PE + K + +DV+ G++L E+ T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 286 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 343
+ + LG+G +G VY+ G VA+K++ D E G + RE+ ++ H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLH 402
++L+ T + LV+ + L++ + L K + RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL- 461
H +I+HRD+K N+L++ D + DFGLA+ + T +V T+ + APE L
Sbjct: 116 SH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILL 171
Query: 462 -----STGKSSERTDVFGYGIMLLELVTGQ 486
ST D++ G + E++TG+
Sbjct: 172 GSKHYSTA-----VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-----AAFQREVEMISVAVHRNLLR 345
LG+G + VY+ G VA+K++ E A RE++++ H N++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66
Query: 346 LIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
L+ + LV+ FM+ +L IK VL K L RGLEYLH +
Sbjct: 67 LLDVFGHKSNINLVFEFMETDLEKV-----IKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
I+HRD+K N+L+ D + DFGLA+ +T QV T + APE L
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 292 LGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMI---SVAVHRNLLR 345
+G+G +GKV+ R + G VA+KR+ G + REV ++ H N++R
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 346 LIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
L CT T+ LV+ + Y + +PG P T K + RGL++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
LH H +++HRD+K N+L+ + + DFGLA++ + T V T+ + APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180
Query: 461 LSTGKSSERTDVFGYGIMLLEL 482
L + D++ G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 306 ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI-GFCTTPTERLLVYPFMQ 364
KV VK +T ++PG RE++++ HR ++ LI + T +++ +
Sbjct: 117 EQRKKVIVKAVTGGKTPG------REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC 170
Query: 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424
+L + + P+ +T +R L A L YLH IIHRDVK N+ LDE
Sbjct: 171 DL---FTYVDRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLDEP 221
Query: 425 FEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 482
AV+GDFG A KL T GT+ +PE L+ +TD++ G++L E+
Sbjct: 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGD---AAFQREVEMISVAV 339
N+ +LGQG FG+VY D G ++A K++ D ESP +A + E++++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAARG 397
H +++ G E+ L FM+ + ++K + + VTRK R L G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTI-FMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EG 118
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 455
+ YLH + I+HRD+K AN+L D +GDFG +K + + T V GT
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVT 484
++PE +S + DV+ G ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 51/178 (28%), Positives = 76/178 (42%), Gaps = 35/178 (19%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRN 342
K LG+G FG+VY+ + G VA+K++ E G RE++++ H N
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 343 LLRLI--------GFCTTPTERLLVYPFM--------QNLSVAYRLREIKPGEPVLDWVT 386
++ LI +V P+M +N SV +IK
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK---------- 118
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444
L G+ YLHE+ I+HRD+KAAN+L+D + DFGLA+ D N
Sbjct: 119 --CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 61/278 (21%), Positives = 121/278 (43%), Gaps = 22/278 (7%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHR 341
NF + +G+G F +VYR L DG VA+K++ F+ A +E++++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N+++ E +V ++ ++ K + ++ T + + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
H +++HRD+K ANV + +GD GL + KT + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
+ ++D++ G +L E+ Q D + L KK+E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEQCDY------P 226
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
L ++ +E+ ++ +C PE RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADG-------TKVAVKRLTDFESPGGDAAFQREVEMIS 336
+N S LG G FGKV A G KVAVK L A E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 337 -VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL- 392
+ H N++ L+G CT P + Y +L L+++ RKR +
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDL---------------LNFLRRKRESFL 138
Query: 393 ----------GAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
A+G+ +L ++C IHRD+ A NVLL + DFGLA+ D+
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR--DIM 192
Query: 442 KTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+ V R + +APE + + +DV+ YGI+L E+ +
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 64/203 (31%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 292 LGQGGFGKVY------RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLL 344
LG+GGFG+V G L K+ KRL + G +R I VH R ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR----ILAKVHSRFIV 56
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYL 401
L T T+ LV M + Y + + P R A+ GLE+L
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHL 113
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGHIAPEY 460
H+ +II+RD+K NVLLD D + D GLA +L D + T GT G +APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQSKTKGYAGTPGFMAPEL 168
Query: 461 LSTGKSSERTDVFGYGIMLLELV 483
L + D F G+ L E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
NF + LG+G + VY+G G VA+K + G + RE+ ++ H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 344 LRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+RL T + +LV+ +M ++L + + LD T K +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLK---KYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 462
E+ +++HRD+K N+L+++ E + DFGLA+ + + +V T+ + AP+ L
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 463 TGKS-SERTDVFGYGIMLLELVTG 485
++ S D++ G ++ E++TG
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 37/290 (12%)
Query: 291 VLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRNLLRL 346
++G+G +G V + + G VA+K+ ES + RE+ M+ H NL+ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
I LV+ F+ + L +++ LD ++ RG+E+ H H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH-- 119
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGK 465
IIHRD+K N+L+ + + DFG A+ + T V T + APE L K
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTK 177
Query: 466 SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL--EREKRLDAIVDRN- 522
D++ G ++ E++TG+ + D+ L H+ K R I +N
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE-----PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 523 ---LNKNYNIQEVETM-----------IQVALLCTQASPEDRPAMSEVVR 558
+ ++E+E + + +A C + P+DRP+ S+++
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 31/148 (20%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV-------TTQV 449
LEYLH + IIHRD+K N+L+D + + DFGL+K+ VR+ ++
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-----------------QRAIDFS 492
GT +IAPE + S+ D + G +L E + G I++
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 493 RLEEEDDVLLLDHVKKL---EREKRLDA 517
E D +D + KL + EKRL A
Sbjct: 222 EDVEVSDE-AIDLISKLLVPDPEKRLGA 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 292 LGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G G FGKV G + G +V VK L S F E + H NLL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRKRVALGAARGLEYLHEHCNP 407
CT T LLV F + LR + E + D T +R+A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKS 466
IH D+ N LL D +GD+GL+ VT Q+ + IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 467 -------SERTDVFGYGIMLLEL 482
++ ++V+ G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 289 KNVLGQGGFGKVYRG------VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
K LG+G FGKV+ D VAVK L D + FQRE E+++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 68
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPV-----LDWVTRKRV 390
+++ G C ++V+ +M++ + LR P G+P L +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
A A G+ YL + +HRD+ N L+ + +GDFG+++ DV T+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 183
Query: 451 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507
TM I PE + K + +DV+ +G++L E+ T + F +L + + + +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF-QLSNTEVIECITQGR 242
Query: 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 566
LER + V Y+I L C Q P+ R + E+ ++L G A
Sbjct: 243 VLERPRVCPKEV-------YDIM---------LGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 50/220 (22%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 286 FSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV----- 339
+ +G+G FG V + +DG + K + D+ + ++E + + V
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMT-----EKEKQQLVSEVNILRE 55
Query: 340 --HRNLLRLIGFCTTPTERLLVYPFM---------QNLSVAYRLREIKPGEPVLDWVTRK 388
H N++R + + L Y M Q + + R+ E +
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------ 108
Query: 389 RVALGAARGLEYLH--EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
R+ L H ++HRD+K AN+ LD + +GDFGLAK++ +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
T V GT +++PE L+ E++D++ G ++ EL
Sbjct: 169 TYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 286 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 342
F + VLG+GGFG+V V A G A KRL + G++ E +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 399
++ L T LV M + + + + G P + +R AA GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
LH ++RD+K N+LLD+ + D GLA V + + GT+G++APE
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE 171
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
L+ + + D +G G ++ E++ GQ R +E VK+ E ++R+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKE-------KVKREEVDRRV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVH 340
T+ + + +G G FG V G VA+K++ F +P RE++++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
N++ L +P E + + + RL +P E + RGL+Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLKY 123
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
+H + ++HRD+K +N+L++E+ + + DFGLA++ D + T + T + APE
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPEI 176
Query: 461 LST-GKSSERTDVFGYGIMLLELVTGQ 486
+ T K D++ G + E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 89/342 (26%), Positives = 140/342 (40%), Gaps = 97/342 (28%)
Query: 291 VLGQGGFGKVYRGVLADGTK------VAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 343
LG+G FGKV + K VAVK L + + A E++ +I + H N+
Sbjct: 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV 73
Query: 344 LRLIGFCTTPTERLLV---YPFMQNLSVAY----------------RLREIKPGEPV--- 381
+ L+G CT P L+V Y NLS Y R RE+K E
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLS-NYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 382 LD------------WVTRKRV-------------------------ALGAARGLEYLHEH 404
LD ++ K + + ARG+E+L
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIAPE 459
+ K IHRD+ A N+LL E+ + DFGLA+ + VRK + R + +APE
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD----ARLPLKWMAPE 245
Query: 460 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
+ + ++DV+ +G++L E+ + G +++EE ++L+ R+ A
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------FCRRLKEGTRMRA- 297
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
Y E + + L C +PEDRP SE+V +L
Sbjct: 298 ------PEYATPE---IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 291 VLGQGGFGKVYRG-VLADGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIG 348
V+G+G +G V + A G VA+K+ + E REV+++ H N++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 349 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
LV+ ++ + L L E PG L + + + Y H H
Sbjct: 68 AFRRKGRLYLVFEYVERTL---LELLEASPGG--LPPDAVRSYIWQLLQAIAYCHSH--- 119
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL----ST 463
IIHRD+K N+L+ E + DFG A+ + R + T T + APE L +
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 464 GKSSERTDVFGYGIMLLELVTGQ 486
GK DV+ G ++ EL+ G+
Sbjct: 180 GKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 36/191 (18%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+GQG FG+V++ VA+K+ L + E G RE++++ + H N++ LI
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 350 CTTPTER--------LLVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
C T LV+ F + N +V + L EIK +V
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK------------KVMKM 127
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---NVTTQVR 450
GL Y+H + KI+HRD+KAAN+L+ +D + DFGLA+ + K N T
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 451 GTMGHIAPEYL 461
T+ + PE L
Sbjct: 185 VTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 42/215 (19%)
Query: 291 VLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMI-----SVAVHRNLL 344
VLG+G FGKV L + A+K A +++V + V R +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49
Query: 345 RLIG--------FCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
L FCT T+ L V ++ + + ++ + R A
Sbjct: 50 ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD-------EARARFYA 102
Query: 395 AR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
A GL++LH+ II+RD+K NVLLD+D + DFG+ K + +T G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-G 158
Query: 452 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
T +IAPE L K +E D + +G++L E++ GQ
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 81/289 (28%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAF----------QREV 332
D+F ++G+G F V + A+K L D + E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--------DKRQLIKEKKVKYVKIEK 52
Query: 333 EMIS-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV-TRKRV 390
E+++ + H +++L + T F Q+ Y + E P +L ++ +
Sbjct: 53 EVLTRLNGHPGIIKL--YYT----------F-QDEENLYFVLEYAPNGELLQYIRKYGSL 99
Query: 391 ALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
R LEYLH IIHRD+K N+LLD+D + DFG AK++D
Sbjct: 100 DEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156
Query: 443 TNVTTQVR-------------------GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483
+ + + GT +++PE L+ + + +D++ G ++ +++
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 484 TG-----------------QRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
TG + F D L++ + L+ + RL
Sbjct: 217 TGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 50/226 (22%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHR 341
D + + +G G +G+V G KVA+K+L+ F+S RE+ ++ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 342 NLLRLIGFCTTPTERL-------LVYPFM----------QNLS---VAYRLREIKPGEPV 381
N++ L+ TP L LV M Q LS + + + +I
Sbjct: 75 NVIGLLD-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQI------ 127
Query: 382 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
RGL+Y+H + IIHRD+K +N+ ++ED E + DFGLA+ D
Sbjct: 128 -------------LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-- 169
Query: 442 KTNVTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 486
+T V T + APE L+ ++ D++ G ++ EL+TG+
Sbjct: 170 -DEMTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 15/210 (7%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRN 342
NF + +G+G +G VY+ G VA+K++ D E+ G + RE+ ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 343 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPV-LDWVTRKRVALGAARGLEY 400
+++L+ T + LV+ F+ Q+L + + P + L + K +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLSGIPLPLI--KSYLFQLLQGLAF 115
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
H H +++HRD+K N+L++ + + DFGLA+ V T +V T+ + APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEI 171
Query: 461 LSTGK-SSERTDVFGYGIMLLELVTGQRAI 489
L K S D++ G + E+VT +RA+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLL 344
F++ +G+G FG+V++G+ +V ++ D E + Q+E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
+ G T+ ++ ++ S LR P + K + +GL+YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI----LKGLDYLHSE 120
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDV---RKTNVTTQVRGTMGHIAPEY 460
K IHRD+KAANVLL E + + DFG+A +L D R T V GT +APE
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEV 172
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + D++ GI +EL G+
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 286 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 342
F + VLG+GGFG+V V A G A K+L + G++ E +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 399
++ L T LV M + + + + GE + R AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFE---EGRAVFYAAEICCGLE 116
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
LH+ +I++RD+K N+LLD+ + D GLA V V + GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPE 171
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + + D + G +L E++ GQ
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
LG G FGKVY+ + +A ++ D +S + E+++++ H N+++L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 352 TPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
++ F +V + E++ EP + V ++ + L YLHE+ KI
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHEN---KI 124
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGK 465
IHRD+KA N+L D + + DFG++ K T Q R GT +APE +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 466 SSER-----TDVFGYGIMLLEL 482
S +R DV+ GI L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 292 LGQGGFGKVY------RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LG+G FGKV G G +VAVK L A ++E+E++ H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 346 LIGFCTTPTER--LLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLH 402
G CT L+ F+ + S L+E P + ++ + + A+ +G++YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEY 460
+ +HRD+ A NVL++ + + +GDFGL K ++ K T + + + APE
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 461 LSTGKSSERTDVFGYGIMLLELVT 484
L K +DV+ +G+ L EL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 344
F V+G G +G+VY+G ++A ++ D + + + E+ M+ + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 345 RLIGFCTTPT------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
G + + LV F SV ++ K DW+ + RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
+LH H K+IHRD+K NVLL E+ E + DFG++ +D R GT +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 190
Query: 459 EYLSTGKSSE-----RTDVFGYGIMLLELVTG 485
E ++ ++ + R+D++ GI +E+ G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 72/238 (30%), Positives = 113/238 (47%), Gaps = 45/238 (18%)
Query: 291 VLGQGGFGKVYRGVLADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
VLG+G FGKV +LA+ K A+K L GD + EVE S+ + +
Sbjct: 6 VLGRGHFGKV---LLAEYKKTGELYAIKALKK-----GDIIARDEVE--SLMCEKRI--- 52
Query: 347 IGFCTTPTERLLVYPFMQNL-------SVAYRLREIKPGEPVL-----DWVTRKRVALGA 394
F T +ER +PF+ NL + E G ++ D + R A
Sbjct: 53 --FETANSER---HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA 107
Query: 395 AR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
A GL+YLHE+ KI++RD+K N+LLD + + DFGL K + + T+ G
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCG 163
Query: 452 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--DVLLLDHVK 507
T +APE L+ + D +G G+++ E++ G+ F +EE+ D ++ D V+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDSIVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT----DFESPGGDAAFQREVEMISVAV 339
N+ +LG+G FG+VY AD G ++AVK++ E+ A + E++++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 340 HRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
H +++ G P E+ L +M S+ +L K + + VTR R +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTR-RYTRQILQG 118
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGH 455
+ YLH + I+HRD+K AN+L D +GDFG +K + + T V GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVT 484
++PE +S + DV+ ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 20/226 (8%)
Query: 292 LGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+GGFG+V V G A K+L + G+ E E++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHC 405
+ T LV M + Y + + GE L+ +RV +A+ G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHLHSM- 114
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 465
I++RD+K NVLLD+ + D GLA V+++ TQ GT G++APE L
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 466 SSERTDVFGYGIMLLELVTGQRAI-DFSRLEEEDDVL---LLDHVK 507
S D F G + E+V G+ D ++++ L D VK
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 36/208 (17%)
Query: 292 LGQGGFGKVYR------GVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
LG G FGKVY+ G LA + K + E + E+E+++ H +++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED------YMVEIEILATCNHPYIVK 73
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGLEYLHE 403
L+G + ++ F +V + E+ G EP + + R+ + L+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLH- 127
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPE 459
+ KIIHRD+KA NVLL D + + DFG++ K T Q R GT +APE
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWMAPE 180
Query: 460 YL--STGKSSE---RTDVFGYGIMLLEL 482
+ T K + + D++ GI L+E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLL 344
F ++G G +G+VY+G ++A ++ D + + ++E+ M+ + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 345 RLIGFCTTPT------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
G + LV F SV ++ K +W+ + RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
+LH+H K+IHRD+K NVLL E+ E + DFG++ +D R GT +AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 180
Query: 459 EYLSTGKSSE-----RTDVFGYGIMLLELVTG 485
E ++ ++ + ++D++ GI +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 51/253 (20%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQRE-VEMISVAV 339
+F+ VLG+G FGKV +LA+ GT A+K L D Q + VE V
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKK------DVIIQDDDVE--CTMV 49
Query: 340 HRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRK 388
+ +L L G C +RL V ++ + Y ++++ K EP +
Sbjct: 50 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--- 106
Query: 389 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
A A GL +LH + II+RD+K NV+LD + + DFG+ K ++ T
Sbjct: 107 --AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT 160
Query: 449 VRGTMGHIAPE---YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LL 503
GT +IAPE Y GKS D + +G++L E++ GQ D E+ED++ ++
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFDG---EDEDELFQSIM 214
Query: 504 DHV----KKLERE 512
+H K L +E
Sbjct: 215 EHNVSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 52/287 (18%)
Query: 285 NFSEKNVLGQGGFGKVYR-GVLADGTKVAVKR-----LTDFESPGGDAAFQREVEMISVA 338
+F LG+G +G VY+ L+D A+K ++ E DA E+ +++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAV--NEIRILASV 56
Query: 339 VHRNLLR-----LIG--FCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKR 389
H N++ L G C ++ Y +LS A R+ K W R
Sbjct: 57 NHPNIISYKEAFLDGNKLCI-----VMEYAPFGDLSKAISKRKKKRKLIPEQEIW----R 107
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 449
+ + RGL+ LHE KI+HRD+K+AN+LL + +GD G++K++ K N+
Sbjct: 108 IFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQ 161
Query: 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509
GT ++APE S ++D++ G +L E+ T + +++
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------------- 208
Query: 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
R K + Y+ + + Q P+ RP ++
Sbjct: 209 LRYKVQRGKYPP-IPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 47/230 (20%)
Query: 291 VLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
VLG+G FGKV LA+ GT AVK L D Q + ++ + +L L
Sbjct: 2 VLGKGSFGKVL---LAELKGTDELYAVKVLKK------DVILQDD-DVECTMTEKRVLAL 51
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR-- 396
G +PF+ L ++ ++ + G+ + R AR
Sbjct: 52 AG----------KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY 101
Query: 397 ------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
GL++LHE II+RD+K NVLLD + + DFG+ K + T+
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFC 157
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500
GT +IAPE LS D + G++L E++ GQ + ++ED++
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 291 VLGQGGFGKVYRGVLADGTKVAVKRLTD---FESPGGDAAFQREVEMISVAVHRNLLRLI 347
++G+GGFG+VY AD K+ + D + G+ E M+S+ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 348 GFCT---TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
TP + + M + Y L + V + A GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMH-- 114
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 464
N +++RD+K AN+LLDE + D GLA +K + + GT G++APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 465 KSSERT-DVFGYGIMLLELVTGQ 486
+ + + D F G ML +L+ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 342
F + N +G+G +G VYR G VA+K++ D E G + RE+ ++ H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 343 LLRL---------------IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 387
++ L + +C LL N+ + ++K
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKC---------- 112
Query: 388 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
+ L RGL+YLHE+ IIHRD+K +N+LL + + DFGLA+ + +T
Sbjct: 113 --LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 448 QVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 486
+V T+ + APE L + D++ G +L EL+ +
Sbjct: 168 KVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 57/223 (25%), Positives = 87/223 (39%), Gaps = 41/223 (18%)
Query: 285 NFSEKNVLGQGGFGKVY----RGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 340
NF VLG G +GKV+ G G A+K L Q+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA------TIVQKAKTAEHTRTE 54
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYR--------LREIKPGEPVLDWVTRKRVAL 392
R +L + C PF+ L A++ L + GE R+
Sbjct: 55 RQVLEAVRRC----------PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE 104
Query: 393 GAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444
R L++LH+ II+RD+K N+LLD + V+ DFGL+K +
Sbjct: 105 SEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 445 VTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 485
GT+ ++APE + G + D + G++ EL+TG
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
D+F LG G FG+V K A+K L ++VE V +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVE--HVLNEKR 53
Query: 343 LLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--- 396
+L+ I F L F + ++ Y + E PG + + + R AR
Sbjct: 54 ILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 397 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
LEYLH + I++RD+K N+LLD D + DFG AK V R T + G
Sbjct: 108 AQVVLALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCG 160
Query: 452 TMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTG 485
T ++APE + + GK+ D + GI++ E++ G
Sbjct: 161 TPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 53/218 (24%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 285 NFSEKNVLGQGGFGKVY--RGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + V+G+G FG V+ R AD V +K++ + + A Q E +++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVA----YRLREIKPGEPVLDWVTRKRVALGAARG 397
N++ ++V + ++A R + + +L + + +AL
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL----- 114
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
++H I+HRD+K N+LLD+ V +GDFG++K++ + T V GT +I
Sbjct: 115 -HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494
+PE ++++D++ G +L EL + +RA + + L
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 292 LGQGGFGKVYR-GVLADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVHRNLLRLIGF 349
+G+G G V++ G VA+K++ GG RE++ + H +++L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 350 CTTPTERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ +LV +M +LS R E E + K +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQV-----KSYMRMLLKGVAYMHAN---G 119
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL-STGKSS 467
I+HRD+K AN+L+ D + DFGLA+L + + + T + APE L K
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 468 ERTDVFGYGIMLLELVTGQ 486
D++ G + EL+ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 45/278 (16%)
Query: 292 LGQGGFGKVYRGVLA--DGTK-VAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
LG G FG V +G+ K VAVK L D P RE ++ + ++R+I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 348 GFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD---WVTRKRV---ALGAARGLEYL 401
G C ++ + L E+ P L VT K + + G++YL
Sbjct: 63 GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHIAPE 459
E +HRD+ A NVLL A + DFGL+K + + + G + APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 460 YLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
++ K S ++DV+ +G+++ E + GQ+ + ++ + +++ +++E +R
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--YKGMKGNEVTQMIESGERMECPQRCPPE 226
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ Y++ + LC ++RP + V
Sbjct: 227 M-------YDLMK---------LCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 64/280 (22%), Positives = 121/280 (43%), Gaps = 28/280 (10%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQR-----EVEMIS 336
NF + +G+G F VY+ + L DG VA+K++ FE A R E++++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM---DAKARQDCLKEIDLLK 57
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 396
H N+++ + E +V ++ ++ K + ++ T + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
LE++H +I+HRD+K ANV + +GD GL + + T + V GT ++
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
+PE + + ++D++ G +L E+ Q D + L KK+E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEKCDY-- 225
Query: 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
L ++ +E+ ++ C PE RP +S V
Sbjct: 226 ----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 41/276 (14%)
Query: 292 LGQGGFGKVYRGVLADGTK-VAVKRLTDFESPGGDAAFQ---REVEMISVAVHRNLLRLI 347
+G G FG VY + + VAVK+++ + + +Q +EV+ + H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 348 GFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
G LV + L A L E+ KP L V + GA +GL YLH H
Sbjct: 88 GCYLKEHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN 141
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY---LS 462
+IHRD+KA N+LL E + + DFG A + V GT +APE +
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMD 193
Query: 463 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522
G+ + DV+ GI +EL + L + + L H+ + +
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNDSP---------T 239
Query: 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
L N + ++ C Q P++RPA +E++R
Sbjct: 240 LQSN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 286 FSEKNVLGQGGFGKVY--RGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVH 340
FS+ +G G FG VY R V VA+K+++ + + +Q +EV + H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGL 398
N ++ G LV + L A L E+ KP L V V GA +GL
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAVTHGALQGL 128
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
YLH H +IHRDVKA N+LL E +GDFG A ++ V GT +AP
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
Query: 459 EY---LSTGKSSERTDVFGYGIMLLEL 482
E + G+ + DV+ GI +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 291 VLGQGGFGKVYRGVLADGTKVAVKRLTD---FESPGGDAAFQREVEMISVAVHRNLLRLI 347
++G+GGFG+VY AD K+ + D + G+ E M+S+ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 348 GFC---TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
TP + + M + Y L + V + A GLE++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMH-- 114
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 464
N +++RD+K AN+LLDE + D GLA D K V GT G++APE L G
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKG 170
Query: 465 KSSERT-DVFGYGIMLLELVTGQ 486
+ + + D F G ML +L+ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 46/217 (21%)
Query: 291 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
VLG+G FGKV L G AVK A +++V +I V
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40
Query: 350 CTTPTERLLVY----PFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR- 396
CT +R+L PF+ +L ++ +E + G+ + + R L A
Sbjct: 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100
Query: 397 -------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 449
GL++LH II+RD+K NV+LD D + DFG+ K +V N +
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTF 156
Query: 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
GT +IAPE L K + D + +G++L E++ GQ
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 308 GTKVAVKRLTDFESPGGD---AAFQREVEMISVAVHRNLLRLIGFCTTPTERLL-VYPFM 363
G +VA+K L ++P + A F+RE + + H N++ L+ P L V+ ++
Sbjct: 3 GHEVAIKLLRT-DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-- 421
+ LRE+ + L R+ L L H N I+HRD+K N+++
Sbjct: 62 PGRT----LREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 422 -DEDFEAVVGDFGLAKL------VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFG 474
A V DFG+ L DV TT+V GT + APE L + +D++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 475 YGIMLLELVTGQRAIDFSRLEE 496
+G++ LE +TGQR + + + E
Sbjct: 175 WGLIFLECLTGQRVVQGASVAE 196
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
D + + +G G +G V + G KVA+K+L F+S RE+ ++ H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 342 NLLRLIGFCTTPTERL-------LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
N++ L+ TP L LV PFM + ++ K E + ++ + +
Sbjct: 75 NVIGLLD-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQML---- 128
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
+GL+Y+H IIHRD+K N+ ++ED E + DFGLA+ D T T
Sbjct: 129 -KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRW 180
Query: 455 HIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 486
+ APE L+ ++ D++ G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 23/177 (12%)
Query: 389 RVALGAARGLEYLH-EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNV 445
++A+ GL YL+ H +I+HRD+K +N+L++ + + DFG++ +L++ + T V
Sbjct: 107 KIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505
GT +++PE + GK + ++DV+ GI ++EL G+ FS DD D
Sbjct: 164 -----GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS---NIDDDGQDDP 215
Query: 506 VKKLEREKRLDAIVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
+ L+ L IV L + +++ + LL P +RP ++ M
Sbjct: 216 MGILD---LLQQIVQEPPPRLPSSDFPEDLRDFVDACLL---KDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 292 LGQGGFGKVYRGVLADGTK---VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG G FG V +GV K VA+K L + RE E++ + ++R+IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----------GL 398
C E L++ + E+ G P+ +++ K+ + + G+
Sbjct: 63 VCEA--EALML------------VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGM 108
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT--MGHI 456
+YL +HRD+ A NVLL A + DFGL+K + + + G +
Sbjct: 109 KYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVT-GQR 487
APE ++ K S R+DV+ YGI + E + GQ+
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+GQG G VY + +A G +VA+K++ + P + E+ ++ H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
E +V ++ S+ + E E + V R+ + LE+LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 137
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 470
HRD+K+ N+LL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 471 DVFGYGIMLLELVTGQ 486
D++ GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 36/118 (30%), Positives = 64/118 (54%), Gaps = 15/118 (12%)
Query: 373 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432
+ + E +L ++A+ + LEYLH +IHRDVK +NVL++ + + + DF
Sbjct: 96 KGLTIPEDIL-----GKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF 148
Query: 433 GLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE----RTDVFGYGIMLLELVTG 485
G++ LVD + T G ++APE ++ + + ++DV+ GI ++EL TG
Sbjct: 149 GISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ---REVEMISVAVHRN 342
F++ +G G FG VY +V + + + +Q +EV+ + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREI--KPGEPVLDWVTRKRVALGAARGLEY 400
+ G LV + L A L E+ KP L V + GA +GL Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--LGSASDLLEVHKKP----LQEVEIAAITHGALQGLAY 140
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
LH H +IHRD+KA N+LL E + + DFG A + + V GT +APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 461 ---LSTGKSSERTDVFGYGIMLLEL 482
+ G+ + DV+ GI +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 331 EVEMISVAVHRNLLRLIGFCTTPTERLLVYP-FMQNLSVAYRLREIKPGEPVLDWVTRKR 389
E ++ H ++++L G T L+ P + +L Y K + D + +R
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDL---YCYLAAKRNIAICDILAIER 189
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQ 448
L R ++YLHE+ +IIHRD+KA N+ ++ + +GDFG A VD+ N
Sbjct: 190 SVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYG 242
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
GT+ APE L+ D++ GI+L E+ T ++
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 292 LGQGGFGKVYRGVLADGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G G FGKV + T VA VK L S F ++ + + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 349 FCTTPTERLLVYPF--MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
C LLV+ + + +L + + +R+A A G+ ++H+H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS--QLLLLQRMACEIAAGVTHMHKH-- 118
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ--VRGTMGHIAPEY---- 460
+H D+ N L D VGD+G+ ++ + T+ + +APE
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 461 ---LSTGKSSERTDVFGYGIMLLELV--TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
L T + ++ ++V+ G+ L EL Q S E +L+HV K +++ +L
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKL 229
Query: 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
L Y+ E +V C SPE R EV R+L
Sbjct: 230 ---FKPQLELPYS----ERWYEVLQFC-WLSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
GL YLH +IIHRDVK N+ +++ + +GD G A+ V + + GT+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELV 483
APE L+ K + + D++ GI+L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 10/103 (9%)
Query: 389 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTT 447
++ + + L YL E +IHRDVK +N+LLD + DFG++ +LVD + T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKT 172
Query: 448 QVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQ 486
+ G ++APE + K R DV+ GI L+EL TGQ
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 286 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 342
F VLG+GGFG+V V A G A K+L + G+A E +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 399
++ L T LV M + + + + G P D +R AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFD---EERAVFYAAEITCGLE 116
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
LH +I++RD+K N+LLD+ + D GLA V++ + GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + + D +G G ++ E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 286 FSEKNVLGQGGFGKVYR-GVLADGTKVAVKRLTD--FESPGGDAAFQREVEMISVAVHRN 342
F VLG+GGFG+V V A G A K+L + G+A E ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLE 399
++ L T LV M + + + + G P D +R AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
L +I++RD+K N+LLD+ + D GLA V + + GT+G++APE
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPE 171
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
++ K + D +G G ++ E++ GQ F + +E VK+ E ++R+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP--FRKRKER--------VKREEVDRRV 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 284 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
D++ + LG+G + VY+G +G VA+K + E G RE ++ H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
++ L T LV+ ++ Y + PG + V K RGL Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH--PGGLHPENV--KLFLFQLLRGLSYIH 120
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YL 461
+ I+HRD+K N+L+ + E + DFGLA+ V + +V T+ + P+ L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLL 176
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRA 488
+ + S D++G G + +E++ G A
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 69/285 (24%), Positives = 130/285 (45%), Gaps = 55/285 (19%)
Query: 291 VLGQGGFGKV----YRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLR 345
V+G+G +G+V +R DG + +K+L S A ++E +++S H N++
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 346 LIGFCTTPTERL-LVYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEY 400
L +V F + + ++L+E K P V++W + A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
LHE I+HRD+K NV L VGD G+A++++ + +T + GT +++PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
S + ++DV+ G + E+ T + A + K ++++V
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN---------------------AKDMNSLVY 212
Query: 521 R-------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
R + K+Y+ + E +I +L + PE RP++ ++R
Sbjct: 213 RIIEGKLPPMPKDYSPELGE-LIA-TMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 50/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+GQG G VY + +A G +VA+K++ + P + E+ ++ + N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
E +V ++ S+ + E E + V R+ + L++LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALDFLHSN---QVI 137
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 470
HRD+K+ N+LL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 471 DVFGYGIMLLELVTGQ 486
D++ GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHR 341
NF + +G+G F +VYR L D VA+K++ FE A +E++++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N+++ + E +V ++ ++ K + ++ T + + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
H +++HRD+K ANV + +GD GL + KT + GT +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 462 STGKSSERTDVFGYGIMLLELVTGQ 486
+ ++D++ G +L E+ Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G G +G V + G KVA+K+L+ F+S RE+ ++ H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 350 CTTPT------ERLLVYPFMQ-NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
T+ + LV P+MQ +L ++ E + ++ + + GL+Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQML-----CGLKYIH 134
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEY 460
IIHRD+K N+ ++ED E + DFGLA+ D T VT R APE
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR------APEV 185
Query: 461 -LSTGKSSERTDVFGYGIMLLELVTGQ 486
L+ ++ D++ G ++ E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 45/304 (14%)
Query: 285 NFSEKNVLGQGGFGKVY----------------RGVLADGTK-VAVKRLTDFESPGGDAA 327
NF EK LG+G FG+V+ AD VAVK L S
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 328 FQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEP 380
F +EV+++S N+ RL+G CT ++ +M+N + L++
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 381 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
L + T +A A G+ YL +HRD+ N L+ +++ + DFG+++ +
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180
Query: 441 RKTNVTTQVRG-TMGHI---APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496
++ +V+G I A E + GK + ++DV+ +G+ L E++T R + L +
Sbjct: 181 -YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ ++++ R+ + R N +I E+ M++ C + EDRP E+
Sbjct: 240 QQ---VIENAGHFFRDDGRQIYLPRPPNCPKDIYEL--MLE----CWRRDEEDRPTFREI 290
Query: 557 VRML 560
L
Sbjct: 291 HLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 292 LGQGGFGKVYRG--VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
LG+G + VY+G L D VA+K + G REV ++ H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
T LV+ ++ Y + ++ K RGL Y H K+
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 468
+HRD+K N+L++E E + DFGLA+ + + +V T+ + P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
+ D++G G + E+ TG+ S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD---VRKTNVTTQVRGT 452
RGL+Y+H +IHRD+K +N+L++ED E +GDFG+A+ + T+ T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 453 MGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
+ APE LS + + D++ G + E++ G+R +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 32/230 (13%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGVL---ADGTK---VAVKRLTDFESPGGDAAFQRE 331
E+ L+T F E+ LG+ FGKVY+G L A G + VA+K L D F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 332 VEMISVAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLR----------EIKPGE 379
M S H N++ L+G T P + Y +L +R + K +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 438
L+ + A G+E+L H ++H+D+ NVL+ + + D GL + V
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 439 --DVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
D K N +R ++PE + GK S +D++ YG++L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE---MISVA 338
TD + +G+G +GKVY+ DG+ AVK L P D + E E + S+
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL----DPISDVDEEIEAEYNILQSLP 76
Query: 339 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
H N+++ G + + LV SV ++ + LD + G
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
A GL++LH N +IIHRDVK N+LL + + DFG++ + + T V GT
Sbjct: 137 ALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTP 192
Query: 454 GHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTG 485
+APE ++ + + R DV+ GI +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 10/208 (4%)
Query: 292 LGQGGFGKVYRG-VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
LG+G + V++G VA+K + G REV ++ H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
T LV+ ++ + Y + ++ K RGL Y H+ KI+
Sbjct: 73 HTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KIL 125
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSER 469
HRD+K N+L++E E + DFGLA+ V + +V T+ + P+ L + + S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 470 TDVFGYGIMLLELVTGQRAIDFSRLEEE 497
D++G G +L E+ TG+ S ++EE
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
NF VLG G +GKV+ G +L + A Q+ + RN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTG--KLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-------- 396
+ +P L Y F + L + GE R + R
Sbjct: 59 EHVR--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL 116
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
LE+LH+ I++RD+K N+LLD + V+ DFGL+K + T GT+ ++
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 457 APEYL-STGKSSERTDVFGYGIMLLELVTG 485
APE + G + D + GI++ EL+TG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 85/347 (24%), Positives = 132/347 (38%), Gaps = 91/347 (26%)
Query: 291 VLGQGGFGKVYRGVLADGTK------VAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 343
VLG G FGKV K VAVK L + + A E++ +I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 344 LRLIGFCTTPTERLLV---YPFMQNLS----------VAYRLREIKPGEPVLDWVT---- 386
+ L+G CT P L+V + NLS YR + K V
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 387 RKRVALGAARGLEYLH-----EHCNP---------------------------------- 407
+R+ G A L NP
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQVRGTMGHIAPEYLS 462
K IHRD+ A N+LL E+ + DFGLA+ + VRK + R + +APE +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS----ARLPLKWMAPESIF 249
Query: 463 TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
+ ++DV+ +G++L E+ + G ++ EE ++L+ R+ A
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTRMRA---- 298
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAER 568
E+ ++ L C Q P++RP S +V +L G+ L E
Sbjct: 299 ---PENATPEIY---RIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+GQG G V+ + +A G +VA+K++ + P + E+ ++ + N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
E +V ++ S+ + E E + V R+ + LE+LH + ++I
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE-----CLQALEFLHAN---QVI 137
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 470
HRD+K+ NVLL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 471 DVFGYGIMLLELVTGQ 486
D++ GIM +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 292 LGQGGFGKVYRG--VLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
LG+G + V++G L + VA+K + G REV ++ H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
T LV+ ++ Y + ++ K RGL Y H K+
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQY----MDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTGKSSE 468
+HRD+K N+L++E E + DFGLA+ V + +V T+ + P+ L + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
+ D++G G + E+ +G+ S +E+E
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 284 DNFSEK--NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFESPGGDAAFQREVEMISV 337
DN S K +LG G FG++ RG L +K VA+ L S F E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
H N++RL G T ++V +M N ++ LR+ E L + G A G
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASG 119
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI- 456
++YL E +H+ + A VL++ D + F +L + + + T + G +
Sbjct: 120 MKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLW 174
Query: 457 -APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAI-DFSRLEEEDDVLLLDHVKKLEREK 513
APE + S +DV+ +GI++ E+++ G+R D S D +K +E
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---------QDVIKAVEDGF 225
Query: 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
RL A N + + Q+ L C Q +RP S++
Sbjct: 226 RLPAPR--------NCPNL--LHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 291 VLGQGGFGKVYRGVL-ADGTKVAVKRLT--------DFESPGGDAAFQREVEMISVAVHR 341
VLG+G FGKV L G AVK L D E E ++S+A +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVE------CTMTEKRILSLARNH 55
Query: 342 NLLRLIGFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
L + C +RL V F+ + + +++ + D + A L +
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMF 111
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
LH+ II+RD+K NVLLD + + DFG+ K + T+ GT +IAPE
Sbjct: 112 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEI 167
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501
L D + G++L E++ G + E EDD+
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA 338
+L D+F + LG G G V + + ++L E P RE++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAAR 396
++ G + E + M S+ L+E K P E + +V++ R
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL------GKVSIAVLR 114
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNVTTQVRGTMGH 455
GL YL E +I+HRDVK +N+L++ E + DFG++ +L+D ++ GT +
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
++PE L S ++D++ G+ L+EL G+ I
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 1e-09
Identities = 49/196 (25%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+GQG G VY + +A G +VA++++ + P + E+ ++ + N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
E +V ++ S+ + E E + V R+ + LE+LH + ++I
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QVI 138
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT 470
HRD+K+ N+LL D + DFG + ++ +T V GT +APE ++ +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 471 DVFGYGIMLLELVTGQ 486
D++ GIM +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKR----LTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
+G+GG G+VY +VA+K+ L++ F RE ++ + +H ++ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL--KKRFLREAKIAADLIHPGIVPV 67
Query: 347 IGFCTTPTERLLVY---PFMQNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAAR 396
C+ + VY P+++ ++ L+ + E + + K +
Sbjct: 68 YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----------VDVRKTNVT 446
+EY+H ++HRD+K N+LL E V+ D+G A +DV + N+
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 447 T-------QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
++ GT ++APE L +SE TD++ G++L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+ + +G+G +G V G KVA+K+++ FE RE++++ H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 343 LLRLIGFCTTPT-----ERLLVYPFM----------QNLS---VAYRLREIKPGEPVLDW 384
++ ++ P+ + +V M Q+LS + Y L +I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI--------- 115
Query: 385 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-- 442
RGL+Y+H N ++HRD+K +N+LL+ + + + DFGLA++ D
Sbjct: 116 ----------LRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 443 TNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTG 485
T T+ T + APE + K ++ D++ G +L E+++
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 54/232 (23%)
Query: 291 VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+LG+G FGKV+ L A+K A +++V ++ V
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40
Query: 350 CTTPTERLLV----YPFMQNLSVAYRLRE--------IKPGEPVLDWVTRKRVALGAAR- 396
CT +R+L +PF+ +L ++ +E + G+ + + + L A
Sbjct: 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100
Query: 397 -------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK---LVDVRKTNVT 446
GL++LH + I++RD+K N+LLD D + DFG+ K L D + T
Sbjct: 101 YAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 498
GT +IAPE L K + D + +G++L E++ GQ F +EE+
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV 339
+L D+F + + LG G G V++ + ++L E I A+
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--------------IKPAI 46
Query: 340 HRNLLR---LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 388
++R ++ C +P F + ++ + + G LD V +K
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQI 104
Query: 389 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVDVRKTNV 445
+V++ +GL YL E KI+HRDVK +N+L++ E + DFG++ +L+D ++
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 158
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
GT +++PE L S ++D++ G+ L+E+ G+ I
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREV---EMISVA 338
D + + +G+G +GKVY+ G VA+K+ + + G RE+ +M+S +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 339 VHRNLLRLIGFCTTPTER-------LLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRV 390
++ ++RL+ E LV+ ++ +L PG P L T K
Sbjct: 61 IY--IVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSF 115
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQV 449
+G+ + H+H ++HRD+K N+L+D+ + + D GL + + + T ++
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 450 RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
T+ + APE L S D++ G + E+ Q
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 36/119 (30%), Positives = 65/119 (54%), Gaps = 17/119 (14%)
Query: 382 LDWVTRK----------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431
LD V +K ++++ RGL YL E KI+HRDVK +N+L++ E + D
Sbjct: 86 LDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 143
Query: 432 FGLA-KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
FG++ +L+D ++ GT +++PE L + ++D++ G+ L+E+ G+ I
Sbjct: 144 FGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 292 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G +G V++ + G VA+K+ + E P RE+ M+ H NL+ LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
+ LV+ + + +V L E++ + K++ + + + H+H
Sbjct: 69 FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSER 469
IHRDVK N+L+ + + + DFG A+++ + T V T + APE L G +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELL-VGDTQYG 179
Query: 470 T--DVFGYGIMLLELVTGQ 486
DV+ G + EL+TGQ
Sbjct: 180 PPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 11/101 (10%)
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTT 447
+A+ + L YL E KIIHRDVK +N+LLD + + DFG++ +LVD + K T
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----T 165
Query: 448 QVRGTMGHIAPEYLSTGKSSE---RTDVFGYGIMLLELVTG 485
+ G ++APE + R+DV+ GI L E+ TG
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 379 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KL 437
E VL R+A+ +GL YL + KI+HRDVK +N+L++ + + DFG++ +L
Sbjct: 94 EHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145
Query: 438 VD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496
V+ + KT V GT ++APE +S + +DV+ GI +EL G+ + ++++
Sbjct: 146 VNSIAKTYV-----GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR--FPYPQIQK 198
Query: 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
L+ + L IVD + Q E + C + P++RPA +
Sbjct: 199 NQGSLMPLQL--------LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250
Query: 557 V 557
+
Sbjct: 251 M 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 291 VLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQR--------EVEMISVAVHR 341
VLG+G FGKV L +V A+K L D Q E ++++A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKK------DVILQDDDVDCTMTEKRILALAAKH 55
Query: 342 NLLRLIGFCTTPTERLL-VYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR--- 396
L + C +RL V ++ + +++ R K EP R AA
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP--------RSRFYAAEVTL 107
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L +LH H +I+RD+K N+LLD + + DFG+ K + TT GT +I
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYI 163
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500
APE L + D + G+++ E++ GQ + + EDD+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVE-MISVAVHRNLLRLIG 348
LG G FG VY G VA+K++ F S + REV+ + + H N+++L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 349 FCTTPTERLLVYPFM-QNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCN 406
E V+ +M NL + R+ KP E V+ + + +GL ++H+H
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVI-----RSIIYQILQGLAHIHKH-- 118
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STG 464
HRD+K N+L+ + DFGLA+ + R T V T + APE L ST
Sbjct: 119 -GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YTDYV-STRWYRAPEILLRSTS 175
Query: 465 KSSERTDVFGYGIMLLELVTGQ 486
SS D++ G ++ EL T +
Sbjct: 176 YSSP-VDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 34/191 (17%)
Query: 308 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367
G +VAVK++ + + F EV ++ H N++ + E +V F++
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE--- 99
Query: 368 VAYRLREIKPGEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANV 419
G + D VT R V L + L +LH +IHRD+K+ ++
Sbjct: 100 ----------GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSI 146
Query: 420 LLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 475
LL D + DFG ++K V RK+ V GT +APE +S D++
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSL 201
Query: 476 GIMLLELVTGQ 486
GIM++E+V G+
Sbjct: 202 GIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 30/164 (18%)
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV------DVRKTNVTTQVRGTMGH 455
H H + +IHRD+K+AN+LL + +GDFG +K+ DV +T GT +
Sbjct: 158 HVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYY 211
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
+APE S++ D+F G++L EL+T +R D +EE V R
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------VMHKTLAGRY 262
Query: 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
D + +I I ALL + P+ RP+ S+++ M
Sbjct: 263 DPLPP-------SISPEMQEIVTALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAVHRN 342
+ +G+G FGK+Y ++ V + D A ++EV +++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-------PGEPVLDWVTRKRVALGAA 395
+ + F + E ++ M+ ++ I + +L W + ++LG
Sbjct: 61 I---VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG-- 113
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
L+++H+ KI+HRD+K+ N+ L ++ A +GDFG+A+ ++ + GT
Sbjct: 114 --LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPY 167
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+++PE + +TD++ G +L EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 15/116 (12%)
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVR-G 451
+ GL +LH II+RD+K NV+LD + + DFG+ K +VD VTT+ G
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD----GVTTRTFCG 163
Query: 452 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LLDH 505
T +IAPE ++ + D + YG++L E++ GQ D E+ED++ +++H
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 62/262 (23%), Positives = 116/262 (44%), Gaps = 52/262 (19%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGD------AAFQREVEMIS-------V 337
LG+G FG VY ++ D VA +RL E P G+ +E +++S V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVA 391
H + L FC ++ + + + +L E+K V +W + +
Sbjct: 66 KFHASFLERDAFC-------IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
G+ Y+H+ +I+HRD+KA N+ L + +GDFG+++L+ + ++ T G
Sbjct: 118 -----GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTG 167
Query: 452 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS-------RLEEEDDVLLLD 504
T +++PE L ++D++ G +L E+ A + R+ E L +
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE 227
Query: 505 HVKKLEREKRLDAIVDRNLNKN 526
++L++I+ LNK+
Sbjct: 228 TY-----SRQLNSIMQSMLNKD 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 291 VLGQGGFGKVY--RGVLAD--GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLR 345
VLGQG FGKV+ R + G A+K L D + I V H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRVALGAAR---GLEYL 401
L T + L+ F++ + RL +E+ T + V A L++L
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--------FTEEDVKFYLAELALALDHL 114
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEY 460
H + II+RD+K N+LLDE+ + DFGL+K +D K GT+ ++APE
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEV 169
Query: 461 LSTGKSSERTDVFGYGIMLLELVTG 485
++ ++ D + +G+++ E++TG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGT--KVAVKRLTDFESPGGDAAFQREVEM 334
R+ ++ ++F+ LG G FG+V + VA+KR FE + ++ ++
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR---FEK----SKIIKQKQV 75
Query: 335 ISVAVHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--- 389
V R +L I FC +Y ++ S Y + E G ++ R +
Sbjct: 76 DHVFSERKILNYINHPFCVN------LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129
Query: 390 --VALGAARGLEYLHEHCNP-KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
V A + + E+ I++RD+K N+LLD+D + DFG AK+VD R T
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ GT +IAPE L + D + GI + E++ G
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 48/251 (19%)
Query: 286 FSEKNVLGQGGFGKVY----------------------RGVLADGTKVAVKRLTDFESPG 323
F EK LG+G FG+V+ R +L VAVK L +
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL-----VAVKILRPDANKN 61
Query: 324 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKP 377
F +EV+++S N++RL+G C ++ +M+N LS + + +
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 378 GE---------PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428
G P + + + VAL A G++YL + +HRD+ N L+ E+
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIK 178
Query: 429 VGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
+ DFG+++ L + + + +A E + GK + +DV+ +G+ L E++ +
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
Query: 488 AIDFSRLEEED 498
+ L +E
Sbjct: 239 EQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 59/215 (27%), Positives = 89/215 (41%), Gaps = 25/215 (11%)
Query: 285 NFSEKNVLGQGGFGKVY--RGVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 340
NF VLG G +GKV+ R V G A+K L Q+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK------ATIVQKAKTTEHTRTE 54
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR---- 396
R +L I +P L Y F + + L I GE R+R +
Sbjct: 55 RQVLEHIR--QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112
Query: 397 ----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 452
LE+LH+ II+RD+K N+LLD + V+ DFGL+K + GT
Sbjct: 113 EIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 453 MGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTG 485
+ ++AP+ + G + D + G+++ EL+TG
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 21/163 (12%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
L YLH+ +I+HRD+ N++L ED + + DFGLAK + + T V GT+ +
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
PE + E+ DV+ +G +L ++ T Q +S ++L L K ++A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-YS-----TNMLSL-------ATKIVEA 228
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
+ + L + ++V +I C E RP + +V M+
Sbjct: 229 VYE-PLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQ---------REVEMISVAVHR 341
+G G FG V+ DG +VA+K++ + FQ RE++M+ H
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPN--------VFQNLVSCKRVFRELKMLCFFKHD 59
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-------IKPGEPVLDWVTRKRVALGA 394
N+L + P + PF + + V L + + P D V K
Sbjct: 60 NVLSALDILQPP----HIDPF-EEIYVVTELMQSDLHKIIVSPQPLSSDHV--KVFLYQI 112
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
RGL+YLH + I+HRD+K N+L++ + + DFGLA++ + ++ TQ T
Sbjct: 113 LRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 455 HIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDF 491
+ APE L + + D++ G + EL+ R I F
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
LG+G + VY+G+ +G VA+K ++ G RE ++ H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410
T V+ +M Y ++ PG L + RGL Y+H I+
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQH--PGG--LHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSSE 468
HRD+K N+L+ E + DFGLA+ + +++V T+ + P+ L +T SS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 469 RTDVFGYGIMLLELVTGQ 486
D++G G + +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 30/172 (17%)
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-----DVRKTNVTTQV 449
A+G+E+L + K IHRD+ A N+LL E+ + DFGLA+ + VRK +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD----A 241
Query: 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 508
R + +APE + + ++DV+ +G++L E+ + G +++EE ++
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 294
Query: 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
L+ R+ A +Y E M Q L C P RP SE+V L
Sbjct: 295 LKEGTRMRA-------PDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 292 LGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR----- 345
+G+G FG+VY+ D ++ A+K L+ E + E+ RN+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-------IVAKKEVAHTIGERNILVRTLLD 53
Query: 346 ----LIGF---CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-- 396
++G T ++ LV +M + + L+ K G + R A
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGR-----FSEDRAKFYIAELV 106
Query: 397 -GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
LE+LH++ I++RD+K N+LLD + DFGL+K ++ T GT +
Sbjct: 107 LALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEY 162
Query: 456 IAPEYLSTGKS-SERTDVFGYGIMLLELVTG 485
+APE L K ++ D + G+++ E+ G
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAV---HRNLLR 345
+G G +G VY+ G VA+K R+ E G + REV ++ H N++R
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 346 LIGFCTT-----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
L+ C T T+ LV+ + Y + PG P T K + RGL++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA---ETIKDLMRQFLRGLDF 123
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
LH +C I+HRD+K N+L+ + + DFGLA++ + T V T+ + APE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEV 178
Query: 461 LSTGKSSERTDVFGYGIMLLEL 482
L + D++ G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 292 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G +G V++ + VA+KR+ D + G ++ RE+ ++ H+N++RL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 350 CTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ + LV+ + Q+L + + G+ D K +GL + H H
Sbjct: 68 LHSDKKLTLVFEYCDQDLK---KYFDSCNGDI--DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAK 436
++HRD+K N+L++++ E + DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G +G VY+G G VA+K++ + E G + RE+ ++ H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
+ L++ F+ + + L + G+ +D K +G+ + H ++
Sbjct: 68 LMQESRLYLIFEFLS-MDLKKYLDSLPKGQ-YMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTNVTTQVRGTMGHIAPEYL-STGKS 466
+HRD+K N+L+D + DFGLA+ + VR V T T+ + APE L + +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTLWYRAPEVLLGSPRY 179
Query: 467 SERTDVFGYGIMLLELVT 484
S D++ G + E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-08
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 23 SDYQGDALFALRTSLRV-PNNQLRDWNQNQVNPCTWSNVICD 63
+ DAL A ++SL P+ L WN + +PC+W+ V CD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 31/237 (13%)
Query: 286 FSEKNVLGQGGFGKVYRGVLADGTK----------------VAVKRLTDFESPGGDAAFQ 329
EK LG+G FG+V+ A+G VAVK L + F
Sbjct: 9 LKEK--LGEGQFGEVHL-CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 330 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN--LSVAYRLREIKP------GEPV 381
+E++++S + N++RL+G C + ++ +M+N L+ REI+ P
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 382 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDV 440
+ +A+ A G++YL + +HRD+ N L+ + + DFG+++ L
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
+ + + +A E + GK + +DV+ +G+ L E+ T + +S L +E
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 382 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
DW K+ G+E LH+ IIHRD+K N+L+D+ + DFGL++
Sbjct: 96 EDWA--KQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150
Query: 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
K V GT ++APE + + +D + G ++ E + G
Sbjct: 151 KKFV-----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 308 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367
G +VAVK++ D EV ++ H N++ + E +V F++
Sbjct: 47 GKQVAVKKM-DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE--- 102
Query: 368 VAYRLREIKPGEPVLDWVTRKR--------VALGAARGLEYLHEHCNPKIIHRDVKAANV 419
G + D VT R V L R L YLH N +IHRD+K+ ++
Sbjct: 103 ----------GGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSI 149
Query: 420 LLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 475
LL D + DFG ++K V RK+ V GT +APE +S D++
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLPYGTEVDIWSL 204
Query: 476 GIMLLELVTGQ 486
GIM++E++ G+
Sbjct: 205 GIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 40/120 (33%), Positives = 65/120 (54%), Gaps = 21/120 (17%)
Query: 374 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433
E P E VL +R+ +GL++L E N IIHRDVK NVL++ + + + DFG
Sbjct: 97 EGIP-EDVL-----RRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG 148
Query: 434 LA-KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSER------TDVFGYGIMLLELVTG 485
++ LV + KTN+ G ++APE + +G ++ +DV+ G+ +LE+ G
Sbjct: 149 VSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 291 VLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-- 344
+LG+G FGKV +L A G A+K L ++EV + V L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKIL------------KKEVIIAKDEVAHTLTES 46
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVA-------LGA-- 394
R++ P L Y F + + + + GE L + ++R+RV GA
Sbjct: 47 RVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE--LFFHLSRERVFSEDRARFYGAEI 104
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
L YLH +++RD+K N++LD+D + DFGL K + GT
Sbjct: 105 VSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 160
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
++APE L D +G G+++ E++ G+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 36/211 (17%)
Query: 291 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR- 345
V+G+G FGKV LA DG AVK L A ++ E + RN+L
Sbjct: 2 VIGKGSFGKVL---LAKHKADGKFYAVKVLQK-------KAILKKKEQKHIMAERNVLLK 51
Query: 346 ------LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV-ALGA 394
L+G + ++L V ++ + + L RE EP R R A
Sbjct: 52 NVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEI 105
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
A L YLH II+RD+K N+LLD V+ DFGL K + + T+ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPE 161
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
++APE L D + G +L E++ G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 290 NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+G +GKV + G VA+K++ E ++ V M +H LR +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM--CGIHFTTLRELK 72
Query: 349 FCTT---PTERLLVYPFMQ----NLSV---AYRLREIKPGEPVLDWVTRKRVALGAARGL 398
LV +++ NL + A L+++ + L K + L GL
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK------LVDV--------RKTN 444
LH +HRD+ AN+ ++ + DFGLA+ D R+
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 445 VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQ 486
+T++V T+ + APE L K D++ G + EL+TG+
Sbjct: 190 MTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 66 NNVASVTLSSMNFSGT-LSPRIGVL-RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
+L N + T + P IG+L L L L N I +P L NL +L +LDL
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174
N L +P L NL L L LS N S +P + LS+L + L +N++
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221
|
Length = 394 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFESPGGDAAFQREVE---MISV 337
+D + +G+G +GKV++ VL +G+K AVK L P D + E E + ++
Sbjct: 17 SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKIL----DPIHDIDEEIEAEYNILKAL 71
Query: 338 AVHRNLLRLIGF-----CTTPTERLLVYPFMQNLSV-----AYRLREIKPGEPVLDWVTR 387
+ H N+++ G + LV SV + R + EP++ ++
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 388 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDVRKTNVT 446
+ A GL++LH + K IHRDVK N+LL + + DFG+ A+L R T
Sbjct: 132 E-----ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 447 TQVRGTMGHIAPEYLSTGKS-----SERTDVFGYGIMLLELVTG 485
+ GT +APE ++ + R DV+ GI +EL G
Sbjct: 184 SV--GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 45/241 (18%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMISVAVH 340
+F+ VLG+G FGKV +LA+ GT A+K L D Q + ++ V
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKK------DVVIQDD-DVECTMVE 50
Query: 341 RNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRLREI-KPGEPVLDWVTRKR 389
+ +L L G C +RL V ++ + Y+++++ + EP +
Sbjct: 51 KRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY---- 106
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTT 447
A A GL +LH + II+RD+K NV+LD + + DFG+ K + D VTT
Sbjct: 107 -AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD----GVTT 158
Query: 448 QVR-GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--LLD 504
+ GT +IAPE ++ + D + +G++L E++ GQ + E+ED++ +++
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSIME 215
Query: 505 H 505
H
Sbjct: 216 H 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 62/281 (22%), Positives = 117/281 (41%), Gaps = 38/281 (13%)
Query: 292 LGQGGFGKVYRGV---LADGTKV----AVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
LGQG F K+++G+ + D ++ + ++ D +F M+S H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
G C E ++V +++ S+ L++ K + W + VA A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLEDK 119
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH----IAPEY 460
+ H +V A NVLL + + G+ KL D ++T + + + PE
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD-PGISITVLPKEILLERIPWVPPEC 175
Query: 461 LSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519
+ ++ S D + +G L E+ +G + + LD KKL+ +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLSALDSQKKLQFYE------ 219
Query: 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
DR+ E+ +I C P+ RP+ ++R L
Sbjct: 220 DRHQLPAPKWTELANLINQ---CMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 333
R+LQ+ +++ V+G+G FG+V KV A+K L+ FE A F E +
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
+++ A +++L FC ++ L Y + E PG +++ ++ V
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYL-----------YMVMEYMPGGDLVNLMSNYDVPEK 142
Query: 394 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445
A+ L+ +H +IHRDVK N+LLD+ + DFG +D
Sbjct: 143 WAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199
Query: 446 TTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 485
GT +I+PE L + G D + G+ L E++ G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
LE LH+ +I+RD+K N+LLD + DFGL KL +++ + T GT ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTG 485
PE L ++ D + G++L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
EYLH + II+RD+K N+LLD V DFG AK V R T + GT ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAP 184
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVTG 485
E + + + D + G++L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 341
D + + N + +G +G VYR G VA+K+L + E G RE+ ++ H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 342 NLLRL--IGFCTTPTERLLVYPF--------MQNLSVAYRLREIKPGEPVLDWVTRKRVA 391
N++ + + + + +V + M+ + + E+K +
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC------------LM 112
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
L G+ +LH++ I+HRD+K +N+LL+ + DFGLA+ T V
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168
Query: 452 TMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTG 485
T+ + APE L + S D++ G + EL+T
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
EYLH II+RD+K N+LLD + + DFG AK + T GT ++A
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCGTPEYVA 160
Query: 458 PEYLSTGKSSERT-DVFGYGIMLLELVTG 485
PE + K + + D + GI+L EL+TG
Sbjct: 161 PEIIL-NKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 51/208 (24%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLAD--GTK--VAVKRLTDFESPGGDAAFQREVEMI 335
++ ++ + +G+G FG VY+GV K VAVK + SP F +E ++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 336 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE-IKPGEPVLDWVTRKRVALGA 394
H ++++LIG T V+ M+ L+ LR ++ + LD + +
Sbjct: 62 RQFDHPHIVKLIGVITENP----VWIVME-LAPLGELRSYLQVNKYSLDLASLILYSYQL 116
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
+ L YL + + +HRD+ A NVL+ +GDFGL++ ++ ++ + +
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLEL 482
+APE ++ + + +DV+ +G+ + E+
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 44/239 (18%)
Query: 271 LKRY-----SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PG 323
L RY +L++ ++F V+G+G FG+V +V A+K L+ FE
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84
Query: 324 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 383
D+AF E I + + L Y F Q+ Y + E PG +++
Sbjct: 85 SDSAFFWEERDI-----------MAHANSEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVN 132
Query: 384 WVTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435
++ + AR L+ +H + IHRDVK N+LLD+ + DFG
Sbjct: 133 LMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 436 KLVDVRKTNVTTQVR-----GTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 485
K + VR GT +I+PE L + G D + G+ L E++ G
Sbjct: 190 M-----KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 292 LGQGGFGKVY--------------RGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMI 335
L G FGK++ RGV + + + G AA Q E E++
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL 215
Query: 336 SVAV--HRNLLRLIGFCTTPTERLLV--------YPFMQNLSVAYRLREIKPGEPVLDWV 385
++ H N+L++ + ++ Y FM + + ++ R P+L
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR------PLL-KQ 268
Query: 386 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445
TR + +EY+H+ K+IHRD+K N+ L+ D + V+GDFG A + +
Sbjct: 269 TR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
GT+ +PE L+ E TD++ G++LL++++
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 288 EKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLR 345
EK +G+G +G VY+ G VA+K++ + E G + RE+ ++ H N++R
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
L+ + + LV+ F+ +L + + LD K +G+ Y H H
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 465
+++HRD+K N+L+D + + DFGLA+ V T +V T+ + APE L +
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 466 S-SERTDVFGYGIMLLELVTGQ 486
S D++ G + E+V +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 27/260 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 341
+ + + +G G +G V G +VAVK+L+ F+S RE+ ++ H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 342 NLLRLIGFCTTPT---ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
N++ L+ T E VY + +L A +K + D V + + RGL
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVY-LVTHLMGADLNNIVKCQKLTDDHV--QFLIYQILRGL 133
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
+Y+H + IIHRD+K +N+ ++ED E + DFGLA+ D T T + AP
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAP 186
Query: 459 E-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
E L+ ++ D++ G ++ EL+TG+ + DH+ +L+ RL
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT-----------DHIDQLKLILRLVG 235
Query: 518 IVDRNLNKNYNIQEVETMIQ 537
L K + + IQ
Sbjct: 236 TPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 20/191 (10%)
Query: 308 GTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365
GT V V R+TD E+ + A Q EV + H N++ TT + ++ PFM
Sbjct: 25 GTLVTV-RITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425
S L+ P E + + + + GA RGL YLH++ IHR++KA+++L+ D
Sbjct: 84 GSANSLLKTYFP-EGMSEALIGN-ILFGALRGLNYLHQN---GYIHRNIKASHILISGD- 137
Query: 426 EAVVGDFGLAKLVDVRKTNVTTQV--------RGTMGHIAPEYLSTGKS--SERTDVFGY 475
+V GL+ L + + +V + ++PE L + ++D++
Sbjct: 138 -GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 476 GIMLLELVTGQ 486
GI EL TG+
Sbjct: 197 GITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 4/119 (3%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L YLHE II+RD+K NVLLD + + D+G+ K +R + T+ GT +I
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 163
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
APE L D + G+++ E++ G+ D + D D++ ++ EK++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFES-PGGDAAFQREVEM 334
R+L++ +++ V+G+G FG+V KV A+K L+ FE D+AF E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE--- 92
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
R+++ F +P L Y F Q+ Y + E PG +++ ++ V
Sbjct: 93 -----ERDIM---AFANSPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW 143
Query: 395 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
AR L+ +H IHRDVK N+LLD+ + DFG K N
Sbjct: 144 ARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-----KMNKE 195
Query: 447 TQVR-----GTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTG 485
VR GT +I+PE L + G D + G+ L E++ G
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 284 DNFSEKNVLGQGGFGKV-YRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
DNF + +G+G G V V + G VAVK++ D EV ++ H N
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR--------VALGA 394
++ + E +V F++ G + D VT R V L
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLE-------------GGALTDIVTHTRMNEEQIAAVCLAV 125
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 450
+ L LH +IHRD+K+ ++LL D + DFG ++K V RK+ V
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----- 177
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
GT +APE +S D++ GIM++E+V G+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 291 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREV-----EMISVAVHR 341
V+G+G FGKV +LA DG AVK L Q+++ E + R
Sbjct: 2 VIGKGSFGKV---LLAKRKLDGKCYAVKVL------------QKKIVLNRKEQKHIMAER 46
Query: 342 NLLR-------LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV 390
N+L L+G + TE+L V F+ + + L RE EP +
Sbjct: 47 NVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFY 101
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
A A L YLH + I++RD+K N+LLD V+ DFGL K + +++ TT
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC 157
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
GT ++APE + D + G +L E++ G
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L +LHE II+RD+K NVLLD D + D+G+ K + + T+ GT +I
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYI 163
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490
APE L + D + G+++ E++ G+ D
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
D F +G+G +G+VY+ D G VA+K++ D E G RE++++ HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 342 NLLRLIGFCTTPTERL----------LVYPFM--------QNLSVAYRLREIKP-GEPVL 382
N++ L T + L LV+ +M ++ V + IK + +L
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ GL Y H +HRD+K +N+LL+ + + DFGLA+L + +
Sbjct: 127 E-------------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 443 TNVTTQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVT 484
+ T T+ + PE L + DV+ G +L EL T
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-07
Identities = 25/60 (41%), Positives = 33/60 (55%)
Query: 115 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174
+L SLDL NNRL + L L+ L LS NN + P++ + L SL S+ L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 340
D+ +G G FG+V+ A+K + + + E ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV-TRKRVALGAAR--- 396
++RL F T +R L Y L E PG + ++ R +
Sbjct: 61 PFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFYA 107
Query: 397 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
LEYLH +I++RD+K N+LLD++ + DFG AK + R T + G
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCG 160
Query: 452 TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
T ++APE + + ++ D + GI++ E++ G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
L +LHE II+RD+K NVLLD + + D+G+ K +R + T+ GT +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499
PE L D + G+++ E++ G+ D + + D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 35/232 (15%)
Query: 291 VLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL-- 344
+LG+G FGKV +L A G A+K L ++EV + V L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKIL------------KKEVIIAKDEVAHTLTES 46
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA-------LGA--A 395
R++ P L Y F + + + + GE ++R+RV GA
Sbjct: 47 RVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGAEIV 105
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
L+YLH + KI++RD+K N++LD+D + DFGL K + GT +
Sbjct: 106 SALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEY 161
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507
+APE L D +G G+++ E++ G+ E+ +++L++ +K
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRN 342
++F +G G +G VY+ + ++A ++ E PG D A Q+E+ M+ H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSN 67
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYL 401
++ G + + F S+ P E + +V+R+ + +GL YL
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYL 122
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIA 457
H + +HRD+K AN+LL ++ + DFG++ + RK+ + GT +A
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMA 174
Query: 458 PEYLST---GKSSERTDVFGYGIMLLEL 482
PE + G ++ D++ GI +EL
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 292 LGQGGFGKVYRGVLAD-GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G G +G V KVAVK+L+ F+S RE+ ++ H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA--------LGAARGLEYL 401
T T ++N + Y + + G + + V ++++ RGL+Y+
Sbjct: 83 FTPATS-------IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-Y 460
H + IIHRD+K +NV ++ED E + DFGLA+ D T T + APE
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIM 187
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQ 486
L+ ++ D++ G ++ EL+ G+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 48/217 (22%)
Query: 291 VLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
V+G+G FGKV +LA DG+ AVK L ++ E + RN+L
Sbjct: 2 VIGKGSFGKV---LLAKRKSDGSFYAVKVLQK-------KTILKKKEQNHIMAERNVLL- 50
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT---------RKRV------- 390
+ L +PF+ L +++ E VLD+V R+R
Sbjct: 51 ---------KNLKHPFLVGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRAR 99
Query: 391 --ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
A A + YLH II+RD+K N+LLD V+ DFGL K V T+
Sbjct: 100 FYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTST 155
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
GT ++APE L D + G +L E++ G
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 286 FSEKNVLGQGGFGKVY----RGVLADGTK-------------VAVKRLTDFESPGGDAAF 328
F EK LG+G FG+V+ G+ K VAVK L + + F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 329 QREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD----- 383
+E++++S N++RL+ C T ++ +M+N + L +P E
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 384 --WVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
+ T +A A G++YL + +HRD+ N L+ +++ + DFG+++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-YS 182
Query: 442 KTNVTTQVRGTMG--HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
Q R + ++ E + GK + +DV+ +G+ L E++T + +S+L +E
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
LG+G + VY+G G VA+K + G RE ++ H N++ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
T LV+ ++ Y + G L + RGL Y H+ ++
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYM--DDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RV 124
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL--STGKSS 467
+HRD+K N+L+ E E + DFGLA+ V + +V T+ + P+ L ST S+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 468 ERTDVFGYGIMLLELVTGQ 486
D++G G + E+ TG+
Sbjct: 184 S-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 23/200 (11%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRNLLRLIGFC 350
+G G +G VY+ ++A ++ E PG D + Q+E+ M+ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
+ + + + S+ P E + +V R+ + +GL YLH
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR----GTMGHIAPEYLSTGK 465
+HRD+K AN+LL ++ + + DFG+A K T R GT +APE + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 466 S---SERTDVFGYGIMLLEL 482
+ ++ D++ GI +EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIG 348
V+G+G +G V + G KVA+K++ D FE RE++++ + H +++ +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLRE------IKPGEPVLDWVTRKRVAL---GAARGLE 399
P+ R +++ V + L E IK D +T + R L+
Sbjct: 67 IMLPPSRREF-----KDIYVVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALK 117
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK--LVDVRKTNVTTQVRGTMGHIA 457
Y+H + HRD+K N+L + D + + DFGLA+ D T T + A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 458 PEYLST--GKSSERTDVFGYGIMLLELVTGQ 486
PE + K + D++ G + E++TG+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 49/203 (24%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 291 VLGQGGFGK--VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
V+G+G FG+ + + V +D K A+K + +S ++E +++ H N+ +
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI---VA 62
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIK-------PGEPVLDWVTRKRVALGAARGLEYL 401
F + +Y M+ +++IK P + +L W + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHI 116
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
HE +++HRD+K+ N+ L ++ + +GDFG A+L+ T V GT ++ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 462 STGKSSERTDVFGYGIMLLELVT 484
+ ++D++ G +L EL T
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 20/131 (15%)
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVD--------VRKTNVT 446
RGL+Y+H + ++HRD+K ANV ++ ED +GDFGLA++VD + + VT
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 447 TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505
R +P LS ++ D++ G + E++TG+ + E E L+L+
Sbjct: 182 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILES 234
Query: 506 VKKLEREKRLD 516
V + E R +
Sbjct: 235 VPVVREEDRNE 245
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 33/118 (27%), Positives = 66/118 (55%), Gaps = 18/118 (15%)
Query: 377 PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436
P + +LDW + +AL +++H+ KI+HRD+K+ N+ L +D +GDFG+A+
Sbjct: 99 PEDQILDWFVQICLAL------KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 437 L----VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490
+ V++ +T + GT +++PE + ++D++ G +L E+ T + A +
Sbjct: 150 VLNSTVELARTCI-----GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 30/166 (18%)
Query: 293 GQGGFGKVYRGVL---ADGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLL 344
G+G +G+VY+ DG + A+K+ F+ G + RE+ ++ H N++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 345 RLIGFCTTPTERL--LVYPFMQNLSVAYRLREI-----KPGEPVLDWVTRKRVALGAARG 397
L+ ++ L++ + + + L +I + + K + G
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE-----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 398 LEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVV--GDFGLAKLVD 439
+ YLH + ++HRD+K AN+L+ + VV GD GLA+L +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 308 GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367
G +VAVK + D EV ++ H+N++ + E ++ F+Q +
Sbjct: 46 GRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427
+ + + + E + V + L YLH +IHRD+K+ ++LL D
Sbjct: 105 LTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRV 156
Query: 428 VVGDFG----LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483
+ DFG ++K V RK+ V GT +APE +S D++ GIM++E+V
Sbjct: 157 KLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 484 TGQ 486
G+
Sbjct: 212 DGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 308 GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366
G VAVK+L+ F++ RE+ ++ H+N++ L+ TP + L + Q++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN-VFTPQKSLEEF---QDV 101
Query: 367 SVAYRLREIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDE 423
+ L + + + + +R++ + G+++LH + IIHRD+K +N+++
Sbjct: 102 YLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158
Query: 424 DFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 482
D + DFGLA+ TN + T T + APE + E D++ G ++ EL
Sbjct: 159 DCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 483 VTG 485
V G
Sbjct: 216 VKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
RGL+Y+H + ++HRD+K +N+LL+ + + + DFGLA+ + +T V T +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 456 IAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 486
APE L SE T DV+ G + EL+ +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 20/143 (13%)
Query: 360 YPFMQNLSVAYRLR-------EIKPGEPVLDWVTRKRVA-------LGA--ARGLEYLHE 403
+PF+ L A++ E G + ++R+RV GA LEYLH
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 113
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
+++RD+K N++LD+D + DFGL K + T GT ++APE L
Sbjct: 114 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 169
Query: 464 GKSSERTDVFGYGIMLLELVTGQ 486
D +G G+++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 292 LGQGGFGKVYRG-VLADGTKVAVKRLTD-FESPGGDAAFQREVE-MISVAVHRNLLRLIG 348
+G+G F +V + G A+K + F+S RE++ + ++ H N+LRLI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 349 FC-TTPTERL-LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
T RL LV+ M NL Y L IK + L K + L+++H +
Sbjct: 66 VLFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE-YLSTG 464
I HRD+K N+L+ +D + DFG + + + T+ T + APE L+ G
Sbjct: 120 --GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDG 174
Query: 465 KSSERTDVFGYGIMLLELVT 484
+ D++ G + E+++
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 60/247 (24%), Positives = 117/247 (47%), Gaps = 59/247 (23%)
Query: 262 VDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD---GTKVAVKRLTD 318
+D+ I L++Y E+ LG+G +G V++ + D VA+K++ D
Sbjct: 1 IDKHI----LRKY---EIL---------QKLGKGAYGIVWKAI--DRRTKEVVALKKIFD 42
Query: 319 FESPGGDAAFQ---------REVEMIS-VAVHRNLLRLIGFCTTPTER--LLVYPFMQ-N 365
AF+ RE+ + + H N+++L+ ++ LV+ +M+ +
Sbjct: 43 --------AFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD 94
Query: 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425
L I+ +L+ V ++ + + L+Y+H + +IHRD+K +N+LL+ D
Sbjct: 95 LHAV-----IRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDC 144
Query: 426 EAVVGDFGLAKLV----DVRKTNVTTQVRGTMGHIAPEYL--STGKSSERTDVFGYGIML 479
+ DFGLA+ + + + V T T + APE L ST + ++ D++ G +L
Sbjct: 145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST-RYTKGVDMWSVGCIL 203
Query: 480 LELVTGQ 486
E++ G+
Sbjct: 204 GEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 30/208 (14%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR---- 345
V+G+G FGKV A+ AVK L A ++ E + RN+L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQK-------KAILKKKEEKHIMSERNVLLKNVK 54
Query: 346 ---LIG--FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKRV-ALGAARG 397
L+G F ++L V ++ + Y L RE EP R R A A
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 108
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
L YLH + I++RD+K N+LLD V+ DFGL K ++ T+ GT ++A
Sbjct: 109 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLA 164
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTG 485
PE L D + G +L E++ G
Sbjct: 165 PEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 42/144 (29%), Positives = 72/144 (50%), Gaps = 17/144 (11%)
Query: 348 GFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPV--LDWVTRKRVALGAARGLEYL-HE 403
GF + ++ + + P + S + ++ + E LD R + A+G+++L +
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK 231
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----VRKTNVTTQVRGTMGHIAP 458
+C IHRDV A NVLL + A + DFGLA+ + V K N V+ +AP
Sbjct: 232 NC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK----WMAP 283
Query: 459 EYLSTGKSSERTDVFGYGIMLLEL 482
E + + ++DV+ YGI+L E+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT--------LSSMNFSGTLSPRI 86
+L + N L D + N +N+ N ++ + L ++ S +
Sbjct: 166 KNLDLSFNDLSDLPKLLSNLSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIEL 224
Query: 87 ----GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142
L+ LS L L N + ++PE +GNLS+L +LDL NN++ SLG+L L+
Sbjct: 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRE 281
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174
L LS N+ S +P L L + L
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 2e-06
Identities = 22/60 (36%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 92 LSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNF 150
L +L L N +T IP+ L +L LDL N L P + L L+ L LS NN
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/249 (18%), Positives = 111/249 (44%), Gaps = 28/249 (11%)
Query: 300 VYRGVLADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357
+Y+G+ + +V ++ F + E++ + N+L++ GF + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 417
+ LRE+ E L + T+ +A+ +GL L+++ N ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152
Query: 418 NVLLDEDFEAVVGDFGLAKLVDV---RKTNVTTQVRGTMGHIAPEYLST--GKSSERTDV 472
+ L+ E+++ + GL K++ + N M + + + L+ + + + D+
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVN-------FMVYFSYKMLNDIFSEYTIKDDI 205
Query: 473 FGYGIMLLELVTGQRAIDFSRLEEED--DVLLLDHVK-KLERE--KRLDAIVDRNLNKNY 527
+ G++L E+ TG+ I F L ++ D+++ + KL + + IV+ + +
Sbjct: 206 YSLGVVLWEIFTGK--IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263
Query: 528 ----NIQEV 532
NI+E+
Sbjct: 264 IKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 341
D + + +G+G +G VY+ +A+K++ + E G + RE+ ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR--KRVALGAARGLE 399
N++RL + LV+ ++ L++ P R K RG+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
Y H H +++HRD+K N+L+D A+ + DFGLA+ + T +V T+ + AP
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 459 EYLSTGKS-SERTDVFGYGIMLLELVT 484
E L + S D++ G + E+V
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 292 LGQGGFGKVYRGVL-ADGTKVAVKRLTDFE------SPGG--DAAFQREVEMISVAVHRN 342
LGQG F +Y+GVL V + AF ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
L++L G C E ++V +++ + L + L W + VA A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHR-EKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 403 EHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVD--VRKTNVTTQVR-GTMGHIA 457
+ K++H +V N+L+ E V KL D + T ++ + R + IA
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPF---IKLSDPGIPITVLSREERVERIPWIA 172
Query: 458 PEYLSTGKSSERT--DVFGYGIMLLEL 482
PE + G++S D + +G LLE+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHI 456
L+ +H ++HRD+K+AN+ L +GDFG +K D +V + GT ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
APE + S++ D++ G++L EL+T R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L+YLH N +++RD+K N++LD+D + DFGL K ++ GT ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
APE L D +G G+++ E++ G+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+F K+++G+G FG+V A G A+K + + E E R+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE-------RD 53
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+L + +P L Y F ++ Y + E +PG +L + R YL
Sbjct: 54 ILSI---SNSPWIPQLQYAFQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA 109
Query: 403 E-----HCNPKI--IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
E H ++ +HRD+K NVL+D + DFG A + K + GT +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 456 IAPEYLST----GKSSE--RTDVFGYGIMLLELVTGQ 486
IAPE L+T GK + D + G++ E++ G+
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
LE+LH+ II+RD+K N+LLD + DFGL K + + VT GT+ ++A
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMA 168
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
PE L + D + G ++ +++TG
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 280 QLATDNFSE---KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 335
A + SE N +G G G VY+ + G A+K + RE+E++
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 336 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV-AYRLREIKPGEPVLDWVTRKRVALGA 394
H N+++ E ++ FM S+ + + E L V R+ ++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILS--- 179
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG----LAKLVDVRKTNVTTQVR 450
G+ YLH I+HRD+K +N+L++ + DFG LA+ +D ++V
Sbjct: 180 --GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----- 229
Query: 451 GTMGHIAPEYLSTGKSSER-----TDVFGYGIMLLELVTGQ 486
GT+ +++PE ++T + D++ G+ +LE G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 40/198 (20%)
Query: 340 HRNLLRLIGFCTTPTERLLV---------YPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 390
+ N ++L TT +L+ + ++ E L K++
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-------------EGKLSEAEVKKI 114
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQV 449
L LH+H IIH D+K NVL D + + + D+GL K++ T
Sbjct: 115 IRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSC 165
Query: 450 -RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508
GT+ + +PE + D + G++ EL+TG+ E+ED+ L ++
Sbjct: 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK----EDEDEEL---DLES 218
Query: 509 LEREKRLDAIVDRNLNKN 526
L + ++ +N++KN
Sbjct: 219 LLKRQQKKLPFIKNVSKN 236
|
Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 358 LVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 416
LV P ++ Y ++P G + V R+ L A ++Y+H IIHRD+K
Sbjct: 237 LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQ--LLSA---IDYIHGE---GIIHRDIKT 288
Query: 417 ANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 475
NVL++ + +GDFG A T + GT+ APE L+ + D++
Sbjct: 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348
Query: 476 GIMLLE 481
G+++ E
Sbjct: 349 GLVIFE 354
|
Length = 461 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 395 ARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVR 450
A+G+ +L ++C IHRD+ A N+LL + DFGLA+ D+R + V R
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNYVVKGNAR 277
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLEL 482
+ +APE + + +DV+ YGI+L E+
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 51/223 (22%)
Query: 292 LGQGGFGKV----YRGVLADGTKVAVKRLTDFESPGGDAAFQ---------REVE-MISV 337
LGQG +G V ++ VA+K++T+ F RE++ +
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITN--------VFSKKILAKRALRELKLLRHF 58
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA-- 395
H+N+ L + F N + Y E E L + R L A
Sbjct: 59 RGHKNITCLYD---------MDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHF 107
Query: 396 --------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT- 446
GL+Y+H + ++HRD+K N+L++ D E + DFGLA+
Sbjct: 108 QSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 447 --TQVRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 486
T+ T + APE LS ++ DV+ G +L EL+ +
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 33/110 (30%), Positives = 60/110 (54%), Gaps = 12/110 (10%)
Query: 380 PVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438
P L ++ + A G+E+L ++C +HRD+ A NVL+ E + DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 439 DVRKTNVTTQVRGT----MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+R +N + +G+ + +APE + + +DV+ +GI+L E+ T
Sbjct: 290 -MRDSNYIS--KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 62/304 (20%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGD--AAFQREVEMISVAVHRNLLRLIGF 349
+ + T VAVK+ + +S + Q+E+ H N+L +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLH-EHC 405
+E +V P M S L+ P E + ++ + L+Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKGF 122
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-----RKTNVTTQVRGTMGHI---A 457
IHR VKA+++LL D + V+ GL V + R+ V + ++ ++ +
Sbjct: 123 ----IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 458 PEYLSTGKS--SERTDVFGYGI-------------------MLLELVTG--QRAIDFSRL 494
PE L +E++D++ GI MLLE V G +D S
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236
Query: 495 EEEDDVLLLDHVKKLERE---KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 551
+D + E +D R +++++ Q LC Q PE RP
Sbjct: 237 PLYEDSMS-QSRSSNEHPNNRDSVDHPYTRTFSEHFH--------QFVELCLQRDPESRP 287
Query: 552 AMSE 555
+ S+
Sbjct: 288 SASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 19/103 (18%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL---------------VDVRK 442
LEYLH N I+HRD+K N+L+ + DFGL+K+ D R+
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ QV GT +IAPE + + D + GI+L E + G
Sbjct: 171 F-LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
+G+G +G VY+ DG L E G + RE+ ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 352 TPTER--LLVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
+ ++R L++ + ++ + +R + L K + G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 406 NPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIAPE 459
++HRD+K AN+L+ E + D G A+L + ++ V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 460 YLSTGKS-SERTDVFGYGIMLLELVTGQ 486
L + ++ D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 268 FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDA 326
F LKRY N QG Y VL VA+K+L+ F++
Sbjct: 13 FTVLKRYQ---------NLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAK 61
Query: 327 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 386
RE+ ++ H+N++ L+ TP + L + Q++ + L + + + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLN-VFTPQKSLEEF---QDVYLVMELMDANLCQVIQMELD 117
Query: 387 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
+R++ + G+++LH + IIHRD+K +N+++ D + DFGLA+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 172
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483
+ T T + APE + E D++ G ++ E+V
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 41/152 (26%), Positives = 61/152 (40%), Gaps = 48/152 (31%)
Query: 370 YRLREIKPGEPVLDWVTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLL 421
+RL + +PG K ++ AR LEYLH I++RD+K N+LL
Sbjct: 89 FRLLQRQPG---------KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILL 136
Query: 422 DEDFEAVVGDFGLAKLVDVRKTNVTTQVR----------------------------GTM 453
E ++ DF L+K DV V+ +R GT
Sbjct: 137 HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTE 196
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+IAPE +S D + GI+L E++ G
Sbjct: 197 EYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 268 FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDA 326
F LKRY N QG Y +L VA+K+L+ F++
Sbjct: 20 FTVLKRYQ---------NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAK 68
Query: 327 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 386
RE+ ++ H+N++ L+ TP + L + Q++ + L + + + +
Sbjct: 69 RAYRELVLMKCVNHKNIIGLLN-VFTPQKSLEEF---QDVYIVMELMDANLCQVIQMELD 124
Query: 387 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
+R++ + G+++LH + IIHRD+K +N+++ D + DFGLA+ +
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 179
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ T T + APE + E D++ G ++ E++ G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-- 452
ARG+E+L + +HRD+ A NVLL + + DFGLA+ D+ + T
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYVSKGSTFL 301
Query: 453 -MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT 484
+ +APE + + +DV+ YGI+L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 292 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+GQGG+G+V+ D G VA+KR+ + + E+ V R++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK-------SLLFKLNEVRHVLTERDIL-----T 56
Query: 351 TTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAAR--------GLE 399
TT +E L L+Y F Q+ Y E PG + V + AR ++
Sbjct: 57 TTKSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
LHE IHRD+K N L+D + DFGL+K + V N V G+ ++APE
Sbjct: 116 ALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPE 168
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496
L D + G ML E + G S E
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 16/208 (7%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351
+G+G +G VY+ DG L E G + RE+ ++ H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 352 TPTER--LLVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
+ +R L++ + ++ + +R + L K + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 406 NPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVD--VRKTNVTTQVRGTMGHIAPE 459
++HRD+K AN+L+ E + D G A+L + ++ V T + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 460 YLSTGKS-SERTDVFGYGIMLLELVTGQ 486
L + ++ D++ G + EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 41/167 (24%)
Query: 294 QGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMIS------VAVHRNLLRL 346
+G FGKVY G + +K+ AVK + ++ +MI+ V R+ L L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVV-------------KKADMINKNMVHQVQAERDALAL 60
Query: 347 IG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---------LDWVTRKRVALGAA 395
F +Y +Q+ + Y + E G V D + A
Sbjct: 61 SKSPFIVH------LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
L+YLH H IIHRD+K N+L+ + + DFGL+K V + +
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG---TM 453
G+++LH + IIHRD+K +N+++ D + DFGLA R + + T
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPYVVTR 181
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ APE + E D++ G ++ E++ G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLTDFE-SPGGDAAFQREVEMISVAVHR 341
+ F V+G+G +G V + + + VA+K+ D E + RE++M+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ L + LV+ +++ ++ L E+ G P + V + + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKV--RSYIYQLIKAIHWC 116
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK-LVDVRKTNVTTQVRGTMGHIAPEY 460
H++ I+HRD+K N+L+ + + DFG A+ L + N T V T + +PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPEL 172
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQ 486
L + D++ G +L EL GQ
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVEMISVAVH 340
D+F V+G+G FG+V + ++ A+K L +E A F+ E
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--------- 51
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
RN+L + G C T L Y F Q+ + Y + + G +L +++ L Y
Sbjct: 52 RNVL-VNGDCQWITT--LHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 401 LHEHC-------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
+ E +HRD+K NVLLD + + DFG ++ T ++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 454 GHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQ 486
+I+PE L GK D + G+ + E++ G+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVEMISVAVH 340
++F V+G+G FG+V L + KV A+K L +E A F+ E +++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQN---LSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
+ + L LV + L++ + + P + ++ +A+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG-LAKLVDVRKTNVTTQVRGTMGHI 456
L Y +HRD+K N+L+D + + DFG KL++ + V GT +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170
Query: 457 APEYLST-----GKSSERTDVFGYGIMLLELVTGQ 486
+PE L GK D + G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
++F V+G+G FG+V R V G A+K L E F+++ ++ V R
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSE------MFKKD-QLAHVKAER 52
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW----------VTRKRVA 391
++L +P L Y F Q+ Y + E PG ++ VTR +A
Sbjct: 53 DVL---AESDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435
+E +H+ IHRD+K N+L+D + DFGL+
Sbjct: 109 -ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.5 bits (83), Expect = 0.002
Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 115 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 151
+L +LDL NN++ +PP L NL L+ L LS N +
Sbjct: 2 NLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 45/131 (34%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL----------------------- 434
+E +H IHRD+K N+L+D D + DFGL
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 435 ------------AKLVDVRKTNVTTQVR-------GTMGHIAPEYLSTGKSSERTDVFGY 475
+L + + R GT +IAPE L ++ D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 476 GIMLLELVTGQ 486
G++L E++ GQ
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 609 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.38 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.32 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.32 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.28 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.22 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.21 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.95 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.95 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.94 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.91 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.79 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.69 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.66 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.66 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.64 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.61 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.6 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.26 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.24 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.23 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-60 Score=555.78 Aligned_cols=468 Identities=26% Similarity=0.480 Sum_probs=344.9
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++.+|..+.++++|+.|+|++|+++|.+|..+.++++|++|+|++|+++|.+|..|+++++|+.|+|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 46888889999998888888889999999999999999899998999999999999999999999999999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCc--ccccCCcccCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCce
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKTLP---HSCESSSNDSGSSKKPKI 220 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~--~l~~l~~l~~~~n~~~c~~~~~---~~c~~~~~~~~~~~~~~~ 220 (609)
++|+++|.+|..+.++++|+.|++++|+++|.+|. .+..+....+.+|++.|+.+.. .+|.. ... ....
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~-----~~~-~~~~ 628 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR-----VRK-TPSW 628 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc-----ccc-ccee
Confidence 99999989999898999999999999999998884 3556677788899988875432 22321 111 1122
Q ss_pred eEEEeeeechhhhhhccceeeeecccccCccceeeecccccchhh-hhcCcccccCHHHHHHHhcCCCccCcccccCCce
Q 007290 221 GIIVGIVGGLIVLISGGLLFFLCKGRHKGYKREVFVDVAGEVDRR-IAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGK 299 (609)
Q Consensus 221 ~ii~~~v~~~~~l~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~ 299 (609)
.++++++++++++++++++++++++|+++.+........+..... ........++++++ ...|...++||+|+||.
T Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~ 705 (968)
T PLN00113 629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGA 705 (968)
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCee
Confidence 222322222233332222222222222211111000000000000 00000112233333 34577788999999999
Q ss_pred EEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCC
Q 007290 300 VYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG 378 (609)
Q Consensus 300 Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~ 378 (609)
||+|++ .+|..||||++..... ....|++++++++|||||+++++|.+++..++||||+++|+|.++++.
T Consensus 706 Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---- 776 (968)
T PLN00113 706 SYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776 (968)
T ss_pred EEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----
Confidence 999997 4789999999864322 123468889999999999999999999999999999999999999964
Q ss_pred CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCc
Q 007290 379 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458 (609)
Q Consensus 379 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aP 458 (609)
++|..+.+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||........ ....+++.|+||
T Consensus 777 ---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aP 847 (968)
T PLN00113 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAP 847 (968)
T ss_pred ---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCc
Confidence 7899999999999999999997767799999999999999999888875 6655432211 123578999999
Q ss_pred ccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC--CCCHHHHHHHH
Q 007290 459 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK--NYNIQEVETMI 536 (609)
Q Consensus 459 E~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~ 536 (609)
|++.+..++.++|||||||++|||+||+.||+.... ......+|............+.++.+.. .....+..++.
T Consensus 848 E~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (968)
T PLN00113 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924 (968)
T ss_pred ccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHH
Confidence 999999999999999999999999999999964322 2223445555444444455555655433 23456777899
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 537 QVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 537 ~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+++.+||+.+|++||+|.|+++.|++.
T Consensus 925 ~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 925 NLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 999999999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=434.41 Aligned_cols=289 Identities=51% Similarity=0.842 Sum_probs=252.2
Q ss_pred cccccCHHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeE
Q 007290 270 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349 (609)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 349 (609)
....|+++++..+|++|...++||+|+||.||+|...+|+.||||++....... ..+|..|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567799999999999999999999999999999999999999999886544332 5679999999999999999999999
Q ss_pred EeCCC-cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 350 CTTPT-ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 350 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
|.+.+ +.++|||||++|+|.++++..... .++|..|.+||.++|+||+|||+.+.|+|+||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 599999999999999999875433 689999999999999999999999999999999999999999999999
Q ss_pred EcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 429 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 429 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+|||+++..............||.+|+|||++..+..+.|+||||||+++.|++||+.|.+.... .....+.+|...
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHH
Confidence 999999965543111111111799999999999999999999999999999999999998886542 223337888888
Q ss_pred Hhhhccchhhcccccc-CCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLN-KNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+.+++|+.+. ..+.. .....+..++.+|++.+|++||+|.||+++|+..
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 8888899999999987 55554 6888899999999999999999999999999653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=388.69 Aligned_cols=255 Identities=33% Similarity=0.500 Sum_probs=210.8
Q ss_pred CCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-cceEEeecc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 363 (609)
....+.||+|+||+||+|.++....||||++.... +....+.|.+|+.++.+++|||||+++|+|..+. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33455699999999999999744449999997533 2223679999999999999999999999999888 799999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 441 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 441 (609)
++|+|..+++.. ....+++..+.+++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999874 345599999999999999999999999 7 99999999999999997 9999999999876543
Q ss_pred CCceeecccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLS--TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||...... ... ..+.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--------~~~---------~~v~ 259 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--------QVA---------SAVV 259 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--------HHH---------HHHH
Confidence 2 2334467999999999999 568999999999999999999999999754321 111 1112
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....++..+...+..+..++.+||+.||+.||++.+++..|+..
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 22223333344667899999999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=368.82 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=210.3
Q ss_pred CccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-cceEEeeccc
Q 007290 287 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLVYPFMQ 364 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 364 (609)
+..+.||+|..|+||+++++ +++.+|+|++.....+...+++.+|+++++..+||+||.+||.|..+. ...++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 33678999999999999987 688999999976666777889999999999999999999999999888 4999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
+|+|+..+... ..+++...-+|+.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+-..
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999875 338999999999999999999996 6 9999999999999999999999999999877543
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....+||..|||||.+++..|+.++||||||++++|+.+|+.|+............+. ..+.+...
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll------------~~Iv~~pp 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL------------CAIVDEPP 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH------------HHHhcCCC
Confidence 44567899999999999999999999999999999999999999976522222211111 12222111
Q ss_pred cCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 524 NKNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 524 ~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+..+. ..++++.+++..|+++||.+||++.|+++
T Consensus 300 -P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 -PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222 36788999999999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=386.13 Aligned_cols=257 Identities=30% Similarity=0.445 Sum_probs=221.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..+.+...+.||+|.||.||.|.++....||+|.++.. .....+|.+|+++|++++|+|||+++|+|..++..+||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 33444557889999999999999987779999999754 3345789999999999999999999999999889999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
||+.|+|.++|+. .++..+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...+.
T Consensus 282 ~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred ecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 9999999999987 4456689999999999999999999999 9999999999999999999999999999966655
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........-+..|.|||++..+.++.|||||||||+||||+| |+.|+... ...+.+..+.+..++..
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~ev~~~le~GyRlp~--- 425 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEEVLELLERGYRLPR--- 425 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHHHHHHHhccCcCCC---
Confidence 5555555556789999999999999999999999999999999 67776532 23355566666666543
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+..++..+.++|..||+.+|++||||+.+...|++.
T Consensus 426 -------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 426 -------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred -------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 445678899999999999999999999999998874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=352.65 Aligned_cols=259 Identities=20% Similarity=0.330 Sum_probs=212.3
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEe-EEeCCCc-ceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIG-FCTTPTE-RLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 359 (609)
.+|++.+.||+|.||+||++.. .+|..||.|.++-. -+....++...|+.+|++++|||||++++ .+..+.+ ..+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4567788999999999999994 58999999998732 23445677889999999999999999998 4444444 8899
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
||++.+|+|...++..+.++..+++.++++++.|+++||..+|++.. + |+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999988889999999999999999999999999432 4 88999999999999999999999999998
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
+.... ......+|||.||+||.+....|++||||||+||++|||+.-.+||.... +.+........
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~qg----- 243 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQG----- 243 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHcC-----
Confidence 86543 33456789999999999999999999999999999999999999997542 22222222111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
...+-....++.++..|+..|+..||+.||+...+++.+.
T Consensus 244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111123667889999999999999999998554444443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=375.70 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=212.9
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.+|...+.||+|||++||.++. ..|..||+|++.+. ..+...+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999997 78999999999753 24556788999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|.|.+++|..+++.. ..+++++++.+..||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999998853 3499999999999999999999999 999999999999999999999999999999874
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh-hhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-REKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 519 (609)
+. ....+.+|||.|+|||++....++..+||||+||++|-|++|++||+.....+. ...+. .+..
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket--------y~~Ik~~~Y~----- 236 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET--------YNKIKLNEYS----- 236 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH--------HHHHHhcCcc-----
Confidence 43 334567899999999999999999999999999999999999999975433211 11111 0111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+...+.+..+|+.++|+.+|.+|||+++|+.
T Consensus 237 -------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 -------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12344567889999999999999999999994
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=358.27 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=203.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..+|...+.||+|+||+||+|+++ ++..||||.+.... .+...+.+..|+.+|+.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999975 68999999997543 4556778889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC------CcEEEccccc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED------FEAVVGDFGL 434 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGl 434 (609)
|||.||+|.++++... .+++.+.+.++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998754 389999999999999999999999 99999999999999864 5689999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
|+.+.. .......+|++.|||||+++.++|+.|+|+||+|+++|+|++|+.||+.....+ ..........
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~~ 231 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGNE 231 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcccc
Confidence 998863 344556789999999999999999999999999999999999999998554322 1112221111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 557 (609)
. .+..+...+..+.+++...++.+|.+|-++.+-.
T Consensus 232 ~--------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 232 I--------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred c--------cCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 1 1122223334455666677777777776655544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=345.03 Aligned_cols=267 Identities=21% Similarity=0.308 Sum_probs=208.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
+.|+...++|+|+||+||+++++ +|+.||||++.+..+ +...+-.++|++++++++|+|+|.++++|......++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999976 599999999987554 3344556799999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++. ++.+.++....+ ++.....+++.|+++|+.|+|++ +++||||||+|||++.++.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9988 444445443333 88899999999999999999999 999999999999999999999999999998875
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc-------chhHHHHHHHHhhhc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-------DVLLLDHVKKLEREK 513 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~ 513 (609)
.....+.++.|.+|.|||.+.+ .+|+..+||||+||++.||+||.+-|+..+...+- +..+..+..-....+
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 4455667788999999999987 68999999999999999999999999765432110 000111111111111
Q ss_pred c-----chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 R-----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~-----~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. +.++-++.......+..+..+.+++..|++.||++|++.+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 11111111111123445568899999999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=354.27 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=205.9
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCc------hHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPG------GDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+..... .....++|+++|++++|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456688899999999999999995 479999999997533221 2234579999999999999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGD 431 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 431 (609)
..|+|+||++||.|.+.+-..+ .+.+..-+.++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999986533 366677788999999999999999 99999999999999766 7899999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
||+|+..+ ....+.+.+||+.|.|||++.+.. +..++||||+||++|-+++|.+||.....+ ..+.+.+..
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~sl~eQI~~ 396 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PSLKEQILK 396 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----ccHHHHHhc
Confidence 99999876 445677889999999999997654 345889999999999999999999743322 111111111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
++.. .-+......+++..+++.+|+..||++|||+.|++++
T Consensus 397 ----G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 ----GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1110 0012234566889999999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.32 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=218.8
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
.+....+....+.||+|.||+||+|+.. +...||||.+++..+.+...+|++|+++++.++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3444555666789999999999999853 3567999999988777788999999999999999999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCC----------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPG----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 422 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 422 (609)
.+..++|+|||..|+|..+|+...+. ...++..+.+.||.|||.||+||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999754321 22388889999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceeeccCCCcee-ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccch
Q 007290 423 EDFEAVVGDFGLAKLVDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDV 500 (609)
Q Consensus 423 ~~~~~kl~DfGl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~ 500 (609)
++..|||+|||+++..-..+.... ....-+.+|||||.|..++||.+||||||||+|||++| |+.||....-
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------ 711 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------ 711 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence 999999999999986643333322 23445789999999999999999999999999999999 7888764322
Q ss_pred hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+.+-...+.+++ -..+..++.++.+||..||+.+|.+||+++||-..|+..
T Consensus 712 ---~EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 712 ---QEVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ---HHHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 112222222222 123556778999999999999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=343.25 Aligned_cols=259 Identities=24% Similarity=0.261 Sum_probs=210.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.++||+|+||+||.++.+ +++.+|+|++++.. .....+....|..++.+++||.||+++-.+.+.+..++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4578999999999999999999965 68999999998643 23346778899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|+||+.||.|...|++. ..+++..++-++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999863 3489999999999999999999999 9999999999999999999999999999854
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
- .....+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...... .+........
T Consensus 176 ~-~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~--------~~~~~I~~~k----- 241 (357)
T KOG0598|consen 176 L-KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--------KMYDKILKGK----- 241 (357)
T ss_pred c-cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH--------HHHHHHhcCc-----
Confidence 3 2333445578999999999999999999999999999999999999999754321 2222222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 566 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 566 (609)
....+...+.+..+++.+.++.||++|-....=...++...+.
T Consensus 242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 1111222446789999999999999996422222234444443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.91 Aligned_cols=262 Identities=28% Similarity=0.448 Sum_probs=214.2
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
.+++++..+.+.+.+.||+|.||+||+|+|. ..||||++.... ++...+.|..|+.++++-+|.||+-+.|+|..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3677777888888999999999999999985 479999997433 4456789999999999999999999999999988
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
. .+|+.+|+|.+|+.+++... ..++..+...|+.|||+|+.|||.+ +|||||||..|||+.+++.|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 99999999999999998744 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCC-CceeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007290 435 AKLVDVRK-TNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 435 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
+..-.... ........|...|||||++.. .+|++.+||||||+++|||+||..||.....+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------------- 600 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------------- 600 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--------------
Confidence 97543321 112233457889999999964 468999999999999999999999997322211
Q ss_pred hhccchhhccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 511 REKRLDAIVDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.+-.+-...+.++ .....+.++.+|+..||+.++++||.+.+|+..|+..
T Consensus 601 ---IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 601 ---IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ---eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 1111111111111 1234556899999999999999999999999988765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=340.84 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=204.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC--cceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 360 (609)
.+|...+.||+|+||+||++... +|...|||.+.....+. .+.+.+|+.++.+++|||||+.+|...... ...+.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 45667899999999999999975 48999999886543222 667899999999999999999999865555 588999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeec
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVD 439 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~ 439 (609)
||+++|+|.+++..... .+++..++.+..||++||+|||++ +|+|+||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987442 499999999999999999999999 9999999999999999 7999999999998776
Q ss_pred c--CCCceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 440 V--RKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 440 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
. ..........||+.|||||++..+. ...++||||+||++.||+||+.||... . .............
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~------~~~~~~~~ig~~~--- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F------EEAEALLLIGRED--- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c------chHHHHHHHhccC---
Confidence 3 2222344577999999999998543 345999999999999999999999742 0 0011111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
..+..+...+.+..+++.+|++.+|++|||++++++..-
T Consensus 240 ------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 ------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111334445678899999999999999999999997544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.74 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=206.6
Q ss_pred HHHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
++..++|++.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999974 235689999997544444557789999999999 89999999998876
Q ss_pred CC-cceEEeecccCchhhhhhhhcCCC-----------------------------------------------------
Q 007290 353 PT-ERLLVYPFMQNLSVAYRLREIKPG----------------------------------------------------- 378 (609)
Q Consensus 353 ~~-~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------- 378 (609)
.+ ..+++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 578899999999999998753210
Q ss_pred -----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc-eeeccccc
Q 007290 379 -----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGT 452 (609)
Q Consensus 379 -----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt 452 (609)
...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12477888899999999999999999 9999999999999999999999999999865332221 12233467
Q ss_pred ccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHH
Q 007290 453 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQE 531 (609)
Q Consensus 453 ~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 531 (609)
+.|+|||++.+..++.++|||||||++|||++ |..||....... .. .......... ......
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~---~~~~~~~~~~----------~~~~~~ 302 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EF---CQRLKDGTRM----------RAPENA 302 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HH---HHHHhcCCCC----------CCCCCC
Confidence 88999999988899999999999999999997 999997533211 01 1111111100 012233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 532 VETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 532 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 46789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=332.39 Aligned_cols=269 Identities=25% Similarity=0.374 Sum_probs=214.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
...+.|++.+.||.|..++||+|+. ..+..||||++.-.......+.+.+|+..++.++||||++++..|..+.+.++|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3567899999999999999999995 468999999997544445578899999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|.||.+|++.+.+....+.+ +++..+..|..++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 103 mpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998876554 89999999999999999999999 99999999999999999999999999876664
Q ss_pred cCCCcee---ecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 440 VRKTNVT---TQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 440 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
....... ...+||++|||||++.. ..|+.|+||||||++..||.+|..||....+. .+.+. .+....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~----tLqn~p- 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLL----TLQNDP- 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHH----HhcCCC-
Confidence 3322211 44689999999999543 46999999999999999999999999743321 11111 111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~ 563 (609)
....-..+..+........+.+++..|+++||++|||++++++ +++..
T Consensus 250 -p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 250 -PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred -CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0000111111223344568999999999999999999999984 55544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.19 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=206.7
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 359 (609)
+.|+.+++||+|.||.||+|++ .+|+.||+|+++-.. .+....-..+||.+|++++||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566678899999999999995 579999999997433 344556677999999999999999999988766 679999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
||||++ +|.-++.. .+..++..+++.++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999988 77777654 234599999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH---hhhccc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL---EREKRL 515 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 515 (609)
.......+..+-|.+|.|||++.+. .|+.+.|+||.|||+.||++|++.|......++.. ...+-+ ....+.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~----kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH----KIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH----HHHHHhCCCChhccc
Confidence 7766667777889999999998874 79999999999999999999999987654332211 111111 000000
Q ss_pred -hhhcccc-c--cCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 -DAIVDRN-L--NKNY-------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 -~~~~~~~-l--~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+..-. + ...+ ....+....+|+..+|..||++|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000 0 0111 1223457789999999999999999999984
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.29 Aligned_cols=268 Identities=21% Similarity=0.270 Sum_probs=208.4
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCC-cceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT-ERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 358 (609)
..++|.+.+.||.|.||+||+|+. .+|..||||++++..-.-++..-.+|++.|++++ ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456889999999999999999995 4799999999975433323334468999999999 999999999998887 8999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|||||+. +|..++++. +..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999975 899999874 56799999999999999999999999 9999999999999998889999999999987
Q ss_pred ccCCCceeecccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-----Hhhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK-----LERE 512 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~ 512 (609)
... ...+.++.|.+|.|||++. .+.|+.+.||||+||+++|+.+-++.|.+....++.. .+.+.... ....
T Consensus 161 ~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~-KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY-KICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH-HHHHHhCCCccccchhH
Confidence 543 3355678899999999875 5679999999999999999999999987644321100 00000000 0000
Q ss_pred ccchhhcccccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 KRLDAIVDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 ~~~~~~~~~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+...+.=.+. ....+..+.+..+++.+|+++||++|||+.|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111110110 11123467889999999999999999999999863
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=365.58 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=219.9
Q ss_pred hcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.....+.++||.|.||.||+|+++- ...||||.++...++.+..+|+.|+.++.+++||||++|.|+........+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3445678999999999999999762 346999999988888899999999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|.|||++|+|+.+|++.. ..+++.+...++.+||.||.||-+. ++|||||..+|||++.+..+||+|||+++.+
T Consensus 708 iTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999754 3389999999999999999999999 9999999999999999999999999999988
Q ss_pred ccCCCceeeccc--ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 439 DVRKTNVTTQVR--GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 439 ~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
.+......+... -+.+|.|||.+..+++|.+|||||||++|||.++ |+.||=.. .+ .+.++..+...++
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--SN------QdVIkaIe~gyRL 853 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SN------QDVIKAIEQGYRL 853 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--ch------HHHHHHHHhccCC
Confidence 655433333222 3579999999999999999999999999999776 88886321 11 1344455555554
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
. .+.+++..|.+||..||++|-.+||+|.||+..|.+..
T Consensus 854 P----------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 854 P----------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred C----------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 3 35566789999999999999999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=344.52 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=208.8
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCc
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 355 (609)
.....+|..++.||+|+|++|++|+.+ +++.||||++.+.. .+...+....|-.+|.++ .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 345578899999999999999999964 68999999986432 223345567888899998 79999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.|+|+||.++|+|.++++.... +++...+.++.+|+.||+|||++ |||||||||+|||+|+|+++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999988643 89999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCc----------e--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 436 KLVDVRKTN----------V--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 436 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
+.+.+.... . ....+||..|.+||++..+..+..+|+|+|||++|+|+.|.+||.....- ...
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-----liF 296 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-----LIF 296 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-----HHH
Confidence 988643222 1 13478999999999999999999999999999999999999999754321 111
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+ ++++ +.-.+++..++...+|+.+.+..||.+|+|..+|-+
T Consensus 297 q------------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 Q------------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred H------------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1 1111 112234445578899999999999999999966653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.66 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=207.4
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|...++||+|.||.||+|++ ++|+.||||+++-.. ..+......+|++.++.++|+||+.+++++...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999995 579999999997433 23345677899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
||+. +|...+++ ....++-.++..++.++.+|++|||++ .|+||||||.|+|++.+|.+||+|||+++.+..+
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9986 88888875 345688899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
....... +.|..|.|||.+.+ ..|+...||||.||++.||+-|.+-|...+.-++ ...+.+.........+.+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-----L~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-----LSKIFRALGTPTPDQWPE 228 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-----HHHHHHHcCCCCcccCcc
Confidence 4443333 67999999998877 4699999999999999999999887765433221 111111111111111000
Q ss_pred -------------cc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 521 -------------RN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 521 -------------~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+. ......+..+.+..+++..++..||.+|+++.|.+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00 0011234455677999999999999999999999853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=342.22 Aligned_cols=263 Identities=27% Similarity=0.392 Sum_probs=226.1
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
++++....+..+.++||.|.||.||.|.|+. .-.||||.++.. ....++|+.|..+++.++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 6677777788889999999999999999974 567999999754 3457899999999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.|+|+|||.+|+|.++|++.... .++....+.++.||+.||+||..+ ++|||||..+|+|+.++..+||+|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999986543 367777889999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
+.+............-++.|.|||.+....++.|+|||+|||+|||+.| |..||.. +.+.+.+.-++...+
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlSqVY~LLEkgyR 484 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLSQVYGLLEKGYR 484 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHHHHHHHHhcccc
Confidence 9987665555555556789999999999999999999999999999998 7777753 334444444554444
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
+. .+..+++.+.+||..||+++|.+||++.|+-+.++.+-
T Consensus 485 M~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 485 MD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 43 35566789999999999999999999999999998753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=369.26 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=215.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC--CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA--DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.+.....+.||+|+||.||.|... +|. .||||.+++..+.+...+|.+|..+++.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455666789999999999999965 344 49999999888888899999999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCC---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
++++|||++|+|..+|++..+. ...++......++.|||+|+.||+++ ++|||||..+|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999985322 34588899999999999999999999 99999999999999999999999999
Q ss_pred cceeeccC-CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007290 434 LAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 434 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
+|+.+... .........-+.+|||||.+..+.++.|+|||||||++||++| |..||...... +.......
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--------~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--------EVLLDVLE 919 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--------HHHHHHHh
Confidence 99944332 2222223345679999999999999999999999999999999 77787632211 11122222
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 565 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 565 (609)
.+++. .+..++..+.++|.+||+.+|++||++..|++.+.....
T Consensus 920 ggRL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GGRLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 33322 244556788999999999999999999999998876643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.71 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=203.1
Q ss_pred CccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 287 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
...+-||.|+.|.||+|+++ ++.||||+++... ..+|+-|++++||||+.+.|+|.....+++|||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 34667999999999999995 7899999886422 35788899999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 446 (609)
-|...|+. +..+.-.....|..+||.||.|||.+ .|||||||.-||||+.+..+||+|||.++..... ...
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 99999986 33477778889999999999999999 9999999999999999999999999999877643 334
Q ss_pred ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC
Q 007290 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526 (609)
Q Consensus 447 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 526 (609)
..++||..|||||++.+.+.+.|+|||||||+||||+||..||..-...+ .+..+-...+.-.
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------------IIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------------IIWGVGSNSLHLP 331 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------------eEEeccCCccccc
Confidence 45789999999999999999999999999999999999999986322110 1111111122223
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 527 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.+..++..+.-|+++||+..|..||+|.+|+.+|+-.
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 4566778899999999999999999999999999754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=329.28 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=206.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|++.+.||+|+||.||+|.++ .+..||+|+++..........+.+|+.++.+++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999863 3568999999765444555788999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987532 3488999999999999999999999 9999999999999999999999999987654
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~--- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFR--- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC---
Confidence 3222111222335678999999999999999999999999999775 99998643211 11111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.......+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 227 -------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11123345678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=332.55 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=214.8
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
....|...+.||+|.||.||+|.+ +.++.||+|++.-.......+++++|+.++.+++++||.++|+.+......+++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 344577789999999999999996 4789999999986666777889999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|||.||++.+.++-.. .+++..+.-++.++..|+.|||++ +.+|||||+.|||+..+|.+||+|||.+..+..
T Consensus 91 ey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999997532 246666677888999999999999 999999999999999999999999999987764
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.... ....+||+.|||||+++...|+.|+||||||++.+||.+|.+|+....+ .+..-++-
T Consensus 164 ~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------------mrvlflIp 224 (467)
T KOG0201|consen 164 TVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------------MRVLFLIP 224 (467)
T ss_pred hhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------------ceEEEecc
Confidence 4333 3667899999999999988999999999999999999999999864332 12222222
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~ 562 (609)
+...+......+..+.+++..|++++|+.||++.++++ +++.
T Consensus 225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 22333344466778999999999999999999999985 5655
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=333.78 Aligned_cols=266 Identities=21% Similarity=0.333 Sum_probs=204.3
Q ss_pred hcCCCccCcccccCCceEEEEEeCC-----------------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD-----------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 345 (609)
.++|.+.+.||+|+||.||+|.+++ +..||+|.+...........|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578889999999999999998532 33699999875444445567999999999999999999
Q ss_pred eEeEEeCCCcceEEeecccCchhhhhhhhcCC---------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007290 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410 (609)
Q Consensus 346 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 410 (609)
+++++...+..++||||+++|+|.+++..... ....+++..+.+++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999998999999999999999998864321 113478888999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC--CC
Q 007290 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG--QR 487 (609)
Q Consensus 411 H~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg--~~ 487 (609)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999866433221 22234467899999999888999999999999999999974 45
Q ss_pred CCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 488 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 488 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
||..... ......+........... .....+..+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD-----EQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH-----HHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6543221 111111111111110000 001122334678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=345.31 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=206.2
Q ss_pred HHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 353 (609)
...++|++.+.||+|+||+||+|.+ .++..||||+++........+.+.+|++++..+ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3455788899999999999999974 246689999997544444567788999999999 899999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCC--------------------------------------------------------
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKP-------------------------------------------------------- 377 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 377 (609)
...++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864221
Q ss_pred ---------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 378 ---------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 378 ---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
....+++..+.+++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 112478888999999999999999999 99999999999999999999999999998664322
Q ss_pred Cce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 443 TNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 443 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
... .....++..|+|||.+.+..++.++|||||||++|||+| |..||....... ..... .....
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~---~~~~~------- 334 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKM---IKEGY------- 334 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHH---HHhCc-------
Confidence 211 122335678999999999999999999999999999998 888886432211 11111 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
....+...+.++.+++.+||+.||++||++.||++.|+.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 000111224578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.52 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=209.9
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
..|..-+.||+|+.|.||.|.. .+++.||||++.... ....+-+..|+.+++..+|+|||.+++.|...++.+.||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3577778999999999999995 478899999996432 33456678999999999999999999999888999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
|+||+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999987633 88999999999999999999999 99999999999999999999999999999886544
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. .....+||+.|||||+.....|++|.||||||++++||+-|++||-....- .-.......+.
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~ng~-------- 486 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT-------- 486 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhcCC--------
Confidence 3 456678999999999999999999999999999999999999998542221 00011111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 562 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~ 562 (609)
..-......+..+.+++.+||+.|+++||++.|+++ +|+.
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 111224556689999999999999999999999996 4533
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=336.90 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=206.5
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC---C-chHHHHHHHHHHHHhcc-CCCcceeEeEEeCCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES---P-GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT 354 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 354 (609)
...+.|.+.+.||+|.||+|+.|.+. +|..||+|.+..... . ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45678999999999999999999864 789999997654311 1 33556678999999999 999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFG 433 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 433 (609)
..++||||+.+|+|.+++.... .+.+...++++.|++.|++|+|++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998732 377899999999999999999999 99999999999999999 999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK-SS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+...... ....
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------l~~k--- 234 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------LYRK--- 234 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--------HHHH---
Confidence 999774 2334455678999999999999877 74 89999999999999999999998632211 1111
Q ss_pred hccchhhccccccCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+....+ .++... +.++.+++.+|+..+|.+|+++.+|+.
T Consensus 235 ------i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ------IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ------HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111111 011112 678999999999999999999999993
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.34 Aligned_cols=262 Identities=15% Similarity=0.235 Sum_probs=205.0
Q ss_pred CcccccCHHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCc--hHHHHHHHHHHHHhccCCCccee
Q 007290 269 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHRNLLRL 346 (609)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l 346 (609)
.+++.++.++++. .....||+|++|.||+|.+ +|+.||||+++...... ..+.+.+|+.++.+++||||+++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 3455556666632 2236799999999999998 68999999987543221 24678899999999999999999
Q ss_pred EeEEeC----CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007290 347 IGFCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 422 (609)
Q Consensus 347 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 422 (609)
+|++.+ ....++||||+++|+|.+++... ..+++....+++.|++.||.|||+.. +++||||||+||+++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~ 157 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVT 157 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEEC
Confidence 999866 34678999999999999999753 24788999999999999999999732 788999999999999
Q ss_pred CCCcEEEcccccceeeccCCCceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007290 423 EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500 (609)
Q Consensus 423 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~ 500 (609)
+++.+||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||+||+.||......
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----- 228 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----- 228 (283)
T ss_pred CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----
Confidence 99999999999988654321 23457899999999976 67899999999999999999999999743211
Q ss_pred hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+...... ........+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 229 ---~~~~~i~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 229 ---EIYDLII---------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---HHHHHHH---------hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111111 00011112223456899999999999999999999999999764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=346.03 Aligned_cols=264 Identities=28% Similarity=0.400 Sum_probs=214.0
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCC--C--cE-EEEEEecc--CCCCchHHHHHHHHHHHHhccCCCcceeEeE
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLAD--G--TK-VAVKRLTD--FESPGGDAAFQREVEMISVAVHRNLLRLIGF 349 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 349 (609)
..++..-++....++||+|+||.||+|+++. + .. ||||..+. ........+|.+|++++++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4456666777778999999999999999752 2 23 89999874 3445667899999999999999999999999
Q ss_pred EeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007290 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 429 (609)
Q Consensus 350 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 429 (609)
+......++|||+|+||+|.++|+.... .++..++..++.+.|+||+|||++ +++||||..+|+|++.++.+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 9999999999999999999999987543 489999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007290 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
+|||+++.-.. .........-+..|+|||.+..+.|++++|||||||++||+++ |..||...... +....
T Consensus 304 SDFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~k 374 (474)
T KOG0194|consen 304 SDFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAK 374 (474)
T ss_pred CccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHH
Confidence 99999875431 1111112235689999999999999999999999999999999 78888644321 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
. .....+...+...+..+..++.+||..+|++||+|.++.+.|+...
T Consensus 375 I---------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 375 I---------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred H---------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1 1111222233355678889999999999999999999999998753
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=310.51 Aligned_cols=238 Identities=23% Similarity=0.284 Sum_probs=203.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|+..+.||.|+||+|.+++.+ +|..+|+|++.+.. ...+.+....|..+++.+.||.++++++.+.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356778899999999999999976 68899999996432 234556777899999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||++||-|..+++.... ++.+..+.++.||+.||+|||++ +|++||+||+|||+|.+|.+||+|||.|+.+.
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999987543 89999999999999999999999 99999999999999999999999999999875
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. +.+.+|||.|+|||.++...+..++|.|||||++|||+.|.+||...... . ....++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~---------iY~KI~ 254 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------Q---------IYEKIL 254 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------H---------HHHHHH
Confidence 43 55678999999999999999999999999999999999999999755431 1 111222
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDR 550 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 550 (609)
...+ .++...+.++.+|+...++.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222 2345556788999999999999999
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=333.88 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=210.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+.. .....+.+.+|+++++.++|||||.+++.|.+..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888899999999999999965 68899999987544 34456789999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+.| +|...+.. +..+++..++.++.|++.||.|||+. +|+|||+||.|||+++.+.+|+||||+++.+..
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 99999976 33499999999999999999999999 999999999999999999999999999998764
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.....+...|||-|||||+..+++|+..+|+||+||++||+++|++||-... +...++... ..
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~---------~d 215 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSIL---------KD 215 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHh---------cC
Confidence 3445566789999999999999999999999999999999999999995322 112222211 11
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ...+...+..+..++...+.+||..|.+..+++.
T Consensus 216 ~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 P--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 1123466678999999999999999999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.28 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=206.6
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
....++|++.+.||+|+||.||+|.+. ++..||+|+++..........+.+|+++++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567889999999999999999842 34579999997544444556788999999999 89999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCC-------------------------------------------------------
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------- 377 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 377 (609)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998864211
Q ss_pred -----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc-e
Q 007290 378 -----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-V 445 (609)
Q Consensus 378 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~ 445 (609)
....+++..+++++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478888999999999999999999 9999999999999999999999999999865432221 1
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccccc
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 524 (609)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..... .. .. ..
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~---~~-~~---------~~ 333 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKM---VK-RG---------YQ 333 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHH---HH-cc---------cC
Confidence 122335678999999988899999999999999999997 999986432211 01010 00 00 00
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 525 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111246789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.13 Aligned_cols=263 Identities=24% Similarity=0.286 Sum_probs=205.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||.||++.+. +|..||+|.+...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999976 6889999998754334445678999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++.... .+++..+..++.|++.||.|||++. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999987632 3788899999999999999999852 6999999999999999999999999998765322
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----------
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------- 511 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 511 (609)
......|++.|+|||++.+..++.++|||||||++|||+||+.||......+ +.........
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhcccccccccCCcccc
Confidence 2233468999999999998899999999999999999999999996433211 0000000000
Q ss_pred ------------------------hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 ------------------------EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 ------------------------~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
......+.............+.++.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000112345689999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=303.30 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=215.3
Q ss_pred HHhcCCCccCcccccCCceEEEEE-eCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-----CC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-----PT 354 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 354 (609)
+..++|++.+.||+|||+-||+++ ..+++.||+|++.- ...++.+..++|++..++++|||+++++++... ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 456789999999999999999999 56789999999863 335567888999999999999999999987733 34
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
+.+++++|...|+|.+.++..+..+..+++.+.+.|+.++++||.+||+. .|+++||||||.|||+.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999998888888899999999999999999999998 33599999999999999999999999999
Q ss_pred ceeeccCCCce--------eecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 435 AKLVDVRKTNV--------TTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 435 ~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
++.....-... ......|..|.|||.+.- ...+.++|||||||++|+|+.|..||+....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------- 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------- 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------
Confidence 87653221111 112346899999999853 4568999999999999999999999974221
Q ss_pred HHHHHHhhhccch-hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 504 DHVKKLEREKRLD-AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 504 ~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..+.+. .+....+.-+....+++.+.+++++|++.||.+||+..+++..+++.
T Consensus 247 -------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 122222 22232332223344788999999999999999999999999988764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=324.30 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=207.6
Q ss_pred cCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
++|++.+.||+|+||.||+|.... ...||+|.+...........+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998642 25799999875444445677899999999999999999999999888999
Q ss_pred EEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 358 LVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
++|||+++++|.+++...... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999754221 13478889999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 503 (609)
.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999986533221 12233456789999999988899999999999999999998 99998643221
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
+...... .. .....+...+.++.+++.+||+.+|++||++.||++.|++
T Consensus 234 ~~~~~i~-~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 EVIEMIR-SR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHH-cC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 11 1111233455789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=321.61 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=208.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45678999999999999999999888889999987642 2235788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999987532 23478889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........++..|+|||.+....++.++|||||||++|+|+| |+.||...... ...........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~------ 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGYR------ 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCC------
Confidence 2222223345778999999988889999999999999999998 99998642211 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.......+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.79 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=215.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc-ceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE-RLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 360 (609)
++|..++++|+|+||.++..+++ +++.|++|.+.-.. +....+...+|+.+++++.|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999975 68899999986432 34445578899999999999999999999988888 89999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
+|++||++.+.+.+.+ +..++...+..++.|++.|+.|||++ +|+|||||+.|||++.+..++|+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 45689999999999999999999998 999999999999999999999999999999876
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. .....++||+.||.||.+.+.+|..|+|||||||++|||++-+++|....+..- +.. +..
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L--------i~k---------i~~ 220 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL--------ILK---------INR 220 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--------HHH---------Hhh
Confidence 54 245567899999999999999999999999999999999999999986654321 111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .....+..++.++..++..|++.+|+.||++.+++..
T Consensus 221 ~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 1223456677899999999999999999999999976
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=319.38 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=208.5
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
...++|++.+.||+|+||.||+|.+.+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3456789999999999999999998778899999986432 23567899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997643 34589999999999999999999999 999999999999999999999999999987753
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
...........+..|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~------ 221 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGY------ 221 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC------
Confidence 32222222223467999999998899999999999999999999 99998643211 0111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
........+..+.+++.+|++.+|++||++.++++.|++
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 ----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011122345689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.49 Aligned_cols=250 Identities=27% Similarity=0.472 Sum_probs=196.0
Q ss_pred ccCcccccCCceEEEEEeC-----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 288 EKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.+.||.|.||.||+|.+. .+..|+||.++........+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 35689999996644444578999999999999999999999999988889999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+++... ....+++..+.+|+.|+++||.|||++ +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999875 234489999999999999999999999 99999999999999999999999999998763222
Q ss_pred C-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 443 T-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 443 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. ...........|+|||.+....++.++||||||+++|||+| |+.||..... .+.........+..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~---- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLP---- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccce----
Confidence 2 22233457789999999988889999999999999999999 6788753311 11222222222211
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.....+..+.+++.+||+.+|++||++.++++.|
T Consensus 226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1222346788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=318.66 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=203.4
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
++|++.+.||+|+||.||++.++++..+|+|.+... ......+.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 567888999999999999999988889999987633 223567899999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++|+|.++++... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999887532 2478999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~---~--- 221 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFRL---Y--- 221 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCC---C---
Confidence 22223345678999999988889999999999999999999 89998643211 111111111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 222 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ----RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.66 Aligned_cols=267 Identities=20% Similarity=0.341 Sum_probs=215.8
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.......+.++||+|-||.|.++....+..||||+++.........+|.+|+++|.+++||||++++|+|..++..++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34556677899999999999999998789999999998777777899999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|||++|+|..++....... ++.....+|+.||+.||+||.+. ++||||+.++|+|++.++++||+|||+++.+-.
T Consensus 615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999998753322 44555667999999999999999 999999999999999999999999999986543
Q ss_pred CC-CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 441 RK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 441 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.+ .......+-+.+|||||.+..+++|.++|||+||+++||+++ ...||..... ....+......+.+....
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQV 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcce
Confidence 33 333445566889999999999999999999999999999877 4566642211 112222222222222221
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
++ ..++-++..+.++|.+||..+.++||+++++...|++.
T Consensus 765 ~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 12344567889999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=326.07 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=210.3
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
....++|+++..||+|+||.||+|+-+ +|..+|+|++++.. ...+.+....|-.+|...++|.||+++-.|.+.+..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 346678999999999999999999965 69999999998643 344567888999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
||||||++||++..+|... ..|++...+.++.+.+-|++.+|+. |+|||||||+|+|||..|++||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999863 3489999999999999999999999 99999999999999999999999999985
Q ss_pred eecc----------------------CCCc-----ee-------------------ecccccccccCcccccCCCCCcch
Q 007290 437 LVDV----------------------RKTN-----VT-------------------TQVRGTMGHIAPEYLSTGKSSERT 470 (609)
Q Consensus 437 ~~~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~ 470 (609)
-+.. .... .. ...+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3311 0000 00 124699999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007290 471 DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 550 (609)
Q Consensus 471 Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 550 (609)
|+||+||++|||+.|.+||....+.+... .+..|...+..+. ....+.+..|+|.+|+. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~r-kI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYR-KIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999998766543221 1222222222111 12223678999999998 99999
Q ss_pred CCHHHHHHHHhcCCccc
Q 007290 551 PAMSEVVRMLEGEGLAE 567 (609)
Q Consensus 551 Ps~~evl~~L~~~~~~~ 567 (609)
-. ..=++.++++.++.
T Consensus 434 LG-~~G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 434 LG-SKGAEEIKKHPFFK 449 (550)
T ss_pred cC-cccHHHHhcCCccc
Confidence 76 33344455554433
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=324.33 Aligned_cols=267 Identities=18% Similarity=0.242 Sum_probs=202.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||+||+|+++ +++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999976 68899999987533 23345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++++++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9999877655432 23488889999999999999999999 9999999999999999999999999999876433
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH--------HHHHHHhhhc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL--------DHVKKLEREK 513 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~ 513 (609)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||......... .... ..........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL-FTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhCCCCHHHHHhhhccc
Confidence 333333456899999999998888999999999999999999999999753321100 0000 0000000000
Q ss_pred cchhhcccccc------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 RLDAIVDRNLN------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~~~~~~~~~l~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+... .......+..+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0011124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=324.44 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=200.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|+||+||+|..+ +++.||+|.++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999975 68999999987544444456778999999999999999999999988899999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 888887643 23478889999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----------
Q 007290 443 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------- 511 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 511 (609)
. ......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||......+. +.........
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE----LHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhccc
Confidence 1 2233457899999998865 5689999999999999999999999975432211 1111110000
Q ss_pred -hccchhhccccccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 -EKRLDAIVDRNLNKN----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 -~~~~~~~~~~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.........+..... ..+....+..+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000 01123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=324.19 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=201.0
Q ss_pred CCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|+..+.||+|+||+||+|.+ .+|+.||+|.+.... .......+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999996 479999999986432 22334567889999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|...+.... ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999988876432 23488999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||......... ........ .
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~~~-~--------- 219 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRRVK-E--------- 219 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHHhh-c---------
Confidence 1 223456899999999999999999999999999999999999999754321110 00000000 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
....+....+..+.+++.+||+.||++||+ ++++++
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 001122334568899999999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=319.05 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=206.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..+|.+.+.||+|+||.||+|.++ +++.||+|.+... ......+.+|++++++++||||+++++++......+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 345778899999999999999975 5889999998642 3345678999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ...+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999986532 23478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........++..|+|||.+.+..++.++|||||||++|||+| |..||...... +.......
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~--------- 220 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEK--------- 220 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHC---------
Confidence 2222222334668999999988899999999999999999998 88888643221 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
..........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 221 -GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11112223345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.38 Aligned_cols=262 Identities=20% Similarity=0.349 Sum_probs=211.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|+.. +++.||||.+.... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999965 78999999876422 2334567889999999999999999999999889999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.........++...+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999876544455688899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
... ......|++.|+|||.+.+..++.++||||||+++|||+||+.||...... ............
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~------- 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCD------- 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCC-------
Confidence 221 122345888999999998888999999999999999999999998533211 111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
.........+..+.+++.+||+.+|++||++.++++.|++.+
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112344578999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.83 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=207.7
Q ss_pred hcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|.+.+.||+|+||.||+|.+.+ ++.||||.+.........+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998643 4789999987654444567899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCC----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007290 357 LLVYPFMQNLSVAYRLREIKP----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 426 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 426 (609)
++||||+++++|.++++.... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976422 234478889999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHH
Q 007290 427 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 504 (609)
++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... +
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------~ 232 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------E 232 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------H
Confidence 99999999976532221 11223345788999999999999999999999999999999 99998533211 1
Q ss_pred HHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...... .+. ........+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 233 ~~~~~~-~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 VIECIT-QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHH-cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111 111 111122345688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=322.11 Aligned_cols=261 Identities=23% Similarity=0.397 Sum_probs=205.6
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
+..++|++.+.||+|+||.||+|.+. ++..||+|++..........++.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999853 356799999865433344567889999999999999999999999889
Q ss_pred cceEEeecccCchhhhhhhhcCCC------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPG------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753221 23467888899999999999999998 999999999999999999999
Q ss_pred EcccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007290 429 VGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 429 l~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 506 (609)
|+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~~ 231 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QVL 231 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 99999987654322211 112345778999999988889999999999999999999 68888643221 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
..... ... .......+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 232 ~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVME-GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHc-CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11110 000 01122234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.26 Aligned_cols=263 Identities=22% Similarity=0.370 Sum_probs=220.4
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCC---Cc--EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLAD---GT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
++.+...+.....+.||+|-||.||+|.+.+ |. .||||..+...++...+.|.+|..+++.++||||++++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3445555666777899999999999999642 33 599999988777888999999999999999999999999997
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
+. ..++|||.++.|-|..+++..+. .++..+...++.||+.||+|||++ ++|||||..+|||+...--+||+|
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 54 57899999999999999987443 488889999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
||+++.+.+......+...-+..|||||.+.-.+++.++|||.|||.+||++. |..||..-....
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------- 600 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------- 600 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------------
Confidence 99999998776666665556789999999999999999999999999999887 899997432211
Q ss_pred hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
....+...-+.+.++.+++.+..++.+||..+|.+||++.++...|.++.
T Consensus 601 ----VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 601 ----VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ----eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 01111112223346677789999999999999999999999999998753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=316.85 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=206.8
Q ss_pred hcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|++.+.||+|+||+||+|.++. ...||||.++..........|..|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578889999999999999999742 457999998765555556788999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+|||+++++|.+++.... ..+++..+.+++.|++.|++|||++ +|+|+||||+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999987532 2488999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~-- 226 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYR-- 226 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCC--
Confidence 522221 1222335678999999988899999999999999999998 99998532211 11111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.......+..+.+++.+|++.+|++||++.++++.|++
T Consensus 227 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 --------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01122345678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.48 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=208.0
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 352 (609)
+...++|.+.++||+|+||.||+|.+. .+..||||+++........+.+.+|+++++++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344678889999999999999999853 234699999975544445678899999999996 9999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCC-------------------------------------------------------
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------- 377 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 377 (609)
....++||||+++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998864210
Q ss_pred -------------------------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 378 -------------------------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 378 -------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
....+++..+.+++.|+++||+|||+. +++|+||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012477888899999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~ 498 (609)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-- 347 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-- 347 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--
Confidence 999999999999999866432221 1223346788999999988899999999999999999997 889986432110
Q ss_pred chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.. ........ ........+..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 348 --~~---~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 --TF---YNKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HH---HHHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 00 11111110 0111223456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.40 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=204.8
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 353 (609)
...++|++.+.||+|+||.||+|... +++.||+|+++........+.+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999742 35789999987544344456778899999999 799999999988654
Q ss_pred -CcceEEeecccCchhhhhhhhcCCC------------------------------------------------------
Q 007290 354 -TERLLVYPFMQNLSVAYRLREIKPG------------------------------------------------------ 378 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------ 378 (609)
...++++||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678899999999999988542110
Q ss_pred ---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc-eeeccccccc
Q 007290 379 ---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMG 454 (609)
Q Consensus 379 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~ 454 (609)
...+++..+.+++.|++.||+|||++ +|+||||||+||++++++.++|+|||+++.+...... ......++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12578999999999999999999999 9999999999999999999999999999876432221 1223446778
Q ss_pred ccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHH
Q 007290 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE 533 (609)
Q Consensus 455 y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 533 (609)
|+|||++.+..++.++|||||||++|||++ |..||....... .+. ....... ..........
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~---~~~~~~~----------~~~~~~~~~~ 303 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFC---RRLKEGT----------RMRAPEYATP 303 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHH---HHHhccC----------CCCCCccCCH
Confidence 999999999999999999999999999998 999986432211 011 1111000 0011122346
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 534 TMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 534 ~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
++.+++.+||+.+|++||++.|+++.|++.
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.15 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..+|++.+.||+|+||+||+|.+. +|. .||+|+++........+.+..|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999864 333 48999987544445567888999999999999999999999764 567
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
++++|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 9999999999999987632 2378889999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
........ .....++..|+|||.+.+..++.++||||||+++|||+| |+.||+..... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCCCC
Confidence 65332221 122334678999999999999999999999999999998 99998643211 111111111110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
......+.++.+++.+||+.+|++||++.+++..|....
T Consensus 231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111223457899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.56 Aligned_cols=249 Identities=23% Similarity=0.299 Sum_probs=208.2
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+-|..++.||.|+-|.|-+|++ .+|+.+|||++.+.. .......+.+|+.+|+.+.|||++++++++.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477889999999999999996 489999999997542 2334567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|-|.+++...++ ++.....+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|.....
T Consensus 92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999987443 88999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.....+.+|+++|.+||++.+.+| +.++||||.||++|.|+||+.||+.... . .....+.++.
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----r---~LLlKV~~G~------ 228 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----R---VLLLKVQRGV------ 228 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----H---HHHHHHHcCc------
Confidence 334456789999999999999988 6899999999999999999999984321 1 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
+ +.+...+.+..+|+.+|+..||++|.|++||+++-
T Consensus 229 ---f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 ---F--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---c--cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 0 11234456889999999999999999999999753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=327.19 Aligned_cols=245 Identities=20% Similarity=0.210 Sum_probs=199.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|... +|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68999999986322 2234567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... .+++.....++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999987532 378889999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. .....|++.|+|||.+.+..++.++|||||||++|||+||+.||...... .........
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~-------- 213 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAG-------- 213 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC--------
Confidence 2 22346899999999999888999999999999999999999999643221 111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
. ..++...+..+.+++.+|++.||.+||+ ++++++
T Consensus 214 -~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 -K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0 0112223467899999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.98 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=204.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|++. +|+.||+|++.... .......+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 58999999987432 2234567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999753 2378889999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......... ....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~---~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWK---ETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhcc---cccc
Confidence 2234568999999999998899999999999999999999999997543211 111110000 0010
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...........+.++.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000012345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.59 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=198.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999976 6899999998754434444567889999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++ ++|.+.+... ...++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 4666666542 23378888999999999999999999 9999999999999999999999999998755322
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc---c--
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR---L-- 515 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 515 (609)
. .......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||........ ............. .
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD----QLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhCCCChhhccc
Confidence 2 22233468999999998865 4588999999999999999999999974321100 0011100000000 0
Q ss_pred -hh--hcccc-cc--CCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 -DA--IVDRN-LN--KNY-------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 -~~--~~~~~-l~--~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ...+. .. ... ....+..+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 00000 00 000 0012356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.88 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=194.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|+..+.||+|+||+||+|++. +|+.||||++...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556788999999999999975 68999999986544444557789999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.... ..+...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999885432 245667788999999999999999 99999999999999999999999999998764321
Q ss_pred CceeecccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 443 TNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||....... ...........
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~----- 291 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMS----- 291 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhcc-----
Confidence 12234568999999998743 234578999999999999999999997322111 00111110000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+.++.+++.+||+.||++||++.|++++
T Consensus 292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122345678999999999999999999999964
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.26 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=203.2
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
++|.+.+.||+|+||+||+|.+.++..+|+|.+.... .....+.+|+.++.+++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4678889999999999999998777789999886432 23567899999999999999999999999888899999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++|+|.+++.... ..+++..+++++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999987532 2488999999999999999999999 999999999999999999999999999886643322
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......++..|+|||.+.+..++.++||||||+++|+|+| |+.||...... .... .......
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~---~~~~~~~-------- 219 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVE---KVSQGLR-------- 219 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHH---HHhcCCC--------
Confidence 22222345678999999988889999999999999999999 99998643211 0111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.......+..+.+++.+||+.+|++||++.++++.|+
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011123468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=305.06 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=202.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-chHHHHHHHHHHHHhccCCCcceeEeEEe--CCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-GGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 358 (609)
.+.|+..+.|++|+||.||+|+++ +++.||+|+++-.... +---...+|+.++.+.+|||||.+-.+.. +-+..++
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345777889999999999999975 7889999999743322 22234578999999999999999988763 4567999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|||||+. +|..+++... ..+...+++-+..|+++|++|||++ .|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999988 8888887644 3488889999999999999999999 8999999999999999999999999999988
Q ss_pred ccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-----
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE----- 512 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 512 (609)
+.+ ....+..+.|.+|.|||.+.+. .|+...||||+||++.||+++++-|.......+...++ ..+-.+
T Consensus 228 gsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If----~llGtPte~iw 302 (419)
T KOG0663|consen 228 GSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF----KLLGTPSEAIW 302 (419)
T ss_pred cCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH----HHhCCCccccC
Confidence 754 3335556789999999998775 59999999999999999999999987655433221111 111000
Q ss_pred ---ccch--------hhccccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 ---KRLD--------AIVDRNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ---~~~~--------~~~~~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+. +.....+...+... .+..-.+++...+..||.+|.|++|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 00011111112111 3467789999999999999999999885
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.95 Aligned_cols=202 Identities=24% Similarity=0.341 Sum_probs=175.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||.||++.+. +|..+|+|.+...........+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999976 688999998865433444567899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... .+++.....++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999987532 3788889999999999999999742 699999999999999999999999999875532
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 492 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~ 492 (609)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 122346899999999999888999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=319.08 Aligned_cols=258 Identities=23% Similarity=0.393 Sum_probs=204.6
Q ss_pred cCCCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++|++.+.||+|+||+||+|.+ .++..||+|.+...........+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677889999999999999984 24678999999754444445778899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 359 VYPFMQNLSVAYRLREIKP-------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
+|||+++++|.+++..... ....+++.....++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853221 123478888999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 503 (609)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence 999999999986543221 12223345678999999988889999999999999999999 88888532210 111
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.. ...... .......+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 237 ~~---~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EM---VRKRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH---HHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 111110 01122234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.96 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=210.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
....+|++.+.||.|+||+||+|.+.++..+|+|.+.... ......+..|+.+++.++||||+++++++......++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 3456788899999999999999999889999999986432 323567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ...+++..+++++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999997632 34489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ........
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~-------- 219 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITA-------- 219 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHh--------
Confidence 2221 223346778999999988899999999999999999998 89998643211 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
......+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 --GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11111223445688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=312.67 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=204.7
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 46799999999999999999998777789999986422 23467899999999999999999999874 4557899999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 23478899999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
........++..|+|||...+..++.++||||||+++|||+| |..||...... .........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~--------- 219 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERG--------- 219 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcC---------
Confidence 322233446778999999988899999999999999999999 78888643211 001111100
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|++||++.++++.|++
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0111223455788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=330.25 Aligned_cols=242 Identities=21% Similarity=0.232 Sum_probs=196.0
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+.||+|+||.||++..+ +|+.||+|++.... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 68999999987422 2334456788999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 446 (609)
+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 999888753 3478999999999999999999999 9999999999999999999999999998753221 1223
Q ss_pred ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC
Q 007290 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526 (609)
Q Consensus 447 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 526 (609)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ .. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~-~~----------~~ 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-EE----------IR 213 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHc-CC----------CC
Confidence 3456999999999999999999999999999999999999999643211 00111100 00 01
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 527 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 527 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
++...+..+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1223456789999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=310.52 Aligned_cols=248 Identities=29% Similarity=0.418 Sum_probs=200.1
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhh
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA 369 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 369 (609)
++||+|+||.||+|...+++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999875444444567889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecc
Q 007290 370 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 449 (609)
Q Consensus 370 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 449 (609)
+++.... ..+++..+..++.|++.||.|+|++ +++|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9886532 2378999999999999999999999 999999999999999999999999999875443222222222
Q ss_pred cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 450 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
.++..|+|||++.+..++.++||||||+++|++++ |..||...... ........... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~----------~~~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYR----------MSCP 216 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCC----------CCCC
Confidence 34678999999988899999999999999999998 99998643211 11111111111 1112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 233568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=313.79 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=205.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 3457888999999999999999988888999999864322 3467899999999999999999999875 456889999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999987532 23478999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~-------- 219 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERG-------- 219 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcC--------
Confidence 2222223345678999999988889999999999999999999 88888642210 111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 --YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.66 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=195.4
Q ss_pred cCCCccCcccccCCceEEEEEeC--CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhc---cCCCcceeEeEEe-----C
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCT-----T 352 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 352 (609)
++|++.+.||+|+||+||+|++. +|+.||+|+++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999963 468899999864332 22345566777777665 6999999999885 2
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
....++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999997 58888886533 23478899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh--
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-- 510 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 510 (609)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||........ +........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~----~~~i~~~~~~~ 228 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGKILDVIGLP 228 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH----HHHHHHHhCCC
Confidence 999866433 223345689999999999888999999999999999999999999975432111 111111000
Q ss_pred hhccc-------hhhccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 REKRL-------DAIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ~~~~~-------~~~~~~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+... .......... ...+..+..+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000000000 011223467789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=332.77 Aligned_cols=247 Identities=27% Similarity=0.347 Sum_probs=205.6
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCC
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT 354 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 354 (609)
.....++|...++||+|.||+|+++..+ +++.+|||++++.. .....+....|.+++.... ||.++.++..+.+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456678999999999999999999976 67899999998754 3445678888999988775 999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
+.++||||+.||++....+ ...+++..++-++..|+.||+|||++ +||+||||.+|||+|.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999332222 23499999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
++..- .....+++.+|||.|||||++.+..|+..+|.|||||+||||+.|..||+....++-.+
T Consensus 515 cKe~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd--------------- 578 (694)
T KOG0694|consen 515 CKEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD--------------- 578 (694)
T ss_pred ccccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------
Confidence 98643 23445677899999999999999999999999999999999999999998655432111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
.++... ..++...+.+..+|+.+++.++|++|--+
T Consensus 579 --sI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 --SIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111111 12344556788999999999999999765
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=311.82 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=197.9
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
+.||+|+||.||+|.+. +++.||+|.............+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999975 78999999886544444567799999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee-e
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-T 447 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~-~ 447 (609)
.+++... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998653 23478999999999999999999999 999999999999999999999999999875432211111 1
Q ss_pred cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC
Q 007290 448 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526 (609)
Q Consensus 448 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 526 (609)
....+..|+|||.+.++.++.++||||||+++|||++ |..||...... ....... ......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~----------~~~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIE----------QGVRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHH----------cCCCCC
Confidence 1123457999999998899999999999999999998 88888532211 0001110 011111
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 527 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.....+..+.+++.+|++.+|++|||+.++.+.|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22233568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=313.67 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=206.8
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+..++|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3457789999999999999999998889999999986432 23568899999999999999999999864 45689999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999986533 33588999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
..........++..|+|||.+....++.++||||||+++|||++ |+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~----- 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYR----- 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCC-----
Confidence 32222223345778999999988889999999999999999999 99999643211 11111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.......+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 -----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11112234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=330.92 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=197.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
...+|++.+.||+|+||.||++.+. +++.||+|... ...+.+|++++++++||||+++++++......++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3467999999999999999999964 68899999653 235678999999999999999999999889999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|++. ++|..++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9986 5777777542 2378899999999999999999999 999999999999999999999999999975433
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc---chhHHHHHHHHhh---h--
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED---DVLLLDHVKKLER---E-- 512 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~---~-- 512 (609)
..........||+.|+|||++.+..++.++|||||||++|||+||+.|+-........ ...+...+..... .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 2222334457999999999999889999999999999999999999876432211100 0001001000000 0
Q ss_pred ----ccchhhc---------cccccCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 ----KRLDAIV---------DRNLNKNY--NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ----~~~~~~~---------~~~l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+.... .+...... ....+.++.+++.+|++.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 1134568899999999999999999999985
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=312.93 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=202.3
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
.+|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++......++|+||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4577889999999999999998877899999886422 23467889999999999999999999999889999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999987532 2488999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||...... +........
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~---------- 217 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAG---------- 217 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcC----------
Confidence 22222234567999999998899999999999999999999 78898643221 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.........+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111222456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.82 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=203.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC---------C----chHHHHHHHHHHHHhccCCCcceeE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES---------P----GGDAAFQREVEMISVAVHRNLLRLI 347 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~----~~~~~~~~E~~~l~~l~h~niv~l~ 347 (609)
..++|++.+.||+|.||.|-+|+.. +++.||||++.+... . ...+...+|+.++++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4578999999999999999999964 799999999864211 0 1235788999999999999999999
Q ss_pred eEEeCC--CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 348 GFCTTP--TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 348 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
++..++ +..|+|+|||..|.+... ......+...+.++++.+++.||+|||.+ +||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999776 568999999998876432 22233389999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccC----CCceeecccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007290 426 EAVVGDFGLAKLVDVR----KTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~ 497 (609)
++||+|||.+...... ........+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-....-
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-- 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-- 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence 9999999999866321 111123367999999999987633 367899999999999999999999643221
Q ss_pred cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
+..++++...+.-...++..+.+.+|++++|.+||+.|.+..+|..+..-
T Consensus 326 ---------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 326 ---------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ---------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11223333333333344567889999999999999999999999877654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.60 Aligned_cols=245 Identities=22% Similarity=0.245 Sum_probs=199.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|+++ +|+.||+|.+.... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 68999999986422 2234567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+.+... ..++......++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998753 2378888889999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. ....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ....... .
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~---------~ 229 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKIL---------A 229 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHh---------c
Confidence 22 2346899999999999988999999999999999999999999643211 1111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
..+ .++...+..+.+++.+||+.||++||+ +++++.
T Consensus 230 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 100 011113356889999999999999997 566654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.42 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=209.9
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCC-----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-CC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PT 354 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 354 (609)
+..++|.+.+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346788999999999999999999765 688999998755555556778899999999999999999998866 46
Q ss_pred cceEEeecccCchhhhhhhhcCCC----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPG----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 430 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 430 (609)
..+++++|+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 788999999999999998764332 24589999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007290 431 DFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 431 DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... +....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~ 231 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EMAAY 231 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HHHHH
Confidence 999998664332221 122345678999999988889999999999999999999 99998643211 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... ......+.++.+++.+||+.+|++|||+.++++.|++.
T Consensus 232 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 232 LKDGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HHcCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111111 11122346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.18 Aligned_cols=264 Identities=28% Similarity=0.411 Sum_probs=209.7
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 351 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 351 (609)
+....++|++.+.||+|+||.||++.+. +...+|+|.+...........+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4456678899999999999999999864 23679999987544444556788999999999 7999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcC------------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 419 (609)
.....+++|||+++|+|..+++... .....+++..+++++.|++.||+|||++ +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999997532 2234588999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 007290 420 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE 497 (609)
Q Consensus 420 ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~ 497 (609)
++++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 9999999999999999876432211 1122335678999999988899999999999999999998 888886432211
Q ss_pred cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......... ........+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus 243 -------~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 -------LFKLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -------HHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111111 1111223346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=317.66 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=202.9
Q ss_pred CCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceE
Q 007290 286 FSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL 358 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 358 (609)
|...+.||+|+||+||++.+ .+++.||+|.++..........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988753 357899999987544344567788999999999999999999988654 35789
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+|||+++++|.+++... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999998652 389999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+......... ...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhh
Confidence 432211 112233566799999998888999999999999999999999998643211000 000000000001111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...........+..+.+++.+||+.+|++|||++++++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111122333457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.12 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=212.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|... +|+.||+|.++.. ......+.+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7999999988632 22334678899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|..++.........++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876555555689999999999999999999999 999999999999999999999999999886543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.......
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--------- 222 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEK--------- 222 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhc---------
Confidence 3221 22345888999999998888999999999999999999999998643211 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...........+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0011111224556889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=318.04 Aligned_cols=258 Identities=28% Similarity=0.383 Sum_probs=204.4
Q ss_pred CCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+|++.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 2357899988654444445678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCC--------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 359 VYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
++||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864211 123478899999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~ 496 (609)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999765332221 1122345678999999988889999999999999999999 99998643211
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... ...........+.++.+++.+|++.+|++||++.++++.|++.
T Consensus 237 -------~~~~~~~----------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 -------RLFNLLK----------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -------HHHHHHh----------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1111111 1111111223346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=311.45 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=198.9
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-----cceE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERLL 358 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 358 (609)
.|...+++|.|+||.||+|... ++..||||++..... --.+|+.++++++|||||++.-++.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999964 579999999864321 1246899999999999999988774332 2458
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEccccccee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKL 437 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~~ 437 (609)
|||||+. +|.+.++.....+..++...++-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999997 99999987665666688888999999999999999998 99999999999999977 8999999999998
Q ss_pred eccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--c-
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--K- 513 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~- 513 (609)
+...... ..+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+...+ +...++-+-.+ +
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEIIKVLGTPTRED 249 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHHHHhCCCCHHH
Confidence 8654443 445678999999998774 699999999999999999999999976443211 11122111111 0
Q ss_pred -----------cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 -----------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 -----------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....+....+..-+....+++..+++.++++.+|++|.++.|++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 001111111111123455678999999999999999999999884
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.89 Aligned_cols=262 Identities=23% Similarity=0.273 Sum_probs=215.7
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCCC-cEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEe-EEeC----
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLADG-TKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIG-FCTT---- 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~---- 352 (609)
++...++++.++|.+|||+.||.|....+ ..||+|++.-. ++.......+|+++++++. |+|||.+++ ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 44566788899999999999999998765 99999998654 5667788899999999998 999999999 3311
Q ss_pred --CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007290 353 --PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 430 (609)
Q Consensus 353 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 430 (609)
..+.++.||||+||.|-+++..+...+ |++.++++|+.|+++|+++||.. +|+|||||||.+||||+.+++.|||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 245788999999999999998765544 99999999999999999999986 7789999999999999999999999
Q ss_pred ccccceeeccCCCcee--------ecccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007290 431 DFGLAKLVDVRKTNVT--------TQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499 (609)
Q Consensus 431 DfGl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~ 499 (609)
|||.++.......... -...-|+.|.|||.+ .+..+++|+|||||||+||-|+....||+..-
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------ 262 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------ 262 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence 9998875432221111 113468999999976 46788999999999999999999999997431
Q ss_pred hhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007290 500 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 566 (609)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 566 (609)
.-.+++..+.-+..+.++..+.+||..||+.||++||++-+|+..+-.+...
T Consensus 263 ---------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ---------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1234555554444578899999999999999999999999999888766433
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=315.97 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=204.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.............|..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678899999999999999999753 567999988654444445678999999999999999999999988888
Q ss_pred ceEEeecccCchhhhhhhhcCCC---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEE
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVV 429 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 429 (609)
.++||||+++++|.+++...... ...+++..+.+++.||+.||+|||++ +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999764321 23589999999999999999999999 999999999999998654 5999
Q ss_pred cccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007290 430 GDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||+...... . ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~---~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----V---ME 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----H---HH
Confidence 9999998663221111 112233568999999998899999999999999999997 999986432211 1 11
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
....... ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111110 1112233467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=330.95 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=207.6
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEe
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCT 351 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 351 (609)
++...++|.+.+.||+|+||.||+|++. .++.||+|+++..........+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445567888899999999999999863 346899999975443444567889999999997 999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCC------------------------------------------------------
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKP------------------------------------------------------ 377 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 377 (609)
.....++|+||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred ----------------------------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007290 378 ----------------------------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 417 (609)
Q Consensus 378 ----------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 417 (609)
....+++....+++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467778899999999999999998 9999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007290 418 NVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 495 (609)
Q Consensus 418 NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~ 495 (609)
||++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532211 11223346788999999988889999999999999999998 88898643211
Q ss_pred cccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 496 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+. . ....... .....+...+.++.+++.+||..+|++||++.+|++.|++.
T Consensus 349 ~~----~---~~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQ----F---YNAIKRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH----H---HHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 10 0 0111111 01111222346899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=317.86 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=207.0
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
++..++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346788999999999999999999754 24589999886544444456788999999999999999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCC------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKP------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
...++||||+++|+|.+++..... +....++..+.+++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975332 123456778889999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 007290 428 VVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 505 (609)
+|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... +.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 99999998765332211 1122335678999999988899999999999999999999 78888542211 11
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......... .......+..+.+++.+|++.+|++|||+.++++.|++.
T Consensus 231 ~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 231 LKFVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111100 011122346899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.93 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=203.5
Q ss_pred cCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.+|++.+.||+|+||+||+|.+. ++..||+|++...........+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999863 257899999975443334567889999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 358 LVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
+++||+++++|.+++..... ....+++..+.+++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 99999999999999853211 123478888999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 503 (609)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |..||..... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------Q 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999886543221 11223346789999999988889999999999999999998 7778753221 1
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
+.......... .......+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 234 ~~~~~i~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRNRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111110 11223345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.26 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=199.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++|++.+.||+|+||+||+|.+. +|+ .+++|.+..........++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56788899999999999999974 344 4788887543333344677788888999999999999998854 45778
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997532 2488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
..... .......++..|+|||.+.++.++.++||||||+++|||+| |..||...... ...+.+ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~---~~~~~~- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLL---EKGERL- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH---HCCCcC-
Confidence 43222 12223456788999999988899999999999999999998 99998643221 011111 100000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.. .......+.+++.+||..+|++|||+.|+++.|+..
T Consensus 231 --~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 231 --AQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred --CC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00 111235678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.27 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=206.9
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC---
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--- 354 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 354 (609)
....++|.+.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+..+..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345679999999999999999999964 79999999986432 3344567889999999999999999887664332
Q ss_pred -----cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007290 355 -----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 429 (609)
Q Consensus 355 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 429 (609)
..++||||+++|+|.+.+.........++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 25789999999999999976554455689999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCC-CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 430 GDFGLAKLVDVRK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 430 ~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 9999998764322 12233457999999999999999999999999999999999999999743221 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
... ... ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 257 ~~~-~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLA-GRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hhc-CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 000 11223345678999999999999999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.08 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=203.6
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 45688899999999999999998777789999876432 23467889999999999999999999875 4567899999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 23478999999999999999999999 99999999999999999999999999998764332
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
........++..|+|||...+..++.++||||||+++|||+| |+.||...... .........
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~--------- 219 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERG--------- 219 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC---------
Confidence 222223346778999999988889999999999999999999 89898643211 011111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+||+.+|++||++++++++|++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011123345789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=316.66 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=207.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
..++|.+.+.||+|+||.||+|..++ +..||+|.+...........+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45678899999999999999998642 468999998654444445678899999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCC------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPG------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 429 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 429 (609)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 99999999999999999754322 23478889999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007290 430 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 430 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |..||...... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~ 232 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVLK 232 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHHH
Confidence 99999876543221 12223346789999999988889999999999999999998 88888532211 1111
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
....... ...+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGH----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111100 01112235688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.10 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=203.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.++|+..+.||+|+||+||+|.+. +|+ .||+|++...........+.+|+.++..+.||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467888999999999999999853 444 48999987655555567888999999999999999999998754 467
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
++++|+++|+|.+.+... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999998753 23488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
........ .....+++.|+|||.+.+..++.++|||||||++|||+| |..||...... .....+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~---~~~-- 228 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPDLLE---KGE-- 228 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH---CCC--
Confidence 65332221 112235678999999988899999999999999999998 88998642211 0111111 100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
........+.++.+++.+||+.||++||++.++++.|+...
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 --------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112234467899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=291.73 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=209.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++++.||+|.||.||.|+.+ ++-.||+|++.+.. ......++.+|+++-+.++||||+++|+++.+....++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578899999999999999999965 67899999987532 12235678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
++||.++|.+...|++.. ...++......+..|+|.|+.|+|.+ +|+||||||+|+|++.++.+|++|||-+-.-
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998633 23478888899999999999999999 9999999999999999999999999988643
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
. .......+||..|.+||...+..++..+|+|++|++.||++.|.+||...... +..+...
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--------etYkrI~-------- 235 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--------ETYKRIR-------- 235 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--------HHHHHHH--------
Confidence 2 45566778999999999999999999999999999999999999999743311 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.-. -.++...+.+..+++.+|+..+|.+|.+..|++..
T Consensus 236 -k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 -KVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -Hcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 000 11223445678999999999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.11 Aligned_cols=242 Identities=21% Similarity=0.230 Sum_probs=194.0
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||+|+||+||+|++. +++.||+|++... ........+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 5889999998642 2233456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+++..... ......
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccc
Confidence 9998752 2388899999999999999999999 9999999999999999999999999998754322 122334
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ .. ..++
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~---------~~--~~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQ---------EP--LRFP 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHc---------CC--CCCC
Confidence 56899999999999989999999999999999999999999643211 11111111 00 0122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
...+..+.+++.+||+.||++||++..+.+.|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 23446789999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.83 Aligned_cols=253 Identities=22% Similarity=0.253 Sum_probs=198.8
Q ss_pred CCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCC---CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTER 356 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 356 (609)
+|++.+.||+|+||+||+++.. +|+.||+|++.+.. .....+.+..|+.++..++ ||||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999853 58899999986421 2223456788999999995 99999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998653 2378899999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
.+............||+.|+|||.+.+. .++.++|||||||++|||+||+.||......... .........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~---- 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILK---- 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhc----
Confidence 6543333333445799999999999765 4789999999999999999999999643221110 011111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 559 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 559 (609)
.+ .......+..+.+++.+|++.||++|| +++++++.
T Consensus 226 ---~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01 111223346788999999999999999 66677643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.60 Aligned_cols=265 Identities=20% Similarity=0.346 Sum_probs=202.9
Q ss_pred hcCCCccCcccccCCceEEEEEeCC---------------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD---------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 347 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 347 (609)
.++|++.+.||+|+||.||+++..+ ...||+|.++..........+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4678999999999999999988642 2258999987544444556789999999999999999999
Q ss_pred eEEeCCCcceEEeecccCchhhhhhhhcCC--------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007290 348 GFCTTPTERLLVYPFMQNLSVAYRLREIKP--------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419 (609)
Q Consensus 348 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 419 (609)
+++......++||||+++++|.+++..... ....+++..+++++.|++.||+|||++ +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 112368889999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcccc
Q 007290 420 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLEE 496 (609)
Q Consensus 420 ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt--g~~p~~~~~~~~ 496 (609)
++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765332211 1222345778999999988889999999999999999998 556665322111
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
............... .........+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 -----~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -----VIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -----HHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111100000 000011123468999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=324.03 Aligned_cols=262 Identities=20% Similarity=0.331 Sum_probs=195.4
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Ccce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 357 (609)
+|++.+.||+|+||.||+|+.. +|..||||++.... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788999999999999999965 68999999986422 223345788999999999999999999987543 2478
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+. ++|..++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 5788877642 2388999999999999999999999 999999999999999999999999999976
Q ss_pred eccCCC--ceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--
Q 007290 438 VDVRKT--NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER-- 511 (609)
Q Consensus 438 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 511 (609)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~ 227 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-----LDLITDLLGTP 227 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-----HHHHHHHhCCC
Confidence 532211 11234568999999999865 5789999999999999999999999965332110 000000000
Q ss_pred ---------hccchhhc---cccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 ---------EKRLDAIV---DRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 ---------~~~~~~~~---~~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........ ........ .+.....+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000000 11234577899999999999999999999953
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=324.38 Aligned_cols=242 Identities=22% Similarity=0.249 Sum_probs=195.1
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+.||+|+||.||++... +|+.||+|+++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999964 68999999987422 2334556778999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 446 (609)
+|..++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 998888653 2488999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC
Q 007290 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526 (609)
Q Consensus 447 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 526 (609)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... ... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~---------~~~--~ 213 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILM---------EEI--R 213 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhc---------CCC--C
Confidence 34568999999999998899999999999999999999999996432210 0111100 000 1
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 527 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 527 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
++...+.++.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1223346789999999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.29 Aligned_cols=258 Identities=21% Similarity=0.257 Sum_probs=203.9
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
.....++|++.+.||+|+||+||+++.. +++.||+|++.... .....+.+..|+.+++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3445678999999999999999999975 68899999986421 22234567789999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++|+|.+++... .++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 99999999999999988652 267788888999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
...............||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~ 261 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMD 261 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHc
Confidence 87653322223345699999999998653 4789999999999999999999999743321 11111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 559 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 559 (609)
... .+.-......+..+.+++.+|++.+|++ ||++.++++.
T Consensus 262 ~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0000111224568899999999999988 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=337.92 Aligned_cols=252 Identities=17% Similarity=0.230 Sum_probs=203.4
Q ss_pred CCCccCcccccCCceEEEEEeC-C-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-D-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.|.+.+.||+|+||.||+|... + +..||+|.+.. ........+..|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888999999999999999864 3 67788887643 2333445678899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+.+.........+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998876444445588899999999999999999999 99999999999999999999999999998765332
Q ss_pred C-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 T-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .........
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~--------- 286 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYG--------- 286 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC---------
Confidence 2 1233456999999999999889999999999999999999999999643211 111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 287 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00 0112233467899999999999999999999975
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.27 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=210.2
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|.. .+|+.+|||.+.... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999996 479999999886432 2233467889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999876444455689999999999999999999999 999999999999999999999999999876643
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ......... ....
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~------~~~~ 225 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE------QCDY 225 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh------cCCC
Confidence 322 122345889999999998888999999999999999999999998643211 111111111 0001
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+ .......+..+.+++.+||+.+|++|||+.+|++.+++.
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 111223556899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=315.31 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=196.3
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||+|+||+||++.+. +|+.||+|.+..... ....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 689999999864221 22335677899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+.+.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444445689999999999999999999999 999999999999999999999999999986643322 2234
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... +.... ....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~---------~~~~~--~~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQR---------ILNDS--VTYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHHh---------hcccC--CCCc
Confidence 5689999999999999999999999999999999999999974322110 0000000 01110 1122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
...+..+.+++.+|++.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 33456889999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.82 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=201.9
Q ss_pred cCCCccCcccccCCceEEEEEeCC-Cc--EEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
++|++.+.||+|+||.||+|..++ +. .+++|.++........+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999999753 33 47888887544444456788999999999 699999999999988899999
Q ss_pred eecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 360 YPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
+||+++++|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975321 113488899999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 506 (609)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|||+| |..||...... ...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------ELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHH
Confidence 99999998643211 11111223557999999988889999999999999999998 99998643321 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... .........+..+.+++.+||+.+|.+||++.++++.|+..
T Consensus 229 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 229 EKLPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 11111223446789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.81 Aligned_cols=253 Identities=24% Similarity=0.273 Sum_probs=204.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|.+.+.||+|+||+||+|... +|+.||||++.... .......+..|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999975 68999999987432 2244567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++... ..++...++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999764 3488999999999999999999998 999999999999999999999999999986643
Q ss_pred CC----------------------------CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007290 441 RK----------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 492 (609)
Q Consensus 441 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~ 492 (609)
.. ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456899999999999999999999999999999999999999754
Q ss_pred ccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 007290 493 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRM 559 (609)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 559 (609)
... ......... ...+........+..+.+++.+|+. +|++||+ ++++++.
T Consensus 234 ~~~--------~~~~~i~~~-------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ--------ETYNKIINW-------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH--------HHHHHHhcc-------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 321 111111100 0001111111145688999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.89 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=206.6
Q ss_pred hcCCCccCcccccCCceEEEEEeCC-----------------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD-----------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 345 (609)
..+|++.+.||+|+||.||+|...+ +..||+|.+.........+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678899999999999999998642 24689999876544455678899999999999999999
Q ss_pred eEeEEeCCCcceEEeecccCchhhhhhhhcCC-------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 346 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
+++++......++++||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999998999999999999999999976442 123589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLE 495 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt--g~~p~~~~~~~ 495 (609)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986543221 12233456788999999988889999999999999999998 5666643211
Q ss_pred cccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 496 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
................ ..........+.++.+++.+|++.+|++|||+.+|++.|+
T Consensus 240 ----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ----QQVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----HHHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111000000 0001112233468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.37 Aligned_cols=243 Identities=23% Similarity=0.254 Sum_probs=196.4
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+.||+|+||.||++... +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999965 68999999997432 2334567888999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 446 (609)
+|...+... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 998888652 2488999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC
Q 007290 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526 (609)
Q Consensus 447 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 526 (609)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ........ . + ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~-~------~----~~ 213 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM-E------D----IK 213 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhcc-C------C----cc
Confidence 3456899999999999889999999999999999999999999643221 11111100 0 0 01
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007290 527 YNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 559 (609)
Q Consensus 527 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 559 (609)
++...+.++.+++.+|++.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1223346789999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=307.67 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=195.7
Q ss_pred cccccCCceEEEEEeC---CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 291 VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
.||+|+||.||+|.++ ++..+|+|++.... .....+.+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999986432 2334567889999999999999999999885 45678999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce-
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV- 445 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~- 445 (609)
+|.+++... ..+++..+.+++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999998653 2378999999999999999999999 99999999999999999999999999998764332221
Q ss_pred -eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 446 -TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 446 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....++..|+|||.+....++.++||||||+++|||+| |..||...... ..........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~---------- 215 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGE---------- 215 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCC----------
Confidence 112234578999999988889999999999999999998 99998643211 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
....+...+.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.63 Aligned_cols=248 Identities=23% Similarity=0.224 Sum_probs=200.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC--CcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..++|++.+.||+|+||.||+|.+++ +..||+|++.... .......+..|+.+++.++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578889999999999999998643 3689999986422 2334567889999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999987532 378889999999999999999999 999999999999999999999999999986
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .......
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~------- 241 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKIL------- 241 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHh-------
Confidence 5432 23456899999999999888999999999999999999999999643211 0111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 559 (609)
.... .++...+..+.+++.+|++.+|++|+ +++++++.
T Consensus 242 --~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 --EGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --cCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1000 01122335678999999999999995 78777643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.42 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=195.5
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
++||+|+||.||++++. +++.||+|+++... .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999975 68899999997532 233345678899999888 699999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|..++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 9998888653 2389999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+..............+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------
Confidence 3345689999999999999999999999999999999999999974332221111111111111111110
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPA------MSEVVR 558 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~ 558 (609)
..+...+..+.+++.+|++.||.+||+ +.++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 011223457899999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.61 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=208.6
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 350 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 350 (609)
.+..++|.+.+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345677888999999999999999741 34579999887544444567789999999999 799999999999
Q ss_pred eCCCcceEEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 351 TTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 351 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
......+++|||+++|+|.+++...... ...+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 9999999999999999999999764221 23478889999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~ 496 (609)
|+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||+| |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 999999999999999998765332221 222345678999999988889999999999999999998 77787533211
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
............ ......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 247 -------~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 247 -------ELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -------HHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 111211111110 11223456889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.55 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=208.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
...++|.+.+.||+|+||+||+|..+++..||||.+.... .....+..|+.++++++|+||+++++++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 4567899999999999999999998888899999986432 34577899999999999999999999999888999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||||+||++++++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997632 23489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
..........++..|+|||.+.+..++.++||||||+++|+|+| |+.||...... .........
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~------- 220 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERG------- 220 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC-------
Confidence 22222222334678999999998889999999999999999999 99998533211 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 ---YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011112224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.82 Aligned_cols=261 Identities=29% Similarity=0.396 Sum_probs=206.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
..++|.+.+.||+|+||.||++.+. ++..+|+|.+...........+..|++++..+ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3467999999999999999999853 23579999987543344456788899999999 79999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
....++||||+++|+|.+++..... ....+++.++.+++.|++.||+|||++ +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999976432 123488899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~ 498 (609)
++.++.+||+|||.++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 999999999999998765422111 1112234568999999988889999999999999999998 88888543211
Q ss_pred chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+......... ........+.++.+++.+|++.+|++||++.++++.|+..
T Consensus 250 -----~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 250 -----ELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -----HHHHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111110 1112223456889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.57 Aligned_cols=266 Identities=21% Similarity=0.347 Sum_probs=204.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-----------------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-----------------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 345 (609)
.++|++.+.||+|+||.||++.+. ++..||+|+++..........+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998643 234699999875444445678999999999999999999
Q ss_pred eEeEEeCCCcceEEeecccCchhhhhhhhcCCC-------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG-------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 346 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
+++++...+..+++|||+++++|.+++...... ...+++..+..++.|++.||+|||++ +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764321 13477889999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh--CCCCCCCCccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT--GQRAIDFSRLE 495 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt--g~~p~~~~~~~ 495 (609)
|+++.++.++|+|||+++.+...... ......++..|++||...++.++.++|||||||++|||+| |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865432211 1222344678999999888889999999999999999998 66777532211
Q ss_pred cccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 496 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
. ................ ........+..+.+++.+||+.||++||++.+|.+.|++
T Consensus 241 ~-----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q-----VIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-----HHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111100000000 000112234688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.83 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=205.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|.+.+.||+|+||+||++... ++..+|+|.+... .......+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 356888999999999999999852 3456899988643 233456789999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCC---------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 357 LLVYPFMQNLSVAYRLREIKP---------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999875431 123489999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 007290 428 VVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 505 (609)
+|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|+| |..||...... ..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EV 231 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 9999999976532221 11222345778999999988889999999999999999999 89888643221 11
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... .... ......+..+.+++.+||+.+|.+|||+.++.+.|++.
T Consensus 232 ~~~i~~-~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 232 IECITQ-GRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHHc-CCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111111 1100 01112345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.41 Aligned_cols=269 Identities=22% Similarity=0.336 Sum_probs=205.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEecc-CCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-----C
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-----P 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 353 (609)
.....|...+.||+|+||.|..+.++ +|+.||||++.+ +......+...+|+++++.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556666789999999999999965 799999999973 4445566788899999999999999999998855 3
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
+..++|+|+|+ .+|...++. +..++......++.|+++||.|+|+. +|+|||+||+|++++.+..+||+|||
T Consensus 99 ~DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 56899999994 488888865 33488999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccC-CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------HH
Q 007290 434 LAKLVDVR-KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LD 504 (609)
Q Consensus 434 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~ 504 (609)
+|+..... .....+.++.|.+|.|||.+.. ..|+.+.||||.||++.||++|++-|.+.....+..... .+
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987542 2233466788999999998754 679999999999999999999999997655432211100 00
Q ss_pred HHHHHhhhccchhhccccc---cCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 505 HVKKLEREKRLDAIVDRNL---NKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l---~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... ..+.....+.... ..+ ..+...+...+|+.+|+..||++|+|++|.++
T Consensus 251 ~l~~i-~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKI-RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHh-ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 0000111111000 001 12344567889999999999999999999986
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.37 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCc--EEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
++|++.+.||+|+||.||+|.++ ++. .+|+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999975 454 46777776544444567888999999999 899999999999999999999
Q ss_pred eecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 360 YPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
+||+++++|.++++.... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999975321 123578999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 506 (609)
||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... +..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 233 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------HHH
Confidence 99999998643211 11111224668999999988889999999999999999998 99998643221 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...... .........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 234 ~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 234 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 0011112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=307.62 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.4
Q ss_pred cccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCch
Q 007290 291 VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.||+|+||.||+|.+. ++..||+|++.........+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999875544444567899999999999999999999885 456789999999999
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee-
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT- 446 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~- 446 (609)
|.+++... ...+++..+++++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988642 23488999999999999999999999 999999999999999999999999999986543322111
Q ss_pred -ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccccc
Q 007290 447 -TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524 (609)
Q Consensus 447 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 524 (609)
....++..|+|||.+.+..++.++||||||+++||+++ |..||...... +......... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~----------~ 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGK----------R 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCC----------C
Confidence 11223578999999988889999999999999999996 99998643211 1111111111 1
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 525 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 112233457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.75 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=199.7
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|+..+.||+|+||.||+|.+ .+++.||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999996 468899999986544444556788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999986542 267788889999999999999999 9999999999999999999999999999865432
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
......|+..|+|||.+.+..++.++||||||+++|+|+||+.||.......... ......... .+..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~---------~~~~ 216 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCI---------VDED 216 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHH---------hccC
Confidence 2233468999999999998899999999999999999999999996432211110 000111110 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+.++.+++.+|++.+|++||+++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000112234578999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.01 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=191.4
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|+.. +++.||+|+++... .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 68899999987532 233445677888888776 799999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence 9998888653 2388999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...............+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2345689999999999999999999999999999999999999963222111111111111111111110
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
..+...+..+.+++.+|++.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1122334678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.33 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=206.7
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 353 (609)
...++|.+.+.||+|+||.||++... ++..||+|+++........+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567899999999999999999742 35579999987544444557789999999999 799999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
+..+++|||+++|+|.++++... ...+++.++..++.|++.||+|||++ +++|+||||+||+++.++.++++|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999987532 23379999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007290 434 LAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 434 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||....... .. .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~----~~~~~ 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KF----YKLIK 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HH----HHHHH
Confidence 99865432211 1222345778999999988889999999999999999998 999986432211 00 01100
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.. .........+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 259 ~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 259 EG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred cC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00 0111112234678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=309.11 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=204.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+.........+.+..|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999864 2347999998654444456788999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997532 2478899999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeec--ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 439 DVRKTNVTTQ--VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 439 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
.......... ..++..|+|||.+.+..++.++||||||+++||+++ |..||...... +..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIEEGYR- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHHhCCCc-
Confidence 5433222211 223568999999998899999999999999999887 99998643211 11111111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 ---------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 11122334678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.29 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=203.3
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
+++....++|++.+.||+|+||.||++++. +++.||+|.+.... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 345556688999999999999999999975 58899999986421 223345678899999999999999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
...++||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999999998652 268888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
++...............||+.|+|||++.+. .++.++||||+||++|||+||+.||...... ......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i 259 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKI 259 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 9987653332223355799999999998654 3789999999999999999999999743321 111111
Q ss_pred hhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007290 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 559 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 559 (609)
..... .+........+..+.+++..|++.++.+ ||++.|++++
T Consensus 260 ~~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11000 0000111233567889999999865544 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=313.56 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=205.1
Q ss_pred cCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45778899999999999999852 3556899988542 2333467889999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 358 LVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
+||||+++++|.+++..... ....+++..+++++.|++.||+|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975332 123488999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 503 (609)
.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------- 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------- 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999999999976543221 11223446788999999988899999999999999999999 99998643221
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... ..... ......+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 233 ~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 EVIECIT-QGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHHHh-CCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11110 11222346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.86 Aligned_cols=253 Identities=18% Similarity=0.214 Sum_probs=202.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|.+.+.||+|+||+||+++.. +|+.||+|+++... .......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 68999999997532 2334567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997642 2488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 4333333456899999999986 456789999999999999999999999643321 11111111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... -......+..+.+++..|++ +|++||++.++++
T Consensus 227 ~~~-------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLK-------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccC-------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 00112234678899999997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.89 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=205.8
Q ss_pred HhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
..++|++.+.||+|+||.||+|... ++..||+|++...........+.+|+.++++++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467889999999999999999863 4678999998754444456778999999999999999999999999899
Q ss_pred ceEEeecccCchhhhhhhhcCC------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007290 356 RLLVYPFMQNLSVAYRLREIKP------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 417 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 417 (609)
.++++||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999975321 123478888999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007290 418 NVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 495 (609)
Q Consensus 418 NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~ 495 (609)
||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876532221 11122234678999999988899999999999999999998 77787532211
Q ss_pred cccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 496 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
+...... ..... ......+..+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 240 --------~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --------EVIYYVR-DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 11110 0112234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=307.43 Aligned_cols=250 Identities=19% Similarity=0.311 Sum_probs=210.1
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++.. +.+..-.+.+|+++++.++||||+.++.+|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788889999999999999994 689999999998644 333445678999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||..+|.|.+++.+... +++...+.++.||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999987543 89999999999999999999999 99999999999999999999999999998775
Q ss_pred cCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.. .....++|++-|.+||.+.+.+| ++.+|-||+|+++|-|+.|..||+.-. ....+++..+..
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~Ga----- 269 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRGA----- 269 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhccc-----
Confidence 33 33456789999999999999888 689999999999999999999998532 122222222211
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.+ .+..+.+..-|+.+|+..+|++|.|..+|..+..
T Consensus 270 ----Yr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 ----YR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----cc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11 1222345667899999999999999999998764
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=308.21 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=201.2
Q ss_pred CCccCcccccCCceEEEEEeC-C---CcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc-----
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-D---GTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 355 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 355 (609)
|.+.+.||+|+||.||+|... + +..||+|+++... .......+..|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999864 2 3679999987432 23345678999999999999999999998865544
Q ss_pred -ceEEeecccCchhhhhhhhcC--CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 356 -RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 356 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
.++++||+++|+|..++.... .....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885532 2234588999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007290 433 GLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 433 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHH
Confidence 9998764332211 112235678999999988889999999999999999999 88888542211 1111111
Q ss_pred hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
... ....+...+..+.+++.+||+.||++||++.|+++.|++.
T Consensus 230 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0111233456889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=313.53 Aligned_cols=268 Identities=28% Similarity=0.374 Sum_probs=198.6
Q ss_pred CCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHH--hccCCCcceeEeEEeCCC----cceE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS--VAVHRNLLRLIGFCTTPT----ERLL 358 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~l 358 (609)
..+..+++|+|+||.||+|.+. ++.||||++. ....+.|+.|-++++ .++|+||++++++-.... ++++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445678999999999999985 6999999996 345678998888877 467999999998875544 7899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH------CNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
|++|.+.|+|.++|.. ..++|....+|+..+++||+|||+. .+|+|+|||||++|||+..|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999976 3489999999999999999999974 3678999999999999999999999999
Q ss_pred ccceeeccCCC-ceeecccccccccCcccccCCC-CC-----cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 433 GLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGK-SS-----ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 433 Gl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
|+|.++..... ...-..+||.+|||||++.+.- +. .+.||||+|.++|||++....++....++. ..-+-..
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y-qlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY-QLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc-cCchhHH
Confidence 99998864322 2223367999999999997642 22 368999999999999997765532221111 1111111
Q ss_pred HHHHhhhccchhhccc-cccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 506 VKKLEREKRLDAIVDR-NLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~-~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+..-+.-+.+++.+-+ +.++.+ ....+..+.+.+..||..||+.|-|+.=+.+++..+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 1111111111111111 111111 124456889999999999999999998888776654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=308.41 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=197.8
Q ss_pred CCccCcccccCCceEEEEEeCC-Cc--EEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------Cc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TE 355 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 355 (609)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++... .....+.+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999754 33 69999886432 333456788999999999999999999987432 24
Q ss_pred ceEEeecccCchhhhhhhhcC--CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
.++++||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2234488999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007290 434 LAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 434 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
+++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||...... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLRQ 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHc
Confidence 998764322211 122345678999999998899999999999999999999 78888642211 11111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.... ......+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 230 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 1122334578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.73 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=196.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|+..+.||+|+||+||+|++. +++.||+|++.... .......+..|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999964 68899999996432 22345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987532 378888899999999999999999 9999999999999999999999999997543110
Q ss_pred CC----------------------------------------------ceeecccccccccCcccccCCCCCcchhhHHH
Q 007290 442 KT----------------------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 475 (609)
Q Consensus 442 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 475 (609)
.. .......||+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHh--ccCCCCCCCCCH
Q 007290 476 GIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALL--CTQASPEDRPAM 553 (609)
Q Consensus 476 G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~ 553 (609)
||++|||+||+.||........ .......... +........+.++.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~-------~~~i~~~~~~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET-------QLKVINWENT--------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH-------HHHHHccccc--------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999975332110 0000000000 0000111234577888877 555666679999
Q ss_pred HHHHHH
Q 007290 554 SEVVRM 559 (609)
Q Consensus 554 ~evl~~ 559 (609)
.+++++
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.15 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=205.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CC---cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.........+.+..|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999975 33 37999988654444456778999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987532 3478899999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCceee--cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 439 DVRKTNVTT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 439 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
......... ....+..|+|||.+.+..++.++|||||||++|||+| |+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~-- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGF-- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCC--
Confidence 433222111 1223457999999988889999999999999999998 99998543211 1111111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 228 --------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 --------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.41 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=206.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+..++|++.+.||+|+||.||++.+.++..+|+|.+... ......+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 456789999999999999999999878888999988642 2235678899999999999999999999877 7789999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997632 33478889999999999999999998 999999999999999999999999999986643
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
..........++..|+|||.+....++.++||||||+++|+++| |+.||...... +.........
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~------ 220 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGY------ 220 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCC------
Confidence 32222223345678999999988889999999999999999999 89998643211 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
........+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=301.15 Aligned_cols=266 Identities=22% Similarity=0.263 Sum_probs=203.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCC-cceeEeEEeCCC------
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRN-LLRLIGFCTTPT------ 354 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 354 (609)
..|...++||+|+||+||+|+.+ +|+.||+|+++-... ++......+|+.+++.++|+| ||++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44666778999999999999964 789999999975433 334456689999999999999 999999998777
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+.. +|..++.........++...++.++.|+++||+|||++ +|+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999976 89999987654323466688999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
|+....+.. ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|+...... ....+.......
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-----ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-----QLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-----HHHHHHHHcCCC
Confidence 997653322 24455689999999999876 79999999999999999999999987654411 111111111110
Q ss_pred ----cchhhccccc----cC-----CCCH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 ----RLDAIVDRNL----NK-----NYNI---QEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ----~~~~~~~~~l----~~-----~~~~---~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+.....-+.. .. .... .......+++.+|++.+|..|.|++..+++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000000000 00 0011 111478899999999999999999999975
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.59 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=193.9
Q ss_pred CcccccCCceEEEEEe----CCCcEEEEEEeccCC---CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 290 NVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.||+|+||.||+++. .+++.||+|+++... .......+..|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999986421 223345677899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+.+... ..+....+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999988653 2367788888999999999999999 99999999999999999999999999987543222
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~---------~~~ 216 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKIL---------KGK 216 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHH---------cCC
Confidence 2223356899999999999888999999999999999999999999743221 1111111 110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
. ..+...+..+.+++.+|++.+|++|| ++.++++
T Consensus 217 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 L--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 11222345789999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=327.88 Aligned_cols=252 Identities=19% Similarity=0.241 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999975 68999999996422 2234456788999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++... ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999998753 2388999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCc-------------------------------------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 007290 441 RKTN-------------------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483 (609)
Q Consensus 441 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ell 483 (609)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245899999999999889999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 007290 484 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA---MSEVVR 558 (609)
Q Consensus 484 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~ 558 (609)
+|..||...... .......... ..+........+..+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQ--------ETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHH--------HHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999743321 1111110000 000000111234578899999996 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.24 Aligned_cols=263 Identities=29% Similarity=0.416 Sum_probs=206.5
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 350 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 350 (609)
....++|.+.+.||+|+||.||++... .+..||+|+++..........+..|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888999999999999999752 24579999987544444566788999999999 599999999999
Q ss_pred eCCCcceEEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 351 TTPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 351 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
......+++|||+++|+|.+++..... ....+++..+.+++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 988889999999999999999976432 123488899999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~ 496 (609)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998664322111 112234567999999988889999999999999999999 88888543211
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........... .......+.++.+++.+|++.+|++||++.++++.|++.
T Consensus 244 -------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 244 -------ELFKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -------HHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111111110 011223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.74 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=202.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC----CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++|.+.+.||+|++|.||+|... ++++||+|.++.... ......+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999964 689999999864321 1123568889999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|+||+++++|.+.+.... .++......++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999887532 378888999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCcee--ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~------ 220 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIA------ 220 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHh------
Confidence 43221111 2345788999999999888999999999999999999999998632211 0001110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+......+.+++.+||..+|++|||+.++++.
T Consensus 221 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 ---TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001111223345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=305.89 Aligned_cols=251 Identities=18% Similarity=0.277 Sum_probs=204.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
+|++.+.||+|+||.||++... ++..||+|.++........+.+..|+.+++.++|+||+++++.+......+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999975 688999999865444445677889999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+++.... ...++......++.|++.||.|||++ +++|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 9999999886532 23478889999999999999999999 99999999999999999999999999998664322
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ...
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~-------- 217 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQ-GSY-------- 217 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhc-CCC--------
Confidence 1223356889999999998888999999999999999999999999643211 11111110 010
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...+...+..+.+++.+||+.||++||++.+++..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.91 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=193.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-------
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------- 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 353 (609)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999975 6889999988532 12345799999999999999998876332
Q ss_pred -CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcc
Q 007290 354 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGD 431 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 431 (609)
...++||||+++ ++.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999985 67676655444445689999999999999999999999 999999999999999664 799999
Q ss_pred cccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
||+++.+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||.+||........ +........
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~~~~ 288 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQVLG 288 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhC
Confidence 99998664322 2233568999999999865 4689999999999999999999999975432111 111111100
Q ss_pred hh--cc------------chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 RE--KR------------LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ~~--~~------------~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+ +. ...+....+...++...+.++.+++.+||+.||++|||+.|+++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 00 00000001111112223468899999999999999999999984
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=308.24 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=202.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-CC---cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.+|++.+.||+|+||.||+|.+. ++ ..||||.+...........|..|+.++++++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35778899999999999999975 33 369999987544444567899999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987532 3478999999999999999999999 99999999999999999999999999987654
Q ss_pred cCCCcee--eccc--ccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 440 VRKTNVT--TQVR--GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 440 ~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
....... .... .+..|+|||.+.+..++.++||||||+++|||++ |..||...... +.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~~- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQDY- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCC-
Confidence 3222111 1111 2457999999998899999999999999999887 99998533211 1111111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
........+..+.+++.+||+.+|++||++.+++..|+.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 ---------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 011122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=304.05 Aligned_cols=250 Identities=30% Similarity=0.428 Sum_probs=205.0
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+..|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 467888999999999999999975 89999999975432 467889999999999999999999999988899999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999976432 3489999999999999999999999 99999999999999999999999999998663221
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. ....+..|+|||.+.+..++.++||||||+++|||++ |..||...... .+... ....
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~---~~~~--------- 215 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPH---VEKG--------- 215 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHH---HhcC---------
Confidence 1 2234668999999988889999999999999999997 99998643211 01111 1100
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0011122335688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.39 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=193.5
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHH---HhccCCCcceeEeEEeCCCcceEE
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMI---SVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
|++.+.||+|+||.||+|.+. +|+.||||+++... .....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 68999999997432 223345666776665 456799999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|...+.. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888754 2389999999999999999999999 99999999999999999999999999987532
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .........
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~------- 216 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVND------- 216 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------
Confidence 21 12233456899999999999889999999999999999999999999743321 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
. ..++...+..+.+++.+|++.||++||+ +.++++
T Consensus 217 --~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 --E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 0112223467889999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.28 Aligned_cols=241 Identities=23% Similarity=0.312 Sum_probs=190.4
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHh-ccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|.+. +++.||+|+++... .....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999975 57899999987422 22334555667777664 4799999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|.+++.... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999887532 378889999999999999999999 99999999999999999999999999997643222 22
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-----------~~ 213 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILND-----------RP 213 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-----------CC
Confidence 33456899999999999889999999999999999999999999743221 111111100 01
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 557 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 557 (609)
.++...+.++.+++.+||+.+|++||++. ++.
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11222345788999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.45 Aligned_cols=202 Identities=20% Similarity=0.274 Sum_probs=174.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||++... +++.||+|++.... .......+..|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999965 68999999986422 2233456788999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999753 2388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC
Q 007290 441 RKT----------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486 (609)
Q Consensus 441 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~ 486 (609)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999889999999999999999999999
Q ss_pred CCCCCC
Q 007290 487 RAIDFS 492 (609)
Q Consensus 487 ~p~~~~ 492 (609)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.45 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=200.5
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|++.+.||+|+||+||++... +++.||+|.+.... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 68999999986422 12234557789999999999999999999999899999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886532 23488999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||....... ....+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~--------- 219 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKE--------- 219 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhh---------
Confidence 2 1223468999999999988889999999999999999999999997432211 00001000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
....+....+..+.+++.+||+.||++|| ++.++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 01112334556789999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.74 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=201.8
Q ss_pred HhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC-
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP- 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 353 (609)
..++|++.+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 456899999999999999999974 357889999997544444456788999999999 689999999988654
Q ss_pred CcceEEeecccCchhhhhhhhcCC--------------------------------------------------------
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKP-------------------------------------------------------- 377 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 377 (609)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999999864211
Q ss_pred -------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC-ceeecc
Q 007290 378 -------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQV 449 (609)
Q Consensus 378 -------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~ 449 (609)
....+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012367888899999999999999999 999999999999999999999999999876532211 112223
Q ss_pred cccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 450 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .......... ..+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~---~~~~~~~~~~----------~~~ 304 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EF---CRRLKEGTRM----------RAP 304 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HH---HHHHhccCCC----------CCC
Confidence 45678999999988889999999999999999997 898986432210 00 1111111000 001
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11235789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.20 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=204.4
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
.+++....++|++.+.||+|+||.||+++++ +++.||+|++.... .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4556677789999999999999999999976 68899999986421 22234567789999999999999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
....++||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999988652 267888889999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCC----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 258 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK 258 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 99987654332233345799999999998653 3789999999999999999999999743321 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRML 560 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 560 (609)
....... +........+..+.+++.+|++..+.+ ||++.+++++.
T Consensus 259 i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1110000 000111234567889999999844433 77888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.53 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|.+.+.||+|+||+||+|+.+ +++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999975 68899999987544444456678899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++ +|...+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 986 777776543 23478888999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----------
Q 007290 443 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---------- 511 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 511 (609)
. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||......+. ..........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE----LHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhhc
Confidence 1 2223457899999998865 4689999999999999999999999975433211 0001000000
Q ss_pred -hccchhhccccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 -EKRLDAIVDRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 -~~~~~~~~~~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.........+.... ...+..+.++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000 001223467889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=306.26 Aligned_cols=251 Identities=26% Similarity=0.438 Sum_probs=196.5
Q ss_pred CcccccCCceEEEEEeCC-Cc--EEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLAD-GT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|..++ |. .+++|.++........+.+..|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 44 47888887544444567888999999999 799999999999999999999999999
Q ss_pred chhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 366 LSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 366 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 123478999999999999999999998 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
++....... .......+..|+|||++....++.++||||||+++|||+| |..||...... .........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHhCC
Confidence 986332111 1111223567999999988889999999999999999997 99998643211 111111111
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
... ......+..+.+++.+||+.+|.+||++.+++..|+..
T Consensus 228 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 111 11122345789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.87 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=191.2
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|+.+ +++.||||++.... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999975 68899999986421 233456677888888776 699999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|..++.... .++...+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence 99998887532 388899999999999999999999 9999999999999999999999999998754222 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~---------~~-- 213 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND---------EV-- 213 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC---------CC--
Confidence 33456899999999999889999999999999999999999999743321 111111110 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
..+...+.++.+++.+|++.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 11122346789999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=309.43 Aligned_cols=252 Identities=25% Similarity=0.289 Sum_probs=197.5
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||+|+||.||++..+ +|+.||+|.+.... .......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 68999999986422 122344566799999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+.+.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 98886532 23478889999999999999999999 99999999999999999999999999988664322 2233
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..|+..|+|||++.+..++.++||||+||++|||++|+.||........ ........ ....... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~---------~~~~~~~-~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRT---------LEDEVKF-EH 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHh---------hcccccc-cc
Confidence 4689999999999888899999999999999999999999864221100 00111110 0000000 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
...+.++.+++.+||+.||++||+++|+++.+....
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~ 255 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHE 255 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcCh
Confidence 123467899999999999999999988876665543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=304.07 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=202.5
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
.+|++.+.||+|+||.||++.+.+++.+|+|.+... ......+..|++++++++|||++++++++......++++||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 467888999999999999999877889999988643 223567899999999999999999999999889999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+++.... ..+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999887532 2378889999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........... ...
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~---~~~-- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFR---LYK-- 222 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCC---CCC--
Confidence 22222335678999999988899999999999999999998 89998642211 11111111100 001
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
....+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.31 Aligned_cols=249 Identities=28% Similarity=0.389 Sum_probs=200.7
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe-CCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT-TPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 361 (609)
-++|.+.+.||+|+||.||++... |+.||+|.+... ...+.+..|+.++++++|+|++++++++. ..+..++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357888999999999999999874 888999988642 23567899999999999999999999764 4567899999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999987632 23478999999999999999999999 9999999999999999999999999998755322
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+........
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~-------- 215 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKG-------- 215 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcC--------
Confidence 1 12334678999999988889999999999999999998 9988863221 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 --YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0111122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=303.35 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=204.9
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|...+.||+|++|.||+|... +|+.|++|.+... ........+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999975 6899999988642 2344567888999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++.... ...+++..+.+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 34588899999999999999999999 99999999999999999999999999988765332
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......|++.|+|||++.+..++.++||||||+++|+|+||+.||...... ........ .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~---------~- 216 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIR---------G- 216 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc---------C-
Confidence 2 223345889999999999888999999999999999999999999643311 11111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0111222445689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.35 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=198.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-----cce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 357 (609)
+|++.+.||+|+||.||++... +|+.||||++.... .....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 79999999986432 2334567889999999999999999999997766 789
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+|+||+.+ +|...+.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999974 66666643 23488999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh----
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE---- 512 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 512 (609)
.............+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~g~~~~~ 227 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-----LDLITDLLGTPSLE 227 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHHHcCCCCHH
Confidence 654333333445688999999998764 479999999999999999999999975432211 0000000000
Q ss_pred -------ccchhhccccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 -------KRLDAIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 -------~~~~~~~~~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.....+....... ......+.++.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 0112234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.67 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=200.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Ccc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 356 (609)
.+|++.+.||+|+||+||++..+ ++..||+|.+... .....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 47888999999999999999853 5789999998643 234456789999999999999999999987543 457
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 89999999999999986532 2488999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-------cchhHHHHHH
Q 007290 437 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE-------DDVLLLDHVK 507 (609)
Q Consensus 437 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~-------~~~~~~~~~~ 507 (609)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..++........ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH-- 234 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH--
Confidence 764332211 1112234569999999888899999999999999999999877543211100 00000000
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+.+..............+..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 235 -------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 -------LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred -------HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011111111111223446799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=311.17 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=203.5
Q ss_pred cCCCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Ccc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 356 (609)
..|++.+.||+|+||.||++.+ .++..||+|.++..........+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999984 257889999987554445567899999999999999999999998765 567
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999986532 2479999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-------ccchhHHHHHH
Q 007290 437 LVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE-------EDDVLLLDHVK 507 (609)
Q Consensus 437 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~-------~~~~~~~~~~~ 507 (609)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 1223456778999999988889999999999999999999877643211100 00000111111
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...... ........+..+.+++.+|++.+|++||++.++++.|++
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 VLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 111100 011122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.76 Aligned_cols=265 Identities=29% Similarity=0.400 Sum_probs=208.5
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeE
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGF 349 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 349 (609)
++....+|.+.+.||+|+||.||+|.+. ++..||+|.++..........+.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445567899999999999999999752 12368999887544444567889999999999 79999999999
Q ss_pred EeCCCcceEEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007290 350 CTTPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 417 (609)
Q Consensus 350 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 417 (609)
+......++++||+++|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9988899999999999999999975322 223478889999999999999999999 9999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007290 418 NVLLDEDFEAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 495 (609)
Q Consensus 418 NIll~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~ 495 (609)
||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999998664322111 122234567999999998899999999999999999998 88888543211
Q ss_pred cccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 496 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
+.......... .......+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 244 --------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 --------ELFKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred --------HHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11111111110 1112233457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.36 Aligned_cols=243 Identities=21% Similarity=0.235 Sum_probs=195.1
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+.||+|+||.||++... +|+.||+|.+.... .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 68999999987422 2234466778999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
+|...+... ..+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 999888653 248899999999999999999997 6 99999999999999999999999999987543221 12
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~-~~~----------~ 213 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELIL-MEE----------I 213 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHh-cCC----------C
Confidence 23456899999999999889999999999999999999999999643221 0111100 000 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 559 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 559 (609)
.++...+.++.+++.+|++.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11222346789999999999999996 89988854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=308.53 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=202.3
Q ss_pred cCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.+|...+.||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777899999999999999742 3668999988643 3344568999999999999999999999999988999
Q ss_pred EEeecccCchhhhhhhhcCCC-----------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007290 358 LVYPFMQNLSVAYRLREIKPG-----------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 426 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 426 (609)
++|||+++++|.+++...... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 999999999999998754321 13478899999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHH
Q 007290 427 AVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 504 (609)
++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |++||...... +
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--------E 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------H
Confidence 99999999976543221 11122335678999999988899999999999999999998 89888532211 0
Q ss_pred HHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.......... .......+..+.+++.+||+.||++||++.+|++.|+
T Consensus 233 ~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 AIECITQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111000 0111223467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=307.29 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=203.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..++|.+.+.||+|+||.||+|.+.+ ...||||...........+.+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34568888999999999999998643 246999988654434456788999999999999999999998865 4578
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999999997532 2489999999999999999999998 999999999999999999999999999987
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.............++..|+|||.+....++.++||||||+++||+++ |..||......+ . ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~---~~~~~~~~~~- 227 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----V---IGRIENGERL- 227 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----H---HHHHHcCCcC-
Confidence 65432222222334568999999988889999999999999999996 999986433211 1 1111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+..+.+++.+|+..+|++|||+.++++.|+..
T Consensus 228 ---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 ---------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11223346899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=301.82 Aligned_cols=255 Identities=28% Similarity=0.367 Sum_probs=193.1
Q ss_pred CcccccCCceEEEEEeCC---CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 290 NVLGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+.||+|+||.||+|.+.+ +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998875444444567889999999999999999999999888999999999999
Q ss_pred hhhhhhhhcCC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 367 SVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 367 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
+|.+++..... .....++..+..++.|++.|++|||+. +++|+||||+||+++.+++++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 223467778889999999999999999 99999999999999999999999999987543222111
Q ss_pred -eecccccccccCcccccCC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 446 -TTQVRGTMGHIAPEYLSTG-------KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 446 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .... .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~---~~-~~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTY---TV-REQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHH---Hh-hcccC
Confidence 1234567889999998642 35789999999999999996 999996432211 0000 00 01111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
...++.+. ...+..+.+++..|| .+|++|||+.||++.|.
T Consensus 229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 122346788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=305.73 Aligned_cols=255 Identities=21% Similarity=0.270 Sum_probs=200.6
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45789999999999999999996 468899999986432 2344567889999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999988653 2378899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
. .......|+..|+|||.+. ...++.++|||||||++|||++|+.||......... ..... .. .
T Consensus 160 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~~~-~~---~ 226 (267)
T cd06646 160 I-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLMSK-SN---F 226 (267)
T ss_pred c-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eeeec-CC---C
Confidence 2 1123345888999999874 345788999999999999999999998532211000 00000 00 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
..+.. ......+..+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 01123456889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.27 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=193.0
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|+.. +++.||+|++.... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999975 57899999986422 233445677888888865 799999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 9999888653 2378889999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... .......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~---------~-- 213 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDD---------V-- 213 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC---------C--
Confidence 33456899999999999889999999999999999999999999754321 1111111100 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRP-------AMSEVVR 558 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~ 558 (609)
..+...+.++.+++.+|++.||++|| ++.++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 01112345788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.04 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=197.4
Q ss_pred CcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|.+.. +..+|+|.+.........+.+..|+.++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 36899999875544445678899999999999999999999876 4567999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997633 478999999999999999999999 99999999999999999999999999998764332221
Q ss_pred ee--cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 446 TT--QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 446 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+. .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~---~~~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLE---SGERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHH---cCCcC-------
Confidence 11 1223568999999988899999999999999999998 9999864321 11111111 11110
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11222346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=312.75 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=202.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|+||.||++.+. +|..+|+|.+...........+.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999965 68889999886433333456688999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999753 33788899999999999999999732 8999999999999999999999999998755322
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh----h-------
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE----R------- 511 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~------- 511 (609)
......|+..|+|||.+.+..++.++||||||+++|+|+||+.||........ ........ .
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-----EAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-----HHhhcCccccccccCCcccc
Confidence 12334688999999999888899999999999999999999999864321110 00000000 0
Q ss_pred -------------hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 -------------EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 -------------~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
......+.............+.++.+++.+|++.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000011245678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.79 Aligned_cols=251 Identities=32% Similarity=0.487 Sum_probs=204.9
Q ss_pred CcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|...+ +..|++|.++........+.+.+|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999753 7899999997654444567889999999999999999999999998999999999999
Q ss_pred chhhhhhhhcCCC-----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 366 LSVAYRLREIKPG-----EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 366 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
++|.+++...... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875322 35589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 441 RKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 441 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~----- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRKGY----- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-----
Confidence 321 12233457889999999988889999999999999999999 59998754211 1111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
........+.++.+++.+|++.+|++||++.|+++.|+
T Consensus 225 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 -----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122333578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.22 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=199.5
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhh
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA 369 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 369 (609)
++||+|+||.||++...+++.||+|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999998875444445678999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee-ec
Q 007290 370 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT-TQ 448 (609)
Q Consensus 370 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~-~~ 448 (609)
+++.... ..+++..+..++.+++.||+|||++ +++||||||+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986532 2478889999999999999999999 999999999999999999999999999876542111111 11
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNY 527 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 527 (609)
..++..|+|||.+.++.++.++||||||+++|||+| |..||...... ......... .....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~----------~~~~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESG----------YRMPA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcC----------CCCCC
Confidence 234567999999988899999999999999999999 78888543211 011111100 00111
Q ss_pred CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 528 NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 528 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 22345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.17 Aligned_cols=242 Identities=23% Similarity=0.290 Sum_probs=193.6
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCC-CcceeEeEEeCCCcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 360 (609)
+|++.+.||+|+||.||+|..+ +++.||||++.... .....+.+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999975 57899999987422 233456778899999998765 5888889998889999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999888653 2378889999999999999999999 999999999999999999999999999875322
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~---------~ 215 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIM---------E 215 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHH---------c
Confidence 11 2233456899999999999999999999999999999999999999743221 1111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
.. ..++...+..+.+++.+|+..||.+|++.
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HN--VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 11122334678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=308.99 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=206.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||++... +|+.||+|++...........+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356788899999999999999965 6889999988654444556788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... .+++.....++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999887632 3789999999999999999999732 8999999999999999999999999998754322
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc---hhHHHHHHHHhhhccchhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD---VLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 518 (609)
......|+..|+|||.+.+..++.++|||||||++|+|+||+.||+......... ..........
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--------- 225 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH---------
Confidence 1223468999999999988889999999999999999999999997543321100 0011111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.............+..+.+++.+|++.||++||++.|++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111101111122456789999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.70 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=196.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|.+.+.||+|+||+||++... +|+.||||++.... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999964 78999999986421 2234567888999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++... ..++...++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999998753 2378888999999999999999999 999999999999999999999999999864321
Q ss_pred CCCc----------------------------------------------eeecccccccccCcccccCCCCCcchhhHH
Q 007290 441 RKTN----------------------------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFG 474 (609)
Q Consensus 441 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 474 (609)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001246899999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCC---C
Q 007290 475 YGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR---P 551 (609)
Q Consensus 475 lG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---P 551 (609)
|||++|||+||..||...... .......... ..+.-......+.++.+++.+|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999999643321 1111110000 000000011234578899999997 66665 5
Q ss_pred CHHHHHHH
Q 007290 552 AMSEVVRM 559 (609)
Q Consensus 552 s~~evl~~ 559 (609)
++.|++++
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99888864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.18 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=203.7
Q ss_pred CCCccCcccccCCceEEEEEeCC--CcEEEEEEeccC---------CCCchHHHHHHHHHHHHh-ccCCCcceeEeEEeC
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDF---------ESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTT 352 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~---------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 352 (609)
+|++.+.||+|+||.||+|.++. ++.+|+|.+... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 688999987532 112234557788888764 789999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
.+..+++|||+++++|.+++.........+++..+++++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886644445568999999999999999999996 5 899999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVE 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhh
Confidence 99998765432 233456889999999999888999999999999999999999998643221 11111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...........+..+.+++.+||+.||++||++.|+..++++
T Consensus 228 ---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 ---------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 000010111234678999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=339.02 Aligned_cols=261 Identities=20% Similarity=0.305 Sum_probs=202.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||+|.+. +|+.||+|++..... ....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999975 589999999874322 233567899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCC-------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 361 PFMQNLSVAYRLREIKP-------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
||+++|+|.+++..... .....++..+.+++.|+++||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 122356778889999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCC-----------------ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 007290 434 LAKLVDVRKT-----------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496 (609)
Q Consensus 434 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~ 496 (609)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01122468999999999999999999999999999999999999996422110
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcC
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGE 563 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 563 (609)
.. . .... .++.. .......+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 239 -----i~-~------~~~i---~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 -----IS-Y------RDVI---LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred -----hh-h------hhhc---cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0 0000 00000 000123346788999999999999996 566677777653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.82 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=196.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.+|++.+.||+|+||.||+|+.. +++.||||.+.... .......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999965 68999999986421 1223466789999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++... ..++......++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999753 2378888889999999999999999 999999999999999999999999999753310
Q ss_pred CC------------------------------------------CceeecccccccccCcccccCCCCCcchhhHHHHHH
Q 007290 441 RK------------------------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM 478 (609)
Q Consensus 441 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~l 478 (609)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000113469999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC---CHHH
Q 007290 479 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP---AMSE 555 (609)
Q Consensus 479 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~e 555 (609)
+|||+||+.||....... ......... ..+........+..+.+++.+|+ .+|.+|+ ++.+
T Consensus 234 lyell~G~~Pf~~~~~~~--------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAE--------TQLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHH--------HHHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999997543211 111110000 00000111123456778888876 5999999 8888
Q ss_pred HHHH
Q 007290 556 VVRM 559 (609)
Q Consensus 556 vl~~ 559 (609)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.17 Aligned_cols=251 Identities=21% Similarity=0.233 Sum_probs=194.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|++.+.||+|+||+||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 68899999986422 22345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++... ..++......++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998753 2378888899999999999999999 9999999999999999999999999997533100
Q ss_pred C----------------------------------------------CceeecccccccccCcccccCCCCCcchhhHHH
Q 007290 442 K----------------------------------------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGY 475 (609)
Q Consensus 442 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 475 (609)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---
Q 007290 476 GIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA--- 552 (609)
Q Consensus 476 G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs--- 552 (609)
||++|||+||+.||....... ........ ...+........+.+..+++.+++ .+|++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--------~~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLE--------TQMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHH--------HHHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 999999999999997433211 00110000 000000111223456778787776 59999987
Q ss_pred HHHHHH
Q 007290 553 MSEVVR 558 (609)
Q Consensus 553 ~~evl~ 558 (609)
+.++++
T Consensus 299 ~~ei~~ 304 (382)
T cd05625 299 ADEIKA 304 (382)
T ss_pred HHHHhc
Confidence 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.13 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=193.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999976 57899999987532 222344566788887776 5889999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999998886532 378899999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .. ..... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~---~~~i~---------~ 215 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----EL---FQSIM---------E 215 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HH---HHHHH---------h
Confidence 21 2233456899999999999999999999999999999999999999743321 11 11111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
.. ..++...+.++.+++.+|++.+|++|++.
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 01122344678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.60 Aligned_cols=249 Identities=29% Similarity=0.401 Sum_probs=199.3
Q ss_pred CcccccCCceEEEEEeCC--C--cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLAD--G--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999743 3 36999998754433556789999999999999999999999887 888999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc-
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN- 444 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~- 444 (609)
++|.+.+..... ..+++...+.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 4589999999999999999999999 9999999999999999999999999999876432211
Q ss_pred -eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 445 -VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 445 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +..........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~-------- 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGE-------- 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCC--------
Confidence 1122456789999999988899999999999999999999 99998633211 11111111000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
........+..+.+++.+|++.+|++||++.++++.|.
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 -RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.26 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=199.0
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchH-HHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
|++.+.||+|+||+||+++.. +++.||+|.+......... ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 667899999999999999976 5678999999754322222 23356999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+++.. ...+++..+..++.|+++||.+||++ +++|+||||+||+++.++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 99999999983 23389999999999999999999999 99999999999999999999999999998642 222
Q ss_pred ceeecccccccccCccccc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......++..|+|||.+. +..++.++||||+|+++|+|++|..||........ ..................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-- 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-----LEIIEKILKRPLPSSSQQ-- 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-----HHHHHHHHHTHHHHHTTS--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhh-----hhhhhhcccccccccccc--
Confidence 3344566899999999998 78899999999999999999999999975411111 011111100000000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+.+++.+||+.||++||++.++++
T Consensus 226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011268999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.22 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=199.6
Q ss_pred CcccccCCceEEEEEeCC-------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 290 NVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.||+|+||.||+|.+.+ +..+|+|.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998643 2579999886544344567889999999999999999999999998999999999
Q ss_pred ccCchhhhhhhhcCC---CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-----cEEEccccc
Q 007290 363 MQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-----EAVVGDFGL 434 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGl 434 (609)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975332 224478899999999999999999998 999999999999999877 899999999
Q ss_pred ceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 435 AKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 435 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
+........ .......++..|+|||.+.++.++.++||||||+++|||+| |+.||...... +........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHhcC
Confidence 876543221 11122345678999999999999999999999999999998 99998633211 111111111
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
. ........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 230 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 111223345788999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.95 Aligned_cols=244 Identities=23% Similarity=0.239 Sum_probs=191.1
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|... +++.||+|+++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999997532 223445678899998887 599999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 9998888653 2389999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ............. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~----------~ 220 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEKP----------I 220 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhCC----------C
Confidence 334568999999999999999999999999999999999999996432211110 0111111111110 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
..+...+..+.+++.+|++.||++||++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122234578899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=315.58 Aligned_cols=242 Identities=25% Similarity=0.311 Sum_probs=194.1
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|++. +++.||||+++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999976 57899999987432 233456677888888877 699999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|.+.+... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 9999888653 2388999999999999999999999 99999999999999999999999999987532211 22
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....|++.|+|||++.+..++.++|||||||++|+|+||+.||...... ........ .. .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~---------~~--~ 213 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILE---------DE--V 213 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHc---------CC--C
Confidence 23346899999999999999999999999999999999999999643311 11111110 00 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAM-----SEVVR 558 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~ 558 (609)
.++...+..+.+++.+||+.||++||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1122334678999999999999999998 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=313.48 Aligned_cols=241 Identities=24% Similarity=0.319 Sum_probs=191.1
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHh-ccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|.+. +++.||||+++... .......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999975 57899999987432 12334556677888775 5899999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..+++.....++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 9999998753 2378889999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~-------~~---- 213 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMD-------NP---- 213 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------CC----
Confidence 23456899999999999889999999999999999999999999743221 111111100 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 557 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 557 (609)
.++...+..+.+++.+|++.+|++||++. ++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 01112345788999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.66 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred cCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
++|+..+.||+|+||+||+|+.+ +.+.|++|.+...........+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999964 346799998865433334578999999999999999999999999888999
Q ss_pred EEeecccCchhhhhhhhcCCCC-----CCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGE-----PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997644221 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... . ..+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~---~~~~~~~- 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----E---EVLNRLQ- 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----H---HHHHHHH-
Confidence 9987543322222333456778999999988889999999999999999999 7788753211 0 1111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
..... .......+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 233 ~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00110 0111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.44 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=204.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999975 68899999987544455567788999999999999999999999988999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++... .+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 488999999999999999999999 99999999999999999999999999998775432
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......+++.|+|||.+.+..++.++||||||+++|+|+||+.||...... ....... ...
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~-~~~-------- 214 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIP-KNN-------- 214 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhh-hcC--------
Confidence 2223346788999999998888999999999999999999999999643211 0111100 000
Q ss_pred ccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....... .+..+.+++.+|+..+|++||+++++++
T Consensus 215 -~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 -PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0111111 4567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.22 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=190.9
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHh-ccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|+++ +|+.||+|.++... .......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 68899999987422 12334566778888765 4899999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 9999888653 2378889999999999999999999 9999999999999999999999999998743221 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~-------~~---- 213 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVD-------TP---- 213 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------CC----
Confidence 33456899999999999999999999999999999999999999643221 111111100 00
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 557 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 557 (609)
..+...+.++.+++.+|++.||++||++. ++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11112345788999999999999999984 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.30 Aligned_cols=250 Identities=30% Similarity=0.432 Sum_probs=192.1
Q ss_pred CcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-CCcceEEeeccc
Q 007290 290 NVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYPFMQ 364 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 364 (609)
+.||+|+||.||+|.+. ++..||+|++...........+.+|+.+++.++||||+++++++.. +...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2457999988644334456788899999999999999999998754 456789999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+|+|.+++.... ...++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987532 2256777888999999999999999 9999999999999999999999999999765332111
Q ss_pred ---eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 445 ---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 445 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
......++..|+|||.+.+..++.++||||||+++|||++| .+||..... .............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCC-----
Confidence 11123457789999999888999999999999999999996 455542211 1111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01112245789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.44 Aligned_cols=249 Identities=19% Similarity=0.297 Sum_probs=201.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 57888999999999999999964 68899999886433 23456788999999999999999999999988999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999988642 368889999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ... .......
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~-~~~~~~~-------- 233 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALY-LIATNGT-------- 233 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHH-HHhcCCC--------
Confidence 1 1223458899999999988889999999999999999999999996432210 000 0000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
............+.+++.+||..+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 001112334467899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.47 Aligned_cols=239 Identities=23% Similarity=0.280 Sum_probs=192.6
Q ss_pred CcccccCCceEEEEEe----CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeeccc
Q 007290 290 NVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
+.||+|+||.||+++. .+|+.||+|++.... .......+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999885 358899999997432 12234556789999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 99999988652 3488999999999999999999999 99999999999999999999999999987654321 2
Q ss_pred eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccccc
Q 007290 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 524 (609)
......|++.|+|||.+.+..++.++|||||||++|||+||+.||...... ......... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~---------~~- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKA---------KL- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcC---------CC-
Confidence 233456899999999998888999999999999999999999999743211 111111100 00
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007290 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSE 555 (609)
Q Consensus 525 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 555 (609)
..+...+..+.+++.+||+.||++||++.+
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 112223467889999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.14 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..+|++.+.||+|+||+||+|.++ +|. .||+|.............+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356788899999999999999964 333 6899988755444456788899999999999999999999987 7789
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999987532 2388999999999999999999998 999999999999999999999999999987
Q ss_pred eccCCCcee-ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
......... ....++..|+|||.+....++.++||||||+++||++| |+.||...... +..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGER- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCCC-
Confidence 653322111 12224568999999988889999999999999999999 99998643221 11111111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112335788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.33 Aligned_cols=264 Identities=24% Similarity=0.369 Sum_probs=205.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC--CCcc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 356 (609)
+.|+..+.||+|+||.||+|.+. ++..||||.+...........|.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999864 3688999998754333346789999999999999999999999876 5578
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997533 2489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc-------chhHHHHHH
Q 007290 437 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-------DVLLLDHVK 507 (609)
Q Consensus 437 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 507 (609)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+......... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 11223456799999998889999999999999999999999998643221100 000111111
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. +............+.++.+++.+||+.+|++||++.||+++|+..
T Consensus 238 ~----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 L----------LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred H----------HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1 111111111223346899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.36 Aligned_cols=256 Identities=20% Similarity=0.237 Sum_probs=197.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+++.. +++.||+|++... ......+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 6899999998642 12233566888999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... ..++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997532 2378889999999999999999999 999999999999999999999999999976654
Q ss_pred CCCceeecccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCc
Confidence 33322333468999999999863 45788999999999999999999999643221 111111110000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPE--DRPAMSEVVRM 559 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~--~RPs~~evl~~ 559 (609)
.. + .......+..+.+++.+|+..+++ .||++.++++.
T Consensus 227 ~~-----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQ-----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cc-----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0 011122456778888887765443 37899888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=299.04 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=190.6
Q ss_pred cccccCCceEEEEEeCCC---cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCch
Q 007290 291 VLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.||+|+||+||+|...++ ..+++|.+.........+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985443 34667766544444456789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC-Ccee
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-TNVT 446 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~-~~~~ 446 (609)
|.++++.........+......++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986443334467778889999999999999999 99999999999999999999999999986432111 1122
Q ss_pred ecccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 447 TQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 447 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||...... ......... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~-~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--------EVLNHVIKD-QQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhh-ccccc
Confidence 23457889999998743 2457899999999999999974 6677532211 111111111 11122
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.++.+.. .....+.+++..|| .+|++||++.+|++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222 23456788999999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.49 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=193.0
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhc---cCCCcceeEeEEeCC-----C
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCTTP-----T 354 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 354 (609)
+|++.+.||+|+||+||+|.+. +|+.||+|.++.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999975 688999999864322 22234556677776654 799999999987542 3
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..+++|||+++ +|..++..... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 47899999985 78787765332 3488999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 512 (609)
++...... ......||..|+|||++.+..++.++|||||||++|||++|++||....... ............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~ 228 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPE 228 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----HHHHHHHHhCCCCh
Confidence 98664322 1233467899999999988899999999999999999999999986432211 111111100000
Q ss_pred -ccch------hhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 -KRLD------AIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 -~~~~------~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ....+... ....+..+..+.+++.+|++.||++|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00000000 0011234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.15 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=195.8
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-----
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----- 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 354 (609)
..++|++.+.||+|+||.||++... +|..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999975 68999999986432 2334567889999999999999999999886443
Q ss_pred -cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 355 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 355 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
..++||||++++ +...+.. .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 468999999764 5444432 267888889999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc----------hhHH
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD----------VLLL 503 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~----------~~~~ 503 (609)
+++..... .......||+.|+|||.+.+..++.++|||||||++|+|+||+.||.......... ....
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99754321 22234568999999999999999999999999999999999999997442211000 0000
Q ss_pred HH----HHHHh-hhcc-----chhhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 504 DH----VKKLE-REKR-----LDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 504 ~~----~~~~~-~~~~-----~~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. +.... .... ..+....... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000 0000 0000000000 00011224578999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.86 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=198.9
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|+..+.||+|+||+||++.+. +++.||+|.+..... ......+..|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999975 688999999864322 2223557789999999999999999999998899999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+.+.... ...++...+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999886532 23488899999999999999999999 9999999999999999999999999998765322
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ........ ..
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-----~~~~~~~~-----~~--- 220 (285)
T cd05630 156 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-----EEVERLVK-----EV--- 220 (285)
T ss_pred c--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-----HHHHhhhh-----hh---
Confidence 2 122346899999999999889999999999999999999999999743211100 00000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
...+....+..+.+++.+||+.||++||| ++|+++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00112223457889999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.92 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=200.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456778899999999999999864 444 57899886544444455788999999999999999999998654 467
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 8999999999999987532 2378889999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~~~~~---~~~~~~~ 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----EIPDL---LEKGERL 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH---HHCCCCC
Confidence 6432221 1122345678999999988899999999999999999998 88998643211 01111 1111110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+..+.+++.+||..+|++||++.++++.|+..
T Consensus 231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 ----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.88 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=201.2
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
.|+..+.||+|+||.||+|.+. ++..||+|.+.........+.+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999864 578999998865444445567899999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+.+.. ..+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++..+.....
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988853 2378889999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
......++..|+|||.+.+..++.++||||||+++|||+||+.|+....... ..... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~----------~~~~ 217 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLI----------PKNS 217 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhh----------hcCC
Confidence 1223457889999999998889999999999999999999999986322110 00000 0011
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+..+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111223345678999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.21 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=198.7
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|++.+.||+|++|.||+|+.. ++..||+|++.... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68999999986432 233346788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
++ ++|.+++..... ...++...+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 98 578887765432 34588999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh-----------
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE----------- 510 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 510 (609)
.......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||........ .........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ----LFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhcch
Confidence 122233578899999988654 578999999999999999999999974332111 000000000
Q ss_pred hhccchhhccccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 REKRLDAIVDRNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ~~~~~~~~~~~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
............. ........+.++.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 00001123467789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=301.77 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=204.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
..|+..+.||.|+||.||+|.+. ++..||+|.+...........+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999975 58899999987544445567888999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++.. ..++......++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998864 2378888899999999999999999 99999999999999999999999999997664322
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......++..|+|||.+.+..++.++|+||||+++|||+||+.||....... ... .....
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~----------~~~~~ 216 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLF----------LIPKN 216 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhh----------hhhcC
Confidence 1 2223457889999999988889999999999999999999999986432110 000 00111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1122344567789999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.59 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=204.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 360 (609)
++|+..+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 68899999987544444567789999999999999999999988543 4678999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.........++......++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865444445588889999999999999999999 999999999999999999999999999875532
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...............+.... ..... .
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~-~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPEL-K 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhh-c
Confidence 21 1234578899999999988999999999999999999999999975533211111111111110 00010 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 001234568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.16 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=198.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC-----
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP----- 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----- 353 (609)
.+++.|++.+.||+|+||.||+|... +++.||+|++... ......+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35677888999999999999999965 6889999998643 23456788999999988 699999999998643
Q ss_pred -CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 354 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
...+++|||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 35789999999999999987632 23488899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
|++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .. .
T Consensus 156 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~-~ 226 (272)
T cd06637 156 GVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------AL-F 226 (272)
T ss_pred CCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HH-H
Confidence 9998654322 2223456889999999985 3357889999999999999999999986322110 00 0
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... ..+.. .....+..+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~~~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 LIPRN------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhcC------CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 00000 11223457899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.44 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=199.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|.+.+.||+|+||.||+|+.+ +++.||+|.+...........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999975 68899999987544444456678899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
++ ++|...+... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 4888777653 22378889999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh---hhccchhh
Q 007290 443 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE---REKRLDAI 518 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 518 (609)
. ......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||........ ........ .......+
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-----LHFIFRILGTPTEETWPGI 232 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCCChhhchhh
Confidence 1 1223457889999998865 4578999999999999999999999975432211 00000000 00000000
Q ss_pred cc---------ccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VD---------RNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~---------~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. +.... ......+..+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00000 001223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.10 Aligned_cols=243 Identities=23% Similarity=0.247 Sum_probs=190.3
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHH-HHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|.+. +|+.||+|++.... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999975 68999999986422 1222344555555 46789999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 9999888652 2478889999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~---------~~~~-- 213 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNIL---------NKPL-- 213 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHH---------cCCC--
Confidence 33456899999999999989999999999999999999999999643211 1111111 0000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...+..+..+.+++.+|++.||++||++.+.+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 1112235678999999999999999998644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.23 Aligned_cols=250 Identities=29% Similarity=0.444 Sum_probs=208.3
Q ss_pred cCcccccCCceEEEEEeC-CC----cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 289 KNVLGQGGFGKVYRGVLA-DG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
.++||.|+||+||+|.|- +| .+||+|++..........++..|+-++..++|||+++++|+|..+. ..+|++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 578999999999999963 33 4799999988888888899999999999999999999999998777 78899999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
+.|+|.+++++... .+.....+.|..|||+||.|||++ ++|||||..+|||+..-..+||.|||+++.......
T Consensus 780 P~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred ccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999998443 378888999999999999999999 999999999999999999999999999998865443
Q ss_pred ce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 444 NV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 444 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.. .....-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+- -..+..++++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------~dlle~geRL------ 919 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------PDLLEKGERL------ 919 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------hHHHhccccC------
Confidence 32 223334678999999999999999999999999999999 8888875443211 1111122221
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.-++-.+.++.-++.+||..|++.||+++++...+.+.
T Consensus 920 ----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 920 ----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 12445567899999999999999999999999877754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=301.55 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=190.6
Q ss_pred CcccccCCceEEEEEeCC---CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 290 NVLGQGGFGKVYRGVLAD---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+.||+|+||.||+|...+ ...+|+|.+...........+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999998543 35788888765444444567889999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCC-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc-
Q 007290 367 SVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN- 444 (609)
Q Consensus 367 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~- 444 (609)
+|.+++...... ....++.....++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764322 23356778889999999999999999 9999999999999999999999999998654322111
Q ss_pred eeecccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 445 VTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... +.......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~-~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQD-I 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccC-c
Confidence 1122345678999998742 356889999999999999999 77787533211 00111111110 1
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
....+. .....+..+.+++..|| .||++||++++|++.|
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111111 12234456778888998 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=319.86 Aligned_cols=264 Identities=20% Similarity=0.237 Sum_probs=196.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
....|.+.+.||+|+||.||+|.+. +++.||||... ...+.+|++++++++|+|||++++++......++||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3557999999999999999999975 57899999642 234578999999999999999999999889999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|++. ++|..++... ...+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 240 e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 240 PKYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9995 5777777542 22489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc---cchhHHHHHHHHhhh-ccc
Q 007290 441 RKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE---DDVLLLDHVKKLERE-KRL 515 (609)
Q Consensus 441 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~-~~~ 515 (609)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..|+-....... ....+...+...... ...
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 2221 22245699999999999999999999999999999999998865432111111 111111111111000 000
Q ss_pred hh---------h-------ccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 516 DA---------I-------VDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 516 ~~---------~-------~~~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. . ..+...... .......+.+++.+||+.||++|||+.|++++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0 000000000 00123478899999999999999999999974
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=297.86 Aligned_cols=252 Identities=30% Similarity=0.479 Sum_probs=202.5
Q ss_pred CCccCcccccCCceEEEEEeCC-----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 286 FSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+++.+.||+|+||.||++.+.+ +..||+|++...........+..|+.++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 37899999975544435778999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998763321 179999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
..........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||..... ............
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~----- 222 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYR----- 222 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCC-----
Confidence 32222222336789999999988889999999999999999998 7888754211 111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.......+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222456899999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=298.52 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=203.7
Q ss_pred hcCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|+..+.||+|+||.||+|...+ ++.|++|.+.... ..+.+.+|++++++++||||+++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3578889999999999999999764 8899999986432 26789999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999986532 3489999999999999999999999 9999999999999999999999999998876433
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.. ......++..|+|||.+.+..++.++||||||+++|+|+||+.||........ ..... .....
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~~------~~~~~ 217 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMIP------NKPPP 217 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhhc------cCCCC
Confidence 21 22334578899999999888999999999999999999999999864322110 00000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ..........+.+++.+||+.+|++|||+.|+++
T Consensus 218 ~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 T--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 0112334567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=289.78 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=205.8
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEecc-CCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++.|++.+.||+|.|+.||++.+. +|+.+|+|.+.- .-+....+++.+|+++-+.++|||||++...+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3567888899999999999999865 789999998752 22344678899999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~~ 436 (609)
||+|.|++|..-+-.. ...++......+.||+++|.|+|.+ +|||||+||+|+++- ...-+||+|||++.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999998776543 3467778888999999999999999 999999999999994 33458999999999
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.++ ........+|||+|||||++...+|+..+|||+-||++|-|+.|.+||...... .+.+.+..-.
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye~I~~g~------ 228 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYEQIKAGA------ 228 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHHHHhccc------
Confidence 887 444556678999999999999999999999999999999999999999642211 1111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.| +....-+..+++..+|+.+|+..||.+|.|+.|.++.-
T Consensus 229 --yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 229 --YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred --cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 00 11112334557889999999999999999999988653
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.69 Aligned_cols=248 Identities=21% Similarity=0.224 Sum_probs=192.9
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHH-HHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|++. +++.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999976 57889999986422 1222334444444 46788999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|.+.+... ..+.......++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 9999988752 2367788888999999999999999 9999999999999999999999999998754322 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~---------~--~ 213 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNK---------P--L 213 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhC---------C--c
Confidence 33456999999999999999999999999999999999999999643221 111111110 0 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
...+..+..+.+++.+|++.+|++||++.+.+..+....
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 112233467899999999999999999886665555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=303.32 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=196.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHH-HHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||.||++.++ +|+.||+|++...........+..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 6999999998754333334556666665 566789999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++ |+|..++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5888887664444456899999999999999999999853 7999999999999999999999999998865322
Q ss_pred CCceeecccccccccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... . ...........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~--- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------F-QQLKQVVEEPS--- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------H-HHHHHHHhcCC---
Confidence 1 1222457889999998864 45689999999999999999999998632111 0 01111100000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+ .......+.++.+++.+||..+|++||++.++++
T Consensus 226 ---~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ---P---QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0011224567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.86 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=204.5
Q ss_pred CCCccCcccccCCceEEEEEeC--CCc--EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.....++||+|.||.|++|.|. .|+ .||||.++...-.....+|.+|+.++.+++|||++++||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445678999999999999986 344 5999999865544467899999999999999999999999987 6788999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|.++.|+|.+.|+.. ....|-......++.|||.||.||.++ ++|||||..+|+|+-....+||+|||+.+.+..
T Consensus 190 ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999982 344577888889999999999999999 999999999999999999999999999998864
Q ss_pred CCCce-e-ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 441 RKTNV-T-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 441 ~~~~~-~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
..... + ....-...|.|||.+....++.++|||+|||++|||+| |+.||..-.. .+..+.+...+++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erL-- 334 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERL-- 334 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccC--
Confidence 33222 1 22334678999999999999999999999999999999 6788864321 1222222222222
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+..++++++++++.||..+|.+||||..|.+
T Consensus 335 --------pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 --------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --------CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 235567789999999999999999999999974
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.76 Aligned_cols=265 Identities=22% Similarity=0.213 Sum_probs=213.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|+..+.||+|.-|+||+++.++ +..+|+|++.+.. ........+.|-++|+.++||.++.+|+.+.++...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34566778899999999999999864 5899999996533 22334567789999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+||||+||+|..+.+.. .+..+++..++.++..++-||+|||-. |||.|||||+||||.++|++.|+||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999988763 345699999999999999999999999 9999999999999999999999999987433
Q ss_pred cc---------------------------------CCC----------------------ceeecccccccccCcccccC
Q 007290 439 DV---------------------------------RKT----------------------NVTTQVRGTMGHIAPEYLST 463 (609)
Q Consensus 439 ~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~ 463 (609)
.. ... ......+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 000 01123569999999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhcc
Q 007290 464 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCT 543 (609)
Q Consensus 464 ~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl 543 (609)
...+.++|+|+|||++|||+.|..||......+ .+..++.+.+.-...+..+..+.|||.+.+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999998655432 222333333322223356678999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCCcccc
Q 007290 544 QASPEDRPAMSEVVRMLEGEGLAER 568 (609)
Q Consensus 544 ~~dP~~RPs~~evl~~L~~~~~~~~ 568 (609)
.+||.+|-....=...+++..+.++
T Consensus 373 vKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred ccChhhhhccccchHHhhcCccccC
Confidence 9999999986666666666666654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=297.52 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=205.1
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|+..+.||+|+||.||.++.. +++.+++|.+.... .......+.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999954 68999999886432 344567788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+.+.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987643 34478999999999999999999999 99999999999999999999999999998764433
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......+++.|+|||.+.+..++.++||||||+++|||++|..||...... +....... ..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~---------~~ 217 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQ---------GN 217 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc---------CC
Confidence 2 233456899999999998888999999999999999999999998643221 11111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ......+..+.+++.+||+.+|++||+++++++.
T Consensus 218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11 1113345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=297.93 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
++|++.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++++++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5688899999999999999986 5788999998642 2346788999999999999999999988654 478999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999997632 23478899999999999999999998 99999999999999999999999999987543211
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .........
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~---------- 213 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------EVKECVEKG---------- 213 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHHhCC----------
Confidence 12234568999999988899999999999999999998 89998643321 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.51 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=202.8
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe--
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT-- 351 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 351 (609)
++.+....++|++.+.||+|+||.||++... +++.+|+|.+... ......+..|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455567789999999999999999999975 6889999987542 22346678899999998 6999999999873
Q ss_pred ---CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 352 ---TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 352 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
.....++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 33568999999999999998875433345588899999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCCceeecccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 429 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 429 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.......
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------- 236 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------- 236 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-------
Confidence 999999886643221 2223468999999998753 457899999999999999999999986432110
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
......... .....+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 237 -~~~~~~~~~-~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 -ALFKIPRNP-PPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -HHhhccccC-CCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000000 000000 11123578999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.99 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=200.3
Q ss_pred CCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCC-----CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+|.+.+.||+|+||+||+|...+|+.+|+|.+..... ......+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864221 11235688899999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997532 378889999999999999999999 99999999999999999999999999987653
Q ss_pred cCC-----CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 440 VRK-----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 440 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
... ........|+..|+|||.+.+..++.++||||||+++|+|+||+.||....... . .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~-~~~~~~~~~ 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------A-MFYIGAHRG 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------H-HHHhhhccC
Confidence 211 111223458899999999998889999999999999999999999996432110 0 000000000
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.........+..+.+++.+||+.+|++||++.++++
T Consensus 226 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 --------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001112234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.88 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=213.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC--chHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 357 (609)
..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.... .......+|+.+++++. |||||.+++.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4567888899999999999999976 4999999999764432 24578899999999998 999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEcccc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFG 433 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG 433 (609)
+|||++.||.|.+.+... . +++.....++.|++.++.|||+. ||+|||+||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999875 2 88999999999999999999999 99999999999999643 579999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||......... .
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~----~---------- 248 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF----L---------- 248 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH----H----------
Confidence 9998765 44566778999999999999899999999999999999999999999754422110 0
Q ss_pred cchhhccc--cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLDAIVDR--NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~~~~~~--~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+... .+.....+..+....+++..|+..||..|+|+.+++++
T Consensus 249 ---~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ---AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 12233445667889999999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.54 Aligned_cols=266 Identities=20% Similarity=0.245 Sum_probs=196.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------ 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 353 (609)
..++|++.+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999964 68899999986532 233446778899999999999999999988543
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
...++||||+++ ++...+.. .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999976 45555532 277888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH-------HH-
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL-------DH- 505 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~-------~~- 505 (609)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865422 222345689999999999988999999999999999999999999975332111000000 00
Q ss_pred ------HHHH-hhhccchhhcccc-----cc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 506 ------VKKL-EREKRLDAIVDRN-----LN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 506 ------~~~~-~~~~~~~~~~~~~-----l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+... ...........+. .. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000000 00 00111234578999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.63 Aligned_cols=238 Identities=22% Similarity=0.247 Sum_probs=187.6
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHH-HHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
++||+|+||.||+|++. +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 68899999986422 1223344555554 57889999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 9998888652 3378888889999999999999999 9999999999999999999999999998753222 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~---------~~~--~ 213 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--------QMYDNIL---------HKP--L 213 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--------HHHHHHh---------cCC--C
Confidence 33456899999999998888999999999999999999999999643211 1111111 110 0
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
..+...+..+.+++.+|++.+|++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223346789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=315.76 Aligned_cols=250 Identities=23% Similarity=0.253 Sum_probs=195.2
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHH-HHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|+.. +|+.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999965 68999999986421 2223445556655 46779999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 9998888652 3488999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ........ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~---------~~~-- 213 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILH---------KPL-- 213 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHc---------CCc--
Confidence 23456899999999999999999999999999999999999999643211 11111111 000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcc
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLA 566 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 566 (609)
...+..+..+.+++.+|++.+|++||++.+.++.+....+.
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 01122345788999999999999999987666665555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.74 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=197.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|.+.+.||+|+||+||+++.. +++.||+|.+.... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999975 68899999986421 2223456788999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|..++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997632 2378888999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-cc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-KR 514 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 514 (609)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... ......... .+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCc
Confidence 33333334569999999999865 46789999999999999999999999643221 111111110 00
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 558 (609)
. .+ +......+..+.+++.+|+...+++ |++++++++
T Consensus 227 ~------~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 F------QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred c------cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 00 1111223567889999999865544 457777664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.23 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=193.2
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 360 (609)
+|+..+.||+|+||+||+|... +|+.||+|++.... .......+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999965 68999999987422 2334456778888888876 577888999998889999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999886532 388999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~---------~ 215 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIM---------E 215 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHH---------h
Confidence 21 1223456899999999999889999999999999999999999999743221 1111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
... .++...+..+.+++.+|++.+|++|++..
T Consensus 216 ~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 HNV--SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCC--CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 000 11222346788999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=296.62 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=201.1
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-CcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-TERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 361 (609)
+|++.+.||+|++|.||++..+ +++.||+|++.... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 57899999986432 233456788999999999999999999887644 45789999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ...+++.++..++.|++.|++|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987632 23478999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ +..
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~-~~~------ 219 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIE-GKL------ 219 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHh-cCC------
Confidence 2 2223445889999999999989999999999999999999999998643211 11111110 111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.......+..+.+++.+|++.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223445689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.72 Aligned_cols=197 Identities=22% Similarity=0.336 Sum_probs=160.1
Q ss_pred cCcccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC--CCcceEEeecc
Q 007290 289 KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVYPFM 363 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 363 (609)
.++||+|+||+||+|+.. +++.||+|.+... .....+.+|+.++++++||||+++++++.. ....+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999965 4678999998643 223567889999999999999999998854 34578999998
Q ss_pred cCchhhhhhhhcCC-----CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEccccc
Q 007290 364 QNLSVAYRLREIKP-----GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGL 434 (609)
Q Consensus 364 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl 434 (609)
.+ +|..++..... ....++...++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 77776653211 123488889999999999999999999 99999999999999 4567899999999
Q ss_pred ceeeccCCC--ceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007290 435 AKLVDVRKT--NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFS 492 (609)
Q Consensus 435 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~ 492 (609)
++....... .......||+.|+|||++.+ ..++.++||||+||++|||+||++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 987643221 12234568999999999876 45899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=335.25 Aligned_cols=261 Identities=17% Similarity=0.264 Sum_probs=201.9
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC--C
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--P 353 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 353 (609)
+.+...++|.+.+.||+|+||+||+|.+. ++..||+|.+.... .......+..|+.++.+++|||||++++++.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34455678999999999999999999975 57789999886432 23345678899999999999999999998744 3
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEEeCC------
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN----PKIIHRDVKAANVLLDE------ 423 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NIll~~------ 423 (609)
...++||||+++|+|.+++.........+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56889999999999999997654444558999999999999999999998521 25999999999999964
Q ss_pred -----------CCcEEEcccccceeeccCCCceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007290 424 -----------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAID 490 (609)
Q Consensus 424 -----------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~ 490 (609)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3358999999998654322 2234568999999999854 458999999999999999999999996
Q ss_pred CCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 491 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ............ .+. ....+..+.+|+..||+.+|++||++.|++.
T Consensus 245 ~~~~-------~~qli~~lk~~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANN-------FSQLISELKRGP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCc-------HHHHHHHHhcCC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 4321 111111111110 000 1123467899999999999999999999984
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=298.25 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=204.1
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC--CCcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 360 (609)
+|++.+.||.|+||.||++... +|+.||+|.+.... .....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999964 68899999986432 23345678899999999999999999998754 34578999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-----EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
||+++++|.+++.........+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999775444556899999999999999999999 66 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... .
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~--- 224 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIK-E--- 224 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHh-c---
Confidence 87654322 123346899999999998888999999999999999999999999743311 1111111 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+..+.+++.+|++.+|++||++.+|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112233455789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.36 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=202.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|+||.||++.+. +|..||+|.+...........+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999976 78999999886533344456788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999988887532 1235899999999999999999999632 8999999999999999999999999998765322
Q ss_pred CceeecccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||...... ........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-------- 221 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSA-------- 221 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHH--------
Confidence 12234578899999998554 3588999999999999999999999643211 01111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+.+.. ........+.++.+++.+||+.+|++||++.+++..
T Consensus 222 -~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 -IVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -HhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11110 111233456788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.94 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=199.8
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCc--------hHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG--------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
+|.+.+.||+|+||.||+|... +++.||+|.+....... ..+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4777899999999999999964 68899999886432211 12567889999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++++||+++++|.+++.... .++...+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997632 378888999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCC-----ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007290 436 KLVDVRKT-----NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 436 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHh
Confidence 87642211 1112245788999999998888999999999999999999999999642210 0011100
Q ss_pred hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. .........+..+.+++.+||+.+|++||++.++++
T Consensus 226 ------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ------EN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------cc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 111122334568899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=303.07 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=195.5
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
|+..+.||+|+||+||+|.+. +++.||+|.+.... .......+.+|++++++++|+||+++.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999975 68899999986432 122345577899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+.+.... ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 23489999999999999999999999 99999999999999999999999999997654221
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
......|+..|+|||.+.+..++.++|+||||+++|||+||+.||........ ........... .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~---~------ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLET---E------ 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhcc---c------
Confidence 12234689999999999888999999999999999999999999974322110 00000000000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
..+....+..+.+++..|++.||++||++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011223345788999999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.89 Aligned_cols=256 Identities=19% Similarity=0.223 Sum_probs=197.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+++++ +++.||+|++.+.. .......+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999976 57889999986421 2223455788999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997532 2378888999999999999999999 999999999999999999999999999976543
Q ss_pred CCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCcc
Confidence 3333333456999999999986 346789999999999999999999999643221 111111111000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 559 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 559 (609)
. . .+......+.++.+++.+|+..++++ |+++.|+++.
T Consensus 227 ~-----~-~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F-----Q-FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c-----c-CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 01111233567889999988665544 6888888854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=319.18 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=195.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|+..+.||+|+||+||++..+ +++.||+|+++... .......+..|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 68999999986422 2334567788999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++... ..++...+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999998753 2378899999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC
Q 007290 441 RKT----------------------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486 (609)
Q Consensus 441 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~ 486 (609)
... .......||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0011346999999999999999999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 007290 487 RAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA---MSEVV 557 (609)
Q Consensus 487 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl 557 (609)
.||....... .......... ... ... ....+..+.+++.+++ .+|++|++ +.+++
T Consensus 234 ~Pf~~~~~~~--------~~~~i~~~~~--~~~---~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 234 PPFCSETPQE--------TYRKVMNWKE--TLV---FPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCCCHHH--------HHHHHHcCCC--cee---cCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9997433211 1111110000 000 000 0113457788888876 49999986 45544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=299.48 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=204.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|+..+.||+|+||.||++.++ +++.||+|++...........+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 68999999987654445567889999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
+++++|.+++.... ..++......++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999987642 347888999999999999999999 7 9999999999999999999999999998765322
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ..+........
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~--------- 219 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNE--------- 219 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcC---------
Confidence 111 156888999999999889999999999999999999999998643221111 11111111111
Q ss_pred cccCCCCH-HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNI-QEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..... ..+..+.+++.+||..+|++|||+.+++.
T Consensus 220 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 PP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 01111 15567899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=303.33 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=202.5
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36788999999999999999996 479999999986433 3345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999988642 368888999999999999999999 9999999999999999999999999998765433
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.. ......+++.|+|||.+.+..++.++||||||+++|+|+||+.||.......... .. ....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~--------~~~~ 231 (297)
T cd06656 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LI--------ATNG 231 (297)
T ss_pred cc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------ee--------ccCC
Confidence 22 1223458889999999988889999999999999999999999996433211100 00 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..........+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000112334467889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=294.84 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=208.2
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
-|.+.++||+|+||.||+|.++ .|..+|||.+.- ....+++.+|+.++.+.+.|++|++||.+......++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3667789999999999999976 699999998853 345788999999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
..|+..+.++-. +..+.+..+..++.+.++||+|||.. .=+|||||..|||++-+|.+||+|||.+..+.+. -
T Consensus 111 GAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-M 183 (502)
T KOG0574|consen 111 GAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-M 183 (502)
T ss_pred CCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-H
Confidence 999999999863 34589999999999999999999998 7899999999999999999999999999866432 2
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....+.||+.|||||+++.-.|..++||||+|++..||..|++||....+-.. .-.+-...
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------------------IFMIPT~P 245 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------------------IFMIPTKP 245 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------------------eEeccCCC
Confidence 234567899999999999999999999999999999999999999974332111 00111111
Q ss_pred cCCC--CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNY--NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+.+ +...+.++.+++++|+-+.|++|-|+.+++++
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1222 56677899999999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=310.75 Aligned_cols=262 Identities=18% Similarity=0.230 Sum_probs=193.5
Q ss_pred ccCccccc--CCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 288 EKNVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 288 ~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
+.++||+| +|++||++..+ +|+.||+|++..... ......+..|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999964 789999999864332 233456778999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865322 2378899999999999999999999 999999999999999999999999986543321110
Q ss_pred c------eeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-Hh----
Q 007290 444 N------VTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK-LE---- 510 (609)
Q Consensus 444 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~---- 510 (609)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~ 232 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM----LLEKLNGTVPCLLD 232 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH----HHHHhcCCcccccc
Confidence 0 0112346778999999875 4589999999999999999999999964322110 0000000 00
Q ss_pred ----hhccch-----hhcc-----------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 ----REKRLD-----AIVD-----------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ----~~~~~~-----~~~~-----------------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+... ...+ ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000000 0000 00000112234568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.84 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=198.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
...+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999999999999853 3678999987532 235689999999999999999999998899999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+||++. ++|..++.. ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999986 577777743 23489999999999999999999999 9999999999999999999999999999766
Q ss_pred ccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc-cch
Q 007290 439 DVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-RLD 516 (609)
Q Consensus 439 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 516 (609)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+........... ...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS-SSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc-HHHHHHHHHHhccCccccC
Confidence 43322 122345699999999999989999999999999999999999999965433221 111111111100000 000
Q ss_pred --------hh---ccccccCCC-------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 --------AI---VDRNLNKNY-------NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 --------~~---~~~~l~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ........+ ......++.+++.+|+..||++||++.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000 01224578899999999999999999999964
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.76 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=200.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|+..+.||+|+||.||+|..+ +|+.||+|++.... .....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 68999999986433 22334567899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++++++....... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99999888876542 2389999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh----------
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE---------- 510 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 510 (609)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||......+. .........
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ----LYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChHHhhhc
Confidence 21 2223457889999999865 4578999999999999999999999974332111 000000000
Q ss_pred -hhccchhhccccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 -REKRLDAIVDRNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 -~~~~~~~~~~~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..........+..... .....+..+.+++.+||+.+|++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.60 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=212.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.-|.+.+.||+|.|+.|-+|++. +|..||||++.+.. +......+.+|++-++.+.|||||++|++..+....|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45778889999999999999965 79999999997544 33456778899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-CCCCcEEEcccccceeecc
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGl~~~~~~ 440 (609)
.-.+|+|.+++.....+ +.+....+++.||+.|+.|+|.. .+|||||||+||.+ .+-|-|||.|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999876655 88999999999999999999999 99999999999876 5678999999999987654
Q ss_pred CCCceeecccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
. ......+|+..|.|||.+.+..|. +++||||+||++|.|++|++||...... +.+..++
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmIm 232 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIM 232 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhh
Confidence 3 344567899999999999998884 7889999999999999999999754332 2334455
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
|.... .+...+.++.+||..|+..||++|.+.++|+..
T Consensus 233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 54433 356777899999999999999999999999854
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.82 Aligned_cols=193 Identities=23% Similarity=0.330 Sum_probs=164.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
....+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 44567999999999999999999975 5778999975321 235689999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+|++. ++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99996 5777777542 23489999999999999999999999 99999999999999999999999999987533
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~ 489 (609)
.. .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 1223456899999999999999999999999999999999966554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.79 Aligned_cols=266 Identities=20% Similarity=0.251 Sum_probs=196.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------ 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 353 (609)
..++|.+.+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999965 68899999986432 233456778899999999999999999987543
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
...++||||+++ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999976 55555532 267888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------HHHH
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LDHV 506 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~~~ 506 (609)
+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||............+ ....
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865432 12234568999999999999999999999999999999999999997543211100000 0000
Q ss_pred HHHh--------hhcc-----chhhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 507 KKLE--------REKR-----LDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 507 ~~~~--------~~~~-----~~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.... .... .......... ..........+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 0000000000 00011123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.89 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=199.6
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
++.+++.+.....||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3445566666778999999999999965 67889999886432 334567889999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccce
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAK 436 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~ 436 (609)
+++||+++++|.+++..... ....+...+..++.|++.||+|||++ +|+||||||+||+++. ++.++|+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999975321 11127788889999999999999999 9999999999999976 6799999999987
Q ss_pred eeccCCCceeecccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
....... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ..+.... .
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~---~- 227 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGM---F- 227 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhh---h-
Confidence 6543222 122335789999999986643 78999999999999999999999863221100 0000000 0
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
......+.....++.+++.+||+.+|++|||+.|+++.
T Consensus 228 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111223344678999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.93 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=186.9
Q ss_pred CcccccCCceEEEEEeCC-------------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 290 NVLGQGGFGKVYRGVLAD-------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
+.||+|+||.||+|.+.+ ...|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 2358888875432 33445788899999999999999999999998999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-------EEE
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-------AVV 429 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 429 (609)
+++|||+++|+|..++... ...+++..+.+++.|+++||+|||++ +++||||||+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998887642 23488899999999999999999999 9999999999999987654 899
Q ss_pred cccccceeeccCCCceeecccccccccCccccc-CCCCCcchhhHHHHHHHHHHH-hCCCCCCCCccccccchhHHHHHH
Q 007290 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~ll~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+ . .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------K-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------H-H
Confidence 999998754321 2345788999999886 466899999999999999998 5888775322110 0 0
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
..... .. . ........+.+++.+||+.||++||++.+|++.++
T Consensus 220 ~~~~~-~~--------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEG-QC--------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhc-Cc--------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 00 0 01112357889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=296.90 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=194.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC----CchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Ccc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 356 (609)
.+|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999974 689999998863221 12345688899999999999999999988653 557
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++++||+++++|.+.+.... .+++...+.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 88999999999999987532 378888899999999999999998 99999999999999999999999999987
Q ss_pred eeccCC--CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 437 LVDVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 437 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~--- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIAT--- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhc---
Confidence 653211 11122345788999999998888999999999999999999999998632110 11111100
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..............+.+++ +||..+|++||+++||++
T Consensus 224 ------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 ------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0001122233345667777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=280.74 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=203.1
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC----Cc---hHHHHHHHHHHHHhcc-CCCcceeEeEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PG---GDAAFQREVEMISVAV-HRNLLRLIGFCT 351 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 351 (609)
..-..|...+.||+|..++|-++.++ +|..+|+|++....+ +. ..++-.+|+.+++++. ||+|+.+.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456777889999999999999865 688999998853221 11 1245568999999875 999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
++.-.++|+|.|+.|.|.+++.... .+++...++|+.|+.+|++|||.+ +||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 9999999999999999999997643 388999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
||.++.+.. .......+|||+|+|||.+.. ..|+...|+||.||+||-|+.|.+||-- ........
T Consensus 167 FGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-----RkQmlMLR- 238 (411)
T KOG0599|consen 167 FGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-----RKQMLMLR- 238 (411)
T ss_pred cceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-----HHHHHHHH-
Confidence 999998754 344566889999999999853 3578899999999999999999999831 00111111
Q ss_pred HHHHhhhccchhhccccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 506 VKKLEREKRLDAIVDRNL--NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.++.... ..+--.+.+.+..+++.+|++.||.+|.|++|.++
T Consensus 239 -----------~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 -----------MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -----------HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111111 11223456678999999999999999999999985
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.23 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=205.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||.|+||+||+|... ++..+|+|++.........+.+.+|++.++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999964 68899999987544444667889999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.++++.... ...+++.....++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976433 23478999999999999999999999 99999999999999999999999999987665332
Q ss_pred Cc---eeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 443 TN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 443 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.. ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||....... ...... ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~----~~~----- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTL----QND----- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHh----cCC-----
Confidence 22 12334688999999998776 78999999999999999999999996432211 011110 000
Q ss_pred ccccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.+.... ....+..+.+++.+|++.||++||++.++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00011100 1244578899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=294.12 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=203.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||.||+|... +++.+++|.+.... ....+.+.+|++++++++||||+++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 357888999999999999999975 57899999986433 2356788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ..++...+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999887531 3388899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeecccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
. .......++..|+|||.+.+. .++.++||||||+++|||+||+.||....... ........ .
T Consensus 155 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~~-~---- 220 (262)
T cd06613 155 I-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISKS-N---- 220 (262)
T ss_pred h-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhc-c----
Confidence 1 122334678899999998776 78999999999999999999999986432111 00000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+ .........+.++.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 001123345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.45 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=199.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.+.|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 466889999999999999999975 5889999998643 34446778899999999999999999999998999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|...+.+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999988876532 2388999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 442 KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
. .......+++.|+|||.+. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~-- 232 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEP-- 232 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCC--
Confidence 1 1122345788999999984 345688999999999999999999998643211 11111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+. .......+.++.+++.+||+.+|++||++.++++
T Consensus 233 ----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 ----PT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----cc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0112233457899999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.47 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=201.9
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.+|++.+.||.|+||+||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4688899999999999999996 478999999986432 33457788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|..++... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988642 378999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ......... ...
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--------~~~~~~~~~-~~~----- 234 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG-TPE----- 234 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcC-Ccc-----
Confidence 2 1223458889999999988889999999999999999999999996533211 011110000 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+..+.+++.+||..+|++||++.++++
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0112233457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=293.38 Aligned_cols=238 Identities=24% Similarity=0.387 Sum_probs=188.4
Q ss_pred CcccccCCceEEEEEeCCCc-----------EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 290 NVLGQGGFGKVYRGVLADGT-----------KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976433 5788876543222 6788999999999999999999999987 77899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-------cEEEcc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-------EAVVGD 431 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 431 (609)
||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++ .++|+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999876332 488899999999999999999999 999999999999999887 799999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||....... ....
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~~~ 218 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KERF 218 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HHHH
Confidence 999986543 2223467789999999776 78999999999999999999 567765432110 0011
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
...... .. ......+.+++.+||..+|++|||+.++++.|+
T Consensus 219 ~~~~~~--------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR--------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC--------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100000 00 001168899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=297.40 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=199.9
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHH--hccCCCcceeEeEEeCCC----
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS--VAVHRNLLRLIGFCTTPT---- 354 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~---- 354 (609)
....+..+.+.||+|.||.||+|.|+ |..||||++.. .+++.+.+|.++++ .++|+||+.+++.-.+++
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 44567788899999999999999996 89999999963 34678888888887 468999999998775543
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCcEEeCCCCcEEE
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVV 429 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl 429 (609)
+.++|.+|.+.|||.|+|.. ..++....++++..+|.||++||- +.+|.|.|||||+.|||+.+++++.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 47899999999999999976 338899999999999999999996 45789999999999999999999999
Q ss_pred cccccceeeccCCCc---eeecccccccccCcccccCCC----C--CcchhhHHHHHHHHHHHhC----------CCCCC
Q 007290 430 GDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTGK----S--SERTDVFGYGIMLLELVTG----------QRAID 490 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slG~ll~elltg----------~~p~~ 490 (609)
+|+|+|-........ .....+||.+|||||++...- + -..+||||||.++||+... +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999776543221 123467999999999985431 1 2358999999999999763 24543
Q ss_pred CCccccccchhHHHHHHHHhhhccchh-hccccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 491 FSRLEEEDDVLLLDHVKKLEREKRLDA-IVDRNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... ..+.+.+ +-.+.+++. ........+.++|+.||..+|..|-|+-.+-+.|.+.
T Consensus 438 d~Vp~DP-------------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 438 DVVPSDP-------------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCCCCC-------------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 2111111 0111111 111122221 2456778999999999999999999998888888764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=302.74 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=200.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||.||+|.++ +++.||+|++..... ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 589999998865332 2235678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++++++..+.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999988776542 2388999999999999999999999 9999999999999999999999999998876433
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-ccchhhc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-KRLDAIV 519 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 519 (609)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|++||....... ............ .......
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID----QLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH----HHHHHHHHhCCCchhhHHHh
Confidence 2 22233457889999999865 457889999999999999999999986432110 000000000000 0000000
Q ss_pred ----------cccccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 ----------DRNLNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ----------~~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 001234567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.81 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=204.0
Q ss_pred CHHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 275 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
+..++..+.++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++.++ +|||++++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34555667889999999999999999999974 6889999998642 22346678899999988 79999999999864
Q ss_pred C-----CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 353 P-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 353 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
. ...++|+||+++++|.++++........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 357899999999999998875444445589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 502 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~ 502 (609)
+|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------- 239 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------- 239 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-------
Confidence 9999999876543221 12234578899999988543 3689999999999999999999998643211
Q ss_pred HHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+....... ...+. ........+.+++.+||+.+|++||++.++++.
T Consensus 240 -~~~~~~~~~~-~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 -KTLFKIPRNP-PPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -HHHHHHhcCC-CCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0011111000 00000 122334578999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.79 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=196.9
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeeccc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++||||+++++++......++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 667789999999999999976 5778899988532 23345678899999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+++|...+... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 99998887642 23488999999999999999999999 99999999999999999999999999987653221 1
Q ss_pred eeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 445 VTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
......+++.|+|||.+. +..++.++|||||||++|||++|+.||...... ............ ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~-~~- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPP-TL- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCCC-CC-
Confidence 223345889999999984 345788999999999999999999998642210 011111100000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112234678999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=293.66 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=200.7
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC----CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+|+..+.||+|+||.||+|... +++.|++|.+..... ....+.+..|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 789999998864321 22456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999987532 378889999999999999999999 99999999999999999999999999988664
Q ss_pred cCCCceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~--- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKEL--- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccC---
Confidence 332 223455889999999987766 89999999999999999999999864321 0111111110011
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..........+.+++.+||+.+|++||++.++++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112233467899999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.69 Aligned_cols=197 Identities=22% Similarity=0.324 Sum_probs=159.4
Q ss_pred cCcccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC--CCcceEEeecc
Q 007290 289 KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLVYPFM 363 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 363 (609)
+.+||+|+||+||+|+.+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 467999999999999965 45789999886432 23567889999999999999999998843 45678999998
Q ss_pred cCchhhhhhhhcC-----CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEccccc
Q 007290 364 QNLSVAYRLREIK-----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGL 434 (609)
Q Consensus 364 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl 434 (609)
++ +|.+.+.... .....+++..++.++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 76 6666654321 1123478889999999999999999999 99999999999999 5667899999999
Q ss_pred ceeeccCCCc--eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007290 435 AKLVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFS 492 (609)
Q Consensus 435 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~ 492 (609)
++........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876533221 2234568999999999876 45899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.03 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=198.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46777889999999999999964 68899999986432 23345678899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++.... .++....+.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999886532 388999999999999999999999 99999999999999999999999999987664322
Q ss_pred CceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 443 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.......|+..|+|||.+. ...++.++|||||||++|+|++|+.||........ . ...... ...
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~----~~~~~~-~~~--- 227 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----L----FLMTKS-NFQ--- 227 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----H----Hhhhcc-CCC---
Confidence 2223456899999999874 45688999999999999999999999853221100 0 000000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.... ....+..+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 1123356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.99 Aligned_cols=257 Identities=27% Similarity=0.370 Sum_probs=197.8
Q ss_pred CCccCcccccCCceEEEEEeC----CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
|.+.+.||+|+||.||+|.+. ++..||||++.... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 36889999986432 3334567889999999999999999999885432
Q ss_pred cceEEeecccCchhhhhhhhcC--CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
..+++++|+++|+|.+++.... .....+++...++++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2367899999999998875322 1223478889999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHh
Q 007290 433 GLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 433 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
|.++........ ......+++.|++||.+....++.++||||||+++|||++ |++||...... .... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~---~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN---YLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHH---HHH
Confidence 998865432211 1122345678999999988889999999999999999999 88887532211 1111 111
Q ss_pred hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..... ......+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 230 ~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 01122346899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.68 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=202.8
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|++.+.||+|+||.||++... +|+.||+|.+.... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999964 68999999986432 233456788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+.+.... ...+++..+.+++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999887532 23478889999999999999999999 99999999999999999999999999998664322
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......|++.|+|||.+.+..++.++||||||+++++|+||+.||...... ..+...... .
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~---------~ 217 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRG---------S 217 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcC---------C
Confidence 1 122345788999999998888999999999999999999999998643211 111111110 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+.++.+++.+||+.+|++||++.+|++.
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.81 Aligned_cols=260 Identities=24% Similarity=0.316 Sum_probs=201.9
Q ss_pred cCHHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe
Q 007290 274 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 351 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 351 (609)
.++.++....+.|++.+.||+|+||.||+|.+. +++.||+|.+... ......+..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 345566667789999999999999999999974 6889999988542 23346788899999888 6999999999884
Q ss_pred C------CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 352 T------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 352 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
. ....+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 3567899999999999999876332 3377888899999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007290 426 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~ 500 (609)
.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||+||+.||........
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--- 234 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--- 234 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---
Confidence 999999999875532211 123346889999999875 34578899999999999999999999964321110
Q ss_pred hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... .............+..+.+++.+||+.||++||++.|+++
T Consensus 235 -----~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 -----LFLI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----hhhH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 0000001111234568999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=296.31 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=200.4
Q ss_pred CCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc---CCCcceeEeEEeCCCcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 360 (609)
.|+..+.||+|+||.||+|.+ .+++.||+|.+.........+.+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 4789999999875444555677889999999987 999999999999888999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.++++.. .+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988642 488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... ...... ...
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~~~------~~~ 218 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMMLIP------KSK 218 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhhccc------cCC
Confidence 332 22334688999999988654 46899999999999999999999996432211 110000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.+. ....+.++.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 01111 1114568899999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.13 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=204.5
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEecc-CCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcc
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTER 356 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 356 (609)
+.+....|++.+.||+||.+.||++...+.+.||+|++.. ..+......|..|+..|.+++ |.+|+++++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3445667999999999999999999998888999988763 345566788999999999996 99999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
|+||||-+ .+|...|+..... .+...++.+..|++.|+.++|.+ ||||.||||.|+|+-+ |.+||+|||+|.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence 99999865 4899999874432 33237788999999999999999 9999999999999965 589999999999
Q ss_pred eeccCCCce-eecccccccccCcccccCC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007290 437 LVDVRKTNV-TTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 437 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~ 504 (609)
.+....... ....+||+.||+||.+... ++++++||||+||++|+|+.|+.||.... .
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----------n 577 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----------N 577 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----------H
Confidence 887655443 3456899999999998532 25789999999999999999999985211 0
Q ss_pred HHHHHhhhccchhhccccccCCCCHHH-HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQE-VETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.-.++..+.++.-..+|+.-. ..++.++|+.||..||++||+..++++
T Consensus 578 ------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 ------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112344555554333332111 123999999999999999999999996
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=294.23 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=196.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC----CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Ccc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 356 (609)
.+|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999975 58999999875321 112345788899999999999999999988654 456
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
+++|||+++++|.+++.... .+++....+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 78999999999999987532 267888899999999999999999 99999999999999999999999999987
Q ss_pred eeccCCC--ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 437 LVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 437 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~---- 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------A-IFKIA---- 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------H-HHHHh----
Confidence 6542111 11223458889999999988889999999999999999999999986321110 0 01110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+......+.+++.+|+. +|++||+++|+++.
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 -----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0001112234555678899999994 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.07 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=194.6
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----- 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 353 (609)
...++|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999964 68899999986432 222345677899999999999999999887533
Q ss_pred -CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 354 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
...+++++++ +++|...+.. ..++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3467888887 6788877653 2388999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.........
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~ 234 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ----LKRIMEVVGT 234 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCC
Confidence 999865432 233468999999999876 5689999999999999999999999964332110 0000000000
Q ss_pred h----------ccchhhccc--cccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 E----------KRLDAIVDR--NLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 ~----------~~~~~~~~~--~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. ......... .... .........+.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000 0000 0001123457899999999999999999999953
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.64 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=196.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 68999999986543333345577899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++ +|.+++.... ..+++...+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 8888876532 2478899999999999999999999 99999999999999999999999999987543221
Q ss_pred CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh--hhccchhh-
Q 007290 443 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE--REKRLDAI- 518 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 518 (609)
. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ .+........ .......+
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED---QLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHhcCCCChhhhhhhh
Confidence 1 1122346889999998865 4588999999999999999999999964331100 0000000000 00000000
Q ss_pred -----c--------cccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 -----V--------DRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 -----~--------~~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ...+.... .......+.+++.+|++.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 0011257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.10 Aligned_cols=239 Identities=24% Similarity=0.326 Sum_probs=184.9
Q ss_pred cccccCCceEEEEEeCC-------------------------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcce
Q 007290 291 VLGQGGFGKVYRGVLAD-------------------------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 345 (609)
.||+|+||.||+|.+.. ...||+|++.... ......+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999997421 1358899885422 223457888999999999999999
Q ss_pred eEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 346 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
+++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||++ +|+||||||+||++++++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999888652 23478889999999999999999999 999999999999997643
Q ss_pred -------cEEEcccccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCcccc
Q 007290 426 -------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEE 496 (609)
Q Consensus 426 -------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~ell-tg~~p~~~~~~~~ 496 (609)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999987643221 12346788999998865 56899999999999999984 7898886432211
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.... ...... . +......+.+++.+||+.+|++||++.++++.|.
T Consensus 230 -----~~~~---~~~~~~--------~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -----KERF---YEKKHR--------L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -----HHHH---HHhccC--------C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0000 000000 0 1111246899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=295.50 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=201.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCC-----
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT----- 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 354 (609)
.+++|++.+.||+|+||.||+|..+ +++.+++|++.... ...+.+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4688999999999999999999975 67899999886432 2456789999999998 6999999999986544
Q ss_pred -cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 355 -ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 355 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
..++||||+++++|.+++......+..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 37899999999999999876543345689999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
.+....... .......|+..|+|||.+.. ..++.++||||||+++|+|+||+.||...... .....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~ 229 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALFK 229 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHHH
Confidence 987654322 22233458899999998753 34678999999999999999999999632211 00011
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ..+. .......+..+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRN------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhcc------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1000 0000 0112235568899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.97 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=201.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||.||++.+. ++..||+|..... .....+.+..|++++++++||||+++++++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888999999999999999975 6889999998632 33445678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999987532 3488999999999999999999999 9999999999999999999999999998755332
Q ss_pred CCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 442 KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.. ......+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ...........
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-- 225 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEP-- 225 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCC--
Confidence 21 223345889999999874 345678999999999999999999998643211 11111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+.+ ......+.++.+++.+||+.+|++||++.++++.
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0122344678999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.56 Aligned_cols=258 Identities=24% Similarity=0.255 Sum_probs=202.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC--chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|+..+.||+|+||+||+|... +++.||+|.+...... ...+.+..|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999976 5899999998754322 24567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987532 24588999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc----------------------------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 007290 441 RKTN----------------------------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 492 (609)
Q Consensus 441 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~ 492 (609)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 111235788999999998888999999999999999999999999643
Q ss_pred ccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 493 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.... .. ..+.............+..+.+++.+|+..+|++||++...++.+...
T Consensus 236 ~~~~-------~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDE-------TF----------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHH-------HH----------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3211 00 011111111111112457899999999999999999944444444443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=295.73 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=198.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--C-------chHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--P-------GGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
+|.+.+.||+|+||.||+|... +|+.||+|.++.... . ...+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999864 689999998753211 1 11246778999999999999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++|+||+++++|.++++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999764 3478889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCc-eeecccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 435 AKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 435 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
+......... ......|+..|+|||.+.... ++.++|+||||+++|++++|..||...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------AAMFKLGN 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------HHHHHhhc
Confidence 9765422111 122345788999999987654 789999999999999999999998532210 00000000
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
... ............+..+.+++.+|+..+|++||++.++++.
T Consensus 227 -~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 -KRS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -ccc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0011111222345789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.59 Aligned_cols=262 Identities=20% Similarity=0.282 Sum_probs=195.7
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|+..+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 68999999986432 223345678899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++ +|.+.+... ...+++..++.++.||++||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 676666542 23489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc------cc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK------RL 515 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 515 (609)
. ......++..|+|||.+.+. .++.++|||||||++|+|+||+.|+........ ............ ..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH----HHHHHHHHhCCCChHHhHHh
Confidence 1 12234578899999988664 478999999999999999999988643221110 000000000000 00
Q ss_pred hhhcccc----cc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRN----LN-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~----l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....+.. .. ....+..+.++.+++.+||+.||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 00 0011234568889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.51 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=198.8
Q ss_pred ccCcccccCCceEEEEEeC-CCcEEE---EEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc--ceEEee
Q 007290 288 EKNVLGQGGFGKVYRGVLA-DGTKVA---VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE--RLLVYP 361 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~-~g~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 361 (609)
...+||+|+|-+||+|.+. +|..|| ||.-.-..++...+.|..|+++|+.++||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999975 576665 2221223345566899999999999999999999999876655 678899
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccceeecc
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDV 440 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~~~~~ 440 (609)
.|..|+|..+..+... .+....++|+.||++||.|||++ .|+|+|||||-+||+|+.+ |.|||+|+|+|+....
T Consensus 124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999988654 67778999999999999999998 6789999999999999865 8999999999998754
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.. ...+.|||.|||||.+. ..|...+||||||+.++||+|+..||..-.- ...+..-+.....+..+..+-|
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHHHHHHHHcCCCHHHhhccCC
Confidence 32 23378999999999986 7899999999999999999999999863222 2223333333333333434333
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 562 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~ 562 (609)
+++.++|.+|+.. ..+|||+.|++. +|..
T Consensus 271 ------------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 271 ------------PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ------------HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 4789999999988 999999999984 4544
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=292.83 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=206.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|++|.||+|... +++.|++|++...........+..|+.++.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 59999999987544334567899999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
+++++|.+++... ..++...++.++.|+++|++|||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999764 348899999999999999999999 8 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
... .....++..|+|||.+.+..++.++||||||+++|+|+||+.||...... . ......... ..
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~~~~~---------~~ 218 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S---FFELMQAIC---------DG 218 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---HHHHHHHHh---------cC
Confidence 222 22345788999999998888999999999999999999999998644320 0 111111111 00
Q ss_pred cccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 522 NLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 522 ~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. ....... .+..+.+++.+|++.+|++||++.++++.
T Consensus 219 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 P-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0111222 55789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=293.35 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=201.7
Q ss_pred CCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+|+..+.||+|+||.||++.. .+++.||+|.+...... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999996 47899999998643211 134678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEccccccee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKL 437 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~ 437 (609)
|+||+++++|.+++.... .+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987532 378899999999999999999999 999999999999998775 599999999876
Q ss_pred eccCCC---ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 438 VDVRKT---NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 438 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
...... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~------ 222 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-----ALIFK------ 222 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-----HHHHH------
Confidence 643211 1122345788999999998888999999999999999999999998643221110 00000
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..........+......+.+++.+|+..+|++||++.++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 ---IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011112234455678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=295.45 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=201.6
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
-|+..+.||+|+||.||+|... ++..||+|...........+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667889999999999999864 688999998865444445577889999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|..++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988864 2378899999999999999999999 999999999999999999999999999876643221
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ......... .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~----------~ 217 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKN----------N 217 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcC----------C
Confidence 122345788999999998888899999999999999999999998632210 111111000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+..+.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111222345678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.41 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=202.1
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|++.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 689999999875432 33457789999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+ +++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987533 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--------c
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--------K 513 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~ 513 (609)
........++..|+|||.+.+. .++.++||||+|+++|||+||.+||....... ............ .
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhcc
Confidence 2223345688999999998654 46899999999999999999988775432110 010111100000 0
Q ss_pred cch---hhcccccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLD---AIVDRNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~---~~~~~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+. .+..+... ....+.....+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000000 00112234788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=290.90 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=201.4
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|+..+.||+|+||.||++... ++..+|+|++.... .......+..|++++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 68899999986432 334467788999999999999999999999888899999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~~~~~~ 441 (609)
+++++|.+++.... ...+++..+.+++.|++.||.|||++ +++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 33478899999999999999999999 99999999999999855 46899999999876433
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~-------- 217 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSGT-------- 217 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhcC--------
Confidence 21 22345788999999998888999999999999999999999998643321 1111111000
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+..+.+++.+||+.+|++|||+.|+++.
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001112234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.70 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=202.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||.||+|.+. +++.||+|+++... .......+.+|++++++++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 58899999886432 23345778999999999999999999999999899999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++++.+..+.... ..++...+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99998777665432 2378899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh----------
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE---------- 510 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 510 (609)
.........++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .+........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID----QLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHhhhc
Confidence 33233345678899999999887 78999999999999999999999986432211 0000000000
Q ss_pred -hhccc-----hhhcccc-ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 -REKRL-----DAIVDRN-LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 -~~~~~-----~~~~~~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... ....+.. ....+....+..+.+++.+||..+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000000 000111123578999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=291.81 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=201.0
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|...+.||+|+||.||+|... +++.||+|.++.... ....+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999965 689999999875332 23567889999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998752 2378888999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccee---ecccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 443 TNVT---TQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 443 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.... ....++..|+|||.+.+.. ++.++||||||+++|++++|+.||...... . ........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~---~~~~~~~~-~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----F---QIMFHVGA-GH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----H---HHHHHHhc-CC--
Confidence 2221 1345788999999998766 889999999999999999999999643211 0 00000000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.+. ........+.+++.+||+.+|++||++.+++.
T Consensus 224 ---~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 11122567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.58 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=198.9
Q ss_pred cccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhh
Q 007290 291 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVA 369 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 369 (609)
+||+|.||+||-|++. +...+|||-+.... ....+-+..|+.+.++++|.|||+++|.+...+...+.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999976 45679999886533 334566889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccceeeccCCCceeec
Q 007290 370 YRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 370 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
++++..- +.-.-.+.++-.+..||++||.|||+. .|||||||-+|||++ -.|.+||+|||.++++.. -...+..
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 9998632 221236677888899999999999999 999999999999996 678999999999987743 2334556
Q ss_pred ccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC
Q 007290 449 VRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN 526 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 526 (609)
..||..|||||++..+ .|+.++|||||||++.||.||++||.....+.. .+ . .+--=..-++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AM----F------kVGmyKvHP~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AM----F------KVGMYKVHPP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hh----h------hhcceecCCC
Confidence 6799999999999765 489999999999999999999999963222110 00 0 0000011234
Q ss_pred CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 527 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+...+.+...++.+|+..||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56778889999999999999999999999985
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.27 Aligned_cols=268 Identities=16% Similarity=0.209 Sum_probs=191.5
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC------CCcceeEeE
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH------RNLLRLIGF 349 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 349 (609)
+++....++|++.+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.++..++| .++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344556788999999999999999999975 5788999998642 2223455667777776654 458888888
Q ss_pred EeCC-CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCC--
Q 007290 350 CTTP-TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDF-- 425 (609)
Q Consensus 350 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~-- 425 (609)
+... .+.++||+++ +++|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 8665 4678888887 66787777653 248899999999999999999997 5 899999999999998765
Q ss_pred --------------cEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 007290 426 --------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDF 491 (609)
Q Consensus 426 --------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~ 491 (609)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999876432 123345789999999999999999999999999999999999999975
Q ss_pred Cccccccchh-------HHHHHHHHhh---------hccchhhcccc-c----c--CCCCHHHHHHHHHHHHhccCCCCC
Q 007290 492 SRLEEEDDVL-------LLDHVKKLER---------EKRLDAIVDRN-L----N--KNYNIQEVETMIQVALLCTQASPE 548 (609)
Q Consensus 492 ~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~-l----~--~~~~~~~~~~l~~l~~~cl~~dP~ 548 (609)
.......... ...|...... ...+....++. + . ..........+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 4321100000 0000000000 00000000000 0 0 000011235678999999999999
Q ss_pred CCCCHHHHHH
Q 007290 549 DRPAMSEVVR 558 (609)
Q Consensus 549 ~RPs~~evl~ 558 (609)
+|||++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999996
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=296.96 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=187.4
Q ss_pred CcccccCCceEEEEEeCC--------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 290 NVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
+.||+|+||.||+|..+. ...||+|.+... .....+.+..|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 468999999999998642 234888877432 23345678889999999999999999999999899999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--------EEEcccc
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--------AVVGDFG 433 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG 433 (609)
|+++|+|..+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999987532 2478899999999999999999999 9999999999999987765 6999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCccccccchhHHHHHHHHhh
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
.+..... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... ........
T Consensus 154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~ 220 (258)
T cd05078 154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------KKLQFYED 220 (258)
T ss_pred cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------HHHHHHHc
Confidence 8865432 1224578899999999764 5799999999999999999995 554322111 00000000
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
. ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0111122357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.78 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=196.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++++|.+.+.||+|+||.||+|... +|+.||+|++...........+.+|+.+++.++|+||+++++++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999964 689999999875444444556788999999999999999999999988999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+. +++...+... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 5666555432 12367778889999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-----------
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK----------- 508 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 508 (609)
... ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||+...... ..+......
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHHHHcCCCChhhhhh
Confidence 211 12233578899999998754 57889999999999999999999997433210 001010000
Q ss_pred Hhh-hccchhhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LER-EKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~-~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... +............... .......+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0000000000000000 0012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.49 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=197.5
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|+..+.||.|++|.||+|+.. +|+.||||++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 68999999886432 233346788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+. ++|..++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 57888876532 23488999999999999999999999 99999999999999999999999999987654322
Q ss_pred CceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--------
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-------- 513 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 513 (609)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ ..........+.
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhhhh
Confidence 1 122334688999999886644 68899999999999999999999964332111 111111100000
Q ss_pred -------cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 -------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 -------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.........+. ...+.....+.+++.+|++.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 001123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.22 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=194.9
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|...+.||+|+||.||++.+. +|+.||+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999975 689999999875443445667889999999986 99999999999988889999999
Q ss_pred ccCchhhhhhhhc-CCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
+.. ++.++.... ......+++....+++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 444433211 112245889999999999999999999732 8999999999999999999999999998765432
Q ss_pred CCceeecccccccccCcccccCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.. .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...........
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~------ 226 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKG------ 226 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCC------
Confidence 21 1223578899999998766 689999999999999999999999863220 11111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+.+........+..+.+++.+||+.+|++|||+++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111112223356789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.80 Aligned_cols=238 Identities=21% Similarity=0.232 Sum_probs=183.5
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc---cCCCcceeEeEEeCCCcceEEeecccC
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA---VHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
||+|+||+||+|+.. +|+.||||++.... .......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999975 68999999986421 122234455666666654 699999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|...+... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999888652 3388999999999999999999999 99999999999999999999999999987543221 22
Q ss_pred eecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccccc
Q 007290 446 TTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 524 (609)
.....||+.|+|||.+.+. .++.++|||||||++|||+||+.||...... ......... .. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~-~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFG-KV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcC-CC------CCC
Confidence 2345689999999998754 4799999999999999999999999643211 111111100 00 000
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007290 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSE 555 (609)
Q Consensus 525 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 555 (609)
....+..+.+++.+||+.||++||++.+
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence 1123457789999999999999995443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=305.61 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=198.8
Q ss_pred CCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|...+.||.|+||.||.|++ ++...||||++.-.. +...+.++.+|++.|.+++|||++.+-|+|-.+...++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 355567899999999999996 478899999985322 23345778899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
||-| +-.+.+.-.+ .++....+..|..+.+.||+|||+. +.||||||..|||+++.|.|||+|||.+....+.
T Consensus 107 YClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9965 7777776533 3388889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
..++|||.|||||++. .+.|+-|+||||+|++..||.-.++|.-.... +. .. +.+...
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MS--AL-------YHIAQN 240 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MS--AL-------YHIAQN 240 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HH--HH-------HHHHhc
Confidence 3467999999999885 46899999999999999999999998632111 00 11 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
-.+.+. ..+.+..+..++..|+++-|.+|||.+++++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111111 46677889999999999999999999999864
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=291.16 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=206.0
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 68899999986432 233456778899999999999999999999888999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|..++.........+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877544445689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ....... ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~----------~~ 216 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQ----------RG 216 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh----------cC
Confidence 222345788999999999888999999999999999999999999643321 0001110 01
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+.++.+++.+|++.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112233556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=297.47 Aligned_cols=256 Identities=20% Similarity=0.229 Sum_probs=200.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||++.+. +++.||+|.+..... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999975 578999998864321 233457789999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996532 378889999999999999999999 999999999999999999999999999864211
Q ss_pred CCC--------------ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 441 RKT--------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 441 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
... .......++..|+|||.+.+..++.++||||||+++|||++|..||...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 000 0111235788999999998888999999999999999999999998633211 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
....... . ..+ ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~-~---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDD-I---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhcc-c---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111100 0 000 0011234678999999999999999998777777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=295.68 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=201.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+..|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 67888999999999999999864 6889999998532 233456788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999988652 267888999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
. ......+++.|+|||.+.+..++.++||||||+++|++++|+.||......... ......+ .
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--------~~~~~~~--------~ 232 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATNG--------T 232 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--------eehhcCC--------C
Confidence 2 223345888999999998888999999999999999999999999643321110 0000000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+..+.+++.+||..+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001122344678899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.80 Aligned_cols=199 Identities=24% Similarity=0.291 Sum_probs=171.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-C-----CCcceeEeEEeCCCcc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-H-----RNLLRLIGFCTTPTER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~ 356 (609)
-+|++.+.||+|+||.|-+|.+. +++.||||++++.. .-..+-..|+.+|..++ | -|+|++++++.-.++.
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 38999999999999999999964 69999999998642 33456678999999887 4 4799999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEccccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGL 434 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGl 434 (609)
++|+|.+.. +|.++++..... .++...++.++.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.
T Consensus 264 ciVfELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999965 999999875443 389999999999999999999999 99999999999999754 3699999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
++..... ...+..+..|.|||++.+.+|+.+.||||||||+.||+||.+.|.....
T Consensus 338 Sc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 338 SCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9865432 2256678899999999999999999999999999999999988875543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=293.95 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=200.4
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
+|++.+.||+|++|.||+|+.. +|..||||.+...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999975 689999999875444444567788999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 78777765332 23489999999999999999999999 999999999999999999999999999976543211
Q ss_pred ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh--hhccchhhc-
Q 007290 444 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE--REKRLDAIV- 519 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~- 519 (609)
......++..|++||.+.+. .++.++||||||+++|+|++|+.||......+. ......... .......+.
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ----LLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCChhhHHHHhc
Confidence 12234578899999988654 578999999999999999999999975432211 000000000 000000000
Q ss_pred ----ccccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 ----DRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ----~~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... ....+..+..+.+++.+|++.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0011233567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.32 Aligned_cols=263 Identities=23% Similarity=0.272 Sum_probs=199.1
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+|+..+.||+|+||.||+|... +|+.||||.+...... .....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999975 6899999999753322 2345677899999999999999999999998899999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+ +++|..++.... ..+++..+..++.|+++||+|||++ +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999987532 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-------
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER------- 511 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 511 (609)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||........ ..........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ----LGKIFEALGTPTEENWP 228 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH----HHHHHHHcCCCchhhhh
Confidence 3321 1223346788999998854 4678999999999999999999887764322110 0011000000
Q ss_pred -hccchhhccccccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 -EKRLDAIVDRNLNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 -~~~~~~~~~~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
............... .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 112335688999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.21 Aligned_cols=267 Identities=21% Similarity=0.258 Sum_probs=198.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 359 (609)
++|++.+.||+|+||.||+|.+. +++.+|+|.++... .......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 68899999986432 222334667899999999999999999998766 789999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+||+++ +|.+.+.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999985 8888876533 2489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH--------HHHH--H
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL--------DHVK--K 508 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~--------~~~~--~ 508 (609)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.............. .|.. .
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 4321 12234578899999988654 468999999999999999999999974332111000000 0000 0
Q ss_pred Hhhh--ccchhhccccccCCCCHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LERE--KRLDAIVDRNLNKNYNIQ-EVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~--~~~~~~~~~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ..........+...+... .+..+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000011111111111 3567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=290.76 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=201.4
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|...+.||+|+||.||+|..+ +|..||+|.+.... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 58899999986432 223456788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 441 (609)
+++++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 23478999999999999999999999 999999999999999885 4699999998866432
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. .......|++.|+|||.+.+..++.++||||||+++|||++|..||...... ..+...... .
T Consensus 156 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~-~------- 218 (257)
T cd08225 156 M-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQG-Y------- 218 (257)
T ss_pred c-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhcc-c-------
Confidence 2 2222345889999999998888999999999999999999999998643211 111111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. ....+..+..+.+++.+|+..+|++|||+.++++.
T Consensus 219 -~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 -F-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -C-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 11122334678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=296.88 Aligned_cols=245 Identities=24% Similarity=0.267 Sum_probs=199.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||.||++.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999975 68999999986432 2234567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++... ..++...+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998763 3488899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ....... ...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~~------ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKIL-EGK------ 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCC------
Confidence 3 23346889999999998888899999999999999999999998643311 0011110 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
...+...+..+.+++.+||+.+|++|| +++|+++
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011122346888999999999999998 5556553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.68 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=196.7
Q ss_pred CccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 287 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
.....||+|+||.||++... ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33467999999999999964 68899999885422 33456788999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
++|.+++.. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++....... ..
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 174 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PK 174 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-cc
Confidence 999998754 1378889999999999999999999 99999999999999999999999999987553222 12
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ........
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~------~~~~~~~~- 239 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRRIR------DNLPPRVK- 239 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH------hcCCCccc-
Confidence 23346889999999998888999999999999999999999998643211 0111110 00111111
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.....+..+.+++.+|+..+|.+|||++++++.
T Consensus 240 -~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112234578899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.81 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=201.5
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcE-EEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTK-VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~-vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.|+++..||.|+||.||+|..++... .|-|++ ...+....++|.-|+++|+.++||+||++++.|.-.+..++..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345667789999999999999875444 455555 445566778999999999999999999999999889999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
|.||.....+-+.. .+++..++.-++.|++.||.|||++ +|||||||..|||++-+|.++|+|||.+.... ..
T Consensus 111 C~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-ST 183 (1187)
T ss_pred cCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hH
Confidence 99999998887643 4589999999999999999999999 99999999999999999999999999876432 22
Q ss_pred CceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 443 TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
......+.|||.|||||+.. ..+|..++||||||+++.||..+.+|-+.-.+ ...+-.+...+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKSeP--- 252 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP--- 252 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhcCC---
Confidence 23345678999999999864 46899999999999999999999998642221 111111111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+.+. -+...+..+.|++.+|+.+||+.||++.+++++
T Consensus 253 ---PTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 ---PTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---Cccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 0111 144566789999999999999999999999864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=293.86 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=197.4
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
|++.+.||.|++|.||+|.+. +|+.||+|++.... .......+.+|+++++.++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999965 79999999986432 2233467889999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
+ ++|.+++..... ..+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 588888865332 3489999999999999999999999 999999999999999999999999999976543221
Q ss_pred ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--------c
Q 007290 444 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--------R 514 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 514 (609)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||........ ............ .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhhhhh
Confidence 12223468899999988654 578999999999999999999999965432111 111111000000 0
Q ss_pred chhh---ccc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAI---VDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~---~~~---~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+.+. ... .......+..+..+.+++.+|++.+|++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 000 0000112223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.24 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=204.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..+.|+..+.||+|+||.||+|.++ ++..|++|++..... ....+..|++++++++|+|++++++++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566888899999999999999976 689999999864332 4677889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998743 3489999999999999999999998 999999999999999999999999998875543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... .....
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~~~--- 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITT-KGIPP--- 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh-cCCCC---
Confidence 221 2223457889999999988889999999999999999999999986432210 0011000 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+..+.+++.+|++.+|.+||++.++++
T Consensus 236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0011224567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.31 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=206.8
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|.+.+.||.|+||.||++.+. ++..||+|++.... .......+..|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 68999999986533 234567788999999999999999999999888999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+.+.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543445689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||...... +........ ..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKG-QY------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcC-CC-------
Confidence 2233456889999999998888999999999999999999999998643211 111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...+...+..+.+++.+||..+|++||++.++++
T Consensus 221 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 --PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112234467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=293.93 Aligned_cols=247 Identities=27% Similarity=0.356 Sum_probs=195.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+.|+..+.||+|+||+||+|... +|+.||+|.+.... .....+.+.+|+++++.++||||+++++++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999975 68999999886432 2233467889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+.+ ++.+.+.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~g-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCLG-SASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhCC-CHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99975 6666554322 2388999999999999999999999 999999999999999999999999999876542
Q ss_pred CCCceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
. ....+++.|+|||.+. ...++.++||||||+++|||+||+.||...... .........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~~----- 229 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQN----- 229 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhcC-----
Confidence 2 2245788999999874 456889999999999999999999998533211 000010000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+..+.+++.+||+.+|++||++.+++..
T Consensus 230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 ----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00011122345689999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.42 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=196.8
Q ss_pred CccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 287 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+....||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++...+..++++||+++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33457999999999999964 68999999986432 33456788999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
++|...+.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 999987754 2378899999999999999999999 99999999999999999999999999987554322 12
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ......... .. ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~-~~-----~~~-- 237 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDS-PP-----PKL-- 237 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcc-CC-----CCc--
Confidence 23356889999999998888999999999999999999999998643211 111111100 00 000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
......+..+.+++.+|++.+|++||+++++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011234578899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=291.59 Aligned_cols=266 Identities=20% Similarity=0.254 Sum_probs=196.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCc-----
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTE----- 355 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 355 (609)
++|++.+.||+|+||.||+|.+. +|+.||+|....... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 689999998864322 223467888999999995 6999999998876655
Q ss_pred ceEEeecccCchhhhhhhhcCCC-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPG-EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFG 433 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 433 (609)
.++||||+++ +|..++...... ...+++..++.++.||+.||.|||++ +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 787777653322 34589999999999999999999999 9999999999999998 8899999999
Q ss_pred cceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
++..+..... ......+++.|+|||.+.+ ..++.++||||||+++|+|+||..||........ ..........+
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIFKLLGTP 231 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence 9886543221 1122346888999998865 4579999999999999999999999964322111 00111100000
Q ss_pred cc--chhh---cc----cccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KR--LDAI---VD----RNLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~--~~~~---~~----~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. .... .+ +... ....+..+..+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 00 0000 0011234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=293.81 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=198.7
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceEEee
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVYP 361 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 361 (609)
|++.+.||+|+||.||+|... +|+.+|+|++.... .......+..|++++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999997543 233456788999999999999999999999887 78999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++ +|..++.... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 7877775432 3589999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hccch--
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EKRLD-- 516 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 516 (609)
.........++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ .......... .....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ----LEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCchhhcccc
Confidence 3222333456889999997764 4579999999999999999999999875432211 0010000000 00000
Q ss_pred -h-----------hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 -A-----------IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 -~-----------~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .....+...+...++..+.+++.+|++.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000000000111125688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.58 Aligned_cols=272 Identities=19% Similarity=0.260 Sum_probs=188.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC--CcEEEEEEe--------------cc--CCCCchHHHHHHHHHHHHhccCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRL--------------TD--FESPGGDAAFQREVEMISVAVHRNL 343 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~--------------~~--~~~~~~~~~~~~E~~~l~~l~h~ni 343 (609)
..++|++.+.||+|+||+||++.++. +..++.|.+ .+ .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 222222211 00 0112234567899999999999999
Q ss_pred ceeEeEEeCCCcceEEeecccCchhhhhhhhcC-CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007290 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 422 (609)
Q Consensus 344 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 422 (609)
+++++++...+..++|++++.+ ++..++.... .............++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999865 5555553321 1112234556778999999999999999 999999999999999
Q ss_pred CCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC-CCCCccccccchh
Q 007290 423 EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA-IDFSRLEEEDDVL 501 (609)
Q Consensus 423 ~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p-~~~~~~~~~~~~~ 501 (609)
.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.+ +...... ....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~--~~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK--PGKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC--HHHH
Confidence 999999999999987754433333446799999999999999999999999999999999998754 3321111 0011
Q ss_pred HHHHHHHHhh--hc------cchhhcccc-c---cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 502 LLDHVKKLER--EK------RLDAIVDRN-L---NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 502 ~~~~~~~~~~--~~------~~~~~~~~~-l---~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+......... .+ .+...++.. . .... .......+.+++.+|++.||++|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111110000 00 000000000 0 0000 01123467788999999999999999999863
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.35 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=197.0
Q ss_pred CCCccCcccccCCceEEEEEeC---CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Ccce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 357 (609)
+|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999975 47899999987532 123346678899999999999999999999887 7799
Q ss_pred EEeecccCchhhhhhhhcCC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEccc
Q 007290 358 LVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE----DFEAVVGDF 432 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 432 (609)
+||||+++ ++.+.+..... ....++...++.++.|++.||+|||++ +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 55555543322 223688999999999999999999999 9999999999999999 999999999
Q ss_pred ccceeeccCCC--ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch-----hHHH
Q 007290 433 GLAKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV-----LLLD 504 (609)
Q Consensus 433 Gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~-----~~~~ 504 (609)
|++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112234578899999988664 578999999999999999999999975443221000 0000
Q ss_pred HHHHHhhh-----------ccchhhccccccCCCC---------H--HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 505 HVKKLERE-----------KRLDAIVDRNLNKNYN---------I--QEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~-----------~~~~~~~~~~l~~~~~---------~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+..+... .......+......+. . .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 0000000000000000 0 23457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.66 Aligned_cols=243 Identities=23% Similarity=0.289 Sum_probs=195.6
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||.|+||.||+++.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999986433 223457789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+++.... .++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997632 378889999999999999999998 99999999999999999999999999998765332 2233
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..++..|++||.+.+..++.++|+||||+++|+|++|..||.....+. ...... +.+......++
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~---------~~~~~~~~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYND---------ILKGNGKLEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHH---------HhccCCCCCCC
Confidence 467889999999988889999999999999999999999997543210 011111 11111111122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
...+..+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 223578999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.24 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=193.3
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCC--CcceEEee
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP--TERLLVYP 361 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 361 (609)
|++.+.||+|+||.||+|... +++.||+|+++............+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999964 689999999875433333344567888888885 99999999999877 78999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9975 7777765422 3489999999999999999999999 9999999999999999 99999999999866432
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--------
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-------- 512 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 512 (609)
.. .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ ...........
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-----QIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-----HHHHHHHHcCCCCHHHHHh
Confidence 22 123457889999997644 557899999999999999999999996543211 00111100000
Q ss_pred ccchhhccccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 KRLDAIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 ~~~~~~~~~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.......+..... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 0112346889999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=290.67 Aligned_cols=248 Identities=24% Similarity=0.277 Sum_probs=201.7
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
+|++.+.||.|+||.||+|... +++.||+|.+.... .....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 58999999986432 22356788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+.+... ..++...+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998763 3478899999999999999999999 9999999999999999999999999998866433
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..........
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------- 216 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET--------- 216 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc---------
Confidence 2 2233458889999999988889999999999999999999999997543210 1111111100
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAM--SEVV 557 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl 557 (609)
.....+...+..+.+++.+||+.||++||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111223344788999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=283.39 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=203.3
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
+|+..+.||+|++|.||++... ++..+++|++..... .....+.+|++++++++|+|++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4777899999999999999975 689999999875332 35678899999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999987642 3489999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ .......
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~---- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIAT-NGPPGLR---- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHHh-cCCCCcC----
Confidence 23456889999999998888999999999999999999999998643211 00011000 1111100
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.....+..+.+++.+|++.||++|||+.++++.
T Consensus 219 ---~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 ---NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011124679999999999999999999999853
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=301.79 Aligned_cols=263 Identities=20% Similarity=0.339 Sum_probs=196.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Ccc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 356 (609)
+++|++.+.||+|+||.||+|.+. +|+.||+|.+...........+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999964 68999999986544344456788899999999999999999887544 347
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++++||+.+ ++...+.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 67666643 2388899999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCc--eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh---
Q 007290 437 LVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE--- 510 (609)
Q Consensus 437 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 510 (609)
........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-----~~~~~~~~~~~ 229 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-----LNLILGVLGTP 229 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCC
Confidence 65432211 1223468899999998754 5689999999999999999999999964322110 00000000
Q ss_pred hhccchhhcccc-------cc--CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 511 REKRLDAIVDRN-------LN--KN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 511 ~~~~~~~~~~~~-------l~--~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+....+.+.. .. .. ..+..+..+.+++.+||+.+|++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 00 00 011234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.86 Aligned_cols=258 Identities=23% Similarity=0.272 Sum_probs=198.6
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------CcceE
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TERLL 358 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 358 (609)
|...+.||+|+||.||+|+++ +|+.||||.++........+.+.+|++++++++|+|||+++++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999954 79999999998877777788999999999999999999999876544 45789
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCC--cEEEccccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDF--EAVVGDFGL 434 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfGl 434 (609)
|||||.+|+|...++.. ++...++....+.+..+++.||.|||++ +|+||||||.||++- .+| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999864 3455699999999999999999999999 999999999999983 323 469999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
|+.++... .....+||..|++||.+.. ..|+..+|.|||||++||++||..||-....+....-. .|......+.
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~--~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI--MWHIITKKPS 246 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh--hhhhhccCCC
Confidence 99876433 5667789999999999985 78999999999999999999999999754333211111 1111111110
Q ss_pred cchhhccc----------cc--cCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007290 514 RLDAIVDR----------NL--NKNYNIQEVETMIQVALLCTQASPEDRP 551 (609)
Q Consensus 514 ~~~~~~~~----------~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RP 551 (609)
.......+ .+ .....+.....+-.++..++..+|++|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 00000000 01 1112344555667788888889999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=290.37 Aligned_cols=260 Identities=17% Similarity=0.202 Sum_probs=181.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHH----------HHHHHHHHHHhccCCCcceeE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDA----------AFQREVEMISVAVHRNLLRLI 347 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~h~niv~l~ 347 (609)
..++|.+.++||+|+||+||+|.+.+ +..+|+|+..........+ ....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 44689999999999999999999754 3456666543211111011 112233345567899999999
Q ss_pred eEEeCCC----cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007290 348 GFCTTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 423 (609)
Q Consensus 348 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 423 (609)
+++.... ..+++++++.. ++.+.+.... ..++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765443 23556666543 4545554321 246777889999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceeeccCCC------ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007290 424 DFEAVVGDFGLAKLVDVRKT------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497 (609)
Q Consensus 424 ~~~~kl~DfGl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~ 497 (609)
++.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999987643211 111234699999999999999999999999999999999999999975422111
Q ss_pred c-chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 498 D-DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 498 ~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
. .....+...... ..... ....+..+.+++..|++.+|++||++.++.+.|+
T Consensus 242 ~~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLH---------EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhh---------hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 000011111111 11110 1122467899999999999999999999998763
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=286.60 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=197.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC----CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Ccc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 356 (609)
.+|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999964 68999999875321 223446788999999999999999999988664 347
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++++||+++++|.+.+.... .+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 88999999999999887532 378888999999999999999999 99999999999999999999999999998
Q ss_pred eeccCC--CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 437 LVDVRK--TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 437 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
...... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~----- 221 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKI----- 221 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHH-----
Confidence 653211 11122345889999999998888999999999999999999999998632111 011111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.........+......+.+++.+|++ +|..||+..+++.
T Consensus 222 ----~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ----ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111112234455789999999998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.57 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=198.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------ 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 353 (609)
..++|++.+.||+|+||.||+|... +|+.||+|.+... ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999965 7899999998642 2333446677899999999999999999988543
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 346899999965 777766431 78888899999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch----------hHH
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV----------LLL 503 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~----------~~~ 503 (609)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........... .+.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9987643221 2334578899999999999999999999999999999999999964332110000 000
Q ss_pred HHHHH----H-hhh-----ccchhhccccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 504 DHVKK----L-ERE-----KRLDAIVDRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 504 ~~~~~----~-~~~-----~~~~~~~~~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..... . ... ............. .........+.+++.+|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 000 0000111110000 0012345678899999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.25 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=213.9
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC----C----CcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEe
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA----D----GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIG 348 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 348 (609)
.++...++..+.+.||+|.||.|++|... . ...||||+++......+.+.+..|++++..+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45566666677779999999999999843 1 45799999988777777899999999999875 999999999
Q ss_pred EEeCCCcceEEeecccCchhhhhhhhcC-----CC-----C--CCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 007290 349 FCTTPTERLLVYPFMQNLSVAYRLREIK-----PG-----E--PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKA 416 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~-----~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp 416 (609)
+|......++|.||+..|+|..+++... .. . ..++....+.++.|||.|++||+++ +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999899999999999999999998755 00 1 2388889999999999999999999 999999999
Q ss_pred CcEEeCCCCcEEEcccccceeeccCCCceeecccc--cccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 007290 417 ANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG--TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSR 493 (609)
Q Consensus 417 ~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~ 493 (609)
+|||+.++..+||+|||+++..............| +..|||||.+....|+.|+||||||+++||++| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765444433232222 456999999999999999999999999999999 677775311
Q ss_pred cccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 494 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.. .+....+....++. .+..+..++.++|..||+.+|++||++.++.+.++.
T Consensus 527 ~~-------~~l~~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 PT-------EELLEFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred cH-------HHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 11122222222221 233346788999999999999999999999999987
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.08 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=189.3
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC----
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP---- 353 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 353 (609)
......+|++.++||+||||.||+++.+ ||+.||||++.-..+......+.+|+.++++++|||||+++..+.+.
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3456678889999999999999999977 99999999997654555567788999999999999999887432100
Q ss_pred --------------------------------------------------------------------------------
Q 007290 354 -------------------------------------------------------------------------------- 353 (609)
Q Consensus 354 -------------------------------------------------------------------------------- 353 (609)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHH
Q 007290 354 -----------------------------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398 (609)
Q Consensus 354 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L 398 (609)
...|+-||||+..++.+.++..... -.....++++.+|++||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHH
Confidence 0014557777776666666543221 14567789999999999
Q ss_pred HHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec-----------------cCCCceeecccccccccCcccc
Q 007290 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----------------VRKTNVTTQVRGTMGHIAPEYL 461 (609)
Q Consensus 399 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~ 461 (609)
.|+|++ |+|||||||.||+++++..|||+|||+++... .......+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 0111123456799999999999
Q ss_pred cCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHH
Q 007290 462 STG---KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQV 538 (609)
Q Consensus 462 ~~~---~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 538 (609)
.+. .|+.|+||||+|++++||+. ||..... -......+. .+.+..- ..+.....+.=.++
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-------Ra~iL~~LR-~g~iP~~------~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-------RASILTNLR-KGSIPEP------ADFFDPEHPEEASL 850 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchHH-------HHHHHHhcc-cCCCCCC------cccccccchHHHHH
Confidence 764 49999999999999999985 4542211 111111111 1111111 11223333455789
Q ss_pred HHhccCCCCCCCCCHHHHHH
Q 007290 539 ALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 539 ~~~cl~~dP~~RPs~~evl~ 558 (609)
+.++++.||++|||+.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=282.92 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=205.0
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceEEe
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLVY 360 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 360 (609)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 689999999864332 24567889999999999999999999999887 7899999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987643 589999999999999999999998 999999999999999999999999999987754
Q ss_pred CCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|..||..... .........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~--------- 217 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIG--------- 217 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhcc---------
Confidence 3321 12334688899999999888899999999999999999999999975431 001111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........+...+..+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 011111223334578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.47 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=194.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||.||+|.+++ ++.||||.++..........+..|+.++.+.. ||||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34667889999999999999999864 89999999975444444566777887766664 99999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+.+ ++.+...... ..+++..+.+++.|++.||+|||+.. +++||||+|+||++++++.++|+|||++..+.
T Consensus 93 ~e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999864 6666654422 25888999999999999999999732 89999999999999999999999999987654
Q ss_pred cCCCceeecccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... .
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~-~ 236 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE-P 236 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-C
Confidence 3221 12234788999999987554 789999999999999999999998632111 01111111110 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. ... .....+.++.+++.+||+.+|++||++.+++++
T Consensus 237 ~-----~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 P-----SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-----CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000 011234678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=289.04 Aligned_cols=247 Identities=21% Similarity=0.276 Sum_probs=197.8
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeeccc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
|...+.||+|++|.||++... +++.+++|++... .....+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444578999999999999964 6889999988532 23345668899999999999999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+....... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~ 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-P 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-c
Confidence 9999998875 2378889999999999999999999 99999999999999999999999999887553322 1
Q ss_pred eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccccc
Q 007290 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 524 (609)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... . .+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~-~-----~~~~~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDN-L-----PPKLK 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhc-C-----CCCCc
Confidence 223345889999999998888999999999999999999999998642211 111111111 0 00000
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 525 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11123468999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=288.03 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=193.2
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||+|+||+||++... +|+.||+|.+.... .......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68999999986422 222345667899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 999876432 3488999999999999999999999 9999999999999999999999999998765431 12233
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ...... ... ......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~--------~~~--~~~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-----EELKRR--------TLE--MAVEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-----HHHHhc--------ccc--ccccCC
Confidence 45788999999998888999999999999999999999999643321110 000000 000 011122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSE-VVRML 560 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~e-vl~~L 560 (609)
...+..+.+++.+||+.+|++||++++ .+..|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 234568899999999999999995554 33333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=287.74 Aligned_cols=243 Identities=25% Similarity=0.315 Sum_probs=186.8
Q ss_pred cccccCCceEEEEEeC-CCcEEEEEEeccCCCC--chHHHHHHHHHHHH---hccCCCcceeEeEEeCCCcceEEeeccc
Q 007290 291 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEMIS---VAVHRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
+||+|+||.||++... +++.||+|.+...... .....+..|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 6899999988643321 22233445554444 3469999999999999899999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+++|.+++... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999888653 2389999999999999999999999 99999999999999999999999999987554321
Q ss_pred eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 445 VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....|+..|+|||.+.+ ..++.++|||||||++|+|+||..||........ ........ . .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~------~----~ 214 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTL------T----V 214 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH------HHHHHHhh------c----C
Confidence 123458999999999864 5689999999999999999999999964322111 00010000 0 0
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 559 (609)
....+...+..+.+++.+|++.||++|| ++++++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112233456889999999999999999 58887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.25 Aligned_cols=264 Identities=25% Similarity=0.296 Sum_probs=195.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 358 (609)
.++|++.+.||+|+||.||+|... +|+.||+|.++... .......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999975 68999999986432 222234567899999999999999999998654 45799
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 7777776532 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hccc
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EKRL 515 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 515 (609)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +......... ....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ----LDLIIQLLGTPNESIW 233 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCChhhc
Confidence 53321 2223345788999999865 4578999999999999999999999974332111 1000000000 0000
Q ss_pred ---------hhh-ccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 ---------DAI-VDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ---------~~~-~~~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... ........ .....+..+.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00000000 00113567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=289.21 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=198.0
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC---
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--- 354 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 354 (609)
+...++|++.+.||+|+||.||+|..+ +|+.||+|+++... .......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999975 58999999986432 2333456788999999999999999999886654
Q ss_pred -------cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 355 -------ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 355 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 68899999987 555555432 23489999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||....... ....+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-----~~~~~ 230 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-----QLELI 230 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Confidence 999999998765433222223346788999998865 457899999999999999999999996432211 11111
Q ss_pred HHHhhh---ccchhhcc--------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 507 KKLERE---KRLDAIVD--------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 507 ~~~~~~---~~~~~~~~--------------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...... .....+.. +.... .....+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111000 00000000 00000 01123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=326.65 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=202.7
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.+-++.-+..||.|.||.||.|.. .+|...|||-++-.. .....+.+.+|+.++..++|||+|+++|+-...+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 334677788999999999999994 579999999775322 234456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
||||++|+|.+.++.. ...++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1313 MEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999763 2256666677889999999999999 99999999999999999999999999998886
Q ss_pred cCCCc---eeecccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 440 VRKTN---VTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 440 ~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
..... ......||+.|||||++.+.. ...++||||+|||+.||+||+.||.....+ -.+.-++.. +
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~aIMy~V~~----g 1457 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WAIMYHVAA----G 1457 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hHHHhHHhc----c
Confidence 54322 123467999999999997643 567899999999999999999999732211 011111111 1
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .++.+...+.+-.+++.+|+..||+.|.++.|+++.
T Consensus 1458 h---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 H---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred C---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 123444567788999999999999999999888754
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.95 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=195.3
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
|...+.||+|+||.||+++.. +|..||+|.+.... .......+..|++++++++|||++++++++......++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999964 68899999986432 223345788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++ ++.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 666666432 23388999999999999999999999 9999999999999999999999999998754321
Q ss_pred CceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 443 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
....|++.|+|||.+. .+.++.++|||||||++|||++|+.||...... ..........
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~------ 240 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE------ 240 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhcc------
Confidence 2345788999999874 456899999999999999999999998532110 0011111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|.+||++.++++.+.-
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0111122345678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=294.96 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=192.4
Q ss_pred Cccccc--CCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
..||+| +||+||++.+. +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999975 79999999986432 223346788999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
+++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876432 2378889999999999999999998 99999999999999999999999998654332111100
Q ss_pred ------eecccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH--------
Q 007290 446 ------TTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL-------- 509 (609)
Q Consensus 446 ------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 509 (609)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCcccc
Confidence 0112346679999998763 478999999999999999999999964321110 00000000
Q ss_pred --------h----------------hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 510 --------E----------------REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 510 --------~----------------~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .........+..+........+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0000000111111122234466789999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.28 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=193.7
Q ss_pred cCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeecccCc
Q 007290 289 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
+..||.|..|.|++++++ +|...|||.+++.......+.++..+.++.+.+ +|.||+.+|||..+....+-||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 567999999999999976 589999999987766667778888888876654 99999999999999999999998853
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCcee
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~ 446 (609)
-+..++.... ..+++...-++...+++||.||.++. +|+|||+||+|||+|+.|++|+||||++.++-+... .
T Consensus 176 C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--h 248 (391)
T KOG0983|consen 176 CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--H 248 (391)
T ss_pred HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--c
Confidence 2333343322 23777778889999999999999876 999999999999999999999999999988764433 3
Q ss_pred ecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 447 TQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 447 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
+...|-+.|||||.+. ...|..++||||||++++||.||..||..-..+ ... ......++. +.+
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----Fe~---ltkvln~eP------P~L 315 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----FEV---LTKVLNEEP------PLL 315 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----HHH---HHHHHhcCC------CCC
Confidence 3446889999999985 346899999999999999999999999753321 111 111111111 111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ....+..+.+++..|+++|+.+||...+++++
T Consensus 316 ~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 22256788999999999999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=290.90 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=195.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|++|+||+|... +|+.||+|.+.... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999975 68999999886432 22334678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeecc
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~ 440 (609)
|+++ ++...+.... ...+++.....++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9964 7777665422 22357788889999999999999999 9999999999999985 56799999999976543
Q ss_pred CCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--ccc--
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--KRL-- 515 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 515 (609)
.. .......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||........ ..........+ ...
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFKIFRILGTPNEETWPG 230 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChhhccc
Confidence 21 112234578899999988664 578999999999999999999999964322110 10100000000 000
Q ss_pred ----hhhc--cccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 ----DAIV--DRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ----~~~~--~~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... .+.... ...+..+..+.+++.+|++.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 011223467889999999999999999999986
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.12 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=193.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc-----
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 355 (609)
.++|++.+.||+|+||.||+|... +++.||||.+.... .......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999975 68999999886432 22233456789999999999999999999866543
Q ss_pred ---ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 356 ---RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 356 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
.++||||+.+ ++.+.+... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4899999975 677766542 23489999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCc---eeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 433 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 433 Gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||+||..||....... .......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-----~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-----QLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHH
Confidence 999866432221 12234578899999988654 47889999999999999999999986543211 1111111
Q ss_pred Hhh---hccchh-----hccc-cccCCC---------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LER---EKRLDA-----IVDR-NLNKNY---------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~---~~~~~~-----~~~~-~l~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... ...... ..+. ...... .......+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 000000 0000 000000 0011346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=289.20 Aligned_cols=257 Identities=20% Similarity=0.249 Sum_probs=200.9
Q ss_pred CCCccCcccccCCceEEEEEe----CCCcEEEEEEeccCC---CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
+|++.+.||+|+||.||++.. .+++.||||+++... .......+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999985 257889999986422 122345678899999999 599999999999888899
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|...+... ..+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999988642 2378889999999999999999999 99999999999999999999999999988
Q ss_pred eeccCCCceeecccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
..............|+..|+|||.+.+.. .+.++||||||+++|||+||..||........ .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~---- 225 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRIL---- 225 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHH----
Confidence 66443322233345889999999987655 78899999999999999999999863221100 011111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
... ..........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 226 -----~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 226 -----KSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----ccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000 111222346789999999999999999999998887763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=284.05 Aligned_cols=252 Identities=20% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC----CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+|.+.+.||+|+||.||++.+. .+..+++|.++... .......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999865 34556666655321 223345677899999999999999999999888899999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+||+++++|.+.+.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999976554556689999999999999999999999 9999999999999975 569999999987664
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .........
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~-------- 219 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVE-------- 219 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHc--------
Confidence 322 122334578899999999888889999999999999999999999863221 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+.++.+++.+|++.+|++||++.++++.
T Consensus 220 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 --GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01111234556788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=291.76 Aligned_cols=260 Identities=22% Similarity=0.264 Sum_probs=191.4
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCch
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.+.+|.|+++.||++.. +|+.||||++... ........+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44445555555555544 6999999998754 334456789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC----
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---- 443 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~---- 443 (609)
|.+++..... ..++......++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+........
T Consensus 86 l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999976432 2378888999999999999999999 999999999999999999999999998875532111
Q ss_pred --ceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh---------
Q 007290 444 --NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE--------- 510 (609)
Q Consensus 444 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 510 (609)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ...+......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCccccccCch
Confidence 11123346788999999865 358899999999999999999999997432111 0000000000
Q ss_pred --hhccchh----hccc----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 --REKRLDA----IVDR----NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 --~~~~~~~----~~~~----~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....... ..++ ..........+.++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000000 0000 0011123445578899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=285.05 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=196.3
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||.|+||.||++++. +|+.+++|.+..... ......+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 499999999864322 23456788999999999999999999999989999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC-----
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT----- 443 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~----- 443 (609)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99987633 489999999999999999999999 999999999999999999999999999876533211
Q ss_pred --ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 444 --NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 444 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.......++..|+|||.......+.++||||||+++|+++||+.||...... ........ +.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~------- 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILN-GK------- 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc-CC-------
Confidence 1223345788999999998888999999999999999999999999643311 11111111 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.........+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 218 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 218 -IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0000011125688999999999999999999666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=284.06 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=199.9
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
|++.+.||+|++|.||+|... +|+.+++|++.... .......+.+|+.++++++|+||+++++++......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999975 68999999986533 2234567889999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++ ++...+.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 86 7777776532 3488999999999999999999999 99999999999999999999999999998775433
Q ss_pred ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--hccchhhcc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--EKRLDAIVD 520 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 520 (609)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+. .......... ........+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ----LFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHcCCCchHhcccchh
Confidence 122234578899999998776 789999999999999999999999865432111 0000000000 000000000
Q ss_pred -----------ccc--cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 521 -----------RNL--NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 521 -----------~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... .....+..+..+.+++.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=287.39 Aligned_cols=266 Identities=21% Similarity=0.253 Sum_probs=197.4
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeecc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
|.+.+.||+|+||+||+|... +++.|+||++.............+|+..+++++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999976 578999999865433333345567899999999 999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
+|+|.+.+.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 788888886533 23489999999999999999999999 999999999999999999999999999986643221
Q ss_pred ceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchh--------HHHHHHHHhhhcc
Q 007290 444 NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL--------LLDHVKKLEREKR 514 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 514 (609)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||............ ...|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223457889999998754 45799999999999999999999998654321110000 0000000000001
Q ss_pred chhhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 515 LDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 515 ~~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
....+..... ....+.....+.+++.+||+.+|++||+++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1000000000 00011124678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.87 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=195.6
Q ss_pred CCCccCcccccCCceEEEEEe----CCCcEEEEEEeccCC---CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
+|++.+.||+|+||.||++.. .+|..||+|++.... .....+.+..|+.++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368999999986422 122346778899999999 599999999999888889
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999998753 2378888899999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
..............|+..|+|||.+... .++.++||||||+++|+|+||+.||........ ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~-- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS-- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhcc--
Confidence 7654333333345688999999998653 468899999999999999999999863221110 11111111000
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
. ..++......+.+++.+|++.+|++|| +..+++.
T Consensus 228 -----~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -----E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 111223446788999999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.35 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=202.0
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+|++.+.||+|++|.||++... +++.|++|.+..... ......+.+|++++++++|||++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 688999999875432 13457789999999999999999999999988999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 3489999999999999999999999 99999999999999999999999999998775433
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ........ ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~-~~-------- 215 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--------AALFRIVQ-DD-------- 215 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhc-cC--------
Confidence 22 23345788999999998888899999999999999999999998632210 00001000 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........+..+.+++.+|++.+|++||++.+++.
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01112233467899999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=293.81 Aligned_cols=268 Identities=20% Similarity=0.342 Sum_probs=197.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC-CCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC--Ccc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP--TER 356 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 356 (609)
..++|++.+.||+|+||.||+|.+. +|+.+|+|++... ........+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999975 6889999988542 2233445677899999999 999999999988654 357
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++ +|..++... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 999999974 888877642 478889999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCC----ceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------HH
Q 007290 437 LVDVRKT----NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LD 504 (609)
Q Consensus 437 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~ 504 (609)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||............. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6643321 12233468899999998755 457899999999999999999999996433211100000 00
Q ss_pred HHHHHhhhccchhhcc----cccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 505 HVKKLEREKRLDAIVD----RNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~----~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
....... ......++ .... ....+..+.++.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKS-PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHh-hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00000010 0000 00112245688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=295.32 Aligned_cols=264 Identities=20% Similarity=0.302 Sum_probs=198.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC----CCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 356 (609)
.++|++.+.||+|+||.||+|... +|+.||+|++.... .......+..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368999999999999999999965 69999999987532 23345677889999999999999999988753 3457
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++|+||+. ++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 89999996 5888877542 2389999999999999999999999 99999999999999999999999999997
Q ss_pred eeccCCCc---eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh--
Q 007290 437 LVDVRKTN---VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE-- 510 (609)
Q Consensus 437 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 510 (609)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-----~~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-----LKLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-----HHHHHHHhCC
Confidence 66432211 1223468899999998865 4689999999999999999999999965332111 00000000
Q ss_pred ---------hhccchhhcccc-ccCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 511 ---------REKRLDAIVDRN-LNKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 511 ---------~~~~~~~~~~~~-l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+.. .... ..+..+..+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 0000 112345789999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=287.91 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=206.9
Q ss_pred ccCHHHHHH-HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEe
Q 007290 273 RYSWRELQL-ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIG 348 (609)
Q Consensus 273 ~~~~~~~~~-~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~ 348 (609)
.+.|-|.+. ..+.|..-++||+|+||.||-+..+ +|+-||.|++.+.. ........+.|-.++.+++.+.||.+--
T Consensus 173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 344555543 4456888899999999999999965 69999999875322 1233455678999999999999999988
Q ss_pred EEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
.+.+.+..++|+..|.||+|...+.+... ..+++..+..++.+|+.||++||.. +||.||+||+|||+|+.|+++
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence 89999999999999999999999987543 5599999999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 429 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 429 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+|+|+|..+..... ....+||.+|||||++++..|+...|.||+||++|||+.|+.||..... .
T Consensus 328 ISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-------------K 392 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-------------K 392 (591)
T ss_pred eeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-------------h
Confidence 999999998764332 3334799999999999999999999999999999999999999952111 1
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
..+++.-+.+... ...++...+++..++....+++||++|-...
T Consensus 393 vk~eEvdrr~~~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 393 VKREEVDRRTLED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhHHHHHHHHhcc--hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1111100011110 1234556677889999999999999996443
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=283.11 Aligned_cols=246 Identities=19% Similarity=0.224 Sum_probs=189.5
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHH-HHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||.||+|... +|+.||+|++..... ......+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999974 689999999864321 1122334455544 3455899999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
++|.+++.... .++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999987532 378889999999999999999999 999999999999999999999999999875432
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....++..|+|||.+.+..++.++||||||+++|+|+||..||...... ........ ... ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~------~~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILS-RRI------NWPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHh-ccc------CCCC
Confidence 22345788999999998888999999999999999999999999643221 11111100 000 0011
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
......+..+.+++.+||+.+|++||++.++.+.|..
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1122345688999999999999999987666555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.94 Aligned_cols=261 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhc---cCCCcceeEeEEeCCCc-----
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA---VHRNLLRLIGFCTTPTE----- 355 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 355 (609)
|++.+.||+|+||.||+|+++ +++.||+|+++.... ......+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999986 489999999974332 22234566788777665 59999999999987766
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 78888765332 2489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc-
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR- 514 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 514 (609)
........ .....++..|+|||.+.+..++.++|||||||++|||+||.+||......+ ..............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 228 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----QLDKIFDVIGLPSEE 228 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----HHHHHHHHcCCCChH
Confidence 87643321 122347889999999998889999999999999999999999986433211 11111111000000
Q ss_pred --c------hhhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 --L------DAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 --~------~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ......... ....+.....+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 0112234577889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=280.70 Aligned_cols=266 Identities=23% Similarity=0.330 Sum_probs=219.9
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeE
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 349 (609)
.+++.+..++++...++-+|.||.||+|.|. +.+.|-+|.++...++.+...+..|.-++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3567788889999999999999999999764 3456888999887778888889999999999999999999999
Q ss_pred EeCC-CcceEEeecccCchhhhhhhhcCC----CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007290 350 CTTP-TERLLVYPFMQNLSVAYRLREIKP----GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424 (609)
Q Consensus 350 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 424 (609)
+..+ ...+..|.++.-|+|..++..... ....++..+...++.|++.|++|||++ ++||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8554 567888999999999999984331 223466677788999999999999999 99999999999999999
Q ss_pred CcEEEcccccceeeccCCCceee-cccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhH
Q 007290 425 FEAVVGDFGLAKLVDVRKTNVTT-QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL 502 (609)
Q Consensus 425 ~~~kl~DfGl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~ 502 (609)
.++||+|=.+++.+.+.+....+ ....+..||+||.+++..|+.++|||||||++|||+| |+.|+.... .
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--------P 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--------P 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--------H
Confidence 99999999999988766554433 2335679999999999999999999999999999999 788875332 2
Q ss_pred HHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.+....+..+.++.. +.+++.+++.+|.-||...|++||+++|++.-|.+
T Consensus 505 fEm~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 505 FEMEHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 234445555555443 33456789999999999999999999999998876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.56 Aligned_cols=262 Identities=21% Similarity=0.315 Sum_probs=200.9
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-----cce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-----ERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 357 (609)
+|++.+.||+|+||.||+|... +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999975 589999999875332 444577889999999999999999999987765 789
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
++|||+++ +|...+... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 788877642 2589999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCC--ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh---
Q 007290 438 VDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--- 511 (609)
Q Consensus 438 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 511 (609)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~~~~~ 227 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-----LNLIVEVLGTPS 227 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHhcCCCC
Confidence 754321 122334578899999999887 789999999999999999999999975432111 000000000
Q ss_pred --------hccchhhcc---ccc---cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 --------EKRLDAIVD---RNL---NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 --------~~~~~~~~~---~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
......... ... .....+..+..+.+++.+||+.+|++||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000 000112245678999999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=277.59 Aligned_cols=248 Identities=21% Similarity=0.234 Sum_probs=191.1
Q ss_pred HHHHHhcCCCccCcc--cccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC
Q 007290 278 ELQLATDNFSEKNVL--GQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP 353 (609)
Q Consensus 278 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 353 (609)
+.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++.+...
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 334445667777766 99999999999964 68899999986422111 122222222 699999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDF 432 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 432 (609)
+..++||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999997532 589999999999999999999999 999999999999999998 9999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.....
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-- 224 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQQ-- 224 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhhc--
Confidence 9987654321 2357899999999998899999999999999999999999997432211 11111111110
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVR 558 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 558 (609)
. ........+..+.+++.+|++.+|.+||+ ++++++
T Consensus 225 --------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 --------K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --------c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 00112245578899999999999999996 588874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.24 Aligned_cols=248 Identities=27% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.|...+.||+|+||.||+|+.. ++..+|+|.+... ........+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999975 6789999988632 222334578889999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+. |++.+.+.... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 57777665322 2378899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
....++..|+|||.+. ...++.++|||||||++|+|++|+.||...... ..........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~----- 230 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNE----- 230 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcC-----
Confidence 2345788999999874 356788999999999999999999998532110 0001111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
.........+..+.+++.+||+.+|++||++.++++...
T Consensus 231 ----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 231 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 001112234567899999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=294.55 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=196.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Cc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 355 (609)
.++|.+.+.||+|+||+||+|... +|+.||||.+... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999964 6899999998642 2233445677899999999999999999987544 34
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++++||+. ++|.+++... ..++...+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 789999996 5787777542 3488999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh---
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--- 511 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 511 (609)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||........ .........
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~ 229 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-----LKLITELLGSPS 229 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-----HHHHHHHhCCCC
Confidence 8664322 22233457889999998765 4689999999999999999999999965322110 000000000
Q ss_pred --------hccchhhc-------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 --------EKRLDAIV-------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 --------~~~~~~~~-------~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........ +.... ...+..+..+.+++.+|++.+|++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 00000 0112345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=283.19 Aligned_cols=243 Identities=21% Similarity=0.278 Sum_probs=194.7
Q ss_pred CcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 290 NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
..||+|+||.||++... +|..||||++... .......+.+|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999974 7899999988532 233456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+++... .+++.....++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 9877532 378888999999999999999999 99999999999999999999999999987654322 12233
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ......... ....+. ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~~~~------~~~~~~--~~ 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN------LPPKLK--NL 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhh------CCcccC--Cc
Confidence 46889999999998888999999999999999999999998642211 111111100 000000 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...+..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=276.30 Aligned_cols=241 Identities=23% Similarity=0.278 Sum_probs=199.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|...++||+|.||.|-+++.+ +|+.||+|++++.. .......-..|-+++...+||.+..+--.+.+.++.++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56777899999999999999965 79999999998643 2334456678999999999999999888889999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||..||.|...+.. ...+++...+.+...|+.||.|||++ +||.||+|.+|.++|++|++||+|||+++.- .
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-I 319 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-c
Confidence 99999999988875 34488888889999999999999999 9999999999999999999999999999853 2
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.....+...+|||.|+|||++....|...+|.|.+||++|||++|+.||....-+.-...+ +-
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-----------------l~ 382 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-----------------LM 382 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-----------------Hh
Confidence 3455677889999999999999999999999999999999999999999643221111000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRP 551 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 551 (609)
.. -.++...+++...|+...+.+||++|-
T Consensus 383 ed--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 ED--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hh--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 00 013344456778889999999999994
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=292.95 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=208.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
....|.+...||+|.|++|.+|++. ++..||||.+.+.. .......+.+|++++..++|||||+++.+...+...++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4567888999999999999999965 69999999987643 233446688999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||..+|.+.+++..... ........++.|+.+|++|||++ .|+|||||++|||++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987443 44478888999999999999999 99999999999999999999999999999886
Q ss_pred cCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
........+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+.....+-. ..+
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rv 267 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRV 267 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chh
Confidence 3344556789999999999998776 78999999999999999999999854432211 112
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
+...++. +.-.+.++.+++.+++..+|.+|++++++.+.-
T Consensus 268 l~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 268 LRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 2222222 222335778999999999999999999998643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=280.84 Aligned_cols=242 Identities=25% Similarity=0.325 Sum_probs=186.2
Q ss_pred cccccCCceEEEEEeC-CCcEEEEEEeccCCCC--chHHHHHHHHHH---HHhccCCCcceeEeEEeCCCcceEEeeccc
Q 007290 291 VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--GGDAAFQREVEM---ISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
.||+|+||.||++... +++.||+|.+...... .....+..|..+ ++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 5889999988643211 122234444443 444579999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+++|.+++... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999888642 3489999999999999999999999 99999999999999999999999999987553221
Q ss_pred eeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 445 VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......... . ...... ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~-~~~~~~------~~~~-- 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----E-IDRMTL------TMAV-- 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----H-HHHHhh------ccCC--
Confidence 1234689999999998754 6899999999999999999999999754221110 0 000000 0011
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
......+..+.+++.+|+..+|.+|| ++.++++
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11222356889999999999999999 8889875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=288.10 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=197.0
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-CCc
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTE 355 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 355 (609)
+...+++|++.+.||+|+||.||+|... +|+.||+|++... ......+.+..|++++..++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999965 7999999988642 223345678899999999999999999998865 456
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++++||+ +++|...+.. ..++......++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 88999998 4588877753 2367788889999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH--------HHH
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL--------DHV 506 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~--------~~~ 506 (609)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||......... .... ++.
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHH
Confidence 754322 123357889999998766 56899999999999999999999999643321000 0000 000
Q ss_pred HHHhhhccchhhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 507 KKLEREKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..............-...... .+..+..+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000000000 11234688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.78 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=201.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 359 (609)
++|.+.+.||+|+||.||+|... +|..||+|++.... .....+.+..|.+++.++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 79999999986422 2334567889999999998 99999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997632 489999999999999999999999 99999999999999999999999999988664
Q ss_pred cCCC-------------------ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007290 440 VRKT-------------------NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500 (609)
Q Consensus 440 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~ 500 (609)
.... .......++..|+|||......++.++||||||++++++++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 3321 1222345788999999998888999999999999999999999998743310
Q ss_pred hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 007290 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM----SEVVR 558 (609)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~ 558 (609)
........ .....+...+..+.+++.+||+.+|++||++ +++++
T Consensus 229 ---~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 ---LTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00111110 0011222335678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=284.16 Aligned_cols=245 Identities=26% Similarity=0.367 Sum_probs=191.7
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
|...+.||+|+||+||+|... +|+.|++|++.... .......+..|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 68899999986432 223345788899999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+.+ ++.+.+... ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 965 666666542 23488999999999999999999999 999999999999999999999999999864321
Q ss_pred CceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 443 TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.....|+..|+|||.+. ...++.++||||||+++|+|++|..||...... ...........
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~----- 237 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNDS----- 237 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC-----
Confidence 22345888999999984 456889999999999999999999998543210 11111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+..+.+++.+|++.+|++||++.++++.
T Consensus 238 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 ----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112233568999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=284.43 Aligned_cols=265 Identities=24% Similarity=0.293 Sum_probs=192.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 689999999864332 222346778999999999999999998875433
Q ss_pred --cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 355 --ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 355 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
..++|+||+.+ ++...+... ...+++..+..++.|+++||+|||++ +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999876 555555432 23489999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCc----------eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchh
Q 007290 433 GLAKLVDVRKTN----------VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501 (609)
Q Consensus 433 Gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~ 501 (609)
|++......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|++||.........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--- 236 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--- 236 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 999765432211 1122356888999998765 45789999999999999999999998643321110
Q ss_pred HHHHHHHHhh--h------ccchhhc----cccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 502 LLDHVKKLER--E------KRLDAIV----DRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 502 ~~~~~~~~~~--~------~~~~~~~----~~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......... + ....... ....... ........+.+++.+|++.+|++|||+.|++.
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 -HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000 0 0000000 0000000 00112257889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=287.92 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=197.5
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
.+++...+++|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 456677889999999999999999999985 478999999986432 222346678899999999999999999987543
Q ss_pred ------CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 354 ------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 354 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
...+++++++ +++|.+.+.. ..+++..+..++.|+++||+|||+. +++||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 2356777766 7788877753 2378899999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
||+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +....
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~ 231 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKLIL 231 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH
Confidence 9999999875432 1233467889999998866 4688999999999999999999999864322110 00000
Q ss_pred HHHh--hhccchhh-----------ccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 507 KKLE--REKRLDAI-----------VDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 507 ~~~~--~~~~~~~~-----------~~~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.... .......+ ........+ ....+..+.+++.+|++.||++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00000000 000000000 01134578999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=279.97 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=198.4
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+..|+.++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999976 58999999987543 2334567788999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 48999887642 3489999999999999999999999 999999999999999999999999999986643322
Q ss_pred ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh--h------cc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER--E------KR 514 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~------~~ 514 (609)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .......... + ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ----LFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHHHhCCCcHHHHHhhcc
Confidence 12233457789999998766 789999999999999999999999864332110 0000000000 0 00
Q ss_pred c---hhhccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 L---DAIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~---~~~~~~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. .......... ...+.....+.+++.+||+.+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000000 001122568999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=288.60 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=193.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
.++|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999964 68999999986432 2233456889999999999999999999886542
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++|+||+.. ++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999864 5554432 2378889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH--hh
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL--ER 511 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 511 (609)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ........ ..
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~ 235 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----LTQILKVTGVPG 235 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCC
Confidence 8754321 223457889999999866 4689999999999999999999999975432110 00000000 00
Q ss_pred hccc--------hhhcc--cc-ccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--HhcC
Q 007290 512 EKRL--------DAIVD--RN-LNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM--LEGE 563 (609)
Q Consensus 512 ~~~~--------~~~~~--~~-l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 563 (609)
+... ..... +. ..... .+..+..+.+++.+||+.||++||++.+++.. +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 00000 00 00000 01234578899999999999999999999853 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.88 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=193.7
Q ss_pred cCCC-ccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCc-------------hHHHHHHHHHHHHhccCCCcceeEe
Q 007290 284 DNFS-EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG-------------GDAAFQREVEMISVAVHRNLLRLIG 348 (609)
Q Consensus 284 ~~~~-~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~ 348 (609)
++|. +.+.||+|+||+||+|... +++.||||.+....... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3577999999999999965 68999999886432211 1125778999999999999999999
Q ss_pred EEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
++...+..++||||+. |+|.+++... ..++......++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 5888887642 2378899999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCC-------------CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 429 VGDFGLAKLVDVRK-------------TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 429 l~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||+||+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998664111 1111223467889999998764 468999999999999999999999975432
Q ss_pred ccccchhHHHHHHHHhhhcc--chhh--------ccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 495 EEEDDVLLLDHVKKLEREKR--LDAI--------VDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... ..........+.. .... ....... ......+..+.+++.+|++.+|++||+++|++.
T Consensus 240 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQ----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 110 1111111000000 0000 0000000 001123467889999999999999999999995
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.85 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=210.5
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
.+++....++|.+.++||+|+||.|..++++ +++.||+|++.+... .....-|..|-.++.-.+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4678888899999999999999999999976 688999999976332 2235678899999999899999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
+...|+|||||+||+|-.++..+. .++...++.++..|+-||.-+|+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998754 388999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCccccc----C-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLS----T-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
|.+-.+.....-.....+|||.|++||+++ + +.|++.+|.||+||++|||+.|..||......+. +.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT--------Y~ 291 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET--------YG 291 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH--------HH
Confidence 999888766555566778999999999985 2 5799999999999999999999999975443222 11
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA---MSEVV 557 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl 557 (609)
.+-..... +. + + .....+.+..+||.+.+ -+|+.|-. .+++-
T Consensus 292 KIm~hk~~---l~--F-P-~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 292 KIMNHKES---LS--F-P-DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred HHhchhhh---cC--C-C-cccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence 11111100 00 0 0 11335678888888877 47888876 65554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=288.86 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=191.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-------- 353 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 353 (609)
..+|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 367899999999999999999975 68999999986433 34457788999999999999999999776543
Q ss_pred ------CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCc
Q 007290 354 ------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE 426 (609)
Q Consensus 354 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 426 (609)
...++|+||++ ++|...+.. ..+++...+.++.|++.||.|||+. +++||||||+||+++ .++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 24689999997 478777753 2378899999999999999999999 999999999999997 4567
Q ss_pred EEEcccccceeeccCCCc--eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 427 AVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
++++|||+++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... .
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~----~ 229 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM----Q 229 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----H
Confidence 899999999866432111 1122357889999997654 56789999999999999999999999643321110 0
Q ss_pred HHHHHHhh------hc---cc-hhhccccccC-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 504 DHVKKLER------EK---RL-DAIVDRNLNK-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 504 ~~~~~~~~------~~---~~-~~~~~~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........ .. .. .......... ...+....++.+++.+|++.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 00 00 0000000000 001123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.10 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=195.0
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC---
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--- 354 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 354 (609)
....++|++.+.||+|+||.||++... +|+.||||++.... .......+..|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999854 78999999985422 2223456789999999999999999999886543
Q ss_pred ---cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 355 ---ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 355 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
..++||||+ +++|..++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 6688877753 2378999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------H
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------L 503 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~ 503 (609)
||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||............. .
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999765322 223357889999999876 458899999999999999999999997432210000000 0
Q ss_pred HHHHHHhhhccchhhccc--ccc----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 504 DHVKKLEREKRLDAIVDR--NLN----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~--~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+...... ......... ... .......+..+.+++.+|++.||++|||+.+++.
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQS-EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcc-hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000000000 000 0011223456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=269.85 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=195.4
Q ss_pred cCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHh-ccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 289 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
...||.|+||+|++-.++ .|+..|||+++......+.++++.|.+...+ -++||||+++|.+..++..++-||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 457999999999999976 6999999999877766778889999988655 4699999999999999999999999964
Q ss_pred hhhhhhhh-cCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 367 SVAYRLRE-IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 367 sL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+..+... +.-....+++...-+|..-.++||.||.+.. .|+|||+||+|||++..|.+||||||++..+...- .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 55444322 1223344778888888888999999998764 89999999999999999999999999998764322 2
Q ss_pred eecccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 446 TTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.+.-.|-..|||||.+... .|..+|||||+|++|||+.||+.|+.... .+.+.+..........-..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~---- 292 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLF---- 292 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecC----
Confidence 2334588899999998543 48999999999999999999999986322 1223333332222111111
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..-..+.+..+.+++.-|+.+|-.+||.+.++.++
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11134466789999999999999999999998753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=286.70 Aligned_cols=260 Identities=24% Similarity=0.311 Sum_probs=195.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc----
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE---- 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 355 (609)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+.++++++|||++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999975 68899999886422 23334667789999999999999999987765554
Q ss_pred --ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 356 --RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 356 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 5688888764 2389999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh-
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER- 511 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 511 (609)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ +.........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~----~~~i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ----LKRIMNLVGTP 235 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCC
Confidence 99865432 223457889999998865 4678999999999999999999999964332110 0000000000
Q ss_pred -hcc--------chhhccc---cccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 -EKR--------LDAIVDR---NLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 -~~~--------~~~~~~~---~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+.. ....... .....+ ....+..+.+++.+|++.+|++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000000 000000 0123568999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=281.13 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=190.4
Q ss_pred CCCccCcccccCCceEEEEEeC-C--CcEEEEEEeccCC-CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCC----Cc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-D--GTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTP----TE 355 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 355 (609)
+|++.+.||+|+||.||++... . +..||+|++.... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999975 3 7799999986432 222356778899999998 599999999875332 34
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.+++++|+. ++|...+.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 677888886 578887754 23488999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCC---ceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------HH
Q 007290 436 KLVDVRKT---NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LD 504 (609)
Q Consensus 436 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~ 504 (609)
........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||............. ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86643221 11223468999999998765 468999999999999999999999987533211000000 00
Q ss_pred HHHHHhhhcc--chhhccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 505 HVKKLEREKR--LDAIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~~~--~~~~~~~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......... ........... ...+.....+.+++.+|++.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000000000 001122467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=261.93 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=196.2
Q ss_pred cCcccccCCceEEEEE-eCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeecccCc
Q 007290 289 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
.+.||+|+|+.|--++ ..+|..||||++.+. .........+|++++.+.+ |+||+.+++++.++...|+|||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 4789999999999998 568999999999765 3445677889999998875 999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEcccccceeeccC--
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVR-- 441 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl~~~~~~~-- 441 (609)
.|...+++.. .+++.+..++..+|+.||.|||.+ ||.|||+||+|||-.+... +|||||.+..-+...
T Consensus 162 plLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 162 PLLSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred hHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999998744 388999999999999999999999 9999999999999976544 799999987654211
Q ss_pred ----CCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc---ccchhHHHHHHHH
Q 007290 442 ----KTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE---EDDVLLLDHVKKL 509 (609)
Q Consensus 442 ----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~---~~~~~~~~~~~~~ 509 (609)
........+|+..|||||+.. ...|..++|.||+||++|-|+.|.+||...-... ..+.....-.+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~-- 312 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN-- 312 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH--
Confidence 111223457889999999762 3468899999999999999999999997533211 11110000000
Q ss_pred hhhccchhhcccccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 510 EREKRLDAIVDRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.-...+.+.... ..--...+.+-.+++...+..++.+|-++.+++.
T Consensus 313 ---~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 ---KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 011112222111 1112345567788999999999999999998886
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=264.09 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=198.7
Q ss_pred HhcCCCcc-CcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHH-hccCCCcceeEeEEeC----CC
Q 007290 282 ATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTT----PT 354 (609)
Q Consensus 282 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~ 354 (609)
.+++|.+. ++||-|-.|.|-.+.++ +|+++|+|++.+ .....+|+++.- .-.|||||.++++|.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 35566554 58999999999999975 799999999864 245677888744 4469999999998854 35
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGD 431 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 431 (609)
..++|||.|+||.|...+++. +...+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+ .|..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 578899999999999999874 445699999999999999999999999 999999999999996 456799999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
||+|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....- ..+....+...+
T Consensus 208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~ 280 (400)
T KOG0604|consen 208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIR 280 (400)
T ss_pred cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhh
Confidence 999986543 2334455679999999999888999999999999999999999999964332 111111121111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+.. .+..+--.+.++...++++.+++.+|.+|-|+++++..
T Consensus 281 ~gqy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111 01111234567888999999999999999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=263.47 Aligned_cols=272 Identities=20% Similarity=0.282 Sum_probs=198.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC---C--CcEEEEEEeccCCCC-chHHHHHHHHHHHHhccCCCcceeEeEEeC-CCc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA---D--GTKVAVKRLTDFESP-GGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 355 (609)
...|+....||+|.||.||+|.-+ + .+.+|+|+++...+. +......+|+.+++.++|||++.+..++-+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 456888999999999999999743 2 237999999754332 334567899999999999999999988866 778
Q ss_pred ceEEeecccCchhhhhhhhcC-CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEc
Q 007290 356 RLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVG 430 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~ 430 (609)
.++++||.+. +|-..++... .....++...+++|+.||+.|+.|||++ =|+||||||.||++..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999987 6666665432 2234688899999999999999999999 69999999999999888 899999
Q ss_pred ccccceeeccCCCc--eeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc-hhHHHHH
Q 007290 431 DFGLAKLVDVRKTN--VTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD-VLLLDHV 506 (609)
Q Consensus 431 DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~ 506 (609)
|||+++.+...-.. ....++.|..|.|||.+.+. .||.+.||||.||+..||+|-++-|.......... ....+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999988654322 23356789999999998875 68999999999999999999998886533322111 1111111
Q ss_pred HHHh------------hhccchhhc------cccccCCC--------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 507 KKLE------------REKRLDAIV------DRNLNKNY--------NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 507 ~~~~------------~~~~~~~~~------~~~l~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.. .-..+.+.. ......+. ...-+..-.+|+.++++.||.+|.|+++.++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1110 000111100 00000000 0001123678999999999999999999886
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=269.16 Aligned_cols=237 Identities=24% Similarity=0.240 Sum_probs=192.4
Q ss_pred ccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchh
Q 007290 292 LGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSV 368 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 368 (609)
||+|+||.||++... +++.+|+|.+..... ......+..|+.++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 589999999865332 22456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeec
Q 007290 369 AYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448 (609)
Q Consensus 369 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~ 448 (609)
.+++.... .+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99987532 378999999999999999999998 99999999999999999999999999998764322 12334
Q ss_pred ccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 449 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
..++..|+|||...+...+.++|+||||+++|++++|..||..... ......... .. ...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~---------~~--~~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK---------DP--LRFP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc---------CC--CCCC
Confidence 5678899999999888889999999999999999999999964321 011111111 00 0112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSE 555 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~e 555 (609)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 222467899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=239.18 Aligned_cols=262 Identities=21% Similarity=0.319 Sum_probs=195.7
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.|...++||+|.||+||+|+.+ +++.||+|+++-.. +++-.....+|+-+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999954 68899999997433 333446778999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
|.. +|..+..... ..++....++++.|+.+||.|+|++ ++.|||+||.|.+|+.+|++|++|||+++.++.+
T Consensus 83 cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 975 6777766533 2388889999999999999999999 9999999999999999999999999999987654
Q ss_pred CceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHH---hhhc--cc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKL---EREK--RL 515 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~---~~~~--~~ 515 (609)
....+..+.|..|.+|.++.+.+ |+...|+||-||++.|+... ++.|.....+.+ +......+ ..+. .+
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq----lkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ----LKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH----HHHHHHHhCCCccccCCcc
Confidence 23344556799999999998754 89999999999999999985 444544333221 11111111 1111 11
Q ss_pred hhhccccccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYN---------IQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+.|-...+.++ +.....=.+++.+.+.-+|..|.++++.++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111211111111 222234467788888889999999888775
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=302.41 Aligned_cols=146 Identities=26% Similarity=0.350 Sum_probs=130.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|.+.+.||+|+||+||+|.+. +++.||||+++... .......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999976 68999999986432 2223467889999999999999999999999899999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987532 378888999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=265.12 Aligned_cols=219 Identities=20% Similarity=0.161 Sum_probs=175.1
Q ss_pred cCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhhhhhh
Q 007290 295 GGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR 373 (609)
Q Consensus 295 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 373 (609)
|.||.||++++. +|+.||+|++.... .+..|...+....||||+++++++...+..+++|||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999975 68999999986432 23345555556679999999999999999999999999999999987
Q ss_pred hcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccc
Q 007290 374 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453 (609)
Q Consensus 374 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~ 453 (609)
... .+++.....++.|+++||+|||++ +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 532 388999999999999999999999 9999999999999999999999999987655322 12234567
Q ss_pred cccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHH
Q 007290 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE 533 (609)
Q Consensus 454 ~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 533 (609)
.|+|||.+.+..++.++||||+|+++|||++|+.|+........ .... ...+...+.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------~~~~----~~~~~~~~~ 203 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------THTT----LNIPEWVSE 203 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------cccc----cCCcccCCH
Confidence 89999999888899999999999999999999988653211000 0000 011122346
Q ss_pred HHHHHHHhccCCCCCCCCCH
Q 007290 534 TMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 534 ~l~~l~~~cl~~dP~~RPs~ 553 (609)
.+.+++.+|++.||++||++
T Consensus 204 ~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 204 EARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHccCCHHHhcCC
Confidence 78899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=246.50 Aligned_cols=213 Identities=22% Similarity=0.308 Sum_probs=177.6
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHH-hccCCCcceeEeEEeCC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~ 353 (609)
.+.+++..+....+..||+|++|.|-+-++. +|+..|+|+++.....+..+....|+.+.. ...+|.+|.++|.....
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 3445556666666788999999999988864 799999999987665666777888888854 45799999999999889
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
...++.||.|.. ||..+..+....+..+++...-+|+..++.||.|||++. .++|||+||+|||++.+|++|+||||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 999999999965 787777766556667899999999999999999999985 79999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
++..+.++-. .+...|-..|||||.+.. ..|+.|+||||+|+++.||.+++.||+...
T Consensus 195 IsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 195 ISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 9988754322 222347789999998853 368999999999999999999999997543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=269.86 Aligned_cols=244 Identities=24% Similarity=0.303 Sum_probs=198.6
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 356 (609)
+...+|..+.+||+|+||.|-+|..+ +.+.+|||++++... ....+--+.|-++|+... -|.+++++.++.+.++.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34457888999999999999999976 356799999986432 122333456777777664 67899999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+.||+|-+.+++... +.++.+..++..||-||-|||++ ||+.||||.+||++|.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999999987654 77888889999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.-- -....+...+|||.|+|||.+...+|+..+|.|||||++|||+.|.+||+....++- ..
T Consensus 499 Eni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-----------------F~ 560 (683)
T KOG0696|consen 499 ENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----------------FQ 560 (683)
T ss_pred ccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------------HH
Confidence 532 233445678899999999999999999999999999999999999999986543211 11
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 551 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 551 (609)
.+.+.+. .++...+.+..++....+.+.|.+|-
T Consensus 561 aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 AIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 2222221 24555667788899999999999994
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=273.79 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=199.6
Q ss_pred cCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCc
Q 007290 289 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
.++||.|.||+||-|+++ +|+.||||++.+.. .......+..|+.++..++||.||.+.-.|+++++.+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 378999999999999965 79999999997543 3455688899999999999999999999999999999999999886
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccceeeccCCC
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~~~~~~~~~ 443 (609)
-|...+... ...++......+..||+.||.|||.+ +|+|+||||+|||+... -++||||||.|+.++..
T Consensus 649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 666666542 23388888888999999999999999 99999999999999644 57999999999988643
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.....++||+.|+|||++.+..|...-|+||.||++|.-++|..||..... +.+.++... .+ .
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNAa-------FM---y 783 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNAA-------FM---Y 783 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhccc-------cc---c
Confidence 345567899999999999999999999999999999999999999963221 112211110 00 0
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.+..-.+.+....+++...++..=.+|-+..+-+..-
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 1222345556788999999999999999988776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=280.81 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=193.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHh-ccCCCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++.|.....+|.|+|+.|-.+.+. +++..+||++.+. ..+-.+|+.++.. -.||||+++.+.+.+..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567888888999999999999965 6888999999654 2233556766554 46999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-CCCCcEEEcccccceeec
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGl~~~~~ 439 (609)
|.+.++-+.+.+..... .. ..+..|+.+++.|+.|||++ |+|||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988888865332 23 67778999999999999999 99999999999999 588999999999998776
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ....+-|..|.|||++....|++++|+||||++||+|++|+.||...... ..+ ..
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei----~~----------- 524 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEI----HT----------- 524 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHH----HH-----------
Confidence 44 22234588999999999999999999999999999999999999743321 001 11
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.-..+.+....+.+..+|+.+|++.||.+||++.++..
T Consensus 525 -~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 525 -RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11112233555678899999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=281.67 Aligned_cols=258 Identities=25% Similarity=0.332 Sum_probs=207.8
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe---
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT--- 351 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 351 (609)
+.+...++.|++.+.||.|.+|.||+++. ++|+.+|+|+..... ...++...|.++++.. .|||++.++|++.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33444567789999999999999999995 478999999886543 3456777888888876 5999999999884
Q ss_pred --CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEE
Q 007290 352 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 429 (609)
Q Consensus 352 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 429 (609)
.++..++|||||.+||..++++... +..+.|..+..|+..++.|+.+||.. .++|||||-.|||++.++.||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 3567999999999999999999877 55699999999999999999999999 9999999999999999999999
Q ss_pred cccccceeeccCCCceeecccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007290 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~ 504 (609)
+|||.+..+.. .........||+.|||||++... .|+..+|+||+|++..||.-|.+|+-...+..
T Consensus 165 vDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------- 235 (953)
T ss_pred eeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------
Confidence 99999987753 33344567899999999999643 46789999999999999999999975333210
Q ss_pred HHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......+ .+...-..+...+..+.+++..|+.+|-+.||++.++++
T Consensus 236 aLF~IpR--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ALFLIPR--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhccCCC--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0000010 111111125567789999999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=257.55 Aligned_cols=239 Identities=27% Similarity=0.329 Sum_probs=192.5
Q ss_pred CCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhhhhhhh
Q 007290 296 GFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 374 (609)
Q Consensus 296 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 374 (609)
+||.||+|... +|+.+|+|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999987544333267899999999999999999999999998999999999999999999876
Q ss_pred cCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeeccccccc
Q 007290 375 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454 (609)
Q Consensus 375 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~ 454 (609)
... +++..+..++.++++++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 332 78899999999999999999999 99999999999999999999999999998775432 2334557889
Q ss_pred ccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHH
Q 007290 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVET 534 (609)
Q Consensus 455 y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 534 (609)
|++||.+....++.++||||||+++|++++|..||...... . ............. .......+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~---~~~~~~~~~~~~~--------~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----L---ELFKKIGKPKPPF--------PPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----H---HHHHHHhccCCCC--------ccccccCCHH
Confidence 99999998888999999999999999999999998642110 0 1111111000000 0000014468
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 007290 535 MIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 535 l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.98 Aligned_cols=261 Identities=18% Similarity=0.224 Sum_probs=170.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-C----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeE------E
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-D----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF------C 350 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 350 (609)
..++|++.+.||+|+||.||+|++. + +..||+|++.... ..+.+..| .+....+.++..++.. +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999975 4 6899999875422 11111111 1112222222222211 2
Q ss_pred eCCCcceEEeecccCchhhhhhhhcCCC----------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007290 351 TTPTERLLVYPFMQNLSVAYRLREIKPG----------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 414 (609)
Q Consensus 351 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 414 (609)
......++|+||+.+++|.+++...... ........+..++.|++.||.|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999988653210 01112334567999999999999999 9999999
Q ss_pred CCCcEEeCC-CCcEEEcccccceeeccCCCceeecccccccccCcccccCC----------------------CCCcchh
Q 007290 415 KAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG----------------------KSSERTD 471 (609)
Q Consensus 415 kp~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 471 (609)
||+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986654333344456789999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc-cc---hhhccccccCC----C--CHHHHHHHHHHHHh
Q 007290 472 VFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK-RL---DAIVDRNLNKN----Y--NIQEVETMIQVALL 541 (609)
Q Consensus 472 v~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~l~~~----~--~~~~~~~l~~l~~~ 541 (609)
||||||++|||+++..+++... ........... .. .....+..... + .........+|+.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~---------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL---------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH---------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 9999999999999776653210 01111110000 00 00001100000 0 00011245589999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 007290 542 CTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 542 cl~~dP~~RPs~~evl~~ 559 (609)
|++.||++|||+.|++++
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=261.61 Aligned_cols=261 Identities=21% Similarity=0.241 Sum_probs=199.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC--CC----cceeEeEEeCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RN----LLRLIGFCTTP 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~ 353 (609)
..+++|.+...+|+|.||.|-.+.+. .+..||||+++.. ....++..-|++++.++.+ |+ +|.+.++++-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 34789999999999999999999965 4789999999753 2345667789999999842 23 67788889999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-----------
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD----------- 422 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~----------- 422 (609)
++.++|+|.+ |.|+.+++.+. +-..++..+++.|+.|++++++|||+. +++|-||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999988 45889999763 345589999999999999999999999 999999999999983
Q ss_pred ---------CCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 423 ---------EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 423 ---------~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
++..++|+|||.|+.-.... ...+.|..|.|||++.+-.++.++||||+||+|+|+.||...|..-.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 24468999999998654332 45667999999999999999999999999999999999999887433
Q ss_pred cccccchhHHHHHHHHhhh-----------------ccc-----------hhhcccccc----CCCCHHHHHHHHHHHHh
Q 007290 494 LEEEDDVLLLDHVKKLERE-----------------KRL-----------DAIVDRNLN----KNYNIQEVETMIQVALL 541 (609)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~-----------------~~~-----------~~~~~~~l~----~~~~~~~~~~l~~l~~~ 541 (609)
..+ ..........+ +++ ..+.++... ......+...|++|+..
T Consensus 314 n~E-----HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 314 NLE-----HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cHH-----HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 111 11111111100 010 001111100 00134455789999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 007290 542 CTQASPEDRPAMSEVVR 558 (609)
Q Consensus 542 cl~~dP~~RPs~~evl~ 558 (609)
|+..||.+|+|+.|+++
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=267.44 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=198.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCC------CchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
...++|-+.++||+|+|+.||+|.+ ...+.||||+-.-... ..-.+...+|.++.+.++||.||++|+|+.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456788899999999999999995 4578899997642211 11224556899999999999999999999654
Q ss_pred -CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEE
Q 007290 354 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV 429 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 429 (609)
+..+-|.|||+|.+|.-+|...+ .+++...++|+.||+.||.||.+. +|+|||-||||.|||+.. -|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 56788999999999999998643 488999999999999999999987 678999999999999954 478999
Q ss_pred cccccceeeccCCCc------eeecccccccccCcccccC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007290 430 GDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLST----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~ 499 (609)
+|||++++++..... .+....||.+|++||.+.- ..++.|+||||.||++|+++.|+.||......
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---- 690 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---- 690 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----
Confidence 999999998654332 3456789999999998853 35789999999999999999999999743221
Q ss_pred hhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007290 500 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557 (609)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 557 (609)
..+. .....+. .....-+..+..+.+..+++.+|++..-++|....++.
T Consensus 691 QdIL------qeNTIlk---AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 QDIL------QENTILK---ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHH------hhhchhc---ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0011 0011000 00011112344556788999999999999998877765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=277.39 Aligned_cols=264 Identities=20% Similarity=0.207 Sum_probs=181.6
Q ss_pred HhcCCCccCcccccCCceEEEEEe-----------------CCCcEEEEEEeccCCCCchHH--------------HHHH
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-----------------ADGTKVAVKRLTDFESPGGDA--------------AFQR 330 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~ 330 (609)
..++|++.++||+|+||+||+|.. .+++.||||++.... ....+ .+..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999964 245689999986322 11122 2344
Q ss_pred HHHHHHhccCCCc-----ceeEeEEeC--------CCcceEEeecccCchhhhhhhhcCC--------------------
Q 007290 331 EVEMISVAVHRNL-----LRLIGFCTT--------PTERLLVYPFMQNLSVAYRLREIKP-------------------- 377 (609)
Q Consensus 331 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------- 377 (609)
|+.++.+++|.++ ++++++|.. ....++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 677777743 3567999999999999999874211
Q ss_pred CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccC
Q 007290 378 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457 (609)
Q Consensus 378 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~a 457 (609)
....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 012356778889999999999999999 99999999999999999999999999997654322222222345789999
Q ss_pred cccccCCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCcccc----ccchhHHHHHHHHh
Q 007290 458 PEYLSTGKS----------------------SERTDVFGYGIMLLELVTGQR-AIDFSRLEE----EDDVLLLDHVKKLE 510 (609)
Q Consensus 458 PE~~~~~~~----------------------~~~~Dv~slG~ll~elltg~~-p~~~~~~~~----~~~~~~~~~~~~~~ 510 (609)
||.+..... ..+.||||+||++++|++|.. |+.....-. ........|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 998754321 234799999999999999875 554211100 000111111110
Q ss_pred hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 007290 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASP---EDRPAMSEVVRM 559 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~ 559 (609)
......-......+....+++.+++..+| .+|+|++|++++
T Consensus 457 --------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 --------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00000001122334678899999999766 689999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=250.95 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=190.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEecc-CCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--------
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-------- 353 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 353 (609)
..|+...+||+|.||.||+|+.+ +|+.||+|++-- ....+--....+|++++..++|+|++.+++.|.+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999965 578899987642 12222334567899999999999999999888432
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
...++||.+|+. +|.-.+.+.. ..++..++.+++.++..||.|+|+. .|+|||+||.|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 237899999987 7777776532 3488999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCce---eecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH-HH
Q 007290 434 LAKLVDVRKTNV---TTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV-KK 508 (609)
Q Consensus 434 l~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~-~~ 508 (609)
+++.+...+... .+..+.|..|.+||.+.+ ..|+++.|||+-||++.||.|+.+-+....... ...+.+.. ..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq--ql~~Is~LcGs 247 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ--QLHLISQLCGS 247 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH--HHHHHHHHhcc
Confidence 998775433221 233456999999998876 569999999999999999999998876443211 11111110 00
Q ss_pred Hhhhcc-------chhhcc-cccc-CCC--CHHH------HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LEREKR-------LDAIVD-RNLN-KNY--NIQE------VETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~~~-------~~~~~~-~~l~-~~~--~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...+-+ +.+.+. +.+. ..+ ..+. ..+..+++.+++..||++|+++.+++.
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000000 000000 0000 000 0011 136678999999999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=248.00 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=196.5
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
....+|...++||+|+|++|..++++ +.+.||+|++++. .......=.+.|-.+..+. +||.+|-+..++.++.+.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 35578999999999999999999965 6788999998752 2223334445677777665 699999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++|.||++||+|--.++. ...+++..++.+...|+-||.|||++ ||+.||||..|||+|..|++|++|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999777765 34489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.- -.+...++..+|||.|+|||.+.+..|....|.|++||+++||+.|+.||+.--+...+ ....+...+..
T Consensus 400 e~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvi------ 471 (593)
T KOG0695|consen 400 EG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVI------ 471 (593)
T ss_pred cC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHH------
Confidence 53 23445567789999999999999999999999999999999999999999843322211 11111222211
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 551 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 551 (609)
+.+.++ .+...+.....+++.-+++||++|-
T Consensus 472 --lekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 --LEKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --hhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 111111 1222233445677888999999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=274.69 Aligned_cols=246 Identities=27% Similarity=0.357 Sum_probs=186.5
Q ss_pred CCccCcccccCCc-eEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeecc
Q 007290 286 FSEKNVLGQGGFG-KVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 286 ~~~~~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
|...+++|.|+-| .||+|.+ +|+.||||++-. ....-..+|+..++.-+ |||||++++.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4455778999998 6899999 489999999853 22345678999998875 999999999888889999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---C--CcEEEcccccceee
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---D--FEAVVGDFGLAKLV 438 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfGl~~~~ 438 (609)
.- +|.++++..............+.+..|++.|+++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 99999976311111111134567889999999999998 9999999999999975 3 57899999999988
Q ss_pred ccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 439 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 439 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... .....||-+|+|||.+....-+.++||||+||++|+.+|| .+||...-. +...-+.....+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~---------R~~NIl~~~~~L 732 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE---------RQANILTGNYTL 732 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH---------hhhhhhcCccce
Confidence 7554432 3456799999999999998888999999999999999997 899963221 111111111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. +.. ..+. +..+||.+|++.+|..||++.+|+.
T Consensus 733 ~~-----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VH-----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee-----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 000 1111 6789999999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=261.37 Aligned_cols=207 Identities=22% Similarity=0.276 Sum_probs=173.7
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..-|..++.||-|+||.|.+++. ++...||+|.+++.. ...+......|-.+|+..+.+-||+||-.|.+.+..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34566788899999999999984 456679999997533 223455677899999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|+|++||++-.+|-.. ..+++...+.++..+..|+++.|.. |+|||||||+|||||.+|++||+|||+++-+.
T Consensus 708 MdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 9999999998888653 3488888999999999999999999 99999999999999999999999999986441
Q ss_pred ---cCC-----Cc----e-----------------------------eecccccccccCcccccCCCCCcchhhHHHHHH
Q 007290 440 ---VRK-----TN----V-----------------------------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM 478 (609)
Q Consensus 440 ---~~~-----~~----~-----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~l 478 (609)
+.. .. . ....+||+.|+|||++....|+..+|.||.||+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000 00 0 012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCcccc
Q 007290 479 LLELVTGQRAIDFSRLEE 496 (609)
Q Consensus 479 l~elltg~~p~~~~~~~~ 496 (609)
||||+.|+.||......+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999998766543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-31 Score=261.97 Aligned_cols=243 Identities=21% Similarity=0.225 Sum_probs=197.9
Q ss_pred cCCCccCcccccCCceEEEEEeCCCc-EEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGT-KVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.+++.+..||-|+||.|=++..+... .+|+|.+++. ....+.+....|-.++...+.|.||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555678999999999999975433 4899988753 34556677888999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|-|-||.+-..+++.. .++..+.+.++.-+.+|++|||++ +||.|||||+|.+++.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999888743 388888999999999999999999 999999999999999999999999999998764
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. ..+-+.+||+.|.|||.+.+.....++|.||+|+++|||+||.+||....+-... ......-..
T Consensus 573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY--------n~ILkGid~----- 637 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY--------NLILKGIDK----- 637 (732)
T ss_pred C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH--------HHHHhhhhh-----
Confidence 3 3455678999999999999999999999999999999999999999865432111 111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPA 552 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 552 (609)
-.++........+++++.+..+|.+|-.
T Consensus 638 ----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 ----IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1123333456678999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=230.52 Aligned_cols=261 Identities=18% Similarity=0.272 Sum_probs=195.4
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCC--cce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT--ERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~ 357 (609)
..++|++.+++|+|.|+.||.|.. .+..+++||+++. ...+.+.+|++++..+. ||||++++++..++. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 456799999999999999999994 5788999999973 44678999999999997 999999999987664 578
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccce
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAK 436 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~~ 436 (609)
+|+||+.+.+...+... ++...++.++.+++.||.|+|+. ||+|||+||.|++||.. ..++|+|+|+|.
T Consensus 112 LiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 99999999777665544 77788889999999999999999 99999999999999965 569999999999
Q ss_pred eeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH-----HHh
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK-----KLE 510 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~ 510 (609)
.+.+.... ...+.+..|.-||.+.. ..|...-|+|||||++..|+..+.||-......+.-+.+..... ...
T Consensus 182 FYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 88654322 22235667889998865 45788999999999999999999998543332221111111111 000
Q ss_pred ------hhccchhhccccccCC--------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 ------REKRLDAIVDRNLNKN--------YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ------~~~~~~~~~~~~l~~~--------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.....++....+.. -..-..++..+++.+.+..|..+|||++|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111112222111110 01112367889999999999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-28 Score=229.69 Aligned_cols=211 Identities=34% Similarity=0.507 Sum_probs=183.2
Q ss_pred ccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhhh
Q 007290 292 LGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 370 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 370 (609)
||+|.+|.||++...+ ++.+++|++...........+.+|++.++.+.|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998754332245789999999999999999999999999899999999999999999
Q ss_pred hhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeeccCCCceeecc
Q 007290 371 RLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVRKTNVTTQV 449 (609)
Q Consensus 371 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~~~~~~~~~~ 449 (609)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987642 3478899999999999999999999 9999999999999999 89999999999987654321 12234
Q ss_pred cccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCC
Q 007290 450 RGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYN 528 (609)
Q Consensus 450 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 528 (609)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 529 IQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 529 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357889999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=236.00 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=193.9
Q ss_pred cCcccccCCceEEEEEe-CCCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----CcceEEee
Q 007290 289 KNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TERLLVYP 361 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 361 (609)
-+.||-|+||.||.+.+ ++|+.||+|++.+. ..-...+.+.+|++++.-++|.|++..+++-.-+ ++.|.++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 57899999999999996 48999999998652 2333457788999999999999999988876543 34566777
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
.|.. +|...+ -....++-..++-+..||++||.|||+. +|.||||||.|.|++.+..+||||||+++..+..
T Consensus 138 LmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 6653 444333 3445588888888999999999999999 9999999999999999999999999999987766
Q ss_pred CCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc------
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR------ 514 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 514 (609)
....++..+.|..|.|||.+.+. .|+.+.||||.||++.|++..+-.|....+.... +.+..+.....
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-----~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-----QMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-----HHHHHHhCCCcHHHHHH
Confidence 66667777789999999999875 6899999999999999999988888654443221 11111111100
Q ss_pred -----chhhccccccC-CC--------CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 515 -----LDAIVDRNLNK-NY--------NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 515 -----~~~~~~~~l~~-~~--------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
-..++...... .+ ......+-.++...++..||+.|.+.++.+..+-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 01111111111 11 1223345677888999999999999998886554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=239.92 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=193.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-----C---CCcceeEeEEe--
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----H---RNLLRLIGFCT-- 351 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~-- 351 (609)
..+|.+.++||=|.|+|||++.+. +.+.||+|+.+.. ..-.+....||++|++++ | .+||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 378999999999999999999964 5778999998742 334567788999999874 3 35999999985
Q ss_pred --CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC------
Q 007290 352 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE------ 423 (609)
Q Consensus 352 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 423 (609)
...+.++|+|++ |.+|..++....- .-++...+++|+.||+.||.|||++| +|||-||||+|||+..
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence 346789999998 4477777765433 33899999999999999999999999 9999999999999810
Q ss_pred --------------------------------------------------------------------------------
Q 007290 424 -------------------------------------------------------------------------------- 423 (609)
Q Consensus 424 -------------------------------------------------------------------------------- 423 (609)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 007290 424 -------------------------------------------------------------------------------- 423 (609)
Q Consensus 424 -------------------------------------------------------------------------------- 423 (609)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred CCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc--cchh
Q 007290 424 DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--DDVL 501 (609)
Q Consensus 424 ~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~--~~~~ 501 (609)
+..+||+|||-|+-+... .+.-..|..|.|||++.+..|++.+||||++|++|||+||...|+...-... ++..
T Consensus 390 di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred ceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 001344444444432211 1222357789999999999999999999999999999999999975443321 1222
Q ss_pred HHHHHH---HHh----hhcc-chhhcccc--------c-----------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 502 LLDHVK---KLE----REKR-LDAIVDRN--------L-----------NKNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 502 ~~~~~~---~~~----~~~~-~~~~~~~~--------l-----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
+...+. ..+ ..++ -.+.+++. + .-.+..+...++.+++.-|++.+|++|||+.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 222221 111 1111 11111111 0 0123577788999999999999999999999
Q ss_pred HHHHH
Q 007290 555 EVVRM 559 (609)
Q Consensus 555 evl~~ 559 (609)
+.++.
T Consensus 546 ~cl~h 550 (590)
T KOG1290|consen 546 QCLKH 550 (590)
T ss_pred HHhcC
Confidence 99864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=228.79 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=186.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeE-EeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGF-CTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~l 358 (609)
..+.|.+.+.||+|.||.+-+++++ ..+.+++|-++... ...++|.+|...--.+ .|.||+.-|+. +.+.+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 3567889999999999999999987 57789999887543 3468899998874444 59999988764 567778889
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEcccccce
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAK 436 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGl~~ 436 (609)
++||++.|+|...+... .+.+....+++.|+++||.|+|++ ++||||||.+||||- +...+||||||+.+
T Consensus 100 ~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999888652 267778889999999999999999 999999999999993 34579999999997
Q ss_pred eeccCCCceeecccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
..+.. ......+..|.+||..... ...+.+|||.||+++|.++||+.||......... ...|....
T Consensus 172 k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~-- 242 (378)
T KOG1345|consen 172 KVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWL-- 242 (378)
T ss_pred ccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHh--
Confidence 54321 1222346679999976432 3478899999999999999999999844333222 22222221
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
++... .+... ....++.+.++.++-+..+|++|-...++.++-+
T Consensus 243 -~rk~~----~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 243 -KRKNP----ALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred -cccCc----cCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11111 11111 1123456778888999999999955555554443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=227.40 Aligned_cols=200 Identities=30% Similarity=0.422 Sum_probs=172.0
Q ss_pred CCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeeccc
Q 007290 286 FSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
|...+.||.|++|+||++...+ ++.+|+|.+.........+.+.+|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567889999999999999864 899999998753322256788899999999999999999999998899999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+++|.+++...... +++.....++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998763321 78889999999999999999999 9999999999999999999999999999877544311
Q ss_pred eeecccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 007290 445 VTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAIDF 491 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~ll~elltg~~p~~~ 491 (609)
......++..|++||.+ ....++.++|||+||+++++|++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578899999998 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=230.48 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=192.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEecc-CCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------C
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 354 (609)
..+|.-...+|.|.- .|..+.+. .+++||+|++.. .......+...+|...+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346666788888888 66666643 689999998753 22334456778999999999999999999998543 4
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
+.++|||+|.. +|...+.. .++-.+..+++.|++.|++|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 57899999965 78777762 167778899999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc----------cchhHHH
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE----------DDVLLLD 504 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~----------~~~~~~~ 504 (609)
++.-+.. ...+.++.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+..--.+ .+..+.+
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9864322 456678899999999999988899999999999999999999988763221110 0000110
Q ss_pred HH----HHHhh--hc----cchhh-ccccccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 505 HV----KKLER--EK----RLDAI-VDRNLNKN--YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 505 ~~----~~~~~--~~----~~~~~-~~~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ....+ ++ ...+. .|..+... .++-......+++.+|+..+|++|.+..+++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00000 00 00000 01111110 112233567899999999999999999999964
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=245.53 Aligned_cols=197 Identities=22% Similarity=0.328 Sum_probs=166.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-------CchHHHHHHHHHHHHhcc---CCCcceeEeEEeC
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------PGGDAAFQREVEMISVAV---HRNLLRLIGFCTT 352 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 352 (609)
.+|...+.+|+|+||.|+.|.++ +...|+||.+.+... ....-..-.|+.+|+.++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999986 466899998865221 111122346999999987 9999999999999
Q ss_pred CCcceEEeecc-cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 353 PTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 353 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
++.++++||-. ++-+|.++++... .+++.....|+.||+.|+++||+. +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999875 5668888887633 389999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCC
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAID 490 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~ 490 (609)
||.+..... ......+||..|.|||++.+.+| +..-|||++|+++|-++..+.||.
T Consensus 714 fgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876543 33445679999999999998887 667899999999999998888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-28 Score=252.03 Aligned_cols=254 Identities=21% Similarity=0.257 Sum_probs=199.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|+...++|.|.||.||+++++ .++..|+|+++-. ......-.++|+-+++..+||||+.++|.+-..+..++.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc-CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3467888999999999999999964 7899999998642 2334566788999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
|||.+|+|.+..+-.. .+++.++..++....+|+.|||+. +=+|||||-.||++++.+.+|+.|||.+..+..
T Consensus 92 EycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999988776533 388889999999999999999999 889999999999999999999999999876643
Q ss_pred CCCceeecccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 441 RKTNVTTQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.........||+.|||||+. ..+.|..++|||+.|+...|+---.+|.-.... ..+-.+-.. .
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~LmTk----S 230 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALFLMTK----S 230 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHHHhhc----c
Confidence 23344567899999999976 456789999999999999999776666321110 000000000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..++.-. .-.....+.+.++++.|+.++|++||+++.++.
T Consensus 231 ~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111100 012345578899999999999999999987764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=241.18 Aligned_cols=210 Identities=22% Similarity=0.225 Sum_probs=177.0
Q ss_pred cCHHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc------CCCccee
Q 007290 274 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV------HRNLLRL 346 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l 346 (609)
|.+.-.+....+|.+....|+|-|++|.+|.+. -|..||||++++.. ...+.=+.|+++|+++. --|++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 455667788899999999999999999999965 47899999998643 33455578999999986 3578999
Q ss_pred EeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-C
Q 007290 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-F 425 (609)
Q Consensus 347 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 425 (609)
+..|...++.++|||-+. .+|...|..+.. ...|.+..+..++.|+.-||..|... +|+|.||||.|||+++. .
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999875 488888887654 34488899999999999999999987 99999999999999876 5
Q ss_pred cEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 426 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
.+||||||.|....... .+.+..+..|.|||++.+-+|+..-|+||.||+||||.||+..|+...
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 68999999998765432 233445678999999999999999999999999999999999887543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=226.13 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=198.0
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCC
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP 353 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 353 (609)
+....+.|..+++||+|.|++||++.+. ..+.||+|.+.....+ .....|++++..+. +.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4445677889999999999999999853 4678999999765544 46889999999886 99999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDF 432 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 432 (609)
+...+|+||+++..-.++... ++...+..++..+..||+++|.+ |||||||||+|+|.+.. +.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999888888876 77889999999999999999999 99999999999999854 66789999
Q ss_pred ccceeeccCC-------------------------------------------CceeecccccccccCcccccC-CCCCc
Q 007290 433 GLAKLVDVRK-------------------------------------------TNVTTQVRGTMGHIAPEYLST-GKSSE 468 (609)
Q Consensus 433 Gl~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ 468 (609)
|++...+... ........||++|.|||++.. ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9987221000 000012459999999999865 45789
Q ss_pred chhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH------HHhhhcc--chh--------------------hcc
Q 007290 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK------KLEREKR--LDA--------------------IVD 520 (609)
Q Consensus 469 ~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~--~~~--------------------~~~ 520 (609)
+.||||-|++++-+++++.||-....+......+..... .....++ +.+ .+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999998644333221111111100 0001111 000 000
Q ss_pred c-----cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 521 R-----NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 521 ~-----~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+ ..........+..+.+++.+|+..||.+|.|+++.++
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 0001112233457899999999999999999999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=213.02 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=192.7
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEecc-CCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCch
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.-+|.+...|..|+|+|. |..+++|++.- ..+....++|..|.-.++-+.||||++++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 446889999999999996 66677787753 2344456789999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc--ccccceeeccCCCce
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG--DFGLAKLVDVRKTNV 445 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfGl~~~~~~~~~~~ 445 (609)
|...+++ ....+.+-.+..+++.++|+|++|||+.. |-|.---+.+..|++|++.+++|. |--++. .
T Consensus 274 lynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--------q 342 (448)
T KOG0195|consen 274 LYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q 342 (448)
T ss_pred HHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence 9999987 34566788899999999999999999973 233344688999999999988874 211111 1
Q ss_pred eecccccccccCcccccCCCC---CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 446 TTQVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.....-.+.||+||.++..+. -.++|+|||++++||+.|.+.||.....-+. -.++--..
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------------gmkialeg 405 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------------GMKIALEG 405 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------------hhhhhhcc
Confidence 111224678999999987654 4689999999999999999999974332211 11122233
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
++...++..+.++.+++.-|++.||.+||.+..|+-.|+..
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 44556777788999999999999999999999999998874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-26 Score=259.41 Aligned_cols=194 Identities=15% Similarity=0.169 Sum_probs=136.8
Q ss_pred ccC-CCcceeEeEE-------eCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007290 338 AVH-RNLLRLIGFC-------TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409 (609)
Q Consensus 338 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 409 (609)
++| +||+++++++ ......+.++||+ +++|.+++... ...++...++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 5777777776 2223466778877 55999999742 23489999999999999999999999 99
Q ss_pred EecCCCCCcEEeCC-------------------CCcEEEcccccceeeccCCC---------------ceeecccccccc
Q 007290 410 IHRDVKAANVLLDE-------------------DFEAVVGDFGLAKLVDVRKT---------------NVTTQVRGTMGH 455 (609)
Q Consensus 410 vH~Dlkp~NIll~~-------------------~~~~kl~DfGl~~~~~~~~~---------------~~~~~~~gt~~y 455 (609)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566777777654221000 001124578899
Q ss_pred cCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHH
Q 007290 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETM 535 (609)
Q Consensus 456 ~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 535 (609)
||||++.+..++.++|||||||++|||++|.+|+.... ........ ....+. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~-----~~~~~~-----~~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRH-----RVLPPQ-----ILLNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHH-----hhcChh-----hhhcCHHH
Confidence 99999999999999999999999999999888764211 00000000 000000 01112345
Q ss_pred HHHHHhccCCCCCCCCCHHHHHH
Q 007290 536 IQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 536 ~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+++.+||+.+|.+||++.|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=203.32 Aligned_cols=166 Identities=20% Similarity=0.191 Sum_probs=124.4
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|.++++.. +..+++..++.++.|++.||+|||++ + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6788888753 23489999999999999999999998 5 999999999999999 99998664321
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......... ......+ .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~----~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGM----PADDPRD----R 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHh----ccCCccc----c
Confidence 258899999999999999999999999999999999999986432111 1111111110 0000000 0
Q ss_pred CCCHHHHH--HHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 526 NYNIQEVE--TMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 526 ~~~~~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
........ .+.+++.+||+.+|++||++.|+++.+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01122222 68999999999999999999999998765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-23 Score=213.35 Aligned_cols=258 Identities=20% Similarity=0.233 Sum_probs=193.2
Q ss_pred CCCccCcccccCCceEEEEEeCCC--cEEEEEEeccCCCCchHHHHHHHHHHHHhccC----CCcceeEeEE-eCCCcce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLADG--TKVAVKRLTDFESPGGDAAFQREVEMISVAVH----RNLLRLIGFC-TTPTERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 357 (609)
+|.+.+.||+|+||.||.+...+. ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 799999999999999999997653 47898887654333333 67888998888763 6888998888 4677788
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-----CcEEEccc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-----FEAVVGDF 432 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df 432 (609)
+||+.+ |.+|.++..... ...++..+..+|+.|++.+|.++|+. |++||||||.|+.+... ..++|.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 998876 668988776544 45599999999999999999999999 99999999999999865 46999999
Q ss_pred ccce--eeccCCCc------e-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 433 GLAK--LVDVRKTN------V-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 433 Gl~~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
|+++ .+...... . .....||..|.++.+..+...+++.|+||++.++.|++.|..||........ .
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~ 246 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----K 246 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----H
Confidence 9998 33211111 1 1234599999999999999999999999999999999999999964432211 0
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..+........... .....+..+.++...+-..+..++|....+...|++.
T Consensus 247 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 11111111111110 1122234566666666678999999999999887764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=212.14 Aligned_cols=166 Identities=27% Similarity=0.303 Sum_probs=130.0
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC--CCcEEEEEEeccCC----CCchHHHHHHHHHHHHhccCCCcce-eEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAVHRNLLR-LIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 352 (609)
....++|.+.+.||+|+||+||+|.++ +++.||||++.... .......|.+|++++++++|+|+++ ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999865 57788999875321 1223567899999999999999985 4432
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEeCCCCcEEEcc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV-KAANVLLDEDFEAVVGD 431 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~D 431 (609)
...++||||++|++|... . .. . ...++.|+++||.|||++ +|+|||| ||+||+++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~---~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R---PH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C---cc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999632 1 11 1 146788999999999999 9999999 99999999999999999
Q ss_pred cccceeeccCCCcee-------ecccccccccCcccccC
Q 007290 432 FGLAKLVDVRKTNVT-------TQVRGTMGHIAPEYLST 463 (609)
Q Consensus 432 fGl~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 463 (609)
||+++.+........ ....+++.|+|||.+..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999997754321111 24567889999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=191.57 Aligned_cols=259 Identities=18% Similarity=0.226 Sum_probs=201.5
Q ss_pred HHhcCCCccCcccccCCceEEEEE-eCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC-CCcceeEeEEeCCCcceE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 358 (609)
+....|.+++.||.|+||.+|.|. ..+|..||||+-... ....++..|.++.+.++| ..|..+..|..+...-.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 345689999999999999999999 467999999987542 234577889999999875 677788888888888999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLA 435 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~ 435 (609)
||+.+ |.+|.+++..... .++..+.+-++.|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||++
T Consensus 89 VMdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 99987 6799999876543 388899999999999999999999 99999999999999643 56899999999
Q ss_pred eeeccCCCce------eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007290 436 KLVDVRKTNV------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 436 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
+.+.+..+.. .....||.+|.+-....+...+.+.|+-|+|.++..+--|..||..-......
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~----------- 230 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK----------- 230 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----------
Confidence 9875433322 23456999999998888888899999999999999999999999854432211
Q ss_pred hhhccchhhcccccc---CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 510 EREKRLDAIVDRNLN---KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.....+....+. ...+...+.++.-.+..|-..--++-|...-+.+.++..
T Consensus 231 ---QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 231 ---QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred ---HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111111111111 112344567788888899999999999987777766644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=192.68 Aligned_cols=258 Identities=17% Similarity=0.202 Sum_probs=199.7
Q ss_pred HhcCCCccCcccccCCceEEEEE-eCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 359 (609)
..-.|.++++||+|.||.++.|+ .-++.+||||.-.. .....++..|.+.++.+. .++|..++-|.....+..+|
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 34579999999999999999999 45799999997643 223467888999998876 78999998888888889999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEccccc
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGL 434 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl 434 (609)
+|.+ |.+|.+++.-+. ..++..++..+|.|++.-++|+|++ .+|.|||||+|+||.. ...+.++|||+
T Consensus 103 idLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9987 679999887543 3489999999999999999999999 9999999999999963 34689999999
Q ss_pred ceeeccCCCce------eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 435 AKLVDVRKTNV------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 435 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+.+.++.+.. .....||.+||+-....+.+.+.+.|+-|+|.++.+.+-|..||..-..+...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---------- 245 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---------- 245 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH----------
Confidence 99886554432 34467999999999999999999999999999999999999999865544221
Q ss_pred HhhhccchhhccccccC---CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLNK---NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
++..++-+..-.. ......+.++...+...-..+-++-|..+-+...+.+.
T Consensus 246 ----~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 246 ----EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred ----HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111111111110 11233445666666666678888889877766655543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=238.09 Aligned_cols=172 Identities=37% Similarity=0.595 Sum_probs=126.8
Q ss_pred CchhHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCcceeEEcCCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCc
Q 007290 23 SDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGI 102 (609)
Q Consensus 23 ~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 102 (609)
+..|..||++||+++.+|.+.+.+|+. ..+||.|.||+|++.++|+.|+|++|+++|.++..|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 557888999999999888888899975 4589999999999888999999999999999999999999999999999999
Q ss_pred CCCCCcccc-cccccccccccccccccc----------------------CCccccCcccchhhhcccCcCCCCcCCCcC
Q 007290 103 TGEIPEELG-NLSSLTSLDLDNNRLVGK----------------------IPPSLGNLKKLQFLTLSQNNFSGTIPDSLT 159 (609)
Q Consensus 103 ~~~~p~~~~-~l~~L~~L~L~~N~l~~~----------------------~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 159 (609)
+|.+|..+. ++++|++|+|++|+++|. +|..|+++++|++|+|++|.+.+.+|..+.
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 988887654 667777777666666554 444555555555556655555555555555
Q ss_pred cccccccccCCCCcccccCCcccc---cCCcccCCCCCC
Q 007290 160 TLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNL 195 (609)
Q Consensus 160 ~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~ 195 (609)
++++|++|+|++|.+++.+|..+. +|..|++++|..
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 566666666666666555554433 333444555543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-20 Score=193.72 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=198.0
Q ss_pred CCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCc--hHHHHHHHHHHHHhccCC-CcceeEeEEeCCCcceEEeec
Q 007290 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG--GDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 362 (609)
|.+.+.||.|+||.||++... ..+++|.+....... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999986 889999987654443 477899999999999988 799999999777778999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 441 (609)
+.++++.+.+...... ..+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666543211 3478889999999999999999999 999999999999999988 7999999999866543
Q ss_pred CCc-----eeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 442 KTN-----VTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 442 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence 322 2355679999999999987 57899999999999999999999997644321 0000111111111100
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223567899999999999999998887754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=222.24 Aligned_cols=164 Identities=34% Similarity=0.575 Sum_probs=116.0
Q ss_pred ccCchhHHHHHHHHHhCCCCCCCcCCCCCCCCCC--CCcceeEEcCCC-----CeEEEEecCCCcccccCccccCCCCCC
Q 007290 21 ALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNP--CTWSNVICDNSN-----NVASVTLSSMNFSGTLSPRIGVLRTLS 93 (609)
Q Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~--c~w~gv~c~~~~-----~l~~L~L~~n~l~~~~~~~~~~l~~L~ 93 (609)
...+.|..||+++|+++.++.. .+|+++.+.| |.|.||+|.... .++.|+|++|++.|.+|..++.|++|+
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~ 445 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCC
Confidence 4566788999999999986642 4797632211 179999996321 377777777777777777777777777
Q ss_pred EEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCc
Q 007290 94 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 173 (609)
Q Consensus 94 ~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 173 (609)
.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+..+
T Consensus 446 ~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~------------ 513 (623)
T PLN03150 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR------------ 513 (623)
T ss_pred EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc------------
Confidence 77777777777777777777777777777777777777777777777777777777777766655432
Q ss_pred ccccCCcccccCCcccCCCCCCCCCCCCCCCCC
Q 007290 174 LSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCE 206 (609)
Q Consensus 174 l~~~ip~~l~~l~~l~~~~n~~~c~~~~~~~c~ 206 (609)
+.++..+++.+|++.|+.+....|.
T Consensus 514 --------~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 514 --------LLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred --------cccCceEEecCCccccCCCCCCCCc
Confidence 1123356788888899877666775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-22 Score=214.97 Aligned_cols=254 Identities=19% Similarity=0.216 Sum_probs=184.2
Q ss_pred CccCcccccCCceEEEEEeC-CCcEEEEEEec----cCCCCc-hHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 287 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLT----DFESPG-GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
...+++|.|++|.|+..... .....+.|..+ ...... ....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999988877743 34444444332 111111 1122455666677889999988877776666555569
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++ +|...+... ..+....+..++.|+..|++|+|+. |+.|||+|++|++++.++.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999988763 2377778888999999999999999 999999999999999999999999999987754
Q ss_pred CCC---ceeecccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 441 RKT---NVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 441 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
... ......+|+..|+|||.+.+..|. ...||||.|+++..|.+|+.||.......... ..........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccc
Confidence 322 345567899999999999998886 46899999999999999999998654432210 0000000000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+... ........+.+...++.++++.+|.+|.|+++|++
T Consensus 546 -~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 -IFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 00112344567789999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=176.04 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=108.1
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCC-ch-------H-----------------HHHHHHHHHHHhccCCCc
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GG-------D-----------------AAFQREVEMISVAVHRNL 343 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~-------~-----------------~~~~~E~~~l~~l~h~ni 343 (609)
...||+|+||.||+|...+|+.||||+++..... .. . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999753211 11 1 122359999999988876
Q ss_pred ceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCcEEeC
Q 007290 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRDVKAANVLLD 422 (609)
Q Consensus 344 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 422 (609)
.....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333322 234899999998776544322 12478888999999999999999 688 999999999999998
Q ss_pred CCCcEEEcccccceeec
Q 007290 423 EDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 423 ~~~~~kl~DfGl~~~~~ 439 (609)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-21 Score=208.05 Aligned_cols=261 Identities=22% Similarity=0.263 Sum_probs=190.5
Q ss_pred CCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHH--HHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM--ISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++...+.||.+.|=+|.+|+++.|. |+||++-+.......+.|.++++- ...++|||.+++.-.-.+..-.++|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998777 999998765545455555544433 5567899999987766677778888898
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee--ecc
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDV 440 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~--~~~ 440 (609)
+.+ +|.+++.. +..+...+.+-|+.|+..|+..+|.. ||+|||||.+||||+.-+=+.|+||..-+. +..
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 876 78888764 44578888888999999999999999 999999999999999988899999975432 222
Q ss_pred CCCceee----cccccccccCcccccCC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHH
Q 007290 441 RKTNVTT----QVRGTMGHIAPEYLSTG----------K-SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 441 ~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 504 (609)
+...... +...-.+|+|||.+... . .+++.||||+||++.||++ |+++|..++.-+....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~---- 250 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG---- 250 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc----
Confidence 2211111 22234589999977431 1 5788999999999999998 5777753221110000
Q ss_pred HHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccccchhh
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEW 572 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 572 (609)
.....+..+.++-| ..+.+++..|++.||..|-++++.++.-++..|++-|..+
T Consensus 251 --~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~F 304 (1431)
T KOG1240|consen 251 --NADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSF 304 (1431)
T ss_pred --CccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHH
Confidence 00011111222222 2578899999999999999999999999998887776653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=179.99 Aligned_cols=173 Identities=13% Similarity=0.099 Sum_probs=133.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCch--HHH------HHHHHHHHHhccCCCcceeEeEEeC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG--DAA------FQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~------~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
...++|...+++|+|+||.||++.. ++..+|||.++....... ... +.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4678999999999999999999766 577899999975332211 112 6789999999999999999887543
Q ss_pred C--------CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007290 353 P--------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424 (609)
Q Consensus 353 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 424 (609)
. ...+++|||++|.+|.+... ++. ....+++.++..+|+. |++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 2 35789999999999977632 221 2456999999999999 99999999999999998
Q ss_pred CcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 007290 425 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483 (609)
Q Consensus 425 ~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ell 483 (609)
+ ++|+|||........... ..+.....+..++|+||||+++....
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654321111 01333445668999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=175.49 Aligned_cols=234 Identities=22% Similarity=0.263 Sum_probs=150.6
Q ss_pred CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhcc----------CCCcceeEeEEe-
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAV----------HRNLLRLIGFCT- 351 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~- 351 (609)
+...+.||.|+++.||.+.+. +|+++|||+..-.. .....+++.+|.-....+. |-.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999986 58999999876332 3334566776665444422 212222222211
Q ss_pred --------CC---C-----cceEEeecccCchhhhhhhh---cCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007290 352 --------TP---T-----ERLLVYPFMQNLSVAYRLRE---IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR 412 (609)
Q Consensus 352 --------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 412 (609)
.. . ..+++|+-+ .++|.+.+.. .......+....+..+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1 124556666 4577777543 222233466667788889999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccC--------CCCCcchhhHHHHHHHHHHHh
Q 007290 413 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--------GKSSERTDVFGYGIMLLELVT 484 (609)
Q Consensus 413 Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~ll~ellt 484 (609)
||+|+|++++.+|.++|+||+.....+.. ......+..|.+||.... -.++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999987754421 111335678999997643 247899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007290 485 GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 550 (609)
Q Consensus 485 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 550 (609)
|..||+.......... ...... +.++.+.+|+..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986544322211 112233 777899999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-19 Score=168.92 Aligned_cols=140 Identities=17% Similarity=0.170 Sum_probs=110.0
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCC-ch------------------------HHHHHHHHHHHHhccCCCc
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GG------------------------DAAFQREVEMISVAVHRNL 343 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni 343 (609)
.+.||+|+||.||+|...+|+.||||+++..... .. ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753211 00 1123578899999999987
Q ss_pred ceeEeEEeCCCcceEEeecccCchhhhh-hhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEe
Q 007290 344 LRLIGFCTTPTERLLVYPFMQNLSVAYR-LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLL 421 (609)
Q Consensus 344 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 421 (609)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ . ||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 554443332 35899999998855433 322 236777889999999999999999 8 99999999999999
Q ss_pred CCCCcEEEcccccceeec
Q 007290 422 DEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 422 ~~~~~~kl~DfGl~~~~~ 439 (609)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-19 Score=165.01 Aligned_cols=185 Identities=21% Similarity=0.112 Sum_probs=137.8
Q ss_pred CccCcccccCCceEEEEEeCCCcEEEEEEeccCCC---CchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeec
Q 007290 287 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---PGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.+...|++|+||+||.+.. ++.+++.+.+..... ......+.+|+++++++. |+++.+++++ ...+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997776 678888777754222 111225789999999996 5889999886 456899999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEeCCCCcEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV-KAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
+.|.+|...... ....++.|++++|.++|++ ||+|||| ||+||+++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999888654321 1134678999999999999 9999999 799999999999999999999865432
Q ss_pred CCc----e--------eecccccccccCcccccCC-CCC-cchhhHHHHHHHHHHHhCCCCCC
Q 007290 442 KTN----V--------TTQVRGTMGHIAPEYLSTG-KSS-ERTDVFGYGIMLLELVTGQRAID 490 (609)
Q Consensus 442 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~ll~elltg~~p~~ 490 (609)
... . ......++.|++|+...-- ..+ ...+.++-|+-+|.++|+..+.-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 210 0 0112357778888754321 233 56788899999999999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=188.59 Aligned_cols=214 Identities=22% Similarity=0.370 Sum_probs=162.0
Q ss_pred HhccCCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCC
Q 007290 336 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI-IHRDV 414 (609)
Q Consensus 336 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vH~Dl 414 (609)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.....+..+++.||+|+|.. +| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 467899999999999999999999999999999999986 334489999999999999999999987 44 89999
Q ss_pred CCCcEEeCCCCcEEEcccccceeeccC-CCceeecccccccccCcccccCC-------CCCcchhhHHHHHHHHHHHhCC
Q 007290 415 KAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTG-------KSSERTDVFGYGIMLLELVTGQ 486 (609)
Q Consensus 415 kp~NIll~~~~~~kl~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~ll~elltg~ 486 (609)
+++|+++|....+|++|||+....... .........-..-|.|||.+... ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876420 11111122245679999998653 1467899999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 487 RAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 487 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.||+.......... +...+.. .....+.+.+... .+..+.+..++.+||..+|++||++++|-..++..
T Consensus 156 ~~~~~~~~~~~~~e-ii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDE-IILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHH-HHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99986444333211 1111111 0111112211111 13344799999999999999999999999888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=188.56 Aligned_cols=226 Identities=24% Similarity=0.259 Sum_probs=179.2
Q ss_pred cccccCCceEEEEEe----CCCcEEEEEEeccCCCCch-HHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeeccc
Q 007290 291 VLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGG-DAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
.+|+|.||.|++++- +.|.-+|+|.+++...... ......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998762 3577899998875432221 124456778888887 9999999999999999999999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
+|.+...+... ..+++.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 99998877653 2367777778888999999999999 9999999999999999999999999999865433222
Q ss_pred eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccccc
Q 007290 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN 524 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 524 (609)
+||..|||||++. .....+|.||||++++||+||..||.. +....+ +...
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~I---------l~~~-- 203 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRI---------LKAE-- 203 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHH---------hhhc--
Confidence 7999999999997 567889999999999999999999863 111111 1111
Q ss_pred CCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 525 KNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 525 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
...+........+++..++..+|..|--.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12355666778889999999999999654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=188.97 Aligned_cols=200 Identities=19% Similarity=0.195 Sum_probs=160.5
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc---CCCcceeEeEEeCC
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTP 353 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 353 (609)
.+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+....- +|.--.+++.+++ -+.|..+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4567778889999999999999999999888999999987643321 1222223333443 23455555555556
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-------CCCc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-------EDFE 426 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~ 426 (609)
+.-++|+||.+.|||.+++. +...+++.....++.|+++.++.||.. +||||||||+|++|. +...
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 77889999999999999997 345589999999999999999999999 999999999999994 2346
Q ss_pred EEEcccccceeeccC-CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCC
Q 007290 427 AVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~ 487 (609)
++|+|||.+-.+.-- +.......++|-.+-.+|...+..++.+.|.|.++.+++-|+.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 899999998766432 2335566778999999999999999999999999999999999974
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=156.47 Aligned_cols=137 Identities=20% Similarity=0.234 Sum_probs=104.4
Q ss_pred CccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-----cCCCcceeEeEEeCCC---c-ce
Q 007290 287 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-----VHRNLLRLIGFCTTPT---E-RL 357 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 357 (609)
...+.||+|+||.||. +.+....+||++.... ....+.+.+|+++++.+ .||||++++|++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 4433334799886432 23457789999999999 5799999999998764 2 23
Q ss_pred EEeec--ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEeCC----CCcEEEc
Q 007290 358 LVYPF--MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL-EYLHEHCNPKIIHRDVKAANVLLDE----DFEAVVG 430 (609)
Q Consensus 358 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~ 430 (609)
+|+|| +.+|+|.+++.+. .++.. ..++.+++.++ +|||++ +|+||||||+||+++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 68999 5589999999652 14444 35577878777 999999 9999999999999974 3479999
Q ss_pred ccccce
Q 007290 431 DFGLAK 436 (609)
Q Consensus 431 DfGl~~ 436 (609)
||+.+.
T Consensus 152 Dg~G~~ 157 (210)
T PRK10345 152 DNIGES 157 (210)
T ss_pred ECCCCc
Confidence 955443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-18 Score=165.15 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=163.8
Q ss_pred hcCCCccCcccccCCceEEEEEeCC-Cc-----------------------------------EEEEEEeccCCCCchHH
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD-GT-----------------------------------KVAVKRLTDFESPGGDA 326 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~-----------------------------------~vavK~~~~~~~~~~~~ 326 (609)
.++|++++.||+|+-..||.+...+ |. +.|+|++.+........
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 3568889999999999999987531 10 46778776544333222
Q ss_pred HHHH----H------------HHH--HHh--------ccCCCcceeEeEEeCC---------------------------
Q 007290 327 AFQR----E------------VEM--ISV--------AVHRNLLRLIGFCTTP--------------------------- 353 (609)
Q Consensus 327 ~~~~----E------------~~~--l~~--------l~h~niv~l~~~~~~~--------------------------- 353 (609)
.+.+ | ..+ .+. .+|||||++.++|.+.
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 2221 1 111 111 3599999998766321
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--CCCC--cEEE
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDF--EAVV 429 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl 429 (609)
...++||.-.+. +|..++.... .+.....-++.|+++|..|||.+ ||.|||+|++|||+ |+|. .+.|
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEE
Confidence 223566655543 6666665422 45566677899999999999999 99999999999998 3443 4789
Q ss_pred cccccceeecc-----CCCceeecccccccccCcccccCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCcccccc
Q 007290 430 GDFGLAKLVDV-----RKTNVTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 498 (609)
Q Consensus 430 ~DfGl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~ 498 (609)
+|||.+-.-+. +.........|...-||||+....+ --.|+|.|+.|.+.||+++...||...-
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG----- 461 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG----- 461 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-----
Confidence 99997643221 1111122345778899999986432 1358999999999999999999996310
Q ss_pred chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
+. ..+.. ..++-.- +..+...+..+.+++...++.||.+|++..-....|+
T Consensus 462 em-~L~~r-------~Yqe~qL----Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 462 EM-LLDTR-------TYQESQL----PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hh-eechh-------hhhhhhC----CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 00 00000 0111111 1223444567889999999999999998665554443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=158.90 Aligned_cols=143 Identities=15% Similarity=0.110 Sum_probs=110.4
Q ss_pred CCCccCcccccCCceEEEEE--eCCCcEEEEEEeccCCCCc-----------------------hHHHHHHHHHHHHhcc
Q 007290 285 NFSEKNVLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPG-----------------------GDAAFQREVEMISVAV 339 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 339 (609)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 4589999999987432100 0123568999999997
Q ss_pred CCC--cceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 007290 340 HRN--LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-IIHRDVKA 416 (609)
Q Consensus 340 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlkp 416 (609)
+.. +.+++++ ...++||||++++++...... ...+.......++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3444443 235899999999887665422 12245556778999999999999999 8 99999999
Q ss_pred CcEEeCCCCcEEEcccccceeec
Q 007290 417 ANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 417 ~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-17 Score=154.89 Aligned_cols=135 Identities=19% Similarity=0.267 Sum_probs=113.3
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCc-------hHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.||+|++|.||+|.+ +|..|++|+........ ....+.+|++++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999998 67889999865322111 123577899999999999988777777777788999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
++|++|.+.+... .. .+..++.+++.+|.++|+. +++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988642 12 7788999999999999999 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-17 Score=153.32 Aligned_cols=145 Identities=20% Similarity=0.147 Sum_probs=111.9
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCC---------------------chHHHHHHHHHHHH
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP---------------------GGDAAFQREVEMIS 336 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~ 336 (609)
++......|.+.+.||+|+||.||++..++|+.||||+++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444458888999999999999999888999999987532200 01123567888888
Q ss_pred hccCCC--cceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007290 337 VAVHRN--LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 414 (609)
Q Consensus 337 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 414 (609)
.+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+. +++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888874 444443 2345899999999988764321 23457889999999999998 9999999
Q ss_pred CCCcEEeCCCCcEEEcccccceeec
Q 007290 415 KAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 415 kp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.8e-18 Score=183.14 Aligned_cols=211 Identities=24% Similarity=0.280 Sum_probs=146.8
Q ss_pred hcCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..+|+.++.|..|+||.||..+++. .+++|+| +.+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee-----------------
Confidence 4578889999999999999999874 6678884 332110 0100 22223333333
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+-...+..... ++. +.+.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 343444433221 222 227889999999 9999999999999999999999999998654211
Q ss_pred C--------------CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 442 K--------------TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 442 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
. .....+++||+.|.|||++....|...+|+|++|+++||.+.|+.||.....++-.+..+.+.+.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 1 11123568999999999999999999999999999999999999999877665544333332222
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
..+ + ......+..+++.+.++.+|.+|--..
T Consensus 277 wpE------~----------dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 277 WPE------E----------DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccc------c----------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111 1 122235788999999999999995433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=151.55 Aligned_cols=131 Identities=19% Similarity=0.280 Sum_probs=106.9
Q ss_pred cccccCCceEEEEEeCCCcEEEEEEeccCCCCc-------hHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 291 VLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
.||+|+||.||+|.+ +|..|++|+........ ....+.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 57899999865322111 1255678999999999887665555566667789999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+|++|.+.+.... . .++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988775411 0 7889999999999999 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-17 Score=171.26 Aligned_cols=174 Identities=24% Similarity=0.346 Sum_probs=129.6
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++.|++|...+|.+++..... ....++...+.++.|++.|+.| + +.+|+|+||.||+...+.++||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46788999999999999975433 3347888899999999999999 6 899999999999999999999999999
Q ss_pred ceeeccCC-----CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHH
Q 007290 435 AKLVDVRK-----TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 435 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
........ ....+...||..||+||.+.+..|+.|+||||||++++|+++- ..+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------ 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------ 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence 98775433 3345567799999999999999999999999999999999972 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 556 (609)
+...+.++-+..+.+.+..+. +.=..++.+++...|.+||++.+.
T Consensus 465 --r~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 465 --RIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --HHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 111112222222221111111 122468889999999999954443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=174.29 Aligned_cols=145 Identities=17% Similarity=0.242 Sum_probs=115.0
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEe-ccCCCC------chHHHHHHHHHHHHhccCCCcceeEe
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESP------GGDAAFQREVEMISVAVHRNLLRLIG 348 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~ 348 (609)
|.........|...+.||+|+||+||+|.+.+. .+++|+. .+.... .....+.+|++++..++|++++....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333334445567789999999999999998543 4444433 221111 12356789999999999999998888
Q ss_pred EEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
++......++||||+++++|.+++. ....++.+++++|.+||+. +++|||+||+||++ +++.++
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEE
Confidence 8777778899999999999988875 3467899999999999999 99999999999999 677899
Q ss_pred Eccccccee
Q 007290 429 VGDFGLAKL 437 (609)
Q Consensus 429 l~DfGl~~~ 437 (609)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=139.25 Aligned_cols=137 Identities=20% Similarity=0.272 Sum_probs=98.1
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCC-chHHHH----------------------HHHHHHHHhccCCC--c
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-GGDAAF----------------------QREVEMISVAVHRN--L 343 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~----------------------~~E~~~l~~l~h~n--i 343 (609)
.+.||+|+||+||+|...+|+.||||+++..... .....+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999988643211 111111 34555555554433 3
Q ss_pred ceeEeEEeCCCcceEEeecccCchhhh-hhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEe
Q 007290 344 LRLIGFCTTPTERLLVYPFMQNLSVAY-RLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLL 421 (609)
Q Consensus 344 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll 421 (609)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +++|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444433 24689999999955432 121111 11 4567889999999999999 7 99999999999999
Q ss_pred CCCCcEEEcccccceeec
Q 007290 422 DEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 422 ~~~~~~kl~DfGl~~~~~ 439 (609)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9e-17 Score=140.47 Aligned_cols=127 Identities=25% Similarity=0.467 Sum_probs=112.2
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|.||+|.++ .+|+.+..|.+|+.|++++|+|+ .+|..++.|+.|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 347899999999999 88889999999999999999999 89999999999999999999999 8999999999999999
Q ss_pred cccCcCCC-CcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCC
Q 007290 145 LSQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195 (609)
Q Consensus 145 l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~ 195 (609)
|.+|+++. .+|..|.-++.|+.|+|+.|.+. .+|...++|++|.+.++..
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrd 159 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRD 159 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeecc
Confidence 99999873 57888888999999999999998 7888888877776655543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-14 Score=131.43 Aligned_cols=135 Identities=17% Similarity=0.145 Sum_probs=113.2
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC--CCcceeEeEEeCCCcceEEeecccC
Q 007290 288 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.+.||+|.++.||++... +..+++|....... ...+..|+.++..+.| .++.+++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3577999999999999985 47899998864322 5678899999999986 5889999988888889999999998
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+.+... +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766443 4456677899999999999986444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.8e-14 Score=136.29 Aligned_cols=136 Identities=18% Similarity=0.159 Sum_probs=104.4
Q ss_pred cCccc-ccCCceEEEEEeCCCcEEEEEEeccCC------------CCchHHHHHHHHHHHHhccCCCc--ceeEeEEeCC
Q 007290 289 KNVLG-QGGFGKVYRGVLADGTKVAVKRLTDFE------------SPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTP 353 (609)
Q Consensus 289 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 353 (609)
...|| .|+.|+||.+... +..++||++.... +......+.+|++++..+.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999884 7889999875311 11223567889999999998885 6667664332
Q ss_pred C----cceEEeecccC-chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 354 T----ERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 354 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
. ..++|+|++++ .+|.+++... .++.. .+.+++.++.+||+. ||+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6888887542 13332 357899999999999 999999999999999989999
Q ss_pred Eccccccee
Q 007290 429 VGDFGLAKL 437 (609)
Q Consensus 429 l~DfGl~~~ 437 (609)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-15 Score=164.50 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=186.9
Q ss_pred hcCCCccCcccccCCceEEEEEeCC--CcEEEEEEeccCC-CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD--GTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 358 (609)
...|...+.||+|+|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++.+++....++..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456777889999999998887533 4456666554322 2233344455777777776 9999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEeCCCC-cEEEcccccce
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAK 436 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~ 436 (609)
..+|..++++..-+.. ......+......++.|+..++.|+| +. ++.|+|+||+|.+++..+ ..++.|||++.
T Consensus 99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999998887731 11113555666778999999999999 77 999999999999999999 99999999998
Q ss_pred eecc-C-CCceeecccc-cccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 437 LVDV-R-KTNVTTQVRG-TMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 437 ~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
.+.. . .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+......... ..|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---~~~~~~~--- 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---SSWKSNK--- 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---eeecccc---
Confidence 7765 2 2223334567 9999999999874 45788999999999999999999998654433211 1111100
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..............++..+++..+|..|.+.+++..
T Consensus 248 ~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cc--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 001111222345677888899899999999887753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.7e-15 Score=130.43 Aligned_cols=127 Identities=26% Similarity=0.448 Sum_probs=114.3
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccc-ccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-GKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|++.+|+|. .+|.+++.|++|+.|+++-|++. .+|..|+.++.|+.|||.+|+++ ..+|..|.-++.|+.|+
T Consensus 56 ~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 47889999999999 88999999999999999999999 99999999999999999999986 46899999999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~ 196 (609)
|+.|.|. .+|..++++++|+.|.+..|.+- .+|.+++ +|..|.+.||...
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 9999999 89999999999999999999998 7997665 4555778888764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.6e-14 Score=135.27 Aligned_cols=205 Identities=18% Similarity=0.262 Sum_probs=144.4
Q ss_pred HHHHhccCCCcceeEeEEeCC-----CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCC
Q 007290 333 EMISVAVHRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407 (609)
Q Consensus 333 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 407 (609)
.-+-++.|.|||+++.|+.+. .+..++.|||..|++..+|++.+.....+......+++.||..||.|||+ |.|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345567799999999888543 34688999999999999999877777778888889999999999999998 578
Q ss_pred CeEecCCCCCcEEeCCCCcEEEcccccceeeccC----CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHH
Q 007290 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR----KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELV 483 (609)
Q Consensus 408 ~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ell 483 (609)
+|+|+++.-+-|++..++-+|++- +........ .........+-++|.+||.-.....+..+|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999888743 221111110 001111233578999999877777888999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 484 TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 484 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
.+..--..+........... +........+. .+++..|++..|..||+|++++.+.
T Consensus 277 ilEiq~tnseS~~~~ee~ia----------~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA----------NVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhhh----------hheeeccCccc-----------cCcCcccccCCCCCCcchhhhhcCc
Confidence 88754221111101000000 00000111111 3567799999999999999988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.1e-13 Score=141.28 Aligned_cols=142 Identities=23% Similarity=0.260 Sum_probs=100.1
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCCch---------------------------------------HHHHH
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGG---------------------------------------DAAFQ 329 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------------------------------~~~~~ 329 (609)
.+.||.|++|.||+|+.++|+.||||+.+....... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999864211000 01244
Q ss_pred HHHHHHHhcc----CCCcceeEeEE-eCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHH-HHHHHHh
Q 007290 330 REVEMISVAV----HRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR-GLEYLHE 403 (609)
Q Consensus 330 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 403 (609)
.|.+.+.++. |.+-+.+-.++ .-....++||||++|++|.+.......+ . .+.+++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence 4555554442 33333332333 2234579999999999998876532111 1 23456666666 4678898
Q ss_pred cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 404 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
. |++|+|+||.||+++.+++++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.6e-13 Score=150.69 Aligned_cols=95 Identities=41% Similarity=0.714 Sum_probs=91.7
Q ss_pred CCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCC
Q 007290 91 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170 (609)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 170 (609)
.++.|+|++|.++|.+|..+++|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCcccccC
Q 007290 171 SNNLSGQIPVHLFQI 185 (609)
Q Consensus 171 ~N~l~~~ip~~l~~l 185 (609)
+|+++|.+|..+..+
T Consensus 499 ~N~l~g~iP~~l~~~ 513 (623)
T PLN03150 499 GNSLSGRVPAALGGR 513 (623)
T ss_pred CCcccccCChHHhhc
Confidence 999999999988754
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.9e-13 Score=141.34 Aligned_cols=125 Identities=34% Similarity=0.541 Sum_probs=75.8
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcc-ccccccccccccccccccccCCccccCcccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.++.||||+|.|. ..|..+.+-+++.+|+||+|+|. +||.. |.+|+.|-+||||+|++. .+|+.+..|..|++|.|
T Consensus 104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 5666667766666 56666666666666666666666 55543 446666666666666666 56666666666666666
Q ss_pred ccCcCC-------------------------CCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCC
Q 007290 146 SQNNFS-------------------------GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNL 195 (609)
Q Consensus 146 ~~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~ 195 (609)
++|.+. ..+|.++..|.+|..+|+|.|+|. .+|+.+. +|.+|++++|..
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 666553 124555566666666666666666 5665443 333455555543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=135.13 Aligned_cols=248 Identities=19% Similarity=0.163 Sum_probs=179.7
Q ss_pred cCCCccCcccc--cCCceEEEEEe---CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcc
Q 007290 284 DNFSEKNVLGQ--GGFGKVYRGVL---ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTER 356 (609)
Q Consensus 284 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 356 (609)
..+.+.+.+|. |.+|.||.+.. .++..+|+|+-+... .+.....=.+|+...++++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556788999 99999999986 368899999854322 2222333345666666665 99999988888888888
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGD 431 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D 431 (609)
++-.|++. .++..+.+... ..++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 88888886 56666665432 23677777888888888 99999999 99999999999999999 8899999
Q ss_pred cccceeeccCCC----ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 432 FGLAKLVDVRKT----NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 432 fGl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
||+...+....- .......|...|++||.. .+.++..+|+|++|.+..+-.++..+........ |..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~ 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQ 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccc
Confidence 999988865431 112234678899999998 4577899999999999999999877654321110 100
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 557 (609)
+-...++.++...-..++...+.++++.+|..|++.+.+.
T Consensus 338 ----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 338 ----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0000112223333344566688999999999999977765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-13 Score=141.13 Aligned_cols=134 Identities=25% Similarity=0.336 Sum_probs=106.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCc---cccCcccchhh
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP---SLGNLKKLQFL 143 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L 143 (609)
+++.|+|++|+|+...+..|..|..|++|+|++|+|+..-...|..+++|+.|||++|.|++.|.+ .|..|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 788888888888877778888888888888888888855566777888888888888888876654 47778888888
Q ss_pred hcccCcCCCCcC-CCcCcccccccccCCCCcccccCCcccc--cCCcccCCCCCCCCCCCC
Q 007290 144 TLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLF--QIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 144 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~ip~~l~--~l~~l~~~~n~~~c~~~~ 201 (609)
+|.+|+|. .|| .+|.++.+|++|||.+|.|...-|..|. +|++|-+..-.+.|+|.+
T Consensus 398 ~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 398 RLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred eecCceee-ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 88888888 555 5788888888888888888866676665 456677777788898874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-13 Score=136.47 Aligned_cols=124 Identities=29% Similarity=0.450 Sum_probs=85.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCcccc-Ccccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLG-NLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l 145 (609)
+++.||..+|-+. .+|+.++.+.+|..|+|..|+|. .+| +|+++..|.+|+++.|+|+ .+|...+ +|++|..|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 3444555555444 66777777777777777777777 666 5777777777777777777 6666554 6777777777
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccC--CcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l--~~l~~~~n~~~ 196 (609)
..|+++ .+|+.+..+.+|++||+|+|.++ .+|.+++++ ..|.+.|||..
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchH
Confidence 777777 77777777777777777777777 466666554 34666777654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-13 Score=140.57 Aligned_cols=113 Identities=27% Similarity=0.251 Sum_probs=66.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.|+|+.|+++..-...+.+|+.|+.|+||+|.|...-++.+...++|+.|+|++|+|+..-+.+|..|..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 56666666666665555666666666666666666665556666666666666666666664444556656666666666
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
+|+++..-...|..+++|+.|||++|.|++.|-
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 665552223344445555555555555544443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-11 Score=114.32 Aligned_cols=130 Identities=22% Similarity=0.170 Sum_probs=96.5
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcce-eEeEEeCCCcceEEeecccCch
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR-LIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.+.|+.|.++.||++... |..|++|....... ....+..|+.++..+.+.++++ ++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 457899999999999975 78899998754321 2345678999999887666544 44443 234589999999987
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
+... . . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6543 0 1 11345678999999999982 12369999999999999 6689999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-12 Score=136.06 Aligned_cols=146 Identities=20% Similarity=0.199 Sum_probs=94.2
Q ss_pred cCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCC---------------------------------chHH---
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESP---------------------------------GGDA--- 326 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---------------------------------~~~~--- 326 (609)
..|+. +.||.|++|.||+|++++ |+.||||+.+....+ +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999887 999999998743100 0011
Q ss_pred ---HHHHHHHHHHhcc----CCCcceeEeEEeC-CCcceEEeecccCchhhhhh--hhcCCCCCCccHHHHHHHHHHHHH
Q 007290 327 ---AFQREVEMISVAV----HRNLLRLIGFCTT-PTERLLVYPFMQNLSVAYRL--REIKPGEPVLDWVTRKRVALGAAR 396 (609)
Q Consensus 327 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~ 396 (609)
++.+|+....+++ +.+.+.+-.++.+ ..+.++||||++|+.+.+.. .........+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2334444444332 3333443333322 45678999999999997743 2211111112222223333333
Q ss_pred HHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEcccccceeecc
Q 007290 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDFGLAKLVDV 440 (609)
Q Consensus 397 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGl~~~~~~ 440 (609)
... |++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999987753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-10 Score=123.71 Aligned_cols=233 Identities=18% Similarity=0.181 Sum_probs=151.6
Q ss_pred eCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccH
Q 007290 305 LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 384 (609)
Q Consensus 305 ~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 384 (609)
..++.+|.|........ .......+-++.++.++||||+++++........|+|+|-+. -|..++.+ +..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 34788888888765433 345566778888999999999999999999999999999874 35555555 223
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCC
Q 007290 385 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG 464 (609)
Q Consensus 385 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 464 (609)
....--+.||+.||.|||+.| +++|++|.-..|+++..|+.||++|-++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 344556889999999999776 899999999999999999999999998865432111 01111112246666655322
Q ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhcc
Q 007290 465 KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE-DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCT 543 (609)
Q Consensus 465 ~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl 543 (609)
. -..|.|.||++++|++.|..+-........ ......... + ..+..... ..+. ..+++..|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~--~------k~~~~~~~------~r~n-~~~~~~~~~ 243 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELY--C------KKLGATEL------KRPN-KLRFILECR 243 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHH--H------HHhccccc------cccc-hhhHHHHHH
Confidence 2 346999999999999999433211100000 000000000 0 00000000 0011 456777777
Q ss_pred CCCCCCCCCHHHHHHHHhcCCccc
Q 007290 544 QASPEDRPAMSEVVRMLEGEGLAE 567 (609)
Q Consensus 544 ~~dP~~RPs~~evl~~L~~~~~~~ 567 (609)
...+--|=.+-+++.+|+.....+
T Consensus 244 ~~~gff~n~fvd~~~fLeel~lks 267 (690)
T KOG1243|consen 244 LLGGFFRNDFVDTLLFLEELRLKS 267 (690)
T ss_pred hccccccchHHHHHHHHHhcccCc
Confidence 777777777888888888776544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-12 Score=133.94 Aligned_cols=131 Identities=29% Similarity=0.437 Sum_probs=73.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCC----------------------CCCccccccccccccccccc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG----------------------EIPEELGNLSSLTSLDLDNN 124 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~----------------------~~p~~~~~l~~L~~L~L~~N 124 (609)
++..+|||.|+|. .+|..+.++++|+.|+||+|+|+. .+|..+++|+.|+.|++.+|
T Consensus 223 NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~N 301 (1255)
T KOG0444|consen 223 NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNN 301 (1255)
T ss_pred hhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccC
Confidence 4455555555555 455555555555555555555541 45555555555555555555
Q ss_pred ccc-ccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCCCCC
Q 007290 125 RLV-GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 125 ~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c~~~ 200 (609)
+++ .-||..|++|.+|+.+..++|.+. .+|..++.|..|+.|.|+.|.|- .+|+. +..+..|++..|+..-..|
T Consensus 302 kL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 302 KLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred cccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 543 125555666666666666666665 56666666666666666666665 46643 3455556666666654433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.7e-13 Score=129.84 Aligned_cols=113 Identities=30% Similarity=0.497 Sum_probs=97.8
Q ss_pred ccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCc
Q 007290 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 160 (609)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 160 (609)
-+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||||.|+|. .+|..+..+..|+.+-.++|++...-|+.+.+
T Consensus 426 fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 426 FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 44556778899999999999998 89999999999999999999999 89999888889999988999998444455999
Q ss_pred ccccccccCCCCcccccCCcccccC---CcccCCCCCCC
Q 007290 161 LSSLISIQLDSNNLSGQIPVHLFQI---PKYNFTGNNLN 196 (609)
Q Consensus 161 l~~L~~L~l~~N~l~~~ip~~l~~l---~~l~~~~n~~~ 196 (609)
|.+|..|||.+|.+. .||..++++ ..|.+.|||+.
T Consensus 504 m~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 999999999999999 788777655 55889999986
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-12 Score=125.76 Aligned_cols=136 Identities=27% Similarity=0.331 Sum_probs=120.1
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc-ccccccCCccccCcccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN-NRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l 145 (609)
..+.|.|..|+|+.+.|.+|+.+++|+.||||+|+|+-.-|..|.+|.+|..|-+-+ |+|+......|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 679999999999988889999999999999999999988899999999988776655 9999444457999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCc----ccccCCcccCCCCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLNCGKTLPH 203 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~----~l~~l~~l~~~~n~~~c~~~~~~ 203 (609)
.-|++.-...+.|..|++|..|.+..|.+. .|+. .+..++.+.++.|++.|+|-++.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccch
Confidence 999999777788999999999999999998 6774 34566778999999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.2e-11 Score=127.62 Aligned_cols=247 Identities=18% Similarity=0.181 Sum_probs=173.5
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC--CCcEEEEEEeccCCCC-chHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFESP-GGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
....+|..+..||.|.|+.|+....+ ++..|++|.+.+.... .....-..|+.+...+ .|.+++.....+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 35567888999999999999998844 6889999988653322 2222234566666555 488888887777777777
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA 435 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~ 435 (609)
++--||++++++.....- ...++...++++..|++.++.++|++ .++|+|+||+||++..+ +..+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 788999999988777621 22367778889999999999999999 99999999999999886 77899999998
Q ss_pred eeeccCCCceeeccccccccc--CcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHI--APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
+.+... .....+.-++. +|+......+..+.|+||||..+.+..++..--.. ... |
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~~---------~-------- 472 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GVQ---------S-------- 472 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-ccc---------c--------
Confidence 753211 11112233344 55555566788999999999999999998753211 000 0
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 560 (609)
..+.. ..... .+.....+..+...+...++..||.+.++..+.
T Consensus 473 --~~i~~-~~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 473 --LTIRS-GDTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --eeeec-ccccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 00000 00011 112225667788888899999999988887544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.2e-12 Score=139.51 Aligned_cols=125 Identities=26% Similarity=0.448 Sum_probs=112.7
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCc-cccccccccccccccccccccCCccccCcccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPE-ELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.|+.|.|.+|.|+...-+.+.+.++|+.|+|++|+|. .+|. .+.+|..|+.|+||+|+++ .+|..+.+++.|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 5888999999999888888999999999999999999 6665 5889999999999999999 89999999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCccc-ccCCccc--ccCCcccCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS-GQIPVHL--FQIPKYNFTGNNL 195 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~ip~~l--~~l~~l~~~~n~~ 195 (609)
.+|++. ..| .+..++.|+.+|++.|+|+ +.+|..+ .+|+.|+++||.+
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 888 8899999999999999997 3345443 5899999999986
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=5e-10 Score=108.51 Aligned_cols=143 Identities=22% Similarity=0.280 Sum_probs=107.5
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCC--CcceeEeEEeCCC---cceEEeeccc
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLIGFCTTPT---ERLLVYPFMQ 364 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~ 364 (609)
+.|+.|..+.||++...+|+.+++|.............+..|.++++.+.+. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999998777899999876433222356788999999998763 4566777765532 5689999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--------------------------------------- 405 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 405 (609)
|.++...+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765531 12555666677777777777777421
Q ss_pred --------------CCCeEecCCCCCcEEeCC--CCcEEEccccccee
Q 007290 406 --------------NPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKL 437 (609)
Q Consensus 406 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~~ 437 (609)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.1e-10 Score=102.96 Aligned_cols=137 Identities=15% Similarity=0.141 Sum_probs=97.7
Q ss_pred CcccccCCceEEEEEeCC-------CcEEEEEEeccCC------------C---------CchHHHHH----HHHHHHHh
Q 007290 290 NVLGQGGFGKVYRGVLAD-------GTKVAVKRLTDFE------------S---------PGGDAAFQ----REVEMISV 337 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~------------~---------~~~~~~~~----~E~~~l~~ 337 (609)
..||.|--+.||.|...+ +..+|||+.+... + ......+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998543 4799999764210 0 11122333 79999988
Q ss_pred ccC--CCcceeEeEEeCCCcceEEeecccCchhh-hhhhhcCCCCCCccHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 007290 338 AVH--RNLLRLIGFCTTPTERLLVYPFMQNLSVA-YRLREIKPGEPVLDWVTRKRVALGAARGLEYL-HEHCNPKIIHRD 413 (609)
Q Consensus 338 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~D 413 (609)
+.. -++.+++++ ...++||||+.+..+. ..+.+. .++......+..+++.+|..+ |+. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 864 455566654 5678999999865332 122221 134445667789999999999 777 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeec
Q 007290 414 VKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 414 lkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|++.||+++ ++.+.|+|||.+-...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4679999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.4e-11 Score=112.77 Aligned_cols=103 Identities=34% Similarity=0.510 Sum_probs=40.6
Q ss_pred CeEEEEecCCCcccccCcccc-CCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccc-cCcccchhhh
Q 007290 67 NVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLT 144 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 144 (609)
+++.|+|.+|.|+. +. .++ .|.+|+.|||++|.|+ .++ .+..|++|+.|+|++|+|+ .+++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 57889999999984 33 455 5788999999999998 565 4888899999999999998 565555 4688999999
Q ss_pred cccCcCCCCcC--CCcCcccccccccCCCCccc
Q 007290 145 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 145 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~ 175 (609)
|++|+|. .+. ..+..+++|+.|+|.+|+++
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 9999987 332 34667888899999999887
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.3e-09 Score=94.98 Aligned_cols=132 Identities=22% Similarity=0.318 Sum_probs=99.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEE-eccCCC-Cch-----HHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKR-LTDFES-PGG-----DAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~~-~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
..+++|+-+.+|.+.+. |.++++|. +++... +.- ...-.+|++++.+++--.|.-.+=+..++....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999875 45566663 222221 211 23456799999988766665555566778888999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
++|-.|.+.+... ...++..+-..+.-||.. +|+|+||.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888763 134566677778889999 999999999999998775 99999999873
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-09 Score=96.45 Aligned_cols=144 Identities=19% Similarity=0.235 Sum_probs=104.9
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEe-ccCC-CCc-----hHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 288 EKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFE-SPG-----GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~~-~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
....+-+|+-+.|+++.+. |+...||.- .+.. .+. ......+|++.+.++.--.|.-..=++.+.....++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999999994 788777742 2211 111 2345678999999887556554444566677778999
Q ss_pred ecccC-chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEcccccce
Q 007290 361 PFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAK 436 (609)
Q Consensus 361 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~ 436 (609)
||+++ .++.+++....... ........++.+|-+.+.-||.. +|+||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 47788877644332 22222356788888999999999 999999999999996554 35899999986
Q ss_pred e
Q 007290 437 L 437 (609)
Q Consensus 437 ~ 437 (609)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.8e-11 Score=108.78 Aligned_cols=106 Identities=33% Similarity=0.508 Sum_probs=39.1
Q ss_pred cccCCCCCCEEEccCCCcCCCCCcccc-ccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCc-Cccc
Q 007290 85 RIGVLRTLSTLTLKGNGITGEIPEELG-NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL-TTLS 162 (609)
Q Consensus 85 ~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~ 162 (609)
.+.+..++++|+|++|.|+ .|. .++ .+.+|+.|||++|+|+ .++ .+..|++|+.|+|++|+|+ .++..+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence 4556678999999999999 665 466 5899999999999999 565 5888999999999999999 665555 3689
Q ss_pred ccccccCCCCcccccCC-----cccccCCcccCCCCCCC
Q 007290 163 SLISIQLDSNNLSGQIP-----VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 163 ~L~~L~l~~N~l~~~ip-----~~l~~l~~l~~~~n~~~ 196 (609)
+|+.|+|++|+|.. +- ..+.+|..|++.|||..
T Consensus 89 ~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 NLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp T--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCccc
Confidence 99999999999973 33 24566777899999873
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-11 Score=122.60 Aligned_cols=123 Identities=30% Similarity=0.532 Sum_probs=95.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.|||+.|.++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.|.+|+.|++.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 5677788888887 6677776665 788888888888 78888888888888888888888 788888888888888888
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccccC---CcccCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI---PKYNFTGNNLN 196 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l---~~l~~~~n~~~ 196 (609)
.|++. .+|..+..|+ |..||+|.|+++ .||..|.+| ..|.+.+||..
T Consensus 198 Rn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 88888 7777777554 888888888888 788666544 45667888764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=104.83 Aligned_cols=220 Identities=14% Similarity=0.148 Sum_probs=154.0
Q ss_pred CCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe----CCCcceEEeecccC-chhh
Q 007290 296 GFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT----TPTERLLVYPFMQN-LSVA 369 (609)
Q Consensus 296 ~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~ 369 (609)
.-.+.|++.. .||..|++|+++..... ....-..-+++++++.|+|+|++.+++. .+...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4468999995 48999999999543222 1112234577899999999999998875 34568899999986 4565
Q ss_pred hhhhhc-----------CCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 370 YRLREI-----------KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 370 ~~l~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+.--.. ...+...++...|.++.|+..||.++|+. |+.-+-|.+.+|+++.+.+++|..+|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 543221 12234577889999999999999999999 9999999999999999999999999988776
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
...+. |.+.. -.+-|.=.||.+++.|.||..---.... .....+.
T Consensus 444 ~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~---------------~~~s~~~-- 488 (655)
T KOG3741|consen 444 QEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS---------------TQSSHLT-- 488 (655)
T ss_pred cCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccc---------------hHHHHHH--
Confidence 54431 11111 2467889999999999999643110000 0000010
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.....++.++.+++......++++ -+..+++.++-+
T Consensus 489 -------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 489 -------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred -------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 123445567778888888888887 577777766543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.4e-11 Score=113.39 Aligned_cols=124 Identities=27% Similarity=0.388 Sum_probs=99.9
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
..++.||||+|.|+ .+..+..-++.++.|++|+|.|. .+-. +..|++|+.||||+|.++ .+...=.+|-|++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 36889999999999 77788888999999999999999 5554 888999999999999998 66666677888999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccC---CcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQI---PKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l---~~l~~~~n~~~ 196 (609)
+.|.|. .+ +.+.++-+|..||+++|++. .+- ..+++| ..+.+.+||..
T Consensus 360 a~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 360 AQNKIE-TL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhHh-hh-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCcc
Confidence 999987 33 46778889999999999987 333 234444 44667788754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.3e-10 Score=124.53 Aligned_cols=75 Identities=31% Similarity=0.445 Sum_probs=57.0
Q ss_pred ccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccC
Q 007290 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNF 190 (609)
Q Consensus 114 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~ 190 (609)
.+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+ .+|..+. ++..|++
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 35777888888877 46643 357888899999988 57754 346889999999998 7997654 5566889
Q ss_pred CCCCCCC
Q 007290 191 TGNNLNC 197 (609)
Q Consensus 191 ~~n~~~c 197 (609)
++|++.+
T Consensus 453 s~N~Ls~ 459 (788)
T PRK15387 453 EGNPLSE 459 (788)
T ss_pred CCCCCCc
Confidence 9999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.2e-09 Score=122.43 Aligned_cols=119 Identities=28% Similarity=0.458 Sum_probs=71.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|+|+ .+|..+ ..+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 220 ~nL~~L~Ls~N~Lt-sLP~~l--~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLT-SIPATL--PDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCccc-cCChhh--hccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 36788888888887 455544 246777777777776 5665553 46677777777776 4565543 36666666
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCc-ccccCCcccCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~-~l~~l~~l~~~~n~~~c 197 (609)
++|+|+ .+|..+. ++|+.|++++|+|+ .+|. ...+|..|++++|...+
T Consensus 291 s~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 291 YDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLPPGLKTLEAGENALTS 339 (754)
T ss_pred CCCccc-cCcccch--hhHHHHHhcCCccc-cCCccccccceeccccCCcccc
Confidence 666666 4554432 35666666666665 3443 22355555555555443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.2e-10 Score=84.80 Aligned_cols=59 Identities=41% Similarity=0.635 Sum_probs=30.6
Q ss_pred CCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCc
Q 007290 91 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 149 (609)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 149 (609)
+|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555553333445555555555555555554444455555555555555554
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-09 Score=122.19 Aligned_cols=119 Identities=26% Similarity=0.473 Sum_probs=97.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 47899999999999 5666553 68999999999999 7787664 57999999999999 7887764 58999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCccc-ccCCcccCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL-FQIPKYNFTGNNLNC 197 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l-~~l~~l~~~~n~~~c 197 (609)
++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+ .++..|++++|....
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLPSGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccc-cCcccchhhHHHHHhcCCcccc
Confidence 999999 6887764 58999999999999 577654 367888999987753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-10 Score=123.97 Aligned_cols=105 Identities=30% Similarity=0.507 Sum_probs=93.9
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.|.......+.+|..|+.|+||+|+|+ .+|+++.++..|++|...+|+|. ..| .+..++.|+.+||
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 48999999999999666677889999999999999999 99999999999999999999999 788 8999999999999
Q ss_pred ccCcCCCC-cCCCcCcccccccccCCCCcc
Q 007290 146 SQNNFSGT-IPDSLTTLSSLISIQLDSNNL 174 (609)
Q Consensus 146 ~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l 174 (609)
|.|+|+-. +|..... ++|++|||++|.-
T Consensus 460 S~N~L~~~~l~~~~p~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPS-PNLKYLDLSGNTR 488 (1081)
T ss_pred ccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence 99999833 3444433 8999999999984
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.8e-08 Score=90.52 Aligned_cols=127 Identities=19% Similarity=0.227 Sum_probs=83.0
Q ss_pred eEEEEEeCCCcEEEEEEeccCCC------------C--------c-----hHHHHHHHHHHHHhccCC--CcceeEeEEe
Q 007290 299 KVYRGVLADGTKVAVKRLTDFES------------P--------G-----GDAAFQREVEMISVAVHR--NLLRLIGFCT 351 (609)
Q Consensus 299 ~Vy~~~~~~g~~vavK~~~~~~~------------~--------~-----~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 351 (609)
.||.|...+|..+|||..+.... . . ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998742100 0 0 113456899999999865 455666543
Q ss_pred CCCcceEEeeccc--CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 352 TPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY-LHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 352 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
...+||||++ |..+..+... . ++......++.+++..+.. +|.. |++|||+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 5689999998 6555443322 1 1123455677788886665 4677 99999999999999988 999
Q ss_pred Ecccccceeec
Q 007290 429 VGDFGLAKLVD 439 (609)
Q Consensus 429 l~DfGl~~~~~ 439 (609)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-08 Score=98.17 Aligned_cols=142 Identities=16% Similarity=0.073 Sum_probs=100.7
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCC----------chHHHHHHHHHHHHhccCCCc--ceeEeEEeC-----
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP----------GGDAAFQREVEMISVAVHRNL--LRLIGFCTT----- 352 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 352 (609)
+.+-+.....|++..+ +|+.|.||+....... .....+.+|...+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444456778766 5889999977432211 111247789998888754333 344555532
Q ss_pred CCcceEEeecccCc-hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-------C
Q 007290 353 PTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-------D 424 (609)
Q Consensus 353 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 424 (609)
....++|+|++++. +|.+++..... ...+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 88888754321 2245566778999999999999999 9999999999999975 4
Q ss_pred CcEEEccccccee
Q 007290 425 FEAVVGDFGLAKL 437 (609)
Q Consensus 425 ~~~kl~DfGl~~~ 437 (609)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998853
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.4e-10 Score=83.44 Aligned_cols=61 Identities=43% Similarity=0.627 Sum_probs=55.6
Q ss_pred ccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcc
Q 007290 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174 (609)
Q Consensus 114 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 174 (609)
++|+.|+|++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999966667899999999999999999966678999999999999999986
|
... |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.1e-10 Score=120.37 Aligned_cols=124 Identities=29% Similarity=0.523 Sum_probs=100.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.|+.+.|.+|.+. .+|..+++|..|++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+
T Consensus 99 ~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s 174 (722)
T KOG0532|consen 99 SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS 174 (722)
T ss_pred HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence 3555666777777 77778888888888888888888 7887787776 888888888888 788888888888888888
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCC--cccCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP--KYNFTGNNLN 196 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~--~l~~~~n~~~ 196 (609)
.|.+. .+|..++.+.+|+.|.+..|++. .+|.++..|+ +|+|+.|+..
T Consensus 175 ~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS 224 (722)
T ss_pred hhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee
Confidence 88888 78888888888888888888888 7888777655 5888888764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.8e-10 Score=124.39 Aligned_cols=249 Identities=17% Similarity=0.183 Sum_probs=162.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..+.+.+.+-+-+|.++.++.+.-. .|...+.|...... .....+....+-.++-..++|-++...--+.-.....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456667778888999988887743 35444555432211 01111222222222222334555543333334456789
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+++|..+++|...++.... .+..-.+.....+..+++|||.. .+.|+|++|.|.++..++..++.|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999987442 33334455666788899999998 7999999999999999999999999843322
Q ss_pred ccC------------------------------CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007290 439 DVR------------------------------KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 488 (609)
Q Consensus 439 ~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p 488 (609)
... .........||+.|.+||...+......+|.|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00112235689999999999999999999999999999999999999
Q ss_pred CCCCccccccchhHHHHHHHHhhhccchhhcccccc-CCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 489 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
|......... ..+...... .......+....+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~f-----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF-----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh-----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9754432111 001111100 112233445677888888899999997765
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.9e-09 Score=73.53 Aligned_cols=40 Identities=40% Similarity=0.905 Sum_probs=30.8
Q ss_pred chhHHHHHHHHHhCC-CCCCCcCCCCCCC-CCCCCcceeEEc
Q 007290 24 DYQGDALFALRTSLR-VPNNQLRDWNQNQ-VNPCTWSNVICD 63 (609)
Q Consensus 24 ~~~~~~l~~~~~~~~-~~~~~l~~w~~~~-~~~c~w~gv~c~ 63 (609)
+.|.+||++||+++. +|.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 568999999999999 4668999999864 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=5e-09 Score=116.88 Aligned_cols=112 Identities=22% Similarity=0.327 Sum_probs=65.4
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|+
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECc
Confidence 46666666666663 443 2466667777777666 45542 346666666666666 444422 345566666
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~ 195 (609)
+|+|+ .+|.. +++|+.|+|++|+|+ .+|....+|..|.+++|..
T Consensus 291 ~N~Lt-~LP~~---p~~L~~LdLS~N~L~-~Lp~lp~~L~~L~Ls~N~L 334 (788)
T PRK15387 291 GNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALPSELCKLWAYNNQL 334 (788)
T ss_pred CCccc-ccccc---ccccceeECCCCccc-cCCCCcccccccccccCcc
Confidence 66666 45542 356777777777776 3555444555555555544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-07 Score=93.65 Aligned_cols=265 Identities=16% Similarity=0.121 Sum_probs=155.2
Q ss_pred CccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHh-ccCCCcceeEeE------EeCC-CcceE
Q 007290 287 SEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRNLLRLIGF------CTTP-TERLL 358 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~------~~~~-~~~~l 358 (609)
..++.||+|+-+.+|-.-.- +. .+-|+.+..-.. .-.+.+.++.. -.||-+-.-+.+ .... ....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCch----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34678999999999975421 22 334666543211 11223334433 346644331111 1112 22556
Q ss_pred EeecccCch-hhhhhh--hcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 359 VYPFMQNLS-VAYRLR--EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 359 v~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.|+.+++.- ...++. .....-....|.-.++++..++.+.+.||.. |.+-+|+.++|+|+.+++.+.|.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 677766531 111111 1112224478999999999999999999999 9999999999999999999999875433
Q ss_pred eeeccCCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhC-CCCCCCCccccccchhHH-HHHHH
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEEEDDVLLL-DHVKK 508 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~~~~~~~~-~~~~~ 508 (609)
... .........+|...|.+||... +..-+...|-|.+|+++++++.| ++||...........-.- +....
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 222 2233445567899999999764 33457789999999999999987 899974322111000000 00000
Q ss_pred H-hhhccchhhccccccCCCCHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHHhc
Q 007290 509 L-EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQAS--PEDRPAMSEVVRMLEG 562 (609)
Q Consensus 509 ~-~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~evl~~L~~ 562 (609)
. ........-..+........-.++++..+..+|+... +.-||+++..+..|..
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 0 0000000000000001112233467788888999654 5689999988877765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.5e-09 Score=123.05 Aligned_cols=125 Identities=22% Similarity=0.320 Sum_probs=74.5
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|++. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+++|++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 5566666666655 4555556666666666666543335553 5666666666666665444666666666666666666
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNN 194 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~ 194 (609)
+|...+.+|..+ ++++|+.|++++|...+.+|....++..|++.+|.
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETA 736 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCc
Confidence 644333566544 56666666666665555556555566666666655
|
syringae 6; Provisional |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.5e-10 Score=95.27 Aligned_cols=134 Identities=22% Similarity=0.403 Sum_probs=94.9
Q ss_pred EcCCCCeEEEEecCCCcccccCcc---ccCCCCCCEEEccCCCcCCCCCccccc-cccccccccccccccccCCccccCc
Q 007290 62 CDNSNNVASVTLSSMNFSGTLSPR---IGVLRTLSTLTLKGNGITGEIPEELGN-LSSLTSLDLDNNRLVGKIPPSLGNL 137 (609)
Q Consensus 62 c~~~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l 137 (609)
|+....+..++|+++.|- .++.. +.....|+..+|++|.+. ..|+.|.. .+.++.|+|++|.|+ .+|..+..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 544445667778877765 44443 344556667788888888 66665544 457888889999888 788888888
Q ss_pred ccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc--cCCc-ccCCCCCCCCCCC
Q 007290 138 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF--QIPK-YNFTGNNLNCGKT 200 (609)
Q Consensus 138 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~--~l~~-l~~~~n~~~c~~~ 200 (609)
+.|+.|+++.|.|. ..|..+..|.+|-.|+..+|.+. +||..+. .++. .++.+++|.-+++
T Consensus 100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 88999999998888 77888888888888888888887 7775432 2222 3445556554443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-07 Score=90.81 Aligned_cols=137 Identities=21% Similarity=0.182 Sum_probs=97.1
Q ss_pred CCccCcccccCCceEEEEEeCCCcEEEEEEeccCCC---------------------CchHHHHHHHHHHHHhccCC--C
Q 007290 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---------------------PGGDAAFQREVEMISVAVHR--N 342 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--n 342 (609)
+.++..||-|--+.||.|...+|.++|||.-+...+ .......++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455789999999999999999999999995421100 01224567899999888754 5
Q ss_pred cceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC
Q 007290 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD 422 (609)
Q Consensus 343 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~ 422 (609)
+.+.++ .+...+|||+++|--|...- ++......++..|++-+.-+-.. |+||+|+++-||+++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 555554 35678999999884443211 12223334555555555555566 999999999999999
Q ss_pred CCCcEEEcccccceee
Q 007290 423 EDFEAVVGDFGLAKLV 438 (609)
Q Consensus 423 ~~~~~kl~DfGl~~~~ 438 (609)
+||.+.++||--+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999877543
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.8e-09 Score=102.18 Aligned_cols=89 Identities=28% Similarity=0.290 Sum_probs=45.6
Q ss_pred ccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccc
Q 007290 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 165 (609)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 165 (609)
|.+|++|++|+|++|+|++.-+..|.++..|+.|+|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+.+|.
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~ 349 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS 349 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence 44455555555555555544455555555555555555555433333455555555555555555544455555555555
Q ss_pred cccCCCCcc
Q 007290 166 SIQLDSNNL 174 (609)
Q Consensus 166 ~L~l~~N~l 174 (609)
.|+|-.|.+
T Consensus 350 ~l~l~~Np~ 358 (498)
T KOG4237|consen 350 TLNLLSNPF 358 (498)
T ss_pred eeehccCcc
Confidence 555544444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.66 E-value=4e-08 Score=117.38 Aligned_cols=125 Identities=18% Similarity=0.300 Sum_probs=96.7
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|++.++.+. .+|..| .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|...+.+| .++.+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEec
Confidence 4666677666665 556655 5688888999888888 778888888999999998876555777 47888899999998
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcc--cccCCcccCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKYNFTGNNL 195 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~--l~~l~~l~~~~n~~ 195 (609)
+|.....+|..+.++++|+.|++++|...+.+|.. +.+|..|++++|..
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 87766688888889999999999887655578863 56777788887754
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-09 Score=111.99 Aligned_cols=131 Identities=24% Similarity=0.346 Sum_probs=92.7
Q ss_pred CCCeEEEEecCCCcccccCccccCCCC---CCEEEccCCCcCC----CCCcccccc-cccccccccccccccc----CCc
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRT---LSTLTLKGNGITG----EIPEELGNL-SSLTSLDLDNNRLVGK----IPP 132 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~ 132 (609)
..+++.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 457888999888888766666666655 8999999888873 233445566 7888999999988842 344
Q ss_pred cccCcccchhhhcccCcCCCC----cCCCcCcccccccccCCCCcccccCC-------cccccCCcccCCCCCC
Q 007290 133 SLGNLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIP-------VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 133 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ip-------~~l~~l~~l~~~~n~~ 195 (609)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++... ..+.+|..|++++|+.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 566777888899988888842 33445556788889999888864322 1234577788888754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.4e-09 Score=99.95 Aligned_cols=107 Identities=24% Similarity=0.332 Sum_probs=91.6
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
..++.|++|+|+|... . .+..|++|+.||||+|.++ .+-..-.+|-+++.|.|+.|.|. .+ ..+++|-+|..||+
T Consensus 307 Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheeccc
Confidence 4799999999999943 3 3888999999999999999 66666677899999999999988 33 35788889999999
Q ss_pred ccCcCCCCcC--CCcCcccccccccCCCCcccccCC
Q 007290 146 SQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 146 ~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
++|+|. .+. ..++++|.|+.|.|.+|+|.+ +|
T Consensus 382 ~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~-~v 415 (490)
T KOG1259|consen 382 SSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAG-SV 415 (490)
T ss_pred cccchh-hHHHhcccccccHHHHHhhcCCCccc-cc
Confidence 999998 443 478999999999999999994 55
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.9e-09 Score=88.59 Aligned_cols=116 Identities=28% Similarity=0.352 Sum_probs=96.4
Q ss_pred CCeEEEEecCCCcccccCccc-cCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.++|++|.+. .+|+.| ..++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..|..|.+|..|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 37899999999999 455555 45679999999999999 89999999999999999999999 7888888899999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 185 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l 185 (609)
..+|.+. .+|-.+.--+.+-..++.+|.+.+.-|..+..+
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 9999998 787664433444556778899998887655444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.4e-08 Score=107.70 Aligned_cols=127 Identities=33% Similarity=0.531 Sum_probs=107.3
Q ss_pred CCeEEEEecCCCcccccCccccCCC-CCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLR-TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..++.|++.+|+++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 46899999999999 7777778885 9999999999999 88878999999999999999999 8888888999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 197 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c 197 (609)
+++|+++ .+|..+..+..|+.|.+++|++. .++..+. ++..+.+.+|+..+
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 9999999 89988777778999999999655 4554444 44456667776655
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.9e-10 Score=116.94 Aligned_cols=124 Identities=31% Similarity=0.439 Sum_probs=96.7
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCc-cccCcccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l 145 (609)
.+.+.+.+.|.|. ....++.-|+.|+.|||++|+++. .. .+..|+.|++|||++|.+. .+|. .-..++ |+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4566677778877 566677888999999999999984 33 6888999999999999998 6664 334444 999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccC---C-cccccCCcccCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI---P-VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~i---p-~~l~~l~~l~~~~n~~~c 197 (609)
+||.++ .+ ..+.+|.+|+.|||+.|-|++.- | ..|..|..|++.|||..|
T Consensus 240 rnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 999988 33 35778899999999999887432 2 356678889999999887
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.4e-09 Score=109.88 Aligned_cols=130 Identities=22% Similarity=0.279 Sum_probs=94.9
Q ss_pred CCeEEEEecCCCcc------cccCccccCCCCCCEEEccCCCcCCCCCcccccccc---ccccccccccccc----cCCc
Q 007290 66 NNVASVTLSSMNFS------GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS---LTSLDLDNNRLVG----KIPP 132 (609)
Q Consensus 66 ~~l~~L~L~~n~l~------~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~ 132 (609)
.+++.|+++.+.+. ..++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 35888888888776 234456777889999999999988766666666666 9999999998873 3344
Q ss_pred cccCc-ccchhhhcccCcCCCC----cCCCcCcccccccccCCCCccccc----CCcccc---cCCcccCCCCCC
Q 007290 133 SLGNL-KKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQ----IPVHLF---QIPKYNFTGNNL 195 (609)
Q Consensus 133 ~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----ip~~l~---~l~~l~~~~n~~ 195 (609)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++. ++..+. +|..|++++|..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i 205 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCcc
Confidence 56666 8889999999998843 334455667899999999988742 333344 778888888764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.3e-08 Score=108.56 Aligned_cols=150 Identities=15% Similarity=0.248 Sum_probs=102.1
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc--------eeecccccccccCcccccC
Q 007290 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--------VTTQVRGTMGHIAPEYLST 463 (609)
Q Consensus 392 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 463 (609)
.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+-........ ...-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999874 8999999999999999999999999987544321110 0111223568999999988
Q ss_pred CCCCcchhhHHHHHHHHHHH-hCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhc
Q 007290 464 GKSSERTDVFGYGIMLLELV-TGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLC 542 (609)
Q Consensus 464 ~~~~~~~Dv~slG~ll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~c 542 (609)
...+.++|+||+|+++|.+. .|+.-+......... ......+..-...+....+.++.+=+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~---------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY---------------SFSRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh---------------hhhhcccccccccccccCcHHHHHHHHHH
Confidence 88899999999999999999 455444332111100 00001111111112344556788888899
Q ss_pred cCCCCCCCCCHHHHHH
Q 007290 543 TQASPEDRPAMSEVVR 558 (609)
Q Consensus 543 l~~dP~~RPs~~evl~ 558 (609)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999997776653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-08 Score=106.31 Aligned_cols=120 Identities=33% Similarity=0.538 Sum_probs=104.3
Q ss_pred EEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccc-cccccccccccccccCCccccCcccchhhhcccC
Q 007290 70 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS-SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148 (609)
Q Consensus 70 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 148 (609)
.++++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 588888887533 345566789999999999999 8888888885 9999999999999 88888999999999999999
Q ss_pred cCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCC
Q 007290 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNN 194 (609)
Q Consensus 149 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~ 194 (609)
+++ .+|.....+++|+.|++++|+++ .+|.. ...+..+.+++|+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999 88887778999999999999999 78874 4458999999996
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.3e-07 Score=85.24 Aligned_cols=125 Identities=19% Similarity=0.193 Sum_probs=90.7
Q ss_pred CCcEEEEEEeccCCC------CchHHHHHHHHHHHHhccCCC--cceeEeEEeCC----CcceEEeecccCc-hhhhhhh
Q 007290 307 DGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVHRN--LLRLIGFCTTP----TERLLVYPFMQNL-SVAYRLR 373 (609)
Q Consensus 307 ~g~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~ 373 (609)
.++.+.+|....... +-......+|...+..+.... +.+.+++.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 356677775432111 123446778888877775433 45566665442 2357899999874 7888887
Q ss_pred hcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEcccccceee
Q 007290 374 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAKLV 438 (609)
Q Consensus 374 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~~~ 438 (609)
.... .+......++.++++.++-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 111 ~~~~----~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ----LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc----cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5322 45566788999999999999999 999999999999999887 8999999987743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.8e-07 Score=94.96 Aligned_cols=141 Identities=23% Similarity=0.270 Sum_probs=92.6
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCc-----------------------------hHH----------HHHH
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-----------------------------GDA----------AFQR 330 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------------------------~~~----------~~~~ 330 (609)
+.|+.++-|.||+|++++|+.||||+.+....+. ..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999875321110 001 2334
Q ss_pred HHHHHHhcc-----CCCcceeEeEE-eCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHH-HHHHHh
Q 007290 331 EVEMISVAV-----HRNLLRLIGFC-TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG-LEYLHE 403 (609)
Q Consensus 331 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~ 403 (609)
|..-+.+++ .+++ ++=.++ .-..+..++|||++|-.+.+...-...+ .+ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---ID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CC---HHHHHHHHHHHHHHHHHh
Confidence 444444432 2332 222333 2346779999999998888775332222 23 33344444433 223333
Q ss_pred cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 404 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
. |++|.|.+|.||+++.++++.+.|||+...++.
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4 899999999999999999999999999987753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=6e-06 Score=77.55 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=102.3
Q ss_pred ccccCCceEEEEEeCCCcEEEEEEeccC-----CCCchHHHHHHHHHHHHhccCCC--cceeEeEEe---C--CCcceEE
Q 007290 292 LGQGGFGKVYRGVLADGTKVAVKRLTDF-----ESPGGDAAFQREVEMISVAVHRN--LLRLIGFCT---T--PTERLLV 359 (609)
Q Consensus 292 lg~G~~g~Vy~~~~~~g~~vavK~~~~~-----~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~---~--~~~~~lv 359 (609)
-|+||-+-|++..+. |..+-+|+-.+. .-+-....|.+|+..+.++...+ +.++. ++. . ..+.++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467888899998874 557999976421 11456789999999999886433 44444 332 1 1235788
Q ss_pred eecccC-chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEcccccce
Q 007290 360 YPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl~~ 436 (609)
+|-+.+ -+|.+++.+... ...+...+..+..+++.+++-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 478777755322 2356667789999999999999999 9999999999999986666 9999998775
Q ss_pred e
Q 007290 437 L 437 (609)
Q Consensus 437 ~ 437 (609)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1e-07 Score=96.02 Aligned_cols=127 Identities=25% Similarity=0.286 Sum_probs=60.6
Q ss_pred CeEEEEecCCCccc-ccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCC--ccccCcccchhh
Q 007290 67 NVASVTLSSMNFSG-TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP--PSLGNLKKLQFL 143 (609)
Q Consensus 67 ~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L 143 (609)
+++.|.|++++|+- .+-.-+..+|+|+.|+|..|..-+.-......++.|+.|||++|++- ..+ .-.+.|+.|..|
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhh
Confidence 44444444444441 11112233455555555555322122223334556666666666655 333 234556666666
Q ss_pred hcccCcCCCC-cCCC-----cCcccccccccCCCCcccccCC-----cccccCCcccCCCCCC
Q 007290 144 TLSQNNFSGT-IPDS-----LTTLSSLISIQLDSNNLSGQIP-----VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 144 ~l~~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~ip-----~~l~~l~~l~~~~n~~ 195 (609)
+++.+.++.. +|+. ...+++|++|+++.|++. ..+ ..+.++..|.+..|..
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccc
Confidence 6666665521 1222 234556666666666664 333 1233444445545544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.6e-06 Score=79.70 Aligned_cols=138 Identities=14% Similarity=0.143 Sum_probs=85.5
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCC--cceeEeEEeCCCcceEEeecccCch
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
..||+|..+.||+. .|..+++|..+... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 25567888875422 3455788999998886443 4667788777777889999999863
Q ss_pred -hhhh---------------------hhhcCCCCCCccHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEec
Q 007290 368 -VAYR---------------------LREIKPGEPVLDWVTRKR-VAL----------GAAR-GLEYLHEH-CNPKIIHR 412 (609)
Q Consensus 368 -L~~~---------------------l~~~~~~~~~l~~~~~~~-i~~----------~ia~-~L~~LH~~-~~~~ivH~ 412 (609)
+... ++....... ....... +.. .+.+ ...+|... ..+.++|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~--~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS--TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC--cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 1111 111111111 1111100 000 0111 12222221 13357899
Q ss_pred CCCCCcEEeCCCCcEEEcccccce
Q 007290 413 DVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 413 Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
|+.|.||++++++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.5e-07 Score=98.49 Aligned_cols=125 Identities=26% Similarity=0.364 Sum_probs=78.7
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.+..+++..|.+.. +-..+..+++|+.|+|..|+|. .+...+..+++|++|+|++|+|+. +. .+..|+.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i~-~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-LE-GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccc-cc-chhhccchhhheec
Confidence 44555566666663 3334666777777777777777 444446667777777777777773 32 35566667777777
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCC---cccccCCcccCCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP---VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip---~~l~~l~~l~~~~n~~~c 197 (609)
+|.|+ .++ .+..+++|+.+++++|.++..-+ ..+.++..+.+++|....
T Consensus 149 ~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 149 GNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIRE 200 (414)
T ss_pred cCcch-hcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhc
Confidence 77777 332 34456777777777777774333 344555666667765543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.5e-07 Score=93.25 Aligned_cols=109 Identities=27% Similarity=0.231 Sum_probs=49.5
Q ss_pred CeEEEEecCCCcccc--cCccccCCCCCCEEEccCCCcCCCCCcc-ccccccccccccccccccc-cCCccccCcccchh
Q 007290 67 NVASVTLSSMNFSGT--LSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVG-KIPPSLGNLKKLQF 142 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 142 (609)
+++.|||+.|-+..- +-.-...|++|+.|+|+.|++.-..... -..+++|+.|.|+.+.|+- .+-..+..+|+|+.
T Consensus 147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~ 226 (505)
T KOG3207|consen 147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV 226 (505)
T ss_pred cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence 667777777666532 2233455677777777777665222211 1124455555555555540 01111223444444
Q ss_pred hhcccCcCCCCcCCCcCcccccccccCCCCccc
Q 007290 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 143 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
|+|..|...+.-.....-+..|+.|||++|++-
T Consensus 227 L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 227 LYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred hhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 444444311121222223344444444444443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.5e-07 Score=96.53 Aligned_cols=129 Identities=26% Similarity=0.338 Sum_probs=101.6
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|.+|.|.++. ..+..+++|++|+|++|.|+ .+.. +..|+.|+.|++++|.|+ .++ .+..+++|+.+++
T Consensus 95 ~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~-~i~~-l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKIT-KLEG-LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhcc-cchhhhhcchheeccccccc-cccc-hhhccchhhheeccCcch-hcc-CCccchhhhcccC
Confidence 47999999999999544 34788999999999999999 4443 788888999999999999 444 5667999999999
Q ss_pred ccCcCCCCcCCC-cCcccccccccCCCCcccccCC--cccccCCcccCCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDS-LTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 146 ~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~c~~~~ 201 (609)
++|++. .+... +..+.+|+.+++.+|.+. .+. ..+..+..+++.+|...+..++
T Consensus 170 ~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 170 SYNRIV-DIENDELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred Ccchhh-hhhhhhhhhccchHHHhccCCchh-cccchHHHHHHHHhhcccccceeccCc
Confidence 999999 55543 578899999999999998 333 2344555567777776654443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=75.97 Aligned_cols=155 Identities=22% Similarity=0.243 Sum_probs=98.9
Q ss_pred ccCHHHHHHHhcCCCccCccc---ccCCceEEEEEeCCCcEEEEEEeccCCCCc------------------hHH----H
Q 007290 273 RYSWRELQLATDNFSEKNVLG---QGGFGKVYRGVLADGTKVAVKRLTDFESPG------------------GDA----A 327 (609)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------~~~----~ 327 (609)
..+++.+.....+..+....| .|--+.||+|...++..+|||+.+.....- ... .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345566666666666555544 566669999998889999999885321110 001 1
Q ss_pred -HHHHHHHHHhccC--CCcceeEeEEeCCCcceEEeecccCc-hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh
Q 007290 328 -FQREVEMISVAVH--RNLLRLIGFCTTPTERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403 (609)
Q Consensus 328 -~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 403 (609)
..+|+.-|.++.. -.+.+.+++ ....+||||+... .-.-.|.+. .+.......+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHH
Confidence 1246666665542 223333333 2467999998653 111112221 12222566677888888888887
Q ss_pred cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 404 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
.+ ++||+||+.-|||+. ++.+.++|||-+....
T Consensus 185 ~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 43 999999999999999 7899999999887554
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.3e-07 Score=61.98 Aligned_cols=36 Identities=44% Similarity=0.710 Sum_probs=20.8
Q ss_pred CCCEEEccCCCcCCCCCcccccccccccccccccccc
Q 007290 91 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 127 (609)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 127 (609)
+|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 5566666666666 45555666666666666666665
|
... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-05 Score=74.38 Aligned_cols=138 Identities=14% Similarity=0.132 Sum_probs=90.8
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHH---------HHHHHHHHhcc---CCCcceeEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAF---------QREVEMISVAV---HRNLLRLIG 348 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~~ 348 (609)
....+|...+++.......|.+-.. +|+.+++|..+... ...++.| .+.+....++. -...+.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4567888888888877777777666 58999999876532 2222222 23333333332 222333332
Q ss_pred EEe-----CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007290 349 FCT-----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 423 (609)
Q Consensus 349 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 423 (609)
... -....+++|||++|..|.+... ++. .++..+++++.-+|+. |++|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 222 1234568999999977655432 111 2456677889999999 9999999999999986
Q ss_pred CCcEEEcccccce
Q 007290 424 DFEAVVGDFGLAK 436 (609)
Q Consensus 424 ~~~~kl~DfGl~~ 436 (609)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 64 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 609 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-124 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-123 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-05 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 570 bits (1471), Expect = 0.0
Identities = 230/326 (70%), Positives = 272/326 (83%)
Query: 255 FVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK 314
F DV E D + GQLKR+S RELQ+A+DNFS KN+LG+GGFGKVY+G LADGT VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 315 RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE 374
RL + + GG+ FQ EVEMIS+AVHRNLLRL GFC TPTERLLVYP+M N SVA LRE
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 375 IKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434
+P LDW R+R+ALG+ARGL YLH+HC+PKIIHRDVKAAN+LLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494
AKL+D + T+VTT VRGT+GHIAPEYLSTGKSSE+TDVFGYG+MLLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 495 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
+DDV+LLD VK L +EK+L+A+VD +L NY +EVE +IQVALLCTQ+SP +RP MS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 555 EVVRMLEGEGLAERWEEWQHVEVTRR 580
EVVRMLEG+GLAERWEEWQ E+ R+
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 416 bits (1072), Expect = e-143
Identities = 107/311 (34%), Positives = 182/311 (58%), Gaps = 22/311 (7%)
Query: 263 DRRIAFGQLKRYSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRL 316
++ + +S+ EL+ T+NF E+ N +G+GGFG VY+G + + T VAVK+L
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 317 T---DFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLR 373
D + F +E+++++ H NL+ L+GF + + LVY +M N S+ RL
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 374 EIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433
G P L W R ++A GAA G+ +LHE+ IHRD+K+AN+LLDE F A + DFG
Sbjct: 123 C-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178
Query: 434 LAKLVDV-RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFS 492
LA+ + +T +T+++ GT ++APE L G+ + ++D++ +G++LLE++TG A+D
Sbjct: 179 LARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
Query: 493 RLEEEDDVLLLDHVKKLEREKR-LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP 551
R + LLLD +++E E++ ++ +D+ +N + + VE M VA C RP
Sbjct: 238 R----EPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 552 AMSEVVRMLEG 562
+ +V ++L+
Sbjct: 293 DIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-129
Identities = 113/294 (38%), Positives = 171/294 (58%), Gaps = 7/294 (2%)
Query: 270 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ 329
+ R +L+ AT+NF K ++G G FGKVY+GVL DG KVA+KR T ES G F+
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFE 83
Query: 330 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 389
E+E +S H +L+ LIGFC E +L+Y +M+N ++ L + W R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQ 448
+ +GAARGL YLH IIHRDVK+ N+LLDE+F + DFG++K ++ +T+++T
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508
V+GT+G+I PEY G+ +E++DV+ +G++L E++ + AI S E V L + +
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAVE 258
Query: 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562
+L+ IVD NL + + A+ C S EDRP+M +V+ LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-76
Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 37/310 (11%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMIS 336
L + V +G FG V++ L VAVK ++Q E E+ S
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYEVYS 71
Query: 337 VAV--HRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 390
+ H N+L+ IG + L+ F + S++ L+ V+ W +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126
Query: 391 ALGAARGLEYLHEH-------CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
A ARGL YLHE P I HRD+K+ NVLL + A + DFGLA + K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 444 NV-TTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
T GT ++APE L + R D++ G++L EL + A D +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV--DE 244
Query: 498 DDVLLLDHV-KKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQASPEDRP 551
+ + + + E + +V + + + + + C E R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 552 AMSEVVRMLE 561
+ V +
Sbjct: 305 SAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-64
Identities = 74/321 (23%), Positives = 117/321 (36%), Gaps = 44/321 (13%)
Query: 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM 334
+ E L DN ++G+G +G VY+G L D VAVK S F E +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNI 58
Query: 335 ISVAV--HRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR 387
V + H N+ R I E LLV + N S+ L DWV+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSS 113
Query: 388 KRVALGAARGLEYLHE------HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-- 439
R+A RGL YLH H P I HRD+ + NVL+ D V+ DFGL+ +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 440 -----VRKTNVTTQVRGTMGHIAPEYL-------STGKSSERTDVFGYGIMLLELVTGQR 487
+ N GT+ ++APE L + ++ D++ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 488 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN-----LNKNYNIQEV--ETMIQVAL 540
+ E + V + + +V R + + + ++ +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 541 LCTQASPEDRPAMSEVVRMLE 561
C E R +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-57
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 36/283 (12%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+ V+G+G FG V + VA+K++ ES AF E+ +S H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI---ESESERKAFIVELRQLSRVNHPNI 63
Query: 344 LRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
++L G C P E + + S+ L +P P L ++G+
Sbjct: 64 VKLYGACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVA 116
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
YLH +IHRD+K N+LL + + DFG A T +G+ +AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAP 172
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
E SE+ DVF +GI+L E++T ++ F + + + R
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEI----GGPAFRIMWAVHNGTRPP-- 224
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ +NL K +E+++ C P RP+M E+V+++
Sbjct: 225 LIKNLPK-----PIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-57
Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 29/287 (10%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 334
W +L + K +G G FG V+R G+ VAVK L F REV +
Sbjct: 36 WCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
+ H N++ +G T P +V ++ S+ L + E LD R +A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDV 146
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
A+G+ YLH + NP I+HR++K+ N+L+D+ + V DFGL++L + GT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPE 204
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514
+APE L S+E++DV+ +G++L EL T Q + L V + + KR
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV-----GFKCKR 257
Query: 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L+ + RNLN +V +I+ C P RP+ + ++ +L
Sbjct: 258 LE--IPRNLNP-----QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-54
Identities = 71/299 (23%), Positives = 131/299 (43%), Gaps = 53/299 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD------AAFQREVEMIS 336
+ + +G+GGFG V++G + D + VA+K L +S G FQREV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 337 VAVHRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
H N+++L G P E F+ + +RL P + W + R+ L
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVME------FVPCGDLYHRLL--DKAHP-IKWSVKLRLML 129
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-----VGDFGLAKLVDVRKTNVTT 447
A G+EY+ + NP I+HRD+++ N+ L E V DFGL++ + +
Sbjct: 130 DIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVS 184
Query: 448 QVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQ---RAIDFSRLEEEDDVLL 502
+ G +APE + +E+ D + + ++L ++TG+ + +++ + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-- 242
Query: 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E R + ++ + +I+ LC P+ RP S +V+ L
Sbjct: 243 ------REEGLRPT------IPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 44/297 (14%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL---TDFESPGGDAAFQREV 332
+ EL L + ++G GGFGKVYR G +VAVK D + ++E
Sbjct: 6 FAELTL-------EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 333 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
++ ++ H N++ L G C LV F + + L + + A+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAV 112
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV--------VGDFGLAKLVDVRKTN 444
ARG+ YLH+ IIHRD+K++N+L+ + E + DFGLA+ +T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTT 170
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504
+ G +APE + S+ +DV+ YG++L EL+TG+ + F ++
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLAVA---- 223
Query: 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ L + + + + M C P RP+ + ++ L
Sbjct: 224 -YGVAMNKLALP--IPSTCPEPF----AKLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-52
Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 12/181 (6%)
Query: 27 GDALFALRTSLRVPNNQLRDWNQN-QVNPCTWSNVICDNSNNVASVT---LSSMNFSGT- 81
AL ++ L P L W TW V+CD V LS +N
Sbjct: 8 KQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 82 -LSPRIGVLRTLSTLTL-KGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKK 139
+ + L L+ L + N + G IP + L+ L L + + + G IP L +K
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 140 LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK----YNFTGNNL 195
L L S N SGT+P S+++L +L+ I D N +SG IP K + N L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 196 N 196
Sbjct: 187 T 187
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 42/147 (28%), Positives = 63/147 (42%), Gaps = 5/147 (3%)
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
S S+T+S +G + P L L+ + L N + G+ G+ + +
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
L N L + +G K L L L N GT+P LT L L S+ + NNL G+IP
Sbjct: 228 LAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 181 --HLFQIPKYNFTGNNLNCGKTLPHSC 205
+L + + N CG LP +C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 41/108 (37%), Positives = 55/108 (50%), Gaps = 2/108 (1%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSL-TSLDLDNNRLVGKIP 131
S SGTL P I L L +T GN I+G IP+ G+ S L TS+ + NRL GKIP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
P+ NL L F+ LS+N G + + I L N+L+ +
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 73/330 (22%), Positives = 122/330 (36%), Gaps = 46/330 (13%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEM 334
+L VLG+G FG+ + G + +K L F+ F +EV++
Sbjct: 9 PSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKV 60
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
+ H N+L+ IG + +++ ++ ++ + W R A
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDI 117
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-------------VR 441
A G+ YLH IIHRD+ + N L+ E+ VV DFGLA+L+
Sbjct: 118 ASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501
V G +APE ++ E+ DVF +GI+L E++ A
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDF 232
Query: 502 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L+ L+R + + + + C PE RP+ ++ LE
Sbjct: 233 GLNVRGFLDRYCPPNCP--------------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
Query: 562 G--EGLAERWEEWQHVEVTRRQEYERLQRR 589
LA +E R +E +R
Sbjct: 279 TLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 68/316 (21%), Positives = 126/316 (39%), Gaps = 44/316 (13%)
Query: 271 LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 330
++R +++Q+ +G+G +G+V+ G G KVAVK E +A++ R
Sbjct: 31 VQRTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFR 78
Query: 331 EVEMISVAV--HRNLLRLIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDW 384
E E+ + H N+L I T+ L+ + +N S+ L+ LD
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDA 133
Query: 385 VTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
+ ++A + GL +LH P I HRD+K+ N+L+ ++ + D GLA
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193
Query: 440 VRKTNV---TTQVRGTMGHIAPE------YLSTGKSSERTDVFGYGIMLLELVTGQRAID 490
V GT ++ PE + +S D++ +G++L E+ R +
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR--RCVS 251
Query: 491 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQA 545
+EE E + + + L N+ + + + M ++ C
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 546 SPEDRPAMSEVVRMLE 561
+P R V + L
Sbjct: 312 NPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-51
Identities = 71/321 (22%), Positives = 134/321 (41%), Gaps = 54/321 (16%)
Query: 271 LKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQR 330
++R R++ L +G+G +G+V+RG G VAVK + + + ++ R
Sbjct: 2 MQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFR 49
Query: 331 EVEMISVAV--HRNLLRLIGFCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDW 384
E E+ + + H N+L I T T+ L+ + + S+ L+ LD
Sbjct: 50 ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDT 104
Query: 385 VTRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
V+ R+ L A GL +LH P I HRD+K+ N+L+ ++ + + D GLA +
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 440 ----VRKTNVTTQVRGTMGHIAPE------YLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
+V GT ++APE + S +R D++ +G++L E+ R +
Sbjct: 165 QSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR--RMV 221
Query: 490 DFSRLEEE----DDVLLLDHVKKLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVAL 540
+E+ DV+ D E + N+ ++ + ++ ++
Sbjct: 222 SNGIVEDYKPPFYDVVPNDPSF----EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277
Query: 541 LCTQASPEDRPAMSEVVRMLE 561
C +P R + + L
Sbjct: 278 ECWYQNPSARLTALRIKKTLT 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-51
Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 44/296 (14%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 334
++ + +G G FG VY+G VAVK L +P AF+ EV +
Sbjct: 23 DGQITV-------GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 335 ISVAVHRNLLRLIGFCTTP-----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 389
+ H N+L +G+ T P T+ + + S+ Y + E +
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAIVTQ------WCEGSSL-YHH--LHASETKFEMKKLID 124
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL-VDVRKTNVTTQ 448
+A ARG++YLH IIHRD+K+ N+ L ED +GDFGLA ++ Q
Sbjct: 125 IARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 449 VRGTMGHIAPE---YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505
+ G++ +APE + S ++DV+ +GI+L EL+TGQ + +S + D ++ +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEM-- 237
Query: 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
V + L + + + M + C + ++RP+ ++ +E
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRL-----MAE----CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-50
Identities = 58/292 (19%), Positives = 110/292 (37%), Gaps = 40/292 (13%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEM 334
+++L L + G++++G G + VK L + S F E
Sbjct: 9 FKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 335 ISVAVHRNLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
+ + H N+L ++G C +P + +M S+ L + V+D + AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFAL 118
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 452
ARG+ +LH P I + + +V++DED A + + +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYA 171
Query: 453 MGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509
+APE L D++ + ++L ELVT + + F+ L + +K
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE--VPFADLSNMEIG-----MKVA 224
Query: 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
R + ++ V +++ +C P RP +V +LE
Sbjct: 225 LEGLRPT--IPPGISP-----HVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-49
Identities = 67/300 (22%), Positives = 130/300 (43%), Gaps = 47/300 (15%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEM 334
+ +L++ ++G+G FG+VY G +VA++ + + ++ AF+REV
Sbjct: 32 FEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
H N++ +G C +P ++ + ++ +R+ K VLD +++A
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEI 139
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVR 450
+G+ YLH I+H+D+K+ NV D + V+ DFGL + V R+ +
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 451 GTMGHIAPEYLSTGKS---------SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501
G + H+APE + S+ +DVF G + EL + F E +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEAIIW 253
Query: 502 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++ + + + + K E+ ++ C E+RP ++++ MLE
Sbjct: 254 ------QMGTGMKPN-LSQIGMGK-----EISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 71/316 (22%), Positives = 128/316 (40%), Gaps = 46/316 (14%)
Query: 272 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQRE 331
+R R + L + +G+G FG+V+RG G +VAVK + E + ++ RE
Sbjct: 37 QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFRE 84
Query: 332 VEMISVAV--HRNLLRLIGFCT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 385
E+ + H N+L I T T+ LV + ++ S+ L +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVE 139
Query: 386 TRKRVALGAARGLEYLHE-----HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
++AL A GL +LH P I HRD+K+ N+L+ ++ + D GLA D
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 441 RKTNVT---TQVRGTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQRAIDF 491
+ GT ++APE L +S +R D++ G++ E+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--- 256
Query: 492 SRLEEEDDVLLLDHVK-KLEREKRLDAIVDRNL-----NKNYNIQEVETMIQVALLCTQA 545
+ E+ + D V E+ + ++ L N+ + + + M ++ C A
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 546 SPEDRPAMSEVVRMLE 561
+ R + + L
Sbjct: 317 NGAARLTALRIKKTLS 332
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 1e-40
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 2/156 (1%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
+ ++S + G SP ++ L + N ++G IP+E+G++ L L+L +
Sbjct: 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGH 665
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-L 182
N + G IP +G+L+ L L LS N G IP +++ L+ L I L +NNLSG IP
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
Query: 183 FQ-IPKYNFTGNNLNCGKTLPHSCESSSNDSGSSKK 217
F+ P F N CG LP S+++ ++
Sbjct: 726 FETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-37
Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 2/146 (1%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
+ + + + L G + + ++TL TL L N +TGEIP L N ++L + L N
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
NRL G+IP +G L+ L L LS N+FSG IP L SLI + L++N +G IP +F
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 184 QIPKYNFTGNNLNCGKTLPHSCESSS 209
+ N GK +
Sbjct: 560 KQS--GKIAANFIAGKRYVYIKNDGM 583
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 5/151 (3%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
N + + S+ LS SGT+ +G L L L L N + GEIP+EL + +L +L LD
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
N L G+IP L N L +++LS N +G IP + L +L ++L +N+ SG IP L
Sbjct: 476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 184 QIPK---YNFTGNNLNCGKTLPHSCESSSND 211
+ N N G T+P + S
Sbjct: 536 DCRSLIWLDLNTNLFN-G-TIPAAMFKQSGK 564
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-36
Identities = 55/141 (39%), Positives = 76/141 (53%), Gaps = 5/141 (3%)
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTS 118
+ + S ++ ++ LSS NFSG + P + TL L L+ NG TG+IP L N S L S
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 119 LDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI 178
L L N L G IP SLG+L KL+ L L N G IP L + +L ++ LD N+L+G+I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 179 PVHLFQIPK---YNFTGNNLN 196
P L + + N L
Sbjct: 483 PSGLSNCTNLNWISLSNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 41/115 (35%), Positives = 63/115 (54%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L + F+G + P + L +L L N ++G IP LG+LS L L L N L G+IP
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
L +K L+ L L N+ +G IP L+ ++L I L +N L+G+IP + ++
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 48/130 (36%), Positives = 68/130 (52%), Gaps = 8/130 (6%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIP 131
+SS F G + P L++L L+L N TGEIP+ L G +LT LDL N G +P
Sbjct: 254 ISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY-- 188
P G+ L+ L LS NNFSG +P D+L + L + L N SG++P L +
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371
Query: 189 --NFTGNNLN 196
+ + NN +
Sbjct: 372 TLDLSSNNFS 381
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 38/144 (26%), Positives = 61/144 (42%), Gaps = 9/144 (6%)
Query: 57 WSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSL 116
V+ D + + +S SG + + L L + N + IP LG+ S+L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 117 TSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176
LD+ N+L G ++ +L+ L +S N F G IP L SL + L N +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTG 283
Query: 177 QIPVHLFQIPKY----NFTGNNLN 196
+IP L + +GN+
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 4/131 (3%)
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSL 119
+ + + + LS +F G + P G L +L L N +GE+P + L + L L
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 120 DLDNNRLVGKIPPSLGNLK-KLQFLTLSQNNFSGTIPDSL--TTLSSLISIQLDSNNLSG 176
DL N G++P SL NL L L LS NNFSG I +L ++L + L +N +G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 177 QIPVHLFQIPK 187
+IP L +
Sbjct: 409 KIPPTLSNCSE 419
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 4/133 (3%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
+ ++ L + +G + + L+ ++L N +TGEIP+ +G L +L L L N
Sbjct: 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSN 523
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
N G IP LG+ + L +L L+ N F+GTIP ++ S I+ +N ++G+ V++
Sbjct: 524 NSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA----ANFIAGKRYVYIK 579
Query: 184 QIPKYNFTGNNLN 196
N
Sbjct: 580 NDGMKKECHGAGN 592
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-29
Identities = 41/160 (25%), Positives = 62/160 (38%), Gaps = 27/160 (16%)
Query: 26 QGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPR 85
+ L + + L N L DW+ N+ NPCT+ V C + V S+ LSS +
Sbjct: 13 EIHQLISFKDVL-PDKNLLPDWSSNK-NPCTFDGVTCRDDK-VTSIDLSSKPLNVGF--- 66
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L +L+ L SL L N+ + G + L L L
Sbjct: 67 ------------------SAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDL 107
Query: 146 SQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLF 183
S+N+ SG + SL + S L + + SN L V
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 31/137 (22%), Positives = 49/137 (35%), Gaps = 9/137 (6%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
N+A + LS+ +FSG + +G R+L L L N G IP + S +
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAA 567
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQN--NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
N + GK + N + + N F G + L LS+ + S G
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 182 LFQIPKY---NFTGNNL 195
+ + N L
Sbjct: 628 FDNNGSMMFLDMSYNML 644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 47/290 (16%)
Query: 288 EKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
V+G+G FG VY G D + A+K L+ AF RE ++ H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 344 LRLIGFCTTPTERLL-VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
L LIG P + P+M + + +R + V D ++ L ARG+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGMEYLA 141
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----A 457
E K +HRD+ A N +LDE F V DFGLA+ D+ + + + A
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTA 196
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREK 513
E L T + + ++DV+ +G++L EL+T G ID D+ L + +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID------PFDLT-----HFLAQGR 245
Query: 514 RLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
RL +L Y + M Q C +A P RP +V +E
Sbjct: 246 RLPQPEYCPDSL---YQV-----MQQ----CWEADPAVRPTFRVLVGEVE 283
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 290 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
V+G+G FG VY G L D AVK L G + F E ++ H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 346 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
L+G C L+V P+M++ + +R V D + L A+G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---GFGLQVAKGMKYLASK 147
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APE 459
K +HRD+ A N +LDE F V DFGLA+ D+ + T + A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 460 YLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL 515
L T K + ++DV+ +G++L EL+T G ++ D+ L + +RL
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DIT-----VYLLQGRRL 251
Query: 516 DAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L Y + M++ C E RP+ SE+V +
Sbjct: 252 LQPEYCPDPL---YEV-----MLK----CWHPKAEMRPSFSELVSRIS 287
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 79/288 (27%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 290 NVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
V+G+G FG VY G L D AVK L G + F E ++ H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 346 LIGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
L+G C L+V P+M++ + +R V D + L A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---GFGLQVAKGMKFLASK 211
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----APE 459
K +HRD+ A N +LDE F V DFGLA+ D+ + T + A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 460 YLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKRL 515
L T K + ++DV+ +G++L EL+T G ++ D+ L + +RL
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDIT-----VYLLQGRRL 315
Query: 516 DAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L Y + M++ C E RP+ SE+V +
Sbjct: 316 LQPEYCPDPL---YEV-----MLK----CWHPKAEMRPSFSELVSRIS 351
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-37
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 49/292 (16%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
++ +G+G FG+V+ G L AD T VAVK + P A F +E ++ H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
++RLIG CT +V +Q LR L T ++ AA G+EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-----A 457
IHRD+ A N L+ E + DFG+++ V G + + A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAA-SGGLRQVPVKWTA 283
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL- 515
PE L+ G+ S +DV+ +GI+L E + G + L + + +E+ RL
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP--YPNLSNQ-QTR-----EFVEKGGRLP 335
Query: 516 ------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
DA+ + + M Q C P RP+ S + + L+
Sbjct: 336 CPELCPDAV--------FRL-----MEQ----CWAYEPGQRPSFSTIYQELQ 370
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 42/299 (14%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVA 338
LG+G FGKV G +VAVK L A ++E+E++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 339 VHRNLLRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 396
H N+++ G CT L+ F+ + S+ L + + ++ + + A+ +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICK 137
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---- 452
G++YL + +HRD+ A NVL++ + + +GDFGL K ++ K T +
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 453 -MGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED------DVLLLD 504
APE L K +DV+ +G+ L EL+T L + + +
Sbjct: 195 WY---APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 505 HVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
V L+ KRL + + Y + M + C + P +R + ++ E
Sbjct: 252 LVNTLKEGKRLPCPPNCPDEV---YQL-----MRK----CWEFQPSNRTSFQNLIEGFE 298
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 47/293 (16%)
Query: 289 KNVLGQGGFGKVYRGVLADG----TKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 343
+LG+G FG V G L KVAVK + D S F E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 344 LRLIGFCT-----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--RVALGAAR 396
+RL+G C + +++ PFM+ + L + + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
G+EYL +HRD+ A N +L +D V DFGL+K + + Q R +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPV 213
Query: 457 ---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 512
A E L+ + ++DV+ +G+ + E+ T G + ++ + + D++ R
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHE---MYDYLLHGHRL 268
Query: 513 KR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
K+ LD + Y I M C + P DRP S + LE
Sbjct: 269 KQPEDCLDEL--------YEI-----MYS----CWRTDPLDRPTFSVLRLQLE 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 74/299 (24%), Positives = 112/299 (37%), Gaps = 54/299 (18%)
Query: 289 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
LG+G FGKV G VAVK L P + +++E++++ H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 344 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
++ G C LV ++ S+ L G L A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 456
H IHRD+ A NVLLD D +GDFGLAK V + G
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE------DDVLLLDHVKKL 509
APE L K +DV+ +G+ L EL+T + E + +L + L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 510 EREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
ER +RL + Y++ M C + RP ++ +L+
Sbjct: 265 ERGERLPRPDKCPAEV--------YHL-----MKN----CWETEASFRPTFENLIPILK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 43/294 (14%)
Query: 289 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+ LG+G FG V G VAVK+L P FQRE++++ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILKALHSDFI 86
Query: 344 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
++ G P + LV ++ + + L+ LD + +G+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYL 143
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI----- 456
+ +HRD+ A N+L++ + + DFGLAKL+ + K V G
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPGQSPIFWY 197
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVT-------GQRAIDFSRLEEEDDVLLLDHVKKL 509
APE LS S ++DV+ +G++L EL T E D L ++ L
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 510 EREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E +RL A + + + M C SP+DRP+ S + L+
Sbjct: 258 EEGQRLPAPPACPAEV---HEL-----MKL----CWAPSPQDRPSFSALGPQLD 299
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 48/294 (16%)
Query: 289 KNVLGQGGFGKVYRGVLADG----TKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNL 343
+LG+G FG V L KVAVK L D + F RE + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 344 LRLIGFCT------TPTERLLVYPFMQNLSVAYRLREIKPGE--PVLDWVTRKRVALGAA 395
+L+G +++ PFM++ + L + GE L T R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
G+EYL IHRD+ A N +L ED V DFGL++ + + Q +
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYRQGCASKLP 202
Query: 456 I---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLER 511
+ A E L+ + +DV+ +G+ + E++T GQ ++ +E + + +++ R
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAE---IYNYLIGGNR 257
Query: 512 EKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
K+ ++ + Y++ M Q C A P+ RP+ + + LE
Sbjct: 258 LKQPPECMEEV--------YDL-----MYQ----CWSADPKQRPSFTCLRMELE 294
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 71/292 (24%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
LGQG FG VY GV T+VA+K + + S F E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKR---VALGAAR 396
++RL+G + L++ M + LR ++P PVL + + +A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
G+ YL+ + K +HRD+ A N ++ EDF +GDFG+ + D+ +T+ +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGLL 202
Query: 457 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 510
+PE L G + +DV+ +G++L E+ T ++ + L E + + L+
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFVMEGGLLD 260
Query: 511 R-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + D + + + M C Q +P+ RP+ E++ ++
Sbjct: 261 KPDNCPDML--------FEL-----MRM----CWQYNPKMRPSFLEIISSIK 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)
Query: 289 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
LG+G FG V G VAVK+L + F+RE+E++ H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNI 104
Query: 344 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
++ G C + R L+ ++ S+ L++ + +D + + +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL 161
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 456
+ IHRD+ N+L++ + +GDFGL K++ K + G
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--------DVLLLDHVKK 508
APE L+ K S +DV+ +G++L EL T E +++ ++
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 509 LEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L+ RL + Y I M + C + RP+ ++ ++
Sbjct: 276 LKNNGRLPRPDGCPDEI---YMI-----MTE----CWNNNVNQRPSFRDLALRVD 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 66/295 (22%), Positives = 119/295 (40%), Gaps = 44/295 (14%)
Query: 289 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
LG+G FG V G VAVK+L + F+RE+E++ H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNI 73
Query: 344 LRLIGFCTTPTER--LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
++ G C + R L+ ++ S+ L++ + +D + + +G+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL 130
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT-----MGHI 456
+ IHRD+ N+L++ + +GDFGL K++ K + G
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED--------DVLLLDHVKK 508
APE L+ K S +DV+ +G++L EL T E +++ ++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 509 LEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L+ RL + Y I M + C + RP+ ++ ++
Sbjct: 245 LKNNGRLPRPDGCPDEI---YMI-----MTE----CWNNNVNQRPSFRDLALRVD 287
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 70/300 (23%), Positives = 134/300 (44%), Gaps = 60/300 (20%)
Query: 289 KNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLL 344
++V+G+G FG+V + + A+KR+ ++ S F E+E + + H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------------RVAL 392
L+G C L + + ++ LR+ + E + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 452
ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +V V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 453 MGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLL 503
MG + A E L+ + +DV+ YG++L E+V+ G + + L
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------- 250
Query: 504 DHVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+KL + RL+ ++ + Y++ M Q C + P +RP+ ++++ L
Sbjct: 251 --YEKLPQGYRLEKPLNCDDEV---YDL-----MRQ----CWREKPYERPSFAQILVSLN 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 68/307 (22%), Positives = 119/307 (38%), Gaps = 56/307 (18%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-M 334
D + LG+G FG+V VAVK L D + + E+E M
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------------LSVAYRLREIKPGEPVL 382
+ H+N++ L+G CT ++ + + Y + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ ARG+EYL K IHRD+ A NVL+ E+ + DFGLA+ D+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 209
Query: 443 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498
+ + + APE L + ++DV+ +G+++ E+ T G + + E+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE 267
Query: 499 DVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
L +K+ +++ + + Y + M C A P RP
Sbjct: 268 ---LFKLLKEGHRMDKPANCTNEL--------YMM-----MRD----CWHAVPSQRPTFK 307
Query: 555 EVVRMLE 561
++V L+
Sbjct: 308 QLVEDLD 314
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 54/301 (17%)
Query: 289 KNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 341
LG+G FG+V VAVK L + + A E++ +I + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 342 NLLRLIGFCTTPTE-RLLVYPFMQN------------LSVAYRLREIKPGEPVLDWVTRK 388
N++ L+G CT P +++ F + V Y++ + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 389 RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
+ A+G+E+L K IHRD+ A N+LL E + DFGLA+ D+ K
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD--Y 204
Query: 449 VRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL 502
VR + APE + + ++DV+ +G++L E+ + G + ++ +++
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC- 261
Query: 503 LDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
++L+ R+ + Y M+ C P RP SE+V L
Sbjct: 262 ----RRLKEGTRMRAPDYTTPEM---YQT-----MLD----CWHGEPSQRPTFSELVEHL 305
Query: 561 E 561
Sbjct: 306 G 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 62/294 (21%)
Query: 290 NVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
VLG G FG VY+G+ VA+K L + SP + E +++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYL 401
RL+G C T T L+ M + +RE K L+W + A+G+ YL
Sbjct: 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 133
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---AP 458
+ +++HRD+ A NVL+ + DFGLAKL+ G I A
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMAL 188
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVT-GQR---AIDFSRLEEEDDVLLLDHVKKLEREKR 514
E + + ++DV+ YG+ + EL+T G + I S ++ LE+ +R
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EIS-----SILEKGER 237
Query: 515 L-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L + Y I M + C + RP E++
Sbjct: 238 LPQPPICTIDV--------YMI-----MRK----CWMIDADSRPKFRELIIEFS 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
LG G FG+VY G ++ +VAVK L + S + F E +IS H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---VALGAARGLE 399
++R IG R ++ M + LRE +P + VA A G +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 400 YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
YL E+ IHRD+ A N LL A +GDFG+A+ D+ + + +G +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR--KGGCAML 207
Query: 457 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 510
PE G + +TD + +G++L E+ + G + + +VL + +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQ-EVL-----EFVT 259
Query: 511 REKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
R+D + + Y I M Q C Q PEDRP + ++ +E
Sbjct: 260 SGGRMDPPKNCPGPV---YRI-----MTQ----CWQHQPEDRPNFAIILERIE 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 71/317 (22%), Positives = 120/317 (37%), Gaps = 56/317 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-M 334
D + LG+G FG+V VAVK L D + + E+E M
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------------LSVAYRLREIKPGEPVL 382
+ H+N++ L+G CT ++ + + Y + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ ARG+EYL K IHRD+ A NVL+ E+ + DFGLA+ D+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR--DINN 255
Query: 443 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498
+ + + APE L + ++DV+ +G+++ E+ T G + + E+
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE 313
Query: 499 DVLLLDHVKKLEREKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
L +K+ R + + + Y + M C A P RP
Sbjct: 314 ---LFKLLKEGHRMDKPANCTNEL--------YMM-----MRD----CWHAVPSQRPTFK 353
Query: 555 EVVRMLEGEGLAERWEE 571
++V L+ EE
Sbjct: 354 QLVEDLDRILTLTTNEE 370
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 47/293 (16%)
Query: 289 KNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
LG G FG+VY G + +VAVK L + S + F E +IS H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---VALGAARGLE 399
++R IG R ++ M + LRE +P + VA A G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 400 YLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
YL E+ IHRD+ A N LL A +GDFG+A+ D+ + +G +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYR--KGGCAML 248
Query: 457 -----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLE 510
PE G + +TD + +G++L E+ + G + ++ +L+ V
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTS-- 301
Query: 511 REKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
R+D + + Y I M Q C Q PEDRP + ++ +E
Sbjct: 302 -GGRMDPPKNCPGPV---YRI-----MTQ----CWQHQPEDRPNFAIILERIE 341
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 68/307 (22%), Positives = 114/307 (37%), Gaps = 60/307 (19%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 341
VLG G FGKV +VAVK L + A E++ M + H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 342 NLLRLIGFCTTPTERLLVYPFMQN----------------LSVAYRLREIKPGEPVLDWV 385
N++ L+G CT L++ + + Y ++ E L+ +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 386 TRKR---VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
T + A A+G+E+L +HRD+ A NVL+ + DFGLA+ D+
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMS 224
Query: 443 TNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496
+ V + APE L G + ++DV+ YGI+L E+ + G + +
Sbjct: 225 DSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG--VNPYPGIPV 280
Query: 497 EDDVLLLDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
+ + K ++ ++D + Y I M C RP+
Sbjct: 281 DANFY-----KLIQNGFKMDQPFYATEEI---YII-----MQS----CWAFDSRKRPSFP 323
Query: 555 EVVRMLE 561
+ L
Sbjct: 324 NLTSFLG 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 71/302 (23%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 289 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVE-MISVAV 339
LG+G FG+V TKVAVK L + + E+E M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR---------- 389
H+N++ L+G CT ++ + ++ L+ +P +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 390 --VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
A ARG+EYL K IHRD+ A NVL+ ED + DFGLA+ D+ +
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 248
Query: 448 QVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503
+ + APE L + ++DV+ +G++L E+ T G + + E+ L
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEE---LF 303
Query: 504 DHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
+K+ +++ + + Y + M C A P RP ++V
Sbjct: 304 KLLKEGHRMDKPSNCTNEL--------YMM-----MRD----CWHAVPSQRPTFKQLVED 346
Query: 560 LE 561
L+
Sbjct: 347 LD 348
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 52/289 (17%)
Query: 289 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
+LG+G FG+VY GV + VAVK + F E ++ H +++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 345 RLIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
+LIG PT ++ + + L K VL V +L + + YL
Sbjct: 77 KLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLV---LYSLQICKAMAYLES 131
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEY 460
+HRD+ N+L+ +GDFGL++ ++ + T I +PE
Sbjct: 132 I---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPES 185
Query: 461 LSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL---- 515
++ + + +DV+ + + + E+++ G++ F LE + DV+ LE+ RL
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENK-DVI-----GVLEKGDRLPKPD 237
Query: 516 ---DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Y + M + C P DRP +E+V L
Sbjct: 238 LCPPVL--------YTL-----MTR----CWDYDPSDRPRFTELVCSLS 269
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 61/313 (19%)
Query: 269 GQLKRYSW----RELQLATDNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDF 319
G +K + EL+ VLG G FG V++GV V +K + D
Sbjct: 1 GAMKVLARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK 53
Query: 320 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 379
A + I H +++RL+G C + LV ++ S+ +R+ +
Sbjct: 54 SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
+ + A+G+ YL EH ++HR++ A NVLL + V DFG+A L+
Sbjct: 113 GPQLLLN---WGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
Query: 440 VRKTNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 495
+ I A E + GK + ++DV+ YG+ + EL+T G
Sbjct: 167 --PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------ 218
Query: 496 EEDDVLLLDHVKKLEREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPE 548
+ L + LE+ +RL + Y + M++ C
Sbjct: 219 --AGLRLAEVPDLLEKGERLAQPQICTIDV--------YMV-----MVK----CWMIDEN 259
Query: 549 DRPAMSEVVRMLE 561
RP E+
Sbjct: 260 IRPTFKELANEFT 272
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 69/302 (22%), Positives = 108/302 (35%), Gaps = 49/302 (16%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MIS 336
+N LG G FGKV KVAVK L A E++ M
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-------- 388
+ H N++ L+G CT L++ + + LR
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 389 --RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
+ A+G+ +L IHRDV A NVLL A +GDFGLA+ D+ +
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSN- 219
Query: 447 TQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDV 500
+ + APE + + ++DV+ YGI+L E+ + G + +
Sbjct: 220 -YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG--LNPYPGILVNSKF 276
Query: 501 LLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
K ++ ++ KN Y+I M C P RP ++
Sbjct: 277 Y-----KLVKDGYQMAQ--PAFAPKNIYSI-----MQA----CWALEPTHRPTFQQICSF 320
Query: 560 LE 561
L+
Sbjct: 321 LQ 322
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G G FG V+ G + KVA+K + + + F E E++ H L++L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
C LV FM++ ++ LR + T + L G+ YL E
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 465
+IHRD+ A N L+ E+ V DFG+ + V + T GT + +PE S +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 466 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 522
S ++DV+ +G+++ E+ + G+ + +V+ + + RL +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP--YENRSNS-EVV-----EDISTGFRLYKPRLASTH 233
Query: 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Y I M C + PEDRPA S ++R L
Sbjct: 234 V---YQI-----MNH----CWRERPEDRPAFSRLLRQLA 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 58/298 (19%), Positives = 111/298 (37%), Gaps = 37/298 (12%)
Query: 270 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ 329
+ ++ + + LG G FG V G VA+K + + + F
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFI 67
Query: 330 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR 389
E +++ H L++L G CT ++ +M N + LRE
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLE 124
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV 449
+ +EYL + +HRD+ A N L+++ V DFGL++ V + T
Sbjct: 125 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS 178
Query: 450 RGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 505
G+ + PE L K S ++D++ +G+++ E+ + G+ + R +
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNS-ETA---- 231
Query: 506 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + + RL + Y I M C ++RP ++ +
Sbjct: 232 -EHIAQGLRLYRPHLASEKV---YTI-----MYS----CWHEKADERPTFKILLSNIL 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-32
Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
LGQG FG+V+ G T+VA+K L F +E +++ H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAV 247
Query: 350 CTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ P +V +M S+ L+ L +A A G+ Y+
Sbjct: 248 VSEEPI--YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE G+ +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKN 526
++DV+ +GI+L EL T R + + + +V + ++ER R+ + +L
Sbjct: 361 KSDVWSFGILLTELTTKGR-VPYPGMVNR-EV-----LDQVERGYRMPCPPECPESL--- 410
Query: 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+++ M Q C + PE+RP + LE
Sbjct: 411 HDL-----MCQ----CWRKEPEERPTFEYLQAFLE 436
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 61/312 (19%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISV 337
N LG+G FGKV + T VAVK L + SP E ++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA--- 394
H ++++L G C+ LL+ + + S+ LRE + P R +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 395 -----------------ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437
++G++YL E K++HRD+ A N+L+ E + + DFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 438 VDVRKTNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSR 493
DV + + + + A E L + ++DV+ +G++L E+VT G +
Sbjct: 199 -DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPG 255
Query: 494 LEEEDDVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED 549
+ E L + +K +ER + + + Y + M+Q C + P+
Sbjct: 256 IPPER---LFNLLKTGHRMERPDNCSEEM--------YRL-----MLQ----CWKQEPDK 295
Query: 550 RPAMSEVVRMLE 561
RP +++ + LE
Sbjct: 296 RPVFADISKDLE 307
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 55/346 (15%)
Query: 233 LISGGLLFFLCKGRHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL 292
L S G + R + +D + +LK + + L
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR--DNLLIADIEL 344
Query: 293 GQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
G G FG V +GV VA+K L RE +++ + ++RLIG
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409
C +LV + L + + + + G++YL E
Sbjct: 405 CQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK---NF 457
Query: 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAPEYLST 463
+HR++ A NVLL A + DFGL+K + + T + G APE ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINF 513
Query: 464 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL------- 515
K S R+DV+ YG+ + E ++ GQ+ + +++ +V+ +E+ KR+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-EVM-----AFIEQGKRMECPPECP 565
Query: 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Y + M C EDRP V + +
Sbjct: 566 PEL--------YAL-----MSD----CWIYKWEDRPDFLTVEQRMR 594
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
LGQG FG+V+ G T+VA+K L F +E +++ H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAV 330
Query: 350 CTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ P +V +M S+ L+ L +A A G+ Y+
Sbjct: 331 VSEEPI--YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE G+ +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 469 RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKN 526
++DV+ +GI+L EL T R + + + +V + ++ER R+ + +L
Sbjct: 444 KSDVWSFGILLTELTTKGR-VPYPGMVNR-EV-----LDQVERGYRMPCPPECPESL--- 493
Query: 527 YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+++ M Q C + PE+RP + LE
Sbjct: 494 HDL-----MCQ----CWRKEPEERPTFEYLQAFLE 519
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVA 338
F + VLG G FG VY+G+ VA+K L + SP + E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
+ ++ RL+G C T T L+ M + +RE K + + A+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLL---NWCVQIAKGM 130
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI-- 456
YL + +++HRD+ A NVL+ + DFGLAKL+ G I
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKW 185
Query: 457 -APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514
A E + + ++DV+ YG+ + EL+T G + D + + LE+ +R
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--------DGIPASEISSILEKGER 237
Query: 515 LDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L ++ Y I M++ C + RP E++
Sbjct: 238 LPQPPICTIDV---YMI-----MVK----CWMIDADSRPKFRELIIEFS 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 59/298 (19%), Positives = 119/298 (39%), Gaps = 46/298 (15%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREV 332
R+ ++ + +G+G FG V++G+ VA+K + S F +E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 333 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
+ H ++++LIG T ++ + L+ K + + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLI---LYAY 498
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ---- 448
+ L YL + +HRD+ A NVL+ + +GDFGL++ + +
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGK 553
Query: 449 --VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 505
++ APE ++ + + +DV+ +G+ + E++ G + F ++ DV+
Sbjct: 554 LPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-DVI---- 602
Query: 506 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++E +RL + L Y++ M + C P RP +E+ L
Sbjct: 603 -GRIENGERLPMPPNCPPTL---YSL-----MTK----CWAYDPSRRPRFTELKAQLS 647
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 65/305 (21%), Positives = 108/305 (35%), Gaps = 51/305 (16%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVE-MIS 336
+ S LG G FGKV VAVK L A E++ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV------ 390
+ H N++ L+G CT L++ + + LR +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 391 --------ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ A+G+ +L IHRD+ A N+LL + DFGLA+ D++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR--DIKN 197
Query: 443 TNVTTQVRGTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498
+ + APE + + +DV+ YGI L EL + G + + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMPVDS 255
Query: 499 DVLLLDHVKKLEREKRLD--AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
K ++ R+ + Y+I M C A P RP ++
Sbjct: 256 KFY-----KMIKEGFRMLSPEHAPAEM---YDI-----MKT----CWDADPLKRPTFKQI 298
Query: 557 VRMLE 561
V+++E
Sbjct: 299 VQLIE 303
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 288 EKNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
LG G FG V +GV VA+K L RE +++ + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
RLIG C +LV + L + + + + G++YL E
Sbjct: 74 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK 129
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 458
+HRD+ A NVLL A + DFGL+K + + T + G AP
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----AP 182
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
E ++ K S R+DV+ YG+ + E ++ GQ+ + +++ +V+ +E+ KR++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP-EVM-----AFIEQGKRMEC 234
Query: 518 IVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ L Y + M C EDRP V + +
Sbjct: 235 PPECPPEL---YAL-----MSD----CWIYKWEDRPDFLTVEQRMR 268
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVHRNLLRLIG 348
+G+G F VY+G+ +VA L D + + F+ E EM+ H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 349 FCTTPTE---RLLVYP-FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
+ + +++ M + ++ L+ K + + +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 405 CNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
P IIHRD+K N+ + +V +GD GLA L + + V GT +APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 204
Query: 464 GKSSERTDVFGYGIMLLELVTGQ 486
E DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 64/297 (21%), Positives = 115/297 (38%), Gaps = 49/297 (16%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
LG+ FGKVY+G L VA+K L D F+ E + + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------------RV 390
++ L+G T +++ + + + L P V + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
A G+EYL H ++H+D+ NVL+ + + D GL + +V + +
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYKLLG 188
Query: 451 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506
++ I APE + GK S +D++ YG++L E+ + G + + + DV+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQ-DVV----- 240
Query: 507 KKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + + L D + Y + MI+ C P RP ++ L
Sbjct: 241 EMIRNRQVLPCPDDCPAWV---YAL-----MIE----CWNEFPSRRPRFKDIHSRLR 285
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 65/279 (23%), Positives = 108/279 (38%), Gaps = 37/279 (13%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG G FG V G VAVK + + + F +E + + H L++ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
C+ +V ++ N + LR G + + G+ +L H +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL---EMCYDVCEGMAFLESH---Q 124
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 465
IHRD+ A N L+D D V DFG+ + V + GT + APE K
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFK 181
Query: 466 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 522
S ++DV+ +GI++ E+ + G+ + +V+ K+ + RL
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP--YDLYTNS-EVV-----LKVSQGHRLYRPHLASDT 233
Query: 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Y I M C PE RP +++ +E
Sbjct: 234 I---YQI-----MYS----CWHELPEKRPTFQQLLSSIE 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 53/298 (17%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
K LG+G FGKV+ + VAVK L + S FQRE E++++ H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQH 104
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR-----------VA 391
++R G CT L+V+ +M++ + LR P +L VA
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
A G+ YL +HRD+ N L+ + +GDFG+++ D+ T+ G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYR--VG 217
Query: 452 TMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 505
+ PE + K + +DV+ +G++L E+ T G++ + +L + +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNT-EAI---- 270
Query: 506 VKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + + L+ + Y I M C Q P+ R ++ +V L+
Sbjct: 271 -DCITQGRELERPRACPPEV---YAI-----MRG----CWQREPQQRHSIKDVHARLQ 315
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 40/281 (14%)
Query: 291 VLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
+G+G FG V++G+ VA+K + S F +E + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
IG T ++ + L+ K + + A + L YL
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLI---LYAYQLSTALAYLESK-- 135
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLST 463
+ +HRD+ A NVL+ + +GDFGL++ ++ + + I APE ++
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESINF 191
Query: 464 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD-- 520
+ + +DV+ +G+ + E++ G + F ++ DV+ ++E +RL +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNN-DVI-----GRIENGERLPMPPNCP 243
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L Y++ M + C P RP +E+ L
Sbjct: 244 PTL---YSL-----MTK----CWAYDPSRRPRFTELKAQLS 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G+G FG V G G KVAVK + + + AF E +++ H NL++L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG 253
Query: 349 FCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
L +V +M S+ LR G VL + +L +EYL +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 467
+HRD+ A NVL+ ED A V DFGL K + V+ T APE L K S
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 468 ERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLN 524
++DV+ +GI+L E+ + G+ + R+ + DV V ++E+ ++DA +
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP--YPRIPLK-DV-----VPRVEKGYKMDAPDGCPPAV- 415
Query: 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
Y++ M C RP ++ LE
Sbjct: 416 --YDV-----MKN----CWHLDAATRPTFLQLREQLE 441
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+G+G FG V G G KVAVK + + + AF E +++ H NL++L+G
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLG 81
Query: 349 FCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
L +V +M S+ LR G VL + +L +EYL +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSS 467
+HRD+ A NVL+ ED A V DFGL K + V+ T APE L K S
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 468 ERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLN 524
++DV+ +GI+L E+ + G+ + R+ + DV+ ++E+ ++DA +
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP--YPRIPLK-DVV-----PRVEKGYKMDAPDGCPPAV- 243
Query: 525 KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
Y + M C RP+ ++ LE
Sbjct: 244 --YEV-----MKN----CWHLDAAMRPSFLQLREQLE 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-31
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 31/276 (11%)
Query: 290 NVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+ LG G +G+VY GV VAVK L E F +E ++ H NL++L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
CT ++ FM ++ LR + + V +A + +EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE 468
IHR++ A N L+ E+ V DFGL++L+ + + APE L+ K S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 469 RTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNK 525
++DV+ +G++L E+ T G L + + LE++ R++ +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YELLEKDYRMERPEGCPEKV-- 448
Query: 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
Y + M C Q +P DRP+ +E+ + E
Sbjct: 449 -YEL-----MRA----CWQWNPSDRPSFAEIHQAFE 474
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 59/291 (20%)
Query: 291 VLGQGGFGKVYRGVL---ADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRL 346
LG G FG V +G VAVK L + P E ++ + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEH 404
IG C + +LV + + L++ + + +++ + G++YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLEES 136
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 458
+HRD+ A NVLL A + DFGL+K + + Q G AP
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----AP 189
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL-- 515
E ++ K S ++DV+ +G+++ E + GQ+ + ++ +V LE+ +R+
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGS-EVT-----AMLEKGERMGC 241
Query: 516 -----DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Y++ M C E+RP + V L
Sbjct: 242 PAGCPREM--------YDL-----MNL----CWTYDVENRPGFAAVELRLR 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 43/286 (15%)
Query: 289 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
+ ++G G G+V G L VA+K L + F E ++ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
RL G T ++V +M+N S+ LR + + + G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGHIAP 458
+HRD+ A NVL+D + V DFGL+++++ T G T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
E ++ S +DV+ +G+++ E++ G+R + + DV+ +E RL A
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNR-DVI-----SSVEEGYRLPA 275
Query: 518 IVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ L + + M+ C RP S++V +L+
Sbjct: 276 PMGCPHAL---HQL-----MLD----CWHKDRAQRPRFSQIVSVLD 309
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 70/309 (22%), Positives = 125/309 (40%), Gaps = 65/309 (21%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+G+G FG+V++ T VAVK L + S A FQRE +++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 343 LLRLIGFCTTPTERLLVYPFMQN--------------------LSVAYRLREIKPGEPVL 382
+++L+G C L++ +M ++ R R PG P L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ +A A G+ YL E K +HRD+ N L+ E+ + DFGL++ ++
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR--NIYS 226
Query: 443 TNVTTQVRGTMGHI-----APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496
+ I PE + + + +DV+ YG++L E+ + G + + +
Sbjct: 227 ADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAH 282
Query: 497 EDDVLLLDHVKK---LER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 552
E+ ++ +V+ L E + YN+ M C P DRP+
Sbjct: 283 EE---VIYYVRDGNILACPENCPLEL--------YNL-----MRL----CWSKLPADRPS 322
Query: 553 MSEVVRMLE 561
+ R+L+
Sbjct: 323 FCSIHRILQ 331
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 80/280 (28%), Positives = 126/280 (45%), Gaps = 39/280 (13%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG G FG+V+ G TKVAVK L F E ++ H+ L+RL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75
Query: 349 FCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNP 407
T P ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 76 VVTQEPI--YIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTG 464
IHRD++AAN+L+ + + DFGLA+L+ + N T G I APE ++ G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 465 KSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--R 521
+ ++DV+ +GI+L E+VT G+ + + +V+ + LER R+ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNP-EVI-----QNLERGYRMVRPDNCPE 237
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L Y + M LC + PEDRP + +LE
Sbjct: 238 EL---YQL-----M----RLCWKERPEDRPTFDYLRSVLE 265
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 289 KNVLGQGGFGKVYRGVL-ADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRNLLRL 346
K+ LG G +G+VY GV VAVK L D F +E ++ H NL++L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 74
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCN 406
+G CT ++ FM ++ LRE E + V +A + +EYL +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK-- 130
Query: 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLST 463
IHRD+ A N L+ E+ V DFGL++L+ + T G I APE L+
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 464 GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD-- 520
K S ++DV+ +G++L E+ T G + ++ V + LE++ R++
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLS-QVY-----ELLEKDYRMERPEGCP 238
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Y + M C Q +P DRP+ +E+ + E
Sbjct: 239 EKV---YEL-----MRA----CWQWNPSDRPSFAEIHQAFE 267
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 69/302 (22%), Positives = 128/302 (42%), Gaps = 60/302 (19%)
Query: 289 KNVLGQGGFGKVYRGVLADG------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
K LG+G FGKV+ + VAVK L D + FQRE E+++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEH 78
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR------------V 390
+++ G C ++V+ +M++ + LR P +L ++ +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
A A G+ YL +HRD+ N L+ + +GDFG+++ DV T+
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG 193
Query: 451 GTMGHI---APEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506
TM I PE + K + +DV+ +G++L E+ T G++ + +L +V+
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNT-EVI----- 245
Query: 507 KKLEREKRL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
+ + + + L + Y++ M+ C Q P+ R + E+ ++
Sbjct: 246 ECITQGRVLERPRVCPKEV--------YDV-----MLG----CWQREPQQRLNIKEIYKI 288
Query: 560 LE 561
L
Sbjct: 289 LH 290
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-30
Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 39/279 (13%)
Query: 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
LG G FG+V+ TKVAVK + F E ++ H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 350 CT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
T P ++ FM S+ L+ + A G+ ++ +
Sbjct: 252 VTKEPI--YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYLSTGK 465
IHRD++AAN+L+ + DFGLA++++ N T G I APE ++ G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 466 SSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD--RN 522
+ ++DV+ +GI+L+E+VT G+ + + +V+ + LER R+ +
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP--YPGMSNP-EVI-----RALERGYRMPRPENCPEE 413
Query: 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L YNI M++ C + PE+RP + +L+
Sbjct: 414 L---YNI-----MMR----CWKNRPEERPTFEYIQSVLD 440
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 37/283 (13%)
Query: 289 KNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
V+G G FG+V G L VA+K L + F E ++ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
RL G T ++V +M+N S+ LR+ + + + G A G++YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI---APEYL 461
+HRD+ A N+L++ + V DFGL ++++ T RG I +PE +
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT-RGGKIPIRWTSPEAI 222
Query: 462 STGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
+ K + +DV+ YGI+L E+++ G+R + + + DV+ K ++ RL +D
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQ-DVI-----KAVDEGYRLPPPMD 274
Query: 521 --RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L Y + M+ C Q +RP ++V +L+
Sbjct: 275 CPAAL---YQL-----MLD----CWQKDRNNRPKFEQIVSILD 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 44/287 (15%)
Query: 289 KNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+ V+G G FG+VY+G+L VA+K L + F E ++ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
+RL G + +++ +M+N ++ LRE + + + G A G++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQ-----VRGTMGHIA 457
+HRD+ A N+L++ + V DFGL++++ D + TT +R T A
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----A 218
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
PE +S K + +DV+ +GI++ E++T G+R + L +V+ K + RL
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNH-EVM-----KAINDGFRLP 270
Query: 517 AIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+D + Y + M+Q C Q RP +++V +L+
Sbjct: 271 TPMDCPSAI---YQL-----MMQ----CWQQERARRPKFADIVSILD 305
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 82/295 (27%), Positives = 113/295 (38%), Gaps = 63/295 (21%)
Query: 291 VLGQGGFGKVYRGVL----ADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLL 344
LG G FG V RG VAVK L P F REV + HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYL 401
RL G TP +V S+ RLR+ + + + A+ A G+ YL
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYL 137
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG------TMGH 455
+ IHRD+ A N+LL +GDFGL + + + Q
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC--- 191
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE-K 513
APE L T S +D + +G+ L E+ T GQ + L +L K+++E +
Sbjct: 192 -APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGS-QIL-----HKIDKEGE 242
Query: 514 RL-------DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
RL I YN+ M+Q C PEDRP + L
Sbjct: 243 RLPRPEDCPQDI--------YNV-----MVQ----CWAHKPEDRPTFVALRDFLL 280
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 289 KNVLGQGGFGKVYRGVL--------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 340
LGQG F K+++GV T+V +K L +F M+S H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSH 71
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
++L+ G C E +LV F++ S+ L++ + ++ + + VA A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHF 128
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAV--------VGDFGLAKLVDVRKTNVTTQ-VRG 451
L E+ +IH +V A N+LL + + + D G++ V ++ + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQERIPW 183
Query: 452 TMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 509
PE + K+ + TD + +G L E+ + G + S L+ + L +
Sbjct: 184 V----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQ-RKL-----QFY 231
Query: 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E +L A L N+ + C P+ RP+ ++R L
Sbjct: 232 EDRHQLPAPKAAEL---ANL-----INN----CMDYEPDHRPSFRAIIRDLN 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 25/219 (11%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEM 334
E + + + +G+G FG+V+R G + AVK RL F E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVA 103
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALG 393
+ ++ L G + ++ S+ ++++ E + + AL
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--AL- 160
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQ---- 448
GLEYLH +I+H DVKA NVLL D + DFG A + +
Sbjct: 161 --EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
+ GT H+APE + + D++ M+L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 52/309 (16%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI 335
+ + ++ LG+GGF V L DG A+KR+ QRE +M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREADMH 80
Query: 336 SVAVHRNLLRLIGFCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 391
+ H N+LRL+ +C L+ PF + ++ + +K L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT---- 447
LG RGLE +H HRD+K N+LL ++ + V+ D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 448 ----QVRGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499
R T+ + APE L + +S ERTDV+ G +L ++ G+ + + ++ D
Sbjct: 198 QDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGD 254
Query: 500 VLLLDHVKKLEREKRLDAIVDRNLNKNYNI-------QEVETMIQVALLCTQASPEDRPA 552
+ L + +I + ++ + P RP
Sbjct: 255 SVAL------------------AVQNQLSIPQSPRHSSALWQLLNSMM---TVDPHQRPH 293
Query: 553 MSEVVRMLE 561
+ ++ LE
Sbjct: 294 IPLLLSQLE 302
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 43/306 (14%), Positives = 76/306 (24%), Gaps = 65/306 (21%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMI----------SV 337
VLGQ G V E P +A + EV +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 338 AVHRNLLRLIGFCTTP-----------------TERLLVYPFMQ--NLSVAYRLREIKPG 378
VH + P R +YP MQ + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 379 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438
L R ++ L R L LH + ++H ++ +++LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 439 DVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493
+ + A L + D + G+ + + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319
Query: 494 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNI-QEVETMIQVALLCTQASPEDRPA 552
+ NI Q V +++ L + EDR
Sbjct: 320 DAAL-------------------GGSEWIFRSCKNIPQPVRALLEGFL---RYPKEDRLL 357
Query: 553 MSEVVR 558
+ +
Sbjct: 358 PLQAME 363
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 42/290 (14%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQR 330
E QL + ++LG+G F +VY + K +K +P +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQ 116
Query: 331 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK-PGEPVLDWVTRKR 389
+E + ++ ++ +LV ++ + K E V+
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 390 VALGAARGLEYLHEHCNPKIIHRDVKAANVLL-----------DEDFEAVVGDFGLAKLV 438
A+ +E +H+ +IIH D+K N +L D + D G + +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 439 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG------------ 485
+ T T G E LS + + D FG + ++ G
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 486 QRAIDFSRLEEED------DVLL-LDHVKKLEREKRLDAIVDRNLNKNYN 528
+ F RL D V+L + L L + + ++Y
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 48/281 (17%), Positives = 93/281 (33%), Gaps = 51/281 (18%)
Query: 291 VLGQGGFGKVYRGV--LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+ GG G +Y + +G V +K L A E + ++ VH +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 349 FCTTPTERLLVYPF--MQNLSVAY----RLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
F + M+ Y L+ K + + L L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH 199
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 462
+++ D+K N++L E+ + + D G + N + GT G APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAV-----SRINSFGYLYGTPGFQAPE-IV 249
Query: 463 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522
+ TD++ G L L + ++ + + L+ ++ R
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPV-----LKTYDSYGRLLRRA 304
Query: 523 LNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRMLEG 562
++ + P R E+ L G
Sbjct: 305 IDPD--------------------PRQRFTTAEEMSAQLTG 325
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 5e-27
Identities = 29/301 (9%), Positives = 65/301 (21%), Gaps = 50/301 (16%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 347
L G V+ + A+K + S + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 348 GFC--------------------------TTPTERLLVYPFMQ--NLSVAYRLREIKPGE 379
LL+ P + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
+ + R L ++H N+ + D ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL---- 241
Query: 440 VRKTNVTTQVRGTMGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
+ + + E+L+ + + + + G+ + + F +
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299
Query: 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVV 557
++ L L V+T+I L R E +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLP-----DFVKTLIG-RFL--NFDRRRRLLPLEAM 351
Query: 558 R 558
Sbjct: 352 E 352
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 54/302 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+F LG+GGFG V+ D A+KR+ REV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 343 LLRLIGF---------CTTPTERLLVYPFMQ---NLSVAYRLREIKPGEPVLDWVTRKRV 390
++R + ++ +Y MQ ++ + E + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD----------- 439
L A +E+LH ++HRD+K +N+ D VGDFGL +D
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 440 -VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 498
T QV GT +++PE + S + D+F G++L EL+ FS
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FS------ 228
Query: 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNI--QEVETMIQVALLCTQASPEDRPAMSEV 556
++ER + L + + + M+Q SP +RP +
Sbjct: 229 --------TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINI 277
Query: 557 VR 558
+
Sbjct: 278 IE 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 62/298 (20%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+F E ++G GGFG+V++ DG +KR+ + + +REV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNN----EKAEREVKALAKLDHVN 65
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRL-------------REIK-------PGEPVL 382
++ G + S L + I+ L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ + +G++Y+H K+I+RD+K +N+ L + + +GDFGL +
Sbjct: 126 ELFEQ------ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--N 174
Query: 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 502
T+ +GT+ +++PE +S+ + D++ G++L EL+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------------- 219
Query: 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRML 560
E K + D ++ ++ ++ +T++Q PEDRP SE++R L
Sbjct: 220 ----TAFETSKFFTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS 336
E D ++ VLG+G +G VY G L++ ++A+K + E+ +
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIALHK 74
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE----IKPGEPVLDWVTRKRVAL 392
H+N+++ +G + + + S++ LR +K E + + T++ +
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-- 132
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRG 451
GL+YLH++ +I+HRD+K NVL++ + + DFG +K + T G
Sbjct: 133 ---EGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTG 185
Query: 452 T---MGHIAPEYLSTGKS--SERTDVFGYGIMLLELVTGQR 487
T M APE + G + D++ G ++E+ TG+
Sbjct: 186 TLQYM---APEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 33/130 (25%), Positives = 49/130 (37%), Gaps = 5/130 (3%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDNNRLVGKIP 131
+S + + L +L L + GN P+ L +LT LDL +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY--- 188
+ +L LQ L +S NNF L+SL + N++ L P
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 189 -NFTGNNLNC 197
N T N+ C
Sbjct: 548 LNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 22/112 (19%), Positives = 34/112 (30%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
LS S L L L I +LS L++L L N +
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ L LQ L + N + + L +L + + N + F
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 5/151 (3%)
Query: 38 RVPNNQLRDWNQNQVNPCTWSNVICD-NSNNVASVTLS--SMNFSGTLSPRIGVLRTLST 94
+ P +L+ + N + + ++ + LS ++F G S +L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS-LGNLKKLQFLTLSQNNFSGT 153
L L NG+ + L L LD ++ L S +L+ L +L +S +
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 154 IPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
LSSL +++ N+ +F
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 28/114 (24%), Positives = 42/114 (36%), Gaps = 2/114 (1%)
Query: 73 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 131
++ +F P I LR L+ L L + P +LSSL L++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTL-SSLISIQLDSNNLSGQIPVHLFQ 184
L LQ L S N+ + L SSL + L N+ + F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 30/160 (18%), Positives = 50/160 (31%), Gaps = 14/160 (8%)
Query: 54 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL 113
PC + N +NF + + + L L N + +
Sbjct: 2 PC-----VEVVPNITYQ--CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSF 51
Query: 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 173
L LDL + + +L L L L+ N + + LSSL + N
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 174 LSGQIPVHLFQIP--KY-NFTGNNLNCGKTLPHSCESSSN 210
L+ + + K N N + K LP + +N
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFK-LPEYFSNLTN 150
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-22
Identities = 32/125 (25%), Positives = 48/125 (38%), Gaps = 1/125 (0%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
LS L LSTL L GN I LSSL L L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 133 SLGNLKKLQFLTLSQNNF-SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFT 191
+G+LK L+ L ++ N S +P+ + L++L + L SN + L + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 192 GNNLN 196
+L+
Sbjct: 179 NLSLD 183
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 32/178 (17%), Positives = 57/178 (32%), Gaps = 16/178 (8%)
Query: 9 LVAIILDCLHYLALSDYQGDALFALR-----TSLRVPNNQLRDWNQNQVNPCTWSNVICD 63
+ L L L + +G F+ L + N L + +
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL---SFKGCCSQSDFG---- 371
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLD 122
+ ++ + LS T+S L L L + + + +L +L LD+
Sbjct: 372 -TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI-PDSLTTLSSLISIQLDSNNLSGQIP 179
+ L L+ L ++ N+F PD T L +L + L L P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 26/129 (20%), Positives = 43/129 (33%), Gaps = 6/129 (4%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
LS L +L L + N L+SL LD N ++
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 133 SLGNL-KKLQFLTLSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN 189
L + L FL L+QN+F+ T L + + ++ + P +P +
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLS 596
Query: 190 FTGNNLNCG 198
N+ C
Sbjct: 597 L---NITCQ 602
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 6/117 (5%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIP 131
N + + IG L+TL L + N I ++PE NL++L LDL +N++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 132 PSLGNLKKLQF----LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
L L ++ L LS N + P + + L + L +N S + Q
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 22/134 (16%), Positives = 36/134 (26%), Gaps = 12/134 (8%)
Query: 73 LSSMNFSGTLSPR-IGVLRTLSTLTLKGNGITGEIPEE---LGNLSSLTSLDLDNNRL-- 126
L + S + I L L L E E L L +L ++ RL
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 127 ----VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
+ I L + +L S ++L + + L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKL 324
Query: 183 FQIPKYNFTGNNLN 196
+ + FT N
Sbjct: 325 KSLKRLTFTSNKGG 338
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH 340
+ F++ +G+G FG+V++G+ VA+K + D E + Q+E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
+ + G T+ ++ ++ S L E + + R +GL+Y
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDY 134
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MGHIA 457
LH K IHRD+KAANVLL E E + DFG+A + + T V GT M A
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM---A 187
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
PE + + D++ GI +EL G+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--RLTDFESPGGDAAFQREVEMISVAVH 340
NF + +G+G F +VYR L DG VA+K ++ D A +E++++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGA 394
N+++ E +V ++ ++ K P V + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
LE++H +++HRD+K ANV + +GD GL + + T + V GT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 488
+++PE + + ++D++ G +L E+ Q
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+GGF K + A K + + P E+ + H++++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVALGAAR--------GLE 399
F V+ + E+ +L+ RK + AR G +
Sbjct: 83 FFEDNDF---VFVVL----------ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
YLH + ++IHRD+K N+ L+ED E +GDFGLA V+ GT +IAPE
Sbjct: 130 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTG 485
LS S DV+ G ++ L+ G
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 62/310 (20%), Positives = 120/310 (38%), Gaps = 41/310 (13%)
Query: 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVE 333
+ +L D+F + + LG G G V++ G +A K + P RE++
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 83
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVAL 392
++ ++ G + E + M S+ L++ E +L +V++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSI 138
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA-KLVD-VRKTNVTTQVR 450
+GL YL E KI+HRDVK +N+L++ E + DFG++ +L+D + + V
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 191
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-------RAIDFSRLEEEDDVLLL 503
GT +++PE L S ++D++ G+ L+E+ G+ + +
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMI---QVALL---------------CTQA 545
+ + R + I E+ I L C
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311
Query: 546 SPEDRPAMSE 555
+P +R + +
Sbjct: 312 NPAERADLKQ 321
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/313 (18%), Positives = 136/313 (43%), Gaps = 37/313 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + +G+G FGK DG + +K + S +REV +++ H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG----EPVLDWVTRKRVALGAARG 397
N+++ +V + + + R+ K + +LDW +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLA 137
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
L+++H+ KI+HRD+K+ N+ L +D +GDFG+A++++ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
PE + ++D++ G +L EL T + A + ++ L+ +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIISGSFPP---- 244
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 577
++ +Y+ ++ +++ + +P DRP+++ + LE +A+R E++ ++
Sbjct: 245 -----VSLHYS-YDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQL 292
Query: 578 TRRQEYERLQRRF 590
+ + +F
Sbjct: 293 IAEEFCLKTFSKF 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHR 341
D++ + V+G G V KVA+KR+ + E +E++ +S H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVA------YRLREIKPG---EPVLDWVTRKRVAL 392
N++ E LV + SV E K G E + + R+
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 129
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT 452
GLEYLH++ IHRDVKA N+LL ED + DFG++ + +VR T
Sbjct: 130 -VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 453 M-GH---IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
G +APE + + + D++ +GI +EL TG
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+GGF K + A K + + P E+ + H++++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD-WVTRKRVALGAAR--------GLE 399
F V+ + E+ +L+ RK + AR G +
Sbjct: 109 FFEDNDF---VFVVL----------ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
YLH + ++IHRD+K N+ L+ED E +GDFGLA V+ GT +IAPE
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 211
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTG 485
LS S DV+ G ++ L+ G
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 66/320 (20%), Positives = 119/320 (37%), Gaps = 71/320 (22%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-M 334
+ ++L + VL +GGF VY + G + A+KRL + A +EV M
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKR----- 389
++ H N+++ + E + L E+ G+ +++++ +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133
Query: 390 -------VALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ R ++++H P IIHRD+K N+LL + DFG A +
Sbjct: 134 SCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 443 TNVTT-----------QVRGTMGHIAPEYLSTGKS---SERTDVFGYGIMLLELVTGQRA 488
+ T + PE + + E+ D++ G +L L Q
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 489 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNI-------QEVETMIQVALL 541
F ED L I +N Y+I ++I+ L
Sbjct: 253 --F-----EDGAKL--------------RI----VNGKYSIPPHDTQYTVFHSLIRAML- 286
Query: 542 CTQASPEDRPAMSEVVRMLE 561
Q +PE+R +++EVV L+
Sbjct: 287 --QVNPEERLSIAEVVHQLQ 304
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 51/208 (24%), Positives = 71/208 (34%), Gaps = 17/208 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMI-SVAVH 340
+F + LG G +G+V++ DG AVKR F P A EV V H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG--EPVLDWVTRKRVALGAARGL 398
+RL L S+ E + L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQV-----WGYLRDTLLAL 170
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
+LH ++H DVK AN+ L +GDFGL + G ++AP
Sbjct: 171 AHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG--TAGAGEVQEGDPRYMAP 225
Query: 459 EYLSTGKSSERTDVFGYGIMLLELVTGQ 486
E L G DVF G+ +LE+
Sbjct: 226 ELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 32/229 (13%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
+F E VLGQG FG+V + D A+K++ + + EV +++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL---GAAR-- 396
++R + ++ S + E + D + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 397 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD------------ 439
L Y+H IIHRD+K N+ +DE +GDFGLAK V
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 440 --VRKTNVTTQVRGTMGHIAPEYLS-TGKSSERTDVFGYGIMLLELVTG 485
N+T+ + GT ++A E L TG +E+ D++ GI+ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 25/220 (11%)
Query: 283 TDNFSEKNVLGQG--GFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISV 337
+ V+G+G V G V V+R+ + E+ + Q E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKL 82
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGA 394
H N++ E +V FM S + E + ++ + G
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GV 137
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG-LAKLVD--VRKTNVTTQVRG 451
+ L+Y+H +HR VKA+++L+ D + + ++ R+ V +
Sbjct: 138 LKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 452 TMGHI---APEYLSTGKS--SERTDVFGYGIMLLELVTGQ 486
++ + +PE L ++D++ GI EL G
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 57/258 (22%), Positives = 98/258 (37%), Gaps = 44/258 (17%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLLR 345
LG GG VY KVA+K + F+REV S H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPP---REKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAY---------RLREIKPGEPVLDWVTRKRVALGAAR 396
+ + Y L E L T
Sbjct: 76 -------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
G+++ H+ +I+HRD+K N+L+D + + DFG+AK + T V GT+ +
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQR--------AIDFSRLEEEDDVLLLDHVKK 508
+PE + E TD++ GI+L E++ G+ +I +++ + D K
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 509 LEREKRLDAIVDRNLNKN 526
+ + L ++ R K+
Sbjct: 240 IPQS--LSNVILRATEKD 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 34/238 (14%), Positives = 64/238 (26%), Gaps = 51/238 (21%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA---------------------- 327
VLGQ G V E P +A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 328 -----FQREVEMISVAVHRNLLRLIGFCTTPT--ERLLVYPFMQ--NLSVAYRLREIKPG 378
F +++ + ++R+ R +YP MQ + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 379 EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438
L R ++ L R L LH + ++H ++ +++LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 439 DVRKTNVTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTG 485
R + G PE + + D + G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 42/222 (18%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNL 343
+F K+VLG G G + + D VAVKR+ P + REV+ + H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---------- 393
+R Y + E+ + ++V +K A
Sbjct: 81 IRYFCTEKDRQF---QYIAI----------ELCAAT-LQEYVEQKDFAHLGLEPITLLQQ 126
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLAKLV--DVRKTNVT 446
GL +LH I+HRD+K N+L+ A++ DFGL K + +
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 447 TQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTG 485
+ V GT G IAPE LS + D+F G + +++
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 19/119 (15%), Positives = 44/119 (36%), Gaps = 9/119 (7%)
Query: 70 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-- 127
+ T + L+ L+ + + ++P L L + +++ NR +
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 128 ------GKIPPSLGNLKKLQFLTLSQNNF-SGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
+ +K+Q + + NN + + SL + L ++ N L G++P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 32/191 (16%), Positives = 73/191 (38%), Gaps = 16/191 (8%)
Query: 17 LHYLALSDYQG-----DALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVA 69
L + + + L AL + V N+ Q + + ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA--PVGEKIQ 308
Query: 70 SVTLSSMNF-SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG 128
+ + N + + + ++ L L N + G++P G+ L SL+L N++
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE 367
Query: 129 KIPPSL-GNLKKLQFLTLSQNNFSGTIPDSL--TTLSSLISIQLDSNNLSGQIPVHLFQI 185
IP + G ++++ L+ + N IP+ ++S + +I N + + +
Sbjct: 368 -IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 186 PKYNFTGNNLN 196
F G N++
Sbjct: 426 DPTPFKGINVS 436
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 32/185 (17%), Positives = 60/185 (32%), Gaps = 22/185 (11%)
Query: 27 GDALFALRTSLRVPNNQLRDWNQNQVNPCTWS-NVICDNSNNVASVTLSSMNFSGTLSPR 85
AL + +L N + + W+ N D V+L+S
Sbjct: 32 YLALKEIWDALNGKNWSQQGFGTQP--GANWNFNKELDMWGAQPGVSLNSNGR------- 82
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG----KIPPSLGNLKKLQ 141
++ L+L+G G +G +P+ +G L+ L L L ++ P + +
Sbjct: 83 ------VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 142 FLTLSQNNFSGTIPDSLT--TLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGK 199
+ ++ T D S LI ++S+ I K G N
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 200 TLPHS 204
+ +
Sbjct: 197 FVSKA 201
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 25/206 (12%), Positives = 65/206 (31%), Gaps = 12/206 (5%)
Query: 17 LHYLALSDYQ---GDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 73
L LAL + + LF + +++ + + ++ +++ +
Sbjct: 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166
Query: 74 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 133
+S ++ + + + N IT + + + L+ L + N+ V +
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225
Query: 134 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY---NF 190
T L L +++ + ++P L +P+ N
Sbjct: 226 AWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280
Query: 191 TGNNLNCGKTLPHSCESSSNDSGSSK 216
N G+ L ++ ++ K
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 20/136 (14%), Positives = 39/136 (28%), Gaps = 17/136 (12%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
+ + F + NL LT +++ N + K+P
Sbjct: 213 MGNSPFVAENICEAWENENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 133 SLGNLKKLQFLTLSQNNF--------SGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLF 183
L L ++Q + ++ N + I + NNL + + L
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327
Query: 184 QIPK---YNFTGNNLN 196
++ K N L
Sbjct: 328 KMKKLGMLECLYNQLE 343
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-20
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 10/110 (9%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVG-------KIPPSLGN 136
G + L+ N + IP + ++S ++++D N + + P+
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 137 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 186
+ + LS N S + +T S L SI L N L+ L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 28/178 (15%), Positives = 61/178 (34%), Gaps = 23/178 (12%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV--LRTL 92
+S+ + N L + +N + + N+ + S+ L + LS L L
Sbjct: 460 SSINLMGNMLTEIPKNSLKDE--NENFK-NTYLLTSIDLRFNKLTK-LSDDFRATTLPYL 515
Query: 93 STLTLKGNGITGEIPEELGNLSSLTSLDLDN------NRLVGKIPPSLGNLKKLQFLTLS 146
+ L N + P + N S+L + N NR + + P + L L +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK-------YNFTGNNLNC 197
N+ + + + ++ + + N ++ + Y+ T + C
Sbjct: 575 SNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 18/134 (13%), Positives = 41/134 (30%), Gaps = 16/134 (11%)
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPR-IGVLRTLSTLTLKGNGITG-------EIPEELGN 112
C + V +++ + + + +S + N I +
Sbjct: 372 FCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 113 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG-------TIPDSLTTLSSLI 165
+++S++L NN++ L + L N + ++ L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 166 SIQLDSNNLSGQIP 179
SI L N L+ +
Sbjct: 492 SIDLRFNKLTK-LS 504
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKR--LTDFESPGGDAAFQREVEMISVAV 339
FS+ +G G FG VY + + VA+K+ + +S +EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARG 397
H N ++ G LV + S + + + E + VT GA +G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTH-----GALQG 166
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGT---MG 454
L YLH H +IHRDVKA N+LL E +GDFG A ++ + V GT M
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM- 217
Query: 455 HIAPEYLSTGKSSE---RTDVFGYGIMLLELVTGQ 486
APE + + + DV+ GI +EL +
Sbjct: 218 --APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
+G+G G V G +VAVK + D EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ + E ++ F+Q ++ + +++ E + V + L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-----VLQALAYL 157
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT---MG 454
H +IHRD+K+ ++LL D + DFG A++ RK+ V GT M
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWM- 208
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
APE +S + D++ GIM++E+V G+
Sbjct: 209 --APEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 39/289 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+++ +G G +G+ + +DG + K L + EV ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 342 NLLRLIGFCTTPTERLLVYPFM---------QNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
N++R T L Y M ++ + R+ E VL +T+
Sbjct: 66 NIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ----- 119
Query: 393 GAARGLEYLHEHCNP--KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
L+ H + ++HRD+K ANV LD +GDFGLA++++ + T V
Sbjct: 120 -LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510
GT +++PE ++ +E++D++ G +L EL +E L +++ +
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIREGK 232
Query: 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
+ + Y+ E+ +I RP++ E++
Sbjct: 233 FRR---------IPYRYS-DELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 343
+S +G GG KV++ + A+K + + +++ E+ ++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 344 --LRLIGFCTTPTERLLVYPFM--QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
+RL + T +Y M N+ + L++ K +D RK +
Sbjct: 89 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 141
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIA 457
+H+H I+H D+K AN L+ + + DFG+A + T+V +QV GT+ ++
Sbjct: 142 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMP 196
Query: 458 PEYL-----------STGKSSERTDVFGYGIMLLELVTGQ 486
PE + S K S ++DV+ G +L + G+
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 25/215 (11%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMIS 336
Q A ++F LG+G FG VY +A+K L E G + +REVE+ S
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKPGEPVLDWVTRKRV 390
H N+LRL G+ T L+ + L + E T +
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---------QRTATYI 115
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
A L Y H ++IHRD+K N+LL E + DFG + +
Sbjct: 116 TE-LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC--- 168
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
GT+ ++ PE + E+ D++ G++ E + G
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
++ +GQG G VY + +A G +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ + E +V ++ S+ + E E + V R+ + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFL 132
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT---MG 454
H + ++IHRD+K+ N+LL D + DFG A++ R T V GT M
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWM- 183
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
APE ++ + D++ GIM +E++ G+
Sbjct: 184 --APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 18/201 (8%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+G F VYR + G +VA+K + G Q EV++ H ++L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK 408
+ LV N + L+ +P + R + G+ YLH H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMH-QIITGMLYLHSH---G 132
Query: 409 IIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV----RKTNVTTQVRGTMGHIAPEYLSTG 464
I+HRD+ +N+LL + + DFGLA + + T + GT +I+PE +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCGTPNYISPEIATRS 187
Query: 465 KSSERTDVFGYGIMLLELVTG 485
+DV+ G M L+ G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 47/230 (20%), Positives = 84/230 (36%), Gaps = 40/230 (17%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVK----------------RLTDFESPGGD 325
+++ L QG F K+ L D A+K
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 326 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKPGE 379
F+ E+++I+ + L G T E ++Y +M+N + L +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC- 146
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV- 438
+ V + + Y+H N I HRDVK +N+L+D++ + DFG ++ +
Sbjct: 147 FIPIQVIKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 439 -DVRKTNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTG 485
K RGT + PE+ S + + D++ GI L +
Sbjct: 204 DKKIKG-----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 30/228 (13%)
Query: 267 AFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPG 323
A ++ + + D+F LG+G FG VY + +A+K L + E G
Sbjct: 2 ALAEMPKRKFT-----IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56
Query: 324 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN------LSVAYRLREIKP 377
+ +RE+E+ S H N+LR+ + L+ F L R E
Sbjct: 57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE--- 113
Query: 378 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437
+ + A L Y HE K+IHRD+K N+L+ E + DFG +
Sbjct: 114 ------QRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163
Query: 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ GT+ ++ PE + E+ D++ G++ E + G
Sbjct: 164 APSLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 58/305 (19%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVE-MISVAVHR 341
+ + +LG G G V G VAVKR+ DF E++ + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69
Query: 342 NLLRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTR---KRVALGAAR 396
N++R TT + ++ NL++ + + L + A
Sbjct: 70 NVIRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLD-------------EDFEAVVGDFGLAKLVDVRKT 443
G+ +LH KIIHRD+K N+L+ E+ ++ DFGL K +D ++
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 444 NVTTQVR---GTMGHIAPEYLSTGKSSERT-------DVFGYGIMLLELVTGQRAIDFSR 493
+ T + GT G APE L + + D+F G + +++ + +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 494 LEEEDDVLLLDHVKKLEREKRLDAIVD--RNLNKNYNIQEVETMIQVALLCTQASPEDRP 551
E +++ + +++ +L + MI P RP
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDL--------ISQMIDH-------DPLKRP 288
Query: 552 AMSEV 556
+V
Sbjct: 289 TAMKV 293
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
+ + LG G FGKVY+ G A K + + +S + E+E+++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAARGLE 399
+++L+G + ++ F +V + EP + V R L
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALN 131
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT--- 452
+LH +IIHRD+KA NVL+ + + + DFG+ AK + R + + GT
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYW 183
Query: 453 MGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 486
M APE + + + D++ GI L+E+ +
Sbjct: 184 M---APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 34/212 (16%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAA----FQREVEMISVAVHRNLL 344
++G+GG G VY VA+K + D QRE +++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETL---SSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 345 RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---------RVALGAA 395
++ F + Y + G + + R+ +
Sbjct: 98 P-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
L+ H HRDVK N+L+ D A + DFG+A K GT+ +
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
+APE S ++ R D++ +L E +TG
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 48/215 (22%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 290 NVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL--LRL 346
+G GG KV++ + A+K + + +++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 347 IGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
+ T +Y M+ N+ + L++ K +D RK + +H+H
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127
Query: 405 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIAPEYL- 461
I+H D+K AN L+ + + DFG+A + T+V +QV GT+ ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 462 ----------STGKSSERTDVFGYGIMLLELVTGQ 486
S K S ++DV+ G +L + G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 12/145 (8%)
Query: 55 CTWSNVICDNSNN------------VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGI 102
CT S+ + D S+ + + L+ + L++L + N I
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 103 TGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLS 162
+ PE L L L+L +N L + L L L N+ +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 163 SLISIQLDSNNLSGQIPVHLFQIPK 187
+LI++ L N LS Q+
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 23/107 (21%), Positives = 37/107 (34%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
+ S L L L L+ N ++ + ++LT L L +N +
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
K L L LS N S T + L +L + L +N +
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-20
Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 12/137 (8%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT--------GEIPEELGNLSSLTSLDLDNN 124
LS+ N + + L L L L+ N + G L LS L L+L++N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+L +L+ + L NN + SL S+ L N ++
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 185 IPKY----NFTGNNLNC 197
+ + N +C
Sbjct: 607 AFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 29/117 (24%), Positives = 40/117 (34%), Gaps = 2/117 (1%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L S L+ L L N I +L +LDL +N L
Sbjct: 80 LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTL--SSLISIQLDSNNLSGQIPVHLFQIPK 187
+ L+ LQ L LS N + L SSL ++L SN + P I +
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 30/158 (18%), Positives = 56/158 (35%), Gaps = 8/158 (5%)
Query: 46 DWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE 105
+ + T + + + + L+ S S L L L L N I E
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 106 IP-EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG--TIPDSLTTLS 162
+ +E L ++ + L N+ + S + LQ L L + + P L
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 163 SLISIQLDSNNLSGQIPVHLFQIPKY----NFTGNNLN 196
+L + L +NN++ I + + + + NNL
Sbjct: 481 NLTILDLSNNNIAN-INDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-19
Identities = 34/134 (25%), Positives = 51/134 (38%), Gaps = 10/134 (7%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG--NLSSLTSLDLDNNRLVGKI 130
LS S T L L L L N I EEL SSL L+L +N++
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 131 PPSLGNLKKLQFLTLSQNNFSGTIPDSLT---TLSSLISIQLDSNNLSGQIPVHLFQIPK 187
P + +L L L+ ++ + L +S+ ++ L ++ LS +
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 188 YNFT-----GNNLN 196
N T NNLN
Sbjct: 248 TNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 26/136 (19%), Positives = 55/136 (40%), Gaps = 6/136 (4%)
Query: 63 DNSNNVASVTLSSMNFSGTLSPRIGV---LRTLSTLTLKGNGITGEIPEELGNL--SSLT 117
+ + L+++ +L+ ++ + ++ L+L + ++ L ++LT
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 118 SLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 177
LDL N L S L +L++ L NN SL L ++ + L +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 178 IPV-HLFQIPKYNFTG 192
I + L +I ++F
Sbjct: 312 ISLASLPKIDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-15
Identities = 23/149 (15%), Positives = 44/149 (29%), Gaps = 37/149 (24%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGN---------GITGEIPEELGNLSSLTSLDLDN 123
L N S + L + L LK + + L L L++++
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQN----------------------------NFSGTIP 155
N + G L L++L+LS + S
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
Query: 156 DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
D+ + L L + L N + ++ ++
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 28/136 (20%), Positives = 41/136 (30%), Gaps = 7/136 (5%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L S F L L + L N + N SL SL+L N +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 133 SLG-NLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI----PVHLFQIPK 187
G + L L + N F T ++ + + LS P H P
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPV 662
Query: 188 YNFTGNNLNCGKTLPH 203
F + +C + H
Sbjct: 663 RLF--DTSSCKDSAHH 676
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 47/220 (21%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 343
+S +G GG KV++ + A+K + + +++ E+ ++ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 344 --LRLIGFCTTPTERLLVYPFMQ--NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
+RL + T +Y M+ N+ + L++ K +D RK +
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVH 169
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIA 457
+H+H I+H D+K AN L+ + + DFG+A + T+V +QV G + ++
Sbjct: 170 TIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMP 224
Query: 458 PEYLS-----------TGKSSERTDVFGYGIMLLELVTGQ 486
PE + K S ++DV+ G +L + G+
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 24/231 (10%)
Query: 269 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA 327
G+LK + ++ + +G+G +G V + V G +AVKR+
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 328 FQREVEMI-SVAVHRNLLRLIGFCTTPTERLLVYPFM-----QNLSVAYRLREIKPGEPV 381
+++++ + +++ G + + M + Y + + E +
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 382 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD- 439
L +T V + L +L E N KIIHRD+K +N+LLD + DFG+ +LVD
Sbjct: 127 LGKITLATV-----KALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 440 VRKTNVTTQVRGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQ 486
+ KT G ++APE + S R+DV+ GI L EL TG+
Sbjct: 180 IAKTRDA----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVH 340
F ++G G +G+VY+G + G A+K + D + ++E+ M+ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTG-DEEEEIKQEINMLKKYSHH 80
Query: 341 RNLLRLIG-----FCTTPTERL-LVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVA 391
RN+ G ++L LV F SV ++ K E + ++ R
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---- 136
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRG 451
RGL +LH+H K+IHRD+K NVLL E+ E + DFG++ +D T + G
Sbjct: 137 -EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191
Query: 452 T---MGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 486
T M APE ++ ++ + ++D++ GI +E+ G
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL---TDFESPGGDAAFQREVEMISVA 338
+ F LG+G +G VY+ + G VA+K++ +D + +E+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQC 81
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVA--YRLREIKPGEPVLDWVTRKRVALGAAR 396
++++ G T+ +V + SV+ RLR E + + + +
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLK 136
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVDV---RKTNVTTQVRGT 452
GLEYLH + IHRD+KA N+LL+ + A + DFG+ +L D R T + GT
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GT 188
Query: 453 ---MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
M APE + + D++ GI +E+ G+
Sbjct: 189 PFWM---APEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 44/230 (19%), Positives = 74/230 (32%), Gaps = 37/230 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAV- 339
T F E +G G FG V++ V DG A+KR + REV +V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 340 HRNLLRLIGFCTTPTERLLVYPFM---QNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 396
H +++R E + S+A + E K + L R
Sbjct: 70 HSHVVRYFSAWA---EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV-------------------GDFGLAKL 437
GL Y+H ++H D+K +N+ + GD G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
+ + G +A E L + + D+F + ++ +
Sbjct: 184 ISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 75/287 (26%), Positives = 116/287 (40%), Gaps = 43/287 (14%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQR--EVEMISVA--VHRNLLR 345
LG GG +V+ L D VAVK L D D +F E + A H ++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADL---ARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 346 L--IGFCTTPTERLLVYPFMQNLSVAY----RLREIKPGEPVLDWVTRKRVALGAARGLE 399
+ G L Y M+ Y LR+I E + V A + L
Sbjct: 77 VYDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT--QVRGTMGHIA 457
+ H++ IIHRDVK AN+++ V DFG+A+ + +VT V GT +++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQR--------AIDFSRLEEEDDVLLLDHVKKL 509
PE R+DV+ G +L E++TG+ ++ + + ED + + L
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGL 246
Query: 510 EREKRLDAIVDRNLNKN----YNIQEVETMIQVALLCTQASPEDRPA 552
+ LDA+V + L KN Y Q M + P + P
Sbjct: 247 SAD--LDAVVLKALAKNPENRY--QTAAEMRADLVRVHNGEPPEAPK 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK--------RLTDFESPGGDAAFQREVE 333
+N+ K +LG+G V R + + AVK + E A +EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 334 -MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---- 388
+ V+ H N+++L T T LV+ M+ GE + D++T K
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GE-LFDYLTEKVTLS 122
Query: 389 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
+ R + LH+ I+HRD+K N+LLD+D + DFG + +D
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PG 177
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 476
+V GT ++APE + + GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-------RLTDFESPGGDAAFQREVE- 333
+ K+V+G+G V R V A G + AVK RL+ + A +RE
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK----- 388
+ VA H +++ LI + + LV+ M+ GE + D++T K
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GE-LFDYLTEKVALSE 199
Query: 389 RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444
+ R + +LH + I+HRD+K N+LLD++ + + DFG + +
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGE 254
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 476
++ GT G++APE L K S GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 55/293 (18%), Positives = 98/293 (33%), Gaps = 28/293 (9%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+ ++LGQG V+RG G A+K + RE E++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 343 LLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
+++L T R L+ F S+ L E + + V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127
Query: 401 LHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L E+ I+HR++K N++ D + DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYL 182
Query: 457 APEYLSTGKS--------SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508
P+ D++ G+ TG + ++ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----YK 238
Query: 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ K AI +N I M L P ++ +LE
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILE 288
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 5e-21
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
+ K LG GGFG V R + G +VA+K+ SP + E++++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 342 NLLRLIGFCTTPTE------RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
N++ + LL + + + L + + + + R + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDIS 131
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV---VGDFGLAKLVDVRKTNVTTQVRGT 452
L YLHE+ +IIHRD+K N++L + + + D G AK +D + + T+ GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGT 186
Query: 453 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
+ ++APE L K + D + +G + E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 48/221 (21%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 279 LQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-S 336
+++ D+ LG+G +G V + + G +AVKR+ + ++++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQ-NLSVAYRLREIKPG---EPVLDWVTRKRVAL 392
+ G + + M +L Y+ K E +L + V
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV-- 119
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD--VRKTNVTTQV 449
+ LE+LH +IHRDVK +NVL++ + + DFG+ LVD + +
Sbjct: 120 ---KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---- 170
Query: 450 RGTMGHIAPEYLSTGKS----SERTDVFGYGIMLLELVTGQ 486
G ++APE ++ + S ++D++ GI ++EL +
Sbjct: 171 -GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-21
Identities = 26/204 (12%), Positives = 54/204 (26%), Gaps = 27/204 (13%)
Query: 17 LHYLALSDYQ----GDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 72
L L+ + G + + + + N +++
Sbjct: 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR-IRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG---- 128
++ + + + + N IT I + + L+ L + N+
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIA 466
Query: 129 ---------------KIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 173
S NLK L + L +PD L L L S+ + N
Sbjct: 467 VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526
Query: 174 LSGQIPVH--LFQIPKYNFTGNNL 195
+ ++ TG +
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 34/187 (18%), Positives = 61/187 (32%), Gaps = 13/187 (6%)
Query: 4 SVKLVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICD 63
+++ + LD L LSD DA+ + + Q+ +N I
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIG--NLTNRITF 439
Query: 64 NSNNVASVT-LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 122
S + +T L + F+ + + NL LT ++L
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSG---------TIPDSLTTLSSLISIQLDSNN 173
N + ++P L +L +LQ L ++ N + D T + + NN
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 174 LSGQIPV 180
L P
Sbjct: 560 LEE-FPA 565
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 9e-19
Identities = 32/190 (16%), Positives = 63/190 (33%), Gaps = 18/190 (9%)
Query: 17 LHYLALSDYQG-----DALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVA 69
L + L + D L+ L SL + N+ Q + + ++ +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED-TGPKIQ 551
Query: 70 SVTLSSMNFSG-TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG 128
+ N S + + L L N + + G LT L LD N++
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE 609
Query: 129 KIPPSLG-NLKKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLFQI 185
IP +++ L S N IP+ + ++ + S+ N + ++
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNIS-C 665
Query: 186 PKYNFTGNNL 195
++ G N
Sbjct: 666 SMDDYKGINA 675
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 33/192 (17%), Positives = 58/192 (30%), Gaps = 23/192 (11%)
Query: 21 ALSDYQGDALFALRTSLRVPNNQLR-DWNQNQVNPCTWS-NVICDNSNNVASVTLSSMNF 78
+ DY+ AL A+ +L N + N ++ W+ N D + V L +
Sbjct: 267 YIKDYK--ALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG- 323
Query: 79 SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLK 138
++ L+L G G G +P+ +G L+ L L +
Sbjct: 324 ------------RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 139 KLQFLTLSQNNFSGTIP------DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 192
++ D LS L+ ++ N I K G
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIG 431
Query: 193 NNLNCGKTLPHS 204
N N + +
Sbjct: 432 NLTNRITFISKA 443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 16/137 (11%), Positives = 37/137 (27%), Gaps = 16/137 (11%)
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGV--LRTLSTLTLKGNGITGEIPE-----ELGNL 113
C ++ V + S + + + ++ N I E +
Sbjct: 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS-------GTIPDSLTTLSSLIS 166
+ +++ L N + + + LS N + + L +
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732
Query: 167 IQLDSNNLSGQIPVHLF 183
I L N L+ +
Sbjct: 733 IDLRFNKLTS-LSDDFR 748
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 25/149 (16%), Positives = 56/149 (37%), Gaps = 16/149 (10%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGV--LRTL 92
+++ + NN + +N + P + N+ + ++ L + +LS L L
Sbjct: 700 STIILSNNLMTSIPENSLKP---KDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL 755
Query: 93 STLTLKGNGITGEIPEELGNLSSLTSLDL------DNNRLVGKIPPSLGNLKKLQFLTLS 146
S + + N + P + N S L + + + NR++ + P + L L +
Sbjct: 756 SNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
N+ + + L L + + N
Sbjct: 815 SNDIR-KVDEKL--TPQLYILDIADNPNI 840
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 269 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA 327
G L R Q ++ +G G G+V++ G +AVK++ + +
Sbjct: 11 GYLTIGGQR-YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKR 69
Query: 328 FQREVE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWV 385
+++ ++ +++ G T T+ + M + + R P E +L +
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129
Query: 386 TRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL-AKLVD-VRKT 443
T V + L YL E +IHRDVK +N+LLDE + + DFG+ +LVD K
Sbjct: 130 TVAIV-----KALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSE-----RTDVFGYGIMLLELVTGQ 486
G ++APE + ++ R DV+ GI L+EL TGQ
Sbjct: 183 RSA----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVE-MISV---AVH 340
+LG+GGFG V+ G L D +VA+K R+ + EV + V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--- 396
++RL+ + T +LV P + + D++T K + G +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 397 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVR 450
+++ H ++HRD+K N+L+D + DFG L + T
Sbjct: 146 GQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDFD- 199
Query: 451 GTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG 485
GT + PE++S + + V+ GI+L ++V G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 28/293 (9%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+ ++LGQG V+RG G A+K + RE E++ H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 343 LLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
+++L T R L+ F S+ L E + + V G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-VLRDVVGGMNH 127
Query: 401 LHEHCNPKIIHRDVKAANVLL--DEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L E+ I+HR++K N++ ED ++V DFG A+ ++ + GT ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYL 182
Query: 457 APEYLSTGKSSERT--------DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508
P+ + D++ G+ TG + ++ K
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----YK 238
Query: 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ K AI +N I M L P ++ +LE
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILE 288
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 268 FGQLKRYSWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGD 325
F + ++ W E Q D F + VLG+GGFG+V+ + K+ A K+L
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK------K 221
Query: 326 AAFQR-EVEMISVAVHRNLLRLIG--FCT-------TPTERLLVYPFMQNLSVAYRLREI 375
+R + V + +L + F T T+ LV M + Y + +
Sbjct: 222 RLKKRKGYQG--AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 376 KPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432
P R A+ GLE+LH+ II+RD+K NVLLD+D + D
Sbjct: 280 DEDNPGFQ---EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333
Query: 433 GLAKLVDVRKTNVTTQVR-GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
GLA +++ T+ GT G +APE L + D F G+ L E++ +
Sbjct: 334 GLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 56/243 (23%)
Query: 265 RIAFGQLKRYSWR-------ELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVA 312
IA + + + + ++ LG G G+V KVA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 313 VK-------RLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365
++ + + E+E++ H ++++ F Y +
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED----YYIVL-- 218
Query: 366 LSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKA 416
E+ G + D V KR+ + ++YLHE+ IIHRD+K
Sbjct: 219 --------ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKP 267
Query: 417 ANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVF 473
NVLL +ED + DFG +K++ +T++ + GT ++APE L + ++
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA------ 319
Query: 474 GYG 476
GY
Sbjct: 320 GYN 322
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 17/226 (7%)
Query: 268 FGQLKRYSWRELQLAT-DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRL--TDFESPG 323
F + ++ W E Q T + F + VLG+GGFG+V + K+ A K+L +
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226
Query: 324 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 383
G+A E +++ R ++ L T LV M + + + G+
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP 284
Query: 384 WVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
R AA GLE LH +I++RD+K N+LLD+ + D GLA V
Sbjct: 285 ---EARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV--HV 336
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ GT+G++APE + + + D + G +L E++ GQ
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVK---RLTDFESPGGDAAFQREVEMISVAVHRNLLRL 346
+LG+G +GKV + + AVK + P G+A ++E++++ H+N+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-VLDWVTRKRVALGAAR--------G 397
+ ++ + Y M+ Y G +LD V KR + A G
Sbjct: 72 VDVLYNEEKQKM-YMVME-----Y----CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMG 454
LEYLH I+H+D+K N+LL + G+A+ + + T+Q G+
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPA 176
Query: 455 HIAPEYLSTGK--SSERTDVFGYGIMLLELVTG 485
PE + S + D++ G+ L + TG
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 37/214 (17%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVAVHR--N 342
+LG GGFG VY G+ ++D VA+K R++D+ EV ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR----- 396
++RL+ + P +L+ +P + + D++T + + AR
Sbjct: 110 VIRLLDWFERPDSFVLILER------------PEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 397 ---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGT 452
+ + H ++HRD+K N+L+D + + + DFG L ++ T T GT
Sbjct: 158 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFD-GT 211
Query: 453 MGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTG 485
+ PE++ + V+ GI+L ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 33/130 (25%), Positives = 47/130 (36%), Gaps = 6/130 (4%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIP 131
+S N L +L+TL + GN N ++LT LDL +L
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY--- 188
L +LQ L +S NN L SL ++ N + L PK
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAF 549
Query: 189 -NFTGNNLNC 197
N T N++ C
Sbjct: 550 FNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-18
Identities = 33/178 (18%), Positives = 61/178 (34%), Gaps = 17/178 (9%)
Query: 14 LDCLHYLALSDYQGDALFALR-----TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNV 68
L L L L+ +G F + L + N L + C++S++ +N++
Sbjct: 327 LPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNAL-----SFSGCCSYSDL---GTNSL 378
Query: 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLV 127
+ LS N + +S L L L + + + +L L LD+
Sbjct: 379 RHLDLSF-NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 128 GKIPPSLGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
L L L ++ N+F + ++L + L L I +F
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-18
Identities = 23/133 (17%), Positives = 41/133 (30%), Gaps = 10/133 (7%)
Query: 54 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELG 111
P + + I N + S ++ + + + L N +
Sbjct: 1 PGSLNPCIEVVPNI--TYQCMDQKLS-----KVPDDIPSSTKNIDLSFNPLKILKSYSFS 53
Query: 112 NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 171
N S L LDL + + L L L L+ N P S + L+SL ++
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 172 NNLSGQIPVHLFQ 184
L+ +
Sbjct: 114 TKLAS-LESFPIG 125
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 20/104 (19%), Positives = 32/104 (30%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
LS S L L L I + L L++L L N + P
Sbjct: 39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176
S L L+ L + + + L +L + + N +
Sbjct: 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 1/111 (0%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L LS L L GN I P L+SL +L +L +G L L+ L ++ N
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN 138
Query: 149 NFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCG 198
+P + L++L+ + L N + L + + +L+
Sbjct: 139 FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 35/173 (20%), Positives = 61/173 (35%), Gaps = 12/173 (6%)
Query: 14 LDCLHYLALSDYQGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASV 71
L S+ L L R+ + +D ++ + +CD + +
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID--EF 266
Query: 72 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 131
L+ N + L +S ++L G I E++ SL + +L + P
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFP 323
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+L L+ LTL+ N G+I L SL + L N LS +
Sbjct: 324 TL--DLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSF-SGCCSYS 371
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 20/130 (15%), Positives = 33/130 (25%), Gaps = 13/130 (10%)
Query: 79 SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNL 137
L + +L + N I I ++ L L L N I L NL
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNL 228
Query: 138 KKLQFLTLSQNNFSGTI------PDSLTTLSSLISIQLD-SNNLSGQIPVHLFQIPKY-- 188
L L F P + L + + + + F
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 189 --NFTGNNLN 196
+ G ++
Sbjct: 289 AMSLAGVSIK 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 26/103 (25%), Positives = 40/103 (38%), Gaps = 3/103 (2%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL-DNNRLVGKIPPSLGNLKK 139
L P I L L L L+G P G + L L L D + L+ +P + L +
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQ 278
Query: 140 LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
L+ L L +P + L + I + +L Q+ H
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 26/128 (20%), Positives = 51/128 (39%), Gaps = 5/128 (3%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 140
+L I L+ L +L ++ + ++ + + +L L LDL + PP G L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 141 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP--KYNFTGNNL--N 196
+ L L + T+P + L+ L + L ++P + Q+P +L
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 197 CGKTLPHS 204
+ P +
Sbjct: 316 LDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 24/118 (20%), Positives = 51/118 (43%), Gaps = 6/118 (5%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLR--TLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
NSNN T + + + L L+ + + P++ LS L + +
Sbjct: 54 NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTI 111
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
D L+ ++P ++ L+ LTL++N +P S+ +L+ L + + + ++P
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 11/104 (10%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN---- 136
L + L TLTL N + +P + +L+ L L + + ++P L +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 137 -----LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
L LQ L L ++P S+ L +L S+++ ++ LS
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 15/95 (15%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 131
L P G L L LK + + +P ++ L+ L LDL + ++P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 166
+ L + + + + + +
Sbjct: 295 SLIAQLPANCIILVP-PHLQAQLDQHR--PVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 21/140 (15%), Positives = 35/140 (25%), Gaps = 29/140 (20%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI------------------ 130
L +G+ + L + D + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 131 -PPSLGNLK--KLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP- 186
L + L L PD LS L + +D+ L ++P + Q
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 187 --KYNFTGNNLNCGKTLPHS 204
N L + LP S
Sbjct: 129 LETLTLARNPL---RALPAS 145
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-19
Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 39/238 (16%)
Query: 268 FGQLKRYSWRELQ--LATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGG 324
F + ++ EL L ++FS ++G+GGFG+VY AD K+ A+K L
Sbjct: 171 FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------ 224
Query: 325 DAAFQR-EVEM----------ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRL- 372
+ + +S ++ + TP + + M + Y L
Sbjct: 225 KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284
Query: 373 REIKPGEPVLDWVTRKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 429
+ E + AA GLE++H +++RD+K AN+LLDE +
Sbjct: 285 QHGVFSEA--------DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333
Query: 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 486
D GLA +K + V GT G++APE L G + + + D F G ML +L+ G
Sbjct: 334 SDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-19
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 1/120 (0%)
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124
N+ + S + L L+ L L I + + L +L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
L+ +L K L+ L Q S L +L S+ L SN++S I +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPKGF 150
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-18
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 3/128 (2%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+ L L GI+ L N +L SL L +N + P +KL+ L N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 149 NFSGTIPDSLTTLSSLISIQLD-SNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
+ +++L ++ L+ + N I F F N + L +
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA--VFQSLNFGGTQNLLVIFKG 221
Query: 208 SSNDSGSS 215
N + S
Sbjct: 222 LKNSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-17
Identities = 26/147 (17%), Positives = 47/147 (31%), Gaps = 3/147 (2%)
Query: 40 PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLS--TLTL 97
Q ++ Q + + ++ T M+ L +S ++ L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 98 KGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDS 157
+ + S L LDL L ++P L L L+ L LS N F S
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 158 LTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ SL + + N ++ +
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 18/132 (13%), Positives = 40/132 (30%), Gaps = 5/132 (3%)
Query: 56 TWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS 115
+ I N + ++ + + + + L N + L +
Sbjct: 4 SDQKCIEKEVNKTYN--CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 116 LTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
LT LDL ++ + + +L L L+ N +L+ +L + +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 176 GQIPVHLFQIPK 187
+ L
Sbjct: 119 SIDFIPLHNQKT 130
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 18/96 (18%), Positives = 27/96 (28%), Gaps = 1/96 (1%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L TL L N + L +L L + L N K L+ L L N
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ S L + +N + +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMS 174
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-17
Identities = 28/161 (17%), Positives = 49/161 (30%), Gaps = 11/161 (6%)
Query: 17 LHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSM 76
+ + + +L + D + +V S+ L
Sbjct: 214 NLLVIFKGLKNSTIQSLW-LGTFEDMDDEDISPAVFEGLCEMSVE--------SINLQKH 264
Query: 77 NFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 136
F S L L L ++ E+P L LS+L L L N+ S N
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 137 LKKLQFLTLSQNNFSGTI-PDSLTTLSSLISIQLDSNNLSG 176
L L++ N + L L +L + L +++
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 34/178 (19%), Positives = 55/178 (30%), Gaps = 21/178 (11%)
Query: 17 LHYLALSDYQ----GDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVAS 70
L L L+ L L L + N+ + + SN ++
Sbjct: 280 LQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE-----NLCQISASNF-----PSLTH 329
Query: 71 VTLSSMNFSGTLSPR-IGVLRTLSTLTLKGNGIT--GEIPEELGNLSSLTSLDLDNNRLV 127
+++ L + L L L L + I +L NLS L SL+L N +
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 128 GKIPPSLGNLKKLQFLTLSQNNFSGTIPDS-LTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ +L+ L L+ S L L + L + L LF
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFD 446
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 7/131 (5%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI---PEELGNLSSLTSLDLDNNRLVGK 129
LS + L L L L+GN L L L L L L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 130 IPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP---VHLFQIP 186
+ +LK + + LS N + + ++L+ L + + L SN++S +P L Q
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 187 KYNFTGNNLNC 197
N N L+C
Sbjct: 551 TINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 27/100 (27%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
L L L + + + NL L L+L ++ L L LQ L L
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 148 NNFSGTI---PDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N+F +SL TL L + L +LS I H F
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFT 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 23/168 (13%), Positives = 47/168 (27%), Gaps = 16/168 (9%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
+L + N L + ++ + + S + +TL +
Sbjct: 84 DTLVLTANPLIFMAETALSGPK----------ALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS-QNNFSGT 153
L L N I+ + L LD NN + + +L++ L+L+ N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 154 IPDSLTTLSSLISIQLDSNNLSGQIP-----VHLFQIPKYNFTGNNLN 196
I + S+ I + + F +
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 27/133 (20%), Positives = 44/133 (33%), Gaps = 12/133 (9%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT--SLDLDNNRLVGKI 130
L S + S P+ L L + N I E++ +L T SL+L+ N + I
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGI 194
Query: 131 PPSLGNLKKLQFLTLSQNNFSGTIPDSL--TTLSSLISIQLDSNNLSGQIPVHLFQIPKY 188
P + Q L I L +T+ SL + + I +F+
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCE 253
Query: 189 ------NFTGNNL 195
N +
Sbjct: 254 MSVESINLQKHYF 266
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 20/81 (24%), Positives = 35/81 (43%), Gaps = 1/81 (1%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
LS + S L+ ++ + L N +T E L +L + L+L +N + +P
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541
Query: 133 SLGNLKKLQFLTLSQNNFSGT 153
L L + + + L QN T
Sbjct: 542 LLPILSQQRTINLRQNPLDCT 562
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 33/219 (15%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVH 340
++ + LG G +G+V + A+K + S ++ EV ++ + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 395
N+++L F LV E G + D + + A
Sbjct: 96 PNIMKLYDFFEDKRNYYLVM-------------ECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 396 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
+ G+ YLH+H I+HRD+K N+LL ++D + DFGL+ + + +
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKE 197
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
GT +IAPE L K E+ DV+ G++L L+ G
Sbjct: 198 RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
F VLG G F +V+ G A+K + D++ + E+ ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR 396
N++ L + T Y M ++ G + D + + + A +
Sbjct: 67 NIVTLEDIYESTTH---YYLVM----------QLVSGGELFDRILERGVYTEKDASLVIQ 113
Query: 397 ----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQV 449
++YLHE+ I+HRD+K N+L +E+ + ++ DFGL+K+ + + +
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTA 167
Query: 450 RGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
GT G++APE L+ S+ D + G++
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 48/251 (19%), Positives = 77/251 (30%), Gaps = 51/251 (20%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 337
+ K +GQG +G V + A+K +P + EV ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 338 AVHRNLLRLIGFCTTPTERLLV------------------YPFMQNLSVAYRLREIKPGE 379
H N+ RL LV + + + E
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 380 PVLDWVTRKRVALG-----------AAR-------GLEYLHEHCNPKIIHRDVKAANVLL 421
+ + + L YLH I HRD+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 422 --DEDFEAVVGDFGLAKLVDVRKTNVTTQVR---GTMGHIAPEYLSTG--KSSERTDVFG 474
++ FE + DFGL+K + GT +APE L+T + D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 475 YGIMLLELVTG 485
G++L L+ G
Sbjct: 262 AGVLLHLLLMG 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 270 QLKRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGG 324
S RE F+E+ +LG+G FG+V + + AVK + +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 325 D-AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 383
D + REVE++ H N+++L + +V E+ G + D
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV---G----------ELYTGGELFD 110
Query: 384 WVTRK-----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGD 431
+ ++ A + G+ Y+H+H I+HRD+K N+LL ++D + + D
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167
Query: 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
FGL+ + GT +IAPE L G E+ DV+ G++L
Sbjct: 168 FGLSTCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 279 LQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQRE 331
+Q +T FS++ VLG+G FG+V G + AVK + + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 332 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--- 388
V+++ H N+++L F LV E+ G + D + +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVG-------------EVYTGGELFDEIISRKRF 123
Query: 389 --RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVD 439
A R G+ Y+H++ KI+HRD+K N+LL +D + DFGL+ +
Sbjct: 124 SEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ GT +IAPE L G E+ DV+ G++L L++G
Sbjct: 181 --ASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 336
D + LG G F V + + G + A K + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 391
+H N++ L T+ +L+ + GE + D++ +K A
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSG------------GE-LFDFLAQKESLSEEEA 117
Query: 392 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKLVDVRKT 443
+ G+ YLH KI H D+K N++L + + + DFGLA ++
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DG 172
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ GT +APE ++ D++ G++ L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 45/214 (21%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGD--AAFQREVEM 334
D + LG G G+V KVA+K + + D + E+E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALG 393
+ H ++++ F Y + E+ G + D V KR+
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114
Query: 394 AAR--------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRK 442
+ ++YLHE+ IIHRD+K NVLL +ED + DFG +K++ +
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169
Query: 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG 476
T++ + GT ++APE L + ++ GY
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 336
D++ LG G F V + G + A K RL+ +REV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 391
H N++ L T+ +L+ + GE + D++ K A
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSG------------GE-LFDFLAEKESLTEDEA 110
Query: 392 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKT 443
+ G+ YLH +I H D+K N++L + + DFG+A ++
Sbjct: 111 TQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AG 165
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
N + GT +APE ++ D++ G++ L++G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 36/175 (20%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD------------VRKTN 444
+E+LH ++HRD+K +N+ D VGDFGL +D
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504
T QV GT +++PE + S + D+F G++L EL+ FS E ++
Sbjct: 233 HTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII--- 283
Query: 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559
+ R + + + + M+Q SP +RP ++++
Sbjct: 284 --TDV-RNLKFPLLFTQ------KYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+F +G+GGFG V+ D A+KR+ REV+ ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSV 368
++R +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLK 91
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 47/222 (21%), Positives = 86/222 (38%), Gaps = 37/222 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 336
D + LG G F V + + G + A K + +REV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 391
+H N++ L T+ +L+ + GE + D++ +K A
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSG------------GE-LFDFLAQKESLSEEEA 117
Query: 392 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKLVDVRKT 443
+ G+ YLH KI H D+K N++L + + + DFGLA ++
Sbjct: 118 TSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DG 172
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ GT +APE ++ D++ G++ L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 48/231 (20%), Positives = 90/231 (38%), Gaps = 36/231 (15%)
Query: 272 KRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA 326
K+Y + +++ + + LG G FG V+R V A G K + + P
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93
Query: 327 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 386
+ E+ +++ H L+ L E +L+ F+ GE + D +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GE-LFDRIA 140
Query: 387 RKRVALG---AAR-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGL 434
+ + GL+++HEH I+H D+K N++ + + DFGL
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
A ++ + T APE + TD++ G++ L++G
Sbjct: 198 ATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 51/259 (19%)
Query: 272 KRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFES 321
K+Y + +++ D+ + LG G FG V+R A G A K +D E+
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 322 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPV 381
++E++ +SV H L+ L E +++Y FM GE +
Sbjct: 201 ------VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GE-L 241
Query: 382 LDWVTRKRVALG---AAR-------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV-- 429
+ V + + A GL ++HE+ +H D+K N++ +
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL 298
Query: 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489
DFGL +D GT APE TD++ G++ L++G
Sbjct: 299 IDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG---- 352
Query: 490 DFSRLEEEDDVLLLDHVKK 508
S E+D L +VK
Sbjct: 353 -LSPFGGENDDETLRNVKS 370
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 43/211 (20%), Positives = 84/211 (39%), Gaps = 31/211 (14%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 340
T+ + LG+G F V R V + G + A + + D +RE + + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 395
N++RL + L++ + GE + + + + A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTG------------GE-LFEDIVAREYYSEADASHCI 116
Query: 396 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
+ + + H+ ++HR++K N+LL + + DFGLA V+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
GT G+++PE L + D++ G++L
Sbjct: 174 A-GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 43/251 (17%)
Query: 277 RELQLATDNFSE----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQRE 331
++L + F++ K +G G + R + A + AVK + + E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65
Query: 332 VE-MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 388
+E ++ H N++ L +V M+ GE +LD + R+
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG------------GE-LLDKILRQKF 112
Query: 389 ---RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAV-VGDFGLAKL 437
R A +EYLH ++HRD+K +N+L + E++ + DFG AK
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
+ + T T +APE L D++ G++L ++TG F+ ++
Sbjct: 170 LRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDD 226
Query: 498 DDVLLLDHVKK 508
+L +
Sbjct: 227 TPEEILARIGS 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 52/232 (22%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVK-------------------------RLTDFESPGGD 325
+G+G +G V D T A+K + G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 326 AAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWV 385
+E+ ++ H N+++L+ P E L Y + E+ PV++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-----------YMVFELVNQGPVMEVP 129
Query: 386 TRKRVALGAAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437
T K ++ AR G+EYLH KIIHRD+K +N+L+ ED + DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQ 486
++ V GT +APE LS + S + DV+ G+ L V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 33/217 (15%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + + +G+G +G V++ G VA+K+ + P RE+ M+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 342 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
NL+ L+ LV+ + + L E+ + + K + + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 455
H+H IHRDVK N+L+ + + DFG A+L+ +V R
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169
Query: 456 IAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 486
+PE L DV+ G + EL++G
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 84.5 bits (208), Expect = 4e-17
Identities = 56/369 (15%), Positives = 118/369 (31%), Gaps = 89/369 (24%)
Query: 253 EVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVL--GQGGFGKVYRGVLADGTK 310
+VF V R + +L++ + EL+ KNVL G G GK +A
Sbjct: 124 QVFAK--YNVSRLQPYLKLRQ-ALLELR------PAKNVLIDGVLGSGK---TWVA---- 167
Query: 311 VAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAY 370
+ V + ++ +++ C +P L + +Q L Y
Sbjct: 168 LDVCLSYKVQC-----KMDFKIFWLNL----------KNCNSPETVLEM---LQKLL--Y 207
Query: 371 RLREIKPGEPVLDWVTRKRVALGAA----RGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 426
++ D + ++ + + R L + N ++ +V+ A F
Sbjct: 208 QID--PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAF- 262
Query: 427 AVVGDFGLAKLVDVRKTNVTTQVRG-TMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ L+ R VT + T HI+ ++ S + + LL
Sbjct: 263 ----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK------SLLLKYLD 312
Query: 486 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLN-KNYNIQEVETMIQVALLCTQ 544
R D R + L + + R+ + N K+ N ++ T+I+ +L +
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDG-----LATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 545 AS------------PEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRRQEYERLQRR--- 589
+ P + ++ ++ W + +V +L +
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLI--------WFDVIKSDV--MVVVNKLHKYSLV 417
Query: 590 FDWGEDSVY 598
++S
Sbjct: 418 EKQPKESTI 426
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + ++G+G +G V + G VA+K+ + RE++++ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 342 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
NL+ L+ C LV+ F+ + L +++ LD+ ++ G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 455
H H IIHRD+K N+L+ + + DFG A+ + +V R
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR----- 191
Query: 456 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
APE L + DV+ G ++ E+ G+
Sbjct: 192 -APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 36/220 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
D F K LG G FG V+ + G + +K + S + E+E++ H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG------AA 395
N++++ +V M E G +L+ + + A
Sbjct: 81 NIIKIFEVFEDYHNMYIV---M----------ETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 396 R-------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNV 445
L Y H ++H+D+K N+L + DFGLA+L
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEH 182
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+T GT ++APE + + D++ G+++ L+TG
Sbjct: 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 35/225 (15%)
Query: 282 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDA----AFQREV--- 332
AT + +G G +G VY+ G VA+K + GG REV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVALL 65
Query: 333 EMISVAVHRNLLRLIGFCTTPTERL-----LVYPFM-QNLSVAYRLREIKPGEPVLDWVT 386
+ H N++RL+ C T LV+ + Q+L + P P L T
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLR---TYLDKAPP-PGLPAET 121
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
K + RGL++LH + I+HRD+K N+L+ + DFGLA++ + +T
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LT 177
Query: 447 TQV-----RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
V R APE L + D++ G + E+ +
Sbjct: 178 PVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 47/225 (20%), Positives = 84/225 (37%), Gaps = 44/225 (19%)
Query: 277 RELQLATDNFSE-----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQR 330
+ + ++ K VLG G GKV G K A+K L D ++
Sbjct: 17 QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70
Query: 331 EVE-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK 388
EV+ + +++ ++ + + + M E G + + +
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120
Query: 389 RVAL----GAAR-------GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGL 434
AA +++LH H I HRDVK N+L ++D + DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
AK + + T T ++APE L K + D++ G+++
Sbjct: 178 AKETT--QNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 31/276 (11%), Positives = 71/276 (25%), Gaps = 57/276 (20%)
Query: 291 VLGQGGFGKVYRGVLAD---GTKVAVK--RLTDFESPGGDAAFQREVEMISVAVHRNLLR 345
G + ++ + D +VA+ +S + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 346 LIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC 405
++ T L+V + L+E+ P R A + H
Sbjct: 96 VLDVVHTRAGGLVV---AE-WIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHRA- 148
Query: 406 NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK 465
+ + V + D + V+ +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPD-- 178
Query: 466 SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525
++ + D+ G G L L+ + + + + D + +D + ++
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS- 237
Query: 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
VA Q R A S ++ +++
Sbjct: 238 -----------AVAARSVQGDGGIRSA-STLLNLMQ 261
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 48/213 (22%), Positives = 77/213 (36%), Gaps = 37/213 (17%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLT-------DFESPGGDAAFQREVEMISVAVHRNL 343
LG G FG V+ V +V VK + + E+ ++S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR------ 396
++++ LV G + + R+ A
Sbjct: 92 IKVLDIFENQGFFQLVMEKH------------GSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 397 --GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
+ YL IIHRD+K N+++ EDF + DFG A ++ K T GT+
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIE 194
Query: 455 HIAPEYLSTGKSSE--RTDVFGYGIMLLELVTG 485
+ APE L G +++ G+ L LV
Sbjct: 195 YCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 47/219 (21%), Positives = 82/219 (37%), Gaps = 47/219 (21%)
Query: 283 TDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREV 332
+ ++ N +G+G +G+V V + A K + D + F++E+
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR------FKQEI 57
Query: 333 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK---- 388
E++ H N++RL T+ LV M E+ G + + V K
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFR 104
Query: 389 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDV 440
A + + Y H+ + HRD+K N L D + DFGLA
Sbjct: 105 ESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK- 160
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
+ GT +++P+ L G D + G+M+
Sbjct: 161 -PGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMM 197
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 37/234 (15%)
Query: 270 QLKRYSWRELQLATDNFSEK----NVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPG 323
S RE F+E+ +LG+G FG+V + + AVK +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 324 GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLD 383
+ REVE++ H N+++L + Y + + G + D
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSS---FYIVGELYT----------GGELFD 110
Query: 384 WVTRK-----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGD 431
+ ++ A + G+ Y+H+H I+HRD+K N+LL ++D + + D
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167
Query: 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
FGL+ + GT +IAPE L G E+ DV+ G++L L++G
Sbjct: 168 FGLSTCFQ--QNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 37/222 (16%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMIS 336
D + LG G F V + + G + A K R +REV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVA 391
H N++ L T+ +L+ + GE + D++ K A
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAG------------GE-LFDFLAEKESLTEEEA 116
Query: 392 LGAAR----GLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLAKLVDVRKT 443
+ G+ YLH +I H D+K N++L + DFGLA +D
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FG 171
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
N + GT +APE ++ D++ G++ L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 35/205 (17%)
Query: 289 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRL 346
LG+G F + V AVK ++ +A Q+E+ + H N+++L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR----G 397
LV M E+ G + + + +K A R
Sbjct: 72 HEVFHDQLHTFLV---M----------ELLNGGELFERIKKKKHFSETEASYIMRKLVSA 118
Query: 398 LEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
+ ++H+ ++HRD+K N+L +++ E + DFG A+L + T T+
Sbjct: 119 VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLH 174
Query: 455 HIAPEYLSTGKSSERTDVFGYGIML 479
+ APE L+ E D++ G++L
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISVAVH 340
+DN+ K LG+G F V R V G + A K + + D +RE + H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 395
N++RL + LV+ + GE + + + + A
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTG------------GE-LFEDIVAREFYSEADASHCI 111
Query: 396 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
+ + Y H + I+HR++K N+LL + + DFGLA V+ +
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 166
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
GT G+++PE L S+ D++ G++L
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGD-AAFQREVEMISVAVH 340
+DN+ K LG+G F V R V G + A K + + D +RE + H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAA 395
N++RL + LV+ + GE + + + + A
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTG------------GE-LFEDIVAREFYSEADASHCI 134
Query: 396 R----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
+ + Y H + I+HR++K N+LL + + DFGLA V+ +
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHG 189
Query: 449 VRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
GT G+++PE L S+ D++ G++L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 23/111 (20%), Positives = 51/111 (45%), Gaps = 5/111 (4%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L L+ L + N I+ + +L+ L L++ +N++ L NL +L L L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFL 294
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 195
+ N + + L++L ++ L N+++ P+ L ++ +F +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 5/96 (5%)
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
+ L L L L + I+ L NL+ + SL+L N + L N+ L +L
Sbjct: 104 SALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYL 160
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
T++++ P + L+ L S+ L+ N + P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 29/90 (32%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L L L + N I+ L NLS L SL L+NN+L + +G L L L L
Sbjct: 261 VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
SQN+ + P L +LS + S + +
Sbjct: 319 SQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 24/112 (21%), Positives = 47/112 (41%), Gaps = 6/112 (5%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L L+ L + N IT L NL++L L L+ + + L NL K+ L L
Sbjct: 84 LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNL 139
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNLN 196
N+ + L+ ++ L + + + + P+ +L + + N +
Sbjct: 140 GANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIE 190
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 6/91 (6%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
I L L +L+L N I P L +L+SL N++ + N+ +L L +
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKI 228
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176
N + P L LS L +++ +N +S
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 23/91 (25%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
L +++ L + G + + + L++L L+L+ N++ P L NL KL L +
Sbjct: 40 QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYI 95
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176
N T +L L++L + L+ +N+S
Sbjct: 96 GTNKI--TDISALQNLTNLRELYLNEDNISD 124
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 13/123 (10%)
Query: 64 NSNNVASVT-------LSSMNFSGT----LSPRIGVLRTLSTLTLKGNGITGEIPEELGN 112
+ NV +T + + + +P I L L L + G +T + L
Sbjct: 52 ANINVTDLTGIEYAHNIKDLTINNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSG 110
Query: 113 LSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 172
L+SLT LD+ ++ I + L K+ + LS N I L TL L S+ + +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169
Query: 173 NLS 175
+
Sbjct: 170 GVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-13
Identities = 17/99 (17%), Positives = 42/99 (42%), Gaps = 4/99 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+ +L+ +TL +T ++ + ++ L ++N P + L L+ L +
Sbjct: 43 MNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA-TNYNP-ISGLSNLERLRIMGK 98
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
+ + +L+ L+SL + + + I + +PK
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 19/118 (16%), Positives = 41/118 (34%), Gaps = 13/118 (11%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
LR+ + ++ T ++ + +S ++ +I L +++
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLT----------SLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG 152
+ L NG +I L L L SL++ + + + + KL L G
Sbjct: 141 IDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 14/99 (14%), Positives = 38/99 (38%), Gaps = 7/99 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+ L + ++SLT + L N V + + ++ LT++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-VTDLTG-IEYAHNIKDLTINNI 76
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
+ + P ++ LS+L +++ +++ +L +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 342
+ + + +G+G +G VY+ + G VA+KR+ D E G + RE+ ++ H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 343 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
++ LI + LV+ FM ++L + + + L K RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLK-----KVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGHI 456
H+H +I+HRD+K N+L++ D + DFGLA+ + + T +V R
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR------ 186
Query: 457 APEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
AP+ L K S D++ G + E++TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 32/208 (15%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
LG+G +G+V V VAVK + + ++E+ + + H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYL 401
Y F++ Y GE + D + A+ G+ YL
Sbjct: 75 REGNI---QYLFLE-----Y----CSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGHIAPE 459
H I HRD+K N+LLDE + DFGLA + + GT+ ++APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 460 YLSTGK--SSERTDVFGYGIMLLELVTG 485
L + +E DV+ GI+L ++ G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 47/228 (20%), Positives = 86/228 (37%), Gaps = 44/228 (19%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL------------TDFESPGGDAAFQ 329
+++ + LG G +G+V ++ A+K + +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 330 REVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK- 388
E+ ++ H N+++L LV + G + + + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLV---TEFYE----------GGELFEQIINRH 141
Query: 389 ----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 437
A + G+ YLH+H I+HRD+K N+LL + + DFGL+
Sbjct: 142 KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
K GT +IAPE L K +E+ DV+ G+++ L+ G
Sbjct: 199 FS--KDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRG--VLADGTKVAVKRL-TDFESPGGDAAFQREV---EMISV 337
+ +G+G +GKV++ + G VA+KR+ G + REV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 338 AVHRNLLRLIGFCTTPTERL-----LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVA 391
H N++RL CT LV+ + Q+L+ + P EP + T K +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT---TYLDKVP-EPGVPTETIKDMM 126
Query: 392 LGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL--VDVRKTN--VTT 447
RGL++LH H +++HRD+K N+L+ + + DFGLA++ + T+ VT
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 448 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
R APE L + D++ G + E+ +
Sbjct: 184 WYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 38/218 (17%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 337
D + V+G+G F V R + G + AVK +RE + +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK--------- 388
H +++ L+ ++ +V+ FM + + + ++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDG------------AD-LCFEIVKRADAGFVYSE 129
Query: 389 RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVR 441
VA R L Y H++ IIHRDVK VLL + +G FG+A +
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
+V GT +APE + + DV+G G++L
Sbjct: 187 GLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 4/90 (4%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
TL L L+ N I ++ ++ + L +LDL +N+L + P + + +++L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
N I +L +L L N
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 24/122 (19%), Positives = 45/122 (36%), Gaps = 10/122 (8%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGV-LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 122
N N ++ + + + L L GN ++ +L + L L+L
Sbjct: 8 NGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
+N L L +L L+ L L+ N L S+ ++ +NN+S ++
Sbjct: 67 SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 183 FQ 184
Q
Sbjct: 119 GQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 26/117 (22%), Positives = 44/117 (37%), Gaps = 5/117 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L TL L N + + E + + +T + L NN+LV I +L + L+ L N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 149 NFS-GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHS 204
F GT+ D + + ++ + +P G C + LP
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGA--YCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 16/99 (16%), Positives = 35/99 (35%), Gaps = 5/99 (5%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ V ++ TL N I+ + ++ L NN++ G ++Q+L L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 146 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
N + + +L + L N + + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L L L N + E + L +LS+L +LDL+NN + L ++ L
Sbjct: 54 LAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ NN S + S +I L +N ++ +
Sbjct: 107 ANNNIS-RVSCS--RGQGKKNIYLANNKIT-MLRDLDEG 141
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 15/70 (21%), Positives = 25/70 (35%)
Query: 106 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 165
I E N + + ++ L + + ++ L LS N S L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 166 SIQLDSNNLS 175
+ L SN L
Sbjct: 62 LLNLSSNVLY 71
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 42/219 (19%)
Query: 285 NFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISVA 338
S+ +LG G FG+V++ A G K+A K + D E + E+ +++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE------VKNEISVMNQL 143
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---AA 395
H NL++L + + +LV ++ GE + D + + L
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDG------------GE-LFDRIIDESYNLTELDTI 190
Query: 396 R-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNVT 446
G+ ++H+ I+H D+K N+L + + + DFGLA+
Sbjct: 191 LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKL 245
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
GT +APE ++ S TD++ G++ L++G
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 43/209 (20%)
Query: 289 KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRL 346
++VLG+G +V + L + AVK + + + REVE + HRN+L L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALGAAR----G 397
I F LV+ M+ G +L + ++ A +
Sbjct: 77 IEFFEEEDRFYLVFEKMRG------------GS-ILSHIHKRRHFNELEASVVVQDVASA 123
Query: 398 LEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV-------DVRKTNVTT 447
L++LH I HRD+K N+L ++ + DF L + + + T
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 448 QVRGTMGHIAPEYLSTGKSSERTDVFGYG 476
G+ ++APE + Y
Sbjct: 181 PC-GSAEYMAPEVVEAFSEEAS----IYD 204
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 41/220 (18%), Positives = 82/220 (37%), Gaps = 41/220 (18%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK----RLTDFESPGGDAAFQREVEMISV 337
+ + LG+G FG V+R V + K + TD ++E+ ++++
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNI 57
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG---A 394
A HRN+L L + E ++++ F+ + + + + L
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISG------------LD-IFERINTSAFELNEREI 104
Query: 395 AR-------GLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNV 445
L++LH H I H D++ N++ + +FG A+ +
Sbjct: 105 VSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-F 160
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
+ APE S TD++ G ++ L++G
Sbjct: 161 RLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 36/125 (28%), Positives = 54/125 (43%), Gaps = 14/125 (11%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
+N + S + + F G ++ LS + + IT IP+ L SLT L LD
Sbjct: 153 GTNPLKSSGIENGAFQG--------MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 124 NRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
N++ K+ SL L L L LS N+ S SL L + L++N L ++P L
Sbjct: 202 NKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 183 FQIPK 187
Sbjct: 260 ADHKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 12/105 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
L L+ L L N I+ + L N L L L+NN+LV K+P L + K +Q + L
Sbjct: 215 LNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 148 NNFSGTIPDS-------LTTLSSLISIQLDSNNLS-GQIPVHLFQ 184
NN S I + T +S + L SN + +I F+
Sbjct: 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 144
+ + L L+ N IT EI + NL +L +L L NN++ KI P + L KL+ L
Sbjct: 49 DLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLY 106
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 192
LS+N +P+ + +L +++ N ++ ++ K F G
Sbjct: 107 LSKNQLK-ELPEKM--PKTLQELRVHENEIT--------KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 4/97 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L+ L TL L N I+ P L L L L N+L ++P + K LQ L + +N
Sbjct: 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHEN 131
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLFQ 184
+ L+ +I ++L +N L S I FQ
Sbjct: 132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 11/93 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS-------LGNLKKLQ 141
L L L N + ++P L + + + L NN + I +
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296
Query: 142 FLTLSQNNFSGTI--PDSLTTLSSLISIQLDSN 172
++L N P + + ++QL +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + +G+G +G V++ VA+KR+ D + G ++ RE+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 342 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
N++RL + + LV+ F Q+L + LD K +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK-----KYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 455
H ++HRD+K N+L++ + E + +FGLA+ + + +V R
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR----- 168
Query: 456 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAI 489
P+ L K S D++ G + EL R +
Sbjct: 169 -PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 40/213 (18%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT---DFESPGGDAAFQREVEMISVA 338
+D F ++ LG+G VYR A+K L D + + E+ ++
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK------IVRTEIGVLLRL 105
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-----RVALG 393
H N+++L TPTE + + E+ G + D + K R A
Sbjct: 106 SHPNIIKLKEIFETPTE---ISLVL----------ELVTGGELFDRIVEKGYYSERDAAD 152
Query: 394 AAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNVT 446
A + + YLHE+ I+HRD+K N+L D + DFGL+K+V+ +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLM 207
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
V GT G+ APE L D++ GI+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L+YL +IIHRD+K N+LLDE + DF +A + + T + GT ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYM 181
Query: 457 APEYLSTGKS---SERTDVFGYGIMLLELVTGQR 487
APE S+ K S D + G+ EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 342
+ + +G+G +G VY+ G A+K++ + E G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 343 LLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
+++L T +LV+ + Q+L + + E L+ VT K L G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLK-----KLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGHI 456
H+ +++HRD+K N+L++ + E + DFGLA+ + T ++ R
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR------ 167
Query: 457 APEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
AP+ L K S D++ G + E+V G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 51/236 (21%)
Query: 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ-REVE 333
+ + ++ V+G G FG V++ L + +VA+K++ D F+ RE++
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQ 84
Query: 334 MISVAVHRNLLRLIGFCTTPTERL------LVYPFM-QNLSVAYRLREIKPGEPVLDWVT 386
++ + H N++ L F + ++ LV ++ + + YR
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YR---------ASRHYA 132
Query: 387 RKRVALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLA 435
+ + + R L Y+H I HRD+K N+LLD + + DFG A
Sbjct: 133 KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189
Query: 436 KLVDVRKTNVTTQV----RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
K++ + NV+ R APE + + + D++ G ++ EL+ GQ
Sbjct: 190 KILIAGEPNVSYICSRYYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 279 LQLATDNFSE-----KNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREV 332
LQ+ + + VLG G GKV + K A+K L D +REV
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREV 105
Query: 333 E-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 388
E + +++R++ + R + M+ L G + + +
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD----------GGELFSRIQDRGD 155
Query: 389 -----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 436
R A + ++YLH I HRDVK N+L + + DFG AK
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479
N T T ++APE L K + D++ G+++
Sbjct: 213 E--TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
LG+G +G+V V VAVK + + ++E+ + + H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEYL 401
Y F++ Y GE + D + A+ G+ YL
Sbjct: 75 REGNI---QYLFLE-----Y----CSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTMGHIAPE 459
H I HRD+K N+LLDE + DFGLA + GT+ ++APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 460 YLSTGK--SSERTDVFGYGIMLLELVTG 485
L + +E DV+ GI+L ++ G
Sbjct: 178 LLK-RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 34/179 (18%)
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-----VRKTNV 445
+ A+G+E+L K IHRD+ A N+LL E + DFGLA+ + VRK +
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLD 504
++ APE + + ++DV+ +G++L E+ + G A + ++ +++
Sbjct: 256 RLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLG--ASPYPGVKIDEEFC--- 306
Query: 505 HVKKLEREKRLDA--IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++L+ R+ A + Y M+ C P RP SE+V L
Sbjct: 307 --RRLKEGTRMRAPDYTTPEM---YQT-----MLD----CWHGEPSQRPTFSELVEHLG 351
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG G FGKV G G KVAVK L S +RE++ + + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 399
+TPT+ +V ++ GE + D+ RV AR ++
Sbjct: 79 VISTPTDFFMVMEYVSG------------GE-LFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
Y H H ++HRD+K NVLLD A + DFGL+ ++ + T+ G+ + APE
Sbjct: 126 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE 180
Query: 460 YLSTGK--SSERTDVFGYGIMLLELVTG 485
+S G+ + D++ G++L L+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 58/232 (25%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQ-REVEMISVAVH 340
++++ V+G G FG VY+ L D G VA+K++ D F+ RE++++ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDH 106
Query: 341 RNLLRLIGFCTTPTERL------LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
N++RL F + E+ LV ++ + + YR V +R + L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YR---------VARHYSRAKQTLP 154
Query: 394 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRK 442
R L Y+H I HRD+K N+LLD D + + DFG AK + +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 443 TNVTTQV-----RGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 486
N + + R APE + +++ T DV+ G +L EL+ GQ
Sbjct: 212 PN-VSYICSRYYR------APELIFG--ATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRG-VLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + + + LG+G + VY+G VA+K + + E G REV ++ H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHA 60
Query: 342 NLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
N++ L T LV+ ++ ++L + + +++ K RGL Y
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLK-----QYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTMGH 455
H K++HRD+K N+L++E E + DFGLA+ + +V R
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR----- 167
Query: 456 IAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
P+ L S + D++G G + E+ TG+
Sbjct: 168 -PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 282 ATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAV 339
++ F + LG G + VY+G+ G VA+K + D E G + RE+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELK 61
Query: 340 HRNLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
H N++RL T + LV+ FM +L R + L+ K +GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----RGTM 453
+ HE+ KI+HRD+K N+L+++ + +GDFGLA+ + +++V R
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--- 175
Query: 454 GHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 486
AP+ L ST D++ G +L E++TG+
Sbjct: 176 ---APDVLMGSRTYSTS-----IDIWSCGCILAEMITGK 206
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 21/98 (21%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
TL L L+ N I ++ ++ + L +LDL +N+L + P + + +++L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
N I +L +L L N F
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 25/121 (20%), Positives = 46/121 (38%), Gaps = 8/121 (6%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123
N N ++ + L+ + L L GN ++ +L + L L+L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
N L L +L L+ L L+ N L S+ ++ +NN+S ++
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 184 Q 184
Q
Sbjct: 120 Q 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 7/118 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L TL L N + + E + + +T + L NN+LV I +L + L+ L N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 149 NFS-GTIPDSLTTLSSLISIQLDSN-NLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHS 204
F GT+ D + + ++ + L+GQ C + LP
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP---TLGHYGAYCCEDLPAP 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 9/100 (9%)
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
+ L TL TL L N + EL S+ +L NN + ++ S + + +
Sbjct: 74 LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCS--RGQGKKNI 125
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
L+ N + S + + L N + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAEL 164
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 16/99 (16%), Positives = 35/99 (35%), Gaps = 5/99 (5%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ V ++ TL N I+ + ++ L NN++ G ++Q+L L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 146 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
N + + +L + L N + + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 15/71 (21%), Positives = 25/71 (35%)
Query: 106 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 165
I E N + + ++ L + + ++ L LS N S L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 166 SIQLDSNNLSG 176
+ L SN L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L L L N + E + L +LS+L +LDL+NN + L ++ L
Sbjct: 54 LAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ NN S + S +I L +N ++ +
Sbjct: 107 ANNNIS-RVSCS--RGQGKKNIYLANNKIT-MLRDLDEG 141
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 12/104 (11%), Positives = 29/104 (27%), Gaps = 3/104 (2%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 140
+ P ++ ++L+ N + I + L +L DL N K
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQ 262
Query: 141 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ T+++ + + + +P
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFAD 305
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 13/143 (9%), Positives = 33/143 (23%), Gaps = 4/143 (2%)
Query: 72 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL----V 127
T++ + L +L +
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 128 GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
++ N + + + + + I + I+++ L Q+ +
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 188 YNFTGNNLNCGKTLPHSCESSSN 210
+ T L H+ E S
Sbjct: 386 LDGTLQQAVGQIELQHATEEQSP 408
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 11/146 (7%), Positives = 33/146 (22%), Gaps = 2/146 (1%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
VP + P +++ + ++ + + L
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS--QNNFSG 152
+ I + + +L+ L ++ +L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQ 400
Query: 153 TIPDSLTTLSSLISIQLDSNNLSGQI 178
+ + L L +I + +
Sbjct: 401 HATEEQSPLQLLRAIVKRYEEMYVEQ 426
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 11/110 (10%), Positives = 31/110 (28%), Gaps = 3/110 (2%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGI-TGEIPEELGNLSSLTSLDL-DNNRLVGKIPPSLGNLK 138
+ + + L L+GNG G + + + ++ +L G+
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 139 KLQFLTLSQNNFSGTIPDSLTTL-SSLISIQLDSNNLSGQIPVHLFQIPK 187
+ + D L L ++ + + ++ +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 49/197 (24%), Positives = 72/197 (36%), Gaps = 27/197 (13%)
Query: 14 LDCLHYLALSDYQ-----GDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSN 66
L L+ L L D + A L L + NN + + ++ +
Sbjct: 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-----SIPSYAFNRI-----P 160
Query: 67 NVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
++ + L + +S L L L L + EIP L L L LDL N
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNH 218
Query: 126 LVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
L I P S L LQ L + Q+ ++ L SL+ I L NNL+ +P LF
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276
Query: 185 IPKY----NFTGNNLNC 197
+ + N NC
Sbjct: 277 PLHHLERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 29/126 (23%), Positives = 41/126 (32%), Gaps = 10/126 (7%)
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSL 119
C SN + V N + G+ L L N I +L L L
Sbjct: 39 CSCSNQFSKVICVRKNLR-----EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93
Query: 120 DLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI 178
L N + I + L L L L N + + LS L + L +N + I
Sbjct: 94 QLSRNHI-RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 179 PVHLFQ 184
P + F
Sbjct: 152 PSYAFN 157
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL---TDFESPGG---DAAFQREVEMIS 336
+ + + LG+G F VY+ VA+K++ E+ G A RE++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL--REIKLLQ 67
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
H N++ L+ + LV+ FM +L IK VL K L
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLE-----VIIKDNSLVLTPSHIKAYMLMTL 122
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-----R 450
+GLEYLH+H I+HRD+K N+LLDE+ + DFGLAK T QV R
Sbjct: 123 QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 179
Query: 451 GTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 486
APE L G D++ G +L EL+
Sbjct: 180 ------APELLFGARMYGVG-----VDMWAVGCILAELLLRV 210
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 27/197 (13%)
Query: 14 LDCLHYLALSDYQ-----GDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSN 66
L L+ L L D A L L + NN + + ++ V
Sbjct: 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-----SIPSYAFNRV-----P 171
Query: 67 NVASVTLSSMNFSGTLSPRIGV-LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
++ + L + +S L L L L I ++P L L L L++ N
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNH 229
Query: 126 LVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+I P S L L+ L + + S ++ L+SL+ + L NNLS +P LF
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
Query: 185 IPKY----NFTGNNLNC 197
+Y + N NC
Sbjct: 288 PLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 29/126 (23%), Positives = 44/126 (34%), Gaps = 10/126 (7%)
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSL 119
C SN + V + S + G+ L L N I + +L L L
Sbjct: 50 CSCSNQFSKVVCTRRGLS-----EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVL 104
Query: 120 DLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI 178
L N + +I + L L L L N + + LS L + L +N + I
Sbjct: 105 QLGRNSI-RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SI 162
Query: 179 PVHLFQ 184
P + F
Sbjct: 163 PSYAFN 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + +GQG FG+V++ G KVA+K++ + E G RE++++ + H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 342 NLLRLIGFCTTPTERL--------LVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
N++ LI C T LV+ F +L+ L + KRV
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA---GLLSNVLVK--FTLSEIKRVMQ 131
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL----VDVRKTNVTTQ 448
GL Y+H + KI+HRD+KAANVL+ D + DFGLA+ + + T +
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 449 V-----RGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQ 486
V R PE L + D++G G ++ E+ T
Sbjct: 189 VVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349
+G+G F KV + G +VA+K + +P REV ++ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 350 CTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLEY 400
T L+ M E G V D+ V R+ AR ++Y
Sbjct: 83 IETEKTLYLI---M----------EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
H+ I+HRD+KA N+LLD D + DFG + V + G + APE
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFC-GAPPYAAPEL 184
Query: 461 LSTGKSSE--RTDVFGYGIMLLELVTG 485
GK + DV+ G++L LV+G
Sbjct: 185 FQ-GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 29/217 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
D + LG+G +G+VY+ + VA+KR+ + E G REV ++ HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ L L++ + + L++ P + K G+ +
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAKLVDVRKTNVTTQV-----RG 451
H + +HRD+K N+LL + DFGLA+ + T ++ R
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR- 204
Query: 452 TMGHIAPEYL--STGKSSERTDVFGYGIMLLELVTGQ 486
PE L S S+ D++ + E++
Sbjct: 205 -----PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 6/112 (5%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 144
+ TL+ L L N I I E L S L L L +N++ I SL L L+ L
Sbjct: 190 DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELH 247
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196
L N S +P L L L + L +NN++ ++ V+ F + N
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 12/105 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
L L L N I I L L +L L LDNN+L ++P L +LK LQ + L
Sbjct: 216 YSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 148 NNFSGTIPDS-------LTTLSSLISIQLDSNNLS-GQIPVHLFQ 184
NN + + + + I L +N + ++ F+
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 144
+ + L L+ N I+ E+ ++ L L +L L NN++ KI + L+KLQ L
Sbjct: 51 EISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+S+N+ IP +L SSL+ +++ N + ++P +F
Sbjct: 109 ISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFS 144
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 26/98 (26%), Positives = 40/98 (40%), Gaps = 6/98 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
L+ L L L N I+ +I E+ L L L + N LV +IPP+L L L +
Sbjct: 77 LQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132
Query: 148 NNFSGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLFQ 184
N + L ++ I++ N L + F
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 11/93 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS-------LGNLKKLQ 141
L TL L L N ++ +P L +L L + L N + K+ +
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297
Query: 142 FLTLSQNNFSGTI--PDSLTTLSSLISIQLDSN 172
++L N P + ++ ++IQ +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 9/131 (6%)
Query: 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 126
L N + T+S L ++TL GI + + L++LT ++ NN+L
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80
Query: 127 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQI 185
P L NL KL + ++ N + P L L++L + L +N ++ P+ +L +
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNL 136
Query: 186 PKYNFTGNNLN 196
+ + N ++
Sbjct: 137 NRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+G+L L L+L GN + L +L++LT LDL NN++ P L L KL L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 195
N S P L L++L +++L+ N L P+ +L + NN+
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 321
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 23/130 (17%), Positives = 47/130 (36%), Gaps = 8/130 (6%)
Query: 68 VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 127
+ S T++ + L L +T + +L +T+L D +
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 128 GKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIP 186
K + L L + S N + P L L+ L+ I +++N ++ P+ +L +
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLT 115
Query: 187 KYNFTGNNLN 196
N +
Sbjct: 116 GLTLFNNQIT 125
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 23/165 (13%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
T+L + NQL D + N N+ +TL N S +SP + L L
Sbjct: 290 TNLELNENQLEDIS------------PISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQR 335
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 154
L N ++ L NL+++ L +N++ P L NL ++ L L+ ++
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391
Query: 155 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY---NFTGNNLN 196
+ +S +++ + L P + Y + T N +
Sbjct: 392 VNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
+ L +L L+ GN +T P L NL++L LD+ +N++ L L L+ L
Sbjct: 150 SALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESL 204
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176
+ N S P L L++L + L+ N L
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 11/61 (18%), Positives = 23/61 (37%), Gaps = 3/61 (4%)
Query: 115 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174
L S + + + +I L + L + N + T+ T L + ++Q D +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 175 S 175
Sbjct: 59 K 59
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 23/147 (15%), Positives = 43/147 (29%), Gaps = 39/147 (26%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
L NN++ D + N N+ ++ S L+P + L ++
Sbjct: 334 QRLFFYNNKVSDVS------------SLANLTNINWLSAGHNQISD-LTP-LANLTRITQ 379
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN------ 148
L L T N+S ++ L+ P ++ + ++ N
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTN 437
Query: 149 -----------------NFSGTIPDSL 158
FSGT+ L
Sbjct: 438 EVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 44/225 (19%), Positives = 85/225 (37%), Gaps = 40/225 (17%)
Query: 283 TDNFSEK-----NVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVE-M 334
+NF+ LG+G F V + + + G + A K L A E+ +
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK------ 388
++ L +E +L+ + GE + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAG------------GE-IFSLCLPELAEMVS 129
Query: 389 -RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDV 440
+ + G+ YLH++ I+H D+K N+LL + + DFG+++ +
Sbjct: 130 ENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG- 185
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG 485
++ GT ++APE L+ + TD++ GI+ L+T
Sbjct: 186 -HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 34/208 (16%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG+G FGKV KVA+K + + +RE+ + + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 399
TTPT+ ++V + E GE + D+ V +KR+ R +E
Sbjct: 77 VITTPTDIVMV---I----------EYAGGE-LFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
Y H H KI+HRD+K N+LLD++ + DFGL+ ++ T+ G+ + APE
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE 177
Query: 460 YLSTGKSSE--RTDVFGYGIMLLELVTG 485
++ GK DV+ GI+L ++ G
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
LG G FGKV G G KVAVK L S +RE++ + + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDW-VTRKRVALGAAR--------GLE 399
+TP++ +V ++ GE + D+ R+ +R G++
Sbjct: 84 VISTPSDIFMVMEYVSG------------GE-LFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 456
Y H H ++HRD+K NVLLD A + DFGL+ ++ + +T+ G+ +
Sbjct: 131 YCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYA 182
Query: 457 APEYLSTGKSSE--RTDVFGYGIMLLELVTG 485
APE +S G+ D++ G++L L+ G
Sbjct: 183 APEVIS-GRLYAGPEVDIWSSGVILYALLCG 212
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 36/184 (19%), Positives = 62/184 (33%), Gaps = 19/184 (10%)
Query: 9 LVAIILDCLHYLALSDYQGDALFALR--TSLRV---PNNQLRDWNQNQVNPCTWSNVICD 63
+ L L L + +G F+ SL N L +
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG---CCSQSD-----F 370
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE--LGNLSSLTSLDL 121
+ ++ + LS N T+S L L L + + + ++ E +L +L LD+
Sbjct: 371 GTTSLKYLDLSF-NGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDI 428
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI-PDSLTTLSSLISIQLDSNNLSGQIPV 180
+ L L+ L ++ N+F PD T L +L + L L Q+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 487
Query: 181 HLFQ 184
F
Sbjct: 488 TAFN 491
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 19/96 (19%), Positives = 31/96 (32%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L L I +LS L++L L N + + L LQ L +
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N + + L +L + + N + F
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 1/110 (0%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L LSTL L GN I LSSL L L +G+LK L+ L ++ N
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 149 NF-SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 197
S +P+ + L++L + L SN + L + + +L+
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 23/131 (17%), Positives = 38/131 (29%), Gaps = 11/131 (8%)
Query: 54 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL 113
PC N + +NF + + L L N + +
Sbjct: 2 PCV-----EVVPNI--TYQCMELNFYKIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSF 51
Query: 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 173
L LDL + + +L L L L+ N + + LSSL + N
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 174 LSGQIPVHLFQ 184
L+ +
Sbjct: 112 LA-SLENFPIG 121
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPS-LGNLKKLQFLTLS 146
L +L L + GN + L +LT LDL +L ++ P+ +L LQ L ++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMA 502
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
N L+SL I L +N
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 27/100 (27%), Positives = 41/100 (41%), Gaps = 4/100 (4%)
Query: 89 LRTLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS- 146
L+TL L + N I ++PE NL++L LDL +N++ L L ++ L LS
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 147 --QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N I L + L +N S + Q
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 28/129 (21%), Positives = 37/129 (28%), Gaps = 12/129 (9%)
Query: 79 SGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT----SLDLDNNRLVGKIPPSL 134
S L L L L L N I +L L + SLDL N + I P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGA 196
Query: 135 GNLKKLQFLTLSQNNFSGTIPD-------SLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
+L LTL N S + L ++ + NL L +
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 188 YNFTGNNLN 196
L
Sbjct: 257 LTIEEFRLA 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 73 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 131
++ +F P I LR L+ L L + P +LSSL L++ +N+L +P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVP 510
Query: 132 PS-LGNLKKLQFLTLSQNNFSGTIPD 156
L LQ + L N + + P
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 30/197 (15%), Positives = 61/197 (30%), Gaps = 37/197 (18%)
Query: 33 LRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTL 92
L L ++++ + + +A + + + L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTI---EEFRLAYLDYYLDDIIDLFNC----LTNV 284
Query: 93 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-------------------KIPPS 133
S+ +L I + + N L+L N + S
Sbjct: 285 SSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342
Query: 134 LGNLKKLQFLTLSQN--NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK---Y 188
+L L+FL LS+N +F G S +SL + L N + + + + +
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401
Query: 189 NFTGNNLNCGKTLPHSC 205
+F +NL K +
Sbjct: 402 DFQHSNL---KQMSEFS 415
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 23/135 (17%), Positives = 43/135 (31%), Gaps = 13/135 (9%)
Query: 75 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDL------DNNRLV 127
S+N + P L LTL+ N + + + + L+ L L + L
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 128 GKIPPSLGNLKKLQF--LTLSQNNFSGT-IPDSLTTLSSLISIQLDSNNLSGQIP--VHL 182
+L L L L+ ++ I D L+++ S L S + ++ +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN 303
Query: 183 FQIPKYNFTGNNLNC 197
F
Sbjct: 304 FGWQHLELVNCKFGQ 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 57/230 (24%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 338
+ +G G +G V + G KVA+K+L+ F+S A A+ RE+ ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAY-RELLLLKHM 80
Query: 339 VHRNLLRLIGFCTTPTERL-------LVYPFM---------QNLS---VAYRLREIKPGE 379
H N++ L+ TP L LV PFM S + Y + ++
Sbjct: 81 QHENVIGLLD-VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM---- 135
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
+GL+Y+H + ++HRD+K N+ ++ED E + DFGLA+ D
Sbjct: 136 ---------------LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 440 VRKTN-VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 486
T V T+ R APE LS ++ D++ G ++ E++TG+
Sbjct: 178 AEMTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 56/213 (26%), Positives = 79/213 (37%), Gaps = 45/213 (21%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC 350
+G G FG VAVK + D QRE+ H N++R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 351 TTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-RVALGAAR--------GLEYL 401
TPT ++ M E G + + + R + AR G+ Y
Sbjct: 86 LTPTHLAII---M----------EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAV--VGDFGLAKLV---DVRKTNVTTQVRGTMGHI 456
H +I HRD+K N LLD + DFG +K K+ V GT +I
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYI 184
Query: 457 APEYLS----TGKSSERTDVFGYGIMLLELVTG 485
APE L GK + DV+ G+ L ++ G
Sbjct: 185 APEVLLRQEYDGKIA---DVWSCGVTLYVMLVG 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 31/122 (25%), Positives = 48/122 (39%), Gaps = 13/122 (10%)
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDN 123
S+N ++ F G L L TL L G+ E+ L++L L L +
Sbjct: 88 SDNAQLRSVDPATFHG--------LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138
Query: 124 NRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182
N L +P + +L L L L N S + L SL + L N ++ + H
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHA 196
Query: 183 FQ 184
F+
Sbjct: 197 FR 198
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 31/115 (26%), Positives = 49/115 (42%), Gaps = 9/115 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
L L L L+ N + +P++ +L +LT L L NR+ +P + L L L L
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLH 185
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ----IPKYNFTGNNLNC 197
QN + P + L L+++ L +NNLS +P + N C
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 4/100 (4%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 145
G+ + L GN I+ +LT L L +N L +I + L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDL 87
Query: 146 SQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
S N ++ + L L ++ LD L ++ LF+
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 5/87 (5%)
Query: 99 GNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDS 157
G+ +P + ++ + L NR+ +P S + L L L N + +
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 158 LTTLSSLISIQLDSNNLSGQIPVHLFQ 184
T L+ L + L N + F
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 28/132 (21%), Positives = 44/132 (33%), Gaps = 15/132 (11%)
Query: 55 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS 114
C++ I L+ + P++ L T L L N I L
Sbjct: 2 CSFDGRIAFYRFC----NLTQV-------PQV--LNTTERLLLSFNYIRTVTASSFPFLE 48
Query: 115 SLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 173
L L+L + I + NL L+ L L + PD+ L L ++L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG 108
Query: 174 LS-GQIPVHLFQ 184
LS + F+
Sbjct: 109 LSDAVLKDGYFR 120
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 30/131 (22%), Positives = 48/131 (36%), Gaps = 8/131 (6%)
Query: 73 LSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEEL-----GNLSSLTSLDLDNNRL 126
L+ FS + +L L L N + EL LS L L L++N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 127 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP 186
P +L L+ L+L+ N + + L ++L + + N L P +
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLS 550
Query: 187 KYNFTGNNLNC 197
+ T N C
Sbjct: 551 VLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 33/169 (19%), Positives = 62/169 (36%), Gaps = 4/169 (2%)
Query: 40 PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLK 98
+ + + + + ++V + LS +L+ R+ L+ L L L
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLA 298
Query: 99 GNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL 158
N I E L +L L+L N L + L K+ ++ L +N+ + +
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF 358
Query: 159 TTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
L L ++ L N L+ I + IP +GN L + +
Sbjct: 359 KFLEKLQTLDLRDNALT-TIH-FIPSIPDIFLSGNKLVTLPKINLTANL 405
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 15/134 (11%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLD 122
++ L F L+ L+ L L N I + G L+SL S+D
Sbjct: 105 YFCGLSDAVLKDGYFRN--------LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 123 NNRLVGKIPPSLGNL--KKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIP 179
+N++ L L K L F +L+ N+ + D ++ ++ L+ ++SG
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN-- 214
Query: 180 VHLFQIPKYNFTGN 193
NF+
Sbjct: 215 -GWTVDITGNFSNA 227
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 21/127 (16%), Positives = 41/127 (32%), Gaps = 17/127 (13%)
Query: 72 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP------------EELGNLSSLTSL 119
+ S+++ ++P + L L + GNG T +I L +
Sbjct: 188 SRVSVDWGKCMNPFRNM--VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 120 DLDNNRLVGKIPPSLGNLKK--LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 177
+ + + L + ++ L LS TL L + L N ++ +
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-K 304
Query: 178 IPVHLFQ 184
I F
Sbjct: 305 IADEAFY 311
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 288 EKNVLGQGGFGKVYRGV---LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 344
E +G+G +G VY+ D A+K+ E G + RE+ ++ H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ---IEGTGISMSACREIALLRELKHPNVI 81
Query: 345 RLIGFCTTPTERL--LVYPFMQN----LSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
L + +R L++ + ++ + +R + L K + G+
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAV----VGDFGLAKL--VDVRK-TNVTTQV-- 449
YLH + ++HRD+K AN+L+ + + D G A+L ++ ++ V
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 450 ---RGTMGHIAPEYL------STGKSSERTDVFGYGIMLLELVTGQ 486
R APE L + D++ G + EL+T +
Sbjct: 199 FWYR------APELLLGARHYTKA-----IDIWAIGCIFAELLTSE 233
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 19/139 (13%)
Query: 82 LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNL---- 137
++PR L + +T E+P E N+ S T + PP G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 138 ---------KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY 188
++ L L+ S ++P+ L SL+ N+L+ ++P +
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSL 116
Query: 189 NFTGNNLNCGKTLPHSCES 207
NNL LP E
Sbjct: 117 LVDNNNLKALSDLPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 32/119 (26%), Positives = 46/119 (38%), Gaps = 9/119 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+L + N + E+PE L NL LT++ DNN L K+P +L+ + N
Sbjct: 172 PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLES---IVAGNN 225
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
L L L +I D+N L +P + N N L LP S
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTF 281
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 9/104 (8%)
Query: 92 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 151
L L + N + ++PE L N S L +D+DNN L K+P +L+ + N
Sbjct: 133 LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGNNQLE 186
Query: 152 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195
+P+ L L L +I D+N+L ++P + N L
Sbjct: 187 -ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNNIL 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 19/120 (15%), Positives = 38/120 (31%), Gaps = 18/120 (15%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS-------------SLTSL 119
L + + +++ + + P G L
Sbjct: 17 LRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 120 DLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
+L+N L +P +L+ L S N+ + +P+ +L SL+ + LS P
Sbjct: 77 ELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 27/119 (22%), Positives = 52/119 (43%), Gaps = 14/119 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+L ++ N + EL NL LT++ DNN L +P +L+ L + N
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRDN 267
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
+ +P+ +L+ L + + LS ++P +L+ + N + N + +L S
Sbjct: 268 YLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYL---NASSNEIR---SLCDLPPS 318
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 22/116 (18%), Positives = 46/116 (39%), Gaps = 17/116 (14%)
Query: 92 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 151
L L N I + + +L L++ NN+L+ ++P L++ L S N+ +
Sbjct: 299 LYYLNASSNEIR-SLCDLPPSL---EELNVSNNKLI-ELPALPPRLER---LIASFNHLA 350
Query: 152 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
+P+ L L ++ N L + P + ++L +P ++
Sbjct: 351 -EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRM-NSHLA---EVPELPQN 397
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 13/103 (12%), Positives = 34/103 (33%), Gaps = 21/103 (20%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNL----------------SSLTSLDLDNNRLVGKIPP 132
+ L L ++ N + E P+ ++ +L L ++ N L + P
Sbjct: 356 PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
+++ L+ ++ + T L + ++
Sbjct: 414 IPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 20/116 (17%), Positives = 43/116 (37%), Gaps = 5/116 (4%)
Query: 71 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGK 129
V + L +T K + + ++P L + + L+L++ ++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 130 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
I + +Q L + N P + L + L+ N+LS +P +F
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 145
V L+ L L+ N +T + L N L +DL N L KI +++L+ L +
Sbjct: 223 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 279
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
S N + + +L + L N+L + + Q +
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 6/111 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
T+ L + N I +P N+ LT L L+ N L +P + N KL L++S
Sbjct: 92 AHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 149
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF-QIPKYNFTGNNLN 196
NN D+ +SL ++QL SN L+ + + L + N + N L+
Sbjct: 150 NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 24/115 (20%), Positives = 39/115 (33%), Gaps = 6/115 (5%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L N S L + + + L N I + + LT L L +N L
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TA 242
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
L N L + LS N + + L + + +N L + ++ IP
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 6/104 (5%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 140
L+ + TL L L N + + L +L LD+N +V + L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTL 341
Query: 141 QFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ LTLS N++ ++ +D + +I L
Sbjct: 342 KNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ ++ +L + N ++ L ++ LD +N + + + +L L L
Sbjct: 182 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 233
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
NN T L L+ + L N L +I H F
Sbjct: 234 QHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFV 269
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 9/79 (11%), Positives = 21/79 (26%), Gaps = 1/79 (1%)
Query: 106 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 165
I L + +D L + +T + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 166 SIQLDSNNLSGQIPVHLFQ 184
+ L+ + +I + F
Sbjct: 73 LLNLNDLQIE-EIDTYAFA 90
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 44/221 (19%), Positives = 84/221 (38%), Gaps = 27/221 (12%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTD-FESPGGDAAFQ---------REV 332
++ + + G +G V GV ++G VA+KR+ + RE+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 333 EMISVAVHRNLLRLIGFCTTPTERL-----LVYPFMQ-NLSVAYRLREIKPGEPVLDWVT 386
+++ H N+L L E LV M+ +L+ + I V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVISPQH 135
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
+ GL LH ++HRD+ N+LL ++ + + DF LA+
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANK 190
Query: 447 TQVRGTMGHIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 486
T + APE + ++ D++ G ++ E+ +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 58/235 (24%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMI---SV 337
D F + + GQG FG V G G VA+K++ D F RE++++ +V
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAV 75
Query: 338 AVHRNLLRLIGFCTTPTER-------LLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRKR 389
H N+++L + T ER +V ++ L +R R++
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HR---------CCRNYYRRQ 123
Query: 390 VALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLV 438
VA R + LH + HRD+K NVL++ D + DFG AK +
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 439 DVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERT---DVFGYGIMLLELVTGQ 486
+ NV + R APE + + T D++ G + E++ G+
Sbjct: 183 SPSEPNVAYICSRYYR------APELIFG--NQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 23/182 (12%), Positives = 53/182 (29%), Gaps = 14/182 (7%)
Query: 17 LHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSM 76
+ + + + L + +V ++ ++ + L ++
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLEN---LEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 77 NFSG--TLSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
+++ + + L L++ E++ +L++LDL +N +G+
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 133 S----LGNLKKLQFLTLSQNNF---SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 185
LQ L L SG L + L N+L
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 186 PK 187
P
Sbjct: 252 PS 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 9e-13
Identities = 37/180 (20%), Positives = 55/180 (30%), Gaps = 14/180 (7%)
Query: 17 LHYLALSD--YQGDALFAL--RTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVT 72
L L L + G A L T + LR+ + + + ++
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRN-VSWATRDAWLAELQQWLKPGLKVLS 155
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE----LGNLSSLTSLDLDNNR--- 125
++ + ++ V LSTL L N GE +L L L N
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT-LSSLISIQLDSNNLSGQIPVHLFQ 184
G +LQ L LS N+ S L S+ L L Q+P L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA 274
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 32/153 (20%), Positives = 45/153 (29%), Gaps = 14/153 (9%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
L + +++ QV + D S+N L L P TL
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFP-ALSTLDLSDNP---ELGERGLISALCP--LKFPTLQV 205
Query: 95 LTLKGNGIT---GEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNF 150
L L+ G+ G L LDL +N L +L L LS
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 151 SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
+P L + L + L N L P
Sbjct: 266 K-QVPKGL--PAKLSVLDLSYNRLDR-NPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 27/146 (18%), Positives = 48/146 (32%), Gaps = 14/146 (9%)
Query: 73 LSSMNFSGTLSPRIGVLRTLST--LTLKGNGITGEIPE---ELGNLSSLTSLDLDNNRLV 127
L ++ L ++++LS LT++ I I + +S L L L+N +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 128 GKIPPSLGNLKKLQFLTLSQNNFS-GTIPDSLTTLSSLISIQLD----SNNLSGQIPVHL 182
G PP L L+ N S T L L + L + S
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 183 FQIPKY----NFTGNNLNCGKTLPHS 204
++ + + N + L +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISA 194
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 22/81 (27%), Positives = 34/81 (41%), Gaps = 6/81 (7%)
Query: 73 LSSMNFSGTLSPRIGV-LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 131
LS + L++L L G+ ++P+ L + L+ LDL NRL
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN-- 289
Query: 132 PSLGNLKKLQFLTLSQNNFSG 152
PS L ++ L+L N F
Sbjct: 290 PSPDELPQVGNLSLKGNPFLD 310
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 338
+ +G G G V VA+K+L+ F++ A A+ RE+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAY-RELVLMKCV 81
Query: 339 VHRNLLRLIGFCTTPTERL------LVYPFM---------QNLS---VAYRLREIKPGEP 380
H+N++ L+ T +V M L ++Y L ++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM----- 136
Query: 381 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
G+++LH + IIHRD+K +N+++ D + DFGLA+
Sbjct: 137 --------------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 178
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + T T + APE + E D++ G ++ E++ G
Sbjct: 179 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 31/116 (26%), Positives = 50/116 (43%), Gaps = 13/116 (11%)
Query: 71 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGK 129
V +S FSG L +L LTL+ +T IP E L +L L L L + +
Sbjct: 141 VYISHRAFSG--------LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-A 190
Query: 130 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
I S L +L+ L +S + T+ + +L S+ + NL+ +P +
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 3/97 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQ 147
L L L + + +LTSL + + L +P ++ +L L+FL LS
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 148 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N S L L L IQL L+ + + F+
Sbjct: 258 NPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFR 293
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
L L TL L+ N + IP LS+LT LD+ N++V + +L L+ L +
Sbjct: 79 LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N+ + + L+SL + L+ NL+ IP
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALS 173
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 3/99 (3%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 145
G+ L L N I +E + L L+L+ N + + P + NL L+ L L
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGL 87
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N T LS+L + + N + + ++FQ
Sbjct: 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
L L L L+ I I + L L L++ + + + P+ L L+++
Sbjct: 175 LHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 148 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N + ++ L L + L N +S I +
Sbjct: 234 CNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 6/112 (5%)
Query: 67 NVASVTLSSMNFSGTLSPR-IGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNN 124
N+ S++++ N + + + L L L L N I+ I L L L + L
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGG 282
Query: 125 RLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
+L + P + L L+ L +S N + ++ +L ++ LDSN L+
Sbjct: 283 QL-AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 22/91 (24%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 94 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGT 153
+ +PE + + LDL NR+ + L+ L L++N S
Sbjct: 15 AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 154 IPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
P + L +L ++ L SN L IP+ +F
Sbjct: 72 EPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 46/223 (20%), Positives = 93/223 (41%), Gaps = 20/223 (8%)
Query: 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGD--AAFQRE 331
++++L ++F V+G+G FG+V L + KV A+K L +E A F+ E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 332 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVA 391
+++ + + L LV + + L + + D + +
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMAR 178
Query: 392 LGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQ 448
A ++ +H+ +HRD+K N+L+D + + DFG + T ++
Sbjct: 179 FYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 449 VRGTMGHIAPEYLSTGKSSERT-----DVFGYGIMLLELVTGQ 486
GT +I+PE L + + D + G+ + E++ G+
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 31/225 (13%)
Query: 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFE--SPGGDAAFQREVE 333
R+L++ +++ V+G+G FG+V KV A+K L+ FE A F E +
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
+++ A +++L +V +M PG +++ ++ V
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEK 168
Query: 394 AAR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445
AR L+ +H IHRDVK N+LLD+ + DFG ++
Sbjct: 169 WARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 446 TTQVRGTMGHIAPEYL-STGKSSERT---DVFGYGIMLLELVTGQ 486
GT +I+PE L S G D + G+ L E++ G
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 51/228 (22%), Positives = 101/228 (44%), Gaps = 48/228 (21%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 339
++ + +G+G +G V + +VA+K+++ FE RE++++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-YCQRTL-REIKILLRFR 83
Query: 340 HRNLLRLIGFCTTPTERL-----LVYPFM----------QNLS---VAYRLREIKPGEPV 381
H N++ + PT +V M Q+LS + Y L +I
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------ 137
Query: 382 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
RGL+Y+H + ++HRD+K +N+LL+ + + DFGLA++ D
Sbjct: 138 -------------LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 442 KTNVT--TQVRGTMGHIAPEY-LSTGKSSERTDVFGYGIMLLELVTGQ 486
+ T+ T + APE L++ ++ D++ G +L E+++ +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 338
+ +G G G V VA+K+L+ F++ A A+ RE+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAY-RELVLMKCV 118
Query: 339 VHRNLLRLIGFCTTPTERL------LVYPFM---------QNLS---VAYRLREIKPGEP 380
H+N++ L+ T LV M L ++Y L ++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM----- 173
Query: 381 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
G+++LH + IIHRD+K +N+++ D + DFGLA+
Sbjct: 174 --------------LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 215
Query: 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ + T T + APE + E D++ G ++ E+V +
Sbjct: 216 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 29/116 (25%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
L +L L + GN + L +LT LDL +L ++ P + +L LQ L +S
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN-----FTGNNLNC 197
NNF L+SL + N++ Q + T N+ C
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 28/140 (20%), Positives = 49/140 (35%), Gaps = 22/140 (15%)
Query: 64 NSNNVASVTLSSMNFSG---------------TLSPRIGVLRTLSTLTLKGNGITGEIPE 108
+SN ++ S + G T+S L L L + + + ++ E
Sbjct: 60 SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
Query: 109 E--LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTI-PDSLTTLSSL 164
+L +L LD+ + L L+ L ++ N+F PD T L +L
Sbjct: 119 FSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 165 ISIQLDSNNLSGQIPVHLFQ 184
+ L L Q+ F
Sbjct: 178 TFLDLSQCQLE-QLSPTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 25/98 (25%), Positives = 35/98 (35%), Gaps = 4/98 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
LR L L + LSSL L + N P L+ L FL LS
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
Q P + +LSSL + + NN + ++
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 3/100 (3%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL--VGKIPPSLGNLKKLQFLT 144
G+ + + L L+ N + L+ LT L L +N L G S L++L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
LS N T+ + L L + +NL +F
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 338
++ +F+ VLG+G FGKV ++ AVK L D Q + ++
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389
Query: 339 VHRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTR 387
V + +L L G C +RL V ++ + Y + + + EP
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------- 442
Query: 388 KRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444
AA GL +L II+RD+K NV+LD + + DFG+ K ++
Sbjct: 443 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGV 497
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
T GT +IAPE ++ + D + +G++L E++ GQ
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 47/249 (18%), Positives = 89/249 (35%), Gaps = 60/249 (24%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAF-QREVEMISVAVH 340
+ +S LG G FG V + G + A+K++ D + RE++++ V H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP-------------------- 380
N+++L+ + T + P + +
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 381 -------VLDWVTRKRVALGAA----------RGLEYLHEHCNPKIIHRDVKAANVLLD- 422
VL R ++ R + ++H I HRD+K N+L++
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 423 EDFEAVVGDFGLAKLVDVRKTNV----TTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGI 477
+D + DFG AK + + +V + R APE + + D++ G
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230
Query: 478 MLLELVTGQ 486
+ EL+ G+
Sbjct: 231 VFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 50/254 (19%)
Query: 246 RHKGYKREVFVDVAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV- 304
G+ R+ A EV + + +G G +G V V
Sbjct: 7 ARSGFYRQEVTKTAWEVRAV--------------------YRDLQPVGSGAYGAVCSAVD 46
Query: 305 LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVAVHRNLLRLIGFCTTPTERL---- 357
G KVA+K+L F+S A A+ RE+ ++ H N++ L+ T
Sbjct: 47 GRTGAKVAIKKLYRPFQSEL-FAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104
Query: 358 --LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVK 415
LV PFM L ++ E L + + +GL Y+H IIHRD+K
Sbjct: 105 FYLVMPFMG-----TDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLK 155
Query: 416 AANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQ-VRGTMGHIAPEY-LSTGKSSERTDV 472
N+ ++ED E + DFGLA+ D T V T+ R APE L+ + ++ D+
Sbjct: 156 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR------APEVILNWMRYTQTVDI 209
Query: 473 FGYGIMLLELVTGQ 486
+ G ++ E++TG+
Sbjct: 210 WSVGCIMAEMITGK 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 338
++ + F +LG+G FGKV + A+K L + ++ E+
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK------EVIVAKD-EVAHTL 196
Query: 339 VHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAA 395
+L+ F T L Y F Q + E G + ++R+RV + A
Sbjct: 197 TENRVLQNSRHPFLTA-----LKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250
Query: 396 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
R L+YLH N +++RD+K N++LD+D + DFGL K ++
Sbjct: 251 RFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMK 307
Query: 448 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
GT ++APE L D +G G+++ E++ G+
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 20/116 (17%), Positives = 43/116 (37%), Gaps = 5/116 (4%)
Query: 71 VTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGK 129
V + L +T K + + ++P L + + L+L++ ++ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 130 IPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
I + +Q L + N P + L + L+ N+LS +P +F
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 6/102 (5%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTL 145
V L+ L L+ N +T + L N L +DL N L KI +++L+ L +
Sbjct: 229 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 285
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
S N + + +L + L N+L + + Q +
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 32/111 (28%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
T+ L + N I +P + N+ LT L L+ N L +P + N KL L++S
Sbjct: 98 AHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 155
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF-QIPKYNFTGNNLN 196
NN D+ +SL ++QL SN L+ + + L + N + N L+
Sbjct: 156 NNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 24/115 (20%), Positives = 39/115 (33%), Gaps = 6/115 (5%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L N S L + + + L N I + + LT L L +N L
Sbjct: 194 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TA 248
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
L N L + LS N + + L + + +N L + ++ IP
Sbjct: 249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 8/103 (7%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 140
L+ + TL L L N + + L +L LD+N +V + L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTL 347
Query: 141 QFLTLSQNNFSGTIPDSLTTL-SSLISIQLDSNNLSGQIPVHL 182
+ LTLS N++ +SL L ++ +D + +I L
Sbjct: 348 KNLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCKIDYQL 387
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 11/99 (11%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ ++ +L + N ++ L ++ LD +N + + + +L L L
Sbjct: 188 LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 239
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
NN T L L+ + L N L +I H F
Sbjct: 240 QHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFV 275
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 9/80 (11%), Positives = 21/80 (26%), Gaps = 1/80 (1%)
Query: 105 EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSL 164
I L + +D L + +T + L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 165 ISIQLDSNNLSGQIPVHLFQ 184
+ L+ + +I + F
Sbjct: 78 ELLNLNDLQIE-EIDTYAFA 96
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
++F +LG+G F V ++ A+K L +E ++ V R+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-------RHIIKENKVPYVTRERD 82
Query: 343 LLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR-KRVALGAAR--- 396
++ + F L + F Q+ Y +L ++ + R
Sbjct: 83 VMSRLDHPFFVK-----LYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 397 -----GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVRKTNVTTQVR 450
LEYLH IIHRD+K N+LL+ED + DFG AK++ K
Sbjct: 137 AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 451 GTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQ 486
GT +++PE L+ KSS D++ G ++ +LV G
Sbjct: 194 GTAQYVSPELLTEKSACKSS---DLWALGCIIYQLVAGL 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 38/206 (18%), Positives = 74/206 (35%), Gaps = 39/206 (18%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 338
D + ++++G G +G V + VA+K++ FE D RE+ +++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI-DCKRIL-REIAILNRL 109
Query: 339 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
H ++++++ +V + + R V L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFRTPVYLT 154
Query: 394 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
G++Y+H I+HRD+K AN L+++D V DFGLA+ VD +
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSER 469
+ + +
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 34/168 (20%), Positives = 62/168 (36%), Gaps = 11/168 (6%)
Query: 37 LRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLT 96
N L D+N ++ + S + + + + + LS +L + +T
Sbjct: 259 DDCTLNGLGDFNPSESD--VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 97 LKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS---LGNLKKLQFLTLSQNNFS-- 151
++ + + +L SL LDL N +V + + G LQ L LSQN+
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376
Query: 152 GTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY---NFTGNNLN 196
+ L TL +L S+ + N +P K N + +
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 3/98 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-KIPPSLGNLKKLQFLTLSQ 147
L +L L L N ++ G LSSL L+L N + NL LQ L +
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 148 NNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
I L+SL +++ + +L +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLK 169
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 34/124 (27%), Positives = 49/124 (39%), Gaps = 8/124 (6%)
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
CD S S +F T P G+ + +L L N IT +L ++L L L
Sbjct: 4 CDASG---VCDGRSRSF--TSIPS-GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57
Query: 122 DNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
++R+ I + +L L+ L LS N+ S LSSL + L N
Sbjct: 58 KSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 181 HLFQ 184
LF
Sbjct: 117 SLFP 120
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 21/160 (13%), Positives = 51/160 (31%), Gaps = 18/160 (11%)
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124
N + ++F+G L +L+ L +K + + L ++ + L L +
Sbjct: 131 GNVETFSEIRRIDFAG--------LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-------- 176
+ L +++L L N + L ++ + S
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 177 --QIPVHLFQIPKYNFTGNNLNCGKTLPHSCESSSNDSGS 214
++ ++ ++ + F LN S ++ G
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 29/127 (22%), Positives = 49/127 (38%), Gaps = 14/127 (11%)
Query: 75 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 134
S N + + L L GI + + +L LD+ NN L
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSL-- 448
Query: 135 GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ----IPKYNF 190
L +LQ L +S+N T+PD+ + L+ +++ N L +P +F + K
Sbjct: 449 -FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWL 504
Query: 191 TGNNLNC 197
N +C
Sbjct: 505 HTNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 28/162 (17%), Positives = 58/162 (35%), Gaps = 9/162 (5%)
Query: 22 LSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT 81
L + D L ++R L + + L + + + S+ + + + +T S N
Sbjct: 187 LLEIFADILSSVRY-LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 82 LSPRIGVLRTLSTLTLKGNGITG------EIPEELGNLS--SLTSLDLDNNRLVGKIPPS 133
L I L + NG+ ++ ELG + ++ L + L +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 134 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
L+K++ +T+ + L SL + L N +
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 4/73 (5%)
Query: 112 NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 171
+ + D + IP L ++ L LS N + L ++L + L S
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 172 NNLSGQIPVHLFQ 184
+ ++ I F
Sbjct: 60 SRIN-TIEGDAFY 71
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 43/186 (23%), Positives = 67/186 (36%), Gaps = 41/186 (22%)
Query: 279 LQLATDNFSEK-----NVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREV 332
LQ+ + + VLG G GKV + K A+K L D +REV
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREV 61
Query: 333 E-MISVAVHRNLLRLIG-FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRK-- 388
E + +++R++ + R + M+ L GE + + +
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD---------GGE-LFSRIQDRGD 111
Query: 389 -----RVALGAAR----GLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 436
R A + ++YLH I HRDVK N+L + + DFG AK
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 437 LVDVRK 442
K
Sbjct: 169 ETTGEK 174
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 34/162 (20%), Positives = 52/162 (32%), Gaps = 24/162 (14%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
T L N L + D S+N L + L+T
Sbjct: 130 TYLNCARNTLTEI---------------DVSHNTQLTELDCHLNKKITKLDVTPQTQLTT 174
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 154
L N IT E+ + L L+ D N + K+ L +L FL S N + I
Sbjct: 175 LDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EI 227
Query: 155 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196
+T L+ L N L+ L ++ + +L
Sbjct: 228 D--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 27/162 (16%), Positives = 50/162 (30%), Gaps = 31/162 (19%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
T+L L + D ++N + + + L
Sbjct: 257 TTLHCIQTDLLEI---------------DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYL 301
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 154
L + GIT E+ L L L L+N L ++ + + KL+ L+ +
Sbjct: 302 LDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DF 354
Query: 155 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196
S+ + +L + +PK T N+L
Sbjct: 355 S-SVGKIPALNNNFEAEGQTI--------TMPKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 23/110 (20%), Positives = 45/110 (40%), Gaps = 11/110 (10%)
Query: 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
+ S+ + + + ++ I L L+ L N IT + L ++LT L D+N+
Sbjct: 42 ATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNK 96
Query: 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
L + + L KL +L N + + ++ L + N L+
Sbjct: 97 LT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 35/162 (21%), Positives = 61/162 (37%), Gaps = 26/162 (16%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
T+L N++ + + V+ N + ++NN+ + L+ L+
Sbjct: 173 TTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKLDLNQ-------------NIQLTF 216
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 154
L N +T EI + L+ LT D N L ++ S L KL L Q + I
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPL-TELDVS--TLSKLTTLHCIQTDLL-EI 269
Query: 155 PDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 195
LT + LI Q + ++ V H Q+ + +
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 17/112 (15%), Positives = 34/112 (30%), Gaps = 10/112 (8%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L +L+ I + +G + +L + + + +L N ++
Sbjct: 335 VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSP 392
Query: 146 SQNNFSG---TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNN 194
+ G I + + + NLS P Y FT N
Sbjct: 393 DLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP-----AVTYTFTSEN 439
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 60/224 (26%), Positives = 87/224 (38%), Gaps = 46/224 (20%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
DNF VLG+G FGKV + + + AVK L D Q + ++ +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75
Query: 343 LLRLIG---------FCTTPTERL-LVYPF------MQNLSVAYRLREIKPGEPVLDWVT 386
+L L C +RL V F M ++ + R E
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE------------ 123
Query: 387 RKRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
R AA L +LH+ II+RD+K NVLLD + + DFG+ K +
Sbjct: 124 -ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178
Query: 444 NVTTQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 486
T GT +IAPE L D + G++L E++ G
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 35/220 (15%)
Query: 284 DNFSEKNVLGQGGFGKVY--RGVLADGTKV--AVKRLTDFESPGGDAAFQREVEMISVAV 339
+ F VLG+GG+GKV+ R V T A+K L + +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70
Query: 340 HRNLLRLIG--------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRKR 389
RN+L + + +L L+ ++ + +L RE E
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122
Query: 390 VALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
A L +LH+ II+RD+K N++L+ + DFGL K + VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
GT+ ++APE L + D + G ++ +++TG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 284 DNFSEKNVLGQGGFGKVY--RGVLADGTKV--AVKRLTDFESPGGDAAFQR-EVEMISVA 338
F VLGQG FGKV+ + + + A+K L R V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75
Query: 339 VHRNLLRLIG--------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTRK 388
R++L + + +L L+ F++ + RL +E+ E
Sbjct: 76 -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126
Query: 389 RVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445
V A L++LH II+RD+K N+LLDE+ + DFGL+K +
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182
Query: 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
GT+ ++APE ++ ++ D + +G+++ E++TG
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 338
++ ++F +LG+G FGKV + A+K L + ++ E+
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKD-EVAHTV 53
Query: 339 VHRNLLRLIG--FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGAA 395
+L+ F T L Y F Q + E G + ++R+RV A
Sbjct: 54 TESRVLQNTRHPFLTA-----LKYAF-QTHDRLCFVMEYANGGELFFHLSRERVFTEERA 107
Query: 396 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
R LEYLH +++RD+K N++LD+D + DFGL K +
Sbjct: 108 RFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMK 163
Query: 448 QVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 486
GT ++APE L R D +G G+++ E++ G+
Sbjct: 164 TFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 56/230 (24%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 338
+ + + +G G +G V G +VAVK+L+ F+S A + RE+ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTY-RELRLLKHM 85
Query: 339 VHRNLLRLIGFCTTPTERL------LVYPFM----------QNLS---VAYRLREIKPGE 379
H N++ L+ T LV M Q L+ V + + +I
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI---- 141
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
RGL+Y+H + IIHRD+K +N+ ++ED E + DFGLA+
Sbjct: 142 ---------------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
Query: 440 VRKTN-VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLELVTGQ 486
T V T+ R APE L+ ++ D++ G ++ EL+TG+
Sbjct: 184 DEMTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 28/116 (24%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L + GN +T +P L L + NRL +P L L ++ +N
Sbjct: 220 PSGLKELIVSGNRLT-SLPVLPSEL---KELMVSGNRLT-SLPMLPSGLLSL---SVYRN 271
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHS 204
+ +P+SL LSS ++ L+ N LS + L +I + S
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 34/173 (19%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
L + NQL + + +++S + +L L
Sbjct: 124 CKLWIFGNQLTS--------------LPVLPPGLQELSVSDNQLA-SLPALPS---ELCK 165
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 154
L N +T +P L L + +N+L +P L K L N + ++
Sbjct: 166 LWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SL 216
Query: 155 PDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
P + L LI + N L+ +PV ++ + +GN L +LP
Sbjct: 217 PALPSGLKELI---VSGNRLT-SLPVLPSELKELMVSGNRL---TSLPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 18/91 (19%), Positives = 35/91 (38%), Gaps = 8/91 (8%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+ L + +G+T +P+ L +T+L + +N L +P L+ L +S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
+ ++P L L +L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 29/142 (20%), Positives = 50/142 (35%), Gaps = 20/142 (14%)
Query: 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
++ ++ + N + +L LRTL + GN +T +P L L+
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 185
L P L K L + N + ++P L L + N L+ +P ++
Sbjct: 116 L----PALPSGLCK---LWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALPSEL 163
Query: 186 PKYNFTGNNLNCGKTLPHSCES 207
K N L +LP
Sbjct: 164 CKLWAYNNQLT---SLPMLPSG 182
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 4/96 (4%)
Query: 75 SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 134
S N +L L +LS + N +T +PE L +LSS T+++L+ N L + +L
Sbjct: 249 SGNRLTSLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304
Query: 135 GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170
+ + F + +L D
Sbjct: 305 REITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 338
L +F V+G+G + KV L ++ A+K + + E ++ V
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57
Query: 339 VHRNLLRLIG---FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGA 394
+++ F L F Q S + + E G ++ + R+R
Sbjct: 58 TEKHVFEQASNHPFLVG-----LHSCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 111
Query: 395 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
AR L YLHE II+RD+K NVLLD + + D+G+ K +R + T
Sbjct: 112 ARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT 167
Query: 447 TQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 486
+ GT +IAPE L G+ + D + G+++ E++ G+
Sbjct: 168 STFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ----FLT 144
+L L+++ N +T +PE +L +LD+ N L +P + F
Sbjct: 159 PTSLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+N + IP+++ +L +I L+ N LS +I L Q
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 32/142 (22%), Positives = 57/142 (40%), Gaps = 19/142 (13%)
Query: 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
N + + L+ +N S +L + ++ L + N + +PE +L LD +NR
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNR 111
Query: 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI 185
L +P +LK L + N + +P+ L + D+N L+ +P +
Sbjct: 112 LS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPELPTSL 162
Query: 186 PKYNFTGNNLNCGKTLPHSCES 207
+ N L LP ES
Sbjct: 163 EVLSVRNNQLT---FLPELPES 181
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 25/153 (16%), Positives = 53/153 (34%), Gaps = 35/153 (22%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNL-----------------SS 115
++ +L +L L N ++ +PE +L +
Sbjct: 87 ITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHLDVDNNQLTMLPELPAL 141
Query: 116 LTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
L ++ DNN+L +P +L+ L++ N + +P+ +L +L + +N L
Sbjct: 142 LEYINADNNQLT-MLPELPTSLEV---LSVRNNQLT-FLPELPESLEAL---DVSTNLLE 193
Query: 176 GQIPVHLFQIPKYNFTGNNLNCG----KTLPHS 204
+P + T C +P +
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRITHIPEN 225
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 16/97 (16%), Positives = 29/97 (29%), Gaps = 6/97 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTS----LDLDNNRLVGKIPPSLGNLKKLQFLT 144
+L L + N + +P NR+ IP ++ +L +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTII 236
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
L N S I +SL+ ++ S
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 13/114 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
+ N + E L ++ + L L+ L +P +L ++ L ++QN
Sbjct: 36 WEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQN 90
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLP 202
++P+ +L L N LS +P + + N L LP
Sbjct: 91 ALI-SLPELPASLEYL---DACDNRLS-TLPELPASLKHLDVDNNQL---TMLP 136
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 5/95 (5%)
Query: 81 TLSPRIGVLRTLST----LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 136
+L + N IT IPE + +L ++ L++N L +I SL
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 137 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 171
+ FS + T L
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW 287
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
++ +H +HRD+K N+LLD + DFG + T + GT ++
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 457 APEYLSTGKSSERTDVFG-------YGIMLLELVTGQ 486
+PE L T +G G+ E+ GQ
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 338
L +F V+G+G + KV L ++ A++ + + E ++ V
Sbjct: 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100
Query: 339 VHRNLLRLIG---FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV-ALGA 394
+++ F L F Q S + + E G ++ + R+R
Sbjct: 101 TEKHVFEQASNHPFLVG-----LHSCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 395 AR--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
AR L YLHE II+RD+K NVLLD + + D+G+ K +R + T
Sbjct: 155 ARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT 210
Query: 447 TQVRGTMGHIAPEYLSTGKSSERT-DVFGYGIMLLELVTGQ 486
+ GT +IAPE L G+ + D + G+++ E++ G+
Sbjct: 211 STFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
GL++LH I++RD+K N+LLD+D + DFG+ K ++ T GT +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
APE L K + D + +G++L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 50/222 (22%), Positives = 82/222 (36%), Gaps = 46/222 (20%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVE-------MI 335
D F LG G FG+V + A+K L +++E ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 336 SVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
L++L + +V ++ + LR R + A
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR------------IGRFSEPHA 143
Query: 396 R--------GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
R EYLH +I+RD+K N+L+D+ V DFG AK V R T
Sbjct: 144 RFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW 196
Query: 448 QVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQ 486
+ GT +APE + + K+ D + G+++ E+ G
Sbjct: 197 TLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKV-AVKRLTDFESPGGDAAFQREVEMISVA 338
++ +F+ VLG+G FGKV ++ AVK L D Q + ++
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 68
Query: 339 VHRNLLRLIG---------FCTTPTERL-LVYPFMQNLSVAYRL-REIKPGEPVLDWVTR 387
V + +L L G C +RL V ++ + Y + + + EP
Sbjct: 69 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------- 121
Query: 388 KRVALGAAR---GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444
AA GL +L II+RD+K NV+LD + + DFG+ K ++
Sbjct: 122 -HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGV 176
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ 486
T GT +IAPE ++ + D + +G++L E++ GQ
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
L YLH I++RD+K N+LLD V+ DFGL K ++ + T+ GT ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206
Query: 457 APEYLSTGKSSERT-DVFGYGIMLLELVTGQ 486
APE L + +RT D + G +L E++ G
Sbjct: 207 APEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 2e-11
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 5/97 (5%)
Query: 105 EIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSS 163
+ L +LT L ++N + + + L L +L+ LT+ ++ PD+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 164 LISIQLDSNNLSGQIPVHLFQIPKY---NFTGNNLNC 197
L + L N L + Q +GN L+C
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 17/123 (13%)
Query: 55 CTWSN-VICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LGN 112
S+ + C + S+ + G L+ L ++ + L
Sbjct: 7 PHGSSGLRCTRDGALDSLH----HLPG--------AENLTELYIENQQHLQHLELRDLRG 54
Query: 113 LSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS 171
L L +L + + L + P + +L L LS N ++ SL + L
Sbjct: 55 LGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSG 112
Query: 172 NNL 174
N L
Sbjct: 113 NPL 115
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 46/203 (22%), Positives = 72/203 (35%), Gaps = 23/203 (11%)
Query: 14 LDCLHYLALSDYQGDALFALRTSLRVPNNQLRD----WNQNQVNPCTWSNVIC------- 62
+ L LS A R + +++ + N + +N
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 63 -DNSNNVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSL 119
++ V + LS + L + L LTL N I +I + L+ L L
Sbjct: 271 GLEASGVKTCDLSK-SKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 120 DLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQI 178
+L N L G I NL KL+ L LS N+ S L +L + LD+N L +
Sbjct: 329 NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-V 386
Query: 179 PVHLF----QIPKYNFTGNNLNC 197
P +F + K N +C
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 21/97 (21%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 91 TLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQN 148
++ + L N I E+ E L L L ++ I + L L L L N
Sbjct: 31 HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNL-SGQIPVHLFQ 184
F + L++L + L NL + + F+
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 26/111 (23%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 89 LRTLSTLTLKGNGITG-EIPEEL-GNLSSLTSLDLDNNRLVGKIPPS--LGNLKKLQFLT 144
L L LTL + G + L+SL L L +N + KI P+ N+++ L
Sbjct: 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLD 160
Query: 145 LSQNNFSGTIPDSLTTLSS--LISIQLDSNNLSGQIPVHLFQIPKYNFTGN 193
L+ N + L ++L S L L N N
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 46/225 (20%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVH 340
D++ LG+G + +V+ + + + KV VK L + +RE++ + ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGG 90
Query: 341 RNLLRLIGFCTTPTERLLVYPF-----------MQNLS---VAYRLREIKPGEPVLDWVT 386
N++ L P R F Q L+ + + + EI
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI----------- 139
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNV 445
+ L+Y H I+HRDVK NV++D E + + D+GLA+ +
Sbjct: 140 --------LKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-Y 187
Query: 446 TTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAI 489
+V + PE L + D++ G ML ++ +
Sbjct: 188 NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
LE+LH+ II+RD+K N+LLD + V+ DFGL+K +T GT+ ++
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 457 APEYLSTGKSSERTDV--FGYGIMLLELVTGQ 486
AP+ + G S V + G+++ EL+TG
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 57/236 (24%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 339
+ +F K++LG+G +G V G VA+K++ F+ P A RE++++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTL-REIKILKHFK 67
Query: 340 HRNLLRLIGFCTTPTERL-----LVYPFM----------QNLS---VAYRLREIKPGEPV 381
H N++ + + ++ M Q LS + Y + +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT------ 121
Query: 382 LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441
R ++ LH +IHRD+K +N+L++ + + V DFGLA+++D
Sbjct: 122 -------------LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 442 KTNVTTQVRGTMGHI----------APEY-LSTGKSSERTDVFGYGIMLLELVTGQ 486
+ ++ G + APE L++ K S DV+ G +L EL +
Sbjct: 166 AAD-NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 5e-11
Identities = 36/223 (16%), Positives = 66/223 (29%), Gaps = 45/223 (20%)
Query: 269 GQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVK--RLTDFESPGGDA 326
Q + L T+ +G+G FG+V++ + AD T VA+K + + G
Sbjct: 6 SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63
Query: 327 -----------AFQREVEMISVAV---HRNLLRLIGFC----TTPTERLLVY-------- 360
+E+ ++S V + L + P L +
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 361 -----PFMQNLSVAYRLREIKPGEPVL--------DWVTRKRVALGAARGLEYLHEHCNP 407
P + + E + G L T K + L +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SL 181
Query: 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
+ HRD+ NVLL + + K + + +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 43/196 (21%), Positives = 71/196 (36%), Gaps = 39/196 (19%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMISVA 338
DN+ K+++G+G +G VY VA+K++ FE D RE+ +++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKRIL-REITILNRL 82
Query: 339 VHRNLLRLIGFCTTPTERL-----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
++RL +V + L + + + L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA---------------DSDLKKLFKTPIFLT 127
Query: 394 AA----------RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
G ++HE IIHRD+K AN LL++D V DFGLA+ ++ K
Sbjct: 128 EEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 444 NVTTQVRGTMGHIAPE 459
P
Sbjct: 185 TNIVNDLEENEEPGPH 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 6e-11
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 13/93 (13%)
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHI 456
LEYLH II+RD+K N+LLD++ + DFG AK V T + GT +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170
Query: 457 APEYLST---GKSSERTDVFGYGIMLLELVTGQ 486
APE +ST KS D + +GI++ E++ G
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 6/94 (6%)
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
+ L ++ L L N + +P L L L L +N L + + NL +LQ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513
Query: 144 TLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLS 175
L N L + L+ + L N+L
Sbjct: 514 LLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.1 bits (124), Expect = 4e-07
Identities = 22/86 (25%), Positives = 32/86 (37%), Gaps = 4/86 (4%)
Query: 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-KIPPSLGNLKK 139
L P + LR L L N + + + NL L L L NNRL L + +
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 140 LQFLTLSQNNFSGTIPDSLTTLSSLI 165
L L L N+ L+ ++
Sbjct: 535 LVLLNLQGNSLC-QEEGIQERLAEML 559
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 27/117 (23%), Positives = 47/117 (40%), Gaps = 13/117 (11%)
Query: 72 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKI 130
T+ S FS L +S + + + ++ NLS +T +++ N R + I
Sbjct: 45 TIPSHAFSN--------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96
Query: 131 PPS-LGNLKKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
P L L L+FL + PD + + +++ N IPV+ FQ
Sbjct: 97 DPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLT 144
+ + TL L + IP NL +++ + + + + ++ S NL K+ +
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 145 LSQNNFSGTIP-DSLTTLSSLISIQLDSNNLS 175
+ I D+L L L + + + L
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 10/102 (9%)
Query: 89 LRTLSTLTLKGNGITGEIPEE--LGNLSSLTSLDLDNNRLVGKIPP----SLGNLKKLQF 142
L L L + G+ P+ + + L++ +N + IP L N
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--TLT 160
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
L L N F+ ++ + L ++ L+ N I F
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 34/164 (20%), Positives = 60/164 (36%), Gaps = 20/164 (12%)
Query: 14 LDCLHYLALSDYQG------DALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNS 65
L + ++ + + + DAL L L + N L+ + T I + +
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEIT 138
Query: 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
+N ++ F G L TL L NG T + N + L ++ L+ N+
Sbjct: 139 DNPYMTSIPVNAFQG-LCNE------TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190
Query: 126 LVGKIPPSL--GNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLIS 166
+ I G L +SQ + + +P L L LI+
Sbjct: 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 17/95 (17%), Positives = 30/95 (31%), Gaps = 7/95 (7%)
Query: 92 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNF 150
+ I IP S +L L L IP + NL + + +S +
Sbjct: 13 EEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67
Query: 151 SGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ S LS + I++ + I +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK 102
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 20/122 (16%), Positives = 42/122 (34%), Gaps = 16/122 (13%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVG----KIPP----SLGNLKK 139
++ +S L L + E SS+ L+L + L ++ SL
Sbjct: 197 IQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 140 LQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY----NFTGNNL 195
+ + ++ + + L +S L+ ++ N L +P +F N
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
Query: 196 NC 197
+C
Sbjct: 314 DC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 19/106 (17%), Positives = 37/106 (34%), Gaps = 3/106 (2%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
L L L + +I + L+ L L++D + L P SL +++ + L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILH 206
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTG 192
+ + SS+ ++L +L L +
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 33/128 (25%), Positives = 50/128 (39%), Gaps = 8/128 (6%)
Query: 58 SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT 117
+++ CD + SS + + S G+ + +L L N IT +L +L
Sbjct: 26 ASLSCDRNG---ICKGSSGSLN---SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQ 79
Query: 118 SLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176
+L L +N + I S +L L+ L LS N S LSSL + L N
Sbjct: 80 ALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT 138
Query: 177 QIPVHLFQ 184
LF
Sbjct: 139 LGETSLFS 146
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 26/164 (15%), Positives = 53/164 (32%), Gaps = 7/164 (4%)
Query: 14 LDCLHYLALSDYQGDALFALR--TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASV 71
L + + Q L L + + L+ + + + + +
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL- 212
Query: 72 TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP 131
L + T S LR T + ++ L + ++ + + L ++
Sbjct: 213 -LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270
Query: 132 PSLGNLKKLQFLTLSQNNFSGTIPDS-LTTLSSLISIQLDSNNL 174
L + L L S+N ++PD L+SL I L +N
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 16/121 (13%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
+ L L L N + + E +L +L L L NN +V + + ++ +LQ L LS
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 147 QNNFSGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLFQ-IPKY-----NFTGNNLN 196
QN S P L L+ + L SN L ++P+ Q +P + N L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLE 202
Query: 197 C 197
C
Sbjct: 203 C 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 5/98 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
L L +L L N + I E + +L LDL +N L + +L+ L+ L L
Sbjct: 63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N+ ++ ++ L + L N +S + PV L +
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 23/95 (24%), Positives = 41/95 (43%), Gaps = 9/95 (9%)
Query: 93 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP--SLGNLKKLQFLTLSQNNF 150
+ L+ + +P+ L S LDL +N L ++ + L L L LS N+
Sbjct: 21 NILSCSKQQLP-NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 151 SGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ I ++ + +L + L SN+L + LF
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFS 109
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 30/140 (21%), Positives = 44/140 (31%), Gaps = 19/140 (13%)
Query: 89 LRTLSTLTLKGNGITGEIPEE----LGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144
+ L L L N I+ P E L L LDL +N+L L L
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 145 LS-QNN-----------FSGTIPDSLTTLSSLIS--IQLDSNNLSGQIPVHLFQIPKYNF 190
L NN FS L+++ + S L + F +Y
Sbjct: 194 LYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKE 253
Query: 191 TGNNLNCGKTLPHSCESSSN 210
+ + G TL C++
Sbjct: 254 SAWEAHLGDTLTIRCDTKQQ 273
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 20/135 (14%), Positives = 42/135 (31%), Gaps = 19/135 (14%)
Query: 54 PCTWSNVICD-NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEE-LG 111
C SN + + V + P + R L + I +
Sbjct: 6 ICHCSNRVFLCQESKVTEI------------PS-DLPRNAIELRFVLTKLR-VIQKGAFS 51
Query: 112 NLSSLTSLDLDNNRLVGKIPPS-LGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQL 169
L +++ N ++ I NL KL + + + N I ++ L +L + +
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 170 DSNNLSGQIPVHLFQ 184
+ + +P
Sbjct: 112 SNTGIK-HLPDVHKI 125
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 30/138 (21%), Positives = 49/138 (35%), Gaps = 19/138 (13%)
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTL-KGNGITGEIPEE-LGNLSSLTSLDLD 122
S N + + FS L L + + K N + I E NL +L L +
Sbjct: 62 SQNDVLEVIEADVFSN--------LPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLIS 112
Query: 123 NNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSS-LISIQLDSNNLSGQIP 179
N + +P + + L + N TI S LS + + L+ N + +I
Sbjct: 113 NTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170
Query: 180 VHLFQIPK---YNFTGNN 194
F + N + NN
Sbjct: 171 NSAFNGTQLDELNLSDNN 188
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 23/99 (23%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPP-SLGNL-KKLQFLTL 145
L L L + GI +P+ + LD+ +N + I S L + L L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
++N I +S + L + L NN ++P +F
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 19/86 (22%), Positives = 32/86 (37%), Gaps = 8/86 (9%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
+ N + E+P + S LD+ R+ +P L NLKKL+ +
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY 234
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSN 172
+P +L L +L+ L
Sbjct: 235 NLK---KLP-TLEKLVALMEASLTYP 256
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 4/86 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
LR+L++L L GN IT E+P+ L L SL L L+ N++ + + +L L L+L
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSN 172
N + + L ++ ++ L N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 32/122 (26%), Positives = 48/122 (39%), Gaps = 15/122 (12%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLD 122
N + + FS + L + L N I+ E+ + L SL SL L
Sbjct: 40 EQNTIKV--IPPGAFSP--------YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLY 88
Query: 123 NNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
N++ ++P SL L LQ L L+ N + D+ L +L + L N L I
Sbjct: 89 GNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146
Query: 182 LF 183
F
Sbjct: 147 TF 148
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 22/76 (28%), Positives = 38/76 (50%), Gaps = 11/76 (14%)
Query: 114 SSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISIQ 168
++T + L+ N + IPP + KKL+ + LS N S + L +L+SL
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL---V 86
Query: 169 LDSNNLSGQIPVHLFQ 184
L N ++ ++P LF+
Sbjct: 87 LYGNKIT-ELPKSLFE 101
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
L +L L L N I + + +L +L L L +N+L + L+ +Q + L+Q
Sbjct: 103 LFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQ 161
Query: 148 NNF 150
N F
Sbjct: 162 NPF 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 29/108 (26%), Positives = 52/108 (48%), Gaps = 7/108 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L ++TL+ G G+T I E + L++L L+L +N++ + P L NL K+ L LS N
Sbjct: 40 LDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGN 95
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNL 195
++ L S+ ++ L S ++ P+ L + N +
Sbjct: 96 PL--KNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L ++ L L GN + + + L S+ +LDL + ++ + P L L LQ L L N
Sbjct: 84 LTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQI-TDVTP-LAGLSNLQVLYLDLN 139
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ P L L++L + + + +S
Sbjct: 140 QITNISP--LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L + + +T + +L +T+L + I + L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ P L L+ + ++L N L
Sbjct: 74 QITDLAP--LKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 12/79 (15%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 97 LKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD 156
+ I P L++ + + + + +L + L+ + TI
Sbjct: 4 TQPTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE- 57
Query: 157 SLTTLSSLISIQLDSNNLS 175
+ L++LI ++L N ++
Sbjct: 58 GVQYLNNLIGLELKDNQIT 76
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 4/87 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L + LK N I+ L N S+L + L N + + NL +
Sbjct: 194 LPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGP 249
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ + P +++ + S L N S
Sbjct: 250 SGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 71/244 (29%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA--AFQREVEMISVAV 339
+ + LG GG G V+ V +VA+K++ P A RE+++I
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQ-SVKHAL-REIKIIRRLD 66
Query: 340 HRNLLRLIGFCTTPTERL--------------LVYPFM----------QNLS---VAYRL 372
H N++++ +L +V +M L +
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM 126
Query: 373 REIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGD 431
++ RGL+Y+H + ++HRD+K AN+ ++ ED +GD
Sbjct: 127 YQL-------------------LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGD 164
Query: 432 FGLAKLVDVRKTN-------VTTQ-VRGTMGHIAPE-YLSTGKSSERTDVFGYGIMLLEL 482
FGLA+++D ++ + T+ R +P LS ++ D++ G + E+
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEM 218
Query: 483 VTGQ 486
+TG+
Sbjct: 219 LTGK 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L ++ + + I + + + L ++T L L+ N+L I P L NLK L +L L +N
Sbjct: 42 LNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDEN 97
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ SL L L S+ L+ N +S
Sbjct: 98 KIK-DL-SSLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 33/106 (31%), Positives = 49/106 (46%), Gaps = 10/106 (9%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ L L +L L N IT L L+ L +L L++N++ I P L L KLQ L L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 146 SQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYN 189
S+N+ I D +L L +L ++L S + H + N
Sbjct: 183 SKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L+ L L L N I ++ L +L L SL L++N + I L +L +L+ L L N
Sbjct: 86 LKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 141
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
T L+ L+ L ++ L+ N +S
Sbjct: 142 KI--TDITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 1e-08
Identities = 18/87 (20%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
LK +T + L+S+ + +N+ + + + L + L L+ N
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGN 75
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ P LT L +L + LD N +
Sbjct: 76 KLTDIKP--LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 8/108 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L TL+L+ N I+ +I L L+ L +L L N + + L LK L L L
Sbjct: 152 LTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQ 207
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196
+ + L ++ N G + ++ N+
Sbjct: 208 ECLNKPINHQSNLVVPNTV----KNTDGSLVTPEIISDDGDYEKPNVK 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 41/202 (20%), Positives = 80/202 (39%), Gaps = 44/202 (21%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTD-FESPGGDA--AFQREVEMIS-V 337
+ LG+G +G V++ + G VAVK++ D F++ DA F RE+ +++ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST-DAQRTF-REIMILTEL 65
Query: 338 AVHRNLLRLIGFCTTPTER--LLVYPFM----------QNLS---VAYRLREIKPGEPVL 382
+ H N++ L+ +R LV+ +M L Y + ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL------- 118
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
+ ++YLH ++HRD+K +N+LL+ + V DFGL++ +
Sbjct: 119 ------------IKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 443 TNVTTQVRGTMGHIAPEYLSTG 464
+
Sbjct: 164 RVTNNIPLSINENTENFDDDQP 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 12/99 (12%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L+ L L +T ++ + G L L +LDL +N+L +P L L L +S N
Sbjct: 54 YTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN 110
Query: 149 NFSGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLF 183
+ ++P L L L L N L +P L
Sbjct: 111 RLT-SLPLGALRGLGELQEL---YLKGNELK-TLPPGLL 144
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 28/86 (32%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L L LKGN + +P L L L L NN L ++P L L+ L L L
Sbjct: 123 LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSN 172
+N+ TIP L L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 7/123 (5%)
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
+ V N + L P + + + L L N + L + LT L+L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181
D L G L L L LS N ++P TL +L + + N L+ +P+
Sbjct: 63 DRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 182 LFQ 184
+
Sbjct: 119 ALR 121
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 31/102 (30%), Positives = 45/102 (44%), Gaps = 7/102 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L+ L + N +T +P L L L L N L +PP L KL+ L+L+
Sbjct: 99 LPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156
Query: 147 QNNFSGTIPDSL-TTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
NN + +P L L +L ++ L N+L IP F
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L+ L L L N + ++ L +L L SL L++N + I L +L +L+ L L N
Sbjct: 89 LKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 144
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
T L+ L+ L ++ L+ N +S
Sbjct: 145 KI--TDITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
I L ++ L L GN +T +I + L NL +L L LD N++ + L +LKKL+ L+L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSL 119
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
N S I + L L L S+ L +N ++
Sbjct: 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 15/87 (17%), Positives = 30/87 (34%), Gaps = 4/87 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L L L N I+ ++ L L +L L+L + + K NL + +
Sbjct: 177 LTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ P+ ++ + +
Sbjct: 235 SL--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 16/125 (12%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L +L L + + G+L +L L++ +N + P NL L+ L LS
Sbjct: 99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 147 QNNFSGTIP----DSLTTLSSL-ISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCG 198
N +I L + L +S+ L N ++ I F ++ + N L
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL--- 212
Query: 199 KTLPH 203
K++P
Sbjct: 213 KSVPD 217
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 25/140 (17%), Positives = 41/140 (29%), Gaps = 23/140 (16%)
Query: 54 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELG 111
PC N + +NF +I + + L L N +
Sbjct: 2 PCV-----EVVPNI--TYQCMELNFY-----KIPDNLPFSTKNLDLSFNPLRHLGSYSFF 49
Query: 112 NLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQN---NFSGTIPDSLTTLSSLISI 167
+ L LDL + I +L L L L+ N + + L++L L
Sbjct: 50 SFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL--- 105
Query: 168 QLDSNNLSGQIPVHLFQIPK 187
NL+ + K
Sbjct: 106 VAVETNLA-SLENFPIGHLK 124
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 26/89 (29%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLT----SLDLDNNRLVGKIPPSLGNLKKLQFL 143
L L L L N I I L L + SLDL N + I P +L+ L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKEL 205
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSN 172
L N L+SL I L +N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 25/118 (21%), Positives = 40/118 (33%), Gaps = 22/118 (18%)
Query: 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLD 122
+ N + L S +F L L L I I + +LS L++L L
Sbjct: 36 SFNPLRH--LGSYSFFS--------FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 123 NNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISIQLDSNNLS 175
N + + L LQ L + N + ++ L TL L + N +
Sbjct: 85 GNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKEL---NVAHNLIQ 137
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
++L +L + N +T I L + LDL +N++ IP + L+ LQ L ++ N
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454
Query: 149 NFSGTIPD-SLTTLSSLISIQLDSNNL 174
++PD L+SL I L +N
Sbjct: 455 QLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 22/99 (22%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 81 TLSPRIGVLRTLSTLT---LKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSLGN 136
LS + + +L + N ++ + + SL SL++ +N L I L
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 137 LKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
+++ L L N +IP + L +L + + SN L
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 22/110 (20%), Positives = 40/110 (36%), Gaps = 8/110 (7%)
Query: 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 126
+ V S P+ + + + L + N I+ ++ +LS L L + +NR+
Sbjct: 1 SEFLVDRSKNGL--IHVPK-DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 127 VGKIPPS-LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ S ++L++L LS N L L L N
Sbjct: 58 -QYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFD 103
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 15/111 (13%), Positives = 34/111 (30%)
Query: 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124
++++V L L+ LS + + S++ + +
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310
Query: 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ L S N + T+ ++ L+ L ++ L N L
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 22/130 (16%), Positives = 39/130 (30%), Gaps = 5/130 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146
L L L N +P E GN+S L L L L + +L + L +
Sbjct: 89 TVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCE 206
+ + L + L + + + + L+ K + +
Sbjct: 148 GETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205
Query: 207 SSSNDSGSSK 216
S S +K
Sbjct: 206 CSYFLSILAK 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 21/87 (24%), Positives = 41/87 (47%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLS 146
++ + L N + + ++ L SL +L L +NR+ + S L ++ L+L
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 147 QNNFSGTIPD-SLTTLSSLISIQLDSN 172
N + T+ + TL SL ++ L +N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 25/98 (25%), Positives = 40/98 (40%), Gaps = 5/98 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEE-LGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L + N IT +I E S + + L +NRL + + L+ L+ L L
Sbjct: 56 LPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLR 113
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
N + DS LSS+ + L N ++ + F
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 14/97 (14%)
Query: 94 TLTLKGNGITGEIPEE--LGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNF 150
L L N T + L L ++ NN++ I + + + L+ N
Sbjct: 36 ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 151 SGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLF 183
+ L +L +L L SN ++ + F
Sbjct: 94 E-NVQHKMFKGLESLKTL---MLRSNRIT-CVGNDSF 125
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 14/76 (18%), Positives = 28/76 (36%), Gaps = 12/76 (15%)
Query: 114 SSLTSLDLDNNRLVGKIPPS--LGNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISI 167
L L+NN + + L +L+ + S N + I + + ++ +
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI--- 86
Query: 168 QLDSNNLSGQIPVHLF 183
L SN L + +F
Sbjct: 87 LLTSNRLEN-VQHKMF 101
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 31/86 (36%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGT 153
L L GN T +P+EL N LT +DL NNR+ + N+ +L L LS N
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 154 IP----DSLTTLSSLISIQLDSNNLS 175
IP D L +L L L N++S
Sbjct: 93 IPPRTFDGLKSLRLL---SLHGNDIS 115
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 18/87 (20%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L +T + LS + + + DN+ + + + L+ L LS N
Sbjct: 18 LANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHN 73
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
S + L L+ L + ++ N L
Sbjct: 74 QIS-DL-SPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 26/131 (19%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP------------- 132
+ L L L N I+ ++ L +L+ L L ++ NRL +
Sbjct: 59 MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDN 115
Query: 133 -------SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-HLFQ 184
SL +LK L+ L++ N +I L LS L + L N ++ + L +
Sbjct: 116 NELRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKK 173
Query: 185 IPKYNFTGNNL 195
+ + TG
Sbjct: 174 VNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 18/90 (20%), Positives = 29/90 (32%), Gaps = 4/90 (4%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+G L L L L GN IT L L + +DL + V + L T+
Sbjct: 146 LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYIT--NTV 201
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
+ P ++ S + +
Sbjct: 202 KDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 4/86 (4%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L+ L+L N + +P+ + L+SL L L NN+L ++P L +L+ L L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLD 189
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSN 172
N + +L L +QL N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 14/128 (10%)
Query: 61 ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120
+C +NN SV SS + + + L L+ N ++ + L+ L L
Sbjct: 11 VCSCNNNKNSVDCSSKKLT---AIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLY 67
Query: 121 LDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGTIP----DSLTTLSSLISIQLDSNNLS 175
L++N+L +P + LK L+ L ++ N +P D L L+ L +LD N L
Sbjct: 68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAEL---RLDRNQLK 122
Query: 176 GQIPVHLF 183
+P +F
Sbjct: 123 -SLPPRVF 129
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 7/98 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L+ L L N + +P + +L+ LT L L N L +P + L L+ L L
Sbjct: 108 LVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLY 165
Query: 147 QNNFSGTIPDSL-TTLSSLISIQLDSNNLSGQIPVHLF 183
N +P+ L+ L +++LD+N L ++P F
Sbjct: 166 NNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 30/146 (20%), Positives = 58/146 (39%), Gaps = 8/146 (5%)
Query: 9 LVAIILDCLHYLALSDYQGDALFAL-RTSLRVPNNQLRDWNQNQVN--PCTWSNVICDNS 65
V L L Q + L + +L N + +N + C +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
++ + LSS +G++ + + L L N I IP+++ +L +L L++ +N+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 126 LVGKIPP-SLGNLKKLQFLTLSQNNF 150
L +P L LQ++ L N +
Sbjct: 485 LK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTL 145
+ L+L N I+ ++ LS L L L +NR+ + + + L++L +
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDV 107
Query: 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175
S N I ++SL + L N+
Sbjct: 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 27/198 (13%), Positives = 62/198 (31%), Gaps = 8/198 (4%)
Query: 7 LVLVAIILDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQ-NQVNPCTWSNVICDNS 65
L L I L+ + L + + + W ++ W +
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV--EY 280
Query: 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125
N+ ++T++ + L++L +K + + L +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS-----GQIPV 180
+ FL +QN F+ ++ +TL L ++ L N L +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 181 HLFQIPKYNFTGNNLNCG 198
++ + + + N+LN
Sbjct: 401 NMSSLETLDVSLNSLNSH 418
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 27/123 (21%), Positives = 50/123 (40%), Gaps = 14/123 (11%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV----GKIPPSLGNLKKLQFLT 144
L+ L TL L+ NG+ + +++SL+ + L + + + L
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434
Query: 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV---HLFQIPKYNFTGNNLNCGKTL 201
LS N +G++ L + + L +N + IP HL + + N N L K++
Sbjct: 435 LSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL---KSV 488
Query: 202 PHS 204
P
Sbjct: 489 PDG 491
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 22/128 (17%), Positives = 44/128 (34%), Gaps = 4/128 (3%)
Query: 87 GVLRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVGKIPPSLGNLK-KLQFL 143
+ +L L L N +P E GNL+ LT L L + + +L L
Sbjct: 118 CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILL 176
Query: 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPH 203
L + G +SL ++ + + N + V++ + +N+
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236
Query: 204 SCESSSND 211
+ ++
Sbjct: 237 RLMTFLSE 244
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 57/181 (31%)
Query: 292 LGQGGFGKVYRGVLADGTKVAVKR-----LTDFESPGGDAAFQREVEM-----------I 335
+GQGGFG +Y + V + ++ E+ I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------PLFTELKFYQRAAKPEQI 96
Query: 336 SVAVHRNLLRLIGFCT-----TPTERLLVYPFM------QNLSVAYRLREIKPGEPVLDW 384
+ L+ +G + Y FM +L + + +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL------------QKIYEA 144
Query: 385 VTRK-------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLA 435
++ +++L LEY+HEH +H D+KA+N+LL+ V D+GLA
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 436 K 436
Sbjct: 202 Y 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 34/179 (18%), Positives = 61/179 (34%), Gaps = 53/179 (29%)
Query: 292 LGQGGFGKVYRGV---------LADGTKVAVKRLTDFESPGGD-----AAFQREVEMISV 337
+ G +Y K ++K ++ G FQR + + V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK----LDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 338 AVHRNLL--------RLIGFCTTPTE-RLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTR 387
+ L +GF + R LV P + ++L + LD +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSL------------QSALDVSPK 153
Query: 388 K--------RVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAK 436
+VA LE+LHE+ +H +V A N+ +D + ++ V +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 21/86 (24%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 91 TLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 149
+ L L + G++ L L N L I +L L KL+ L LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNR 75
Query: 150 FSGTIPDSLTTLSSLISIQLDSNNLS 175
SG + +L + L N +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-06
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L+ G+T I L L+ L L+L +NR+ G + L L LS N
Sbjct: 41 FEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 149 NFSG-TIPDSLTTLSSLISIQLDSN 172
+ + L L +L S+ L +
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 106 IPEELG--NLSSLTSLDLDNNRL-VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLS 162
I EL S + L LDN+R GK+ ++L+FL+ + +I + L L+
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLN 64
Query: 163 SLISIQLDSNNLSGQIPVHLFQIPK---YNFTGNNLN 196
L ++L N +SG + V + P N +GN +
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 43/247 (17%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMI-----------SVA 338
LG G F V+ + + T VA+K + + +AA + E++++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAA-EDEIKLLQRVNDADNTKEDSM 83
Query: 339 VHRNLLRLIG---FCTTPTERL-LVYPFM-QNLSVAYRLREIKPGEPV-LDWVTRKRVAL 392
++L+L+ + +V+ + +NL L + + L +V K+++
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENL---LALIKKYEHRGIPLIYV--KQISK 138
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDE------DFEAVVGDFGLAKLVDVRKTN-- 444
GL+Y+H C IIH D+K NVL++ + + D G A D TN
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504
T + R +PE L D++ ++ EL+TG F E D
Sbjct: 197 QTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDD 248
Query: 505 HVKKLER 511
H+ ++
Sbjct: 249 HIAQIIE 255
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 24/86 (27%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L+L G+ + L L L L+L NR+ G + L L L LS N
Sbjct: 48 FVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105
Query: 149 NFS--GTIPDSLTTLSSLISIQLDSN 172
T+ + L L L S+ L +
Sbjct: 106 KLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 23/86 (26%), Positives = 33/86 (38%), Gaps = 3/86 (3%)
Query: 91 TLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 149
+ L L G+I +L L L N L+ + L L KL+ L LS+N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 150 FSGTIPDSLTTLSSLISIQLDSNNLS 175
G + L +L + L N L
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 112 NLSSLTSLDLDNNRL-VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170
+++ L LDN + GKI L+FL+L ++ +L L L ++L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 171 SNNLSGQIPVHLFQIPK---YNFTGNNLN 196
N + G + + ++P N +GN L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 26/121 (21%), Positives = 46/121 (38%), Gaps = 9/121 (7%)
Query: 58 SNVICDNSNNVASVTLSSMNFSGTLSPRI----GVLRTLSTLTLKGNGITGEIPEELGNL 113
+ +I + +V ++ G P I L + N I ++ + L
Sbjct: 6 AELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLL 63
Query: 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS--GTIPDSLTTLSSLISIQLDS 171
L +L ++NNR+ L L L L+ N+ G + D L +L SL + +
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILR 122
Query: 172 N 172
N
Sbjct: 123 N 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 3/87 (3%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L+G I I L ++D +N + K+ L++L+ L ++ N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 74
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLS 175
L L + L +N+L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 25/101 (24%), Positives = 40/101 (39%), Gaps = 13/101 (12%)
Query: 88 VLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLK- 138
+L+ + L G+T I L +L L+L +N L V + L
Sbjct: 26 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 85
Query: 139 KLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 175
K+Q L+L +G + +L TL +L + L N L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 13/98 (13%)
Query: 91 TLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLK-KLQ 141
L L L+ ++ + L L + NN + V + L + +L+
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 142 FLTLSQNNFS----GTIPDSLTTLSSLISIQLDSNNLS 175
L L + + + + +SL + L SN L
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 22/99 (22%), Positives = 36/99 (36%), Gaps = 13/99 (13%)
Query: 90 RTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGN-LKKL 140
L TL + GIT + + L SL L L N L + +L +L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 141 QFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 175
+ L + +F+ L L+ +Q+ +N L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 22/99 (22%), Positives = 33/99 (33%), Gaps = 13/99 (13%)
Query: 90 RTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPPSLG-----NLKKL 140
L +L +K T L L L + NNRL L L
Sbjct: 313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 141 QFLTLSQNNFS----GTIPDSLTTLSSLISIQLDSNNLS 175
+ L L+ + S ++ +L SL + L +N L
Sbjct: 373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 29/138 (21%), Positives = 45/138 (32%), Gaps = 27/138 (19%)
Query: 54 PCTWSNVICDNSNNVASV----------TLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT 103
+V + + N I L + L L GN +
Sbjct: 18 FAETIKANL-KKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH 76
Query: 104 GEIPEELG---NLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFS---GTIPD 156
++ L++LT L L N+L +P + L L+ L L +N + D
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFD 130
Query: 157 SLTTLSSLISIQLDSNNL 174
LT L+ L L N L
Sbjct: 131 KLTNLTYL---NLAHNQL 145
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L L LK N +T I S + L L N++ +I + L +L+ L L
Sbjct: 53 LPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLY 110
Query: 147 QNNFSGTIPD-SLTTLSSLISIQLDSN 172
N S + S L+SL S+ L SN
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 24/87 (27%), Positives = 33/87 (37%), Gaps = 11/87 (12%)
Query: 95 LTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSG 152
L L N + + L G L L L+L N+L I P+ +Q L L +N
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 153 TIP----DSLTTLSSLISIQLDSNNLS 175
I L L +L L N +S
Sbjct: 92 EISNKMFLGLHQLKTL---NLYDNQIS 115
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 17/81 (20%), Positives = 32/81 (39%), Gaps = 4/81 (4%)
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTI 154
L I ++ L L + L L N + KI L ++ L+ L+L +N I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85
Query: 155 PDSLTTLSSLISIQLDSNNLS 175
+ +L + + N ++
Sbjct: 86 ENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 20/88 (22%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145
+ + L L+L N I +I +L L + N++ + + L L+ L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYM 122
Query: 146 SQNNFSG-TIPDSLTTLSSLISIQLDSN 172
S N + D L L L + L N
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 20/105 (19%)
Query: 90 RTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLKKLQ 141
++ +LK + IT E + L S+ + L N + + ++ + K L+
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 142 FLTLSQNNFSGTIPD-----------SLTTLSSLISIQLDSNNLS 175
S + F+G + D +L L +++L N
Sbjct: 64 IAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 15/116 (12%), Positives = 40/116 (34%), Gaps = 13/116 (11%)
Query: 73 LSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL-- 126
++ ++ + L ++ N + + + L ++ + N +
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 127 ---VGKIPPSLGNLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 175
+ L ++L+ L L N F+ + +L + +L + L+ LS
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 15/105 (14%)
Query: 86 IGVLRTLSTLTLKGNGITGE-----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGN 136
R L T+ + NGI E + E L L LDL +N + +L +
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 137 LKKLQFLTLSQNNFSGT----IPDSLTTLS--SLISIQLDSNNLS 175
L+ L L+ S + D+ + L L +++L N +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 11/94 (11%)
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNF--- 150
L L+ G+ L+ LT L+LD N+L + + +L +L L L+ N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 151 -SGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183
G + D LT L L L N L +P +F
Sbjct: 99 PLG-VFDHLTQLDKL---YLGGNQLKS-LPSGVF 127
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/87 (32%), Positives = 39/87 (44%), Gaps = 6/87 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEEL-GNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLS 146
L L L L GN + +P + L+ L L L+ N+L IP L LQ L+LS
Sbjct: 106 LTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLS 163
Query: 147 QNNFSGTIPD-SLTTLSSLISIQLDSN 172
N ++P + L L +I L N
Sbjct: 164 TNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 31/99 (31%), Positives = 45/99 (45%), Gaps = 15/99 (15%)
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGH 455
LEY+HE+ +H D+KAAN+LL V D+GL+ + Q GH
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 456 I-APEYLST----GKS-SERTDV--FGYGIMLLELVTGQ 486
E+ S G + S R+DV GY +L + G+
Sbjct: 221 NGTIEFTSLDAHKGVALSRRSDVEILGY--CMLRWLCGK 257
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 13/77 (16%), Positives = 25/77 (32%), Gaps = 7/77 (9%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGN---LSSLTSLDLDNNRL----VGKIPPSLGNLKKLQ 141
L L + + E L L ++D+ L + + +K L+
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 142 FLTLSQNNFSGTIPDSL 158
F+ + N S + L
Sbjct: 311 FINMKYNYLSDEMKKEL 327
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 35/162 (21%), Positives = 54/162 (33%), Gaps = 37/162 (22%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVH-RNLLRLIG 348
+G G FG++ G L VA+K E A E + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 349 FCTTPTERLLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLE 399
F +V ++ L S+ E + D R +A+ +E
Sbjct: 73 FGPCGKYNAMV---LELLGPSL----------EDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAK 436
Y+H +I+RDVK N L+ DF LAK
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 35/161 (21%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISVAVH-RNLLRLIG 348
+G+G FG ++ G L + +VA+K ++P + E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVYY 73
Query: 349 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLEY 400
F +LV + +L E +LD RK A ++
Sbjct: 74 FGQEGLHNVLVIDLLGPSL------------EDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 401 LHEHCNPKIIHRDVKAANVLL----DEDFEAV-VGDFGLAK 436
+HE +++RD+K N L+ ++ + V DFG+ K
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 39/169 (23%), Positives = 66/169 (39%), Gaps = 35/169 (20%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKR-LTDFESPGGDAAFQREVEMISV-AVHRNLLRLIG 348
+G G FG +Y G +A G +VA+K + P E ++ + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIRW 72
Query: 349 FCTTPTERLLVYPFMQNL--SVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLE 399
++V M+ L S+ E + ++ +RK +A +E
Sbjct: 73 CGAEGDYNVMV---MELLGPSL----------EDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 400 YLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLVDVRKTNV 445
Y+H IHRDVK N L+ + + DFGLAK +T+
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 11/102 (10%)
Query: 87 GVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGN-LKKLQFLTL 145
G+ + L L+ N + L+SLT L L N+L +P + N L L +L L
Sbjct: 25 GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNL 83
Query: 146 SQNNFSGTIP----DSLTTLSSLISIQLDSNNLSGQIPVHLF 183
S N ++P D LT L L L++N L +P +F
Sbjct: 84 STNQLQ-SLPNGVFDKLTQLKEL---ALNTNQLQ-SLPDGVF 120
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 13/101 (12%)
Query: 88 VLRTLSTLTLKGNGITGE----IPEEL-GNLSSLTSLDLDNNRL----VGKIPPSLGNLK 138
V L L+ N + E + + L + +T+L L NN L V + L
Sbjct: 124 VFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNT 183
Query: 139 KLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 175
+ L+L + L L + + N
Sbjct: 184 SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 10/85 (11%)
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGT 153
L L N IT P +L +L L L +N+L +P + +L +L L L N +
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 154 IP----DSLTTLSSLISIQLDSNNL 174
+P D L L L + N L
Sbjct: 103 LPSAVFDRLVHLKEL---FMCCNKL 124
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 33/168 (19%)
Query: 292 LGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDA-AFQREVEMISV-AVHRNLLRLIG 348
+G G FG++Y G + +VA+K E+ E ++ + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 349 FCTTPTERLLVYPFM-QNLSVAYRLREIKPGEPVLDWVTRK-------RVALGAARGLEY 400
F +LV + +L E + ++ +RK +A +E+
Sbjct: 71 FGVEGDYNVLVMDLLGPSL------------EDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEA---VVGDFGLAKLVDVRKTNV 445
+H +HRD+K N L+ A + DFGLAK T+
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 48/275 (17%), Positives = 78/275 (28%), Gaps = 105/275 (38%)
Query: 378 GEPVLDWVTR-----------KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----- 421
G +L W+ + K++ +GL+YLH C IIH D+K N+LL
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQ 185
Query: 422 --------------------------------------------DEDFEAVVGDFGLAKL 437
E + + D G A
Sbjct: 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW 245
Query: 438 VDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR---AIDFS 492
V T T Q R + E L + D++ M EL TG
Sbjct: 246 VHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299
Query: 493 RLEEEDDVLL-----------------------------LDHVKKLEREKRLDAIVDRNL 523
++D + L H+ KL+ + +V++
Sbjct: 300 EYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEK-- 357
Query: 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
++ +E L + PE R +E +R
Sbjct: 358 -YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 26/85 (30%), Positives = 37/85 (43%), Gaps = 10/85 (11%)
Query: 95 LTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQNNFSGT 153
L L+ N + L+ LT L L N++ +P + L KL L L +N +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 154 IP----DSLTTLSSLISIQLDSNNL 174
+P D LT L L LD+N L
Sbjct: 91 LPNGVFDKLTQLKEL---ALDTNQL 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 609 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.88 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.8 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.74 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.74 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.73 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.7 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.68 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.68 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.68 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.67 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.62 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.62 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.61 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.61 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.61 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.61 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.61 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.6 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.6 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.6 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.59 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.59 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.58 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.57 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.57 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.57 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.57 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.57 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.57 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.57 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.56 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.56 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.56 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.55 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.55 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.55 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.55 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.55 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.54 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.54 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.53 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.53 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.52 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.52 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.51 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.51 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.5 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.5 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.5 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.49 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.49 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.48 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.48 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.47 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.46 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.46 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.44 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.42 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.42 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.41 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.41 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.4 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.4 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.4 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.39 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.38 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.34 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.34 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.34 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.34 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.32 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.3 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.27 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.24 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.24 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.24 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.19 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.16 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.98 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.87 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.79 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.7 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.65 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.19 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.1 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.9 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.44 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.37 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.68 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.27 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.02 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.86 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.51 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.09 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.95 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.65 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.59 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.03 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 81.01 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=436.20 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=213.4
Q ss_pred cCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.++++.+.||+|+||+||+|++. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45666789999999999999963 467899999986655566788999999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 358 LVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
+|||||++|+|.+++....+. ...+++..+.+++.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999753221 23589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 503 (609)
.+||+|||+++....... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||......
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-------- 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------- 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999999999987643322 23345679999999999999999999999999999999999 89999743321
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+.......... .+.+...+..+.+++.+||+.||++||||.||++.|+..
T Consensus 255 ~~~~~i~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122211111 112334457899999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=431.88 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=212.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|.+.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 357888899999999999999864 4788999999753 344567899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcC---------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 357 LLVYPFMQNLSVAYRLREIK---------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
++|||||++|+|.++++... .....+++..+.+++.||++||+|||++ +|+||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997632 2234599999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 007290 428 VVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 505 (609)
||+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--------~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 99999999876543322 2234568999999999999999999999999999999999 89999753321 11
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......... ...+...+.++.+++.+||+.||++||||+||.+.|++.
T Consensus 240 ~~~i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 240 IECITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 122211111 112233456899999999999999999999999999763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=432.44 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=206.3
Q ss_pred hcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|.+.+.||+|+||+||+|+++ +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356777889999999999999864 4788999999753 344567899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCC-----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 357 LLVYPFMQNLSVAYRLREIKP-----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
++|||||++|+|.++++.... ....+++..+++|+.|||+||+|||++ +|+||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 999999999999999976432 124589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 503 (609)
.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------- 267 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------- 267 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--------
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999987644322 23345679999999999999999999999999999999999 89999743321
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+.+.......++ ..+...+.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 268 ~~~~~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 268 EAIDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111122111111 12233456899999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=424.80 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=204.9
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++..+++.+.+.||+|+||+||+|+++ ..||||+++... .....+.|.+|++++++++|||||+++|++.. +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 445678888999999999999999975 369999987433 33456789999999999999999999998864 56899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|||||++|+|.++++... ..+++..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCC-CceeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 439 DVRK-TNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 439 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
.... ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... .+... ......
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~---~~~~~~ 255 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFM---VGRGYA 255 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHH---HHTTCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHH---HhcCCC
Confidence 5322 223445679999999999864 468999999999999999999999997432211 11111 111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.+.+ .......+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 256 -----~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 256 -----SPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp -----CCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred -----CCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 112334457899999999999999999999999988753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=429.66 Aligned_cols=270 Identities=26% Similarity=0.381 Sum_probs=221.0
Q ss_pred cCHHHHHHHhcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccC-CCccee
Q 007290 274 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRL 346 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l 346 (609)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||++.........+.|.+|++++.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4557788888999999999999999999999642 468999999866555566789999999999975 899999
Q ss_pred EeEEeCC-CcceEEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007290 347 IGFCTTP-TERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 413 (609)
Q Consensus 347 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 413 (609)
+|+|..+ +..++|||||++|+|.++++.... ....+++..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 007290 414 VKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF 491 (609)
Q Consensus 414 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~ 491 (609)
|||+|||+++++.+||+|||+|+.+..... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654333 23445679999999999999999999999999999999998 8999975
Q ss_pred CccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 492 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..... .+.. ......++ ..+...+.++.+++.+||+.||++||||.||+++|+..
T Consensus 291 ~~~~~----~~~~---~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDE----EFCR---RLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSH----HHHH---HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH----HHHH---HHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 43221 1111 11111111 12223456889999999999999999999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=425.59 Aligned_cols=251 Identities=20% Similarity=0.329 Sum_probs=203.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||+||+|++. +|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 67999999999999999999975 69999999997533 33345788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++||+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997532 33478889999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +......... .
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~-~------ 242 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--------NLVLKIISGS-F------ 242 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTC-C------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCC-C------
Confidence 12234567999999999999999999999999999999999999999754321 1111111111 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 ---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122234568899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=413.38 Aligned_cols=249 Identities=20% Similarity=0.256 Sum_probs=207.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 56999999999999999999975 69999999996432 33456788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999752 389999999999999999999999 99999999999999999999999999999775432
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +......... .+.
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~------~~~ 289 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNL------PPR 289 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSS------CCC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCC------CCC
Confidence 2344568999999999999999999999999999999999999999743221 1111111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+.++.+++.+||+.||++|||+.|+++
T Consensus 290 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 290 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112234568899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=415.20 Aligned_cols=250 Identities=21% Similarity=0.218 Sum_probs=204.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.|++.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+++..++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56788889999999999999975 699999999974321 24699999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~~~~ 441 (609)
++||+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999998643 389999999999999999999999 999999999999999987 6999999999987543
Q ss_pred CCc----eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 442 KTN----VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 442 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||........ . ..+.. .....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~-~~i~~--~~~~~-- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----C-LKIAS--EPPPI-- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----H-HHHHH--SCCGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----H-HHHHc--CCCCc--
Confidence 221 12335799999999999999999999999999999999999999975433211 1 11111 00000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...++..+..+.+++.+||+.||++|||+.|+++.|..
T Consensus 276 -------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11223345688999999999999999999999998865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=416.86 Aligned_cols=321 Identities=71% Similarity=1.123 Sum_probs=268.8
Q ss_pred ccccchhhhhcCcccccCHHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHh
Q 007290 258 VAGEVDRRIAFGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV 337 (609)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 337 (609)
.+.+.......++...+++++++...++|++.+.||+|+||+||+|.+.+|+.||||++...........+.+|+++++.
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~ 83 (326)
T 3uim_A 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83 (326)
T ss_dssp -----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGT
T ss_pred CCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHh
Confidence 34445556667778889999999999999999999999999999999888999999999765444444578999999999
Q ss_pred ccCCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007290 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 417 (609)
Q Consensus 338 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 417 (609)
++||||+++++++......++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 99999999999999999999999999999999999887666667999999999999999999999987789999999999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007290 418 NVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497 (609)
Q Consensus 418 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~ 497 (609)
||+++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||+||+.||+.......
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred hEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 99999999999999999998765555555566799999999999888899999999999999999999999975554445
Q ss_pred cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccccchhhhhhhh
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 577 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~ 577 (609)
.......++.............+..+........+..+.+++.+||+.||++|||+.||+++|++....+++++|+..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 323 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM 323 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence 55566677777777777778888877778889999999999999999999999999999999999999999988876654
Q ss_pred h
Q 007290 578 T 578 (609)
Q Consensus 578 ~ 578 (609)
.
T Consensus 324 ~ 324 (326)
T 3uim_A 324 F 324 (326)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=406.91 Aligned_cols=247 Identities=23% Similarity=0.397 Sum_probs=196.3
Q ss_pred CccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC----CCcceEEe
Q 007290 287 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVY 360 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 360 (609)
+..+.||+|+||+||+|.+. ++..||+|++.... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999975 68899999997533 33445779999999999999999999998854 34578999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeec
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVD 439 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~ 439 (609)
|||++|+|.+++.... .+++..+..++.||+.||+|||++ +++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998643 389999999999999999999998 112999999999999984 7899999999998543
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ............. .
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~~~-~-- 249 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVKP-A-- 249 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCCC-G--
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCCCC-C--
Confidence 2 23445689999999999864 6999999999999999999999999643211 1111111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......++++.+++.+||+.||++|||+.|+++
T Consensus 250 ------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112357899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=412.50 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=212.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+|++. +|+.||||++.+. ......+.+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6999999999642 12344678999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||++||+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ......... ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~-~~---- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKL-EY---- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT-CC----
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CC----
Confidence 33 23345678999999999999999999999999999999999999999754321 111111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhcCCc
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEGEGL 565 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~~~~ 565 (609)
.++...+.++.+++.+||+.||++|||++|++. .+....+
T Consensus 252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCC
Confidence 112233467899999999999999999998753 3444433
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=409.28 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=199.6
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHH--HHHHHHHhccCCCcceeEeEEeCCC----cce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQ--REVEMISVAVHRNLLRLIGFCTTPT----ERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 357 (609)
++|.+.+.||+|+||+||+|++ +|+.||||++... ....+. .|+..+.+++|||||+++|++..++ ..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4677889999999999999998 5899999999642 233444 4555567889999999999997653 468
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
+||||+++|+|.++++.. .+++..+.+++.|+++||+|||+++ .++|+||||||+|||++.++++||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 999999999999999763 3899999999999999999999762 458999999999999999999999999
Q ss_pred ccceeeccCCCc---eeecccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc-----
Q 007290 433 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED----- 498 (609)
Q Consensus 433 Gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~----- 498 (609)
|+++........ ......||+.|||||++.+. .++.++|||||||++|||+||++|+.........
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999887544322 22345799999999999754 3678999999999999999999887533221110
Q ss_pred --chhHHHHHHHHhhhccchhhccccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 499 --DVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 499 --~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.... .......... ..++.+... ...+.+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 233 ~~~~~~-~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 233 PSDPSV-EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCH-HHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchH-HHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011 1111111111 111111111 1335667899999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=398.71 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=191.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. .......+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 79999999996532 2334567999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+ +|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999988763 2489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ......... ..
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--------~~~~~i~~~-~~---- 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--------VLFKNISNG-VY---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT-CC----
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcC-CC----
Confidence 2 22345679999999999988776 68999999999999999999999753321 111111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.++...+.++.+++.+||+.||++|||++|+++
T Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112223467899999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=414.49 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=208.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999975 69999999996433 33456788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
|+||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999752 289999999999999999999999 99999999999999999999999999999775432
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .......... .+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~------~~~ 366 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNL------PPR 366 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSC------CCC
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCC------CCC
Confidence 2344568999999999999999999999999999999999999999643221 1111111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+ ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 367 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 112234568899999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=405.60 Aligned_cols=243 Identities=22% Similarity=0.266 Sum_probs=194.3
Q ss_pred cCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++|++.+.||+|+||+||+|+.. +++.||||+++... .......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999863 47899999986432 12233468889999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||++||+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998643 389999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... +........ .
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~-~---- 242 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------ETMTMILKA-K---- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-C----
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--------HHHHHHHcC-C----
Confidence 4322 2234567999999999999999999999999999999999999999754321 111111111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
..++...+.++.+++.+||+.||++|||+
T Consensus 243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01122345678999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=397.72 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=189.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC--------
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-------- 354 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 354 (609)
++|++.+.||+|+||+||+|+++ +|+.||||+++........+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 799999999976554445678899999999999999999999886443
Q ss_pred ----cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007290 355 ----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 430 (609)
Q Consensus 355 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 430 (609)
..++||||+++|+|.+++..... ....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 25899999999999999976432 12245667889999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCCc-----------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007290 431 DFGLAKLVDVRKTN-----------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499 (609)
Q Consensus 431 DfGl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~ 499 (609)
|||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 99999877543211 1234579999999999999999999999999999999996 664211
Q ss_pred hhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 500 VLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......... .... +......++...+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~~-~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDVR-NLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHHH-TTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHh-cCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001111111 0000 0111233456788999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=386.97 Aligned_cols=263 Identities=18% Similarity=0.258 Sum_probs=201.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeC------CC
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTT------PT 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 354 (609)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ....+.+.+|+++++.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999975 799999999975432 2345678899999999999999999998754 35
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++|||||+ |+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 6799999996 6788888653 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCC---CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007290 435 AKLVDVRK---TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 435 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
++.+.... .......+||+.|+|||++.+. .++.++||||+||++|||+||++||....... ....+....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-----~l~~I~~~~ 279 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-----QLQLIMMVL 279 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-----HHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHhc
Confidence 98764321 2234456899999999998775 56999999999999999999999997543211 111111111
Q ss_pred hhccch-----------hhccccc-cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 REKRLD-----------AIVDRNL-NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ~~~~~~-----------~~~~~~l-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...... ....... .... .+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000000 0000 1123467899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=385.68 Aligned_cols=199 Identities=24% Similarity=0.372 Sum_probs=171.1
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 355 (609)
...++|++.+.||+|+||+||+|+++ +++.||||++... .....+.+|+++++.+ +|||||++++++.+.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 35678999999999999999999863 4678999998653 2356788999999988 69999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGL 434 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 434 (609)
.++||||+++|+|.+++.. +++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999998853 78899999999999999999999 99999999999999877 7999999999
Q ss_pred ceeeccCCC---------------------------ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCC
Q 007290 435 AKLVDVRKT---------------------------NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQ 486 (609)
Q Consensus 435 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~ 486 (609)
|+....... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986643221 112335799999999999775 5899999999999999999999
Q ss_pred CCCCCC
Q 007290 487 RAIDFS 492 (609)
Q Consensus 487 ~p~~~~ 492 (609)
.||...
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 999643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=374.54 Aligned_cols=283 Identities=39% Similarity=0.641 Sum_probs=239.2
Q ss_pred CHHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 275 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
++.+++..+++|++.+.||+|+||+||+|.+++|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 334455677899999999999999999999888999999988653 3445678999999999999999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976544445689999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCC-CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 435 AKLVDVRK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 435 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
++...... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .....+........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC--CCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH--HHHHHHhhhccccc
Confidence 98754322 2223345689999999999888999999999999999999999999975443322 22334444445555
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.+....++.+........+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 66666777776677889999999999999999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=393.72 Aligned_cols=250 Identities=24% Similarity=0.300 Sum_probs=199.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHH---HHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQRE---VEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
-++|++.++||+|+||+||+|+++ +|+.||||++.+.. ..........| +.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999976 69999999996421 11223333444 5566677899999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||++||+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999998643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||+||++||........ ........ ...
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~-~~~- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-TMA- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHH-HCC-
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhc-CCC-
Confidence 765332 344689999999999975 5799999999999999999999999974332211 11111110 000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
..++...+.++.+|+.+||+.||++|++ ++||.+
T Consensus 411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122334568899999999999999998 577653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=394.96 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=207.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|+++ +|+.||+|++.... ....+.+.+|+.+++.++|||||++++++.+....++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 368999999999999999999975 69999999986532 3345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGl~~~~~ 439 (609)
||+||+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999988642 23489999999999999999999999 99999999999999854 899999999999875
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ...........
T Consensus 309 ~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~----- 373 (573)
T 3uto_A 309 PK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDW----- 373 (573)
T ss_dssp TT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC-----
T ss_pred CC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCC-----
Confidence 43 2344567999999999999999999999999999999999999999754321 11111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+........+.++.+|+.+||+.||++|||+.|++++
T Consensus 374 --~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112234678999999999999999999999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=367.02 Aligned_cols=261 Identities=28% Similarity=0.415 Sum_probs=213.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
..++|.+.+.||+|+||+||+|++. ++..||||+++........+.+.+|+.+++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999862 35679999997654444567899999999999 89999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 99999999999999999999864321 23478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~ 498 (609)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999987654322 12233457889999999999999999999999999999999 999997543211
Q ss_pred chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.. ....... ....+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 314 ---~~---~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 ---LF---KLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---HH---HHHHTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HH---HHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1111111 1112233456899999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.62 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=210.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.. ......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 467889999999999999999975 689999999854 334556789999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999998632 3489999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCce-------------eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 442 KTNV-------------TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 442 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+................
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~--- 238 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG--- 238 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH---
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc---
Confidence 2211 114569999999999999999999999999999999999999987543322211111000
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..+.. .....+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 ---------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 239 ---------FLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ---------HHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------ccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000 1112234688999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.00 Aligned_cols=283 Identities=36% Similarity=0.653 Sum_probs=230.6
Q ss_pred cccccCHHHHHHHhcCCCcc------CcccccCCceEEEEEeCCCcEEEEEEeccCC---CCchHHHHHHHHHHHHhccC
Q 007290 270 QLKRYSWRELQLATDNFSEK------NVLGQGGFGKVYRGVLADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVH 340 (609)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h 340 (609)
....+++.++..++++|... +.||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34668899999999998877 8999999999999997 58999999986532 23446789999999999999
Q ss_pred CCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 341 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
|||+++++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||++ +++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999975332 34589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~ 499 (609)
++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|+||..||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 999999999999999876543222 2334568999999998864 589999999999999999999999975443221
Q ss_pred hhHHHHHHHHhh-hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 500 VLLLDHVKKLER-EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 500 ~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...... ...+...+++.+ .......+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 243 --LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp --TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1122222211 222334444433 335677888999999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=358.59 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=210.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..++|++.+.||+|+||+||+|.+. .+..||||+++........+.+.+|+.++++++||||+++++++...+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3567889999999999999999974 355699999976555556678999999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.++++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999653 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 438 VDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 438 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ..........
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~- 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEGY- 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTC-
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCC-
Confidence 7543222 2223446788999999998899999999999999999999 99999643221 1111111111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1112233456899999999999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=358.32 Aligned_cols=265 Identities=26% Similarity=0.389 Sum_probs=205.3
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
..+++...++|++.+.||+|+||+||+|++ +|+.||||++.... .....+.+.+|++++++++||||+++++++....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345556678899999999999999999988 58999999987543 2334567889999999999999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999975321 12388999999999999999999999 8 999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|+++...... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .........
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~ 254 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFK 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHS
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc
Confidence 9997554321 2233456999999999999999999999999999999999999999743321 111111000
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. .....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 255 ~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 255 C---------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp C---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 01112233446789999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.95 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=213.8
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..++|++.+.||+|+||+||+|.++++..||+|++.... ...+.+.+|++++.+++||||+++++++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 457899999999999999999999888899999997532 245779999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999997642 2488999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+..... ...........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~------ 223 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHR------ 223 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCC------
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCC------
Confidence 4434444557788999999988889999999999999999999 99999743321 11111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 ----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0111222457899999999999999999999999998853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.36 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=207.2
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46899999999999999999996 478999999986433 3346778999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999763 378899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... ............
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~------ 234 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTP------ 234 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSC------
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC------
Confidence 32 234457999999999999999999999999999999999999999643221 111111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 --ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00112233467899999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=347.79 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=212.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..++|++.+.||+|+||+||+|.+.+++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 45688999999999999999999988999999999743 2345779999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999997532 3489999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||...... ..........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~------- 224 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGF------- 224 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC-------
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCc-------
Confidence 3223334457888999999998999999999999999999999 99999743321 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....+...+..+.+++.+||+.||++||++.++++.|++.
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 ---RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0111222346789999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=370.16 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=211.3
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+...++|.+.+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345578889999999999999999986 7899999998754444445678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999997532 2388999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCCCcee-ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
........ ....+++.|+|||.+.+..++.++|||||||++|||+| |..||...... ..........+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~-- 333 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKGGR-- 333 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTTCC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC--
Confidence 43211111 12235778999999998899999999999999999999 99998643221 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 334 --------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 --------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=361.26 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=212.6
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 351 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 351 (609)
++...++|.+.+.||+|+||+||+|.+ .++..||||++.........+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 445678999999999999999999996 245689999997654455567899999999999 8999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCC-------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPG-------------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHR 412 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 412 (609)
..+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999764321 13478999999999999999999999 99999
Q ss_pred CCCCCcEEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 007290 413 DVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAID 490 (609)
Q Consensus 413 Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~ 490 (609)
||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543322 2334567889999999988999999999999999999998 999997
Q ss_pred CCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 491 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
....... .... .. . ......+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 277 ~~~~~~~----~~~~---~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 277 GIPVDAN----FYKL---IQ-N---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TCCCSHH----HHHH---HH-T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCcHHH----HHHH---Hh-c---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 5432211 1111 11 1 1111112233468899999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=364.44 Aligned_cols=270 Identities=26% Similarity=0.395 Sum_probs=217.2
Q ss_pred cCHHHHHHHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCccee
Q 007290 274 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRL 346 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 346 (609)
+...+++...++|++.+.||+|+||.||+|++ .+++.||||+++........+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45567778889999999999999999999984 246789999997655455567899999999999 79999999
Q ss_pred EeEEeCCCc-ceEEeecccCchhhhhhhhcCCC-----------------------------------------------
Q 007290 347 IGFCTTPTE-RLLVYPFMQNLSVAYRLREIKPG----------------------------------------------- 378 (609)
Q Consensus 347 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------- 378 (609)
++++...+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999977654 89999999999999999764321
Q ss_pred ---------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 379 ---------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 379 ---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12288999999999999999999999 999999999999999999999999999986643322
Q ss_pred -ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 444 -NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 444 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.......||+.|+|||++.+..++.++||||||+++|||+| |+.||........ ... .......
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~---~~~~~~~------- 314 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCR---RLKEGTR------- 314 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHH---HHHHTCC-------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----HHH---HHHcCCC-------
Confidence 23344568999999999999999999999999999999999 9999975432211 111 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||+.||++|||+.|++++|+..
T Consensus 315 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 315 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.96 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=200.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..++|++.+.||+|+||+||+|++. ++..||||+++........+.|.+|+.++++++||||+++++++......+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999965 577899999976544555678999999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.++++.. ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999999753 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 438 VDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 438 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .........
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~-- 266 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEG-- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTT--
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC--
Confidence 65432221 122345778999999999999999999999999999998 99998643211 111111111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.........+..+.+++.+||+.||++||++.++++.|+..
T Consensus 267 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 --------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 11112223456899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=363.05 Aligned_cols=262 Identities=29% Similarity=0.398 Sum_probs=214.8
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 351 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 351 (609)
...++|.+.+.||+|+||+||+|++. ++..||||+++..........+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999962 34679999997655555567899999999999 8999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 419 (609)
..+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 999999999999999999999875421 23589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 007290 420 LLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE 497 (609)
Q Consensus 420 ll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~ 497 (609)
+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987653322 22334457889999999999999999999999999999999 99998643321
Q ss_pred cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........... .......+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 301 ------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 301 ------ELFKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ------HHHHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111111 111223346789999999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.36 Aligned_cols=274 Identities=18% Similarity=0.212 Sum_probs=216.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC--cceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 359 (609)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.........+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999976 589999999976444455678889999999999999999999987655 67899
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEcccccc
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLA 435 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl~ 435 (609)
|||+++++|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999986432 23389999999999999999999999 99999999999999 88888999999999
Q ss_pred eeeccCCCceeecccccccccCccccc--------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLS--------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||..................
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 87654322 23456899999999886 567899999999999999999999999754333222222222211
Q ss_pred HHhhhccchhhc---------ccc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 508 KLEREKRLDAIV---------DRN--LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 508 ~~~~~~~~~~~~---------~~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.. .......+. ... ............+.+++.+||+.||++|||+.|+++...+.
T Consensus 242 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11 111000000 001 11234678888999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=347.91 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=206.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||+||+|++. +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999965 689999999864322 23346788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997643 389999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ........ ....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~-~~~~-- 231 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--------IAIKHIQD-SVPN-- 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--------HHHHHHSS-CCCC--
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhhc-cCCC--
Confidence 443334445679999999999999999999999999999999999999997543211 00111000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGEG 564 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~ 564 (609)
.........+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 232 ---~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 ---VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ---HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ---cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 00011223346789999999999999998 8999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.91 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=211.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|++.+.||+|+||+||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999953 46789999997655555667889999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCC---CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEc
Q 007290 357 LLVYPFMQNLSVAYRLREIKP---GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVG 430 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 430 (609)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999987542 224589999999999999999999999 999999999999999554 59999
Q ss_pred ccccceeeccC-CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007290 431 DFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 431 DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|||+++..... .........||+.|+|||.+.+..++.++|||||||++|||+| |..||...... .....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--------~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence 99999765322 2223334568999999999999999999999999999999998 99999743321 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... .......+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 299 i~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 299 VTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111 111223346789999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.23 Aligned_cols=263 Identities=28% Similarity=0.399 Sum_probs=215.0
Q ss_pred HHHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
+...++|.+.+.||+|+||.||+|.+ .+++.||||+++........+.+.+|++++++++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34567899999999999999999986 245789999997655555567889999999999999999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCC--------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 413 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 413 (609)
+..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999986433 123488999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 007290 414 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF 491 (609)
Q Consensus 414 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~ 491 (609)
|||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999877543322 2233457889999999988889999999999999999999 9999975
Q ss_pred CccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 492 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..... .... ..... ........+..+.+++.+||+.||++||++.++++.|++.
T Consensus 256 ~~~~~-----~~~~---~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPER-----LFNL---LKTGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCGGG-----HHHH---HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH-----HHHH---hhcCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 43221 1111 11110 1112233456889999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=354.40 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=207.2
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456899999999999999999997 479999999996533 334456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++.... .++...++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCCceeecccccccccCcccccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSS-ERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.. .......||+.|+|||++.+..+. .++||||+||++|||+||+.||+..... ......... .
T Consensus 166 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~-~---- 230 (328)
T 3fe3_A 166 VG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRG-K---- 230 (328)
T ss_dssp SS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-C----
T ss_pred CC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-C----
Confidence 32 223456799999999999887764 8999999999999999999999754321 111111111 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ----~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ----Y--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----C--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----C--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0112234678899999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.89 Aligned_cols=266 Identities=24% Similarity=0.402 Sum_probs=215.8
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
.+....++|++.+.||+|+||.||+|++. +++.||||+++........+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44556789999999999999999999974 348899999976555555678999999999999999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCC--------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPG--------------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIH 411 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 411 (609)
..+..++||||+++|+|.+++...... ...+++..++.++.|+++||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999864321 24589999999999999999999999 9999
Q ss_pred cCCCCCcEEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCC
Q 007290 412 RDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAI 489 (609)
Q Consensus 412 ~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~ 489 (609)
|||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986643221 22234568899999999998899999999999999999999 99999
Q ss_pred CCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 490 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
...... ......... .. ...+...+..+.+++.+||+.||++||++.++++.|++..
T Consensus 278 ~~~~~~--------~~~~~~~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 278 YGMAHE--------EVIYYVRDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TTSCHH--------HHHHHHHTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCChH--------HHHHHHhCC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 643221 111111111 11 1112233467899999999999999999999999998853
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=346.53 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=209.8
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+...++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 34567899999999999999999999888899999997432 3457799999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 99999999999997632 2389999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
...........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~----- 238 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGL----- 238 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTC-----
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhccc-----
Confidence 332222333457788999999998899999999999999999998 99999743321 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 -----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111122246789999999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=372.03 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=215.2
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+...++|++.+.||+|+||.||+|.++. +..||||+++.. ....+.|.+|+.++++++||||+++++++......++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3455778899999999999999999864 889999999753 2346789999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999998643 23488999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
............+++.|+|||++.+..++.++|||||||++|||+| |..||....... ... .....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----~~~---~~~~~----- 435 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYE---LLEKD----- 435 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHH---HHHTT-----
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHH---HHHcC-----
Confidence 5433333334456789999999998899999999999999999999 999987543211 111 11111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
.....+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 436 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111122334568899999999999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=345.68 Aligned_cols=259 Identities=21% Similarity=0.338 Sum_probs=199.8
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
+...++|++.+.||+|+||+||+|.+.. +..||+|++.........+.+.+|+.++++++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3456789999999999999999999742 45799999876554555678999999999999999999999984 567
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 889999999999999997632 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
+..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... .. ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~---~~i~~~~~ 235 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VI---GRIENGER 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH---HHHHTTCC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HH---HHHHcCCC
Confidence 8775443333344457889999999998899999999999999999997 999997543211 11 11111111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112233456889999999999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=352.66 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=203.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999976 7899999998654444445678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999988652 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-ceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 442 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 442 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||........ ....+ .....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~----~~~~~----- 226 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDW----KEKKT----- 226 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHH----HTTCT-----
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHH----hcccc-----
Confidence 22 22334579999999999987765 7899999999999999999999975432211 11111 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000112234678899999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=346.35 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=202.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHh--ccCCCcceeEeEEeC----CCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFCTT----PTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~ 355 (609)
..++|++.+.||+|+||+||+|++ +|+.||||++.. .....+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 357899999999999999999998 689999999863 235667778887776 789999999998643 345
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--------EHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
.++||||+++|+|.++++. ..+++..+++++.|++.||+||| ++ +|+||||||+||+++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 7899999999999999954 24899999999999999999999 77 99999999999999999999
Q ss_pred EEcccccceeeccCCCce---eecccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhC----------CCC
Q 007290 428 VVGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTG----------QRA 488 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~ll~elltg----------~~p 488 (609)
||+|||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999998765443322 2234799999999999776 455799999999999999999 777
Q ss_pred CCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 489 IDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
|......... .................. ........+..+.+++.+||+.||++|||+.++++.|++
T Consensus 233 f~~~~~~~~~---~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 233 FYDVVPNDPS---FEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTTTSCSSCC---HHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCCCCcc---hhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 7543222211 111111111111100000 011234567889999999999999999999999999976
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=343.09 Aligned_cols=262 Identities=20% Similarity=0.265 Sum_probs=212.4
Q ss_pred cccCHHHHHHHhcC----------CCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC
Q 007290 272 KRYSWRELQLATDN----------FSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 340 (609)
Q Consensus 272 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 340 (609)
..++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 44667777766654 667789999999999999976 79999999986433 3456778999999999999
Q ss_pred CCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 341 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
|||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999988642 389999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~ 500 (609)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----- 247 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----- 247 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999987654322 234457999999999999999999999999999999999999999643221
Q ss_pred hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.......... .+.+. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ---~~~~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 ---QAMKRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111110 00000 112234678999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=371.29 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=212.6
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+++..++|.+.+.||+|+||+||+|.++++..||||+++.. ....+.|.+|+.++++++||||+++++++. .+..++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 34456788999999999999999999988899999999753 235788999999999999999999999986 567899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999997532 12378889999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
............+|+.|+|||++....++.++|||||||++|||+| |+.||...... +.........++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~-- 404 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRM-- 404 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCC--
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCC--
Confidence 4322222233446789999999998999999999999999999999 99999743221 111112111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
..+...+..+.+++.+||+.||++|||+.+|++.|++..
T Consensus 405 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 --------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112234568899999999999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=353.72 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=201.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.++|++.+.||+|+||+||+|++. +|+ +||+|.+.........+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467899999999999999999964 344 468888865555566788999999999999999999999998754 78
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+|++|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 8999999999999997643 3489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||....... .... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~---~~~~--- 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSI---LEKG--- 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHH---HHTT---
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HHHH---HHcC---
Confidence 6543322 2233457889999999999999999999999999999999 999997543221 1111 1111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.........+..+.+++.+||+.||++||++.++++.|+..
T Consensus 236 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11112233446789999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=350.33 Aligned_cols=270 Identities=27% Similarity=0.307 Sum_probs=207.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc----ce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----RL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 357 (609)
..++|++.+.||+|+||+||+|++. ++.||||++... ......+..|+.++++++||||+++++++..... .+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4578999999999999999999985 899999998642 2234456678888999999999999999976543 69
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCcEEeCCCCcEEEc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-------NPKIIHRDVKAANVLLDEDFEAVVG 430 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~ 430 (609)
+||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999762 2899999999999999999999862 3389999999999999999999999
Q ss_pred ccccceeeccCCCc-eeecccccccccCcccccCC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch----
Q 007290 431 DFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTG-----KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV---- 500 (609)
Q Consensus 431 DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~---- 500 (609)
|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||...........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999877543322 23345799999999999763 456789999999999999999999975433221100
Q ss_pred ----hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 501 ----LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 501 ----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......... ............. .....+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 254 ~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVV-VHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHH-TTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhh-hcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111111 0111100011000 1234567799999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=345.35 Aligned_cols=259 Identities=17% Similarity=0.166 Sum_probs=207.7
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46799999999999999999996 4789999999865322 34688999999999 8999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-----EEEcccccc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGLA 435 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGl~ 435 (609)
||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 99999999864 23489999999999999999999999 9999999999999998887 999999999
Q ss_pred eeeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007290 436 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 436 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
+.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~ 235 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDT 235 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHHHhh
Confidence 876543221 12356799999999999999999999999999999999999999975432211 1111111111
Q ss_pred hhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......... ....+ ++.+++.+||+.||++||++.+|.+.|++.
T Consensus 236 ~~~~~~~~~---------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 236 KRATPIEVL---------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHSCHHHH---------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCCHHHH---------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 111111000 00122 889999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=347.95 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=217.2
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
+++...++|++.+.||+|+||+||+|.+. ++..||+|++... ....+.+.+|++++++++||||+++++++......
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 34456788999999999999999999986 4889999998642 34567899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999997643 34489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~~---~~~~---- 227 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYE---LLEK---- 227 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHH---HHHT----
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH---HHhc----
Confidence 776544444445567889999999998999999999999999999999 999987543221 111 1111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..........+..+.+++.+|++.||++|||+.++++.|+..
T Consensus 228 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 228 ------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111112233446889999999999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.85 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=214.4
Q ss_pred HHHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
+...++|++.+.||+|+||+||+|.+ .+++.||||+++........+.+.+|+.+++++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34567899999999999999999985 256789999997655445567899999999999 89999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCC--------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPG--------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999764321 23489999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~ 496 (609)
|+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999999876543322 2234457889999999998999999999999999999999 999997543221
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
. ....... . .........+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 256 ~----~~~~~~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 K----FYKMIKE---G----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp H----HHHHHHH---T----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----HHHHhcc---C----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1 1111110 0 1111122334688999999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.13 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=202.8
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+|++.+|+.||+|++.... .......+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999996433 2334577889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++ +|.+.+... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 777777653 23488999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--cchh
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--RLDA 517 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 517 (609)
.. .......||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||........ ............ ....
T Consensus 172 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 PV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----LPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----HHHHHHHHCCCCTTTSGG
T ss_pred Cc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHHCCCChHHhhh
Confidence 32 22334568999999999876 5689999999999999999999999975433221 111111110000 0000
Q ss_pred ------hcccccc--C-----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 ------IVDRNLN--K-----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ------~~~~~l~--~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....... . ...+..+.++.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 0 001123457899999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=341.58 Aligned_cols=261 Identities=15% Similarity=0.179 Sum_probs=209.6
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|.+ .+|+.||||++.... ....+.+|+.++..+ +|+|++++++++......++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 456899999999999999999996 479999999986433 234578899999999 799999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-----EEEccccc
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-----AVVGDFGL 434 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGl 434 (609)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 999999998632 3489999999999999999999999 9999999999999987766 99999999
Q ss_pred ceeeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 435 AKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 435 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
++........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 235 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGE 235 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHHh
Confidence 9877543221 233456999999999999999999999999999999999999999754322111 11111111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......... ....+..+.+++.+||+.||++||++.+|++.|++.
T Consensus 236 ~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 236 KKQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111111111 112346889999999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.40 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=213.8
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEE
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 350 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 350 (609)
+++...++|.+.+.||+|+||+||+|.+.. +..||+|.+.........+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567889999999999999999999742 2479999997655555567899999999999 899999999999
Q ss_pred eCCCcceEEeecccCchhhhhhhhcCC----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 351 TTPTERLLVYPFMQNLSVAYRLREIKP----------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 351 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999975321 123478999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccccc
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEED 498 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~ 498 (609)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999866433222 2234457889999999998899999999999999999999 899987533211
Q ss_pred chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... .. .....+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 275 --~~~~~~~----~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 --KFYKLVK----DG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHHHHHH----HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHh----cC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111 10 00111122346789999999999999999999999999873
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.19 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=206.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999976 69999999996421 233456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999987633 388999999999999999999999 99999999999999999999999999998543
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .
T Consensus 157 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-~----- 221 (337)
T 1o6l_A 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILME-E----- 221 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-C-----
T ss_pred cC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHcC-C-----
Confidence 22 22334567999999999999999999999999999999999999999643221 111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 559 (609)
..++...+.++.+++.+||+.||++|| +++|++++
T Consensus 222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011223346889999999999999999 89888753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=352.11 Aligned_cols=253 Identities=20% Similarity=0.246 Sum_probs=206.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
..++|++.+.||+|+||+||+|.++ +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999976 6899999999754322 135788999999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEcc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGD 431 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 431 (609)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999999653 3489999999999999999999999 999999999999998877 799999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~ 232 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITA 232 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHT
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh
Confidence 99998765432 234457999999999999889999999999999999999999999753221 11111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. . ..++.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~-~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VS-Y--DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TC-C--CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC-C--CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 000000 0122467899999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=338.77 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=203.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCch------HHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGG------DAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
..++|++.+.||+|+||+||+|.+. +++.||+|++........ .+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3578999999999999999999974 789999999864332221 167899999999999999999999986554
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCc-----E
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFE-----A 427 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~ 427 (609)
++||||+++|+|.+.+... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 7999999999998888653 23489999999999999999999999 8 999999999999988776 9
Q ss_pred EEcccccceeeccCCCceeecccccccccCccccc--CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS--TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
||+|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ ..
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~ 238 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI------KF 238 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH------HH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH------HH
Confidence 9999999974432 234457899999999983 45678999999999999999999999975432211 11
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...... ...........+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 239 INMIRE---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHH---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHhc---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111111 111112233445689999999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=366.30 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=206.4
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
++..++|++.+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++||||+++++++.. +..++|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 34557788999999999999999999888899999997532 335789999999999999999999999876 678999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 257 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999997532 23378999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
...........+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... +.........+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~---- 399 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYR---- 399 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC----
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC----
Confidence 433333334457889999999998999999999999999999999 99998643221 11111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
...+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 400 ------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 ------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1122334568899999999999999999999999998853
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.79 Aligned_cols=252 Identities=20% Similarity=0.298 Sum_probs=200.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------- 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 354 (609)
.++|++.+.||+|+||.||+|++. +|+.||||++.........+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999986 799999999976555566788999999999999999999999885433
Q ss_pred --------------------------------------------------cceEEeecccCchhhhhhhhcCCCCCCccH
Q 007290 355 --------------------------------------------------ERLLVYPFMQNLSVAYRLREIKPGEPVLDW 384 (609)
Q Consensus 355 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 384 (609)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 26899999999999999986432 233566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC-----------ceeecccccc
Q 007290 385 VTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-----------NVTTQVRGTM 453 (609)
Q Consensus 385 ~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-----------~~~~~~~gt~ 453 (609)
..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 67899999999999999999 999999999999999999999999999987754321 1223356999
Q ss_pred cccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHH
Q 007290 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVE 533 (609)
Q Consensus 454 ~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 533 (609)
.|+|||.+.+..++.++||||||+++|||++|..|+.. ......... .... +......+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~-~~~~---------~~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVR-NLKF---------PLLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHH-TTCC---------CHHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhh-ccCC---------CcccccCCh
Confidence 99999999999999999999999999999998766420 000011100 0000 011233446
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 534 TMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 534 ~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+.+++.+||+.||++|||+.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 7899999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=352.72 Aligned_cols=254 Identities=22% Similarity=0.253 Sum_probs=200.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 357 (609)
..++|++.++||+|+||+||+|+++ +++.||||++++.. .......+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4568999999999999999999976 58899999997532 223345678899998876 8999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|..++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999997643 389999999999999999999999 999999999999999999999999999985
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.........................
T Consensus 203 ~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 203 GLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCC-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccc-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 322 2223445679999999999999999999999999999999999999997433221111111111111111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
..++...+.++.+++.+||+.||++||++
T Consensus 279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11222345678999999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.82 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=213.1
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFC 350 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 350 (609)
+...++|.+.+.||+|+||+||+|.+. ++..||||++...........+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345688999999999999999999863 46789999997655455567889999999999 899999999999
Q ss_pred eCCCcceEEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 351 TTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 351 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
...+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 9999999999999999999999864321 23488999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEE 496 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~ 496 (609)
|+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence 99999999999999999877543322 2233457889999999988889999999999999999999 99998643321
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........... .......+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 267 -------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 -------ELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -------HHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHHhcCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111110 111223346789999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=345.22 Aligned_cols=266 Identities=23% Similarity=0.359 Sum_probs=205.3
Q ss_pred HhcCCCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--C
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--T 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 354 (609)
..++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 457899999999999999999984 26889999998643 334457889999999999999999999998543 5
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 5899999999999999997642 2388999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCC--ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-------ccchhHHHH
Q 007290 435 AKLVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE-------EDDVLLLDH 505 (609)
Q Consensus 435 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~-------~~~~~~~~~ 505 (609)
++....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987653322 12233457788999999999999999999999999999999999986432110 000000000
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. ...+........+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 241 ~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 L---------IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp H---------HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred H---------HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 011111111122334457899999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=347.33 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=206.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC----CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
..++|++.+.||+|+||+||+|.+. +|+.||||++... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999975 6899999998531 1223467899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEcccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFG 433 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG 433 (609)
++||||+++++|.+.+.........+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999988876544445589999999999999999999999 9999999999999986654 9999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
++....... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... .. ........
T Consensus 179 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~---~~~i~~~~ 248 (351)
T 3c0i_A 179 VAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RL---FEGIIKGK 248 (351)
T ss_dssp TCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HH---HHHHHHTC
T ss_pred ceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HH---HHHHHcCC
Confidence 998775432 223345799999999999999999999999999999999999999974321 01 11111100
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..+.. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 249 -~~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 -YK--MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CC--CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 0112467899999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=361.34 Aligned_cols=252 Identities=28% Similarity=0.388 Sum_probs=207.4
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC-cceEE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-ERLLV 359 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv 359 (609)
...++|++.+.||+|+||+||+|.+. |+.||||+++... ..+.|.+|++++++++||||+++++++.... ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 45678899999999999999999985 7899999997532 4578999999999999999999999987665 68999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++.... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999999998642 23478899999999999999999999 99999999999999999999999999998543
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.. .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... . ........+
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~---~~~i~~~~~---- 404 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V---VPRVEKGYK---- 404 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----H---HHHHHTTCC----
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHHHHcCCC----
Confidence 22 122357889999999999999999999999999999999 999997543221 1 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 405 ------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 405 ------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112233457899999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.36 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=205.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++...... ...+.+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467899999999999999999975 6899999998753321 2367899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 432 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 432 (609)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999653 3489999999999999999999999 999999999999999887 8999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .........
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~ 232 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAV 232 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHT
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHhc
Confidence 9998765322 233456999999999999889999999999999999999999999643221 111111100
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. . ..... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~--~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NY--E-FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC--C-CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC--C-cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 00000 01223578899999999999999999999973
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.48 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=196.1
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCC---CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES---PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||+||+|.+. |+.||||+++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999999999985 89999999864322 23357789999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--------CCcEEEcc
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--------DFEAVVGD 431 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D 431 (609)
|||+++++|.+++.. ..+++..++.++.|++.||+|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998853 24889999999999999999999992112999999999999986 77899999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
||++....... .....||+.|+|||.+.+..++.++||||||+++|+|+||+.||...... .......
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~- 227 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYGVA- 227 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHH-
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHhhh-
Confidence 99998654322 22346899999999999889999999999999999999999999743211 0111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
............+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 228 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 --------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111112223345689999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.88 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=210.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
..++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 456889999999999999999999888999999997533 235789999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999997632 3478999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.........+++.|+|||.+.+..++.++||||||+++|+|+| |+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~------ 223 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFR------ 223 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCC------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCc------
Confidence 2222233457789999999988899999999999999999999 89998643221 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||+.||++||++.++++.|++.
T Consensus 224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 ----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=363.62 Aligned_cols=264 Identities=19% Similarity=0.241 Sum_probs=211.7
Q ss_pred CHHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 275 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
.++++....++|++.++||+|+||+||+|+++ +++.||||++.+.. .......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566677889999999999999999999986 57899999986421 1222345889999999999999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999763 23489999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
||+++.............+||+.|+|||++. ...++.++|||||||++|||+||+.||......+ ..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--------HH
Confidence 9999877654444445568999999999986 5678999999999999999999999997543211 11
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVR 558 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~ 558 (609)
........ ...- +......+.++.+++.+|+..+|++ ||+++|+++
T Consensus 291 ~~i~~~~~--~~~~----p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNHKE--RFQF----PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTHHH--HCCC----CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Hhhhhccc--cccC----CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11110000 0000 0011123467899999999998888 999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=361.45 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=210.0
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeC
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
.+++....++|++.+.||+|+||+||+|+++ +++.||+|++.+.. .......+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3456667789999999999999999999976 58899999986421 12223457899999999999999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
....++||||+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999753 278899999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK----SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||+||+.||...... .....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hHHHH
Confidence 999877654433444668999999999997655 789999999999999999999999754321 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPED--RPAMSEVVRM 559 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 559 (609)
...... . +.-......+.++.+++.+|++.+|++ ||+++||+++
T Consensus 285 i~~~~~--~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 IMNHKN--S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHTHHH--H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHhccc--c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111000 0 000001123467899999999999988 9999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.45 Aligned_cols=267 Identities=16% Similarity=0.188 Sum_probs=203.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCc----------hHHHHHHHHHHHHhccCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLR 345 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~ 345 (609)
..++|++.+.||+|+||+||+|.+.+ ++.||||++....... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 4789999986432100 0112334555566778999999
Q ss_pred eEeEEeCC----CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe
Q 007290 346 LIGFCTTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL 421 (609)
Q Consensus 346 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll 421 (609)
+++++... ...++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998654 4479999999 99999999763 23489999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEcccccceeeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 422 D--EDFEAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 422 ~--~~~~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876533221 1123459999999999999999999999999999999999999997432
Q ss_pred cccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 494 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
... ....... ......+..++++.+.. ...+..+.+++..||+.+|++||++.+|++.|++.
T Consensus 266 ~~~----~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 266 KDP----KYVRDSK-IRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TCH----HHHHHHH-HHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCH----HHHHHHH-HHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 211 1111111 11122333344433321 12236789999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=346.30 Aligned_cols=270 Identities=26% Similarity=0.391 Sum_probs=217.3
Q ss_pred cCHHHHHHHhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCccee
Q 007290 274 YSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRL 346 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 346 (609)
+...+++...++|++.+.||+|+||+||+|.+ .+++.||||+++........+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44566677789999999999999999999984 256899999997655445567889999999999 69999999
Q ss_pred EeEEeCCC-cceEEeecccCchhhhhhhhcCCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007290 347 IGFCTTPT-ERLLVYPFMQNLSVAYRLREIKPG------------EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 413 (609)
Q Consensus 347 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 413 (609)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987655 489999999999999999764331 22388999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 007290 414 VKAANVLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF 491 (609)
Q Consensus 414 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~ 491 (609)
|||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987644322 22334567899999999999999999999999999999998 9999975
Q ss_pred CccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 492 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..... ... ........ .......+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 254 ~~~~~----~~~---~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE----EFC---RRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH----HHH---HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH----HHH---HHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 43221 111 11111111 011122346789999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=351.43 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=203.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.++|++.+.||+|+||+||+|.+. +++ +||+|.+...........+.+|+.++++++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467889999999999999999975 444 388888865444444567788999999999999999999886 45688
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999753 23488889999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||....... ... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~---~~~~~~~- 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----VPD---LLEKGER- 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----HHH---HHHTTCB-
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----HHH---HHHcCCC-
Confidence 6543322 2344567889999999998999999999999999999999 999997543221 111 1111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......+..+.+++.+||+.||++||++.++++.|+..
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011112234678999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.86 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=211.5
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+++..++|++.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 445567899999999999999999999888899999996432 34678999999999999999999999886 456899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999999986531 12488999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
............+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~---- 227 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGY---- 227 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTC----
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhccc----
Confidence 6443333334557889999999988889999999999999999999 89998643221 1111111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+..+.+++.+|++.||++|||+.++++.|++.
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 ------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0111223346889999999999999999999999999873
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.81 Aligned_cols=252 Identities=18% Similarity=0.231 Sum_probs=205.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|.+.+.||+|+||+||+|.+. +|+.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 468999999999999999999976 6889999998632 3345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~~~~ 439 (609)
|+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998652 23489999999999999999999999 9999999999999987 7899999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ .
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~---~ 222 (321)
T 1tki_A 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYT---F 222 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCC---C
T ss_pred CC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCC---C
Confidence 33 2334456899999999998888999999999999999999999999753321 111111111000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.... ....+.++.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 223 DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 01224678999999999999999999999973
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=339.20 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=205.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..++|.+.+.||+|+||+||+|.+.+ +..||+|.+.........+.+.+|+.++++++||||+++++++.. +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999998642 346999999765445566789999999999999999999999865 4568
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997632 3388999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.............+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+ .....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~---~~~~~-- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVL---EKGDR-- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHH---HHTCC--
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHH---hcCCC--
Confidence 65443333344567889999999988899999999999999999998 999996433211 11111 11111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......+..+.+++.+||+.||++||++.|+++.|+..
T Consensus 233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 --------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 011122346789999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=346.31 Aligned_cols=264 Identities=24% Similarity=0.360 Sum_probs=207.6
Q ss_pred hcCCCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--Cc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 355 (609)
.++|++.+.||+|+||.||+|++ .+++.||||++.........+.+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45688899999999999999984 368899999998655555678899999999999999999999999776 56
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 789999999999999996533 2389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccc-------cccchhHHHHH
Q 007290 436 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLE-------EEDDVLLLDHV 506 (609)
Q Consensus 436 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~-------~~~~~~~~~~~ 506 (609)
......... ......||..|+|||.+.+..++.++||||||+++|+|+||..|+...... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 877544322 223456888999999999889999999999999999999999986422110 00000000111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
... ........+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 254 ~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 254 NTL----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHH----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH----------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111 1111112233445789999999999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.66 Aligned_cols=267 Identities=24% Similarity=0.376 Sum_probs=216.1
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeE
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 349 (609)
.++++...++|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455667889999999999999999999864 3778999999765544556678999999999999999999999
Q ss_pred EeCCCcceEEeecccCchhhhhhhhcC------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007290 350 CTTPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 423 (609)
Q Consensus 350 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 423 (609)
+...+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 999999999999999999999997532 1123468899999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchh
Q 007290 424 DFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVL 501 (609)
Q Consensus 424 ~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~ 501 (609)
++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 247 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------ 247 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------
Confidence 999999999999865432221 1223456889999999998899999999999999999999 88998643221
Q ss_pred HHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 502 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........... .......+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 248 --~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 248 --QVLRFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp --HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 11111111110 111223446789999999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=340.71 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=196.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-------------------------chHHHHHHHHHHHH
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-------------------------GGDAAFQREVEMIS 336 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~ 336 (609)
.++|++.+.||+|+||.||+|.+. +|+.||||++...... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 6889999998643211 12356889999999
Q ss_pred hccCCCcceeEeEEeC--CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007290 337 VAVHRNLLRLIGFCTT--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 414 (609)
Q Consensus 337 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 414 (609)
+++||||+++++++.. ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999976 5578999999999999876532 3489999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCC
Q 007290 415 KAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDF 491 (609)
Q Consensus 415 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~ll~elltg~~p~~~ 491 (609)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 234457999999999997655 47889999999999999999999964
Q ss_pred CccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 492 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ........ ... ........+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~--------~~~~~~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM--------CLHSKIKS-QAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH--------HHHHHHHH-CCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH--------HHHHHHhc-ccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 11111111 110 00011223467899999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.16 Aligned_cols=267 Identities=25% Similarity=0.340 Sum_probs=208.7
Q ss_pred CCccCcccccCCceEEEEEeC-----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceE
Q 007290 286 FSEKNVLGQGGFGKVYRGVLA-----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLL 358 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 358 (609)
|++.+.||+|+||+||++.+. +|+.||||++.........+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 68899999998655555567899999999999999999999999764 56789
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999753 288999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... ......+|..|+|||.+.+..++.++||||||+++|+|+||+.||......... ...+...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE---LIGIAQGQMTVLRLT 261 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCSCCHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh---hhcccccchhHHHHH
Confidence 543322 223445788999999999889999999999999999999999998642211000 000000000001111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..+............+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11222222223344557899999999999999999999999999873
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.23 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=192.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|.+. +|+.||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999975 6899999999755445556788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcC--CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|++ |+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888886532 2223488999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc---cc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---RL 515 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 515 (609)
... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||....... ....+....... ..
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-----QLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSCCTTTC
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCChhHh
Confidence 322 22334568999999999876 468999999999999999999999997543211 111111110000 00
Q ss_pred hhh-----ccccc------------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAI-----VDRNL------------NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~-----~~~~l------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+ ..+.. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 00000 00001123457899999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=337.72 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=208.5
Q ss_pred hcCCCccC-cccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|.+.+ .||+|+||+||+|.+. ++..||||+++........+.+.+|++++++++||||+++++++. .+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence 45666666 8999999999999864 578899999976555556678999999999999999999999994 456899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999998642 23489999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 439 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 439 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~-- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGK-- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCC--
Confidence 5433222 223456889999999988889999999999999999999 99999743321 1111111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112233456899999999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.08 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=200.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 358 (609)
.++|++.+.||+|+||.||+|+++ +|+.||+|++.... .....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367899999999999999999976 68899999997533 223346678899999887 89999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997643 389999999999999999999999 9999999999999999999999999999854
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........................
T Consensus 161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 161 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred cCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 322 223345679999999999999999999999999999999999999997432211110000011111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
..++...+..+.+++.+||+.||++||++
T Consensus 236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 01222344678999999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=337.55 Aligned_cols=263 Identities=20% Similarity=0.251 Sum_probs=201.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 68999999997543 33345778899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|++++.+. .+... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~l~~-~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQDLKK-YFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHH-HHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCCCHHH-HHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99875444 44332 23489999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch----
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD---- 516 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 516 (609)
. .......||+.|+|||.+.+.. ++.++|||||||++|||+||..|+...... ......+..........
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~----~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHHHCCCCTTTCTT
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHHhCCCChhhhhh
Confidence 2 2234456899999999997765 799999999999999999998886422211 11111111111000000
Q ss_pred --hhcc---------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 517 --AIVD---------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 517 --~~~~---------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...+ ........+..+..+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00001112334568899999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=356.24 Aligned_cols=255 Identities=18% Similarity=0.231 Sum_probs=205.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|.+. +|+.||+|++..... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999975 789999999875332 23456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~~ 436 (609)
|||+++|+|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999987632 389999999999999999999999 999999999999998 56789999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ......... ...
T Consensus 162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~-~~~ 231 (444)
T 3soa_A 162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--------RLYQQIKAG-AYD 231 (444)
T ss_dssp CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHT-CCC
T ss_pred EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhC-CCC
Confidence 765432 2233457999999999999989999999999999999999999999643211 111111111 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0011112334678999999999999999999999873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=345.55 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeCC-C---cEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLAD-G---TKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
++....++|++.+.||+|+||+||+|.+.. + ..||||+++... .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334456789999999999999999999753 3 279999987532 34456789999999999999999999999987
Q ss_pred CCcc------eEEeecccCchhhhhhhhcCC--CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007290 353 PTER------LLVYPFMQNLSVAYRLREIKP--GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424 (609)
Q Consensus 353 ~~~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 424 (609)
.... ++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 899999999999999965432 223589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhH
Q 007290 425 FEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL 502 (609)
Q Consensus 425 ~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~ 502 (609)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||+| |..||....... .
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~ 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----I 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----H
Confidence 9999999999987643322 12223457889999999999999999999999999999999 899997543221 1
Q ss_pred HHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......... .......+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 249 ---~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 ---YNYLIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ---HHHHHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111110 111233446889999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.64 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=200.2
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|+||+||+|.+.+|+.||+|++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999889999999986432 223347788999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++ +|.+++.... ..++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 8888886532 3388899999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc--cchh--
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK--RLDA-- 517 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-- 517 (609)
.......||+.|+|||.+.+. .++.++|||||||++|||+||+.||....... ............. ....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHHCCCChhhchhhh
Confidence 222344689999999998764 58999999999999999999999997533211 1111111110000 0000
Q ss_pred ---hcccccc-------CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 ---IVDRNLN-------KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ---~~~~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..++... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0011224567899999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.56 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=202.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.++|++.+.||+|+||+||+|.+. +++ +||+|.+...........+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 444 468888866555667788999999999999999999999998754 78
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+|++|+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 8999999999999997643 3388999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... .... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~---~~~~--- 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSI---LEKG--- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHH---HHTT---
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHH---HHcC---
Confidence 6433222 2233456889999999999999999999999999999999 999997543321 1111 1111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.........+..+.+++.+||+.||++||++.|+++.|+..
T Consensus 236 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 236 -------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112233446789999999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=345.74 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=202.5
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++.... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999997 478999999986421 122346788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+ +|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 678888886533 389999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||+........ ..+
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------~~i 220 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------KKV 220 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------CCC
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------HHH
Confidence 322 2334569999999999988776 78999999999999999999999754332111 011
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1100 0112234567899999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.14 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=201.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|.+.+.||+|+||+||+|... ++..||+|++.........+.+.+|++++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467899999999999999999975 6899999999765555567889999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEcccccceee
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~~~ 438 (609)
|+++|+|.+.+.........+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999875433345589999999999999999999999 99999999999999 45678999999999865
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...... ............
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~~~--- 243 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--------EVQQKATYKEPN--- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC---
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--------HHHhhhccCCcc---
Confidence 4322 233456899999999985 57899999999999999999999999753321 111111111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ----~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 ----YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00112357889999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=332.86 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=202.5
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEE-eCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC-TTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|++ .+++.||||++..... ...+.+|+++++.++|++++..+.++ ......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999996 5789999998754322 23578899999999998877777665 566778999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~ 436 (609)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 999999997532 2389999999999999999999999 99999999999999 788999999999998
Q ss_pred eeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007290 437 LVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 437 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 234 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH--HHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh--hhhhhccc
Confidence 77543321 22345789999999999999999999999999999999999999975443222111 11111111
Q ss_pred hhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 511 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........ ....+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 235 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 235 MSTPIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSCHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccchhhhh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11111000 011235789999999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.52 Aligned_cols=251 Identities=26% Similarity=0.334 Sum_probs=200.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
...++|++.+.||+|+||+||+|+++ +|+.||||+++... .......+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44578999999999999999999975 68999999996421 223456778899999988 699999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
..... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||...... .........
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~---- 239 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND---- 239 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC----
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC----
Confidence 54322 22334567999999999998888999999999999999999999999754321 111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM------SEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~ 558 (609)
. ..++...+..+.+++.+|++.||++||++ .|+++
T Consensus 240 -----~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 -----E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 01122234678999999999999999998 66654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.07 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=204.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999975 58899999986421 233457888999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+.+|+|..++... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999753 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ..........
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~---- 235 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFETT---- 235 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHHC----
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhhc----
Confidence 32 23345679999999999864 4589999999999999999999999974332211 1111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 558 (609)
...++...+..+.+++.+||+.||++||+ ++++.+
T Consensus 236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122234568899999999999999998 666654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.05 Aligned_cols=254 Identities=21% Similarity=0.243 Sum_probs=195.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 3568999999999999999999976 78999999997533 23467889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEcccccceee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFGLAKLV 438 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl~~~~ 438 (609)
||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 96 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999997633 389999999999999999999999 9999999999999987765 999999999743
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSER-TDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ...........
T Consensus 169 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~----- 237 (361)
T 3uc3_A 169 VLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSV----- 237 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTT-----
T ss_pred ccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcC-----
Confidence 322 22234569999999999988877655 8999999999999999999975433221 11111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+..+.+++.+||+.||++|||+.|++++
T Consensus 238 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 ----KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000111234678999999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=341.66 Aligned_cols=246 Identities=25% Similarity=0.296 Sum_probs=204.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||+||+|+.+ +|+.||+|+++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467899999999999999999975 69999999986421 123456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997632 388999999999999999999999 99999999999999999999999999998754
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~------- 218 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNA------- 218 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHC-------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------
Confidence 32 23457999999999999999999999999999999999999999643221 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
.. .++...+.++.+++.+|++.||++|| +++++++
T Consensus 219 --~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 --EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 11223346789999999999999999 7888874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.93 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=205.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||.||+|.++ +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999975 68999999997533 233456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~~ 436 (609)
|||+++|+|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999988653 3489999999999999999999999 99999999999999865 459999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ......... ...
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~-~~~ 248 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAG-AYD 248 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT-CCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC-CCC
Confidence 765322 233457999999999999989999999999999999999999999643211 111111111 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.........+..+.+++.+||+.||++||++.|+++.
T Consensus 249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000012234678999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.10 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=203.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeCC-----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
..++|.+.+.||+|+||+||+|.+.. +..||||+++..........+.+|+.++++++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34567788999999999999998652 2469999997654445567789999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999763 23489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 437 LVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 437 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ..........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~ 267 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGF 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCC
Confidence 76533221 1223346789999999998999999999999999999999 99999643211 1111111111
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. .......+..+.+++.+||+.||++||++.++++.|+..
T Consensus 268 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 268 R----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred c----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111223456789999999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.03 Aligned_cols=263 Identities=20% Similarity=0.229 Sum_probs=209.0
Q ss_pred CHHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 275 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
.+++.....++|++.+.||+|+||+||+|+.+ +|+.||||++.+.. .......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34566667889999999999999999999975 69999999996421 1122345788999999999999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999997642 2489999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCccccc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~ 504 (609)
||+++.............+||+.|+|||++. ...++.++|||||||++|||+||+.||.......
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------- 277 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------- 277 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------
Confidence 9999877654443344567999999999987 3568999999999999999999999997543211
Q ss_pred HHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR---PAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~ 558 (609)
.......... ...- +......+.++.+++.+||. +|++| |+++|+++
T Consensus 278 ~~~~i~~~~~--~~~~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKE--HLSL----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHH--HCCC----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhccc--CcCC----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111110000 0000 00112234688999999999 99998 58888864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.27 Aligned_cols=274 Identities=18% Similarity=0.213 Sum_probs=214.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC--cceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT--ERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 359 (609)
.++|.+.+.||+|+||+||+|++. +|+.||||++.........+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999976 589999999976444455678889999999999999999999987655 67999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcEEEcccccc
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEAVVGDFGLA 435 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfGl~ 435 (609)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999976432 22389999999999999999999999 99999999999999 78888999999999
Q ss_pred eeeccCCCceeecccccccccCcccccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLST--------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..................
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 8765332 2234569999999999864 46788999999999999999999999754332222221111111
Q ss_pred HHhhhccchhh---c------ccc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 508 KLEREKRLDAI---V------DRN--LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 508 ~~~~~~~~~~~---~------~~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. ........+ . ... ............+.+++.+||+.||++||++.|+++.+++.
T Consensus 242 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 G-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp S-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred C-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1 000000000 0 001 11233577888999999999999999999999999988765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=335.24 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=204.6
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC--CcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP--TERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 359 (609)
.++|++.+.||+|+||+||+|+++ |+.||||++.... .....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467899999999999999999985 8999999997543 233456789999999999999999999999877 678999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999997632 23589999999999999999999998 7 99999999999999999999999988754
Q ss_pred eccCCCceeecccccccccCcccccCCCCCc---chhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSE---RTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
... ....||+.|+|||.+.+..++. ++||||||+++|||+||+.||...... .........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~-- 226 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--------EIGMKVALE-- 226 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--------HHHHHHHHS--
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--------HHHHHHHhc--
Confidence 321 2345899999999998765544 899999999999999999999743221 111111111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 227 -------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111122233456799999999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=346.10 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=198.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccC--CCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||+||++...+++.||||++.... .....+.+.+|+.++.+++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999999889999999987433 23345778999999999986 999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||| +.+++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 56889999998632 388999999999999999999999 999999999999997 578999999999876
Q ss_pred ccCCCc-eeecccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 439 DVRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 439 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... . ...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------I-SKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------H-HHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------H-HHH
Confidence 543222 2334579999999999864 67899999999999999999999999632210 0 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
....++.....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 ---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111112222233578999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=341.64 Aligned_cols=262 Identities=20% Similarity=0.203 Sum_probs=203.8
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC----CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF----ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
+....++|++.+.||+|+||+||+|.+. +++.||+|++... ......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456788999999999999999999974 6889999998642 2345567899999999999999999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCC------------------------------------CCCccHHHHHHHHHHHHHH
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPG------------------------------------EPVLDWVTRKRVALGAARG 397 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~ 397 (609)
+..++||||+++|+|.+++...... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998532111 2234677788999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCcEEeCCCC--cEEEcccccceeeccCCCc---eeecccccccccCcccccC--CCCCcch
Q 007290 398 LEYLHEHCNPKIIHRDVKAANVLLDEDF--EAVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLST--GKSSERT 470 (609)
Q Consensus 398 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~ 470 (609)
|+|||++ +|+||||||+||+++.++ .+||+|||+++.+...... ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 8999999999876432221 2344569999999999865 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCC
Q 007290 471 DVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 550 (609)
Q Consensus 471 Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 550 (609)
||||||+++|||+||+.||...... +............ ........+..+.+++.+||+.||++|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999744321 1111111111000 000111234678999999999999999
Q ss_pred CCHHHHHH
Q 007290 551 PAMSEVVR 558 (609)
Q Consensus 551 Ps~~evl~ 558 (609)
|++.|+++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.27 Aligned_cols=273 Identities=18% Similarity=0.198 Sum_probs=205.3
Q ss_pred HhcCCCccCccccc--CCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 282 ATDNFSEKNVLGQG--GFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 282 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
..++|++.+.||+| +||+||+|++. +|+.||||++.... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999976 69999999997533 2334567888999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999976422 3389999999999999999999999 999999999999999999999999999875
Q ss_pred eccCCC------ceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007290 438 VDVRKT------NVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 438 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 532111 11223468999999999987 5789999999999999999999999975433211100000000000
Q ss_pred hhh-----c-------------cchhhc---------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 510 ERE-----K-------------RLDAIV---------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 510 ~~~-----~-------------~~~~~~---------~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
... . ...... ............+..+.+++.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0 000000 0000001223345679999999999999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=341.57 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=207.4
Q ss_pred HhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe----CCCcc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT----TPTER 356 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~ 356 (609)
..++|++.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 457899999999999999999997 57999999998642 3345678899999999999999999999986 34467
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987555556689999999999999999999999 99999999999999999999999999987
Q ss_pred eeccCCCc--------eeecccccccccCcccccCCC---CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 437 LVDVRKTN--------VTTQVRGTMGHIAPEYLSTGK---SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 437 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhhHH
Confidence 65321110 012345799999999987554 68999999999999999999999853111100 00000
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGL 565 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 565 (609)
. ............+..+.+++.+||+.||++|||+.++++.|+....
T Consensus 260 ~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 V-------------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-------------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-------------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0001111122334689999999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.53 Aligned_cols=247 Identities=21% Similarity=0.231 Sum_probs=193.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||+||+|++. +|+.||||++..... ......+..|+..+.++ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999986 799999999864332 22334455666665554 89999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+ +++|.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 568888876643 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ......... .
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~~~~~-~--- 269 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQLRQGY-L--- 269 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHHTTTC-C---
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHhccC-C---
Confidence 4322 2334568999999999875 79999999999999999999977654211 011111100 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 270 -~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -PPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 11123467899999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.01 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=201.0
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999996 479999999997432 233456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.........++...++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976544455689999999999999999999999 99999999999999999999999999998664
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ............ .
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-~---- 255 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCD-Y---- 255 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTC-S----
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhccc-C----
Confidence 322 2223446899999999999999999999999999999999999999643221 111111111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 256 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 256 ----PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111122346789999999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.98 Aligned_cols=253 Identities=19% Similarity=0.257 Sum_probs=206.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467999999999999999999975 68999999986432 3345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC--CCcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~~~~ 439 (609)
|+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988652 23489999999999999999999999 9999999999999974 5789999999998775
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ...........
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~i~~~~~----- 267 (387)
T 1kob_A 203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDW----- 267 (387)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCC-----
T ss_pred CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-----
Confidence 432 233446999999999999999999999999999999999999999743221 11111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 268 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 --EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111122344688999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=369.06 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=213.0
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.+++..++|++.+.||+|+||+||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.. +..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3455677899999999999999999999888899999997533 345789999999999999999999999876 6789
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999997532 12378999999999999999999999 999999999999999999999999999986
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.............++..|+|||++.+..++.++|||||||++|||+| |+.||...... +.........+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~-- 482 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYR-- 482 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTTCC--
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC--
Confidence 64322222233456789999999998999999999999999999999 89998643211 11112211111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
.......+..+.+++.+||+.||++|||+.+|++.|++..
T Consensus 483 --------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 --------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1112234568899999999999999999999999998853
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=330.69 Aligned_cols=260 Identities=19% Similarity=0.242 Sum_probs=205.3
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEE-eCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFC-TTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ..+.+.+|+.+++.++|++++..+.++ ......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 56899999999999999999997 579999999986432 234688999999999998877776665 5566779999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~~ 437 (609)
||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 899999997532 3489999999999999999999999 99999999999999 4888999999999987
Q ss_pred eccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 438 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 438 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........... . ..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~-~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-Y-ERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-H-HHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh-h-hhhccccc
Confidence 7543321 12345799999999999999999999999999999999999999975433222111 1 11111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... + ....+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 236 ~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 236 STPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCHHH-----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred CCchHH-----H----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 111000 0 112235789999999999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.90 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=197.6
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++..++|++.+.||+|+||+||+|++. ..||||+++... .....+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999999874 369999987433 333457789999999999999999999965 4556899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999998653 23489999999999999999999999 9999999999999999999999999999865
Q ss_pred ccCC-CceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 439 DVRK-TNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 439 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
.... ........||+.|+|||.+. +..++.++||||||+++|||+||+.||....... .....+.. ..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~----~~ 242 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGR----GS 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHH----TS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcc----cc
Confidence 4322 22233456899999999986 5678999999999999999999999997433211 11111111 11
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
... .+ .......+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 243 ~~~----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 243 LSP----DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp CCC----CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cCc----ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 110 00 111223456899999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.26 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=197.7
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.++|++.+.||+|+||+||+|.+. ++.||||++.. ....+.+.+|++++++++||||+++++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 467888999999999999999985 78999999863 345678999999999999999999999886 348999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc-EEEcccccceeeccC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-AVVGDFGLAKLVDVR 441 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGl~~~~~~~ 441 (609)
+++|+|.+++..... ...++...++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999975322 223688889999999999999999932228999999999999988876 799999999765422
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||....... ............
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~------- 222 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTR------- 222 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHTTCC-------
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhcCCC-------
Confidence 223458999999999999899999999999999999999999997432211 011111111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 223 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 223 ---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111122346789999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=349.94 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=195.8
Q ss_pred cCCCccCcccccCCceEEEEEeC--CC--cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-CCcceE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA--DG--TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLL 358 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 358 (609)
..|.+.+.||+|+||+||+|.+. ++ ..||||.+.........+.+.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677789999999999999964 22 36899998765556667889999999999999999999998754 457899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999999753 23478899999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCc---eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 439 DVRKTN---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 439 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
...... ......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||....... .... ......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~---~~~~~~ 314 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVY---LLQGRR 314 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHH---HHTTCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHH---HHcCCC
Confidence 432211 1233457889999999999999999999999999999999 677776433211 1111 111111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. ..+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 315 ~----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 L----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 11122346789999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=338.16 Aligned_cols=261 Identities=24% Similarity=0.346 Sum_probs=206.7
Q ss_pred HHHHHHhcCCCccC-cccccCCceEEEEEeC---CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 277 RELQLATDNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 277 ~~~~~~~~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
.++....++|.+.+ .||+|+||+||+|.+. +++.||||+++... .....+.+.+|+++++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34445567788888 9999999999999642 47889999997543 233467899999999999999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
..+..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEcc
Confidence 456788999999999999999863 2388999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCcee--ecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHH
Q 007290 432 FGLAKLVDVRKTNVT--TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 432 fGl~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
||++........... ....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||...... .....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~ 232 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAM 232 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHH
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHH
Confidence 999987754433221 22346789999999988889999999999999999999 99999753321 11111
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..... ....+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 233 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 233 LEKGE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 1112233456899999999999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.25 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=206.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||.||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999976 6899999999754445566889999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.. ...++...++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998864 23488999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-ceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 442 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 442 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||........ ....+ ......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~----~~~~~~---- 227 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDW----KEKKTY---- 227 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHHH----HTTCTT----
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHh----hhcccc----
Confidence 21 22334568999999999987665 7899999999999999999999975432111 11111 110000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+..+.+++.+||+.||++|||+.|+++
T Consensus 228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011223467889999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=348.24 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=203.7
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCC
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT 354 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 354 (609)
.....++|.+.+.||+|+||+||+|+++ +|+.||||+++... .......+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456789999999999999999999976 68999999997421 123456778899998876 8999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 9999999999999999997643 388999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 165 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~- 234 (345)
T 1xjd_A 165 CKENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN- 234 (345)
T ss_dssp CBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-
T ss_pred hhhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCC-
Confidence 9854322 22234567999999999999999999999999999999999999999743321 1111111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS-EVV 557 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl 557 (609)
..++...+..+.+++.+||+.||++||++. ++.
T Consensus 235 ----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011222346789999999999999999987 554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.65 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=190.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+|++. +++.||||++.... ..+.+.+|++++++++||||+++++++......++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4577999999999999999999986 58899999997532 3466889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl~~~ 437 (609)
||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999998753 3489999999999999999999999 9999999999999975 88999999999986
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .. .........
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~---~~~i~~~~~--- 268 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FM---FRRILNCEY--- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HH---HHHHHTTCC---
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HH---HHHHHhCCC---
Confidence 6432 22334568999999999999899999999999999999999999996432211 01 111111100
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111122345688999999999999999999999873
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.31 Aligned_cols=246 Identities=21% Similarity=0.251 Sum_probs=204.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999975 68999999986421 223456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++.... .++...++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999998643 388999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-~~---- 255 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSG-KV---- 255 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-CC----
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--------HHHHHHHcC-CC----
Confidence 32 23456999999999999999999999999999999999999999743221 111111111 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
.++...+..+.+++.+||+.||++||+ ++|+++
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112233467899999999999999998 777764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.18 Aligned_cols=269 Identities=17% Similarity=0.195 Sum_probs=200.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCc----------hHHHHHHHHHHHHhccCCCcceeEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLRLIG 348 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~ 348 (609)
.++|.+.+.||+|+||+||+|.+. ++..||||+........ ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 57889999987532211 1234667888889999999999999
Q ss_pred EEeC----CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007290 349 FCTT----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424 (609)
Q Consensus 349 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 424 (609)
++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9876 67789999999 999999997643 489999999999999999999999 99999999999999888
Q ss_pred C--cEEEcccccceeeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc
Q 007290 425 F--EAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496 (609)
Q Consensus 425 ~--~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~ 496 (609)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 1134569999999999999899999999999999999999999996321111
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 567 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 567 (609)
... ......... ........... ....+..+.+++.+||+.||++||++.+|++.|+...+..
T Consensus 268 ---~~~-~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 268 ---VAV-QTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp ---HHH-HHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred ---HHH-HHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 111 111111111 11111100000 0123458999999999999999999999999999865533
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.24 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=195.1
Q ss_pred HhcCCCccCcccccCCceEEEEEe----CCCcEEEEEEeccCC---CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
..++|++.+.||+|+||+||+++. .+|+.||+|+++... .......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357899999999999999999997 478999999997532 1233456788999999999999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++|+|.+++.... .++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 9999999999999999997633 378889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
++..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .........
T Consensus 168 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~-- 236 (327)
T 3a62_A 168 CKESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--------KTIDKILKC-- 236 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHT--
T ss_pred ccccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC--
Confidence 9754322 12233457999999999999889999999999999999999999999753321 111111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
. ...+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 237 -------~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 -------K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 011223346789999999999999999 6777765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.79 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=204.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcE--EEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTK--VAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
++|++.+.||+|+||.||+|++. +|.. ||+|++.........+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999965 5664 4999987655555567889999999999 899999999999999999999
Q ss_pred eecccCchhhhhhhhcC------------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 360 YPFMQNLSVAYRLREIK------------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
|||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2234589999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 506 (609)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--------HHH
Confidence 99999998743321 11223456889999999988889999999999999999998 99999643321 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... .........+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 252 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 11112223446789999999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=334.43 Aligned_cols=259 Identities=20% Similarity=0.228 Sum_probs=199.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 688999999875322 22347788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
...........|++.|+|||.+.+..++.++||||||+++|||+||+.||...... .............
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~--- 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIPRP--- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCCCG---
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCCCc---
Confidence 44333344556899999999999889999999999999999999999999743221 0001111000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEGEG 564 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~ 564 (609)
.......+..+.+++.+||+.||++|| +++++++.|+...
T Consensus 255 -----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 -----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 011223345789999999999999999 9999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=338.02 Aligned_cols=273 Identities=23% Similarity=0.324 Sum_probs=205.4
Q ss_pred ccCHHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHh--ccCCCcceeEeEE
Q 007290 273 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFC 350 (609)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~ 350 (609)
..+........++|++.+.||+|+||.||+|++. |+.||||++.. .....+..|.+++.. ++||||+++++++
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec----cccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 3444555566789999999999999999999985 89999999853 234455666666654 4899999999998
Q ss_pred eCC----CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEe
Q 007290 351 TTP----TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLL 421 (609)
Q Consensus 351 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll 421 (609)
... ...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+++ .++|+||||||+||++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 766 6789999999999999999753 3899999999999999999999752 3489999999999999
Q ss_pred CCCCcEEEcccccceeeccCCCce---eecccccccccCcccccCCCCCcc------hhhHHHHHHHHHHHhC-------
Q 007290 422 DEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMGHIAPEYLSTGKSSER------TDVFGYGIMLLELVTG------- 485 (609)
Q Consensus 422 ~~~~~~kl~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~ll~elltg------- 485 (609)
+.++.+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999998764332221 124569999999999987766554 9999999999999999
Q ss_pred ---CCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 486 ---QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 486 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
..||......... . ............ .+..... .....+..+.+++.+||+.||++|||+.++++.|+
T Consensus 256 ~~~~~p~~~~~~~~~~---~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPS---Y-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CCCCCTTTTTSCSSCC---H-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccccccHhhhcCCCCc---h-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 5555432221111 1 111111111111 1111110 12367788999999999999999999999999998
Q ss_pred cC
Q 007290 562 GE 563 (609)
Q Consensus 562 ~~ 563 (609)
..
T Consensus 328 ~l 329 (337)
T 3mdy_A 328 KM 329 (337)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.22 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=203.4
Q ss_pred cCCCccC-cccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKN-VLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+++.+.+ .||+|+||+||+|.++ ++..||||+++........+.+.+|++++++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999864 4667999999865555567889999999999999999999999976 568999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999653 33489999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 440 VRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 440 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... .....+++.|+|||++.+..++.++|||||||++|||+| |+.||...... +.........+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~-- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR-- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCC--
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCC--
Confidence 332211 222345689999999998999999999999999999998 99999753321 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus 558 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112233457899999999999999999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.41 Aligned_cols=257 Identities=29% Similarity=0.408 Sum_probs=202.7
Q ss_pred hcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe-CCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT-TPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 357 (609)
..+|++.+.||+|+||+||+|.+.+ +..||+|.+.........+.+.+|+.++++++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568889999999999999999642 23689999976555556678999999999999999999999864 456789
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999752 23478899999999999999999999 999999999999999999999999999986
Q ss_pred eccCCC---ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 438 VDVRKT---NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 438 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|+| |.+||....... ... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~---~~~~~~ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITV---YLLQGR 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHH---HHHTTC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHH---HHhcCC
Confidence 643221 12234457889999999999999999999999999999999 555654332211 111 111110
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. ...+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus 250 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 R----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 011122345789999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=337.20 Aligned_cols=258 Identities=20% Similarity=0.281 Sum_probs=206.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEe--CCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 358 (609)
.++|++.+.||+|+||+||+|... +|+.||+|.+.... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999975 68999999997533 2334567889999999999999999999874 4567899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCcEEeCCCCcEEEcccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK-----IIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
||||+++++|.+++.........+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986544455589999999999999999999998 7 9999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
+++...... .......|++.|+|||.+.+..++.++||||||+++|+|+||+.||...... ........ .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~-~ 231 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIRE-G 231 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-T
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--------HHHHHHhh-c
Confidence 998654322 1223356899999999999889999999999999999999999999743211 11111111 1
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.. ...+...+..+.+++.+||+.||++||++.|+++.+..
T Consensus 232 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 11122344688999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=335.34 Aligned_cols=256 Identities=29% Similarity=0.366 Sum_probs=203.1
Q ss_pred CCCccCcccccCCceEEEEEeC-C---CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc-eEE
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-D---GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER-LLV 359 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 359 (609)
.|...+.||+|+||+||+|.+. + +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999963 2 2379999997655555567899999999999999999999999776655 899
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
+||+.+|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999762 23478999999999999999999999 99999999999999999999999999998654
Q ss_pred cCC---CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 440 VRK---TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 440 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
... ........+|+.|+|||.+.+..++.++||||||+++|+|+||..|+....... ..... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~----~~~~~---~~~~~--- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----DLTHF---LAQGR--- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG----GHHHH---HHTTC---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH----HHHHH---hhcCC---
Confidence 321 122234567899999999999999999999999999999999665543221111 11111 11111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+..+.+++.+||+.||++|||+.++++.|++.
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111222346789999999999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.88 Aligned_cols=251 Identities=19% Similarity=0.267 Sum_probs=180.8
Q ss_pred cCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeecccCc
Q 007290 289 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 366 (609)
.+.||+|+||+||+|.+. +|+.||||++.. .....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 689999999864 24567889999999997 999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---cEEEcccccceeeccCCC
Q 007290 367 SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF---EAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 367 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGl~~~~~~~~~ 443 (609)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++......
T Consensus 92 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 92 ELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp BHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 999999863 3489999999999999999999999 999999999999997665 89999999998664332
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 523 (609)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ............. . ..
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~i~~~~-~------~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT-SAVEIMKKIKKGD-F------SF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC-CHHHHHHHHTTTC-C------CC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc-cHHHHHHHHHcCC-C------CC
Confidence 22334568999999999999999999999999999999999999997533211110 0111111111110 0 00
Q ss_pred cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 524 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........+.++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000012235688999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=337.66 Aligned_cols=253 Identities=20% Similarity=0.245 Sum_probs=206.3
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467999999999999999999976 6899999998753322 1367899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 432 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 432 (609)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999753 3489999999999999999999999 999999999999999888 7999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|++....... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||...... .........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSV 233 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTT
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhc
Confidence 9998765432 223456899999999999899999999999999999999999999643221 111111110
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ...+.. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SY---DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC---CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc---ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 01223578999999999999999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.63 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=198.4
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhcc--CCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||+||+|...+++.||||++.... .....+.+.+|+.++.++. ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999998889999999986533 2334578899999999996 59999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 67889999998633 478889999999999999999999 999999999999996 5789999999998765
Q ss_pred cCCCc-eeecccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 440 VRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 440 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------HHHHH
Confidence 33222 2334579999999999865 36899999999999999999999999642210 01111
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+.++.....++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 279 ---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111111122224578999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.52 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=207.5
Q ss_pred HhcCCCccCcccccCCceEEEEEe------CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
..++|++.+.||+|+||+||+|++ .++..||||++...........+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 25778999999765555566788999999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCC---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEE
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPG---EPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV 429 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 429 (609)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999875422 24488999999999999999999999 9999999999999984 456999
Q ss_pred cccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHH
Q 007290 430 GDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 430 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+|||++........ .......||+.|+|||.+.+..++.++||||||+++|+|+| |..||...... ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EVLE 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HHHH
Confidence 99999975533221 22334567899999999988899999999999999999998 99998643221 1111
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... .......+..+.+++.+||+.||++||++.++++.|+..
T Consensus 257 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 257 FVTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111 111223346789999999999999999999999999763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.61 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=212.0
Q ss_pred ccCHHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHh--ccCCCcceeEeEE
Q 007290 273 RYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISV--AVHRNLLRLIGFC 350 (609)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~ 350 (609)
..++.......++|.+.+.||+|+||+||+|++ +|+.||||++.. .....+.+|.+++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 445555566778999999999999999999998 589999999863 245678889999887 7899999999999
Q ss_pred eCCC----cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCc
Q 007290 351 TTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--------EHCNPKIIHRDVKAAN 418 (609)
Q Consensus 351 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dlkp~N 418 (609)
.... ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 8775 789999999999999999752 3889999999999999999999 77 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCc---eeecccccccccCcccccCC------CCCcchhhHHHHHHHHHHHhC----
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTG------KSSERTDVFGYGIMLLELVTG---- 485 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~ll~elltg---- 485 (609)
|+++.++.+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||+||
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 99999999999999999877544322 12345689999999999765 234789999999999999999
Q ss_pred ------CCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCC-CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 486 ------QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKN-YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 486 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..||......... ......... ... ..+.+... .....+..+.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~p~~~~~~~~~~---~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPS---VEEMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCC---HHHHHHHHT-TSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccccCccccCcCccc---HHHHHHHHH-HHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 6677543222111 111111111 111 11111110 13466778999999999999999999999999
Q ss_pred HHhcC
Q 007290 559 MLEGE 563 (609)
Q Consensus 559 ~L~~~ 563 (609)
.|+..
T Consensus 330 ~L~~i 334 (342)
T 1b6c_B 330 TLSQL 334 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=333.18 Aligned_cols=268 Identities=18% Similarity=0.241 Sum_probs=199.5
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||+||+|.+. +|+.||||++...... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 5899999998654322 235678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999888653 2389999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH-------HHHHHHHhhhc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL-------LDHVKKLEREK 513 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~ 513 (609)
.. ......||+.|+|||.+.+ ..++.++||||||+++|+|+||+.||............. ...........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2334568999999999876 678999999999999999999999997543221100000 00000000000
Q ss_pred cchhhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.......+...... .+..+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000000 12344678999999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=329.88 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=205.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999975 68999999986533 3334567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl~~~ 437 (609)
||+++++|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999988887643 388999999999999999999999 9999999999999986655 99999999987
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ........... .
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~-~- 225 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGAY-D- 225 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC-C-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhccc-c-
Confidence 65332 223456899999999999999999999999999999999999999643221 11111111100 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.........+..+.+++.+|++.||++|||+.|+++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000111233467899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=344.21 Aligned_cols=271 Identities=25% Similarity=0.321 Sum_probs=210.7
Q ss_pred hcCCCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe--CCCc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 355 (609)
.++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 46889999999999999999984 36889999999653 3344567899999999999999999999886 4456
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 889999999999999997632 2389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 436 KLVDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 436 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
......... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||............ .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~ 251 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG---CERDVPALS 251 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc---cccccccHH
Confidence 877543322 223345788899999998888999999999999999999999998632211000000 000000000
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..................+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111122223344557899999999999999999999999999885
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.23 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=194.6
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc---
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER--- 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 356 (609)
.++|++.+.||+|+||+||+|++ .+++.||||+++.... ......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 4789999999975332 22346788999999999999999999998765544
Q ss_pred -eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 357 -LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 357 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 89999999999999997643 389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCC--ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 436 KLVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 436 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
+....... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCC
Confidence 87654322 22234568999999999999999999999999999999999999997543211 111111111
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... . ......+..+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~---~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 PIPP---S----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCH---H----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCc---c----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0000 0 001123467899999999999999997766654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=333.25 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=208.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.+.|++.+.||+|+||+||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456889999999999999999964 6899999999765555567889999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999864 2488999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
.. ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||...... ......... . .
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~-~-----~- 236 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKN-N-----P- 236 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS-C-----C-
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHHHhhcC-C-----C-
Confidence 22 233456899999999999999999999999999999999999998643211 111111111 0 0
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.......+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11122234678999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.77 Aligned_cols=244 Identities=21% Similarity=0.255 Sum_probs=202.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-------chHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-------GGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
..++|++.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999964 6899999999753311 1234577899999999999999999999999
Q ss_pred CcceEEeecccCc-hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 354 TERLLVYPFMQNL-SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 354 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
+..++||||+.+| +|..++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999887532 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654322 334569999999999988776 88999999999999999999999632110
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...... .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 237 -------~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -------VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011134678999999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.63 Aligned_cols=211 Identities=20% Similarity=0.264 Sum_probs=183.5
Q ss_pred cccccCHHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-----CCCc
Q 007290 270 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----HRNL 343 (609)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni 343 (609)
+...+++++.....++|.+.+.||+|+||+||+|++. +++.||||++.. .......+..|+.+++.+. ||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3455667777778899999999999999999999974 689999999963 2334566788999999886 9999
Q ss_pred ceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC
Q 007290 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE 423 (609)
Q Consensus 344 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 423 (609)
+++++++...+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDD 172 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESC
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcc
Confidence 99999999999999999999 8999999976432 3488999999999999999999999 9999999999999975
Q ss_pred -------------------------CCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHH
Q 007290 424 -------------------------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIM 478 (609)
Q Consensus 424 -------------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~l 478 (609)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 789999999999865432 234568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 007290 479 LLELVTGQRAIDFS 492 (609)
Q Consensus 479 l~elltg~~p~~~~ 492 (609)
+|||+||+.||...
T Consensus 249 l~ell~g~~pf~~~ 262 (360)
T 3llt_A 249 LAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHSSCSCCCS
T ss_pred HHHHHHCCCCCCCC
Confidence 99999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=336.56 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=201.2
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
+++....++|.+.+.||+|+||+||+|.+. ++..||+|++.... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556788999999999999999999864 34589999987433 2334567899999999999999999999997
Q ss_pred CCCc-----ceEEeecccCchhhhhhhhcC--CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007290 352 TPTE-----RLLVYPFMQNLSVAYRLREIK--PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424 (609)
Q Consensus 352 ~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 424 (609)
.... .++||||+++|+|.+++.... .....+++..++.++.|+++||.|||++ +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 6553 489999999999999985422 3345589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhH
Q 007290 425 FEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLL 502 (609)
Q Consensus 425 ~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~ 502 (609)
+.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |..||....... .
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----M 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----H
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----H
Confidence 9999999999987643322 12233457889999999999999999999999999999999 888986543221 1
Q ss_pred HHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.. ....... .......+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 259 ~~---~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 259 YD---YLLHGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HH---HHHTTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHHcCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1111100 111223346789999999999999999999999999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.14 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=203.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
...++|++.+.||+|+||+||+|+++ +|+.||||+++... .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 35578999999999999999999986 47899999987421 223456788899999887 799999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 99999999999999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~----- 235 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIME----- 235 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-----
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHh-----
Confidence 54322 22334567999999999999999999999999999999999999999743221 11111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
.. ..++...+.++.+++.+||+.||++||+ ++++++
T Consensus 236 ----~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 ----HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 10 0112234568899999999999999996 455553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.90 Aligned_cols=268 Identities=26% Similarity=0.371 Sum_probs=197.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHH--HHhccCCCcceeEeEEe-----CCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEM--ISVAVHRNLLRLIGFCT-----TPT 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~ 354 (609)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+..|.++ +..++||||+++++.+. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 457899999999999999999987 6899999998632 23445555555 44589999999997553 223
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEeCCCCcEE
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------NPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
..++||||+++|+|.+++.... .++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 5689999999999999997532 578889999999999999999873 33899999999999999999999
Q ss_pred EcccccceeeccCC-------CceeecccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 429 VGDFGLAKLVDVRK-------TNVTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 429 l~DfGl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
|+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765322 112224569999999999976 3567899999999999999999777643322
Q ss_pred ccccchhHHH---------HHHHHhhhccchhhccccccCC--CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 495 EEEDDVLLLD---------HVKKLEREKRLDAIVDRNLNKN--YNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 495 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.......... .......... ..+.+... .....+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 2111111110 0001000000 01111111 1334667899999999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=331.30 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=202.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999975 57799999985421 12235678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+.+.... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997643 388999999999999999999999 9999999999999999999999999988654
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~----- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE----- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC-----
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCC-----
Confidence 322 223456899999999999989999999999999999999999999743321 1111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 224 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122234678899999999999999999999963
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=352.29 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=205.3
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367899999999999999999976 79999999986421 223456789999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999998752 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+..... .........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~------ 231 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDG------ 231 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTT------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC------
Confidence 322 2334579999999999988765 78999999999999999999999754321 111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 ---IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00 011123457899999999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=340.78 Aligned_cols=248 Identities=27% Similarity=0.358 Sum_probs=199.7
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.+.|+..+.||+|+||+||+|+. .+|+.||||++..... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588899999999999999996 4789999999864322 22346788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+. |++.+.+.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99998 57777775432 3489999999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
.. ....||+.|+|||++. ...++.++|||||||++|||+||+.||...... ...........
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------~~~~~~~~~~~-- 270 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES-- 270 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC--
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC--
Confidence 32 2346899999999984 567899999999999999999999998643211 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
+.. .....+..+.+++.+||+.||++|||+.++++.
T Consensus 271 ----~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ----PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 112234678999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.84 Aligned_cols=261 Identities=18% Similarity=0.214 Sum_probs=203.1
Q ss_pred hcCCCccCcccccCCceEEEEEeCC---------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcce--------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD---------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLR-------- 345 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 345 (609)
.++|.+.+.||+|+||+||+|++.. ++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4689999999999999999999763 789999998642 36789999999999999987
Q ss_pred -------eEeEEeC-CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 007290 346 -------LIGFCTT-PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAA 417 (609)
Q Consensus 346 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~ 417 (609)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 5666655 67789999999 999999998642 23489999999999999999999999 9999999999
Q ss_pred cEEeCCCC--cEEEcccccceeeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 007290 418 NVLLDEDF--EAVVGDFGLAKLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489 (609)
Q Consensus 418 NIll~~~~--~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~ 489 (609)
||+++.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 8999999999876532211 123347999999999999989999999999999999999999999
Q ss_pred CCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 490 DFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... ........... .......+.... ....+..+.+++.+||+.||++||++.++++.|+..
T Consensus 269 ~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 269 TNCLPNT---EDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGGTTCH---HHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCcCH---HHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 7433111 11111111111 111111111000 011236789999999999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=355.85 Aligned_cols=254 Identities=26% Similarity=0.330 Sum_probs=207.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|.+.+.||+|+||.||+|+++ +|+.||||++.... .......+..|+.++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999985 69999999996421 12345678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999987654455699999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......... ..
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~-~~---- 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLE-QA---- 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHH-CC----
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhh-cc----
Confidence 54322 23345799999999999999999999999999999999999999975432111 1111111111 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 554 (609)
..++...+..+.+++.+||+.||++||++.
T Consensus 410 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 ------VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ------cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 112233456889999999999999999763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.71 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=192.0
Q ss_pred cCCCcc-CcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHH-hccCCCcceeEeEEeC----CCcc
Q 007290 284 DNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTT----PTER 356 (609)
Q Consensus 284 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 356 (609)
++|.+. +.||+|+||+||+|.+. +|+.||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456655 68999999999999975 689999999863 246778888874 5589999999998864 5568
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFG 433 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 433 (609)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999997632 34589999999999999999999999 9999999999999997 7899999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........... ....+.. .
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~~----~ 282 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRM----G 282 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHHH----T
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHHc----C
Confidence 99865432 223345789999999999999999999999999999999999999975433221111 1111110 0
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
... +........+.++.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000112334678999999999999999999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.53 Aligned_cols=250 Identities=21% Similarity=0.243 Sum_probs=195.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 6899999998742 233345677889999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999997633 38999999999999999999998 7 999999999999999999999999999975
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......... .
T Consensus 299 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~-~--- 365 (446)
T 4ejn_A 299 GIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILME-E--- 365 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-C---
T ss_pred ccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHhC-C---
Confidence 4322 22234567999999999999999999999999999999999999999643321 111111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
..++...+..+.+++.+||+.||++|| +++|+++
T Consensus 366 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 -------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011223346789999999999999999 9999885
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=331.55 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=201.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+..+..+ +||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999976 79999999987543 334567788999999998 89999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--------------
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-------------- 424 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 424 (609)
||||+++++|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999986533334589999999999999999999999 99999999999999844
Q ss_pred -----CcEEEcccccceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc
Q 007290 425 -----FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED 498 (609)
Q Consensus 425 -----~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~ 498 (609)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765332 23489999999999765 567899999999999999999877642210
Q ss_pred chhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 499 DVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...... ... ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 -------~~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -------WHEIRQ-GRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -------HHHHHT-TCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHHc-CCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 011111 111 1112223467899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.55 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=204.6
Q ss_pred hcCCCccCcccccCCceEEEEEe----CCCcEEEEEEeccCC---CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCC
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRLTDFE---SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPT 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 354 (609)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... .......+.+|++++..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999997 368999999986422 122345677899999999 5999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997643 388999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
++..............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~ 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhcc
Confidence 98765444444445679999999999975 3478999999999999999999999974432211 11111111100
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVRML 560 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 560 (609)
...++...+..+.+++.+||+.||++|| ++.|+++..
T Consensus 282 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0112233446789999999999999999 899988643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.56 Aligned_cols=265 Identities=24% Similarity=0.300 Sum_probs=199.2
Q ss_pred HHhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC----CCchHHHHHHHHHHHHhcc---CCCcceeEeEEeC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE----SPGGDAAFQREVEMISVAV---HRNLLRLIGFCTT 352 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 352 (609)
...++|++.+.||+|+||+||+|++ .+|+.||||++.... .......+.+|+.+++++. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4568999999999999999999996 478999999986322 1222456778888877665 9999999999876
Q ss_pred CC-----cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 353 PT-----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 353 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
.. ..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 54 4789999997 599998876432 3389999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... .......
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~ 233 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFD 233 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHHHH
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHH
Confidence 99999999865432 22344678999999999999999999999999999999999999997543211 1111111
Q ss_pred HHhhhccchhhc------cccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 508 KLEREKRLDAIV------DRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 508 ~~~~~~~~~~~~------~~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... ....+. ...+.. ...+..+..+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLP-PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCC-CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCC-ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11000 000000 000000 001223467899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=331.25 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=198.8
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-CcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-TERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+|.+. |+.||||+++.. ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 4578999999999999999999984 899999998643 3457889999999999999999999987554 4789999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997532 12368888999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
. .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....... . .......
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~---~~~~~~~------- 230 (278)
T 1byg_A 170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----V---VPRVEKG------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----H---HHHHTTT-------
T ss_pred c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---HHHHhcC-------
Confidence 2 122357889999999998899999999999999999998 999997543211 1 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.........+..+.+++.+||+.||++||++.++++.|+..
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11112233456889999999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.46 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=200.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHH-HHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEM-ISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|++.+.||+|+||+||+|+++ +++.||||++.+.. .......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999976 58899999997532 22334556667766 567899999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.... .++...++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997633 378889999999999999999999 9999999999999999999999999999754
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~------- 253 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILN------- 253 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHH-------
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHh-------
Confidence 322 22334567999999999999999999999999999999999999999743321 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 567 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 567 (609)
..+ .+....+..+.+++.+||+.||++||++.+.++.+....+..
T Consensus 254 --~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 254 --KPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp --SCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred --ccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 100 112223467899999999999999999977666666665443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=331.37 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=202.0
Q ss_pred hcCCCccCcccccCCceEEEEEeCC-C-------cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLAD-G-------TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 354 (609)
.++|.+.+.||+|+||+||+|.+.. + ..||+|++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4678999999999999999999652 3 57999998643 2345678999999999999999999999999999
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--------
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE-------- 426 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------- 426 (609)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999997632 3388999999999999999999999 9999999999999998887
Q ss_pred EEEcccccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 427 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
+||+|||++..... .....||+.|+|||.+.+ ..++.++||||||+++|||+||..|+...... ...
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~ 227 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRK 227 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHH
Confidence 99999999864432 223457899999999987 67899999999999999999965544322111 011
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCccc
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAE 567 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 567 (609)
.......... ....+..+.+++.+||+.||++|||+.++++.|++...+.
T Consensus 228 ~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 228 LQFYEDRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHHTTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHHhhccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111111 1111346789999999999999999999999999875443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.84 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=184.7
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999997 479999999986421 122357789999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++... ...+++..++.++.|+++||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999753 23489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......... ..+.
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------------~~~~ 225 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------------NKVV 225 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CC
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------------HHHh
Confidence 3222 223456899999999999888999999999999999999999999754322110 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ..+...+.++.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000 112223467899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.20 Aligned_cols=264 Identities=21% Similarity=0.347 Sum_probs=200.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467889999999999999999976 5899999998654332 23456789999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999998876542 2389999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH-----------
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK----------- 508 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 508 (609)
.. .......||+.|+|||.+.+. .++.++|||||||++|+|+||+.||........ .......
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ----LYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCChhhhhH
Confidence 22 223345689999999999775 789999999999999999999999975432211 1111100
Q ss_pred HhhhccchhhccccccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
............+...... .+..+..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000111111111111101 1234578999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.82 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=192.3
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCC--c
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPT--E 355 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 355 (609)
...++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999975 68999999986432 2334567789999999997 999999999997544 6
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||++ ++|...+... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 799999998 5888888752 388899999999999999999999 9999999999999999999999999999
Q ss_pred eeeccC--------------------CCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 436 KLVDVR--------------------KTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 436 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
+.+... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 876321 1112234579999999999976 6789999999999999999999999975432
Q ss_pred ccccchhHHHHHHHHhhhc--cchhhc------------------cccccCC------------CCHHHHHHHHHHHHhc
Q 007290 495 EEEDDVLLLDHVKKLEREK--RLDAIV------------------DRNLNKN------------YNIQEVETMIQVALLC 542 (609)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~l~~~------------~~~~~~~~l~~l~~~c 542 (609)
... +.........+. .+..+. ....... .....+..+.+++.+|
T Consensus 237 ~~~----~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 237 MNQ----LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp HHH----HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred HHH----HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 211 111110000000 000000 0000000 0002246789999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 007290 543 TQASPEDRPAMSEVVRM 559 (609)
Q Consensus 543 l~~dP~~RPs~~evl~~ 559 (609)
|+.||++|||+.|++++
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999865
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.39 Aligned_cols=254 Identities=17% Similarity=0.176 Sum_probs=206.2
Q ss_pred HHHhcCCCccCcccccCCceEEEEE------eCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc---CCCcceeEeEE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFC 350 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 350 (609)
+...++|.+.+.||+|+||+||+|. ..+++.||||++.. ....++..|++++..++ |+||+++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3456789999999999999999994 34688999999964 23567888888888887 99999999999
Q ss_pred eCCCcceEEeecccCchhhhhhhhcCC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC------
Q 007290 351 TTPTERLLVYPFMQNLSVAYRLREIKP-GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE------ 423 (609)
Q Consensus 351 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 423 (609)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999975432 244599999999999999999999999 9999999999999998
Q ss_pred -----CCcEEEcccccceeeccC-CCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007290 424 -----DFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497 (609)
Q Consensus 424 -----~~~~kl~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~ 497 (609)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 899999999999876422 2334455679999999999999999999999999999999999999985322110
Q ss_pred cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhcC
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR-PAMSEVVRMLEGE 563 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~ 563 (609)
...... +... .....+.+++..|++.+|.+| |++.++.+.|++.
T Consensus 293 ---------------~~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ---------------CKPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eeechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 001111 1111 124567889999999999998 6788888888764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=343.31 Aligned_cols=246 Identities=20% Similarity=0.229 Sum_probs=195.0
Q ss_pred cCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccCch
Q 007290 289 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 568999999999999974 68999999997532 2456788999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe--CCCCcEEEcccccceeeccCCCce
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~ 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--K 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--B
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--c
Confidence 99988652 23488999999999999999999999 99999999999999 677899999999998775432 2
Q ss_pred eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccC
Q 007290 446 TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNK 525 (609)
Q Consensus 446 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 525 (609)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ........... . +..
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~--~-----~~~ 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRW--D-----LED 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC--C-----SCS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccC--C-----CCh
Confidence 23346999999999998889999999999999999999999999754321 11111111100 0 000
Q ss_pred CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 526 NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 526 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001123468899999999999999999999997
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.04 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=203.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3567999999999999999999976 57799999987533 234678999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~~ 437 (609)
||+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999999887633 388999999999999999999999 99999999999999 7889999999999987
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
..... ......||+.|+|||.+.+ .++.++||||||+++|||+||+.||...... .......... ..
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~- 225 (277)
T 3f3z_A 159 FKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGT-FT- 225 (277)
T ss_dssp CCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC-
T ss_pred ccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC-CC-
Confidence 65332 2334568999999999865 4899999999999999999999999753321 1111111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... ....+..+.+++.+|++.||++|||+.++++
T Consensus 226 ~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 FPEKD-----WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCchh-----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0023468899999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=335.08 Aligned_cols=262 Identities=20% Similarity=0.258 Sum_probs=197.3
Q ss_pred hcCCCcc-CcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
.+.|++. +.||+|+||+||+|.+. +++.||||++.... ......+.+|++++.++ +||||+++++++...+..++|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 3567774 78999999999999964 79999999997542 34567889999999884 799999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl~~ 436 (609)
|||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 99999999999997643 388999999999999999999999 9999999999999998776 9999999987
Q ss_pred eeccCCC------ceeecccccccccCcccccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch-----
Q 007290 437 LVDVRKT------NVTTQVRGTMGHIAPEYLST-----GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV----- 500 (609)
Q Consensus 437 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~----- 500 (609)
....... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 11223458999999999865 4578999999999999999999999975432211000
Q ss_pred --hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 501 --LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 501 --~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
........... .... ..... ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~i~~-~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 243 PACQNMLFESIQE-GKYE-FPDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHH-CCCC-CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHHhc-cCcc-cCchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00001111110 0000 00000 01134678999999999999999999999873
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=328.22 Aligned_cols=252 Identities=19% Similarity=0.253 Sum_probs=202.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-----CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-----PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|++.+.||+|+||+||+|.+. +|+.||+|.+..... ....+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999986 689999999875321 12367899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 432 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 432 (609)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997632 389999999999999999999999 999999999999998877 8999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|++....... ......|++.|+|||.+.+..++.++||||||+++|+|+||+.||...... .........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~ 226 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAV 226 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhc
Confidence 9998764322 223456899999999999889999999999999999999999999743221 111111100
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ...... ....+..+.+++.+||+.||++||++.|+++
T Consensus 227 ~~---~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NY---DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC---CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc---CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 000000 0122357899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.73 Aligned_cols=268 Identities=22% Similarity=0.269 Sum_probs=206.1
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+|.+. +|..||+|++.........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3568999999999999999999976 689999999976544555678899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... .+++..+..++.|++.||.|||+++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 111 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999997643 3889999999999999999999832 799999999999999999999999999875532
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH--------------
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV-------------- 506 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~-------------- 506 (609)
. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.................
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 2 22345689999999999999999999999999999999999999975432111000000000
Q ss_pred -------HHHhhhc----cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 507 -------KKLEREK----RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 507 -------~~~~~~~----~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....... ....+.............+..+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 000000000011111223467899999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.14 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=202.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC--------
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-------- 352 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 352 (609)
...+|++.+.||+|+||.||+|.+. +|+.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567999999999999999999986 79999999996432 356789999999999999999998753
Q ss_pred --------CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC
Q 007290 353 --------PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED 424 (609)
Q Consensus 353 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 424 (609)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +|+|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 344789999999999999997642 23488999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007290 425 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 425 ~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~ 504 (609)
+.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||+||..|+... ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~ 226 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SK 226 (284)
T ss_dssp TEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HH
T ss_pred CCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HH
Confidence 999999999998765432 223446899999999999889999999999999999999999886310 01
Q ss_pred HHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 505 HVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... ...+. ...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 227 ~~~~~~---------~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTDLR---------DGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHH---------TTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhh---------ccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 11111 12235688999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.48 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=208.4
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
...++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34577999999999999999999975 79999999986421 2234567889999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 9999999999999997633 23489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ....... ..
T Consensus 336 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~---~i~~~i~-~~---- 404 (576)
T 2acx_A 336 VPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-E---EVERLVK-EV---- 404 (576)
T ss_dssp CCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-H---HHHHHHH-HC----
T ss_pred cccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-H---HHHHHhh-cc----
Confidence 65332 233457999999999999889999999999999999999999999754321110 0 1111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
...++...+..+.+++.+||+.||++|| ++.|+++
T Consensus 405 ------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 ------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0112233446889999999999999999 6788875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.50 Aligned_cols=261 Identities=20% Similarity=0.234 Sum_probs=195.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999965 68999999997432 2334567889999999999999999999996553
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||++++ +...+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 469999999875 4444432 278899999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 512 (609)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +...+.....+
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~----~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ----WNKVIEQLGTPCP 284 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCSCCH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCCH
Confidence 9876432 223456799999999999999999999999999999999999999975432111 11111100000
Q ss_pred -----------------c-----cchhhccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 -----------------K-----RLDAIVDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 -----------------~-----~~~~~~~~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .........+.... ....+..+.+++.+||+.||++|||++|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000000 11235789999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=331.69 Aligned_cols=259 Identities=29% Similarity=0.382 Sum_probs=198.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeC--CCc--EEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA--DGT--KVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
..++|++.+.||+|+||+||+|.+. +++ .||||+++... .....+.+.+|++++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3468999999999999999999863 333 68999886432 3345678899999999999999999999997755
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++|+||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 889999999999999997632 3388999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 436 KLVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 436 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~ 240 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKE 240 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTS
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------HHHHHHHcc
Confidence 8775433221 223457889999999988889999999999999999999 99999643321 111111111
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
. .........+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 241 ~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 G---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1 011112234568999999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.78 Aligned_cols=256 Identities=19% Similarity=0.244 Sum_probs=189.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHH-HHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAA-FQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|.+. +|+.||||+++.......... +.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999974 789999999975433333333 34444557788999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++ +|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999984 888877654444456899999999999999999999853 89999999999999999999999999998664
Q ss_pred cCCCceeecccccccccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
... ......||+.|+|||.+ .+..++.++||||||+++|+|+||+.||....... ...........
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-------QQLKQVVEEPS- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------HHHHHHHHSCC-
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------HHHHHHhccCC-
Confidence 332 22334689999999996 55678999999999999999999999997422111 11111111110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........+..+.+++.+||+.||++|||+.|+++
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 --------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111233467899999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.37 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=208.3
Q ss_pred HhcCCCccCcccccCCceEEEEEe-----CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC--
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-----ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT-- 354 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 354 (609)
..++|++.+.||+|+||.||+|++ .+|+.||||++.. ......+.+.+|++++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 456789999999999999999984 3688999999975 33445678999999999999999999999986544
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6899999999999999997642 3488999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccc-------ccchhHHHH
Q 007290 435 AKLVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE-------EDDVLLLDH 505 (609)
Q Consensus 435 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~-------~~~~~~~~~ 505 (609)
+.......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+....... .........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98775433221 223457788999999988889999999999999999999999875321100 000000000
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+.+.+............+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 272 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 272 ---------LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp ---------HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111111112233456899999999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=337.62 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=195.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|.+.+.||+|+||+||+|.+. +++.||||++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999976 78999999996543333333456799999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
++ |+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 4888888753 23488999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc---cchhh
Q 007290 443 TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---RLDAI 518 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 518 (609)
.......||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||....... ....+....... .....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchhh
Confidence 22334568999999999876 568999999999999999999999997543221 111111111000 00000
Q ss_pred cc---------ccccCC----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 519 VD---------RNLNKN----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 519 ~~---------~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. +..... ..+..+..+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 000000 01123467899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=339.08 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=187.8
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEe------
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCT------ 351 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~------ 351 (609)
+....+|++.+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 345568999999999999999999975 6899999998543 2344567889999999996 999999999983
Q ss_pred --CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeCCCCcE
Q 007290 352 --TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 352 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~ 427 (609)
.....++||||+. |+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 3344789999996 688888865332 23489999999999999999999998 7 9999999999999999999
Q ss_pred EEcccccceeeccCCCce-----------eecccccccccCcccc---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 428 VVGDFGLAKLVDVRKTNV-----------TTQVRGTMGHIAPEYL---STGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
||+|||+++......... .....||+.|+|||.+ .+..++.++||||||+++|||+||+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765332211 1134589999999998 56678999999999999999999999996422
Q ss_pred cccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 494 LEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
... +.............+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 258 ~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 258 KLR---------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 110 0000000011111224578999999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=329.76 Aligned_cols=256 Identities=19% Similarity=0.261 Sum_probs=200.5
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeC--CCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT--PTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 358 (609)
.++|++.+.||+|+||+||+|.+ .+++.||||++.. ...+.+.+|++++++++ ||||+++++++.. ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 46799999999999999999996 4789999999863 33578899999999997 9999999999987 566899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEccccccee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKL 437 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~ 437 (609)
||||+++++|..++.. ++...++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.
T Consensus 111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999998864 78889999999999999999999 999999999999999776 899999999987
Q ss_pred eccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... .....|+..|+|||.+.+ ..++.++|||||||++|||+||+.||........ .+........ .....
T Consensus 181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~l~~~~~~~~-~~~~~ 254 (330)
T 3nsz_A 181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVRIAKVLG-TEDLY 254 (330)
T ss_dssp CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH---HHHHHHHHHC-HHHHH
T ss_pred cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH---HHHHHHHhcC-Cchhh
Confidence 653322 334568999999999877 6789999999999999999999999954322111 1111111100 00000
Q ss_pred hhcc-----------------------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 517 AIVD-----------------------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 517 ~~~~-----------------------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..++ ...........+..+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00001111224578999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=364.17 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=197.9
Q ss_pred CcccccCCceEEEEEeC---CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|.+. +++.||||+++... .....+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999997533 23446789999999999999999999999964 457899999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC--
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT-- 443 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~-- 443 (609)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999753 3488999999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 444 NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 444 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... ...........
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~-------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER-------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC--------
Confidence 12233456789999999999999999999999999999999 99999753321 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...+...+.++.+++.+||+.||++||++.+|++.|++
T Consensus 591 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 591 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223345789999999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.31 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=200.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|.++ +|+.||||++..... ...+|++++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999976 688999999975332 235688888877 799999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC----CcEEEcccccc
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFGLA 435 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGl~ 435 (609)
|||+++|+|.+.+... ..+++..+..++.|++.||+|||++ +|+||||||+||++.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999998753 3489999999999999999999999 99999999999998543 35999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ..
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~-~~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSG-KF 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHC-CC
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccC-Cc
Confidence 87654322 2334578999999999988789999999999999999999999997432111 11111111111 10
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+........+..+.+++.+||+.||++||++.++++
T Consensus 241 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111112334568899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.94 Aligned_cols=244 Identities=14% Similarity=0.111 Sum_probs=192.1
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccC--CCCchHHHHHHHHH---HHHhccCCCcceeE-------eE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDF--ESPGGDAAFQREVE---MISVAVHRNLLRLI-------GF 349 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 349 (609)
.++|.+.+.||+|+||+||+|++ .+|+.||||++... ......+.+.+|+. .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 46999999999743 23445678899995 45566899999998 66
Q ss_pred EeCCCc-----------------ceEEeecccCchhhhhhhhcC---CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007290 350 CTTPTE-----------------RLLVYPFMQNLSVAYRLREIK---PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409 (609)
Q Consensus 350 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 409 (609)
+..++. .++||||+ +|+|.+++.... .....+++..++.++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 555432 78999999 689999997532 2223456788889999999999999999 99
Q ss_pred EecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCC-----------CCCcchhhHHHHHH
Q 007290 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-----------KSSERTDVFGYGIM 478 (609)
Q Consensus 410 vH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~l 478 (609)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3344567 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 479 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 479 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+|||+||+.||........ ...+... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG-----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC-----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc-----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999964332111 1111110 0122367899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=336.40 Aligned_cols=268 Identities=26% Similarity=0.366 Sum_probs=187.9
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.....++|++.+.||+|+||+||+|.+. +++.||||++.........+.+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3456788999999999999999999964 689999999865444445677889999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcC----CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 358 LVYPFMQNLSVAYRLREIK----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
+||||+++++|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999987421 1234589999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCC----CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 434 LAKLVDVRK----TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 434 l~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
++....... ........||+.|+|||.+.+ ..++.++||||||+++|||+||+.||........ . ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~---~~~ 239 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----L---MLT 239 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----H---HHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----H---HHH
Confidence 987654321 112234568999999999865 5689999999999999999999999975432110 0 000
Q ss_pred HhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ...................+..+.+++.+||+.||++||++.++++
T Consensus 240 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQ--NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HT--SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hc--cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0000000000001111223457899999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.94 Aligned_cols=261 Identities=18% Similarity=0.225 Sum_probs=205.6
Q ss_pred HHHHHHhcCCCcc-CcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhcc-CCCcceeEeEEeC
Q 007290 277 RELQLATDNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV-HRNLLRLIGFCTT 352 (609)
Q Consensus 277 ~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 352 (609)
...+...++|.+. +.||+|+||+||+|... +|+.||+|++.... .......+.+|+.++..+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3445566778877 89999999999999976 68999999987533 2334678899999999985 6999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEE
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVV 429 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 429 (609)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 99999999999999999998642 234489999999999999999999999 9999999999999998 789999
Q ss_pred cccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007290 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||....... .....
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i 245 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------TYLNI 245 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------HHHHH
Confidence 9999998765322 2234569999999999999999999999999999999999999996533211 11111
Q ss_pred hhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
... ............+..+.+++.+||+.||++|||++++++.
T Consensus 246 ~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQV-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHT-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hhc-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 100 0001111122344678999999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.18 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=197.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC----CCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 357 (609)
..|.+.+.||+|+||+||+|.+. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999975 68899999987533 33445778999999999999999999998754 34578
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeC-CCCcEEEccccc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLD-EDFEAVVGDFGL 434 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl 434 (609)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++ + ++||||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999997643 388999999999999999999998 7 99999999999998 789999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
+...... ......||+.|+|||.+. +.++.++||||||+++|+|+||+.||...... ............
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccCC
Confidence 9754332 233456899999999886 46899999999999999999999999643221 111111111111
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 P-A--------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C-G--------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-c--------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 0 011112357899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.30 Aligned_cols=195 Identities=24% Similarity=0.349 Sum_probs=154.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Cc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 355 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999975 68999999986532 233457788999999999999999999998433 56
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+. ++|..++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 6888888652 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCC--------------------------ceeecccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhC
Q 007290 436 KLVDVRKT--------------------------NVTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTG 485 (609)
Q Consensus 436 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~ll~elltg 485 (609)
+....... ......+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87642211 123345789999999986 456799999999999999999993
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=328.20 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=205.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|.+.+.||+|+||+||++.+. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999976 58899999986532 233456788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... .+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999887632 388999999999999999999999 99999999999999999999999999998764
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... .......||+.|+|||.+.+..++.++||||||+++|+|+||+.||...... ..........
T Consensus 167 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~------ 231 (294)
T 2rku_A 167 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNE------ 231 (294)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC------
T ss_pred cCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhhcc------
Confidence 322 2233456899999999999888999999999999999999999999753321 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ---Y--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---C--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---C--CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 111223457899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=334.67 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=195.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999974 69999999986432 2233567889999999999999999999997653
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+ +++|.+++... .++...+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999998752 378899999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 512 (609)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ +.........+
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~~~ 246 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ----LKEIMKVTGTPP 246 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCC
Confidence 9875432 334568999999999877 6799999999999999999999999975432111 10110000000
Q ss_pred ----------------ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 ----------------KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ----------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+.......+ .......+..+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000 0112233567899999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.81 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=197.7
Q ss_pred HHHhcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----- 353 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 353 (609)
+...++|++.+.||+|+||+||+|.+ .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45678899999999999999999997 4799999999864322 224799999999999999999988432
Q ss_pred ---------------------------------CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHH
Q 007290 354 ---------------------------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400 (609)
Q Consensus 354 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~ 400 (609)
...++||||++ |+|.+.+.........+++..++.++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 23779999998 58887776544445568999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHH
Q 007290 401 LHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIM 478 (609)
Q Consensus 401 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~l 478 (609)
||++ +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999997 68899999999998764332 23345689999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc---------cchh-----hccccccCCCCHHHHHHHHHHHHhccC
Q 007290 479 LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK---------RLDA-----IVDRNLNKNYNIQEVETMIQVALLCTQ 544 (609)
Q Consensus 479 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~-----~~~~~l~~~~~~~~~~~l~~l~~~cl~ 544 (609)
+|||++|+.||....... .+...+.....+. ...+ .....+...+....+..+.+++.+||+
T Consensus 232 l~ell~g~~pf~~~~~~~----~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID----QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999997543221 1111111110000 0000 000001111122345678999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007290 545 ASPEDRPAMSEVVR 558 (609)
Q Consensus 545 ~dP~~RPs~~evl~ 558 (609)
.||++|||+.|+++
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=325.67 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=204.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999976 57899999986421 123356789999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997643 388999999999999999999999 99999999999999999999999999997654
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~------- 227 (284)
T 2vgo_A 166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNV------- 227 (284)
T ss_dssp SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTT-------
T ss_pred cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhcc-------
Confidence 32 123456899999999999989999999999999999999999999743321 111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+ ..++...+..+.+++.+|++.||++||++.++++
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 0112233467899999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.37 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=206.2
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-------chHHHHHHHHHHHHhc-cCCCccee
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-------GGDAAFQREVEMISVA-VHRNLLRL 346 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l 346 (609)
+.......++|++.+.||+|+||.||+|.+. +|+.||||++...... ...+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4445556678999999999999999999985 7999999998643321 1135678899999998 79999999
Q ss_pred EeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc
Q 007290 347 IGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE 426 (609)
Q Consensus 347 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 426 (609)
++++......++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 999999999999999999999999997632 389999999999999999999999 9999999999999999999
Q ss_pred EEEcccccceeeccCCCceeecccccccccCcccccC------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccch
Q 007290 427 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDV 500 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~ 500 (609)
+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----- 311 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----- 311 (365)
T ss_dssp EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-----
Confidence 9999999998765432 2334579999999999853 35889999999999999999999999643211
Q ss_pred hHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 501 LLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......... ... ...+.. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 312 ---~~~~~i~~~-~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 ---LMLRMIMEG-QYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHHHT-CCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHhC-CCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111110 000 000000 012357899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.50 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=199.6
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------- 353 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 353 (609)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 478999999986433 233456788999999999999999999998663
Q ss_pred -CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 354 -TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
+..++||||+++ +|...+.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 457899999986 6666665422 3389999999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCC---CceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 433 GLAKLVDVRK---TNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 433 Gl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ....+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~ 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALISQ 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHH
Confidence 9998765322 222334568999999999876 458999999999999999999999997543211 1111111
Q ss_pred Hhhhcc---chhhcccccc--------CCCC-HH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LEREKR---LDAIVDRNLN--------KNYN-IQ------EVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~~~---~~~~~~~~l~--------~~~~-~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...... .......... .... .. .+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 110000 0000000000 0000 00 1356889999999999999999999996
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.59 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=191.7
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-------CCchHHHHHHHHHHHHhccCCCcceeEeEEeC
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT 352 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 352 (609)
...++|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999975 68999999986421 11122357899999999999999999999864
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEE
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVV 429 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 429 (609)
+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+ ..+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4578999999999999888653 3489999999999999999999999 99999999999999754 45999
Q ss_pred cccccceeeccCCCceeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 430 GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 430 ~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||........ ....+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~~i 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQI 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----HHHHH
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----HHHHH
Confidence 999999876432 22344679999999999853 5688999999999999999999999974332211 11111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ..... .+.. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 358 ~~----~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TS----GKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HT----TCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hc----CCCCC--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 10 00000 0000 01124678999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=339.06 Aligned_cols=265 Identities=19% Similarity=0.276 Sum_probs=193.5
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
...++|++.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+.++++++||||+++++++......++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45578999999999999999999965 789999999964332 2234567899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe-----CCCCcEEEcccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL-----DEDFEAVVGDFG 433 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfG 433 (609)
||||+++ +|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999985 8988887633 388999999999999999999999 99999999999999 455669999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........+
T Consensus 183 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID----QLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCC
T ss_pred CccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH----HHHHHHHHhCCC
Confidence 998664322 223345689999999999774 48999999999999999999999997543211 111111111000
Q ss_pred cc--chhhc-----cccc---cCC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KR--LDAIV-----DRNL---NKN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~--~~~~~-----~~~l---~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..... .... ... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 00000 0000 000 00113467899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=327.17 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=204.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3567999999999999999999975 79999999997532 223467889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~~ 437 (609)
||+++++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||++ +.++.+||+|||++..
T Consensus 86 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 9999999999987643 388999999999999999999999 99999999999999 7889999999999875
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... .
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~-~-- 224 (304)
T 2jam_A 159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGY-Y-- 224 (304)
T ss_dssp CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCC-C--
T ss_pred cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCC-C--
Confidence 4322 223346899999999999999999999999999999999999999643211 1111111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 562 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~ 562 (609)
..........+..+.+++.+|++.||++|||+.|+++ .+++
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 225 ----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 0011112234568899999999999999999999986 4444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=330.42 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=205.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
.++|.+.+.||+|+||.||++.+. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999999999999976 58899999986432 233457788999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999887632 388999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .......... .
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~-~---- 258 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNE-Y---- 258 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC-C----
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHhcCC-C----
Confidence 322 2233456899999999999889999999999999999999999999743321 1111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011223357889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.26 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=200.2
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
...++|++.+.||+|+||.||+|.+. +|+.||||.+... .....+.+|+.++..++||||+++++++......++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 35678999999999999999999976 5899999999753 2356789999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999998742 23489999999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........
T Consensus 177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~----- 242 (314)
T 3com_A 177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--------RAIFMIPTNPP----- 242 (314)
T ss_dssp TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC-----
T ss_pred hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCCC-----
Confidence 3322 233456899999999999889999999999999999999999999643211 11111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+.. ......+..+.+++.+||+.||++|||+.++++
T Consensus 243 -~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 -PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 011223467899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=362.23 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=208.0
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
+.+...++|++.+.||+|+||+||+|.+. .+..||||+++........+.+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34445678999999999999999999974 256799999876554555678999999999999999999999985 4
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 56899999999999999997532 3488999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... +........
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~ 608 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENG 608 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcC
Confidence 998765443333344557889999999998899999999999999999997 99998743221 111111111
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.. ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 609 ~~----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ER----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 112223446889999999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.15 Aligned_cols=261 Identities=18% Similarity=0.223 Sum_probs=205.3
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCC-CcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR-NLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+..|++++..+.|+ ++..+..++......++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 46899999999999999999996 4699999998864332 23578899999999874 5555666667778889999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~~~ 437 (609)
||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 899999997532 3489999999999999999999999 99999999999999 6889999999999988
Q ss_pred eccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 438 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 438 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~~~ 233 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKISEKKV 233 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHhhccc
Confidence 7543322 122567999999999999999999999999999999999999999754332111 11111111111
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
......+.. ..+.++.+++.+||+.+|++||++.+|++.|++..
T Consensus 234 ~~~~~~l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 ATSIEALCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HSCHHHHHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHHhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111111 12357899999999999999999999999998763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.39 Aligned_cols=270 Identities=20% Similarity=0.264 Sum_probs=199.3
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCc----------hHHHHHHHHHHHHhccCCCcce
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG----------GDAAFQREVEMISVAVHRNLLR 345 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~ 345 (609)
..++....++|.+.+.||+|+||+||+|.+.+|+.||||++....... ..+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 567888999999999999999999999998889999999986433221 1377899999999999999999
Q ss_pred eEeEEeC-----CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 007290 346 LIGFCTT-----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVL 420 (609)
Q Consensus 346 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIl 420 (609)
+++++.. ....++||||++ |+|.+.+... ...+++..+..++.|++.||.|||++ +|+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999843 335789999998 5777777642 33589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEcccccceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc
Q 007290 421 LDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD 499 (609)
Q Consensus 421 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~ 499 (609)
++.++.+||+|||++...... .......||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-- 242 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 999999999999999754322 22334568999999999876 6789999999999999999999999975432211
Q ss_pred hhHHHHHHHHhhhc----------cchhhccccccC-------CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 500 VLLLDHVKKLEREK----------RLDAIVDRNLNK-------NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 500 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..........+. ............ ...+..+..+.+++.+||+.||++|||+.|+++
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 --LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111000000 000000000000 001223467899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.22 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=203.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467999999999999999999975 78999999986422 233467889999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~~ 436 (609)
|||+++|+|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999887643 389999999999999999999999 999999999999995 55679999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .............
T Consensus 173 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKYAF 241 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCS
T ss_pred ECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC
Confidence 65432 22334579999999999865 5999999999999999999999999643321 1111111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C-------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00012234678999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=331.26 Aligned_cols=265 Identities=24% Similarity=0.284 Sum_probs=197.2
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
..++|++.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+++++.++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 6899999998643211 1234678999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++ +|...+... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 787777642 23478889999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
...... .......||+.|+|||.+.+. .++.++|||||||++|||++|.+||....... .+.......... ..
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~-~~ 234 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTP-TE 234 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCC-CT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCC-Ch
Confidence 664322 223345689999999998664 58999999999999999999999987543211 111111111000 00
Q ss_pred hhhcc------c---cccCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 516 DAIVD------R---NLNKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 516 ~~~~~------~---~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
....+ . ...... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0 000000 12234689999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=323.49 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=197.6
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFM 363 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 363 (609)
+|....+||+|+||+||+|.+. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3444568999999999999974 68899999987533 344677899999999999999999999999999999999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEcccccceeeccCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl~~~~~~~~ 442 (609)
++++|.+++.... ....+++..+..++.|++.||.|||++ +++|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999997642 233467888999999999999999999 9999999999999987 8999999999998764322
Q ss_pred CceeecccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
.......|++.|+|||.+.+.. ++.++||||||+++|+|+||+.||....... . ..... ...
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~~~~~-~~~-------- 241 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----A-AMFKV-GMF-------- 241 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----H-HHHHH-HHH--------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----H-HHHhh-ccc--------
Confidence 1223456899999999987643 7899999999999999999999986321110 0 00000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......+...+..+.+++.+||+.||++||++.++++
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0011122334468899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.07 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=201.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC------------chHHHHHHHHHHHHhccCCCcceeEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP------------GGDAAFQREVEMISVAVHRNLLRLIG 348 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~ 348 (609)
..++|.+.+.||+|+||+||+|.+. +++.||||++...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999975 5889999998753211 33567899999999999999999999
Q ss_pred EEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---
Q 007290 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF--- 425 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 425 (609)
++.+....++||||+++|+|.+.+.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999887643 389999999999999999999999 999999999999998775
Q ss_pred cEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 426 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... ..
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~ 255 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DI 255 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence 69999999998765432 233456999999999986 56999999999999999999999999754321 11
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......... ..... ....+..+.+++.+|++.||++|||+.|+++
T Consensus 256 ~~~i~~~~~~---~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEKGKYY---FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHCCCC---CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCC---CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111100 00000 0112467899999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.70 Aligned_cols=266 Identities=20% Similarity=0.232 Sum_probs=201.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc--------CCCcceeEeEEe-
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV--------HRNLLRLIGFCT- 351 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 351 (609)
..++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3578999999999999999999964 6889999999632 334567889999999886 788999999886
Q ss_pred ---CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC---
Q 007290 352 ---TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF--- 425 (609)
Q Consensus 352 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 425 (609)
.....++||||+.+ ++.+.+.... ...+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGH-HLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCCCC-BHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEeccCc-cHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 55678999999955 4444444321 234899999999999999999999864 799999999999999775
Q ss_pred ----------------------------------------------cEEEcccccceeeccCCCceeecccccccccCcc
Q 007290 426 ----------------------------------------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459 (609)
Q Consensus 426 ----------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE 459 (609)
.+||+|||+++..... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999876432 23346899999999
Q ss_pred cccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc-chhHHHHHHHHhhhc---------cchhhcccc-------
Q 007290 460 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-DVLLLDHVKKLEREK---------RLDAIVDRN------- 522 (609)
Q Consensus 460 ~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~~------- 522 (609)
++.+..++.++|||||||++|||+||+.||......... ............... .........
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999754432211 111111111110000 000000000
Q ss_pred ------------ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 ------------LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 ------------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
-........+..+.+++.+||+.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001235677789999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.28 Aligned_cols=262 Identities=19% Similarity=0.307 Sum_probs=202.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Ccc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 356 (609)
.++|++.+.||+|+||+||+|.+. +++.||||++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999975 68899999997544444557889999999999999999999998654 357
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+. |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 89999998 4888888652 388999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCce--eecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 437 LVDVRKTNV--TTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 437 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||........ . ..+.......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~-~~i~~~~~~~ 251 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----L-NHILGILGSP 251 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH----H-HHHHHHHCSC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH----H-HHHHHHhCCC
Confidence 765332221 234579999999998754 4589999999999999999999999975443221 1 1111100000
Q ss_pred cc---h------------hhcccccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 RL---D------------AIVDRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~~---~------------~~~~~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. . ....+... ....+..+..+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0 00000000 0001223467899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=325.31 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=199.4
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..++|++.+.||+|+||+||+|.+. +|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4578999999999999999999986 5899999998643 3445678999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 96 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp ECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999887632 2389999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCceeecccccccccCcccc-----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYL-----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
. ........||+.|+|||.+ ....++.++||||||+++|+|+||+.||...... ............
T Consensus 170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 240 (302)
T 2j7t_A 170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSDPP 240 (302)
T ss_dssp H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCC
T ss_pred c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HHHHHHhccCCc
Confidence 1 1112334689999999998 4667899999999999999999999999743321 111111111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. .......+..+.+++.+||+.||++|||+.++++
T Consensus 241 -~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0012223467899999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=343.06 Aligned_cols=200 Identities=25% Similarity=0.334 Sum_probs=167.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Cc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 355 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999975 68899999997532 233457788999999999999999999998765 56
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+. |+|.+++... ..+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 5999988752 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCC---------------------ceeecccccccccCcccc-cCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007290 436 KLVDVRKT---------------------NVTTQVRGTMGHIAPEYL-STGKSSERTDVFGYGIMLLELVTGQRAID 490 (609)
Q Consensus 436 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~ll~elltg~~p~~ 490 (609)
+....... ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87653321 123456799999999986 55679999999999999999999665554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.21 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=199.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||+||+|++. ++..||+|++.... .......+.+|+.+++.++||||+++++++......++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999976 68899999987533 233467889999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcccccce
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFGLAK 436 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl~~ 436 (609)
|||+++|+|.+.+.... .+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999887643 388999999999999999999999 9999999999999976 4559999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...... ............
T Consensus 188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~- 255 (494)
T 3lij_A 188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGKYT- 255 (494)
T ss_dssp ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCC-
T ss_pred ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC-
Confidence 765432 234456999999999985 57999999999999999999999999754321 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 256 --~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 --FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 001123467899999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=342.14 Aligned_cols=255 Identities=10% Similarity=0.014 Sum_probs=182.3
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhc--cCCCcceeE-------eEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVA--VHRNLLRLI-------GFC 350 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 350 (609)
...|.+.+.||+|+||+||+|.+. +|+.||||++..... ....+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999975 789999999976432 23345677886555555 599988754 344
Q ss_pred eCC-----------------CcceEEeecccCchhhhhhhhcCCCCCCccHHHH------HHHHHHHHHHHHHHHhcCCC
Q 007290 351 TTP-----------------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTR------KRVALGAARGLEYLHEHCNP 407 (609)
Q Consensus 351 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~ 407 (609)
..+ ...++||||++ |+|.+++..... .++...+ ..++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 322 23799999999 899999986421 1344445 67889999999999999
Q ss_pred CeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhC
Q 007290 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTG 485 (609)
Q Consensus 408 ~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg 485 (609)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986542 1224457799999999987 6799999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 486 QRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 486 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+.||........... .....................+..+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999975432211000 000000000111111111234578999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.78 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=197.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999976 79999999986421 23345678899999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.+++.... .++...+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999997643 378999999999999999999999 9999999999999999999999999999866
Q ss_pred ccCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ........ ...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~-- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRG-GVF-- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-CCC--
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhc-Ccc--
Confidence 4322 2234468999999999987765 68999999999999999999999643221 11111111 000
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..+...+..+.+++.+|++.||++|||+.|+++.
T Consensus 229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112234578999999999999999999999973
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=346.58 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=205.6
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++......++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567999999999999999999976 78999999986432 23456789999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe---CCCCcEEEcccccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL---DEDFEAVVGDFGLA 435 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl~ 435 (609)
||||+.+|+|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999988753 3389999999999999999999999 99999999999999 56789999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ............
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~ 245 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKGKYT 245 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence 8765332 2334569999999999865 6999999999999999999999999753321 111111111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. .......+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CC-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 0001223467899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=334.01 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=204.1
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCC--c--------------hHHHHHHHHHHHHhccCCCccee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP--G--------------GDAAFQREVEMISVAVHRNLLRL 346 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~--------------~~~~~~~E~~~l~~l~h~niv~l 346 (609)
.++|.+.+.||+|+||.||+|.+ +|+.||||++...... . ....+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998642211 1 11789999999999999999999
Q ss_pred EeEEeCCCcceEEeecccCchhhhh------hhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcE
Q 007290 347 IGFCTTPTERLLVYPFMQNLSVAYR------LREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANV 419 (609)
Q Consensus 347 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NI 419 (609)
++++...+..++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ + +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 433 113558999999999999999999999 8 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCccccc
Q 007290 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSE-RTDVFGYGIMLLELVTGQRAIDFSRLEEE 497 (609)
Q Consensus 420 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~ll~elltg~~p~~~~~~~~~ 497 (609)
+++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|||+||+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 9999999999999999876432 33455789999999999877 6666 9999999999999999999997543211
Q ss_pred cchhHHHHHHHHhhhccchhhccc--cc-------cCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDR--NL-------NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~--~l-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......... ......+. .. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 260 ------~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ------ELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------HHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111 00000000 00 00001334568899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.65 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=200.5
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC--
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT-- 352 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 352 (609)
.++....++|++.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.+++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 344456788999999999999999999974 7899999998643 23457889999999998 79999999999865
Q ss_pred ----CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 353 ----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 353 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
....++||||+++|+|.+++.... ...++...++.++.|++.||.|||++ +|+|+||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 457899999999999999997642 23488899999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 429 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 429 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
|+|||++....... .......||+.|+|||.+. +..++.++||||||+++|+|+||+.||......
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------- 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------- 240 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--------
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------
Confidence 99999998664322 1223456899999999986 567899999999999999999999999643211
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH--HHhc
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR--MLEG 562 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~--~L~~ 562 (609)
........... +. ......+..+.+++.+||+.||++||++.++++ .+++
T Consensus 241 ~~~~~~~~~~~------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 241 RALFLIPRNPA------PR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp HHHHHHHHSCC------CC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred HHHHHhhcCcc------cc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 11111111100 00 011223467899999999999999999999997 4544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.28 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=195.0
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc------c
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE------R 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 356 (609)
..+|.+.+.||+|+||+||+|++.++..||+|++...... ..+|+++++.++||||+++++++..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3568899999999999999999987778999988643221 2369999999999999999999854332 6
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCcEEEcccccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLA 435 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGl~ 435 (609)
++||||++++.+...... ......+++..++.++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHY-AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHHHHHHHH-HHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 799999998655443322 22234589999999999999999999999 999999999999999 7999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc-
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK- 513 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 513 (609)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.........+.
T Consensus 190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----LVEIIKVLGTPSR 263 (394)
T ss_dssp EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCH
T ss_pred ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCH
Confidence 8764332 23345689999999998764 589999999999999999999999975432211 111111110000
Q ss_pred -cch----hhccc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 -RLD----AIVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 -~~~----~~~~~--------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.+. ..... .+...+....+.++.+++.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 00000 00001122245689999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=358.68 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=202.5
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 356 (609)
...++|++.+.||+|+||+||+|+++ +++.||||+++... .....+.+..|..++..+ +||+|+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 35578999999999999999999975 68899999987421 233456788899999887 699999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 99999999999999998643 389999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......
T Consensus 491 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i------- 554 (674)
T 3pfq_A 491 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSI------- 554 (674)
T ss_dssp ECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH-------
T ss_pred ccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHH-------
Confidence 64322 22344567999999999999999999999999999999999999999753321 111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
.... ..++...+.++.+|+.+||+.||++||++
T Consensus 555 --~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 555 --MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --HSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --HhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1111 11223345688999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=328.00 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=196.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-------CchHHHHHHHHHHHHhccCCCcceeEeEEeCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-------PGGDAAFQREVEMISVAVHRNLLRLIGFCTTP 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 353 (609)
..++|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4568999999999999999999975 588999999864321 12234588999999999999999999998765
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVG 430 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 430 (609)
. .++||||+++++|.+.+... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 89999999999999988652 3488999999999999999999999 9999999999999987654 9999
Q ss_pred ccccceeeccCCCceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 431 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 431 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|+||+.||........ +...+.
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~ 233 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQIT 233 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----HHHHHH
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----HHHHHH
Confidence 99999876432 2223456899999999973 56789999999999999999999999975332211 111111
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. .... ..+.. ....+..+.+++.+||+.||++||++.++++
T Consensus 234 ~----~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 S----GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp H----TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred h----Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 0000 00000 0112467899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.96 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=200.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Ccc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 356 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||++...........+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 568999999999999999999975 68999999997544444566788999999999999999999988654 668
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+. ++|.+.+... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 5898888752 388999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCc---------eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH
Q 007290 437 LVDVRKTN---------VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 437 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 506 (609)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~ 236 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIF 236 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHH
Confidence 76532211 1123468999999998754 6789999999999999999999999975432110 00000
Q ss_pred HHHhhhc---c--------chhhcccc--ccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 507 KKLEREK---R--------LDAIVDRN--LNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 507 ~~~~~~~---~--------~~~~~~~~--l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.....+. . ..+..... ... ...+..+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 0 00000000 000 001233467899999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.18 Aligned_cols=260 Identities=24% Similarity=0.298 Sum_probs=193.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC----C--cc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP----T--ER 356 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~ 356 (609)
.+|++.+.||+|+||+||+|++. +|+.||||++.... ..+.+|+++++.++||||+++++++... + ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 46888999999999999999985 69999999986432 1234799999999999999999988432 1 25
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-CcEEEcccccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLA 435 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl~ 435 (609)
++||||+++ ++...+.........+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 56555554333345589999999999999999999999 99999999999999965 67899999999
Q ss_pred eeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE-- 512 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 512 (609)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+...+.....+
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCSCCH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCH
Confidence 8764322 22345689999999998764 78999999999999999999999997543211 111111111000
Q ss_pred -------ccchhhcccccc-----CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 -------KRLDAIVDRNLN-----KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 -------~~~~~~~~~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....+...+... ..+....+.++.+|+.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000000000 0012233568999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.90 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=198.2
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhcc--CCCcceeEeEEeCCCc
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTPTE 355 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 355 (609)
+....++|++.+.||+|+||.||++.+.+++.||||++.... .......+.+|++++.+++ ||||+++++++...+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 344667899999999999999999999889999999986433 2334577899999999997 5999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||| +.+++|.+++.... .+++..++.++.|+++||.|||++ +|+||||||+||++++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 67889999997632 478899999999999999999999 9999999999999964 79999999999
Q ss_pred eeeccCCCc-eeecccccccccCcccccC-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 436 KLVDVRKTN-VTTQVRGTMGHIAPEYLST-----------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 436 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
......... ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||...... .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~- 246 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------I- 246 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------H-
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------H-
Confidence 876533221 2234568999999999865 46889999999999999999999999643211 0
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ...++.....+....+..+.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SKLH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH---------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111 111111111122222467899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.85 Aligned_cols=270 Identities=21% Similarity=0.238 Sum_probs=191.3
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
.+.....++|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.++++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345567789999999999999999999975 68999999986432 233456778888899999999999999855333
Q ss_pred -------ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEeCC-CC
Q 007290 356 -------RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH--EHCNPKIIHRDVKAANVLLDE-DF 425 (609)
Q Consensus 356 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~ 425 (609)
.++||||++++ |...+.........++...+..++.|++.||.||| ++ +|+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 68999999875 44444433333455889999999999999999999 88 9999999999999996 89
Q ss_pred cEEEcccccceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHH
Q 007290 426 EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLD 504 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~ 504 (609)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ....
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHHH
Confidence 99999999998765332 23345689999999998665 48999999999999999999999997543221 1111
Q ss_pred HHHHHhhhc--cch---------hhcc------ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 505 HVKKLEREK--RLD---------AIVD------RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 505 ~~~~~~~~~--~~~---------~~~~------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.......+. ... ...+ ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111100000 000 0000 00011112234678999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=330.29 Aligned_cols=262 Identities=25% Similarity=0.431 Sum_probs=203.1
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
++++...++|++.+.||+|+||+||+|.+.+ .||+|++.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 4445567889999999999999999999853 49999986432 23344667889999999999999999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999753 23488999999999999999999999 999999999999998 679999999998
Q ss_pred eeeccCC----CceeecccccccccCcccccC---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhH
Q 007290 436 KLVDVRK----TNVTTQVRGTMGHIAPEYLST---------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 502 (609)
Q Consensus 436 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~ 502 (609)
+...... ........|++.|+|||.+.+ ..++.++||||||+++|||+||+.||......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------- 249 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------- 249 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 7653211 112223458999999999864 45789999999999999999999999743321
Q ss_pred HHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
.......... .+... ....+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 250 -~~~~~~~~~~------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 250 -AIIWQMGTGM------KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp -HHHHHHHTTC------CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred -HHHHHhccCC------CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 01110 1122346889999999999999999999999998864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.64 Aligned_cols=260 Identities=19% Similarity=0.239 Sum_probs=191.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999975 68999999997532 2334567889999999999999999999997654
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999985 67777642 278889999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH------
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK------ 508 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 508 (609)
++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .......
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ----WNKVIEQLGTPCP 247 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHC-CCCCCH
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCH
Confidence 9865432 223345789999999999998999999999999999999999999975432110 0000000
Q ss_pred ------------H-hhhc-----cchhhccccccCCC---CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 ------------L-EREK-----RLDAIVDRNLNKNY---NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ------------~-~~~~-----~~~~~~~~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. .... ...........+.. ....+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0000 00000000000000 1234678999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=321.09 Aligned_cols=252 Identities=18% Similarity=0.283 Sum_probs=198.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC---CCchHHHHHHHHHHHHhccCCCcceeEeEEe--CCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 356 (609)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 68999999986421 2345678999999999999999999999984 45578
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||++++ +.+.+.... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999987 666665533 23489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCC-CceeecccccccccCcccccCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 437 LVDVRK-TNVTTQVRGTMGHIAPEYLSTGK--SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 437 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
...... ........||+.|+|||.+.+.. ++.++||||||+++|||+||+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKG- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcC-
Confidence 765322 22233456899999999987644 378999999999999999999999743221 111111111
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 SY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 1112234678899999999999999999999963
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.23 Aligned_cols=199 Identities=20% Similarity=0.251 Sum_probs=171.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc------cCCCcceeEeEEeCCCc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVA------VHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 355 (609)
..+|++.+.||+|+||+||+|.+. +++.||||+++.. ......+.+|+++++.+ .|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457999999999999999999975 5899999999642 23346778898888877 57799999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc--EEEcccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE--AVVGDFG 433 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG 433 (609)
.++||||+. ++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999997 588888876432 3389999999999999999999999 9999999999999999887 9999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||++||....
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99764422 234578999999999999999999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=320.49 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=203.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC--------chHHHHHHHHHHHHhcc-CCCcceeEeEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP--------GGDAAFQREVEMISVAV-HRNLLRLIGFCT 351 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 351 (609)
..++|++.+.||+|+||.||+|.+. +|+.||||++...... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999975 6899999998643211 12356789999999996 999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
.....++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999763 2388999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
||++....... ......|++.|+|||.+. ...++.++||||||+++|+|++|+.||...... ..
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~ 237 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LM 237 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--------HH
Confidence 99998765332 233456899999999885 456899999999999999999999999643211 11
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........ .. .........+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111110 00 000111234568899999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=328.70 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=201.1
Q ss_pred HhcCCCccCcccccCCceEEEEEe--CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhc---cCCCcceeEeEEe----
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL--ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCT---- 351 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 351 (609)
..++|++.+.||+|+||+||+|.+ .+|+.||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 368899999986432 222234566788777766 8999999999986
Q ss_pred -CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEc
Q 007290 352 -TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVG 430 (609)
Q Consensus 352 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 430 (609)
.....++||||+. |+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 599999876432 3388999999999999999999999 99999999999999999999999
Q ss_pred ccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHh
Q 007290 431 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510 (609)
Q Consensus 431 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 510 (609)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|+|+||+.||....... ..........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHcC
Confidence 999998654322 2334568999999999999899999999999999999999999997543211 1111111110
Q ss_pred hhc--cc-hh------hccc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 REK--RL-DA------IVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 ~~~--~~-~~------~~~~---~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
... .. .. .... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 00 0000 0000112234567899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.12 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=183.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------C
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------T 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 354 (609)
.++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999964 68999999986432 233456788999999999999999999998654 5
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
..++|+|++ +++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 578999998 6899888764 2389999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 512 (609)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ +.........+
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKLILRLVGTPG 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCC
Confidence 9865422 334578999999999877 6789999999999999999999999975432111 11111100000
Q ss_pred -ccch--------hhccccc-cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 -KRLD--------AIVDRNL-NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 -~~~~--------~~~~~~l-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.... ..+.... .... ....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0000000 0000 11224678999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.56 Aligned_cols=270 Identities=20% Similarity=0.268 Sum_probs=183.3
Q ss_pred hcCCCc-cCcccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe--CCCcc
Q 007290 283 TDNFSE-KNVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT--TPTER 356 (609)
Q Consensus 283 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 356 (609)
.+.|++ .++||+|+||+||+|+++ +++.||||++... .....+.+|+.++++++||||+++++++. .....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 344665 568999999999999975 5789999999643 23457889999999999999999999984 46678
Q ss_pred eEEeecccCchhhhhhhhcC-----CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe----CCCCcE
Q 007290 357 LLVYPFMQNLSVAYRLREIK-----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL----DEDFEA 427 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~ 427 (609)
++||||+.+ +|.+.+.... .....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 999999975 6766665321 1123489999999999999999999999 99999999999999 678899
Q ss_pred EEcccccceeeccCCC--ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccc-----cc
Q 007290 428 VVGDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE-----DD 499 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~-----~~ 499 (609)
||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999987653221 223446789999999999774 589999999999999999999999975432110 00
Q ss_pred hhHHHHHHHHhhhcc--chhh------------ccccccCCCC---------HHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 007290 500 VLLLDHVKKLEREKR--LDAI------------VDRNLNKNYN---------IQEVETMIQVALLCTQASPEDRPAMSEV 556 (609)
Q Consensus 500 ~~~~~~~~~~~~~~~--~~~~------------~~~~l~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPs~~ev 556 (609)
..+.........+.. ...+ .......... ...+..+.+|+.+||+.||++|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 111111111100000 0000 0000000000 0013578899999999999999999999
Q ss_pred HHH
Q 007290 557 VRM 559 (609)
Q Consensus 557 l~~ 559 (609)
+++
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 963
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=326.63 Aligned_cols=265 Identities=19% Similarity=0.269 Sum_probs=199.4
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-----------CCCcceeEeEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----------HRNLLRLIGFC 350 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 350 (609)
.++|.+.+.||+|+||+||+|.+ .+++.||||++.. .......+.+|+++++++. ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 46899999999999999999997 4789999999863 2234567889999988876 89999999998
Q ss_pred eCCC----cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC----
Q 007290 351 TTPT----ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---- 422 (609)
Q Consensus 351 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---- 422 (609)
.... ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 6543 688999999 8899999976432 33889999999999999999999953 899999999999994
Q ss_pred --CCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcccccc--
Q 007290 423 --EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEED-- 498 (609)
Q Consensus 423 --~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~-- 498 (609)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999876432 23346899999999999999999999999999999999999999754322110
Q ss_pred chhHHHHHHHHhhh--------ccchhhccc-------------------cccCCCCHHHHHHHHHHHHhccCCCCCCCC
Q 007290 499 DVLLLDHVKKLERE--------KRLDAIVDR-------------------NLNKNYNIQEVETMIQVALLCTQASPEDRP 551 (609)
Q Consensus 499 ~~~~~~~~~~~~~~--------~~~~~~~~~-------------------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 551 (609)
...+.......... ......+.. .-...+....+..+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00111111100000 000000000 001124567788999999999999999999
Q ss_pred CHHHHHH
Q 007290 552 AMSEVVR 558 (609)
Q Consensus 552 s~~evl~ 558 (609)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.52 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=203.0
Q ss_pred HhcCCCccCcccccCCceEEEEEe-C-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCC------cceeEeEEeCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVL-A-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN------LLRLIGFCTTP 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 353 (609)
..++|++.+.||+|+||+||+|.+ . +|+.||||+++.. ....+.+.+|+++++.++|++ ++++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 356899999999999999999997 3 6889999999642 234567889999999887765 99999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC----------
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---------- 423 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---------- 423 (609)
+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 889999887632 23488999999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 424 ---------DFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 424 ---------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865432 2345689999999999998999999999999999999999999975432
Q ss_pred ccccchhHHHHHHHHhhhcc--------chh---------------------hcccc-ccCCCCHHHHHHHHHHHHhccC
Q 007290 495 EEEDDVLLLDHVKKLEREKR--------LDA---------------------IVDRN-LNKNYNIQEVETMIQVALLCTQ 544 (609)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~--------~~~---------------------~~~~~-l~~~~~~~~~~~l~~l~~~cl~ 544 (609)
.. ....+........ ... ...+. .........+..+.+++.+||+
T Consensus 240 ~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 KE-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp HH-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred HH-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 11 1111111100000 000 00000 0011234567889999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007290 545 ASPEDRPAMSEVVR 558 (609)
Q Consensus 545 ~dP~~RPs~~evl~ 558 (609)
.||++|||+.|+++
T Consensus 315 ~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 315 YDPAKRITLREALK 328 (339)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cCcccccCHHHHhc
Confidence 99999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.60 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=180.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHH-HHHhccCCCcceeEeEEeCCCcceEE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
..++|++.+.||+|+||.||+|.+. +|+.||||++...........+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478889999999999999999975 789999999976544444556666666 67778999999999999999999999
Q ss_pred eecccCchhhhhhhhc-CCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 360 YPFMQNLSVAYRLREI-KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|||+++ +|.+++... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999986 777766532 112345889999999999999999999852 7999999999999999999999999999866
Q ss_pred ccCCCceeecccccccccCcccc----cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYL----STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
.... ......||+.|+|||.+ .+..++.++||||||+++|+|+||+.||........ . . ..
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~---~---~~ 241 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------Q---L---TQ 241 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------CC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------H---H---HH
Confidence 4322 22234689999999998 456789999999999999999999999964321100 0 0 00
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
......+.+........+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000011111111234468899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.81 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=195.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc----
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER---- 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 356 (609)
.++|.+.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467889999999999999999975 689999999975332 23356788999999999999999999999877654
Q ss_pred --eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 357 --LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 357 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
++||||+. ++|...+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 577776632 288999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
++..... .....||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||........ ............
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~ 262 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----LTQILKVTGVPG 262 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCc
Confidence 9865432 234568999999999877 6789999999999999999999999975432111 111111000000
Q ss_pred --cc--------hhh---ccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 514 --RL--------DAI---VDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 514 --~~--------~~~---~~~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.. ... ........ ..+..+..+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000 00000000 012235688999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.90 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=203.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
...++|++.+.||+|+||+||+|... +++.||+|++.... .......+.+|++++++++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999976 68999999986432 33456789999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC---CcEEEcccccc
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED---FEAVVGDFGLA 435 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl~ 435 (609)
|+||+++++|.+.+.... .+++..++.++.|++.||.|||++ +++|+||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999887533 388999999999999999999999 99999999999999754 47999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ............
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKYA 240 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence 8654322 2233458999999999865 5899999999999999999999999743221 111111111100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. + .......+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~---~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F---D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C---C----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---C----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0 0001123467899999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=320.29 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=193.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC---------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--------- 352 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 352 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++... ....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 567999999999999999999975 7999999998642 3345778899999999999999999998754
Q ss_pred ----CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 353 ----PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 353 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
....++||||+++|+|.+++... ...++...++.++.|++.||+|||++ +++||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 34578999999999999999753 23477889999999999999999999 999999999999999999999
Q ss_pred EcccccceeeccCC-------------CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 429 VGDFGLAKLVDVRK-------------TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 429 l~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
|+|||++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999998654221 1122345689999999999764 78999999999999999998 4431110
Q ss_pred ccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 495 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
.......... ....+........+..+.+++.+||+.||++|||+.++++.
T Consensus 234 -------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 -------RVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -------HHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------HHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0011111110 01112222334445678999999999999999999999973
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.17 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=188.6
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34556788999999999877667899999999864 2345678999999876 899999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCC---ccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC-------------Cc
Q 007290 363 MQNLSVAYRLREIKPGEPV---LDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED-------------FE 426 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~ 426 (609)
+. |+|.+++......... .++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 6999999764322211 13335678999999999999999 99999999999999654 48
Q ss_pred EEEcccccceeeccCCCc---eeecccccccccCcccccC-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCccc
Q 007290 427 AVVGDFGLAKLVDVRKTN---VTTQVRGTMGHIAPEYLST-------GKSSERTDVFGYGIMLLELVT-GQRAIDFSRLE 495 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~ 495 (609)
+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999987543222 1234579999999999865 568999999999999999999 99999643211
Q ss_pred cccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 496 EEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 496 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ... ....... +..........+.++.+++.+||+.||++|||+.++++
T Consensus 247 ~------~~i---~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E------SNI---IRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H------HHH---HHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H------HHH---hcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 000 0000000 01111224567789999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.57 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=192.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe----------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT---------- 351 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 351 (609)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 467999999999999999999986 5899999998643 3445678899999999999999999999874
Q ss_pred ----CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCc
Q 007290 352 ----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE 426 (609)
Q Consensus 352 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 426 (609)
.....++||||++ |+|.+++.. ..++...++.++.|++.||+|||++ +|+||||||+||+++ .++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3356789999998 599988864 2378899999999999999999999 999999999999997 5679
Q ss_pred EEEcccccceeeccCCC--ceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 427 AVVGDFGLAKLVDVRKT--NVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
+||+|||+++....... .......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~ 235 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ----MQ 235 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH----HH
Confidence 99999999987643221 12234457999999998865 6789999999999999999999999975432111 00
Q ss_pred HHHHHHhh---------hccchhhcccccc-CC-----CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 504 DHVKKLER---------EKRLDAIVDRNLN-KN-----YNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 504 ~~~~~~~~---------~~~~~~~~~~~l~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........ ............. .. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 0000000000000 00 01123568899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.93 Aligned_cols=204 Identities=21% Similarity=0.238 Sum_probs=171.5
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CC-----CcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HR-----NLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~ 352 (609)
+...++|++.+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.++..+. |+ +|+++++++..
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 345678999999999999999999975 6889999999632 233566778899888875 55 49999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVG 430 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~ 430 (609)
.+..++||||+++ +|.+++..... ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CCceEEEEecCCC-CHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999975 99998876432 3388999999999999999999952 12899999999999995 57889999
Q ss_pred ccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 007290 431 DFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 493 (609)
Q Consensus 431 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~ 493 (609)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876432 234568999999999999999999999999999999999999997543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.66 Aligned_cols=247 Identities=22% Similarity=0.360 Sum_probs=199.8
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhcc--CCCcceeEe
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAV--HRNLLRLIG 348 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~ 348 (609)
++.+...++|++.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+++++. ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 455556788999999999999999999964 6899999998753221 12345678999999996 599999999
Q ss_pred EEeCCCcceEEeecccC-chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CCCc
Q 007290 349 FCTTPTERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-EDFE 426 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 426 (609)
++...+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999976 89999987632 388999999999999999999999 999999999999999 7899
Q ss_pred EEEcccccceeeccCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHH
Q 007290 427 AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDH 505 (609)
Q Consensus 427 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 505 (609)
+||+|||+++..... ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||.....
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------- 254 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence 999999999876532 2234568999999999977665 7889999999999999999999963210
Q ss_pred HHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 506 VKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 506 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... .. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 255 ---~~~~-~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ---IIRG-QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHC-CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhcc-cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 011123357899999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=322.03 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=173.9
Q ss_pred HhcCCCccC-cccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC----CCc
Q 007290 282 ATDNFSEKN-VLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTE 355 (609)
Q Consensus 282 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 355 (609)
..++|.+.+ +||+|+||+||+|.+. +|+.||||++... .....+....+..+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 456788854 6999999999999976 6999999998641 2222233334667889999999999865 344
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF 432 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 432 (609)
.++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 789999999999999998643 24589999999999999999999999 9999999999999976 455999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|+++..... ......||+.|+|||++.+..++.++||||||+++|+|+||+.||.......... ....... .
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~-~ 247 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIR-L 247 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhh-c
Confidence 999865432 2234568999999999988889999999999999999999999996433211100 0000000 0
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ............+..+.+++.+||+.||++|||+.|+++
T Consensus 248 ~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 G------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000011111234568899999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.83 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=195.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC-CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc-----
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES-PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 355 (609)
.++|.+.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467888999999999999999975 689999999965332 2335678899999999999999999999977654
Q ss_pred -ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 356 -RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 356 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
.++||||+. ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 577776642 288999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 512 (609)
++..... .....||+.|+|||.+.+ ..++.++||||||+++|+|+||+.||........ +.........+
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~ 244 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----LTQILKVTGVPG 244 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH----HHHHHHHHCBCC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCC
Confidence 9865422 234568999999999876 6789999999999999999999999975432110 11111100000
Q ss_pred -c---------------cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 -K---------------RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 -~---------------~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. .+.......+ .......+..+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000000 1112344578999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.51 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=191.6
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhc----cCCCccee
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVA----VHRNLLRL 346 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l 346 (609)
.+.+...++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345566788999999999999999999964 6899999999643221 1223456799999888 89999999
Q ss_pred EeEEeCCCcceEEeec-ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC-CC
Q 007290 347 IGFCTTPTERLLVYPF-MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD-ED 424 (609)
Q Consensus 347 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~ 424 (609)
++++...+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCC
Confidence 9999999999999999 78999999998633 389999999999999999999999 999999999999999 88
Q ss_pred CcEEEcccccceeeccCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH
Q 007290 425 FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 425 ~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~ 503 (609)
+.+||+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence 999999999998765432 234568999999999877666 4589999999999999999999863210
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .. .. ..+....+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 -~---~~--~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -I---LE--AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -H---HH--TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -H---hh--hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 00 01122234678999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=312.17 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=179.3
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHH-HHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAF-QREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~-~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||.||+|.+. +|+.||||++...........+ ..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 7899999999754433333333 44445678889999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
||+ ++.+....... ...+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 45555554432 2348899999999999999999998 6 89999999999999999999999999997654
Q ss_pred cCCCceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
... ......||+.|+|||.+. ...++.++||||||+++|||+||+.||...... ............
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCC
Confidence 322 223446899999999984 456899999999999999999999999742211 011111111110
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. .+. .....+..+.+++.+||+.||++||++.++++
T Consensus 248 ~------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 P------LLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C------CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------CCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 000 01123467899999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.29 Aligned_cols=260 Identities=18% Similarity=0.226 Sum_probs=198.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CC-cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCC------cceeEeEEeCC
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DG-TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN------LLRLIGFCTTP 353 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 353 (609)
..++|++.+.||+|+||+||+|.+. ++ +.||+|+++.. ......+.+|+.++++++|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3578999999999999999999975 34 68999999642 234567889999999998766 89999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEe------------
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL------------ 421 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll------------ 421 (609)
...++||||+. +++.+.+.... ...+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 95 GHMCIAFELLG-KNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CeEEEEEeccC-CChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 99999999995 55555655422 23489999999999999999999999 99999999999999
Q ss_pred -------CCCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc
Q 007290 422 -------DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494 (609)
Q Consensus 422 -------~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~ 494 (609)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999864432 2345689999999999999999999999999999999999999975432
Q ss_pred ccccchhHHHHHHHHhhhc---------cch--------------------hhccc-cccCCCCHHHHHHHHHHHHhccC
Q 007290 495 EEEDDVLLLDHVKKLEREK---------RLD--------------------AIVDR-NLNKNYNIQEVETMIQVALLCTQ 544 (609)
Q Consensus 495 ~~~~~~~~~~~~~~~~~~~---------~~~--------------------~~~~~-~l~~~~~~~~~~~l~~l~~~cl~ 544 (609)
.. ....+....... ... ....+ ..........+..+.+++.+||+
T Consensus 245 ~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 245 RE-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp HH-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred HH-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 11 111111110000 000 00000 00001133456789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007290 545 ASPEDRPAMSEVVR 558 (609)
Q Consensus 545 ~dP~~RPs~~evl~ 558 (609)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.83 Aligned_cols=267 Identities=21% Similarity=0.241 Sum_probs=199.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC------CCc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT------PTE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 355 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||+++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999974 6899999998765555556789999999999999999999998755 667
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCc---EEEccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFE---AVVGDF 432 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 432 (609)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999986432 23488889999999999999999999 9999999999999997664 999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH-HHHHHHhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL-DHVKKLER 511 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~ 511 (609)
|++....... ......||+.|+|||.+.+..++.++||||||+++|+|+||..||.............. ........
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9998764332 23345789999999999999999999999999999999999999964321100000000 00000000
Q ss_pred hccchhh--cccc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 007290 512 EKRLDAI--VDRN--LNKNYNIQEVETMIQVALLCTQASPEDRPAMSE 555 (609)
Q Consensus 512 ~~~~~~~--~~~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 555 (609)
....... .... .........+..+.+++.+||+.||++|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 0000 112234557789999999999999999999866
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.89 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=186.9
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 360 (609)
...+|.+.+.||+|+||+||.....+|+.||||++.... ...+.+|+++++.+ +||||+++++++.+....++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 455788899999999999765555679999999986422 22356899999998 7999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEcccccc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA 435 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl~ 435 (609)
||+. |+|.+++..... ......+..++.|++.||+|||++ +|+||||||+||+++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9997 599998876432 234445678999999999999999 9999999999999953 346889999999
Q ss_pred eeeccCCC--ceeecccccccccCccccc---CCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHH
Q 007290 436 KLVDVRKT--NVTTQVRGTMGHIAPEYLS---TGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 436 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
+....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHHH
Confidence 87653321 2234467999999999997 4567889999999999999999 89898532211 01111
Q ss_pred hhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....... . ..........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCcc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1000000 0 0112344567889999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=344.37 Aligned_cols=239 Identities=20% Similarity=0.306 Sum_probs=193.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC--CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc-----
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA--DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE----- 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 355 (609)
.++|++.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999975 6899999998765444556778899999999999999999999977655
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++++|.+.+.. .+++..++.++.||+.||.|||++ +|+||||||+||+++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887643 389999999999999999999999 99999999999999986 8999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
+..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 876432 345699999999998765 489999999999999999999887632211000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHhc
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-MSEVVRMLEG 562 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~ 562 (609)
........+..+.+++.+||+.||++||+ ++++.+.|.+
T Consensus 286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001123367899999999999999995 5556665554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.22 Aligned_cols=230 Identities=12% Similarity=0.033 Sum_probs=183.3
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
..++|++.+.||+|+||.||+|++. +|+.||||++..... ....+.+.+|+..+.+++||||+++++++...+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3467999999999999999999976 589999999975433 2234788999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++++|.++++.. .......+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999998541 24446788999999999999999 99999999999999999999997443
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
|++ .++.++|||||||++|||+||+.||........... ....
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~ 217 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERD 217 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHH
Confidence 333 368899999999999999999999985443211000 0000
Q ss_pred cccccc--CCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 519 VDRNLN--KNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 519 ~~~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...... .......+..+.+++.+||+.||++| |+.|+++.|+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 000000 00112234678999999999999999 999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=317.20 Aligned_cols=243 Identities=14% Similarity=0.084 Sum_probs=181.3
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccC-CCccee---------EeE-
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVH-RNLLRL---------IGF- 349 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l---------~~~- 349 (609)
..|...++||+|+||+||+|.+. +|+.||||++..... ....+.+.+|+.+++.+.| +|.... ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45777889999999999999964 799999999873332 2236789999999999887 322111 111
Q ss_pred -----------EeC-----CCcceEEeecccCchhhhhhhhc---CCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 007290 350 -----------CTT-----PTERLLVYPFMQNLSVAYRLREI---KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKII 410 (609)
Q Consensus 350 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 410 (609)
+.. ....+++|++ .+++|.++++.. ......+++..++.++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 1223555554 467899888532 23345588889999999999999999999 999
Q ss_pred ecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccc----------cCCCCCcchhhHHHHHHHH
Q 007290 411 HRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL----------STGKSSERTDVFGYGIMLL 480 (609)
Q Consensus 411 H~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~ll~ 480 (609)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865432 344567 999999999 5556889999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 481 ELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 481 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
||+||+.||........ ...++... ...+..+.+++.+||+.||++||++.++++
T Consensus 309 elltg~~Pf~~~~~~~~-----------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG-----------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC-----------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh-----------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975432211 11111110 112367899999999999999999988864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=294.89 Aligned_cols=226 Identities=21% Similarity=0.277 Sum_probs=178.2
Q ss_pred cCCCcc-CcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHH-HhccCCCcceeEeEEeC----CCcc
Q 007290 284 DNFSEK-NVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMI-SVAVHRNLLRLIGFCTT----PTER 356 (609)
Q Consensus 284 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 356 (609)
++|.+. +.||+|+||.||+|.+. +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 556666 78999999999999974 789999999863 34677888887 56689999999999866 5678
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEcccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDFG 433 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 433 (609)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999998743 23589999999999999999999999 9999999999999998 7899999999
Q ss_pred cceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
++.... +..++.++|||||||++|||+||+.||......... ..
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~~ 209 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PG 209 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------CC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------HH
Confidence 987542 234678999999999999999999999643221100 00
Q ss_pred cchhhccccccCCCC----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 RLDAIVDRNLNKNYN----IQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
....+..... ... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000 011 123568999999999999999999999996
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.82 Aligned_cols=243 Identities=15% Similarity=0.117 Sum_probs=184.7
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-------CCchHHHHHHHHHHHHhcc---------CCCcce
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-------SPGGDAAFQREVEMISVAV---------HRNLLR 345 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------h~niv~ 345 (609)
..++|++.+.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356788999999999999999998 68999999997542 2233478899999998886 677766
Q ss_pred eEeEE-----------------e-------------CCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHH
Q 007290 346 LIGFC-----------------T-------------TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395 (609)
Q Consensus 346 l~~~~-----------------~-------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 395 (609)
+.+.+ . .....++||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 66653 2 26788999999999977666643 2378999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCcEEeCCCC--------------------cEEEcccccceeeccCCCceeeccccccc
Q 007290 396 RGLEYLH-EHCNPKIIHRDVKAANVLLDEDF--------------------EAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454 (609)
Q Consensus 396 ~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~ 454 (609)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 89 999999999999999887 8999999999876532 2369999
Q ss_pred ccCcccccCCCCCcchhhHHHHHH-HHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh-hccccccCCCCHHHH
Q 007290 455 HIAPEYLSTGKSSERTDVFGYGIM-LLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA-IVDRNLNKNYNIQEV 532 (609)
Q Consensus 455 y~aPE~~~~~~~~~~~Dv~slG~l-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~ 532 (609)
|+|||++.+.. +.++||||+|++ .+++++|..||... .|....... .... ..............+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----------LWLHYLTDK-MLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----------HHHHHHHHH-HHHTCCCSSCCCSHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----------hhhhHHHHh-hhhhhccCcccchhhhhhcC
Confidence 99999998665 899999998777 78888899887310 111111000 0000 001111111234677
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHH
Q 007290 533 ETMIQVALLCTQASPEDRPAMSEVV 557 (609)
Q Consensus 533 ~~l~~l~~~cl~~dP~~RPs~~evl 557 (609)
.++.+++.+||+.| |+.|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 89999999999866 888888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-29 Score=274.01 Aligned_cols=186 Identities=14% Similarity=0.046 Sum_probs=130.0
Q ss_pred cccccCCceEEEEE-eCCCcEEEEEEeccCCC---------CchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFES---------PGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 291 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
..+.|++|.+..++ .-.|+.||||.+..... ....++|.+|+++|+++ .|+||+++++++.++...|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34556666666555 23589999999864321 12245789999999999 699999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||++|++|.+.+....+ ++. .+|+.||+.||+|+|++ |||||||||+|||+++++.+||+|||+++...
T Consensus 321 MEyv~G~~L~d~i~~~~~----l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE----IDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTCC----CCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCCC----CCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999986432 444 35899999999999999 99999999999999999999999999998765
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 488 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p 488 (609)
... ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 23445679999999999965 567789999999998887665544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=238.23 Aligned_cols=174 Identities=29% Similarity=0.545 Sum_probs=159.9
Q ss_pred ccCchhHHHHHHHHHhCCCCCCCcCCCCCCCCCCCC--cceeEEcCC---CCeEEEEecCCCccc--ccCccccCCCCCC
Q 007290 21 ALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCT--WSNVICDNS---NNVASVTLSSMNFSG--TLSPRIGVLRTLS 93 (609)
Q Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~ 93 (609)
.|.+.|.+||++||+++.+|. .+.+|.. +.+||. |.||+|+.. ++|+.|+|++|+++| .+|..|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 367789999999999998876 7889976 458998 999999864 699999999999999 9999999999999
Q ss_pred EEEccC-CCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCC
Q 007290 94 TLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 172 (609)
Q Consensus 94 ~L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 172 (609)
+|+|++ |++++.+|..|+++++|++|+|++|+|++.+|..|+++++|++|+|++|++++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccc----CCcccCCCCCCC
Q 007290 173 NLSGQIPVHLFQ----IPKYNFTGNNLN 196 (609)
Q Consensus 173 ~l~~~ip~~l~~----l~~l~~~~n~~~ 196 (609)
+++|.+|..+.+ |+.|++++|...
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeee
Confidence 999999987764 556888888653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=250.76 Aligned_cols=187 Identities=14% Similarity=0.188 Sum_probs=145.8
Q ss_pred CCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCc-------hHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPG-------GDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.+...+.||+|+||+||+|.. .++.+++|+........ ..+.+.+|++++++++||||+++..++...+..+
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 334467899999999999965 57889999875422111 1345789999999999999996666666777889
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++.
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999875 457899999999999999 9999999999999999 999999999998
Q ss_pred eccCCCce------eecccccccccCcccccC--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 007290 438 VDVRKTNV------TTQVRGTMGHIAPEYLST--GKSSERTDVFGYGIMLLELVTGQRAI 489 (609)
Q Consensus 438 ~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~ll~elltg~~p~ 489 (609)
........ .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 75432211 235679999999999976 56788899999999988888877665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-24 Score=244.76 Aligned_cols=172 Identities=24% Similarity=0.295 Sum_probs=153.1
Q ss_pred hccCchhHHHHHHHHHhCCCCCCCcCCCCCCC----CCC--CCc------------ceeEEcCCCCeEEEEecCCCcccc
Q 007290 20 LALSDYQGDALFALRTSLRVPNNQLRDWNQNQ----VNP--CTW------------SNVICDNSNNVASVTLSSMNFSGT 81 (609)
Q Consensus 20 ~~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~l~~L~L~~n~l~~~ 81 (609)
++....|..||++||+++.+| +|+.++ .+| |+| .||+|+..++|+.|+|++|++.|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 344556899999999999877 776543 356 999 999999888999999999999999
Q ss_pred cCccccCCCCCCEEEc-cCCCcCCC-------------------------------------------------------
Q 007290 82 LSPRIGVLRTLSTLTL-KGNGITGE------------------------------------------------------- 105 (609)
Q Consensus 82 ~~~~~~~l~~L~~L~l-~~N~l~~~------------------------------------------------------- 105 (609)
+|+.|++|++|+.|+| ++|.++|.
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 77766554
Q ss_pred ---------------------CCccccccccccccccccccccc-----------------cCCcccc--Ccccchhhhc
Q 007290 106 ---------------------IPEELGNLSSLTSLDLDNNRLVG-----------------KIPPSLG--NLKKLQFLTL 145 (609)
Q Consensus 106 ---------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~l 145 (609)
+|..|++|++|++|+|++|+|+| .+|..++ +|++|+.|+|
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 88899999999999999999998 4999988 9999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCc-ccc-cCCcccc----------cCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNN-LSG-QIPVHLF----------QIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~ip~~l~----------~l~~l~~~~n~~~ 196 (609)
++|++.+.+|..+.++++|+.|+|++|+ ++| .+|..+. +|..|++++|...
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 9999999999999999999999999998 998 8886554 6778899999876
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.9e-24 Score=241.84 Aligned_cols=176 Identities=26% Similarity=0.350 Sum_probs=115.1
Q ss_pred HhhhccCchhHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCcceeEEcCCCCeEEEEecCCCcccc---cCc---------
Q 007290 17 LHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT---LSP--------- 84 (609)
Q Consensus 17 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~---~~~--------- 84 (609)
++++++.+.|.+||++||+++.+|. .+.+|.. +.+||.|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~ 80 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence 3444556779999999999999888 8999974 4589999999999 68999999999999987 554
Q ss_pred --------------cccCCCCCCEEEccCCCcCCCCCc--cccccccccccccccccccccCCccc-cCcccchhhhccc
Q 007290 85 --------------RIGVLRTLSTLTLKGNGITGEIPE--ELGNLSSLTSLDLDNNRLVGKIPPSL-GNLKKLQFLTLSQ 147 (609)
Q Consensus 85 --------------~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~ 147 (609)
.|+++++|++|+|++|.++|.+|. .+++|++|++|+|++|.+++.+|..+ .++++|++|+|++
T Consensus 81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 455556666666666666666665 56666666666666666665555544 5556666666666
Q ss_pred CcCCCCcCCC---cCcccccccccCCCCcccccCC-cccccCCcccCCCCCC
Q 007290 148 NNFSGTIPDS---LTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 148 N~l~~~~p~~---~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~ 195 (609)
|++++..|.. +.++++|++|++++|.+++.+| ..+.+|+.|++++|..
T Consensus 161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l 212 (768)
T 3rgz_A 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNF 212 (768)
T ss_dssp SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCC
T ss_pred CccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcC
Confidence 6655544433 4444455555555555444443 2334444555555544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-23 Score=207.48 Aligned_cols=153 Identities=13% Similarity=0.035 Sum_probs=122.3
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCC-----------------chHHHHHHHHHHHHhcc
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-----------------GGDAAFQREVEMISVAV 339 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~ 339 (609)
..+......|.+.+.||+|+||.||+|.+.+|+.||||.++..... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 4445556667788999999999999999977999999998642211 13456889999999998
Q ss_pred CCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007290 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419 (609)
Q Consensus 340 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 419 (609)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||++ +|+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 4 556555433 56799999999999988 421 12346999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCCceeecccccccccCccccc
Q 007290 420 LLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 462 (609)
Q Consensus 420 ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 462 (609)
+++ ++.+||+|||+++. +..|+|||.+.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999973 44578899874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-23 Score=234.82 Aligned_cols=172 Identities=24% Similarity=0.285 Sum_probs=154.6
Q ss_pred CchhHHHHHHHHHhCCCCCCC--------cCCCCCCCCCCCCc---ceeEEcCCCCeEEEEecCCCcccccCccccCCCC
Q 007290 23 SDYQGDALFALRTSLRVPNNQ--------LRDWNQNQVNPCTW---SNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRT 91 (609)
Q Consensus 23 ~~~~~~~l~~~~~~~~~~~~~--------l~~w~~~~~~~c~w---~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~ 91 (609)
...|..||.+|+.+++.++.. ..+|+.+ .+||.| .||+|+..++|+.|+|++|+++|.+|+.|++|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 345888999999999876543 2369864 689999 9999988889999999999999999999999999
Q ss_pred CCEEEccCC-----------------------------------------------------------------------
Q 007290 92 LSTLTLKGN----------------------------------------------------------------------- 100 (609)
Q Consensus 92 L~~L~l~~N----------------------------------------------------------------------- 100 (609)
|++|+|++|
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 999999998
Q ss_pred -------CcCCCCCcccccccccccccccccccccc-----------------CCcccc--CcccchhhhcccCcCCCCc
Q 007290 101 -------GITGEIPEELGNLSSLTSLDLDNNRLVGK-----------------IPPSLG--NLKKLQFLTLSQNNFSGTI 154 (609)
Q Consensus 101 -------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~ 154 (609)
+|+| +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 4445 899999999999999999999986 999999 9999999999999999999
Q ss_pred CCCcCcccccccccCCCCc-ccc-cCCccc---------ccCCcccCCCCCCC
Q 007290 155 PDSLTTLSSLISIQLDSNN-LSG-QIPVHL---------FQIPKYNFTGNNLN 196 (609)
Q Consensus 155 p~~~~~l~~L~~L~l~~N~-l~~-~ip~~l---------~~l~~l~~~~n~~~ 196 (609)
|..+.++++|++|+|++|+ ++| .+|..+ .+|+.|++++|...
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 9999999999999999999 998 899765 56788999999876
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=187.49 Aligned_cols=148 Identities=22% Similarity=0.275 Sum_probs=132.2
Q ss_pred CCCCCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccc
Q 007290 52 VNPCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121 (609)
Q Consensus 52 ~~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 121 (609)
...|+|++|.|++. .+++.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 16 ~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 95 (229)
T 3e6j_A 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95 (229)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEEC
Confidence 47899999999862 37999999999999999999999999999999999998655667899999999999
Q ss_pred ccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCC
Q 007290 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCG 198 (609)
Q Consensus 122 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~ 198 (609)
++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+ .+|..|++.+|++.|.
T Consensus 96 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 96 GTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999776777899999999999999999 899999999999999999999995544444 5677789999999998
Q ss_pred CC
Q 007290 199 KT 200 (609)
Q Consensus 199 ~~ 200 (609)
|+
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 75
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.7e-22 Score=202.61 Aligned_cols=171 Identities=19% Similarity=0.309 Sum_probs=148.9
Q ss_pred cCchhHHHHHHHHHhCC-CCCCCcCCCC---CCCCCCCCcceeEEcC---------CCCeEEEEecCCCcccccCccccC
Q 007290 22 LSDYQGDALFALRTSLR-VPNNQLRDWN---QNQVNPCTWSNVICDN---------SNNVASVTLSSMNFSGTLSPRIGV 88 (609)
Q Consensus 22 ~~~~~~~~l~~~~~~~~-~~~~~l~~w~---~~~~~~c~w~gv~c~~---------~~~l~~L~L~~n~l~~~~~~~~~~ 88 (609)
....+.+||++||+++. ++.+.+.+|. ....++|.|.|++|+. ..+|+.|+|++|+++ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 44568899999999984 6767778895 4456899999999962 368999999999999 78888999
Q ss_pred CCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCc--------
Q 007290 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT-------- 160 (609)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-------- 160 (609)
+++|++|+|++|.|+ .+|..++++++|++|+|++|+|+ .+|..|+++++|+.|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 999999999999999 89999999999999999999999 88999999999999999999998899988765
Q ss_pred -ccccccccCCCCcccccCCcccc---cCCcccCCCCCCC
Q 007290 161 -LSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 161 -l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~ 196 (609)
+++|++|+|++|.++ .+|..+. +|..|++++|...
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC
Confidence 899999999999998 7887655 5566788888765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=7e-21 Score=183.35 Aligned_cols=148 Identities=22% Similarity=0.279 Sum_probs=132.1
Q ss_pred CCCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 54 PCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 54 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
.|.|..|.|.+. .+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 368999999752 3799999999999988888999999999999999999988899999999999999999
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCCCCC
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c~~~ 200 (609)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+. +|..|++++|++.|+|.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 999965556689999999999999999988889999999999999999999976665454 56778999999999876
Q ss_pred C
Q 007290 201 L 201 (609)
Q Consensus 201 ~ 201 (609)
+
T Consensus 170 l 170 (220)
T 2v9t_B 170 L 170 (220)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=181.29 Aligned_cols=147 Identities=24% Similarity=0.290 Sum_probs=131.4
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCcccccC-ccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTLS-PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
|.|..+.|++. ..++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 67888888752 267899999999998865 4589999999999999999987777999999999999999
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCCCCC
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c~~~ 200 (609)
|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..|..|. +|..|++++|++.|+|+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999987777899999999999999999988899999999999999999999987787665 56678999999999876
Q ss_pred C
Q 007290 201 L 201 (609)
Q Consensus 201 ~ 201 (609)
+
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=173.56 Aligned_cols=148 Identities=21% Similarity=0.260 Sum_probs=128.8
Q ss_pred CCCCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccc
Q 007290 53 NPCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 122 (609)
Q Consensus 53 ~~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~ 122 (609)
..|.|.+|.|+.. .+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 5 C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 5 CSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence 3478999999763 369999999999998777788999999999999999996666678999999999999
Q ss_pred cccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCCCC
Q 007290 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGK 199 (609)
Q Consensus 123 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c~~ 199 (609)
+|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..+.. +.+|..|++++|++.|.+
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 99999766667899999999999999999766667899999999999999999655543 456777899999998876
Q ss_pred C
Q 007290 200 T 200 (609)
Q Consensus 200 ~ 200 (609)
+
T Consensus 165 ~ 165 (208)
T 2o6s_A 165 P 165 (208)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-20 Score=212.16 Aligned_cols=125 Identities=36% Similarity=0.637 Sum_probs=115.3
Q ss_pred ccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccc
Q 007290 86 IGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 165 (609)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 165 (609)
++.+++|+.|||++|+|+|.+|..|+++++|+.|+|++|+|+|.+|..|++|++|+.|||++|+++|.+|..+..+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 34467899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccCCc--ccccCCcccCCCCCCCCCCCCCCCCCCCCCC
Q 007290 166 SIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKTLPHSCESSSND 211 (609)
Q Consensus 166 ~L~l~~N~l~~~ip~--~l~~l~~l~~~~n~~~c~~~~~~~c~~~~~~ 211 (609)
+|+|++|+|+|.||. .+..++.+.+.||++.||.+.+ +|.....+
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~~~~ 754 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPSNAD 754 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSCC--
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCCccC
Confidence 999999999999995 5778889999999999999987 89765433
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.8e-19 Score=174.22 Aligned_cols=138 Identities=17% Similarity=0.155 Sum_probs=107.0
Q ss_pred CCCccCcccccCCceEEEEEe-CCCcE--EEEEEeccCCCC-----------------------chHHHHHHHHHHHHhc
Q 007290 285 NFSEKNVLGQGGFGKVYRGVL-ADGTK--VAVKRLTDFESP-----------------------GGDAAFQREVEMISVA 338 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l 338 (609)
-|++.+.||+|+||.||+|.+ .+|+. ||||+++..... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 68999 999987532111 0113678999999999
Q ss_pred cCCCc--ceeEeEEeCCCcceEEeecccC-c----hhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 007290 339 VHRNL--LRLIGFCTTPTERLLVYPFMQN-L----SVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH-EHCNPKII 410 (609)
Q Consensus 339 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iv 410 (609)
.|+++ ..++++ ...++||||+.+ | +|.+.... .+......++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 98864 334432 367899999942 4 55554322 234467789999999999999 88 999
Q ss_pred ecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 411 HRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 411 H~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||||+|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 8999999999754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=166.26 Aligned_cols=125 Identities=27% Similarity=0.364 Sum_probs=90.6
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCcccccCc-cccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSP-RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
|.|+.+.|++. .+++.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777642 2677777777777765553 367777777777777777766677777777777777777
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
|+|++..|..|.++++|+.|+|++|+|++..|..+..+++|++|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77776666667777777777777777776667777777777777777777776655
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.74 E-value=6.8e-19 Score=179.04 Aligned_cols=136 Identities=30% Similarity=0.482 Sum_probs=104.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|.+++.+|..+..++ |++|+|++|++++.+|..|.++++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 455666666666666666666655 66666666666666666677777777777777777765554 7778888888888
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCc--ccccCCcccCCCCCCCCCCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKTLPHSC 205 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~--~l~~l~~l~~~~n~~~c~~~~~~~c 205 (609)
+|+|++.+|..+..+++|+.|+|++|+++|.+|. .+.+|..+++.+|++.|+.|.+ .|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 8888888899999999999999999999999995 4667788899999999998765 45
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.74 E-value=6.3e-18 Score=166.15 Aligned_cols=133 Identities=20% Similarity=0.265 Sum_probs=90.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 36677777777777666666677777777777777777555566677777777777777777555555677777777777
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCG 198 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~ 198 (609)
++|+|++..|..+..+++|+.|+|++|+|++..|..+ .+|..|++++|++.|.
T Consensus 139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 7777775445567777777777777777775444333 3555667777777765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-18 Score=160.32 Aligned_cols=130 Identities=22% Similarity=0.348 Sum_probs=115.8
Q ss_pred EEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCc-cccccccccccccccccccccCCccccCcccchhhhccc
Q 007290 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPE-ELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147 (609)
Q Consensus 69 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 147 (609)
+.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 68999999997 67776643 999999999999966654 489999999999999999998899999999999999999
Q ss_pred CcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCCCCCC
Q 007290 148 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 148 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c~~~~ 201 (609)
|+|++..|..+..+++|++|+|++|+|++.+|..+. +|..|++++|++.|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 999987788899999999999999999988887665 566789999999998763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-19 Score=193.90 Aligned_cols=142 Identities=23% Similarity=0.273 Sum_probs=116.0
Q ss_pred CCCcceeEEcCCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccc-ccccccccccccccccccCCc
Q 007290 54 PCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG-NLSSLTSLDLDNNRLVGKIPP 132 (609)
Q Consensus 54 ~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~ 132 (609)
-|.+.++.|....+++.|+|++|.+++..|..++.+++|+.|+|++|.|++.+|..+. ++++|+.|+|++|.|++. |
T Consensus 108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~- 185 (487)
T 3oja_A 108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K- 185 (487)
T ss_dssp SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-
T ss_pred CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-
Confidence 3566777777777889999999999988888888899999999999999988888776 789999999999999865 3
Q ss_pred cccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCC
Q 007290 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGK 199 (609)
Q Consensus 133 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~ 199 (609)
.+..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.|++ +|..+ .+|..|++++|++.|++
T Consensus 186 ~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 186 GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcc
Confidence 34468899999999999984 55568888999999999999984 77655 45667888999988764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.8e-18 Score=165.89 Aligned_cols=130 Identities=20% Similarity=0.251 Sum_probs=115.4
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 68999999999999888899999999999999999998888889999999999999999997777889999999999999
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLN 196 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~ 196 (609)
+|+|++..+..+..+++|+.|+|++|+|++..|..+ .+|..|++++|...
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 999996666668899999999999999996555444 56777889999765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=165.40 Aligned_cols=136 Identities=20% Similarity=0.206 Sum_probs=112.0
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|+++++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 34788888888888877777788889999999999999877777788889999999999998876666788889999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~ 200 (609)
|++|++++..|..+..+++|+.|+|++|++++..|..+ .+|..|++++|++.|.++
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99999987666677888999999999999987666444 466678889998888765
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=156.95 Aligned_cols=129 Identities=29% Similarity=0.381 Sum_probs=111.8
Q ss_pred EEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccC
Q 007290 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148 (609)
Q Consensus 69 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 148 (609)
+.+++++|+++ .+|..+ .++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 35777888888 667655 368999999999999 88999999999999999999999877788999999999999999
Q ss_pred cCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCCC
Q 007290 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 149 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~~ 201 (609)
+|++..|..|..+++|+.|+|++|+|++..+..| .+|..|++++|++.|+|.+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 9997777889999999999999999995444334 5677789999999998764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-17 Score=166.23 Aligned_cols=133 Identities=27% Similarity=0.295 Sum_probs=107.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.++ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 46788888888887 66777888888888888888888666677888888999999999888666667888888999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c~~~ 200 (609)
++|+|++..+..+..+++|+.|+|++|+|+ .+|..+. +++.+++.+|+|.|+|.
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 999988544455678888999999999988 6776554 45667889999998775
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=154.66 Aligned_cols=126 Identities=23% Similarity=0.307 Sum_probs=71.1
Q ss_pred CCCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 54 PCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 54 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
.|.|.+|.|++. .+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..+.++++|++|+|++
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 367888888642 2455566666665554444555556666666666666544444455556666666666
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
|+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 66654444445555666666666666653333334555556666666666554443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.8e-17 Score=161.64 Aligned_cols=135 Identities=20% Similarity=0.251 Sum_probs=95.5
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 164 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL 164 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence 35677777777777655566677777777777777777666666777777777777777777555555777778888888
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~ 200 (609)
++|++++..+..+..+++|+.|+|++|++++..+..+ .+|..|++++|++.|+|.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 8888775555567778888888888888874333333 456667788888888764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=5e-17 Score=161.54 Aligned_cols=129 Identities=22% Similarity=0.226 Sum_probs=80.9
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|+.|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 45666666666665555566667777777777777764444445666777777777777765445556667777777777
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNL 195 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~ 195 (609)
+|++++..|..+..+++|++|+|++|.+++..+.. +.+|..|++++|..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 77776555555666677777777777766433322 23455566666654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.8e-17 Score=182.27 Aligned_cols=145 Identities=18% Similarity=0.199 Sum_probs=124.4
Q ss_pred CCCCc----ceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccc
Q 007290 53 NPCTW----SNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTS 118 (609)
Q Consensus 53 ~~c~w----~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 118 (609)
+||.+ ..|.|.+. .+++.|+|++|+|+++.+.+|.++++|++|+|++|+|++..|..|.+|++|++
T Consensus 25 ~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~ 104 (635)
T 4g8a_A 25 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 104 (635)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCE
Confidence 45643 35778642 37999999999999888889999999999999999999777788999999999
Q ss_pred cccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccc-cCCccc---ccCCcccCCCCC
Q 007290 119 LDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHL---FQIPKYNFTGNN 194 (609)
Q Consensus 119 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~ip~~l---~~l~~l~~~~n~ 194 (609)
|+|++|+|++..+..|.+|++|++|+|++|+|++..+..|+++++|++|+|++|.+++ .+|..+ .+|..|++++|.
T Consensus 105 L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 105 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp EECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred EEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 9999999997666789999999999999999997666789999999999999999975 356554 466778899998
Q ss_pred CCC
Q 007290 195 LNC 197 (609)
Q Consensus 195 ~~c 197 (609)
...
T Consensus 185 l~~ 187 (635)
T 4g8a_A 185 IQS 187 (635)
T ss_dssp CCE
T ss_pred ccc
Confidence 754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=172.05 Aligned_cols=109 Identities=24% Similarity=0.223 Sum_probs=60.2
Q ss_pred CeEEEEecCCCcccccCcccc-CCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 355566666666655555554 5555666666666555444445555555555555555555444444555555555555
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCccc
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 555555444455555555555555555555
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.2e-17 Score=163.38 Aligned_cols=134 Identities=22% Similarity=0.260 Sum_probs=82.8
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|.+++..|..+.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 185 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence 56666666666665555556666666666666666664444456666666666666666664444456666666666666
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c~~~ 200 (609)
+|++++..|..+..+++|+.|++++|++++..|.. +.+|..|++++|++.|+|+
T Consensus 186 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 66666555666666666777777777766433332 3345556677777776654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=6.3e-17 Score=173.28 Aligned_cols=135 Identities=26% Similarity=0.258 Sum_probs=124.7
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++.+..|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999888999999999999999999999888899999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c~~~ 200 (609)
++|++++..|..+..+++|++|+|++|++++..+.. +.+|..|++++|++.|.|+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999888999999999999999999999644433 4567789999999999887
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.8e-17 Score=166.99 Aligned_cols=143 Identities=13% Similarity=0.129 Sum_probs=101.0
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCC-------------CchHHHHH--------HHHHHHHh
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFES-------------PGGDAAFQ--------REVEMISV 337 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~--------~E~~~l~~ 337 (609)
+..-..-|++.+.||+|+||.||+|...+|+.||||+++.... ........ +|...+.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3333334899999999999999999998999999998753110 01112222 34445555
Q ss_pred ccCCCcc--eeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 007290 338 AVHRNLL--RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVK 415 (609)
Q Consensus 338 l~h~niv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 415 (609)
+.+.++. ..+++ ...++||||++|++|..+... .....++.|++.+|.+||+. ||||||||
T Consensus 170 L~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLK 232 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFN 232 (397)
T ss_dssp HHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred HHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence 5433321 11221 235799999999888654321 12356789999999999999 99999999
Q ss_pred CCcEEeCCCC----------cEEEcccccceee
Q 007290 416 AANVLLDEDF----------EAVVGDFGLAKLV 438 (609)
Q Consensus 416 p~NIll~~~~----------~~kl~DfGl~~~~ 438 (609)
|.|||+++++ .+.|+||+-+-..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998776 3899999987643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.1e-17 Score=167.51 Aligned_cols=136 Identities=28% Similarity=0.311 Sum_probs=118.5
Q ss_pred CCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhh
Q 007290 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143 (609)
Q Consensus 64 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 143 (609)
+..+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 34589999999999998888899999999999999999997777789999999999999999998888999999999999
Q ss_pred hcccCcCCCCcCCCc----CcccccccccCCCCcccccCC-cccccC-----CcccCCCCCCCCCCCC
Q 007290 144 TLSQNNFSGTIPDSL----TTLSSLISIQLDSNNLSGQIP-VHLFQI-----PKYNFTGNNLNCGKTL 201 (609)
Q Consensus 144 ~l~~N~l~~~~p~~~----~~l~~L~~L~l~~N~l~~~ip-~~l~~l-----~~l~~~~n~~~c~~~~ 201 (609)
+|++|+|+ .+|..+ ..+++|+.|+|++|+|++ +| ..+..+ ..|++.+|++.|+|.+
T Consensus 142 ~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 142 YLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp ECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCCC-CCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred ECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCCc-cCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 99999999 566544 579999999999999995 55 555555 4589999999998853
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-17 Score=164.03 Aligned_cols=134 Identities=25% Similarity=0.322 Sum_probs=77.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCC-CCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
+++.|+|++|.+.+..+..+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 45555555555555555555556666666666666554 35555566666666666666666555555666666666666
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc----cCCcccCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF----QIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~----~l~~l~~~~n~~~c~~~ 200 (609)
++|++++..+..+..+++|+.|+|++|++++..|..+. +|..|++++|++.|+|.
T Consensus 207 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 66666644344555566666666666666655554433 33445666666666543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=150.76 Aligned_cols=123 Identities=25% Similarity=0.384 Sum_probs=110.2
Q ss_pred CCCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 54 PCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 54 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
.|.|..|.|++. .+++.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 356778888652 37999999999999 7788999999999999999999988888899999999999999
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCccccc
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 177 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 177 (609)
|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|++...
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999988888999999999999999999955555789999999999999999753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=177.99 Aligned_cols=136 Identities=24% Similarity=0.316 Sum_probs=124.1
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcC-CCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.++++.|.+.+..+..+..+++|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..|..|++|++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 47889999999999999999999999999999999854 45788999999999999999999998999999999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc----cCCcccCCCCCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF----QIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~----~l~~l~~~~n~~~c~~~~ 201 (609)
|++|+|++..|..+..+++|++|+|++|+|++..|..+. +|..|++++|+|.|+|..
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 999999987788899999999999999999988887764 566799999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=162.45 Aligned_cols=131 Identities=22% Similarity=0.307 Sum_probs=116.0
Q ss_pred CCCeEEEEecCCCcccccCccccC---------CCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCcccc
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGV---------LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLG 135 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~---------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 135 (609)
..+++.|+|++|++.+.+|..++. +++|++|+|++|+|+ .+|..++++++|++|+|++|+++ .+|..++
T Consensus 149 l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~ 226 (328)
T 4fcg_A 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226 (328)
T ss_dssp CTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGG
T ss_pred CcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhc
Confidence 358999999999999899988765 999999999999999 88999999999999999999999 5777899
Q ss_pred CcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCC
Q 007290 136 NLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 197 (609)
Q Consensus 136 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c 197 (609)
++++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+. +|..|++++|+...
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 999999999999999999999999999999999999999999997665 45567888887654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=145.06 Aligned_cols=130 Identities=21% Similarity=0.268 Sum_probs=111.2
Q ss_pred eEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhccc
Q 007290 68 VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147 (609)
Q Consensus 68 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 147 (609)
.+.+++++|+++ .+|..+ .++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467999999998 456544 47999999999999977777789999999999999999976667789999999999999
Q ss_pred CcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCCCCC
Q 007290 148 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 148 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c~~~ 200 (609)
|+|++..+..+..+++|++|+|++|++++..+.. +.+|..|++++|++.|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999766677899999999999999999544433 3567778999999998765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-16 Score=151.48 Aligned_cols=115 Identities=19% Similarity=0.228 Sum_probs=108.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 45899999999999988888999999999999999999988888899999999999999999988899999999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99999998889999999999999999999997665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-16 Score=145.43 Aligned_cols=128 Identities=23% Similarity=0.277 Sum_probs=111.8
Q ss_pred CCeEEEEecCCCcc-cccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 47999999999998 88898999999999999999999965 7799999999999999999987888888999999999
Q ss_pred cccCcCCCCcC--CCcCcccccccccCCCCcccccCC---cc---cccCCcccCCCCCCC
Q 007290 145 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIP---VH---LFQIPKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ip---~~---l~~l~~l~~~~n~~~ 196 (609)
|++|+|++ +| ..+..+++|+.|++++|++++..+ .. +.+|..|++.+|...
T Consensus 102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 99999995 44 789999999999999999995444 24 446666788887654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=6.5e-16 Score=153.93 Aligned_cols=130 Identities=18% Similarity=0.180 Sum_probs=113.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|+.|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 68999999999998888789999999999999999997777789999999999999999998778889999999999999
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccc-cCCcccc---cCCcccCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~ip~~l~---~l~~l~~~~n~~~ 196 (609)
+|++++..+..+..+++|++|++++|.+++ .+|..+. +|..|++++|...
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence 999997666689999999999999999986 3676654 5566788888653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-16 Score=176.17 Aligned_cols=135 Identities=23% Similarity=0.251 Sum_probs=114.8
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCC-CCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|.+.+..|..+..+++|++|+|++|++++ .+|..+.++++|+.|+|++|++++..|..|+++++|+.|+
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 478888888888888888888888888888888888887 3788888899999999999999888888889999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCccccc----CCcccCCCCCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ----IPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~----l~~l~~~~n~~~c~~~~ 201 (609)
|++|++++.+|..+..+++|+.|+|++|+++ .+|..+.. |..|++++|++.|+|+.
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999999877888889999999999999998 67765543 56688999999998764
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.7e-16 Score=172.14 Aligned_cols=132 Identities=17% Similarity=0.171 Sum_probs=114.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 47899999999999888889999999999999999999877888999999999999999999877899999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccc-cCCcccc---cCCcccCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHLF---QIPKYNFTGNNLNC 197 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~ip~~l~---~l~~l~~~~n~~~c 197 (609)
++|++++..|..+.++++|++|++++|.+++ .+|..+. +|+.|++++|....
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 9999996666889999999999999999985 6787665 55567788886543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.4e-16 Score=167.59 Aligned_cols=145 Identities=26% Similarity=0.324 Sum_probs=125.2
Q ss_pred CCCCcce--eEEcCC---------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCC-Cccccccccccccc
Q 007290 53 NPCTWSN--VICDNS---------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLD 120 (609)
Q Consensus 53 ~~c~w~g--v~c~~~---------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ 120 (609)
..|.|.+ |.|++. .+++.|+|++|++++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3465555 778753 47999999999999998999999999999999999998776 56799999999999
Q ss_pred cccccccccCCccccCcccchhhhcccCcCCCCcCCC--cCcccccccccCCCCcccccCCcc----cccCCcccCCCCC
Q 007290 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDS--LTTLSSLISIQLDSNNLSGQIPVH----LFQIPKYNFTGNN 194 (609)
Q Consensus 121 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~ip~~----l~~l~~l~~~~n~ 194 (609)
|++|++++..|..|+++++|++|+|++|++++.+|.. +..+++|++|+|++|++++..|.. +.+|..|++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999866554 899999999999999999877864 3566778899997
Q ss_pred CCC
Q 007290 195 LNC 197 (609)
Q Consensus 195 ~~c 197 (609)
...
T Consensus 166 l~~ 168 (455)
T 3v47_A 166 VKS 168 (455)
T ss_dssp BSC
T ss_pred ccc
Confidence 643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.9e-16 Score=173.79 Aligned_cols=142 Identities=22% Similarity=0.323 Sum_probs=122.9
Q ss_pred CCCcceeEEcCC------------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccc
Q 007290 54 PCTWSNVICDNS------------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121 (609)
Q Consensus 54 ~c~w~gv~c~~~------------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 121 (609)
.|.|.|+ |+.. .+++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4889998 8742 37999999999999998999999999999999999999888889999999999999
Q ss_pred ccccccccCCccccCcccchhhhcccCcCCC-CcCCCcCcccccccccCCCCcccccCC-cccc---cCCcccCCCCCCC
Q 007290 122 DNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIP-VHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 122 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~---~l~~l~~~~n~~~ 196 (609)
++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|++|++++|.+.+.+| ..+. +|..|++++|...
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999997777779999999999999999986 367889999999999999999666776 3444 5556788888754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-16 Score=142.50 Aligned_cols=121 Identities=22% Similarity=0.290 Sum_probs=106.3
Q ss_pred CCeEEEEecCCCcc-cccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|++++|+++ +.+|..+..+++|++|+|++|+|++. ..++++++|++|+|++|+|++.+|..++++++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 47999999999999 88999999999999999999999965 6799999999999999999987898889999999999
Q ss_pred cccCcCCCC-cCCCcCcccccccccCCCCcccccCC---cccccCCcc
Q 007290 145 LSQNNFSGT-IPDSLTTLSSLISIQLDSNNLSGQIP---VHLFQIPKY 188 (609)
Q Consensus 145 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~ip---~~l~~l~~l 188 (609)
|++|++++. .|..+..+++|++|++++|++++..+ ..+..+++|
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L 142 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQL 142 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCc
Confidence 999999953 34889999999999999999996544 345544443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.1e-16 Score=151.91 Aligned_cols=129 Identities=18% Similarity=0.209 Sum_probs=111.5
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCC-cCCCCCcccccccccccccccc-ccccccCCccccCcccchhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG-ITGEIPEELGNLSSLTSLDLDN-NRLVGKIPPSLGNLKKLQFL 143 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 143 (609)
.+++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999998888899999999999999997 8866666899999999999999 99997667789999999999
Q ss_pred hcccCcCCCCcCCCcCcccccc---cccCCCC-cccccCCcccc---cCC-cccCCCCCCC
Q 007290 144 TLSQNNFSGTIPDSLTTLSSLI---SIQLDSN-NLSGQIPVHLF---QIP-KYNFTGNNLN 196 (609)
Q Consensus 144 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~ip~~l~---~l~-~l~~~~n~~~ 196 (609)
+|++|++++ +|. +..+++|+ .|++++| .+++..+..|. +|. .|++++|...
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 999999994 887 88888888 9999999 99854444454 555 7888888764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=8.7e-16 Score=170.26 Aligned_cols=153 Identities=16% Similarity=0.183 Sum_probs=111.0
Q ss_pred CcCCCCCCCCCCCC----cceeEEcC-----------------CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCC
Q 007290 43 QLRDWNQNQVNPCT----WSNVICDN-----------------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG 101 (609)
Q Consensus 43 ~l~~w~~~~~~~c~----w~gv~c~~-----------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 101 (609)
.+++|.+. ++||. |.++.|+. ..+++.|++++|.+....+..+..+++|++|+|++|.
T Consensus 8 ~l~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~ 86 (597)
T 3oja_B 8 NVKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86 (597)
T ss_dssp ---CCCSE-ECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred cccCCCCC-CcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence 46788764 45553 77666641 1356778888888876666667778888888888888
Q ss_pred cCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc
Q 007290 102 ITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH 181 (609)
Q Consensus 102 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~ 181 (609)
|++..|..|+++++|++|+|++|.|++..|..|+++++|+.|+|++|.|++..+..|.++++|++|+|++|.+++..|..
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 88777778888888888888888888777777888888888888888888444444678888888888888888766655
Q ss_pred cc---cCCcccCCCCCCC
Q 007290 182 LF---QIPKYNFTGNNLN 196 (609)
Q Consensus 182 l~---~l~~l~~~~n~~~ 196 (609)
+. +|..|++++|...
T Consensus 167 ~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp TTTCTTCCEEECTTSCCS
T ss_pred hhcCCcCcEEECcCCCCC
Confidence 54 4555777777654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-16 Score=175.84 Aligned_cols=170 Identities=21% Similarity=0.235 Sum_probs=89.5
Q ss_pred cCchhHHHHHHHHHhCCCCC-CCcCCCCCCCCCCCCcceeEEcCCCCeEE------------------EEecCCCccc--
Q 007290 22 LSDYQGDALFALRTSLRVPN-NQLRDWNQNQVNPCTWSNVICDNSNNVAS------------------VTLSSMNFSG-- 80 (609)
Q Consensus 22 ~~~~~~~~l~~~~~~~~~~~-~~l~~w~~~~~~~c~w~gv~c~~~~~l~~------------------L~L~~n~l~~-- 80 (609)
..+.+.++|+++..++..+. ..-..|......+++|.+++++.. +++. ++|+.|.|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTP-LTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCC-ccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 45567788999887775322 222356554555667877666542 2223 3333333332
Q ss_pred -------ccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCC
Q 007290 81 -------TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGT 153 (609)
Q Consensus 81 -------~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 153 (609)
..+..+..+++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+ .
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 22555667777777777777777 67766777777777777777777 67777777777777777777777 6
Q ss_pred cCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCC
Q 007290 154 IPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 154 ~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~ 196 (609)
+|..|..|++|++|+|++|.|+ .+|..|. +|..|++++|+..
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 7777777777777777777776 6775554 4445667777664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-16 Score=162.22 Aligned_cols=143 Identities=22% Similarity=0.320 Sum_probs=119.9
Q ss_pred CCCCCcceeEEcCC------------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccc
Q 007290 52 VNPCTWSNVICDNS------------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSL 119 (609)
Q Consensus 52 ~~~c~w~gv~c~~~------------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 119 (609)
..+|.|.|+ |+.. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 366889888 7632 379999999999998777799999999999999999998888889999999999
Q ss_pred ccccccccccCCccccCcccchhhhcccCcCCCCcCC--CcCcccccccccCCCCc-ccccCCcccc---cCCcccCCCC
Q 007290 120 DLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNN-LSGQIPVHLF---QIPKYNFTGN 193 (609)
Q Consensus 120 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~ip~~l~---~l~~l~~~~n 193 (609)
+|++|+|++..+..|+++++|++|+|++|+++ .+|. .+..+++|++|++++|+ +++..|..+. +|..|++++|
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 99999999544445999999999999999999 5665 78899999999999995 6644455554 5566788888
Q ss_pred CCC
Q 007290 194 NLN 196 (609)
Q Consensus 194 ~~~ 196 (609)
...
T Consensus 185 ~l~ 187 (353)
T 2z80_A 185 DLQ 187 (353)
T ss_dssp TCC
T ss_pred CcC
Confidence 754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=9e-16 Score=163.67 Aligned_cols=134 Identities=27% Similarity=0.304 Sum_probs=107.3
Q ss_pred CCeEEEEecCCCcccccCc-------------------------cccCCCCCCEEEccCCCcCCCCCccccccccccccc
Q 007290 66 NNVASVTLSSMNFSGTLSP-------------------------RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~-------------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 120 (609)
.+++.|+|++|.+++..+. .|.++++|++|+|++|+|+ .+|. +..+++|+.|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEE
Confidence 3677777777766644432 4556677777777777777 5664 77888889999
Q ss_pred cccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCC
Q 007290 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNC 197 (609)
Q Consensus 121 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c 197 (609)
|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+.. +.+|..|++++|+|.|
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 9999999888889999999999999999999877888999999999999999999555544 4567778999999999
Q ss_pred CCCC
Q 007290 198 GKTL 201 (609)
Q Consensus 198 ~~~~ 201 (609)
+|..
T Consensus 294 dC~l 297 (440)
T 3zyj_A 294 NCDI 297 (440)
T ss_dssp SSTT
T ss_pred CCCc
Confidence 9864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=143.18 Aligned_cols=127 Identities=21% Similarity=0.196 Sum_probs=108.3
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 35899999999999977777789999999999999999976667789999999999999999977677789999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~ 195 (609)
|++|++++..+..+..+++|+.|++++|++.+..| ++..|++..|..
T Consensus 131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~----~l~~L~~~~n~~ 177 (208)
T 2o6s_A 131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP----GIRYLSEWINKH 177 (208)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT----TTHHHHHHHHHC
T ss_pred CCCCccceeCHHHhccCCCccEEEecCCCeecCCC----CHHHHHHHHHhC
Confidence 99999996666678999999999999999987655 344444444443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=149.47 Aligned_cols=131 Identities=22% Similarity=0.274 Sum_probs=115.1
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++. +.+..+++|++|+|++|+|++..|..+.++++|++|+|++|++++..|..|+++++|+.|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 35899999999999973 4789999999999999999987777889999999999999999977777899999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNC 197 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c 197 (609)
|++|++++..|..+..+++|+.|++++|++++..|.. +.+|..|++++|+...
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 9999999777777899999999999999999766644 4567778899997653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=151.62 Aligned_cols=131 Identities=21% Similarity=0.238 Sum_probs=112.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccc-ccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR-LVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|++++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+ ++...|..|.++++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 478999999999998877889999999999999999997778889999999999999997 7766688899999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~ 196 (609)
|++|++++..|..+..+++|++|++++|++++..+..+ .+|..|++++|...
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence 99999997778888999999999999999985554434 46677888888654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=145.99 Aligned_cols=112 Identities=23% Similarity=0.283 Sum_probs=103.9
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 35899999999999999999999999999999999999955556689999999999999999988899999999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccc
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG 176 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 176 (609)
|++|+|++..+..+..+++|+.|+|++|++..
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99999997777789999999999999999974
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.4e-15 Score=162.75 Aligned_cols=134 Identities=23% Similarity=0.258 Sum_probs=109.6
Q ss_pred CCeEEEEecCCCcccccCc-------------------------cccCCCCCCEEEccCCCcCCCCCccccccccccccc
Q 007290 66 NNVASVTLSSMNFSGTLSP-------------------------RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLD 120 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~-------------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 120 (609)
.+++.|+|++|.+++..+. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~ 224 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEE
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEE
Confidence 4788888888877754443 3556677777777778877 455 377888999999
Q ss_pred cccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCCC
Q 007290 121 LDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLNC 197 (609)
Q Consensus 121 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~c 197 (609)
|++|+|++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+.. +.+|..|++++|++.|
T Consensus 225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 9999999888889999999999999999999888889999999999999999999554444 4567778999999999
Q ss_pred CCCC
Q 007290 198 GKTL 201 (609)
Q Consensus 198 ~~~~ 201 (609)
+|..
T Consensus 305 dC~~ 308 (452)
T 3zyi_A 305 DCDI 308 (452)
T ss_dssp STTT
T ss_pred CCCc
Confidence 9874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.7e-16 Score=181.42 Aligned_cols=135 Identities=21% Similarity=0.232 Sum_probs=115.8
Q ss_pred CCCeEEEEecCCCcccccCc-cccCCCCCCEEEccCCCcC-----CCCCccccccccccccccccccccccCCccccCcc
Q 007290 65 SNNVASVTLSSMNFSGTLSP-RIGVLRTLSTLTLKGNGIT-----GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLK 138 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 138 (609)
..+++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|.+++
T Consensus 425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence 34788888888888865443 4566888999999999887 44556788999999999999999988888899999
Q ss_pred cchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCCCCCCCC
Q 007290 139 KLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 139 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~~c~~~~ 201 (609)
+|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..+.++..|++++|++.|+|+.
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 999999999999965555555 8999999999999999999999999999999999998864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.7e-15 Score=150.84 Aligned_cols=135 Identities=20% Similarity=0.259 Sum_probs=92.5
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccccc-CCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK-IPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++. +|..|+++++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEE
T ss_pred cCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEE
Confidence 4677777777777777667777777777777777777765555677777777777777777642 567777777777777
Q ss_pred cccCcCCCCcCCCcC---------------------------cccccccccCCCCcccccCCcc---cccCCcccCCCCC
Q 007290 145 LSQNNFSGTIPDSLT---------------------------TLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNN 194 (609)
Q Consensus 145 l~~N~l~~~~p~~~~---------------------------~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~ 194 (609)
|++|++++..+..+. ...+|+.|+|++|++++..+.. +.+|..|++++|+
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 235 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSC
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCc
Confidence 777777643333332 2336777888888887443333 3456667888888
Q ss_pred CCCCCC
Q 007290 195 LNCGKT 200 (609)
Q Consensus 195 ~~c~~~ 200 (609)
+.|+|+
T Consensus 236 ~~c~c~ 241 (276)
T 2z62_A 236 WDCSCP 241 (276)
T ss_dssp BCCCTT
T ss_pred ccccCC
Confidence 888775
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2e-15 Score=162.73 Aligned_cols=141 Identities=20% Similarity=0.213 Sum_probs=121.6
Q ss_pred CcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccc
Q 007290 56 TWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125 (609)
Q Consensus 56 ~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 125 (609)
.|..|.|.+. .+++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3677888642 378999999999998888999999999999999999998889999999999999999999
Q ss_pred ccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCC
Q 007290 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 126 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~ 196 (609)
|++..+..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..|..|. +|..|++++|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 9965556789999999999999999988888999999999999999999977675554 5666788888654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=2.4e-15 Score=167.10 Aligned_cols=140 Identities=21% Similarity=0.208 Sum_probs=122.8
Q ss_pred cceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccc
Q 007290 57 WSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 126 (609)
Q Consensus 57 w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 126 (609)
+..+.|.+. .+++.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 456778642 3799999999999999899999999999999999999988899999999999999999999
Q ss_pred cccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccc-cCCcc--cccCCcccCCCCCCC
Q 007290 127 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVH--LFQIPKYNFTGNNLN 196 (609)
Q Consensus 127 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~ip~~--l~~l~~l~~~~n~~~ 196 (609)
++..|..|+++++|++|+|++|++++..|..+.++++|++|++++|.+++ .+|.. +.+|..|++++|...
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 166 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence 98889999999999999999999997668889999999999999999986 33532 457778888888765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.7e-15 Score=174.62 Aligned_cols=141 Identities=21% Similarity=0.240 Sum_probs=108.2
Q ss_pred CCcceeEEcCCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCC-CccccccccccccccccccccccCCcc
Q 007290 55 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDNNRLVGKIPPS 133 (609)
Q Consensus 55 c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~ 133 (609)
|+|+.|.+ ...+++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.+|++|++|+|++|+|++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 56777776 5568888999988888888888888888888888888666666 677888888888888888888777888
Q ss_pred ccCcccchhhhcccCcCCCCcCCC--cCcccccccccCCCCcccccCC-cc---cccCCcccCCCCCCC
Q 007290 134 LGNLKKLQFLTLSQNNFSGTIPDS--LTTLSSLISIQLDSNNLSGQIP-VH---LFQIPKYNFTGNNLN 196 (609)
Q Consensus 134 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~ip-~~---l~~l~~l~~~~n~~~ 196 (609)
|++|++|++|+|++|.+++.+|.. +.++++|++|+|++|.+++..| .. +.+|+.|++++|...
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 888888888888888888766654 7788888888888888876544 23 345555667777653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=3.3e-15 Score=137.36 Aligned_cols=108 Identities=29% Similarity=0.312 Sum_probs=95.2
Q ss_pred EEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccC
Q 007290 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148 (609)
Q Consensus 69 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 148 (609)
+.|++++|+++ .+|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 46788888998 467666 489999999999999888999999999999999999999776777899999999999999
Q ss_pred cCCCCcCCCcCcccccccccCCCCcccccCC
Q 007290 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 149 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
+|++..|..+..+++|+.|+|++|+++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9996666679999999999999999985443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-15 Score=138.89 Aligned_cols=110 Identities=22% Similarity=0.251 Sum_probs=96.2
Q ss_pred EEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccC
Q 007290 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148 (609)
Q Consensus 69 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 148 (609)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67899999997 6777664 89999999999999888999999999999999999999765566899999999999999
Q ss_pred cCCCCcCCCcCcccccccccCCCCcccccCCccc
Q 007290 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL 182 (609)
Q Consensus 149 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l 182 (609)
+|++..+..+..+++|+.|+|++|++. ..|..+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc-cccccH
Confidence 999655556999999999999999998 455433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.6e-15 Score=168.49 Aligned_cols=134 Identities=24% Similarity=0.279 Sum_probs=101.3
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCC---CCccccccccccccccccccccccCCccccCcccchh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE---IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 142 (609)
.+++.|+|++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|++|+|++|++++..|..|+++++|+.
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 504 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCE
Confidence 3577777777777777777777777777777777777752 2345777778888888888887777777888888888
Q ss_pred hhcccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCC
Q 007290 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 143 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~ 200 (609)
|+|++|++++..|..+.++++| +|++++|++++.+|..+ .++..|++++|++.|+|+
T Consensus 505 L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp EECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred EECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 8888888887777788888888 88888888886666543 466778889999888775
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5e-15 Score=148.61 Aligned_cols=106 Identities=25% Similarity=0.290 Sum_probs=53.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|.+++..+..|..+++|++|+|++|+|++ +|.. +.+++|++|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 45556666666655555555555555555555555552 2221 44445555555555554 444444445555555555
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCccc
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
+|+|++..|..|..+++|+.|+|++|+|+
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence 55554333344444555555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.2e-15 Score=159.97 Aligned_cols=141 Identities=23% Similarity=0.251 Sum_probs=122.0
Q ss_pred cceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccc
Q 007290 57 WSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRL 126 (609)
Q Consensus 57 w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 126 (609)
|..|.|.+. .+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 678888753 3799999999999999999999999999999999999988889999999999999999999
Q ss_pred cccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCc----ccccCCcccCCCCCCCC
Q 007290 127 VGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 127 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~----~l~~l~~l~~~~n~~~c 197 (609)
++..+..|.++++|++|+|++|+|++..+..+.++++|+.|++++|+..+.+|. .+.+|..|++++|....
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 976677799999999999999999955556889999999999999555546664 34567778899887653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.5e-15 Score=165.53 Aligned_cols=136 Identities=22% Similarity=0.276 Sum_probs=105.9
Q ss_pred CCeEEEEecCCCcccccC-ccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccc-ccCCccccCcccchhh
Q 007290 66 NNVASVTLSSMNFSGTLS-PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-GKIPPSLGNLKKLQFL 143 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L 143 (609)
.+++.|+|++|.+.+..| ..+..+++|++|+|++|.+++.+|..+.++++|+.|+|++|+++ +.+|..|+.+++|+.|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 356666666666665544 45677788888888888888777878888888888888888887 5788888888888888
Q ss_pred hcccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCCC
Q 007290 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 144 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~~ 201 (609)
+|++|++++..|..+..+++|+.|++++|++++..|..+ .+|..|++++|++.|.|+.
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 888888887778888888888888888888887666554 4556678888888887653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.5e-15 Score=157.53 Aligned_cols=151 Identities=17% Similarity=0.225 Sum_probs=117.4
Q ss_pred cCCCCCCCCCCCC----cceeEEcC-----------------CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCc
Q 007290 44 LRDWNQNQVNPCT----WSNVICDN-----------------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGI 102 (609)
Q Consensus 44 l~~w~~~~~~~c~----w~gv~c~~-----------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 102 (609)
+++|... .+||. |.++.|+. ..+++.|++++|.+....+..+..+++|++|+|++|+|
T Consensus 3 ~~~~~~~-~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i 81 (390)
T 3o6n_A 3 VKPRQPE-YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81 (390)
T ss_dssp ----CCE-ECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCC
T ss_pred cCCCCCc-cceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcc
Confidence 5678754 46664 55555541 14688899999999866556678899999999999999
Q ss_pred CCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCC-cCcccccccccCCCCcccccCCcc
Q 007290 103 TGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDS-LTTLSSLISIQLDSNNLSGQIPVH 181 (609)
Q Consensus 103 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~ip~~ 181 (609)
++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|.. +.++++|++|++++|.+++..|..
T Consensus 82 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 160 (390)
T 3o6n_A 82 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160 (390)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred cccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhh
Confidence 9777778999999999999999999877888999999999999999999 55554 688999999999999999766655
Q ss_pred c---ccCCcccCCCCCCC
Q 007290 182 L---FQIPKYNFTGNNLN 196 (609)
Q Consensus 182 l---~~l~~l~~~~n~~~ 196 (609)
+ .+|..|++++|...
T Consensus 161 ~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 161 FQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp TSSCTTCCEEECCSSCCS
T ss_pred ccCCCCCCEEECCCCcCC
Confidence 5 45666888888754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=3.5e-15 Score=168.13 Aligned_cols=136 Identities=21% Similarity=0.243 Sum_probs=112.3
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCC----C----ccccccccccccccccccccccCCccccCc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI----P----EELGNLSSLTSLDLDNNRLVGKIPPSLGNL 137 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~----p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 137 (609)
.+++.|+|++|++++..+..|..+++|++|+|++|+|++.. | ..+.++++|+.|+|++|+|+...+..|.++
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 46888899999888777777888999999999999888532 1 237888999999999999994334468999
Q ss_pred ccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCc----ccccCCcccCCCCCCCCCCCC
Q 007290 138 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 138 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~----~l~~l~~l~~~~n~~~c~~~~ 201 (609)
++|+.|+|++|+|++..+..+..+++|+.|+|++|+|++..|. .+.++..+++++|+|.|+|+.
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 9999999999999965556678999999999999999976665 456788999999999999863
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.7e-15 Score=142.81 Aligned_cols=114 Identities=24% Similarity=0.234 Sum_probs=104.2
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 358999999999998777777899999999999999999777777899999999999999999 8999999999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
|++|+|++..+..+..+++|+.|+|++|++++..+
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 99999996666779999999999999999997654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=153.47 Aligned_cols=139 Identities=23% Similarity=0.298 Sum_probs=100.5
Q ss_pred cceeEEcCCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccc-ccccccccccccccccccCCcccc
Q 007290 57 WSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG-NLSSLTSLDLDNNRLVGKIPPSLG 135 (609)
Q Consensus 57 w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~ 135 (609)
..++.+....+++.|+|++|.+++..+..+..+++|++|+|++|+|++..|..+. .+++|++|+|++|+|++. | ...
T Consensus 111 l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~ 188 (317)
T 3o53_A 111 ISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQV 188 (317)
T ss_dssp CSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCC
T ss_pred cCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-ccc
Confidence 3444444455677777888888777777777788888888888888866666653 678888888888888743 3 233
Q ss_pred CcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCC
Q 007290 136 NLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGK 199 (609)
Q Consensus 136 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~ 199 (609)
.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+ .+|..|++++|++.|++
T Consensus 189 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp CCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred ccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 4788888888888888 56666778888888888888888 567554 45666778888887653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.2e-15 Score=164.54 Aligned_cols=134 Identities=23% Similarity=0.344 Sum_probs=87.2
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCC--CCCccccccccccccccccccccccCCcc-ccCc----
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG--EIPEELGNLSSLTSLDLDNNRLVGKIPPS-LGNL---- 137 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l---- 137 (609)
..+++.|+|++|.+++.+|..+.++++|++|+|++|+|++ .+|..+.++++|++|+|++|++++.+|.. +..+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 3456666666666666666666666666666666666664 22344566666666666666666534432 3333
Q ss_pred ------------------ccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc-c---ccCCcccCCCCCC
Q 007290 138 ------------------KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-L---FQIPKYNFTGNNL 195 (609)
Q Consensus 138 ------------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~-l---~~l~~l~~~~n~~ 195 (609)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. + .+|..|++++|++
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 509 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCB
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCc
Confidence 46666777777776 67777778888888888888888 56654 4 3555677888888
Q ss_pred CCCCC
Q 007290 196 NCGKT 200 (609)
Q Consensus 196 ~c~~~ 200 (609)
.|+|+
T Consensus 510 ~c~c~ 514 (562)
T 3a79_B 510 DCTCP 514 (562)
T ss_dssp CCCHH
T ss_pred CCCcc
Confidence 88765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.3e-15 Score=163.99 Aligned_cols=134 Identities=23% Similarity=0.330 Sum_probs=83.5
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCC--CCCccccccccccccccccccccccCCcc-ccCcc---
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITG--EIPEELGNLSSLTSLDLDNNRLVGKIPPS-LGNLK--- 138 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~--- 138 (609)
..+++.|+|++|.+++.+|..++.+++|++|+|++|+|++ .+|..+.++++|++|+|++|++++.+|.. +..++
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3467777777777777667777777777777777777765 44555666667777777777766545443 44444
Q ss_pred -------------------cchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcc-c---ccCCcccCCCCCC
Q 007290 139 -------------------KLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH-L---FQIPKYNFTGNNL 195 (609)
Q Consensus 139 -------------------~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~-l---~~l~~l~~~~n~~ 195 (609)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ .+|.. + .+|..|++++|++
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCB
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCC
Confidence 4555555555555 55555556666666666666666 45543 3 3445566677777
Q ss_pred CCCCC
Q 007290 196 NCGKT 200 (609)
Q Consensus 196 ~c~~~ 200 (609)
.|+|+
T Consensus 481 ~c~c~ 485 (520)
T 2z7x_B 481 DCSCP 485 (520)
T ss_dssp CCCHH
T ss_pred cccCC
Confidence 66654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.1e-15 Score=141.10 Aligned_cols=123 Identities=22% Similarity=0.305 Sum_probs=64.0
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|.++ .++.+..+++|++|+|++|++++..|..++++++|++|+|++|++++..|..|+++++|+.|+|+
T Consensus 67 ~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 4555555555443 12245555555555555555555455555555555555555555555455555555555555555
Q ss_pred cCc-CCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCC
Q 007290 147 QNN-FSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNN 194 (609)
Q Consensus 147 ~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~ 194 (609)
+|+ ++ .+| .+..+++|+.|++++|++++ +| ..+.+|..|++++|+
T Consensus 145 ~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 145 YNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp SCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred CCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCcc
Confidence 555 33 444 45555555555555555553 32 223344445555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=3.7e-15 Score=163.21 Aligned_cols=108 Identities=24% Similarity=0.361 Sum_probs=100.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .|++|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999996 565 999999999999999999 899999999999999999999996 77 89999999999999
Q ss_pred cCcCCCCc-CCCcCcccccccccCCCCcccccCC
Q 007290 147 QNNFSGTI-PDSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 147 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
+|+|++.. |..+..+++|+.|+|++|+|++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99999776 9999999999999999999997655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=150.27 Aligned_cols=139 Identities=22% Similarity=0.314 Sum_probs=120.4
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 124 (609)
|.|+.+.|... .+++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 68999999752 37899999999999888889999999999999999999888999999999999999999
Q ss_pred cccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCccc--ccCCcccc--cCCcccCCCCCCC
Q 007290 125 RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS--GQIPVHLF--QIPKYNFTGNNLN 196 (609)
Q Consensus 125 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~ip~~l~--~l~~l~~~~n~~~ 196 (609)
+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|++++|.++ +..|..+. +|..|++++|...
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCS
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCC
Confidence 999 7787766 89999999999999655566899999999999999996 35565554 6777888888764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.3e-15 Score=166.87 Aligned_cols=130 Identities=18% Similarity=0.242 Sum_probs=115.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++ ++.+..+++|+.|+|++|.|++.+|..|+++++|+.|+|++|+|++ +|..+..+++|+.|+|
T Consensus 232 ~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L 308 (597)
T 3oja_B 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 308 (597)
T ss_dssp SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEEC
Confidence 468888888888886 3678899999999999999998889999999999999999999995 6878888999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGK 199 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~~c~~ 199 (609)
++|.++ .+|..+..+++|+.|+|++|.+++..+..+.+|..|++++|++.|.+
T Consensus 309 s~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHH
T ss_pred CCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCChh
Confidence 999999 78888899999999999999999665577888999999999999865
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-15 Score=171.77 Aligned_cols=129 Identities=29% Similarity=0.413 Sum_probs=117.0
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 357999999999999 78888889999999999999999 99999999999999999999999 8899999999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCC----cccCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIP----KYNFTGNNLNC 197 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~----~l~~~~n~~~c 197 (609)
|++|.|+ .+|..|..|++|+.|+|++|+|+|.+|..+..+. .+++.+|....
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 9999998 8999999999999999999999999998775432 25677777653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.5e-15 Score=148.97 Aligned_cols=130 Identities=21% Similarity=0.263 Sum_probs=77.8
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCC-ccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP-EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|.+. .+|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus 78 ~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 45666777776666 345556666666666666666664333 3566666666666666666655566666666666666
Q ss_pred cccCcCCC-CcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCC
Q 007290 145 LSQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~ 196 (609)
|++|.+++ .+|..+..+++|++|+|++|++++..|..+. +|..|++++|...
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 212 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence 66666654 3556666666666666666666654454433 3444556666543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=8.4e-15 Score=165.03 Aligned_cols=131 Identities=19% Similarity=0.217 Sum_probs=100.1
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 36888888888888777777888888888888888888777777888888888888888888544446888888888888
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~ 196 (609)
++|++++..|..+.++++|++|+|++|.+++..|..+ .+|..|++++|...
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence 8888876666778888888888888888887666544 35555677777543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-15 Score=169.83 Aligned_cols=130 Identities=19% Similarity=0.343 Sum_probs=118.8
Q ss_pred CCCeEEEEecCCCcccc-----------------cCcccc--CCCCCCEEEccCCCcCCCCCcccccccccccccccccc
Q 007290 65 SNNVASVTLSSMNFSGT-----------------LSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 125 (609)
..+++.|+|++|.++|. +|..++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 45899999999999986 999999 99999999999999999999999999999999999998
Q ss_pred -ccc-cCCccccCc------ccchhhhcccCcCCCCcCC--CcCcccccccccCCCCcccccCCccc---ccCCcccCCC
Q 007290 126 -LVG-KIPPSLGNL------KKLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTG 192 (609)
Q Consensus 126 -l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~ 192 (609)
++| .+|..++++ ++|+.|+|++|+++ .+|. .+.++++|+.|++++|+++|.+| .+ .+|..|++++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 998 899998887 99999999999999 8999 89999999999999999999999 55 4666788888
Q ss_pred CCCC
Q 007290 193 NNLN 196 (609)
Q Consensus 193 n~~~ 196 (609)
|...
T Consensus 363 N~l~ 366 (636)
T 4eco_A 363 NQIT 366 (636)
T ss_dssp SEEE
T ss_pred Cccc
Confidence 8755
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-14 Score=155.44 Aligned_cols=141 Identities=24% Similarity=0.228 Sum_probs=119.3
Q ss_pred CcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccc
Q 007290 56 TWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125 (609)
Q Consensus 56 ~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 125 (609)
.|..|.|.+. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 3678888752 368999999999999888999999999999999999997777889999999999999999
Q ss_pred ccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCc----ccccCCcccCCCCCCC
Q 007290 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYNFTGNNLN 196 (609)
Q Consensus 126 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~----~l~~l~~l~~~~n~~~ 196 (609)
|++..+..|.++++|+.|+|++|+|++..+..+.++++|+.|+|++|+..+.+|. .+.+|..|++++|...
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 9966666899999999999999999965566888999999999998655546664 3456677888888765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=5.5e-15 Score=136.70 Aligned_cols=124 Identities=19% Similarity=0.242 Sum_probs=103.6
Q ss_pred CCeEEEEecCCCcccccCccccCCC-CCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLR-TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|+++. +|. +..+. +|++|+|++|.|++. ..+.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 489999999999995 454 55555 999999999999964 5799999999999999999965445569999999999
Q ss_pred cccCcCCCCcCC--CcCcccccccccCCCCcccccCCcc----cc---cCCcccCCCCCC
Q 007290 145 LSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVH----LF---QIPKYNFTGNNL 195 (609)
Q Consensus 145 l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~ip~~----l~---~l~~l~~~~n~~ 195 (609)
|++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +. +|..|++++|..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 9999997 7776 8899999999999999998 67763 44 555667777754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-14 Score=133.93 Aligned_cols=107 Identities=18% Similarity=0.280 Sum_probs=93.8
Q ss_pred CCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCC
Q 007290 91 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170 (609)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 170 (609)
..+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3579999999999 7887774 899999999999998889999999999999999999996666678999999999999
Q ss_pred CCcccccCCccc---ccCCcccCCCCCCCCCCC
Q 007290 171 SNNLSGQIPVHL---FQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 171 ~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~ 200 (609)
+|+|++..|..| .+|..|++++|++.|.|+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999996555444 566778999999999875
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-15 Score=153.52 Aligned_cols=132 Identities=18% Similarity=0.238 Sum_probs=106.7
Q ss_pred CCCeEEEEecCCCcccccCccc--cCCCCCCEEEccCCCcCCCCCcccccc-----ccccccccccccccccCCccccCc
Q 007290 65 SNNVASVTLSSMNFSGTLSPRI--GVLRTLSTLTLKGNGITGEIPEELGNL-----SSLTSLDLDNNRLVGKIPPSLGNL 137 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l 137 (609)
..+++.|+|++|++++.+|..+ ..+++|++|+|++|+|++. |..++.+ ++|++|+|++|+|++..|..|+++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 3578899999999998888876 8899999999999999966 8878877 899999999999997777889999
Q ss_pred ccchhhhcccCcCCCC--cCCCc--CcccccccccCCCCcccc--cCCc----ccccCCcccCCCCCCCC
Q 007290 138 KKLQFLTLSQNNFSGT--IPDSL--TTLSSLISIQLDSNNLSG--QIPV----HLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 138 ~~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~--~ip~----~l~~l~~l~~~~n~~~c 197 (609)
++|++|+|++|++.+. +|..+ ..+++|++|+|++|++++ .+|. .+.+|..|++++|....
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 242 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc
Confidence 9999999999998765 33344 788899999999999883 2332 23578888888887654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=151.49 Aligned_cols=131 Identities=24% Similarity=0.215 Sum_probs=117.7
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.+++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|+|+...+..|+++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 58999999999999888889999999999999999999888888999999999999999999444445799999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~~ 196 (609)
++|++++..|..+..+++|+.|++++|++++.-...+.++..|++++|...
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCS
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccc
Confidence 999999777888999999999999999999655567888888999988654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.53 E-value=5.8e-15 Score=139.21 Aligned_cols=126 Identities=23% Similarity=0.358 Sum_probs=111.0
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|+++ .+| .+..+++|++|+|++|.++ .+ ..+..+++|++|+|++|++++..|..|+.+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 48999999999999 566 6999999999999999877 44 47999999999999999999888999999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCc-ccccCC--cccccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNN-LSGQIP--VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~ip--~~l~~l~~l~~~~n~~~ 196 (609)
++|++++..|..+..+++|++|++++|. ++ .+| ..+.+|..|++++|+..
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCCC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCCc
Confidence 9999998788899999999999999998 55 677 23456777889988754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.2e-15 Score=158.29 Aligned_cols=134 Identities=19% Similarity=0.195 Sum_probs=101.7
Q ss_pred eEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhccc
Q 007290 68 VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147 (609)
Q Consensus 68 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 147 (609)
++.|+|++|.+.+.+|..+....+|+.|+|++|+|++..+..+.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence 33333433333333333333344566666666777743335688899999999999999987788899999999999999
Q ss_pred CcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCCC
Q 007290 148 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 148 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~~ 201 (609)
|++++..|..+..+++|+.|+|++|+|++..+..| .+|..|++++|++.|+|..
T Consensus 282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~ 338 (477)
T 2id5_A 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL 338 (477)
T ss_dssp SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence 99998889999999999999999999996444444 5677899999999998763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.1e-15 Score=149.05 Aligned_cols=131 Identities=20% Similarity=0.240 Sum_probs=110.2
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCC--C--CccccccccccccccccccccccCCc----cccC
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE--I--PEELGNLSSLTSLDLDNNRLVGKIPP----SLGN 136 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~ 136 (609)
..+++.|+|++|.+.+..+..|..+++|++|+|++|++.+. + +..++++++|++|+|++|+|+ .+|. .+++
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 45899999999999988889999999999999999998753 2 233478999999999999997 4444 3578
Q ss_pred cccchhhhcccCcCCCCcCCCcCcc---cccccccCCCCcccccCCccc-ccCCcccCCCCCCCC
Q 007290 137 LKKLQFLTLSQNNFSGTIPDSLTTL---SSLISIQLDSNNLSGQIPVHL-FQIPKYNFTGNNLNC 197 (609)
Q Consensus 137 l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~ip~~l-~~l~~l~~~~n~~~c 197 (609)
+++|++|+|++|+|++.+|..+..+ ++|++|+|++|+|+ .+|..+ .+|..|++++|+...
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR 286 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence 8999999999999998778888777 69999999999999 678654 588889999998753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2e-14 Score=158.32 Aligned_cols=131 Identities=18% Similarity=0.171 Sum_probs=102.1
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 36888888888888777778888888888888888888766777888888888888888888766778888888888888
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccc-cCCcccc---cCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSG-QIPVHLF---QIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~ip~~l~---~l~~l~~~~n~~~ 196 (609)
++|++++..+..++++++|++|++++|.+++ .+|..+. +|+.|++++|...
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 8888885444468888888888888888875 4676554 4555777777654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.9e-15 Score=160.97 Aligned_cols=136 Identities=25% Similarity=0.388 Sum_probs=113.8
Q ss_pred cCCCCCCCCCCC-----Cccee-EEcCCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccc
Q 007290 44 LRDWNQNQVNPC-----TWSNV-ICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLT 117 (609)
Q Consensus 44 l~~w~~~~~~~c-----~w~gv-~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 117 (609)
+.+|.. +.+|| .|.|+ .|.. ++++.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 456755 34778 69999 7874 489999999999997 77766 488999999999999 788 4578999
Q ss_pred ccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCCCC
Q 007290 118 SLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 118 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~~c 197 (609)
+|+|++|+|++ +|. |.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|..+.+|..|++++|....
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCCC
Confidence 99999999996 787 766 99999999999995 777 67899999999999985 88877888899999997654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.4e-15 Score=150.76 Aligned_cols=130 Identities=18% Similarity=0.236 Sum_probs=90.0
Q ss_pred CCeEEEEecCCCcccccCccccCC-----CCCCEEEccCCCcCCCCCcccccccccccccccccccccc--CCccc--cC
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVL-----RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK--IPPSL--GN 136 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~~ 136 (609)
.+++.|+|++|.+++. |..++.+ ++|++|+|++|+|++..|..|+++++|++|+|++|++.|. +|..+ ++
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4788888888888866 6777766 7888888888888876667788888888888888887654 23333 77
Q ss_pred cccchhhhcccCcCCC--CcC-CCcCcccccccccCCCCcccccCCc-c---cccCCcccCCCCCCC
Q 007290 137 LKKLQFLTLSQNNFSG--TIP-DSLTTLSSLISIQLDSNNLSGQIPV-H---LFQIPKYNFTGNNLN 196 (609)
Q Consensus 137 l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~ip~-~---l~~l~~l~~~~n~~~ 196 (609)
+++|+.|+|++|+|++ .++ ..+..+++|+.|+|++|++++.+|. . +.+|..|++++|...
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 7777777777777772 122 2234567777777777777765542 2 346666777777654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-14 Score=147.27 Aligned_cols=140 Identities=22% Similarity=0.320 Sum_probs=119.2
Q ss_pred CCCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 54 PCTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 54 ~c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
.|.|+.+.|.+. .+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 368999999752 3789999999999988888999999999999999999988899999999999999999
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccc--cCCccc---ccCCcccCCCCCCC
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSG--QIPVHL---FQIPKYNFTGNNLN 196 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~ip~~l---~~l~~l~~~~n~~~ 196 (609)
|+|+ .+|..+. ++|+.|++++|++++..+..+.++++|+.|++++|.++. ..|..+ .+|..|++++|...
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 9999 6777665 799999999999996666678899999999999999963 555554 45666778888754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-14 Score=146.00 Aligned_cols=129 Identities=29% Similarity=0.368 Sum_probs=97.3
Q ss_pred CCCeEEEEecCCCcc--cccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchh
Q 007290 65 SNNVASVTLSSMNFS--GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 142 (609)
..+++.|+|++|.+. +..+..+..+++|++|++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|+.
T Consensus 144 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 220 (330)
T 1xku_A 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAK 220 (330)
T ss_dssp CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred CccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 357888899888885 366778888888888888888888 5666554 77888888888888777777888888888
Q ss_pred hhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCC
Q 007290 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNC 197 (609)
Q Consensus 143 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c 197 (609)
|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+. +|..|++++|+...
T Consensus 221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred EECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence 888888887666667777888888888888887 6776554 45556777776643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.8e-14 Score=131.56 Aligned_cols=105 Identities=17% Similarity=0.270 Sum_probs=91.7
Q ss_pred CEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCC
Q 007290 93 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 172 (609)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 172 (609)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 78999999998 8888775 89999999999999888999999999999999999999655556789999999999999
Q ss_pred cccccCCccc---ccCCcccCCCCCCCCCCC
Q 007290 173 NLSGQIPVHL---FQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 173 ~l~~~ip~~l---~~l~~l~~~~n~~~c~~~ 200 (609)
+|++..+..| .+|..|++++|++.|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 9995444434 567778999999999764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.1e-14 Score=148.03 Aligned_cols=132 Identities=19% Similarity=0.173 Sum_probs=103.5
Q ss_pred CCcceeEEcCCCCeEEEEecCC-CcccccCccccCCCCCCEEEccC-CCcCCCCCccccccccccccccccccccccCCc
Q 007290 55 CTWSNVICDNSNNVASVTLSSM-NFSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132 (609)
Q Consensus 55 c~w~gv~c~~~~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 132 (609)
|.|.+|.|+ ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|.
T Consensus 8 C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 888777775 34 677 4777 99999999999996 999977778999999999999999999998899
Q ss_pred cccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC-ccccc---CCcccCCCCCCCCCCC
Q 007290 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQ---IPKYNFTGNNLNCGKT 200 (609)
Q Consensus 133 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~---l~~l~~~~n~~~c~~~ 200 (609)
.|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|+|...-. ..|.. .....+..+...|..+
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~ 145 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence 999999999999999999955555555555 9999999999984322 12221 2223344566666554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-14 Score=160.24 Aligned_cols=127 Identities=21% Similarity=0.199 Sum_probs=109.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57999999999999888889999999999999999999888888999999999999999999 67776 8999999999
Q ss_pred ccCcCCC-CcCCCcCcccccccccCCCCcccccCCcccccC--CcccCCCCCC
Q 007290 146 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNL 195 (609)
Q Consensus 146 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l--~~l~~~~n~~ 195 (609)
++|++++ .+|..+.++++|++|++++|++++.....+.++ +.|++++|..
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence 9999985 346789999999999999999986444555566 7788888865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.9e-15 Score=167.87 Aligned_cols=129 Identities=18% Similarity=0.290 Sum_probs=114.7
Q ss_pred CCCeEEEEecCCCccc-----------------ccCcccc--CCCCCCEEEccCCCcCCCCCcccccccccccccccccc
Q 007290 65 SNNVASVTLSSMNFSG-----------------TLSPRIG--VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR 125 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 125 (609)
..+++.|+|++|+|+| .+|..++ ++++|++|+|++|++.|.+|..|++|++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 4589999999999998 4899988 99999999999999999999999999999999999998
Q ss_pred -ccc-cCCccccCcc-------cchhhhcccCcCCCCcCC--CcCcccccccccCCCCcccccCCcccc---cCCcccCC
Q 007290 126 -LVG-KIPPSLGNLK-------KLQFLTLSQNNFSGTIPD--SLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFT 191 (609)
Q Consensus 126 -l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~ 191 (609)
|+| .+|..|++++ +|+.|+|++|+|+ .+|. .+.++++|+.|+|++|+++ .+| .+. +|..|+++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECc
Confidence 998 8898777776 9999999999999 8998 8999999999999999998 888 554 55667888
Q ss_pred CCCCC
Q 007290 192 GNNLN 196 (609)
Q Consensus 192 ~n~~~ 196 (609)
+|...
T Consensus 604 ~N~l~ 608 (876)
T 4ecn_A 604 YNQIE 608 (876)
T ss_dssp SSCCS
T ss_pred CCccc
Confidence 88765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.4e-14 Score=146.85 Aligned_cols=132 Identities=18% Similarity=0.175 Sum_probs=109.3
Q ss_pred CCCeEEEEecCCCcccccC----ccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccccc--C--CccccC
Q 007290 65 SNNVASVTLSSMNFSGTLS----PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK--I--PPSLGN 136 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~ 136 (609)
..+++.|+|++|.+++..+ ..+..+++|++|+|++|+|++..|..|+++++|++|+|++|++.+. + +..++.
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 3479999999999997655 4456799999999999999988888999999999999999998752 2 234578
Q ss_pred cccchhhhcccCcCCCCcCC----CcCcccccccccCCCCcccccCCccc------ccCCcccCCCCCCCC
Q 007290 137 LKKLQFLTLSQNNFSGTIPD----SLTTLSSLISIQLDSNNLSGQIPVHL------FQIPKYNFTGNNLNC 197 (609)
Q Consensus 137 l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~ip~~l------~~l~~l~~~~n~~~c 197 (609)
+++|++|+|++|+++ .+|. .+..+++|++|+|++|++++.+|..+ .+|..|++++|....
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~ 265 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ 265 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc
Confidence 999999999999998 4554 24678999999999999998877544 467788999998763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.8e-14 Score=132.03 Aligned_cols=112 Identities=22% Similarity=0.253 Sum_probs=100.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccC-CccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI-PPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|.+++. ..+..+++|++|+|++|+|++.+|..+.++++|++|+|++|+|++.. +..+..+++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 4899999999999976 78999999999999999999878988888999999999999999532 27899999999999
Q ss_pred cccCcCCCCcCC----CcCcccccccccCCCCcccccCCcc
Q 007290 145 LSQNNFSGTIPD----SLTTLSSLISIQLDSNNLSGQIPVH 181 (609)
Q Consensus 145 l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~ip~~ 181 (609)
|++|.+++ +|. .+..+++|++|++++|.+. .+|..
T Consensus 127 l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 127 LFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp CCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999994 555 7899999999999999998 67754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=9.6e-15 Score=159.11 Aligned_cols=127 Identities=23% Similarity=0.209 Sum_probs=112.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 58999999999999888889999999999999999999888889999999999999999999 67766 8999999999
Q ss_pred ccCcCCC-CcCCCcCcccccccccCCCCcccccCCcccccC--CcccCCCCCC
Q 007290 146 SQNNFSG-TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI--PKYNFTGNNL 195 (609)
Q Consensus 146 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l--~~l~~~~n~~ 195 (609)
++|++++ .+|..++++++|++|++++|.+++.....+.++ ..|++++|..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccc
Confidence 9999996 478899999999999999999987544556667 7788888876
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.3e-14 Score=148.01 Aligned_cols=130 Identities=22% Similarity=0.244 Sum_probs=112.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCc--cccCcccchh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP--SLGNLKKLQF 142 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~ 142 (609)
..+++.|+|++|++++..|..|.++++|++|+|++|+|++..+..+.++++|++|+|++|+++ .+|. .|.++++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 358999999999999988889999999999999999999544455899999999999999999 5665 7999999999
Q ss_pred hhcccCc-CCCCcCCCcCcccccccccCCCCcccccCCccccc---CCcccCCCCCC
Q 007290 143 LTLSQNN-FSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ---IPKYNFTGNNL 195 (609)
Q Consensus 143 L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~---l~~l~~~~n~~ 195 (609)
|++++|+ +++..|..+.++++|+.|++++|.+++..|..+.+ |..|++++|..
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 9999995 77555778999999999999999999888877655 45577888764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.9e-14 Score=137.82 Aligned_cols=126 Identities=16% Similarity=0.201 Sum_probs=106.6
Q ss_pred CCeEEEEecCCC-cccccCccccCCCCCCEEEccC-CCcCCCCCccccccccccccccccccccccCCccccCcccch--
Q 007290 66 NNVASVTLSSMN-FSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ-- 141 (609)
Q Consensus 66 ~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-- 141 (609)
.+++.|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |+.+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 579999999997 8877777899999999999998 99996666788999999999999999995 776 88888888
Q ss_pred -hhhcccC-cCCCCcCCCcCcccccc-cccCCCCcccccCCccc---ccCCcccCCCCC
Q 007290 142 -FLTLSQN-NFSGTIPDSLTTLSSLI-SIQLDSNNLSGQIPVHL---FQIPKYNFTGNN 194 (609)
Q Consensus 142 -~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~ 194 (609)
.|++++| ++++..+..+..+++|+ .|++++|+++ .+|... .+|..|++++|+
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 89855556688999999 9999999998 677543 356778888885
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=139.95 Aligned_cols=125 Identities=20% Similarity=0.290 Sum_probs=59.8
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcC--CCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGIT--GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
+++.|+|++|.+++..+..|..+++|+.|+|++|.++ +..|..+..+ +|++|+|++|+++ .+|..+. ++|+.|+
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~ 199 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELH 199 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCB
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEE
Confidence 4555555555555444444666666666666666664 2444444444 3333333333333 1222221 3455555
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNL 195 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~ 195 (609)
|++|++++..|..+..+++|+.|+|++|++++..|..+ .+|..|++++|..
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 253 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcC
Confidence 55555554444455555555555555555554333322 2333344555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.4e-14 Score=154.47 Aligned_cols=34 Identities=21% Similarity=0.088 Sum_probs=26.7
Q ss_pred CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc
Q 007290 322 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE 355 (609)
Q Consensus 322 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 355 (609)
....++|..|++++.+++|+|+|+++|||.+...
T Consensus 320 ~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~~ 353 (487)
T 3oja_A 320 GQGSETERLECERENQARQREIDALKEQYRTVID 353 (487)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred cccHHHHHHHHHHHhcccccchhhHHHHhcChHH
Confidence 3446789999999999999999999999977653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=4.8e-14 Score=154.57 Aligned_cols=130 Identities=22% Similarity=0.210 Sum_probs=111.2
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccc-cCCccccCcccchhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVG-KIPPSLGNLKKLQFL 143 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L 143 (609)
..+++.|+|++|++++..|..|+++++|++|+|++|+|++..|..|+++++|++|+|++|++++ .+|..|+++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 3589999999999999888999999999999999999997777779999999999999999986 367789999999999
Q ss_pred hcccCcCCCCcC-CCcCcccccccccCCCCcccccCCcccccCC---cccCCCCC
Q 007290 144 TLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIPVHLFQIP---KYNFTGNN 194 (609)
Q Consensus 144 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~---~l~~~~n~ 194 (609)
+|++|++.+.+| ..+.++++|++|++++|.+++.+|..+.+++ .|++.+|.
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 999999665776 5799999999999999999988887654433 34444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-13 Score=137.94 Aligned_cols=124 Identities=26% Similarity=0.411 Sum_probs=99.8
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|++++..+ +..+++|++|+|++|+|++ +|. +.++++|++|+|++|+|++ + +.+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 578999999999986554 8889999999999999984 554 8889999999999999985 4 46888999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~c 197 (609)
++|++++ + ..+..+++|+.|++++|++++..| ..+.+|..|++++|....
T Consensus 142 ~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 142 GNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred cCCcCCc-c-hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC
Confidence 9999985 4 568888999999999999986544 234566678888887643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=9.6e-14 Score=143.00 Aligned_cols=106 Identities=22% Similarity=0.277 Sum_probs=94.1
Q ss_pred CEEEccCC-CcCCCCCcccccccccccccccc-ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCC
Q 007290 93 STLTLKGN-GITGEIPEELGNLSSLTSLDLDN-NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170 (609)
Q Consensus 93 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 170 (609)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 999 6898 99999999999996 99998777899999999999999999998888899999999999999
Q ss_pred CCcccccCCcccc--cCCcccCCCCCCCCCCC
Q 007290 171 SNNLSGQIPVHLF--QIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 171 ~N~l~~~ip~~l~--~l~~l~~~~n~~~c~~~ 200 (609)
+|+|++..|..+. .|..|++.+|++.|+|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999954444443 38889999999999886
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.3e-13 Score=136.08 Aligned_cols=120 Identities=27% Similarity=0.357 Sum_probs=57.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|.+++..+ +..+++|+.|+|++|+|++ +|. +.. ++|+.|+|++|+|++ +| .++++++|+.|+|+
T Consensus 64 ~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 64 NLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 45555555555553332 5555555555555555552 332 222 555555555555553 22 35555555555555
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~ 196 (609)
+|+|++ +| .+..+++|+.|+|++|++++. + ..+.+|..|++++|+..
T Consensus 137 ~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 137 NNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp TSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEE
T ss_pred CCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCccc
Confidence 555552 33 345555555555555555532 1 12233344445555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-13 Score=139.71 Aligned_cols=127 Identities=27% Similarity=0.417 Sum_probs=106.4
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++. +.+..+++|++|+|++|+|++ +|. +..+++|++|+|++|++++. +. ++.+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~ 157 (308)
T 1h6u_A 84 LTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLS 157 (308)
T ss_dssp CCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEE
T ss_pred CCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEE
Confidence 45899999999999964 368999999999999999995 554 99999999999999999954 43 89999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNCGK 199 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~c~~ 199 (609)
|++|++++ ++. +..+++|+.|++++|++++..| ..+.+|..|++++|+.....
T Consensus 158 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 158 IGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred ccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence 99999995 444 8899999999999999995433 34567778899999876443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.41 E-value=9.1e-16 Score=144.90 Aligned_cols=86 Identities=23% Similarity=0.332 Sum_probs=44.5
Q ss_pred cccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCccccc
Q 007290 85 RIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSL 164 (609)
Q Consensus 85 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 164 (609)
.+..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 45555555555555555553 44 4555555555555555555 445444445555555555555552 33 34455555
Q ss_pred ccccCCCCccc
Q 007290 165 ISIQLDSNNLS 175 (609)
Q Consensus 165 ~~L~l~~N~l~ 175 (609)
++|++++|+++
T Consensus 118 ~~L~l~~N~i~ 128 (198)
T 1ds9_A 118 RVLYMSNNKIT 128 (198)
T ss_dssp SEEEESEEECC
T ss_pred CEEECCCCcCC
Confidence 55555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.40 E-value=4.2e-14 Score=126.77 Aligned_cols=105 Identities=17% Similarity=0.224 Sum_probs=93.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccccc-CCccccCcccchhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGK-IPPSLGNLKKLQFL 143 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 143 (609)
..+++.|+|++|.+++. ..+..+++|++|+|++|+|++.+|..+.++++|++|+|++|+|++. .|..++++++|+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 35899999999999976 7899999999999999999987998888899999999999999963 34889999999999
Q ss_pred hcccCcCCCCcC---CCcCcccccccccCCC
Q 007290 144 TLSQNNFSGTIP---DSLTTLSSLISIQLDS 171 (609)
Q Consensus 144 ~l~~N~l~~~~p---~~~~~l~~L~~L~l~~ 171 (609)
++++|++++..+ ..+..+++|+.|++++
T Consensus 119 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 119 DLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred eCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999995443 3788999999999874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.6e-13 Score=132.98 Aligned_cols=123 Identities=24% Similarity=0.329 Sum_probs=104.6
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|+++. ++ .+..+++|++|+|++|+|++ +|. +.++++|++|+|++|+|++ +|.... ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 489999999999984 55 78999999999999999995 444 9999999999999999995 654333 99999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLNCG 198 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~c~ 198 (609)
++|++++ +| .+..+++|+.|+|++|++++ +| ..+.+|..|++++|+....
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCC-ChHHccCCCCCEEECCCCcCcch
Confidence 9999994 54 58999999999999999995 55 2456777789999987654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.3e-13 Score=136.45 Aligned_cols=124 Identities=29% Similarity=0.398 Sum_probs=106.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++ ++ .+..+++|++|+|++|+|++ ++ .+..+++|+.|+|++|++++. ..++.+++|+.|+
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 162 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 162 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-Ch-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEE
Confidence 4589999999999996 33 49999999999999999995 44 699999999999999999954 6899999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCc--ccccCCcccCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~--~l~~l~~l~~~~n~~~c 197 (609)
|++|++++..| +..+++|+.|+|++|.+++ +|. .+.+|..|++++|+..+
T Consensus 163 L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEEC
T ss_pred ccCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccC
Confidence 99999996554 8999999999999999994 663 34567778899987643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-13 Score=136.09 Aligned_cols=125 Identities=22% Similarity=0.409 Sum_probs=100.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++..+ +..+++|++|+|++|+|++ +| .+.++++|++|+|++|++++ +|. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 3588999999999986544 8899999999999999984 44 58889999999999999985 443 88999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~c 197 (609)
|++|++++. |. +..+++|+.|+|++|++++..+ ..+.+|..|++++|....
T Consensus 136 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 136 LDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred CCCCccCcC-cc-ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCc
Confidence 999999854 43 8889999999999999985333 344567778888887643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.38 E-value=7.8e-14 Score=128.87 Aligned_cols=106 Identities=23% Similarity=0.284 Sum_probs=95.6
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCc--cccCcccchhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP--SLGNLKKLQFL 143 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L 143 (609)
.+++.|+|++|.|++. +.+..+++|++|+|++|+|++..|..+..+++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 3899999999999976 68999999999999999999554455599999999999999997 6776 89999999999
Q ss_pred hcccCcCCCCcCCC----cCcccccccccCCCCccc
Q 007290 144 TLSQNNFSGTIPDS----LTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 144 ~l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 175 (609)
+|++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999998 77875 889999999999999886
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.38 E-value=3.1e-13 Score=139.10 Aligned_cols=124 Identities=25% Similarity=0.360 Sum_probs=70.5
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|++++|.+.+..+ +..+++|++|+|++|++++ +|. +..+++|++|+|++|++++ + +.+..+++|+.|++
T Consensus 199 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l 272 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV 272 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred CccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence 356666666666664433 5566666666666666663 332 5666666666666666663 2 34566666666666
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNC 197 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c 197 (609)
++|++++ +| .+..+++|+.|++++|++++..|..+ .+|..|++++|+...
T Consensus 273 ~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 273 GSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 6666663 32 35556666666666666665444333 344445566665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.37 E-value=5e-13 Score=147.25 Aligned_cols=123 Identities=26% Similarity=0.408 Sum_probs=84.1
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+|+.|+|++|.|++..| +..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++ + +.+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 477788888888776544 7777777777777777773 44 57777777777777777774 3 35777777777777
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~ 196 (609)
++|+|++. ..+..+++|+.|+|++|.|++..| ..+.+|..|++++|+..
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCC
Confidence 77777743 456677777777777777775544 23345555667776554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.1e-13 Score=138.61 Aligned_cols=124 Identities=19% Similarity=0.207 Sum_probs=106.9
Q ss_pred CCeEEEEecCCCcccccCcccc-CCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|+|++|.+++..+..+. .+++|++|+|++|+|++. |. ...+++|++|+|++|+|+ .+|..|..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-cchhhhcccCcccEEE
Confidence 5899999999999988887774 799999999999999944 44 446999999999999999 4666799999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCccc-ccCCcccccCCc---ccCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLS-GQIPVHLFQIPK---YNFTGN 193 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~ip~~l~~l~~---l~~~~n 193 (609)
|++|+|+ .+|..+..+++|+.|++++|+++ +.+|..+.+++. +++.+|
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence 9999999 78999999999999999999999 777776665554 555543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.3e-13 Score=150.15 Aligned_cols=137 Identities=20% Similarity=0.293 Sum_probs=94.4
Q ss_pred CcCCCCCCCCCCCCcceeEEcC-------CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccc
Q 007290 43 QLRDWNQNQVNPCTWSNVICDN-------SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS 115 (609)
Q Consensus 43 ~l~~w~~~~~~~c~w~gv~c~~-------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 115 (609)
.+..|.. ..+||.|+|..|.. ..+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 11 VWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 3556754 34678886643211 125788888888888 6676664 78888888888888 5665 5678
Q ss_pred ccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCC
Q 007290 116 LTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195 (609)
Q Consensus 116 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~ 195 (609)
|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|++++|+|+ .+|..+.+|..|++++|..
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~-~lp~~l~~L~~L~Ls~N~l 153 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLT-SLPVLPPGLQELSVSDNQL 153 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCC-cCCCCCCCCCEEECcCCcC
Confidence 888888888887 4665 5677888888888877 4555 4566777777777776 4666666677777776654
Q ss_pred C
Q 007290 196 N 196 (609)
Q Consensus 196 ~ 196 (609)
.
T Consensus 154 ~ 154 (622)
T 3g06_A 154 A 154 (622)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=142.92 Aligned_cols=115 Identities=22% Similarity=0.346 Sum_probs=83.3
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4578888888888886 666 654 88888888888885 666 57788888888888884 665 567788888
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccC-------CcccCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQI-------PKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l-------~~l~~~~n~~~ 196 (609)
|++|+|++ +|. +. ++|+.|+|++|+|+ .+|....+| ..|++++|...
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~~~~~L~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT 220 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCCCC--------CCEEEECCSSCCC
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhhHHHhhhcccccceEEecCCCcce
Confidence 88888874 666 54 77777788777777 566622355 66777777665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.34 E-value=9.4e-13 Score=145.05 Aligned_cols=124 Identities=29% Similarity=0.400 Sum_probs=107.7
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++. ..|+.|++|+.|+
T Consensus 86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 159 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEE
T ss_pred CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEE
Confidence 4589999999999996 33 79999999999999999995 44 599999999999999999964 6899999999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~c 197 (609)
|++|+|++..| +..+++|+.|+|++|+|++ +| ..+.+|..|++++|+...
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEECCSEEEEC
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCC-ChHHccCCCCCEEEccCCcCcC
Confidence 99999997666 8999999999999999995 55 245677778899987643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=135.20 Aligned_cols=141 Identities=16% Similarity=0.189 Sum_probs=109.0
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCc-cccccccccc-cccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPE-ELGNLSSLTS-LDLD 122 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~-L~L~ 122 (609)
|+|..|.|++. .+++.|+|++|+|+.+.+..|.+|++|++|+|++|++.+.+|. .|.+|++|+. +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 68999999752 3689999999999966667899999999999999998777764 5788888765 6777
Q ss_pred cccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCC-CcccccCC-ccccc----CCcccCCCCCCC
Q 007290 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDS-NNLSGQIP-VHLFQ----IPKYNFTGNNLN 196 (609)
Q Consensus 123 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~ip-~~l~~----l~~l~~~~n~~~ 196 (609)
+|+|++..|..|.++++|+.|++++|+|++..+..+....++..|++.+ |++. .+| ..|.. +..|++++|...
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhcccccccc
Confidence 8999977788899999999999999999865555666777788888865 5666 455 33333 445777777653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.2e-12 Score=140.56 Aligned_cols=122 Identities=30% Similarity=0.442 Sum_probs=73.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| ++.+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 367777777777765544 6666777777777777764333 6666666666666666664332 566666666666
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~ 196 (609)
++|++++..| +..+++|+.|++++|++++. + ..+.+|..|++++|+..
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccC
Confidence 6666665444 55666666666666666642 2 12334444555555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-14 Score=137.53 Aligned_cols=110 Identities=23% Similarity=0.290 Sum_probs=99.3
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|++++ +| .+..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 4589999999999997 66 8999999999999999999 789888889999999999999995 56 699999999999
Q ss_pred cccCcCCCCcC--CCcCcccccccccCCCCcccccCCc
Q 007290 145 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPV 180 (609)
Q Consensus 145 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ip~ 180 (609)
|++|+++ .+| ..+..+++|++|++++|++++.+|.
T Consensus 122 l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCCcCC-chhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999999 444 4788999999999999999987765
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.2e-12 Score=136.59 Aligned_cols=123 Identities=23% Similarity=0.258 Sum_probs=97.9
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|++++ +| +..+++|+.|+|++|+|++. .++.+++|++|+|++|+|++ +| ++.+++|+.|+
T Consensus 169 l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~ 239 (457)
T 3bz5_A 169 QTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD 239 (457)
T ss_dssp CTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred CCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence 3578999999999987 44 78889999999999999854 38888999999999999996 66 88889999999
Q ss_pred cccCcCCCCcCCCcCccc-------ccccccCCCCcccccCCc-ccccCCcccCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLS-------SLISIQLDSNNLSGQIPV-HLFQIPKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~-------~L~~L~l~~N~l~~~ip~-~l~~l~~l~~~~n~~~ 196 (609)
|++|++++..+..+.++. +|+.|++++|.+.|.+|. .+.+|..|++++|+..
T Consensus 240 l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l 299 (457)
T 3bz5_A 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQL 299 (457)
T ss_dssp CCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTC
T ss_pred eeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCccc
Confidence 999999876555555555 567788888887777773 4567778888888643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2.6e-12 Score=140.58 Aligned_cols=103 Identities=29% Similarity=0.406 Sum_probs=92.3
Q ss_pred CCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCC
Q 007290 91 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170 (609)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 170 (609)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57889999999995 787 999999999999999999 899999999999999999999995 78 89999999999999
Q ss_pred CCcccccC-Ccccc---cCCcccCCCCCCCCC
Q 007290 171 SNNLSGQI-PVHLF---QIPKYNFTGNNLNCG 198 (609)
Q Consensus 171 ~N~l~~~i-p~~l~---~l~~l~~~~n~~~c~ 198 (609)
+|+|++.+ |..+. +|..|++++|+....
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 99999776 87665 556688999987543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=6.5e-12 Score=134.14 Aligned_cols=122 Identities=19% Similarity=0.211 Sum_probs=88.7
Q ss_pred CCCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhh
Q 007290 64 NSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143 (609)
Q Consensus 64 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 143 (609)
...+++.|+|++|++++. .++.+++|++|++++|+..+.+ .+..+++|++|+|++|+|++ +| ++.+++|+.|
T Consensus 125 ~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L 196 (457)
T 3bz5_A 125 QNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRL 196 (457)
T ss_dssp TCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEE
T ss_pred CCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEE
Confidence 345788889998888874 2777888888888888655566 37777888888888888875 55 7777788888
Q ss_pred hcccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCCC
Q 007290 144 TLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 144 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~c 197 (609)
++++|++++. .+..+++|+.|++++|++++ +| ..+.+|..|++++|+...
T Consensus 197 ~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 197 NCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp ECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCSC
T ss_pred ECcCCcCCee---ccccCCCCCEEECcCCcccc-cCccccCCCCEEEeeCCcCCC
Confidence 8888887743 36777778888888888775 55 334566667777776543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.28 E-value=3.7e-13 Score=143.69 Aligned_cols=122 Identities=25% Similarity=0.310 Sum_probs=73.3
Q ss_pred CeEEEEecCCCcccccCccccCCCCC-------------CEEEccCCCcCCCCCccccccccccccccccccccccCCcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTL-------------STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 133 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 133 (609)
+++.|+|++|.+.|.+|..++++++| ++|++++|.+++ +|.. .++|++|+|++|++++ +|..
T Consensus 35 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~ 109 (454)
T 1jl5_A 35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL 109 (454)
T ss_dssp CHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC
T ss_pred chhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc
Confidence 45555555555555555555555543 556666666553 3331 2455666666666664 4433
Q ss_pred ccC----------------c-ccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCCC
Q 007290 134 LGN----------------L-KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 134 ~~~----------------l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~~ 196 (609)
+.+ + ++|++|+|++|++++ +| .+.++++|++|++++|++++ +|..+.+|+.|++++|...
T Consensus 110 ~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~~~L~~L~L~~n~l~ 186 (454)
T 1jl5_A 110 PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLE 186 (454)
T ss_dssp CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred cCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCcccccEEECcCCcCC
Confidence 211 1 466677777777763 66 47777777777777777774 6766677777777777654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.27 E-value=8.2e-12 Score=133.25 Aligned_cols=117 Identities=24% Similarity=0.291 Sum_probs=75.6
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .|+++++|+.|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 56777777777775 55 47777777777777777773 55433 467777777777774 55 57777777777777
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCc--ccccCCcccCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLN 196 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~--~l~~l~~l~~~~n~~~ 196 (609)
+|++++ +|... ++|+.|++++|.++ .+|. .+.+|..|++++|...
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCC
Confidence 777773 44432 35666666666666 5663 2334555667776554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.26 E-value=5e-12 Score=135.63 Aligned_cols=126 Identities=27% Similarity=0.403 Sum_probs=103.2
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++. +.+..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 35789999999998864 468889999999999999996554 8889999999999999995443 88899999999
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLNCG 198 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~c~ 198 (609)
|++|++++..| +..+++|+.|++++|++++..| ..+.+|..|++++|+....
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 99999986544 7889999999999999997666 3556777888988876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.9e-11 Score=119.06 Aligned_cols=146 Identities=12% Similarity=0.068 Sum_probs=113.2
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 359 (609)
.....|.+...++.|+.+.||++... |+.+++|+...... .....+.+|+++++.+. +..+.++++++...+..++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456888888898999999999864 78999999864211 12345889999999885 67788899999888889999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC---------------------------------- 405 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 405 (609)
|||++|.++...+.. ......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999998775321 1123467889999999999810
Q ss_pred ----------------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 406 ----------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 406 ----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13689999999999998766677999998763
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.24 E-value=7.2e-12 Score=128.78 Aligned_cols=120 Identities=28% Similarity=0.456 Sum_probs=68.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|++++ +|. +..+++|+.|+|+
T Consensus 178 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~ 251 (347)
T 4fmz_A 178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIG 251 (347)
T ss_dssp TCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred CCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECC
Confidence 56666666666654322 5566666666666666663332 5566666666666666663 332 5666666666666
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~ 195 (609)
+|.+++ + ..+..+++|+.|++++|++++ +| ..+.+|..|++++|+.
T Consensus 252 ~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 252 TNQISD-I-NAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp SSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCC
T ss_pred CCccCC-C-hhHhcCCCcCEEEccCCccCC-ChhhcCCCCCCEEECcCCcC
Confidence 666663 3 245566666666666666653 33 2334555556666654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.6e-13 Score=140.54 Aligned_cols=128 Identities=21% Similarity=0.218 Sum_probs=87.4
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCC-CCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE-IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
.+++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..++++++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4677777777777765544 45677777777777777654 666677777777777777777766777777777777777
Q ss_pred cccC-cCCCC-cCCCcCcccccccccCCCC-ccccc-CCcc---cc-cCCcccCCCCC
Q 007290 145 LSQN-NFSGT-IPDSLTTLSSLISIQLDSN-NLSGQ-IPVH---LF-QIPKYNFTGNN 194 (609)
Q Consensus 145 l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-ip~~---l~-~l~~l~~~~n~ 194 (609)
|++| .+++. +|..+..+++|++|++++| .+++. +|.. +. +|..|++++|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 7777 56642 5555667777777777777 77643 3432 33 56666777664
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2.8e-13 Score=141.62 Aligned_cols=129 Identities=21% Similarity=0.303 Sum_probs=70.3
Q ss_pred CeEEEEecCCCcc-cccC---ccccCCCCCCEEEccCCCcC--C---CCCcccccccccccccccccccc----ccCCcc
Q 007290 67 NVASVTLSSMNFS-GTLS---PRIGVLRTLSTLTLKGNGIT--G---EIPEELGNLSSLTSLDLDNNRLV----GKIPPS 133 (609)
Q Consensus 67 ~l~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~ 133 (609)
+++.|+|++|+++ +.++ ..+..+++|++|+|++|+|+ | .+|..+.++++|+.|+|++|+|+ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4555555555554 2222 24445556666666666655 2 23334556666666666666664 455555
Q ss_pred ccCcccchhhhcccCcCCCC----cCCCc--CcccccccccCCCCcccc----cCCccc----ccCCcccCCCCCC
Q 007290 134 LGNLKKLQFLTLSQNNFSGT----IPDSL--TTLSSLISIQLDSNNLSG----QIPVHL----FQIPKYNFTGNNL 195 (609)
Q Consensus 134 ~~~l~~L~~L~l~~N~l~~~----~p~~~--~~l~~L~~L~l~~N~l~~----~ip~~l----~~l~~l~~~~n~~ 195 (609)
+..+++|+.|+|++|.|++. +|..+ ..+++|+.|+|++|.+++ .+|..+ .+|..|++++|+.
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 66666666666666666543 34444 225666666666666664 255432 4455566666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.1e-12 Score=135.87 Aligned_cols=129 Identities=27% Similarity=0.348 Sum_probs=73.7
Q ss_pred CeEEEEecCCCcccccC----ccccCCC-CCCEEEccCCCcCCCCCcccccc-----ccccccccccccccccCCccccC
Q 007290 67 NVASVTLSSMNFSGTLS----PRIGVLR-TLSTLTLKGNGITGEIPEELGNL-----SSLTSLDLDNNRLVGKIPPSLGN 136 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~ 136 (609)
+++.|+|++|.+++..+ ..+..++ +|++|+|++|+|++..+..+..+ ++|++|+|++|+|++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 46666666666665544 4555666 66666666666665555555554 66666666666666544443333
Q ss_pred ----c-ccchhhhcccCcCCCCcCCCcC----c-ccccccccCCCCcccccCCccc--------ccCCcccCCCCCC
Q 007290 137 ----L-KKLQFLTLSQNNFSGTIPDSLT----T-LSSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNL 195 (609)
Q Consensus 137 ----l-~~L~~L~l~~N~l~~~~p~~~~----~-l~~L~~L~l~~N~l~~~ip~~l--------~~l~~l~~~~n~~ 195 (609)
+ ++|+.|+|++|+|++..+..+. . .++|++|+|++|.+++..+..+ .+|..|++++|..
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 2 5666666666666643333322 2 2466666666666664332221 2555666666654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.4e-13 Score=135.53 Aligned_cols=130 Identities=18% Similarity=0.268 Sum_probs=104.1
Q ss_pred CCeEEEEecCCCcccc-cCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccc-ccccc-CCccccCcccchh
Q 007290 66 NNVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN-RLVGK-IPPSLGNLKKLQF 142 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~ 142 (609)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.+++..|..++++++|++|+|++| .+++. +|..+.++++|+.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4789999999998866 7788888999999999999988888888888999999999998 67753 6777888899999
Q ss_pred hhcccC-cCCCC-cCCCcCccc-ccccccCCCC--ccc-ccCCc---ccccCCcccCCCCCC
Q 007290 143 LTLSQN-NFSGT-IPDSLTTLS-SLISIQLDSN--NLS-GQIPV---HLFQIPKYNFTGNNL 195 (609)
Q Consensus 143 L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~ip~---~l~~l~~l~~~~n~~ 195 (609)
|+|++| .+++. ++..+..++ +|++|++++| .++ +.+|. .+.+|..|++++|..
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 999998 88754 566777888 8888888888 454 34554 345677788888873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=7.3e-11 Score=115.83 Aligned_cols=137 Identities=13% Similarity=0.040 Sum_probs=100.6
Q ss_pred CCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc--ceeEeEEeCCCcceEEeec
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~ 362 (609)
.+.+..+.+.|..+.||++...+|+.+++|..... ....+..|+++++.+.+.++ .+++++....+..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 34443333456669999998777889999987542 22457889999998875554 4588888877788999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------------- 405 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 405 (609)
++|.++. ... .+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 2356777788888888641
Q ss_pred ------------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 406 ------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 406 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
.+.++|+|++|.||+++++..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999999864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.6e-11 Score=131.81 Aligned_cols=113 Identities=22% Similarity=0.324 Sum_probs=68.6
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEEC
Confidence 36777777777777 3444 4677777777777777 4555 5567777777777776 3444 4456666666
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~ 195 (609)
++|+|+ .+|.. +++|++|+|++|+++ .+|..+.+|..|++++|..
T Consensus 129 ~~N~l~-~lp~~---l~~L~~L~Ls~N~l~-~l~~~~~~L~~L~L~~N~l 173 (622)
T 3g06_A 129 FGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALPSELCKLWAYNNQL 173 (622)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred CCCCCC-cCCCC---CCCCCEEECcCCcCC-CcCCccCCCCEEECCCCCC
Confidence 666666 35543 255666666666665 3454445555555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=8.5e-13 Score=137.98 Aligned_cols=130 Identities=21% Similarity=0.318 Sum_probs=91.0
Q ss_pred CCeEEEEecCCCccc----ccCccccCCCCCCEEEccCCCcCCCCCcccc----cc---------cccccccccccccc-
Q 007290 66 NNVASVTLSSMNFSG----TLSPRIGVLRTLSTLTLKGNGITGEIPEELG----NL---------SSLTSLDLDNNRLV- 127 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~- 127 (609)
.+++.|+|++|.+++ .+|..+..+++|++|+|++|.|++..+..+. .+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 578888888888886 4677777888888888888888644333333 33 78888888888876
Q ss_pred ccCC---ccccCcccchhhhcccCcCC--C---CcCCCcCcccccccccCCCCccc----ccCCccc---ccCCcccCCC
Q 007290 128 GKIP---PSLGNLKKLQFLTLSQNNFS--G---TIPDSLTTLSSLISIQLDSNNLS----GQIPVHL---FQIPKYNFTG 192 (609)
Q Consensus 128 ~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~ip~~l---~~l~~l~~~~ 192 (609)
+.+| ..|..+++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.++ +.+|..+ .+|..|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 4444 45667778888888888777 2 34556777788888888888875 4566443 4556677777
Q ss_pred CCC
Q 007290 193 NNL 195 (609)
Q Consensus 193 n~~ 195 (609)
|..
T Consensus 254 n~i 256 (386)
T 2ca6_A 254 CLL 256 (386)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.1e-12 Score=133.80 Aligned_cols=127 Identities=24% Similarity=0.261 Sum_probs=107.7
Q ss_pred EEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCC----ccccccc-cccccccccccccccCCccccCc-----cc
Q 007290 70 SVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP----EELGNLS-SLTSLDLDNNRLVGKIPPSLGNL-----KK 139 (609)
Q Consensus 70 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 139 (609)
.+.|+.|+++|.+|..+...++|++|+|++|+|++..+ ..+.+++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999997666 6788888 99999999999998778788776 99
Q ss_pred chhhhcccCcCCCCcCCCcCc----c-cccccccCCCCcccccCCccc--------ccCCcccCCCCCCC
Q 007290 140 LQFLTLSQNNFSGTIPDSLTT----L-SSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNLN 196 (609)
Q Consensus 140 L~~L~l~~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~ip~~l--------~~l~~l~~~~n~~~ 196 (609)
|++|+|++|++++..+..+.. + ++|+.|+|++|++++..+..+ .+|+.|++++|...
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 999999999999766665444 3 899999999999986555432 47888999999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=6.5e-10 Score=114.80 Aligned_cols=144 Identities=14% Similarity=0.184 Sum_probs=106.1
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEec--cCCCCchHHHHHHHHHHHHhcc--CCCcceeEeEEeCC---CcceEEe
Q 007290 288 EKNVLGQGGFGKVYRGVLADGTKVAVKRLT--DFESPGGDAAFQREVEMISVAV--HRNLLRLIGFCTTP---TERLLVY 360 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 360 (609)
..+.|+.|.++.||+.... +..+++|+.. ..........+.+|+.+++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999875 4688888775 3222223456788999999887 45578888888766 4478999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC----------------------------------- 405 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------- 405 (609)
||++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999977643211 12567778889999999999999731
Q ss_pred --------------------CCCeEecCCCCCcEEeCCCCc--EEEcccccceee
Q 007290 406 --------------------NPKIIHRDVKAANVLLDEDFE--AVVGDFGLAKLV 438 (609)
Q Consensus 406 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGl~~~~ 438 (609)
.+.++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999998753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-11 Score=132.89 Aligned_cols=132 Identities=19% Similarity=0.216 Sum_probs=94.0
Q ss_pred CCCeEEEEecCCCcccc----cCccccCCCCCCEEEccCCCcCCCCCcccccc-----cccccccccccccccc----CC
Q 007290 65 SNNVASVTLSSMNFSGT----LSPRIGVLRTLSTLTLKGNGITGEIPEELGNL-----SSLTSLDLDNNRLVGK----IP 131 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~----~p 131 (609)
..+++.|+|++|++++. ++..+..+++|++|+|++|.|++..+..+... ++|++|+|++|.+++. ++
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 35788899998888864 56677778888888888888875544444432 5888888888888754 45
Q ss_pred ccccCcccchhhhcccCcCCCCcCCCcCc-----ccccccccCCCCcccc----cCCccc---ccCCcccCCCCCCC
Q 007290 132 PSLGNLKKLQFLTLSQNNFSGTIPDSLTT-----LSSLISIQLDSNNLSG----QIPVHL---FQIPKYNFTGNNLN 196 (609)
Q Consensus 132 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~ip~~l---~~l~~l~~~~n~~~ 196 (609)
..+..+++|+.|+|++|++++..+..+.. .++|+.|+|++|++++ .+|..+ .+|..|++++|+..
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 66677788888888888877544433332 5678888888888875 566543 56666778887654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.97 E-value=6.9e-10 Score=114.15 Aligned_cols=124 Identities=19% Similarity=0.138 Sum_probs=75.2
Q ss_pred eEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccc--------------------------cccccc
Q 007290 68 VASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSS--------------------------LTSLDL 121 (609)
Q Consensus 68 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~--------------------------L~~L~L 121 (609)
.+.+.+++|+|++..|..|..+++|++|++++|+|++..+..+....+ |+.|+|
T Consensus 82 ~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L 161 (350)
T 4ay9_X 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161 (350)
T ss_dssp CEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred hhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcc
Confidence 445677788888777888888888999988888888544433333333 455556
Q ss_pred ccccccccCCccccCcccchhhhccc-CcCCCCcCC-CcCcccccccccCCCCcccccCC-cccccCCcccCCCCC
Q 007290 122 DNNRLVGKIPPSLGNLKKLQFLTLSQ-NNFSGTIPD-SLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNN 194 (609)
Q Consensus 122 ~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~ 194 (609)
++|+|+ .+|.......+|+.|++++ |.++ .+|. .|..+++|+.|+|++|+|+ .+| ..+.+|++|...++.
T Consensus 162 ~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp CSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTCT
T ss_pred cccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccCC
Confidence 666665 3444444445566666653 3444 4443 4556666666666666666 344 345556665555543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.94 E-value=1.2e-11 Score=132.31 Aligned_cols=131 Identities=19% Similarity=0.170 Sum_probs=105.2
Q ss_pred CCeEEEEecCCCccccc-----CccccCCCCCCEEEccCCCcCCC----CCccccccccccccccccccccccCCccccC
Q 007290 66 NNVASVTLSSMNFSGTL-----SPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPPSLGN 136 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 136 (609)
.+++.|+|++|.+++.. +..+..+++|++|+|++|+|++. ++..+.++++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 58999999999988642 23334689999999999999954 6777888999999999999998655544443
Q ss_pred c-----ccchhhhcccCcCCCC----cCCCcCcccccccccCCCCcccccCCccc--------ccCCcccCCCCCCC
Q 007290 137 L-----KKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPVHL--------FQIPKYNFTGNNLN 196 (609)
Q Consensus 137 l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ip~~l--------~~l~~l~~~~n~~~ 196 (609)
. ++|+.|+|++|.+++. +|..+..+++|+.|+|++|.+++..+..+ .+|..|++++|...
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 3 7999999999999865 56677788999999999999986545333 37888999999754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=109.36 Aligned_cols=185 Identities=17% Similarity=0.189 Sum_probs=119.9
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCC--cceeEeEEeCCC---cceEEeec
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRN--LLRLIGFCTTPT---ERLLVYPF 362 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 362 (609)
.+.++.|....||+.. ..+++|+... ......+.+|.++++.+. +.. +.+++....... ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4668999999999863 5688998642 233567889999998874 333 334555443333 34789999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH-------------------------------------- 404 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------- 404 (609)
++|.++...... .++...+..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888653321 145566677777788777777751
Q ss_pred -----------------CCCCeEecCCCCCcEEeCC--CCcEEEcccccceeeccCCCceeec--------------ccc
Q 007290 405 -----------------CNPKIIHRDVKAANVLLDE--DFEAVVGDFGLAKLVDVRKTNVTTQ--------------VRG 451 (609)
Q Consensus 405 -----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGl~~~~~~~~~~~~~~--------------~~g 451 (609)
..+.++|+|++|.||++++ +..+.|+||+.+....... ..... ...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHH
Confidence 1246899999999999998 5568899999987643210 00000 000
Q ss_pred cccccC-cccccCCCCCcchhhHHHHHHHHHHHhCCCCC
Q 007290 452 TMGHIA-PEYLSTGKSSERTDVFGYGIMLLELVTGQRAI 489 (609)
Q Consensus 452 t~~y~a-PE~~~~~~~~~~~Dv~slG~ll~elltg~~p~ 489 (609)
..++.. |+... ......+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 001111 22211 1123368999999999999998765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.87 E-value=3.3e-11 Score=117.82 Aligned_cols=135 Identities=23% Similarity=0.240 Sum_probs=89.2
Q ss_pred CCCCcceeEEcCCC-CeEEEEecC---CCcccccCc------------------------cccCCCCCCE--EEccCCCc
Q 007290 53 NPCTWSNVICDNSN-NVASVTLSS---MNFSGTLSP------------------------RIGVLRTLST--LTLKGNGI 102 (609)
Q Consensus 53 ~~c~w~gv~c~~~~-~l~~L~L~~---n~l~~~~~~------------------------~~~~l~~L~~--L~l~~N~l 102 (609)
..|.|.|+.|+..+ ++..+...+ ..+.+.+++ .|...+.|.. ++++.|+.
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~ 155 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR 155 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence 35789999998643 565554443 222222221 1223334444 56677754
Q ss_pred CCCCCc----cccccccccccccccccccc--cCCccccCcccchhhhcccCcCCCCcCCCcCccc--ccccccCCCCcc
Q 007290 103 TGEIPE----ELGNLSSLTSLDLDNNRLVG--KIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLS--SLISIQLDSNNL 174 (609)
Q Consensus 103 ~~~~p~----~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l 174 (609)
. .++. ...++++|+.|+|++|+|++ .+|..++.+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++
T Consensus 156 ~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 156 S-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp H-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred H-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 4 3332 22467899999999999997 5567788999999999999999954 3345555 899999999999
Q ss_pred cccCCc-------ccccCCcccC
Q 007290 175 SGQIPV-------HLFQIPKYNF 190 (609)
Q Consensus 175 ~~~ip~-------~l~~l~~l~~ 190 (609)
++.+|. .+..+++|..
T Consensus 233 ~~~~~~~~~y~~~il~~~P~L~~ 255 (267)
T 3rw6_A 233 CDTFRDQSTYISAIRERFPKLLR 255 (267)
T ss_dssp GGGCSSHHHHHHHHHHHCTTCCE
T ss_pred ccccCcchhHHHHHHHHCcccCe
Confidence 987773 2455665543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=9.8e-11 Score=121.32 Aligned_cols=130 Identities=18% Similarity=0.206 Sum_probs=91.0
Q ss_pred CCeEEEEecCCCcccccCccc-cCCCCCCEEEccCCCcCCCCCccc-----cccccccccccccccccc----cCCcccc
Q 007290 66 NNVASVTLSSMNFSGTLSPRI-GVLRTLSTLTLKGNGITGEIPEEL-----GNLSSLTSLDLDNNRLVG----KIPPSLG 135 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~ 135 (609)
.+++.|+|++|.++......+ ..+++|+.|+|++|+|+......+ ...++|+.|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 478888888888875433333 346788888888888875433333 235778899999998863 2445557
Q ss_pred CcccchhhhcccCcCCCC----cCCCcCcccccccccCCCCccccc----CCccc---ccCCcccCCCCCC
Q 007290 136 NLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQ----IPVHL---FQIPKYNFTGNNL 195 (609)
Q Consensus 136 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----ip~~l---~~l~~l~~~~n~~ 195 (609)
.+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|+.. ++..+ .+|..|++++|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 788899999999988742 345566777899999999988742 22222 5677888888864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.70 E-value=1.3e-09 Score=106.51 Aligned_cols=80 Identities=24% Similarity=0.344 Sum_probs=67.5
Q ss_pred cCCCCCCEEEccCCCcCC--CCCccccccccccccccccccccccCCccccCcc--cchhhhcccCcCCCCcCC------
Q 007290 87 GVLRTLSTLTLKGNGITG--EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLK--KLQFLTLSQNNFSGTIPD------ 156 (609)
Q Consensus 87 ~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 156 (609)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|++|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999997 5567788999999999999999964 4456665 999999999999987774
Q ss_pred -CcCccccccccc
Q 007290 157 -SLTTLSSLISIQ 168 (609)
Q Consensus 157 -~~~~l~~L~~L~ 168 (609)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 367788888887
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.65 E-value=1e-09 Score=113.59 Aligned_cols=117 Identities=22% Similarity=0.196 Sum_probs=91.8
Q ss_pred CeEEEEecCCCcccccCccc-----cCCCCCCEEEccCCCcCC----CCCcccccccccccccccccccccc----CCcc
Q 007290 67 NVASVTLSSMNFSGTLSPRI-----GVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGK----IPPS 133 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 133 (609)
+++.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|+|+.. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 79999999999986544444 346889999999999974 2455567889999999999999842 3566
Q ss_pred ccCcccchhhhcccCcCCCC----cCCCcCcccccccccCCCCcccccCCcccc
Q 007290 134 LGNLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPVHLF 183 (609)
Q Consensus 134 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~ 183 (609)
+..+++|+.|+|++|.|+.. ++..+...++|++|+|++|.|+..-...+.
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 78889999999999999842 344555678999999999999854444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.54 E-value=1e-07 Score=96.99 Aligned_cols=127 Identities=15% Similarity=0.189 Sum_probs=90.0
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCC-------------CCcc---------------c-------
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGE-------------IPEE---------------L------- 110 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-------------~p~~---------------~------- 110 (609)
.+++.|+|.+ +++.+-+..|.++++|+.|+|++|.++.. +|.. |
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 4788888888 88877777888888888888888876311 1100 0
Q ss_pred -------------------------------------------cccccccccccccccccccCCccccCcccchhhhccc
Q 007290 111 -------------------------------------------GNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147 (609)
Q Consensus 111 -------------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 147 (609)
..+++|+.|+|++|+++...+..|.+|++|+.|+|.+
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 0267888999999888855555789999999999988
Q ss_pred CcCCCCcCCCcCcccccc-cccCCCCcccccCC-ccccc---CCcccCCCCCCC
Q 007290 148 NNFSGTIPDSLTTLSSLI-SIQLDSNNLSGQIP-VHLFQ---IPKYNFTGNNLN 196 (609)
Q Consensus 148 N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~ip-~~l~~---l~~l~~~~n~~~ 196 (609)
| ++..-+.+|.++++|+ .|++.+ .++ .|+ ..|.+ |+.+++.+|...
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCC
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccC
Confidence 8 7734456788889998 999888 676 454 45544 445666666544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.47 E-value=1.1e-07 Score=96.78 Aligned_cols=99 Identities=12% Similarity=0.033 Sum_probs=68.5
Q ss_pred CCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccch-hhhcccCcCCCCcCCCcCcccccccc
Q 007290 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQ-FLTLSQNNFSGTIPDSLTTLSSLISI 167 (609)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L 167 (609)
+++|+.|+|++|+++...+..|.+|++|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+.+|.+|++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 677888888888777444456777888888888777 6644455678888887 888877 6663335677788888888
Q ss_pred cCCCCcccccCCcccccCCccc
Q 007290 168 QLDSNNLSGQIPVHLFQIPKYN 189 (609)
Q Consensus 168 ~l~~N~l~~~ip~~l~~l~~l~ 189 (609)
++++|+++..-+..|.++++|.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~ 324 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSK 324 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCC
T ss_pred EeCCCccCccchhhhcCCcchh
Confidence 8888887733334565555543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.8e-06 Score=84.92 Aligned_cols=135 Identities=18% Similarity=0.132 Sum_probs=95.7
Q ss_pred cccccCCc-eEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCcceEEeecccCch
Q 007290 291 VLGQGGFG-KVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 291 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.+..|..| .||+.... ++..+++|+-.. .....+..|..+++.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 44556655 68998764 567899998652 34567888999988775 3346678888888888999999999988
Q ss_pred hhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 007290 368 VAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------------------ 405 (609)
Q Consensus 368 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------ 405 (609)
+.+..... ......+..++++.|+.||+..
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 77654321 1122344555555555555421
Q ss_pred -------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 406 -------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 406 -------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12388999999999999887778999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=8.4e-09 Score=95.67 Aligned_cols=110 Identities=15% Similarity=0.246 Sum_probs=83.7
Q ss_pred CCeEEEEecCC-Cccc----ccCccccCCCCCCEEEccCCCcCCC----CCcccccccccccccccccccccc----CCc
Q 007290 66 NNVASVTLSSM-NFSG----TLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPP 132 (609)
Q Consensus 66 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 132 (609)
.+++.|+|++| .+.. .+...+...++|++|+|++|.|+.. +...+...++|++|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47899999998 8874 2445566778999999999998742 344455667899999999998843 456
Q ss_pred cccCcccchhhhc--ccCcCCCC----cCCCcCcccccccccCCCCccc
Q 007290 133 SLGNLKKLQFLTL--SQNNFSGT----IPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 133 ~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
.+...++|+.|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6777888999999 88988743 3344555688999999999885
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.38 E-value=4.3e-08 Score=108.08 Aligned_cols=102 Identities=13% Similarity=0.156 Sum_probs=45.6
Q ss_pred eEEEEecCCC-ccc-ccCccccCCCCCCEEEccCCCcCCC----CCcccccccccccccccccccc----ccCCccccCc
Q 007290 68 VASVTLSSMN-FSG-TLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLV----GKIPPSLGNL 137 (609)
Q Consensus 68 l~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l 137 (609)
++.|+|+++. ++. .++..+.++++|++|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 5555555544 110 1112223455555555555555433 2223334555555555555554 2223333445
Q ss_pred ccchhhhcccCcCCCCcCCCcCcccccccccCC
Q 007290 138 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLD 170 (609)
Q Consensus 138 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 170 (609)
++|+.|+|++|.+.+ +|..+..+++|+.|+++
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence 555555555555442 33333334444444443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.1e-06 Score=84.94 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=91.3
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCC---CcceeEeEEe-CCCcceEEeeccc
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCT-TPTERLLVYPFMQ 364 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 364 (609)
.+.++.|....||+. |..+++|+-.. ......+..|.++++.+.+. .+.+++.++. ..+..++||+|++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788888899988 57788887532 23456788999999998753 2556666664 4456789999999
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH---------------------------------------- 404 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------- 404 (609)
|.++...... .++...+..++.++++.|+.||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9887653111 022233333334444444333321
Q ss_pred -----------------CCCCeEecCCCCCcEEeCC---CCc-EEEcccccceee
Q 007290 405 -----------------CNPKIIHRDVKAANVLLDE---DFE-AVVGDFGLAKLV 438 (609)
Q Consensus 405 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGl~~~~ 438 (609)
..+.++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999987 355 589999988753
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.32 E-value=8.4e-08 Score=105.73 Aligned_cols=127 Identities=14% Similarity=0.101 Sum_probs=93.7
Q ss_pred CCeEEEEecCCCcccc----cCccccCCCCCCEEEccCCCcCC----CCCccccccccccccccccccccccCCccccCc
Q 007290 66 NNVASVTLSSMNFSGT----LSPRIGVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNL 137 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 137 (609)
.+++.|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|+.|+|++|.+.+ +|..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 5899999999988765 44456678999999999999973 344556678999999999999885 77888888
Q ss_pred ccchhhhcccCcCC---CCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCC
Q 007290 138 KKLQFLTLSQNNFS---GTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNN 194 (609)
Q Consensus 138 ~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~ 194 (609)
++|+.|+++++... +..+..+..+++|+.|+++++... .+|.. +.+|+.|++++|.
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 99999988864333 234456667777888877775433 45543 3466677777776
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.19 E-value=2e-08 Score=110.73 Aligned_cols=128 Identities=15% Similarity=0.140 Sum_probs=67.8
Q ss_pred CeEEEEecCCCcccccCcccc-CCCCCCEEEcc--C----CCcCCC-----CCccccccccccccccccccccccCCccc
Q 007290 67 NVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLK--G----NGITGE-----IPEELGNLSSLTSLDLDNNRLVGKIPPSL 134 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 134 (609)
+++.|.++.|++++.....+. .+++|+.|+|+ + |++++. ++..+.++++|+.|+|++ .+++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 455555555555544433343 35666666666 3 444411 111144556666666655 4444444444
Q ss_pred cC-cccchhhhcccCcCCCCcCCCc-CcccccccccCCCCcccccCC----cccccCCcccCCCCCC
Q 007290 135 GN-LKKLQFLTLSQNNFSGTIPDSL-TTLSSLISIQLDSNNLSGQIP----VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 135 ~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~ip----~~l~~l~~l~~~~n~~ 195 (609)
+. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+ ..+.+|+.|++++|+.
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 44 6667777777776654333333 456677777777777653322 2344566666666643
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.17 E-value=4.3e-08 Score=90.81 Aligned_cols=117 Identities=19% Similarity=0.221 Sum_probs=88.8
Q ss_pred ccccCccccCCCCCCEEEccCC-CcCCC----CCcccccccccccccccccccccc----CCccccCcccchhhhcccCc
Q 007290 79 SGTLSPRIGVLRTLSTLTLKGN-GITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPPSLGNLKKLQFLTLSQNN 149 (609)
Q Consensus 79 ~~~~~~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~ 149 (609)
...+...+...++|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|.
T Consensus 25 ~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~ 104 (185)
T 1io0_A 25 EETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 104 (185)
T ss_dssp HHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence 3345556778899999999999 88742 345566778999999999999732 34456667899999999999
Q ss_pred CCCC----cCCCcCcccccccccC--CCCcccccCC----ccc---ccCCcccCCCCCC
Q 007290 150 FSGT----IPDSLTTLSSLISIQL--DSNNLSGQIP----VHL---FQIPKYNFTGNNL 195 (609)
Q Consensus 150 l~~~----~p~~~~~l~~L~~L~l--~~N~l~~~ip----~~l---~~l~~l~~~~n~~ 195 (609)
|... +...+...++|++|+| ++|.++..-. ..+ .+|..|++++|..
T Consensus 105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 9843 4566778889999999 8899974322 222 4677888888853
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=4.9e-06 Score=85.34 Aligned_cols=81 Identities=10% Similarity=0.027 Sum_probs=55.1
Q ss_pred cCcc-cccCCceEEEEEeC-------CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccC---CCcceeEeEEeCC--
Q 007290 289 KNVL-GQGGFGKVYRGVLA-------DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVH---RNLLRLIGFCTTP-- 353 (609)
Q Consensus 289 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 353 (609)
.+.| +.|....+|+.... +++.+++|+...... ......+..|+.+++.+.. -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998764 267899997643210 0012456788888887753 3466788877655
Q ss_pred -CcceEEeecccCchhh
Q 007290 354 -TERLLVYPFMQNLSVA 369 (609)
Q Consensus 354 -~~~~lv~e~~~~gsL~ 369 (609)
...++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.4e-07 Score=96.78 Aligned_cols=128 Identities=14% Similarity=0.209 Sum_probs=77.0
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccc--cccccccccccc--cccccc-----CCccc-
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELG--NLSSLTSLDLDN--NRLVGK-----IPPSL- 134 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~- 134 (609)
..+++.|+|++|.-. .+++ + .+++|+.|+|..|.++......+. .+++|+.|+|+. |...|. +...+
T Consensus 171 ~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 357888888876311 2333 3 378888888888777643333343 677888888753 222111 11122
Q ss_pred -cCcccchhhhcccCcCCCCcCCCcC---cccccccccCCCCccccc----CCc---ccccCCcccCCCCCC
Q 007290 135 -GNLKKLQFLTLSQNNFSGTIPDSLT---TLSSLISIQLDSNNLSGQ----IPV---HLFQIPKYNFTGNNL 195 (609)
Q Consensus 135 -~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~~----ip~---~l~~l~~l~~~~n~~ 195 (609)
..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.|++. ++. .+.+|..|++++|..
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 2467888888888877643332222 467888888888888753 332 345677777777653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.6e-07 Score=103.54 Aligned_cols=107 Identities=18% Similarity=0.199 Sum_probs=61.3
Q ss_pred CCeEEEEecCCCcccccCcccc-CCCCCCEEEccCC-CcCCC-CCccccccccccccccccccccccCCccc----cCcc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIG-VLRTLSTLTLKGN-GITGE-IPEELGNLSSLTSLDLDNNRLVGKIPPSL----GNLK 138 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~ 138 (609)
.+++.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 3667777777776665555554 4677777777776 44422 33334466777777777777664433333 2455
Q ss_pred cchhhhcccCc--CCCC-cCCCcCcccccccccCCCC
Q 007290 139 KLQFLTLSQNN--FSGT-IPDSLTTLSSLISIQLDSN 172 (609)
Q Consensus 139 ~L~~L~l~~N~--l~~~-~p~~~~~l~~L~~L~l~~N 172 (609)
+|+.|+|++|. ++.. ++..+.++++|++|++++|
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 77777777665 1100 1111234567777777766
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=5.6e-05 Score=76.67 Aligned_cols=141 Identities=15% Similarity=0.207 Sum_probs=79.1
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC--CCcceeEe------EEeCCCcceEEee
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RNLLRLIG------FCTTPTERLLVYP 361 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e 361 (609)
+.|+.|..+.||+....+| .+++|+... ....+..|..++..+.. -.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4466677899999987654 599998864 12344455565554431 12333332 1123456789999
Q ss_pred cccCchhh--------------hhhhhcCC-----CC-----CCccHHHH------------------------------
Q 007290 362 FMQNLSVA--------------YRLREIKP-----GE-----PVLDWVTR------------------------------ 387 (609)
Q Consensus 362 ~~~~gsL~--------------~~l~~~~~-----~~-----~~l~~~~~------------------------------ 387 (609)
|++|.++. ..++.... .. ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986442 11221111 00 01122110
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 388 -KRVALGAARGLEYLHE----------HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 388 -~~i~~~ia~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
..+...+.+++++|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 123489999999999999888889999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=6.5e-05 Score=78.18 Aligned_cols=76 Identities=13% Similarity=0.126 Sum_probs=49.9
Q ss_pred cCcccccCCceEEEEEeC-CCcEEEEEEeccCCC------CchHHHHHHHHHHHHhccC--CCcc-eeEeEEeCCCcceE
Q 007290 289 KNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES------PGGDAAFQREVEMISVAVH--RNLL-RLIGFCTTPTERLL 358 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 358 (609)
.+.||.|..+.||++... +++.++||....... +.....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 478899998653211 1223456788888887742 4433 45544 3445689
Q ss_pred EeecccCc
Q 007290 359 VYPFMQNL 366 (609)
Q Consensus 359 v~e~~~~g 366 (609)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.3e-06 Score=89.66 Aligned_cols=128 Identities=16% Similarity=0.216 Sum_probs=85.9
Q ss_pred CCCeEEEEecCCCcc---------cccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCcccc
Q 007290 65 SNNVASVTLSSMNFS---------GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLG 135 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 135 (609)
..+|+.|.+.++... +.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.++......++
T Consensus 138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 358899988765432 234455677899999999988311 2443 4 388999999998887643333444
Q ss_pred --Ccccchhhhccc--CcCCCC-----cCCCc--CcccccccccCCCCcccccCCc------ccccCCcccCCCCCC
Q 007290 136 --NLKKLQFLTLSQ--NNFSGT-----IPDSL--TTLSSLISIQLDSNNLSGQIPV------HLFQIPKYNFTGNNL 195 (609)
Q Consensus 136 --~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~ip~------~l~~l~~l~~~~n~~ 195 (609)
.+++|+.|+|+. |...|. +...+ ..+++|++|+|++|.+.+..+. .+.+|..|+++.|..
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 789999999863 332221 11122 3578999999999998754432 356788899988764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.89 E-value=1.4e-05 Score=83.19 Aligned_cols=123 Identities=15% Similarity=0.142 Sum_probs=85.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccc-----ccCCccccCcccch
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV-----GKIPPSLGNLKKLQ 141 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~ 141 (609)
+++.|+|.+ +++.+-...|.+ .+|+.+.| .|+++..-+..|.+|++|+.++|.+|.+. ..-+..|.+|++|+
T Consensus 227 ~L~~l~l~~-~l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~ 303 (401)
T 4fdw_A 227 QLKTIEIPE-NVSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA 303 (401)
T ss_dssp TCCCEECCT-TCCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred CCCEEecCC-CccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence 677788876 366555666766 78888888 45566444667888888888888887765 34456788888888
Q ss_pred hhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccc--cCCcccCCCCCC
Q 007290 142 FLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLF--QIPKYNFTGNNL 195 (609)
Q Consensus 142 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~--~l~~l~~~~n~~ 195 (609)
.++|. |.++..-..+|.+|++|+.|.|.+| ++ .|+ ..|. +|..+.+.+|..
T Consensus 304 ~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~~ 357 (401)
T 4fdw_A 304 RFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTTP 357 (401)
T ss_dssp EECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSSCCCEEEECCSSC
T ss_pred eEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCCC
Confidence 88888 4476333457778888888888655 55 344 3333 566677777743
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.85 E-value=5.1e-05 Score=79.65 Aligned_cols=78 Identities=13% Similarity=0.108 Sum_probs=48.5
Q ss_pred CCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCceeecc-cccccccCcccccCC---CCCcchhhHHHHHHHHHH
Q 007290 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQV-RGTMGHIAPEYLSTG---KSSERTDVFGYGIMLLEL 482 (609)
Q Consensus 407 ~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~Dv~slG~ll~el 482 (609)
+.++|||++|.||+++.++ ++|+||+.+..-.... ...... .-...|.+|+..... ......++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 9999999987543211 000000 011345666554311 122345566788888888
Q ss_pred HhCC
Q 007290 483 VTGQ 486 (609)
Q Consensus 483 ltg~ 486 (609)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00019 Score=71.87 Aligned_cols=140 Identities=16% Similarity=0.175 Sum_probs=92.2
Q ss_pred ccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc---CCCcceeEeEEeCCCcceEEeeccc
Q 007290 288 EKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV---HRNLLRLIGFCTTPTERLLVYPFMQ 364 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~ 364 (609)
..+.|+.|....+|+... ++..+++|+... .....+..|.+.++.+. ...+.++++++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 346789999999999986 477899998753 23567889999988775 3567788888887788999999999
Q ss_pred Cchhhh-----------hhhhcCC-CC-----------------CCccHHHHH---HHHH----------------HHHH
Q 007290 365 NLSVAY-----------RLREIKP-GE-----------------PVLDWVTRK---RVAL----------------GAAR 396 (609)
Q Consensus 365 ~gsL~~-----------~l~~~~~-~~-----------------~~l~~~~~~---~i~~----------------~ia~ 396 (609)
+..+.. .++.... .. ..-+|.... ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 875421 2233221 00 011343221 1111 1111
Q ss_pred H-HHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 397 G-LEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 397 ~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223321 2256899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00012 Score=72.37 Aligned_cols=79 Identities=24% Similarity=0.277 Sum_probs=56.9
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCC---CcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR---NLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv 359 (609)
.......+.+|.|..+.||+.+..||+.|++|+-.... ......|..|.+.|+.+... .+.+++++. ..++|
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 34455567899999999999999999999999865322 33345678899999887522 244555543 34789
Q ss_pred eecccCc
Q 007290 360 YPFMQNL 366 (609)
Q Consensus 360 ~e~~~~g 366 (609)
|||++++
T Consensus 89 ~e~l~~~ 95 (288)
T 3f7w_A 89 MEWVDER 95 (288)
T ss_dssp EECCCCC
T ss_pred EEeeccc
Confidence 9998765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.64 E-value=5.9e-05 Score=78.52 Aligned_cols=120 Identities=16% Similarity=0.231 Sum_probs=73.4
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.+.|.+ ++..+-+..|.++++|+.++|++|+++ .+|...-.+++|+.+.|.+| ++..-...|.+|++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 467777765 666566677888888888888888887 44443333577788877744 554445567778888888877
Q ss_pred cCcCCCCcC-CCcCcccccccccCCCCcccccCC-cccc---cCCcccCCCCC
Q 007290 147 QNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIP-VHLF---QIPKYNFTGNN 194 (609)
Q Consensus 147 ~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~ip-~~l~---~l~~l~~~~n~ 194 (609)
.| ++ .++ .+|.+ .+|+.+.+ .|.++ .|+ ..|. +|+.+.+.+|.
T Consensus 235 ~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~ 282 (401)
T 4fdw_A 235 EN-VS-TIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGST 282 (401)
T ss_dssp TT-CC-EECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSC
T ss_pred CC-cc-Ccccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCcc
Confidence 64 44 333 34444 56666666 34444 343 3333 34444454443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.44 E-value=1e-05 Score=73.25 Aligned_cols=82 Identities=16% Similarity=0.177 Sum_probs=40.3
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCC-cCCCCCcccccc----cccccccccccc-ccccCCccccCcccc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNG-ITGEIPEELGNL----SSLTSLDLDNNR-LVGKIPPSLGNLKKL 140 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 140 (609)
+++.|||+++.++..--..+..+++|+.|+|+++. |+..--..++.+ ++|++|+|+++. |+..-=..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 56666666666554333345566666666666653 443222223332 245666665553 442111234445555
Q ss_pred hhhhcccC
Q 007290 141 QFLTLSQN 148 (609)
Q Consensus 141 ~~L~l~~N 148 (609)
+.|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.37 E-value=2.9e-05 Score=70.23 Aligned_cols=94 Identities=11% Similarity=0.033 Sum_probs=69.5
Q ss_pred cCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccc-ccccCCccccCc----ccchhhhcccCc-CCCCcC
Q 007290 82 LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNR-LVGKIPPSLGNL----KKLQFLTLSQNN-FSGTIP 155 (609)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p 155 (609)
+|.....-.+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..++.+ ++|+.|+|+++. ++..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 34433233579999999999986655668899999999999995 764322345553 479999999975 774323
Q ss_pred CCcCcccccccccCCCCc-cc
Q 007290 156 DSLTTLSSLISIQLDSNN-LS 175 (609)
Q Consensus 156 ~~~~~l~~L~~L~l~~N~-l~ 175 (609)
..+.++++|++|+|+++. ++
T Consensus 133 ~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHGGGCTTCCEEEEESCTTCC
T ss_pred HHHhcCCCCCEEECCCCCCCC
Confidence 457789999999999986 44
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0013 Score=66.47 Aligned_cols=144 Identities=17% Similarity=0.067 Sum_probs=72.7
Q ss_pred cCcccccCCce-EEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC--CCcceeEeEEeCCCcceEEeecccC
Q 007290 289 KNVLGQGGFGK-VYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH--RNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 289 ~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
.+.|+.|.... +|+....+|..+++|...... ...+..|+.++..+.. -.+.+++.+.... .+++||++.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCC
Confidence 34566565544 667765447788887654321 0233456666665542 2345566654332 3789999877
Q ss_pred chhhhhhhh---------------------cCCC-CCCccHHHHH-------H-------------HHHHHHHHHHHHHh
Q 007290 366 LSVAYRLRE---------------------IKPG-EPVLDWVTRK-------R-------------VALGAARGLEYLHE 403 (609)
Q Consensus 366 gsL~~~l~~---------------------~~~~-~~~l~~~~~~-------~-------------i~~~ia~~L~~LH~ 403 (609)
.++.+.+.. .... ...++..... . ....+...++.+..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 655433321 1000 0111111000 0 00111122222211
Q ss_pred ---cCCCCeEecCCCCCcEEeCCC----CcEEEcccccceee
Q 007290 404 ---HCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKLV 438 (609)
Q Consensus 404 ---~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGl~~~~ 438 (609)
...+.++|||+.+.||+++.+ ..+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999875 68999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0026 Score=63.68 Aligned_cols=160 Identities=11% Similarity=0.060 Sum_probs=87.4
Q ss_pred cCHHHHHHHhcCCCc-----cCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCC--ccee
Q 007290 274 YSWRELQLATDNFSE-----KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRL 346 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 346 (609)
.+.+++......|.+ .+.|+.|....+|+....+| .+++|....... ...+..|..++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344555555555654 23466788899999987655 688998864211 234556777776664222 2233
Q ss_pred EeE------EeCCCcceEEeecccCchhhh--------------hhhhcCC----CC----CCccHHHHHH---------
Q 007290 347 IGF------CTTPTERLLVYPFMQNLSVAY--------------RLREIKP----GE----PVLDWVTRKR--------- 389 (609)
Q Consensus 347 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~----~~l~~~~~~~--------- 389 (609)
+.. ....+..+++++|++|..+.. .++.... .. ....|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112345678999998754321 1221111 00 0011222110
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 390 ---VALGAARGLEYLHEH----CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 390 ---i~~~ia~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+...+.+.++++++. ...+++|+|+++.||+++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455566532 134799999999999999876668999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0016 Score=64.79 Aligned_cols=139 Identities=12% Similarity=0.037 Sum_probs=75.8
Q ss_pred cCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceEEeecc-cCc
Q 007290 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLVYPFM-QNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 366 (609)
.+.|+.|....+|+. ..+++|+....... ......|+.+++.+...++ .+++++ ..+..++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 577888999999999 56888887542111 1123567877777653333 345544 344457899999 655
Q ss_pred hhhhh------------------hhhcCCC-CCCccH-HHHHHHHH--------------HHHHHHH----HHHh-cCCC
Q 007290 367 SVAYR------------------LREIKPG-EPVLDW-VTRKRVAL--------------GAARGLE----YLHE-HCNP 407 (609)
Q Consensus 367 sL~~~------------------l~~~~~~-~~~l~~-~~~~~i~~--------------~ia~~L~----~LH~-~~~~ 407 (609)
++... ++..... ...... .....+.. .+.+.+. .+.. ...+
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 44310 1111110 000111 11111100 0111111 1111 1233
Q ss_pred CeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 408 ~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5566789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0013 Score=68.97 Aligned_cols=73 Identities=12% Similarity=0.167 Sum_probs=50.5
Q ss_pred cCcccccCCceEEEEEeCC--------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceEE
Q 007290 289 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 359 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 359 (609)
.+.|+.|....+|++...+ +..+++|+.... .....+..|..+++.+...++ .++++.+.. .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 4568888899999998753 578999987431 112556689999888764444 456665532 389
Q ss_pred eecccCchh
Q 007290 360 YPFMQNLSV 368 (609)
Q Consensus 360 ~e~~~~gsL 368 (609)
++|++|.++
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00031 Score=60.43 Aligned_cols=56 Identities=23% Similarity=0.275 Sum_probs=39.1
Q ss_pred EEEecCCCcc-cccCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccccccc
Q 007290 70 SVTLSSMNFS-GTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLV 127 (609)
Q Consensus 70 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 127 (609)
.++.++++|+ ..+|..+ .++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6777778876 3555443 346788888888888544556677788888888887765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0065 Score=60.93 Aligned_cols=143 Identities=15% Similarity=0.134 Sum_probs=81.3
Q ss_pred CcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCC--cceeEeE-----EeCCCcceEEeec
Q 007290 290 NVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN--LLRLIGF-----CTTPTERLLVYPF 362 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~ 362 (609)
..++ |....||+....+|+.+++|...... .....+..|..++..+.... +.+++.. ....+..+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 88889999887778889999986321 13456777888877765222 3444433 1113345679999
Q ss_pred ccCchhhh-----------h---hhhcCC-----CCCCccHHHH----HHH---------------HHHHHHHHHHHHhc
Q 007290 363 MQNLSVAY-----------R---LREIKP-----GEPVLDWVTR----KRV---------------ALGAARGLEYLHEH 404 (609)
Q Consensus 363 ~~~gsL~~-----------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~ 404 (609)
++|..+.. . ++.... ....+++... ..+ ...+.+.++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754321 0 111110 0111222111 000 11111223333221
Q ss_pred ----CCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 405 ----CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 405 ----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00094 Score=57.35 Aligned_cols=57 Identities=25% Similarity=0.325 Sum_probs=47.7
Q ss_pred CEEEccCCCcC-CCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCC
Q 007290 93 STLTLKGNGIT-GEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFS 151 (609)
Q Consensus 93 ~~L~l~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 151 (609)
..++.+++.|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999997 46776554 57999999999999655667899999999999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0086 Score=63.10 Aligned_cols=74 Identities=12% Similarity=0.108 Sum_probs=48.1
Q ss_pred cCcccccCCceEEEEEeCC-CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceEEeecccCc
Q 007290 289 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLVYPFMQNL 366 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 366 (609)
.+.|+.|-...+|+....+ +..+++|+..... .. .-....|..+++.+...++ .++++++. ...|+||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCc
Confidence 4568888899999999864 4788898774321 11 1122578888888875555 45666662 23599999875
Q ss_pred hh
Q 007290 367 SV 368 (609)
Q Consensus 367 sL 368 (609)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0067 Score=62.18 Aligned_cols=143 Identities=15% Similarity=0.155 Sum_probs=83.1
Q ss_pred cCcccccCCceEEEEEeC--------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceEE
Q 007290 289 KNVLGQGGFGKVYRGVLA--------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 359 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 359 (609)
.+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+...++ .++++++.. .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 356777888999999874 2578999986321 2234566789999887763333 456666543 389
Q ss_pred eecccCchhhhh-----------------hhhcCC-CCCCc--cHHHHHHHHHHHH-------------------HHHHH
Q 007290 360 YPFMQNLSVAYR-----------------LREIKP-GEPVL--DWVTRKRVALGAA-------------------RGLEY 400 (609)
Q Consensus 360 ~e~~~~gsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~~ia-------------------~~L~~ 400 (609)
+||++|.++... ++.... ..... -+.++.++..++. ..+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998655311 111111 11111 2334444443332 12233
Q ss_pred HH----hc-CCCCeEecCCCCCcEEeCCC----CcEEEccccccee
Q 007290 401 LH----EH-CNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKL 437 (609)
Q Consensus 401 LH----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGl~~~ 437 (609)
|. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 21 12368999999999999876 7899999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.86 E-value=7.6e-05 Score=68.78 Aligned_cols=109 Identities=14% Similarity=0.192 Sum_probs=64.6
Q ss_pred CCeEEEEecCC-Cccc----ccCccccCCCCCCEEEccCCCcCCC----CCcccccccccccccccccccccc----CCc
Q 007290 66 NNVASVTLSSM-NFSG----TLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPP 132 (609)
Q Consensus 66 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 132 (609)
..++.|+|++| +|.. .+...+..-+.|+.|+|++|.|... +...+..-+.|+.|+|++|+|+.. +-.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46888888875 6653 2344555567788888888888733 233344456788888888887632 222
Q ss_pred cccCcccchhhhcccCcC---CCC----cCCCcCcccccccccCCCCcc
Q 007290 133 SLGNLKKLQFLTLSQNNF---SGT----IPDSLTTLSSLISIQLDSNNL 174 (609)
Q Consensus 133 ~~~~l~~L~~L~l~~N~l---~~~----~p~~~~~l~~L~~L~l~~N~l 174 (609)
.+..-+.|+.|+|++|.. ... +-..+..-+.|+.|+++.|.+
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 344445677777776532 211 222333445677777766654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0039 Score=63.90 Aligned_cols=74 Identities=9% Similarity=0.033 Sum_probs=44.4
Q ss_pred cCcccccCCceEEEEEeCC---------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceE
Q 007290 289 KNVLGQGGFGKVYRGVLAD---------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLL 358 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 358 (609)
.+.++.|....+|+....+ ++.+++|+..... ........|.++++.+...++ .++++.. ..++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec----CCcE
Confidence 3567888889999998754 2688888764321 111124578888887754343 3566544 2468
Q ss_pred EeecccCchh
Q 007290 359 VYPFMQNLSV 368 (609)
Q Consensus 359 v~e~~~~gsL 368 (609)
||+|++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0015 Score=67.60 Aligned_cols=108 Identities=11% Similarity=0.231 Sum_probs=57.8
Q ss_pred ccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCc
Q 007290 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 160 (609)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 160 (609)
.-...|.++.+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.+|.+|+.++|..| ++..-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 33445666666777766554433 334456666666666664 3344233345666666666666543 44222345666
Q ss_pred ccccccccCCCCcccccCC-cccc---cCCcccCCCC
Q 007290 161 LSSLISIQLDSNNLSGQIP-VHLF---QIPKYNFTGN 193 (609)
Q Consensus 161 l~~L~~L~l~~N~l~~~ip-~~l~---~l~~l~~~~n 193 (609)
|.+|+.+.+..+ ++ .|. ..|. +|+.+.+.+|
T Consensus 333 C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 333 CEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp CTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred CCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 666666666543 44 344 2333 3344445544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0037 Score=64.22 Aligned_cols=102 Identities=15% Similarity=0.127 Sum_probs=49.2
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.+.+..+ +..+....+.+..+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.+|++|+.+.+.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 3444444332 33333445555566666665544 33222334555555555555433 332223345555556555555
Q ss_pred cCcCCCCcCCCcCcccccccccCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDS 171 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~ 171 (609)
+|.++..-+.+|.++.+|+.+.|..
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCT
T ss_pred ccccceehhhhhcCCCCCCEEEcCc
Confidence 5555522234455555555555543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.01 Score=59.89 Aligned_cols=32 Identities=25% Similarity=0.338 Sum_probs=28.2
Q ss_pred CCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 407 PKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 407 ~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.38 E-value=0.015 Score=53.91 Aligned_cols=104 Identities=16% Similarity=0.096 Sum_probs=67.2
Q ss_pred CchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCc
Q 007290 365 NLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN 444 (609)
Q Consensus 365 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~ 444 (609)
.-+|.+.|+.+. .++++.++|.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 347888887643 4599999999999999998876321111 1233457899999999888763 1110
Q ss_pred eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCC
Q 007290 445 VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA 488 (609)
Q Consensus 445 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p 488 (609)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888763 3557889999999999998865544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0029 Score=65.50 Aligned_cols=114 Identities=15% Similarity=0.109 Sum_probs=80.9
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.+.+..+. +....|..+.+|+.+.+..| ++..-...|.++++|+.++|.++ ++..-...|.+|++|+.++|.
T Consensus 277 ~l~~~~~~~~~---i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp 351 (394)
T 4fs7_A 277 GLKKVIYGSVI---VPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP 351 (394)
T ss_dssp TCCEEEECSSE---ECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred ccceeccCcee---eccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence 34444444432 23456788999999999765 66344567999999999999755 664445689999999999998
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcc
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKY 188 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l 188 (609)
.| ++..-..+|.+|++|+.+++..| ++ .+...|.+.++|
T Consensus 352 ~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L 390 (394)
T 4fs7_A 352 LS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKF 390 (394)
T ss_dssp TT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEE
T ss_pred cc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCC
Confidence 77 76333568999999999998754 33 344455555544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0045 Score=64.04 Aligned_cols=117 Identities=14% Similarity=0.071 Sum_probs=84.5
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.+.+..+... .....|.....|+.+.+..+.+. ...+..+.+|+.+.+.+| ++..-...|.+|++|+.++|.
T Consensus 254 ~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 254 DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 4556666655433 55677888999999998876543 345888999999999766 663445679999999999997
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCC-ccccc---CCcccCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQ---IPKYNFT 191 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~---l~~l~~~ 191 (609)
++ ++..-..+|.++++|+.+.+..| ++ .|+ ..|.+ |+.+++.
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELP 374 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEE
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEEC
Confidence 54 76333568999999999999877 66 455 45554 4444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.013 Score=60.07 Aligned_cols=101 Identities=18% Similarity=0.144 Sum_probs=54.8
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.+.+..+ ++.+-...|.++.+|+.+.+..+ ++..-...|.++++|+.+++.+|.++..-...|.+|.+|+.+.|.
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence 4555555443 44344455566666666666433 442233445666666666666666653334456666666666665
Q ss_pred cCcCCCCc-CCCcCcccccccccCCC
Q 007290 147 QNNFSGTI-PDSLTTLSSLISIQLDS 171 (609)
Q Consensus 147 ~N~l~~~~-p~~~~~l~~L~~L~l~~ 171 (609)
.| ++ .| ..+|.++++|+.+.+..
T Consensus 319 ~~-l~-~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 319 TA-LK-TIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp TT-CC-EECTTTTTTCTTCCCCCCCT
T ss_pred cc-cc-EEHHHHhhCCCCCCEEEECC
Confidence 43 44 33 34566666666665543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.85 E-value=0.00063 Score=62.63 Aligned_cols=90 Identities=13% Similarity=0.168 Sum_probs=64.6
Q ss_pred ccccCCCCCCEEEccCC-CcCCC----CCcccccccccccccccccccccc----CCccccCcccchhhhcccCcCCCC-
Q 007290 84 PRIGVLRTLSTLTLKGN-GITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPPSLGNLKKLQFLTLSQNNFSGT- 153 (609)
Q Consensus 84 ~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~- 153 (609)
..+.+-+.|+.|+|++| .|... +-..+..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455688999999986 77632 344566668999999999999832 233444568899999999999842
Q ss_pred ---cCCCcCcccccccccCCCCc
Q 007290 154 ---IPDSLTTLSSLISIQLDSNN 173 (609)
Q Consensus 154 ---~p~~~~~l~~L~~L~l~~N~ 173 (609)
+-..+..-+.|+.|+|++|.
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHHHhhCCceeEEECCCCc
Confidence 22345555679999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.46 E-value=0.017 Score=59.52 Aligned_cols=105 Identities=12% Similarity=0.164 Sum_probs=70.0
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
.++.+.+.++.. .+-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-...|.+|++|+.+.|.
T Consensus 266 ~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 345555544332 2445567778888888885 4565344456788888888888765 553445578888888888886
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCccc
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
.+ ++..-..+|.+|++|+.+++.+|...
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 54 65223457788888888888877543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.094 Score=54.43 Aligned_cols=74 Identities=7% Similarity=0.037 Sum_probs=48.3
Q ss_pred cCcccccCCceEEEEEeCC--------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceEE
Q 007290 289 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 359 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 359 (609)
.+.+..|-...+|+....+ +..+++|+..... . ..-+..+|..+++.+...++ .++++.+. .+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-G-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 4567778889999998753 5789999864321 1 11233578888887753333 44555332 3789
Q ss_pred eecccCchh
Q 007290 360 YPFMQNLSV 368 (609)
Q Consensus 360 ~e~~~~gsL 368 (609)
++|++|.++
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.95 E-value=0.26 Score=50.81 Aligned_cols=29 Identities=28% Similarity=0.470 Sum_probs=25.1
Q ss_pred eEecCCCCCcEEe------CCCCcEEEccccccee
Q 007290 409 IIHRDVKAANVLL------DEDFEAVVGDFGLAKL 437 (609)
Q Consensus 409 ivH~Dlkp~NIll------~~~~~~kl~DfGl~~~ 437 (609)
++|+|+.+.||++ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999999874
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.65 E-value=0.92 Score=41.84 Aligned_cols=116 Identities=12% Similarity=0.098 Sum_probs=79.4
Q ss_pred cCCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 339 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
.||++++. .+-.+.+...+.|+.-+.+.=...++. .+...+++++.+|+..-.+++.. +|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888866 455666666666665543222222333 68889999999999988777655 788899999
Q ss_pred EEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~ 490 (609)
++++.++.+++.=.|+...+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999866654322 222 11222224478889999999998874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.59 E-value=1.4 Score=40.82 Aligned_cols=115 Identities=14% Similarity=0.160 Sum_probs=78.1
Q ss_pred cCCCcceeEeEEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 007290 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE-YLHEHCNPKIIHRDVKAA 417 (609)
Q Consensus 339 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlkp~ 417 (609)
.||++ -..+-.+.+...+.|+.-+++.=...++. ++...+++++.+++.... +++.. +|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 57877 34445667777777766544333333433 688899999999988777 66654 78889999
Q ss_pred cEEeCCCCcEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 007290 418 NVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490 (609)
Q Consensus 418 NIll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~ 490 (609)
|+++|.++.+++.-.|+-.. ++|.-+ +..-=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987665432 233221 111123377888899999887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.03 E-value=0.17 Score=53.16 Aligned_cols=62 Identities=10% Similarity=0.007 Sum_probs=18.3
Q ss_pred CccCcccccCCceEEEEEeCC-CcEEEE------EEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 287 SEKNVLGQGGFGKVYRGVLAD-GTKVAV------KRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~~-g~~vav------K~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
.+.+.|| ||.||+|.+.. ..+||| |..+... +......|.+|..+....+|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999999863 467888 7665422 2233456888899988999999999988764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.01 E-value=0.062 Score=35.67 Aligned_cols=26 Identities=35% Similarity=0.461 Sum_probs=12.9
Q ss_pred EEEeeeechhhhhhccceeeeecccc
Q 007290 222 IIVGIVGGLIVLISGGLLFFLCKGRH 247 (609)
Q Consensus 222 ii~~~v~~~~~l~~~~~~~~~~~~r~ 247 (609)
+..++++|+++++++++.++++.+||
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 44466666666554444443333333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 609 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 4e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-64
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 25/278 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+ LG G FG+V+ G TKVAVK L + AF E ++ H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
+RL T ++ +M+N S+ L+ P L +A A G+ ++ E
Sbjct: 71 VRLYAVVTQE-PIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
IHRD++AAN+L+ + + DFGLA+L++ + + + APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 464 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523
G + ++DV+ +GI+L E+VT R + ++ ++++ R R D +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNLERGYRMVRPDNCPEE-- 238
Query: 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Q+ LC + PEDRP + +LE
Sbjct: 239 -----------LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-62
Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 27/283 (9%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 342
+ +G G FG VY+G VAVK L +P AF+ EV ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+L +G+ T P +V + + S+ + L I+ + + +A A+G++YLH
Sbjct: 66 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH 121
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD-VRKTNVTTQVRGTMGHIAPEYL 461
IIHRD+K+ N+ L ED +GDFGLA + ++ Q+ G++ +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 462 STGKS---SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
S ++DV+ +GI+L EL+TGQ + ++ V + L +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ M ++ C + ++RP +++ +E
Sbjct: 235 RS---------NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-60
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 25/278 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+ +G G FG V+ G + KVA+K + E + F E E++ H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
++L G C LV+ FM++ ++ LR + T + L G+ YL E
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
C +IHRD+ A N L+ E+ V DFG+ + V + +T + + +PE S
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 464 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523
+ S ++DV+ +G+++ E+ + + +R E +++ + R +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLASTH-- 230
Query: 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ Q+ C + PEDRPA S ++R L
Sbjct: 231 -----------VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 1e-59
Identities = 67/311 (21%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQRE 331
L+ +N +G+G FG+V++ T VAVK L + S A FQRE
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 332 VEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIK--------------- 376
+++ + N+++L+G C L++ +M + LR +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 377 -----PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431
PG P L + +A A G+ YL E K +HRD+ N L+ E+ + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183
Query: 432 FGLAKLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAID 490
FGL++ + + + PE + + + +DV+ YG++L E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 491 FSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDR 550
+ EE ++ +V+ + + + LC P DR
Sbjct: 244 YGMAHEE----VIYYVRDGNILACPENCPLE-------------LYNLMRLCWSKLPADR 286
Query: 551 PAMSEVVRMLE 561
P+ + R+L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-59
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 25/278 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
++ + LGQG FG+V+ G T+VA+K L AF +E +++ H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
++L + +V +M S L +A A G+ Y+
Sbjct: 75 VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
+HRD++AAN+L+ E+ V DFGLA+L++ + + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 464 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523
G+ + ++DV+ +GI+L EL T R + E +LD V++ R +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-- 242
Query: 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + C + PE+RP + LE
Sbjct: 243 -----------LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 3e-59
Identities = 69/305 (22%), Positives = 131/305 (42%), Gaps = 40/305 (13%)
Query: 274 YSWRELQLATDNFSEK---------NVLGQGGFGKVYRGVLADGTK----VAVKRLTDFE 320
+++ + A F+++ V+G G FG+V G L K VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 321 SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP 380
+ F E ++ H N++ L G T T +++ FM+N S+ LR+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 381 VLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440
+ + G A G++YL + +HRD+ A N+L++ + V DFGL++ ++
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 441 RKTNVTT----QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496
++ T + + APE + K + +DV+ YGI++ E+++ + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMTN 239
Query: 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ D + +E++ RL +D + Q+ L C Q RP ++
Sbjct: 240 Q------DVINAIEQDYRLPPPMD----------CPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 557 VRMLE 561
V L+
Sbjct: 284 VNTLD 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-59
Identities = 63/290 (21%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGT-----KVAVKRLTDFESPGGDAAFQREVEM 334
++ + + V+G G FG+VY+G+L + VA+K L + F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
+ H N++RL G + +++ +M+N ++ LRE + + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGT 452
A G++YL +HRD+ A N+L++ + V DFGL++++ D T T+ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 453 MGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512
+ APE +S K + +DV+ +GI++ E++T + E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562
+ ++ + + Q+ + C Q RP +++V +L+
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-58
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 30/291 (10%)
Query: 277 RELQLATDNFSEKNV-LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREV 332
++L L DN ++ LG G FG V +GV VA+K L RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 333 EMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVAL 392
+++ + ++RLIG C +LV + L + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 393 GAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT--NVTTQVR 450
+ G++YL E +HRD+ A NVLL A + DFGL+K + + + +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510
+ APE ++ K S R+DV+ YG+ + E ++ + ++ ++ +++ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMAFIEQGK 229
Query: 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
R + + + C EDRP V + +
Sbjct: 230 RMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-57
Identities = 52/278 (18%), Positives = 103/278 (37%), Gaps = 25/278 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+ + LG G FG V G VA+K + E + F E +++ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
++L G CT ++ +M N + L ++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLST 463
+HRD+ A N L+++ V DFGL++ V + + + + PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 464 GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNL 523
K S ++D++ +G+++ E+ + + + R + + +L R
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHIAQGLRLYRPHLAS------- 227
Query: 524 NKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
E + + C ++RP ++ +
Sbjct: 228 ---------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 60/306 (19%), Positives = 121/306 (39%), Gaps = 35/306 (11%)
Query: 279 LQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISV 337
++L D+F + + LG G G V++ G +A K + P RE++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
++ G + E + M S+ L++ + +V++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKG 116
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
L YL E KI+HRDVK +N+L++ E + DFG++ + ++ GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL---------------- 501
PE L S ++D++ G+ L+E+ G+ I +E + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 502 ---------LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA 552
+D + + LD IV+ K + C +P +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 553 MSEVVR 558
+ +++
Sbjct: 292 LKQLMV 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 2e-57
Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 25/291 (8%)
Query: 272 KRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQR 330
++ + ++ + + K+ LG G +G+VY GV VAVK L E F +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLK 62
Query: 331 EVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRV 390
E ++ H NL++L+G CT ++ FM ++ LRE E + V +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120
Query: 391 ALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVR 450
A + +EYL + IHRD+ A N L+ E+ V DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510
+ APE L+ K S ++DV+ +G++L E+ T + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------- 224
Query: 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ +++++ E + ++ C Q +P DRP+ +E+ + E
Sbjct: 225 ----VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 3e-57
Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 41/302 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMIS- 336
+ S LG G FGKV VAVK L A E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLRE--------------IKPGEPVL 382
+ H N++ L+G CT L++ + + LR ++ E L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV-DVR 441
D + A+G+ +L IHRD+ A N+LL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 442 KTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501
V R + +APE + + +DV+ YGI L EL + + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 502 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ ++ M + C A P RP ++V+++E
Sbjct: 256 ------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 562 GE 563
+
Sbjct: 304 KQ 305
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-56
Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL 343
+G+G FG V G G KVAVK + + AF E +++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62
Query: 344 LRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
++L+G L +V +M S+ LR G VL + +L +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 462
+ +HRD+ A NVL+ ED A V DFGL K + + + APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALR 173
Query: 463 TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522
K S ++DV+ +GI+L E+ + R ++ ++ V+K + D
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA- 228
Query: 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ +V C RP+ ++ LE
Sbjct: 229 ------------VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 64/307 (20%), Positives = 111/307 (36%), Gaps = 46/307 (14%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFESPGGDAAFQREVEMIS- 336
+N VLG G FGKV +VAVK L + A E++M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 337 VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKP------------------- 377
+ H N++ L+G CT L++ + + LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 378 GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437
VL + A A+G+E+L +HRD+ A NVL+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 438 VDVRKTNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEE 496
+ V R + +APE L G + ++DV+ YGI+L E+ + + +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272
Query: 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ + ++ + E + + C RP+ +
Sbjct: 273 DANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 557 VRMLEGE 563
L +
Sbjct: 318 TSFLGCQ 324
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-56
Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 37/304 (12%)
Query: 285 NFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVH 340
+F+E V+G+G FG VY G L D AVK L G + F E ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 341 RNLLRLIGFCT-TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
N+L L+G C + L+V P+M++ + + P L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNP--TVKDLIGFGLQVAKGM- 143
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV---DVRKTNVTTQVRGTMGHI 456
+ K +HRD+ A N +LDE F V DFGLA+ + + + T + + +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 457 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
A E L T K + ++DV+ +G++L EL+T + + + ++ + R + +
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVNTFDITVYLLQGRRLLQPE 257
Query: 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERW--EEWQH 574
D + +V L C E RP+ SE+V + + + E + H
Sbjct: 258 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRI--SAIFSTFIGEHYVH 302
Query: 575 VEVT 578
V T
Sbjct: 303 VNAT 306
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-55
Identities = 63/294 (21%), Positives = 127/294 (43%), Gaps = 38/294 (12%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADG---TKVAVKRLTDFESPGGDAAFQREVEMIS-VAV 339
++ ++V+G+G FG+V + + A+KR+ ++ S F E+E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEP------------VLDWVTR 387
H N++ L+G C L + + ++ LR+ + E L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 388 KRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTT 447
A ARG++YL + + IHRD+ A N+L+ E++ A + DFGL++ +V T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 448 QVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507
R + +A E L+ + +DV+ YG++L E+V+ + L + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG----TPYCGMTCAELYEKLP 240
Query: 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ R ++ D + + C + P +RP+ ++++ L
Sbjct: 241 QGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-55
Identities = 64/294 (21%), Positives = 118/294 (40%), Gaps = 29/294 (9%)
Query: 289 KNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIG 348
+ +G+G FG+V+RG G +VAVK + E + E+ + H N+L I
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 64
Query: 349 FCT----TPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
T T+ LV + ++ S+ L + ++AL A GL +LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 119
Query: 405 C-----NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV---TTQVRGTMGHI 456
P I HRD+K+ N+L+ ++ + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 457 APEYLST------GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE--DDVLLLDHVKK 508
APE L +S +R D++ G++ E+ + D++ D +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 509 LEREKRLDAIVDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
R+ + + N+ + + + + M ++ C A+ R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-54
Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 31/280 (11%)
Query: 288 EKNVLGQGGFGKVYRGVLAD---GTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHRNL 343
E LG G FG V +G VAVK L + P E ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 344 LRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE 403
+R+IG C + +LV + + L++ + + + + G++YL E
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE 125
Query: 404 HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV--DVRKTNVTTQVRGTMGHIAPEYL 461
+HRD+ A NVLL A + DFGL+K + D T + + APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
+ K S ++DV+ +G+++ E + + + ++ + +L+ +++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEKGERMGCPAGCP----- 236
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
M + LC E+RP + V L
Sbjct: 237 -----------REMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 7e-54
Identities = 53/281 (18%), Positives = 108/281 (38%), Gaps = 25/281 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+++ +G G +G+ + +DG + K L + EV ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 342 NLLRLIGFCTTPTERLL--VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
N++R T L V + + +A + + LD RV L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 400 YLHEH--CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
H ++HRD+K ANV LD +GDFGLA++++ T+ GT +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKAFVGTPYYMS 182
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
PE ++ +E++D++ G +L EL L +++ + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRR---- 233
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
+ Y+ + + ++ RP++ E++
Sbjct: 234 -----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-53
Identities = 68/309 (22%), Positives = 129/309 (41%), Gaps = 33/309 (10%)
Query: 268 FGQLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGVL------ADGTKVAVKRLTDFES 321
F Y E ++A + + LGQG FG VY GV T+VA+K + + S
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 322 PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE-- 379
F E ++ +++RL+G + L++ M + LR ++P
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 380 ----PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435
++A A G+ YL+ + K +HRD+ A N ++ EDF +GDFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 436 KLV-DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRL 494
+ + + + + ++PE L G + +DV+ +G++L E+ T
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---- 236
Query: 495 EEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS 554
+ + +L V + + D D + ++ +C Q +P+ RP+
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFL 283
Query: 555 EVVRMLEGE 563
E++ ++ E
Sbjct: 284 EIISSIKEE 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 8e-53
Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 32/277 (11%)
Query: 289 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTD-FESPGGDAAFQREVEMISVAVHRNLLRL 346
+G+G F VY+G+ + +VA L D + F+ E EM+ H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 347 IGFCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+ + +LV M + ++ L+ K + + +GL++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 403 EHCNPKIIHRDVKAANVLL-DEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
P IIHRD+K N+ + +GD GLA L + V GT +APE
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY 185
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
K E DV+ +G+ +LE+ T + E ++ + V + D +
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
+ ++ C + + ++R ++ +++
Sbjct: 241 EV------------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 57/278 (20%), Positives = 110/278 (39%), Gaps = 26/278 (9%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+++ LG+G +G+V V VAVK + + ++E+ + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+++ G + L + + R+ + +R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPEYL 461
I HRD+K N+LLDE + DFGLA + + + ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 462 STGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
+ +E DV+ GI+L ++ G+ D ++ + L K++D+
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
L+K +P R + ++ +
Sbjct: 238 ALLHK----------------ILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-52
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 36/280 (12%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 340
++F LG+G FG VY +A+K L E G + +REVE+ S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
N+LRL G+ T L+ + +V L+++ D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
H ++IHRD+K N+LL E + DFG + ++ T + GT+ ++ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEM 175
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
+ E+ D++ G++ E + G+ + + +E
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------------------TYK 214
Query: 521 RNLNKNYNIQEV--ETMIQVALLCTQASPEDRPAMSEVVR 558
R + + E + + +P RP + EV+
Sbjct: 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 2e-51
Identities = 71/282 (25%), Positives = 107/282 (37%), Gaps = 35/282 (12%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV 339
FS+ +G G FG VY + + VA+K++ + +S +EV +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
H N ++ G LV + + KP L V V GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
YLH H +IHRDVKA N+LL E +GDFG A ++ GT +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPE 181
Query: 460 YLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
+ G+ + DV+ GI +EL + L + + L H+ + E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQS 236
Query: 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
E C Q P+DRP +++
Sbjct: 237 GHWS------------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 7e-51
Identities = 64/304 (21%), Positives = 122/304 (40%), Gaps = 32/304 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD-----GTKVAVKRLTDFESPGGDAAFQREVEMISVA 338
F + VLG G FG VY+G+ VA+K L + SP + E +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGL 398
+ ++ RL+G C T T +L+ M + +RE K + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGM 124
Query: 399 EYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR-KTNVTTQVRGTMGHIA 457
YL + +++HRD+ A NVL+ + DFGLAKL+ K + + +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 458 PEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
E + + ++DV+ YG+ + EL+T + + + +L+ ++L +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEKGERLPQPPICT- 239
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEV 577
+ + + C + RP E++ +A + + ++
Sbjct: 240 ---------------IDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVIQG 282
Query: 578 TRRQ 581
R
Sbjct: 283 DERM 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 76/286 (26%), Positives = 107/286 (37%), Gaps = 31/286 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVL----ADGTKVAVKRL--TDFESPGGDAAFQREVEMISV 337
+ LG G FG V RG VAVK L P F REV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
HRNL+RL G TP ++ V S+ RLR+ + T R A+ A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTN--VTTQVRGTMGH 455
+ YL IHRD+ A N+LL +GDFGL + + + + +
Sbjct: 124 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515
APE L T S +D + +G+ L E+ T + + +L K+ ER R
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERLPRP 237
Query: 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + V + C PEDRP + L
Sbjct: 238 EDCPQD-------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 40/299 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV------LADGTKVAVKRLTDFESPGGDAAFQREVEMISV 337
D LG+G FG+V A VAVK L + + A E++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 338 AVHR-NLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKP------------GEPVLD 383
H N++ L+G CT P L ++ F + +++ LR + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 384 WVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443
+ A+G+E+L K IHRD+ A N+LL E + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 444 NV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 502
V R + +APE + + ++DV+ +G++L E+ + + + D
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP---GVKIDEEF 246
Query: 503 LDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+K+ R + D M Q L C P RP SE+V L
Sbjct: 247 CRRLKEGTRMRAPDYTTPE-------------MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-48
Identities = 53/282 (18%), Positives = 108/282 (38%), Gaps = 28/282 (9%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAV 339
+ +G+G FG V++G+ VA+K + S F +E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
H ++++LIG T ++ + L+ K LD + A + L
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALA 122
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
YL + +HRD+ A NVL+ + +GDFGL++ ++ ++ + + +APE
Sbjct: 123 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519
++ + + +DV+ +G+ + E++ + ++ ++ ER
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC- 234
Query: 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
T+ + C P RP +E+ L
Sbjct: 235 ------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 42/300 (14%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVL--------ADGTKVAVKRLTDFESPGGDAAFQREVEMI 335
D LG+G FG+V TKVAVK L + + E+EM+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 336 S-VAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPG------------EPVL 382
+ H+N++ L+G CT ++ + ++ L+ +P E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 383 DWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442
A ARG+EYL K IHRD+ A NVL+ ED + DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 443 TNVTTQV-RGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVL 501
T R + +APE L + ++DV+ +G++L E+ T + EE
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245
Query: 502 LLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
L +K+ R + + + + C A P RP ++V L+
Sbjct: 246 LFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 57/277 (20%), Positives = 116/277 (41%), Gaps = 27/277 (9%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
++ +GQG G VY + +A G +VA++++ + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ + E +V ++ S+ + E D V + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFL 132
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
H + ++IHRD+K+ N+LL D + DFG + ++ +T V GT +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
+ + D++ GIM +E++ G+ ++ + +L+ ++L AI
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
LN+ C E R + E+++
Sbjct: 249 FLNR----------------CLDMDVEKRGSAKELLQ 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-46
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 30/282 (10%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
D + LG G FGKVY+ A K + D +S + E+++++ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N+++L+ ++ F +V + E++ L + V L YL
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDALNYL 126
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
H++ KIIHRD+KA N+L D + + DFG++ R GT +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVV 182
Query: 462 STGKS-----SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
S + DV+ GI L+E+ + + L + R
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
C + + + R S++++
Sbjct: 243 ----------------SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-43
Identities = 58/282 (20%), Positives = 106/282 (37%), Gaps = 30/282 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 340
++F +LG+G F V LA + A+K L RE +++S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
++L + + +N + +R+I D + LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 123
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV-RKTNVTTQVRGTMGHIAPE 459
LH IIHRD+K N+LL+ED + DFG AK++ K GT +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519
L+ + + +D++ G ++ +LV G ++ L+ + KLE +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKLEYD------- 228
Query: 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ + + +++ R E+
Sbjct: 229 ---FPEKFF-PKARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (390), Expect = 1e-42
Identities = 59/299 (19%), Positives = 111/299 (37%), Gaps = 31/299 (10%)
Query: 265 RIAFGQLKRYSWRELQLAT----DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDF 319
F K+Y + +++ D++ LG G FG V+R A G A K +
Sbjct: 3 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MT 61
Query: 320 ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGE 379
++E++ +SV H L+ L E +++Y FM + ++ +
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK- 120
Query: 380 PVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLL--DEDFEAVVGDFGLAKL 437
+ +GL ++HE+ +H D+K N++ E + DFGL
Sbjct: 121 --MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEE 497
+D +++ T GT APE TD++ G++ L++G E
Sbjct: 176 LDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGE 228
Query: 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+D L +VK + +D ++++ A P R + +
Sbjct: 229 NDDETLRNVKSCDW--NMDDSAFSGISED--------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (386), Expect = 2e-42
Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 22/284 (7%)
Query: 276 WRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEM 334
W++ + D + ++VLG G F +V VA+K + G + + + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 335 ISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGA 394
+ H N++ L + L+ + + R+ E R+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQV 116
Query: 395 ARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMG 454
++YLH+ + LDED + ++ DFGL+K+ D +V + GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPG 174
Query: 455 HIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514
++APE L+ S+ D + G++ L+ G +E+D L + + L+ E
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQI--LKAEYE 227
Query: 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
D+ +++ + + PE R + ++
Sbjct: 228 FDSPYWDDISDS--------AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 2e-41
Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 35/308 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
D + LG G FG V+R V A G K + + P + E+ +++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPK 87
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
L+ L E +L+ F+ + R+ + A GL+++H
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMH 144
Query: 403 EHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
EH I+H D+K N++ + + + DFGLA ++ + T APE
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEI 199
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
+ TD++ G++ L++G EDD+ L +VK+ + E DA
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEGLAERWEEWQHVEVTRR 580
+ Q P R + + L W + H +T R
Sbjct: 255 VS----------PEAKDFIKNLLQKEPRKRLTVHDA--------LEHPWLKGDHSNLTSR 296
Query: 581 QEYERLQR 588
R +
Sbjct: 297 IPSSRYNK 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (376), Expect = 3e-41
Identities = 54/286 (18%), Positives = 113/286 (39%), Gaps = 18/286 (6%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHRN 342
+ + +G+G +G VY+ G A+K++ + E G + RE+ ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+++L T +LV+ + + + E L+ VT K L G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLS 462
+ +++HRD+K N+L++ + E + DFGLA+ + T ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 463 TGKSSERTDVFGYGIMLLELVTGQRAIDFS----------RLEEEDDVLLLDHVKKLERE 512
+ K S D++ G + E+V G R+ + +V +L +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
+ + +++ E+ I + + P R + +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 3e-41
Identities = 59/289 (20%), Positives = 109/289 (37%), Gaps = 40/289 (13%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--------TDFESPGGDAAFQREVE- 333
+N+ K +LG+G V R + + AVK + + E A +EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 334 MISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
+ V+ H N+++L T T LV+ M+ + L E L +++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRA 118
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
+ LH+ I+HRD+K N+LLD+D + DFG + +D +V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP 173
Query: 454 GHIAPEYLSTG------KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507
++APE + + D++ G+++ L+ G +L+L +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228
Query: 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ D + +T+ + P+ R E
Sbjct: 229 SGNYQFGSPEWDDYS----------DTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 150 bits (379), Expect = 7e-41
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 21/254 (8%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRL--TDFESPGGDAAFQREVEMISVAV- 339
++FS ++G+GGFG+VY AD G A+K L + G+ E M+S+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 340 --HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
++ + TP + + M + Y L + + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIA 457
LE++H +++RD+K AN+LLDE + D GLA +K GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173
Query: 458 PEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516
PE L G + D F G ML +L+ G + +++ ++ + +E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 517 ----AIVDRNLNKN 526
++++ L ++
Sbjct: 234 PELRSLLEGLLQRD 247
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (365), Expect = 8e-40
Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 32/289 (11%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV 339
+D + +LG GG +V+ L VAVK L P F+RE + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 340 HRNLLRLIGFCTTPTERL----LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
H ++ + T +V ++ +++ + P + V A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV--TTQVRGTM 453
+ L + H++ IIHRDVK AN+++ V DFG+A+ + +V T V GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513
+++PE R+DV+ G +L E++TG+ + + HV++
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVRE----- 229
Query: 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLE 561
D I ++ + + V L +PE+R +E+ L
Sbjct: 230 --DPIPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 20/286 (6%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+NF + +G+G +G VY+ G VA+K++ D E+ G + RE+ ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N+++L+ T + LV+ F+ + G + K +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
H H ++HRD+K N+L++ + + DFGLA+ V T +V L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAID-----------FSRLEEEDDVLLLDHVKKLE 510
S D++ G + E+VT + F L D+V+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ ++ +K E + P R +
Sbjct: 236 YKPSFPKWARQDFSKVVP-PLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 4e-39
Identities = 54/295 (18%), Positives = 94/295 (31%), Gaps = 33/295 (11%)
Query: 278 ELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS 336
EL++ + + +G G FG +Y G +A G +VA+K E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57
Query: 337 VAVHRNLLRLIGFCTTPTERL-LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
+ + I +C + +V + + T +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVL---LDEDFEAVVGDFGLAKLVDVRKTNV------T 446
+EY+H IHRDVK N L + + DFGLAK +T+
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV 506
+ GT + + + S R D+ G +L+ G + +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
KK+ L K Y C +D+P S + ++
Sbjct: 231 KKMS-------TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 53/283 (18%), Positives = 118/283 (41%), Gaps = 13/283 (4%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 341
++ + +G+G +G V + +VA+K+++ FE RE++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ + PT + ++ + L ++ + L RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT--TQVRGTMGHIAPE 459
H ++HRD+K +N+LL+ + + DFGLA++ D + T+ T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 460 YLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518
+ ++ D++ G +L E+++ + F D + + + ++ L+ I
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
++ + + L A + A+ + +ML
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSK---ALDLLDKMLT 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 5e-39
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 14/207 (6%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 340
+F LG G FG+V+ +G A+K L E M+S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
++R+ G + ++ +++ L + K A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
LH II+RD+K N+LLD++ + DFG AK V +VT + GT +IAPE
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQR 487
+ST ++ D + +GI++ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 12/208 (5%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAV- 339
++F +LG+G FGKV+ A+K L E ++S+A
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 340 HRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
H L + T V ++ + Y ++ D A GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
+LH I++RD+K N+LLD+D + DFG+ K + T GT +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQR 487
L K + D + +G++L E++ GQ
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 8e-39
Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 21/291 (7%)
Query: 282 ATDNFSEKNVLGQGGFGKVYRG--VLADGTKVAVKRL-TDFESPGGDAAFQREVE---MI 335
A + +G+G +GKV++ + G VA+KR+ G + REV +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 336 SVAVHRNLLRLIGFCTTPT--ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
H N++RL CT + +++ K EP + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
RGL++LH H +++HRD+K N+L+ + + DFGLA++ + T V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513
+ APE L + D++ G + E+ + S ++ +L E +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 514 RLDAIVDRNLNKNYNIQEVETMIQ------VALL--CTQASPEDRPAMSEV 556
D + R + + Q +E + LL C +P R +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (353), Expect = 5e-38
Identities = 40/291 (13%), Positives = 88/291 (30%), Gaps = 34/291 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
++ +G+G FG ++ G L + +VA+K + E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCT 61
Query: 343 LL-RLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
+ + F +LV + + T A ++ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSI 117
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVG-----DFGLAKLVDVRKTNV------TTQVR 450
HE +++RD+K N L+ DFG+ K T +
Sbjct: 118 HEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 451 GTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLE 510
GT +++ + S R D+ G + + + G + L+ + + + + +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKK 232
Query: 511 REKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+ L R L + E + + + P + +
Sbjct: 233 QSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 49/278 (17%), Positives = 103/278 (37%), Gaps = 28/278 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
+ + LG+G FG V+R V + K + ++E+ ++++A HRN
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
+L L + E ++++ F+ L + R+ L+ L++LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLH 119
Query: 403 EHCNPKIIHRDVKAANVLLDEDFEAVV--GDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
H I H D++ N++ + + +FG A+ + + + + APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEV 174
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
S TD++ G ++ L++G E + +++++ E D
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP-----FLAETNQQIIENIMNAEYT------FD 223
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
K + E + + R SE ++
Sbjct: 224 EEAFKEIS-IEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 23/281 (8%)
Query: 288 EK-NVLGQGGFGKVYRGV-LADGTKVAVKRL----TDFESPGGDAAFQREVEMISVAVHR 341
EK + LG+G F VY+ VA+K++ G + RE++++ H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++ L+ + LV+ FM+ IK VL K L +GLEYL
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
H+H I+HRD+K N+LLDE+ + DFGLAK T QV T + APE L
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELL 172
Query: 462 STGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
+ D++ G +L EL+ L + D+ L + + + D
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF-----LPGDSDLDQLTRIFETLGTPTEEQWPD 227
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561
+Y + I + + + A + + + +
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDD---LLDLIQGLFL 265
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 8e-37
Identities = 63/293 (21%), Positives = 106/293 (36%), Gaps = 32/293 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRN 342
++++ V+G G FG VY+ L D G VA+K++ RE++++ H N
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74
Query: 343 LLRLIGFCTTPTER------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAAR 396
++RL F + E+ LV ++ + + L + K R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFR 133
Query: 397 GLEYLHEHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
L Y+H I HRD+K N+LLD D + DFG AK + VR + +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYR 189
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL------------L 503
+ DV+ G +L EL+ GQ F D ++ +
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEV 556
+ E + I K + + I + + +P R E
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 53/285 (18%), Positives = 93/285 (32%), Gaps = 34/285 (11%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVK-----RLTDFESPGGDAAFQREVEMISV 337
D + LG G F V + + G + A K R +REV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 338 AVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARG 397
H N++ L T+ +L+ + L + + L G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLDED----FEAVVGDFGLAKLVDVRKTNVTTQVRGTM 453
+ YLH I H D+K N++L + + DFGLA +D N + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTP 180
Query: 454 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513
+APE ++ D++ G++ L++G +E L +V
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSA----- 230
Query: 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
V+ Y P+ R + + ++
Sbjct: 231 -----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 50/289 (17%), Positives = 110/289 (38%), Gaps = 22/289 (7%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + +G+G +G V++ VA+KR+ D + G ++ RE+ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 342 NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYL 401
N++RL + + LV+ F Y + + V + L+ L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQLLKGL 114
Query: 402 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
+ ++HRD+K N+L++ + E + +FGLA+ + + +V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
S D++ G + EL R + F + +D + + + E++ ++
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 522 NLNKNYNIQEVETMIQVALL------------CTQASPEDRPAMSEVVR 558
K Y + T + + + +P R + E ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 3e-34
Identities = 54/277 (19%), Positives = 96/277 (34%), Gaps = 33/277 (11%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHRNLLRLIG 348
VLG G GKV + K A+K L D +REVE + +++R++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVD 72
Query: 349 FCTTPTER----LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEH 404
L+V + + R++ G+ + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 405 CNPKIIHRDVKAANVLLDEDFE---AVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
I HRDVK N+L + DFG AK + T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 462 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521
K + D++ G+++ L+ G + + +K R + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYE----- 235
Query: 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
+ E + + + P R ++E +
Sbjct: 236 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 55/278 (19%), Positives = 99/278 (35%), Gaps = 44/278 (15%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRL-----TDFESPGGDAAFQREVEMIS--VAVHRN 342
+LG GGFG VY G+ ++D VA+K + +D+ EV ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 343 LLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLH 402
++RL+ + P +L+ + + + + L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 403 EHCNPKIIHRDVKAANVLLDED-FEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYL 461
++HRD+K N+L+D + E + DFG L+ K V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 462 STGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520
+ V+ GI+L ++V G + V V ++
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-----SECQHLIR 236
Query: 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558
L P DRP E+
Sbjct: 237 WCLALR--------------------PSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 11/207 (5%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDAAFQREVEMISVAVH 340
++F +LG+G FGKV A G A+K L + A E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
L L T V + + + L + T +R A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
L + +++RD+K N++LD+D + DFGL K GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQR 487
L D +G G+++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-33
Identities = 66/302 (21%), Positives = 115/302 (38%), Gaps = 38/302 (12%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + +GQG FG+V++ G KVA+K++ + E G RE++++ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 342 NLLRLIGFCTTPTER--------LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALG 393
N++ LI C T LV+ F ++ + KRV
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 394 AARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT---NVTTQVR 450
GL Y+H + KI+HRD+KAANVL+ D + DFGLA+ + K N T
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 451 GTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509
T+ + PE L + D++G G ++ E+ T E+ + L+ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI--MQGNTEQHQLALISQLCGS 240
Query: 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALL---------------CTQASPEDRPAMS 554
+ + + L + + + + L P R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 555 EV 556
+
Sbjct: 301 DA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 7e-32
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 16/221 (7%)
Query: 270 QLKRYSWRELQLATDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL--TDFESPGGDA 326
+ + S QL D F LG G FG+V G A+K L
Sbjct: 29 KWETPSQNTAQL--DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 327 AFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVT 386
E ++ L++L + +V ++ + LR I
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPH 142
Query: 387 RKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVT 446
+ A EYLH +I+RD+K N+L+D+ V DFG AK R T
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRT 195
Query: 447 TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 487
+ GT +APE + + ++ D + G+++ E+ G
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 32/293 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVHR 341
+ + +G G +G V V G KVA+K+L F+S RE+ ++ H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 342 NLLRLIGFCTTP------TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
N++ L+ T T+ LV PFM +L + + L + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL--GKLMKHEK----LGEDRIQFLVYQML 131
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
+GL Y+H HRD+K N+ ++ED E + DFGLA+ D + +T V
Sbjct: 132 KGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYR 185
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRA-IDFSRLEEEDDVLLLDHVKKLEREKR 514
L+ + ++ D++ G ++ E++TG+ L++ +++ + E +R
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 515 LDAIVDRNLNKNYNIQEVETMIQV---------ALL--CTQASPEDRPAMSEV 556
L + +N K E + + LL E R E
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 17/214 (7%)
Query: 284 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRL---TDFESPGGDAAFQREVEMIS 336
+NF VLG G +GKV+ G A+K L T + + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 337 VAVHR-NLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAA 395
L+ L T T+ L+ ++ + L + + T V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136
Query: 396 RGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGH 455
+ L II+RD+K N+LLD + V+ DFGL+K +T GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 456 IAPEYLSTGKS--SERTDVFGYGIMLLELVTGQR 487
+AP+ + G S + D + G+++ EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (284), Expect = 2e-28
Identities = 55/289 (19%), Positives = 106/289 (36%), Gaps = 30/289 (10%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVE-MISVAVHR 341
D++ LG+G + +V+ + + + KV VK L P +RE++ + ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90
Query: 342 NLLRLIGFCTTPTERL--LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
N++ L P R LV+ + N + L + + L+
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALD 143
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAV-VGDFGLAKLVDVRKTNVTTQVRGTMGHIAP 458
Y H I+HRDVK NV++D + + + D+GLA+ + + P
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 459 E-YLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517
E + D++ G ML ++ + F + D L+ K L E D
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRI-AKVLGTEDLYDY 255
Query: 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSE-----VVRMLE 561
I N+ + ++ E++ +S + ++L
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 6e-28
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 8/206 (3%)
Query: 283 TDNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRL-TDFESPGGDAAFQREVEMISVAVH 340
+ + + +G G +G V G +VAVK+L F+S RE+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
N++ L+ T + L + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEY 460
+H HRD+K +N+ ++ED E + DFGLA+ D T V
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 190
Query: 461 LSTGKSSERTDVFGYGIMLLELVTGQ 486
L+ ++ D++ G ++ EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 12/207 (5%)
Query: 284 DNFSEKNVLGQGGFGKVYRGV-LADGTKVAVKRLT-DFESPGGDAAFQREVEMISVAVHR 341
+ +G G G V VA+K+L+ F++ RE+ ++ H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 342 NLLRLIGFCTTPT--ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLE 399
N++ L+ T E + L A + I+ + G++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIK 133
Query: 400 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPE 459
+LH IHRD+K +N+++ D + DFGLA+ + + T T + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 188
Query: 460 YLSTGKSSERTDVFGYGIMLLELVTGQ 486
+ E D++ G ++ E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 3e-25
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 21/236 (8%)
Query: 291 VLGQGGFGKVYRGV-LADGTKVAVKRLTDFESPGGDAAFQREVEMIS-----------VA 338
LG G F V+ + + T VA+K + A + E++++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 339 VHRNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVL-DWVTRKRVALGAARG 397
++L+L+ + + + L IK E + K+++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 398 LEYLHEHCNPKIIHRDVKAANVLLD-EDFEAVVGDFGLAKLVDVRKTNVTTQ-VRGTMGH 455
L+Y+H C IIH D+K NVL++ D + +A L + + T +
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 456 IAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511
+PE L D++ ++ EL+TG F E DH+ ++
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 7e-20
Identities = 24/159 (15%), Positives = 47/159 (29%), Gaps = 20/159 (12%)
Query: 290 NVLGQGGFGKVYRGVLADGTKVAVK---------RLTDFESPGGDAAFQREVEMISVAVH 340
++G+G V+ + VK + + GD F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 341 RNLLRLIGFCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEY 400
R L +L G Y + N + + + ++ V +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118
Query: 401 LHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439
+ I+H D+ NVL+ + + DF + V
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.7 bits (190), Expect = 6e-16
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 6/84 (7%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L+ L+ LTL N I+ P + +L+ L L NN++ SL NL + +L+ N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 149 NFSGTIPDSLTTLSSLISIQLDSN 172
S P L L+ + + L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 1e-11
Identities = 36/152 (23%), Positives = 57/152 (37%), Gaps = 10/152 (6%)
Query: 35 TSLRVPNNQLRDWN-----QNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVL 89
L + NQL+D N + +N I + + L+ + I L
Sbjct: 222 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPL 281
Query: 90 RTLSTLTLKGNGI-TGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L+ LT E + NL +LT L L N + P + +L KLQ L + N
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV 180
S SL L+++ + N +S P+
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTPL 369
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 2e-09
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 6/170 (3%)
Query: 36 SLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTL 95
++ + + Q++ + +N L + + + L L +L
Sbjct: 143 TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESL 202
Query: 96 TLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIP 155
N I+ P L++L L L+ N+L +L +L L L L+ N S P
Sbjct: 203 IATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258
Query: 156 DSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSC 205
L+ L+ L ++L +N +S P+ N + +
Sbjct: 259 --LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 3e-08
Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 5/77 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L +T + + +L +T+L D + K + L L + S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 149 NFSGTIP-DSLTTLSSL 164
+ P +LT L +
Sbjct: 77 QLTDITPLKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 1e-07
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 63 DNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLD 122
L N + T+S L ++TL GI I + + L++LT ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 74
Query: 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNF 150
NN+L P L NL KL + ++ N
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 52/184 (28%), Positives = 76/184 (41%), Gaps = 14/184 (7%)
Query: 26 QGDALFALRTSLRVPNNQLRDWNQNQVNPC--TWSNVICDNSNNVASVT---LSSMNFSG 80
AL ++ L P L W + C TW V+CD V LS +N
Sbjct: 7 DKQALLQIKKDLGNPTT-LSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 81 --TLSPRIGVLRTLSTLTLKGN-GITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNL 137
+ + L L+ L + G + G IP + L+ L L + + + G IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 138 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK----YNFTGN 193
K L L S N SGT+P S+++L +L+ I D N +SG IP K + N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 194 NLNC 197
L
Sbjct: 185 RLTG 188
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 97 LKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIP 155
L+ N I G +P+ L L L SL++ N L G+I P GNL++ + N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.5 bits (163), Expect = 9e-13
Identities = 27/94 (28%), Positives = 33/94 (35%), Gaps = 27/94 (28%)
Query: 114 SSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDS--LTTLSSLISIQLDS 171
+L LDL NNR+ G +P L LK L L +S NN G IP L
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS------- 296
Query: 172 NNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSC 205
+ N CG LP +C
Sbjct: 297 -----------------AYANNKCLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 1e-10
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 47 WNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI 106
N + S N+ + L + GTL + L+ L +L + N + GEI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 107 PEELGNLSSLTSLDLDNNR-LVGKIPPS 133
P + GNL NN+ L G P+
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.7 bits (169), Expect = 1e-13
Identities = 32/156 (20%), Positives = 53/156 (33%), Gaps = 14/156 (8%)
Query: 55 CTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLS 114
C V C + + V P+ + + L L+ N IT + NL
Sbjct: 10 CHLRVVQCSD-LGLEKV------------PK-DLPPDTALLDLQNNKITEIKDGDFKNLK 55
Query: 115 SLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174
+L +L L NN++ P + L KL+ L LS+N TL L + + +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 175 SGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCESSSN 210
+ L Q+ N L + +
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 48/186 (25%), Positives = 71/186 (38%), Gaps = 9/186 (4%)
Query: 14 LDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 73
L L L LS Q L L + +LR ++N++ S N V +
Sbjct: 78 LVKLERLYLSKNQ---LKELPEKMPKTLQELR-VHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 74 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 133
+ + SG + ++ LS + + IT IP+ G SLT L LD N++ S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190
Query: 134 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKYNFT 191
L L L L LS N+ S SL L + L++N L I
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 192 GNNLNC 197
NN++
Sbjct: 251 NNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 7e-07
Identities = 33/195 (16%), Positives = 63/195 (32%), Gaps = 38/195 (19%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
L + NN++ + N+ ++ L + S L L
Sbjct: 34 ALLDLQNNKITEIKDGDFKNLK----------NLHTLILINNKISKISPGAFAPLVKLER 83
Query: 95 LTLKGNGITGEIPEE----------------------LGNLSSLTSLDLDN--NRLVGKI 130
L L N + E+PE+ L+ + ++L + G
Sbjct: 84 LYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 131 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNF 190
+ +KKL ++ ++ N + TIP L SL + LD N ++ L +
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 191 TGNNLNCGKTLPHSC 205
G + N + +
Sbjct: 200 LGLSFNSISAVDNGS 214
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (146), Expect = 2e-10
Identities = 15/111 (13%), Positives = 29/111 (26%), Gaps = 5/111 (4%)
Query: 92 LSTLTLKGNGITGE-IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLKKLQFLTLS 146
+ +L ++ ++ E L L + LD+ L I +L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 197
N + S ++ +L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 114
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (146), Expect = 2e-10
Identities = 20/80 (25%), Positives = 26/80 (32%), Gaps = 9/80 (11%)
Query: 91 TLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPPSLG-----NLKKLQ 141
L L L ++ + L SL LDL NN L L L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 142 FLTLSQNNFSGTIPDSLTTL 161
L L +S + D L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 6e-09
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 10/96 (10%)
Query: 65 SNNVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSL 119
S ++ S+ + S + + +L+ + L G+T I L +L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 120 DLDNNRLVGKIPPSLG-----NLKKLQFLTLSQNNF 150
+L +N L + K+Q L+L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 1e-07
Identities = 15/109 (13%), Positives = 33/109 (30%), Gaps = 9/109 (8%)
Query: 40 PNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGT----LSPRIGVLRTLSTL 95
Q+ + + + + + L+ + S + L+ + +L L
Sbjct: 343 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402
Query: 96 TLKGNGITGEIPEELG-----NLSSLTSLDLDNNRLVGKIPPSLGNLKK 139
L N + +L L L L + ++ L L+K
Sbjct: 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 4/60 (6%)
Query: 136 NLKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFT 191
L+ L L+ + S + + +L SL + L +N L + L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (129), Expect = 2e-09
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 4/121 (3%)
Query: 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQF 142
P S L +G + L +LT L ++N + + + L L +L+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKT 200
LT+ ++ PD+ L + L N L + + +GN L+C
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 201 L 201
L
Sbjct: 121 L 121
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (132), Expect = 4e-09
Identities = 37/185 (20%), Positives = 58/185 (31%), Gaps = 5/185 (2%)
Query: 14 LDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 73
L LH L L L L L+ + + N+ + L
Sbjct: 104 LGRLHTLHLDRCGL---QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 74 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 133
S L +L L L N + P +L L +L L N L +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 134 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGN 193
L L+ LQ+L L+ N + + + L + S+ + +P L N
Sbjct: 221 LAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAAN 279
Query: 194 NL-NC 197
+L C
Sbjct: 280 DLQGC 284
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 23/131 (17%), Positives = 34/131 (25%), Gaps = 24/131 (18%)
Query: 102 ITGEIPEELGNLSSLTSLDLDN------------------------NRLVGKIPPSLGNL 137
+ P L L +L LD N L + +L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 138 KKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 197
L L L N S + L SL + L N ++ P + + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 198 GKTLPHSCESS 208
LP +
Sbjct: 213 LSALPTEALAP 223
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.001
Identities = 17/95 (17%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 90 RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 149
T + G+ +P + ++ + L NR+ S + L L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 150 FSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQ 184
+ + T L+ L + L N + F
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.2 bits (123), Expect = 9e-08
Identities = 18/123 (14%), Positives = 34/123 (27%), Gaps = 8/123 (6%)
Query: 91 TLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRL----VGKIPPSLGNLKKLQF 142
++ +LK + IT E + L S+ + L N + + ++ + K L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 143 LTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLP 202
S + L L+ L L P + T
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 203 HSC 205
Sbjct: 124 EHL 126
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 1e-06
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 12/81 (14%)
Query: 97 LKGNGITGEIPEELGN------LSSLTSLDLDNNRLVGKIPPSL-----GNLKKLQFLTL 145
L ++ + + L +L L N + +L + L FL L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 146 SQNNFSGTIPDSLTTLSSLIS 166
+ N FS D + + + S
Sbjct: 310 NGNRFSE-EDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 1e-05
Identities = 14/99 (14%), Positives = 28/99 (28%), Gaps = 17/99 (17%)
Query: 47 WNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI 106
N ++ S + L TL L+ N I +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-----------GLQTLRLQYNEIELDA 289
Query: 107 PEEL-----GNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 140
L + L L+L+ NR + + ++++
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 26/106 (24%)
Query: 94 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL------------- 140
L L +T + L L +T LDL +NRL +PP+L L+ L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58
Query: 141 ---------QFLTLSQNNFSGT-IPDSLTTLSSLISIQLDSNNLSG 176
Q L L N + L + L+ + L N+L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 17/107 (15%), Positives = 32/107 (29%), Gaps = 15/107 (14%)
Query: 35 TSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLST 94
T L + +N+LR + +++ A + + L
Sbjct: 23 THLDLSHNRLRALPPA---LAALRCLEVLQASDNALENVDGVANL----------PRLQE 69
Query: 95 LTLKGNGITG-EIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKL 140
L L N + + L + L L+L N L L ++
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 3e-07
Identities = 19/76 (25%), Positives = 24/76 (31%), Gaps = 2/76 (2%)
Query: 76 MNFSGTLSPRIGVLRTLSTLTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSL 134
N TL P + N +T L L +L +L L N L IP
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191
Query: 135 GNLKKLQFLTLSQNNF 150
L F L N +
Sbjct: 192 FGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 9e-07
Identities = 12/59 (20%), Positives = 19/59 (32%), Gaps = 3/59 (5%)
Query: 92 LSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNF 150
+ +T +P +L T L L N L +L +L L L +
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 3/64 (4%)
Query: 62 CDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDL 121
+ V N + L P + + + L L N + L + LT L+L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 122 DNNR 125
D
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 5e-05
Identities = 33/161 (20%), Positives = 46/161 (28%), Gaps = 7/161 (4%)
Query: 14 LDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 73
L L L + L + N ++ + + +
Sbjct: 54 YTRLTQLNLDRAELTKLQ------VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107
Query: 74 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPS 133
S + + L L L LKGN + P L L L L NN L
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167
Query: 134 LGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNL 174
L L+ L L L +N+ TIP L L N
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 4/70 (5%)
Query: 88 VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147
LK +T + + L+S+ + +N+ + K + L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNG 77
Query: 148 NNFSGTIPDS 157
N + P +
Sbjct: 78 NKLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 12/40 (30%), Positives = 16/40 (40%), Gaps = 2/40 (5%)
Query: 107 PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146
L L+ L +L L N + +L LK L L L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELF 208
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 1e-06
Identities = 16/100 (16%), Positives = 30/100 (30%), Gaps = 1/100 (1%)
Query: 106 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLI 165
+ L L +L+L +N++ +P S +L L L +N L
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLR 152
Query: 166 SIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSC 205
L+ P + + + + C C
Sbjct: 153 KKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSENSEGC 192
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 3e-06
Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 29/108 (26%)
Query: 100 NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLT 159
N + EI SL L++ NN+L+ ++P L++L S N+ + +P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ 324
Query: 160 TLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPHSCES 207
L L + N L +P S E
Sbjct: 325 NLKQL------------------------HVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 3e-06
Identities = 13/54 (24%), Positives = 22/54 (40%), Gaps = 5/54 (9%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQF 142
L L N + E+PE NL L ++ N L + P +++ L+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 8e-06
Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 5/66 (7%)
Query: 90 RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNN 149
R L L G++ +PE +L SL N L ++P +LK L +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 150 FSGTIP 155
S P
Sbjct: 93 LSDLPP 98
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 4e-06
Identities = 13/59 (22%), Positives = 19/59 (32%), Gaps = 10/59 (16%)
Query: 106 IPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSL 164
+ S LD+ R+ L NLKKL+ + L L +L
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN----------LKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 7e-05
Identities = 8/50 (16%), Positives = 14/50 (28%), Gaps = 3/50 (6%)
Query: 130 IPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
L +S+ L L L + + NL ++P
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 12/64 (18%), Positives = 24/64 (37%), Gaps = 3/64 (4%)
Query: 91 TLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNF 150
+ + + +T EIP +L + L +L + L+ + +SQN+
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 151 SGTI 154
I
Sbjct: 66 LEVI 69
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 9/44 (20%), Positives = 13/44 (29%), Gaps = 3/44 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPP 132
L + I L NL L + N + K+P
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 5e-06
Identities = 17/95 (17%), Positives = 36/95 (37%), Gaps = 3/95 (3%)
Query: 94 TLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSG- 152
TL L G + ++ L + + + + + + + +Q + LS +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 153 TIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPK 187
T+ L+ S L ++ L+ LS I L +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 7e-05
Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 5/119 (4%)
Query: 41 NNQLRDWNQNQVNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKG- 99
L + +N + V + S+ L L L+L
Sbjct: 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVH-LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210
Query: 100 NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL 158
I E ELG + +L +L + G + L LQ ++ ++F+ ++
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 22/167 (13%), Positives = 51/167 (30%), Gaps = 4/167 (2%)
Query: 14 LDCLHYLALSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPCTWSNVICDNSNNVASVTL 73
L+ S++ L + + L N + ++V + S
Sbjct: 100 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159
Query: 74 SSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN-NRLVGKIPP 132
++ S + + + + +E L+ L L L ++ +
Sbjct: 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219
Query: 133 SLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP 179
LG + L+ L + GT+ L L Q++ ++ +
Sbjct: 220 ELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIAR 263
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 1e-05
Identities = 18/105 (17%), Positives = 32/105 (30%), Gaps = 6/105 (5%)
Query: 102 ITGEIPEELG---NLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSL 158
+T E+ E+ N LDL ++ I L + + S N D
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 159 TTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNCGKTLPH 203
L L ++ +++N + +P N L
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 2e-05
Identities = 19/109 (17%), Positives = 34/109 (31%), Gaps = 3/109 (2%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L+G I I L ++D +N + + L++L+ L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 149 NFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLNC 197
L L + L +N+L + K L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 22/66 (33%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 107 PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 166
L NLS LT+L D+N++ P L +L L + L N S P L S+L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 167 IQLDSN 172
+ L +N
Sbjct: 222 VTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 11/62 (17%), Positives = 21/62 (33%), Gaps = 4/62 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L + + +T + + +L +T+L + I + L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 149 NF 150
Sbjct: 74 QI 75
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 3e-05
Identities = 12/64 (18%), Positives = 22/64 (34%), Gaps = 4/64 (6%)
Query: 89 LRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148
L L +T + + +L +T+L D + K + L L + S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 149 NFSG 152
+
Sbjct: 73 QLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 14/45 (31%), Positives = 22/45 (48%), Gaps = 4/45 (8%)
Query: 99 GNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
N +T P L NL++L LD+ +N++ L L L+ L
Sbjct: 159 SNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.7 bits (91), Expect = 4e-04
Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 11/68 (16%)
Query: 106 IPEELGNLS---SLTSLDLDNNRLVGKIPP------SLGNLKKLQFLTLSQNNFSGTIPD 156
I + + S+ + + + L G IPP +L LK + L LS NN I
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS- 64
Query: 157 SLTTLSSL 164
SL+ + +L
Sbjct: 65 SLSGMENL 72
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.0 bits (84), Expect = 0.003
Identities = 12/58 (20%), Positives = 21/58 (36%), Gaps = 8/58 (13%)
Query: 92 LSTLTLKGNGITGEIP------EELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFL 143
+ + + G IP L L + L L N + + SL ++ L+ L
Sbjct: 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRIL 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 609 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.64 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.64 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.48 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.39 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.39 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.39 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.28 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.21 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.2 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.18 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.02 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.99 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.98 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.87 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.6 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.52 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.49 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.31 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.29 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.01 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.93 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.86 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.65 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.6 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.02 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.87 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.61 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.31 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=408.47 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=200.4
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.++|++.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++..++..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3578889999999999999999988999999999753 33467899999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+++... ...+++..+.+++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999998753 34488999999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
........||+.|+|||++.+..++.++|||||||++|||+|+. +|+..... . +.........+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~---~~~~~i~~~~~------- 220 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----S---EVVEDISTGFR------- 220 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----H---HHHHHHHHTCC-------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----H---HHHHHHHhcCC-------
Confidence 44444567899999999999999999999999999999999964 44432211 1 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+.++.+++.+||+.||++|||++||++.|+++
T Consensus 221 ---~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 ---LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111222346789999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-52 Score=414.41 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=218.1
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
++++..++|++.+.||+|+||+||+|.++ +|+.||||+++.. ....++|.+|++++++++|||||++++++.+.+..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 44556788999999999999999999986 5889999998643 33467899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999997632 34589999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
..............|++.|+|||++.+..++.++|||||||++|||+||+.|+...... ........
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~------ 230 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLE------ 230 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHH------
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHh------
Confidence 77655544455566899999999999999999999999999999999987776422211 11111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGEG 564 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 564 (609)
.......+...+..+.+++.+||+.||++|||+.||++.|+...
T Consensus 231 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 231 ----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11112223344568999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=410.37 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=211.3
Q ss_pred HHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 279 LQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 279 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
+++..++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 34456789999999999999999999988899999999643 3346789999999999999999999998754 56789
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.... ...+++..+.+++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 999999999998876432 23389999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhh
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAI 518 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (609)
............||+.|+|||++.+..++.++|||||||++|||+||+.|+...... .+.........+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~~~---- 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR---- 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC----
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCC----
Confidence 655444445567899999999999899999999999999999999976655322111 111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 519 VDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 519 ~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...+...+.++.+++.+||+.||++||||+||++.|++
T Consensus 229 ------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11122344678999999999999999999999999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=407.72 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=204.7
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccC-CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDF-ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++..++|++.+.||+|+||+||+|+++ ..||||+++.. ......+.|.+|++++++++|||||++++++.. +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678999999999999999999874 36999999743 245567889999999999999999999998754 56899
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 v~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 999999999999997532 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred ccCC-CceeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 439 DVRK-TNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 439 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
.... ........||+.|||||++.+ ..++.++|||||||++|||+||+.||....... .....+........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYLSPD 230 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSCCCC
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCCc
Confidence 5432 223345679999999999864 358999999999999999999999997432211 11111111100001
Q ss_pred chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 515 LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 515 ~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
. .......+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 231 ~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 231 L---------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp G---------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c---------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 112233446899999999999999999999999999763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=405.28 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=203.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|+++ +|+.||||++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 6999999999754444455678999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999998642 3489999999999999999999999 9999999999999999999999999999977543
Q ss_pred CC-ceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 442 KT-NVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 442 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ .. ........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~----~~~~~~~~----- 224 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EY----SDWKEKKT----- 224 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HH----HHHHTTCT-----
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HH----HHHhcCCC-----
Confidence 32 22345679999999999988776 6789999999999999999999975432111 01 11111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........+.++.+++.+||+.||++|||++|+++
T Consensus 225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111223467889999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=398.90 Aligned_cols=254 Identities=20% Similarity=0.347 Sum_probs=214.1
Q ss_pred hcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.++|+..+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++||||++++|++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 3689999999999999999999988899999999753 33467899999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|..++.... ..+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999999876532 3478899999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.........+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~------- 219 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLR------- 219 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCC-------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCC-------
Confidence 444445678999999999999999999999999999999998 89998754321 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 522 NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 522 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...+...+..+.+++.+||+.||++|||+++|++.|.+
T Consensus 220 ---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11122334688999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-50 Score=408.20 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=201.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CC---cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DG---TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|++.++||+|+||+||+|+++ +| ..||||++.........+.|.+|++++++++|||||+++|++..++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 356788899999999999999975 23 36899998765556667789999999999999999999999999999999
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++... ...+++..+.+++.||++||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999988753 23489999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCce----eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 439 DVRKTNV----TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 439 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
....... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.........
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC
Confidence 5432221 123457999999999999999999999999999999998 89998643221 1112221111
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+ ...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 251 ~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 R----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 122334457899999999999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=404.56 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=196.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC--CCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT--PTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 359 (609)
++|++.+.||+|+||+||+|+++ +|+.||||++.... .....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999975 68999999987543 33345678899999999999999999998864 4567899
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC--NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
|||+++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999764444456999999999999999999999872 12499999999999999999999999999987
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +....... ....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~-~~~~- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIRE-GKFR- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHH-TCCC-
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHc-CCCC-
Confidence 65332 2334567999999999999999999999999999999999999999743221 11111111 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 233 --------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112234568999999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=401.49 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=208.9
Q ss_pred hcCCCccCc-ccccCCceEEEEEeC---CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 283 TDNFSEKNV-LGQGGFGKVYRGVLA---DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 283 ~~~~~~~~~-lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
.++|.+.+. ||+|+||+||+|.++ ++..||||+++........+.|.+|++++++++|||||+++|++.+ +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 355666674 999999999999864 3557999999766555567889999999999999999999999875 45789
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
||||+++|+|.+++... ...+++..+.+++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 86 vmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999987643 23489999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 439 DVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 439 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.........+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~- 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR- 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC-
Confidence 6433222 234568999999999999999999999999999999998 89999743321 11111111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...+...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus 231 ---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223345688999999999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=401.35 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=203.6
Q ss_pred hcCCCccCcccccCCceEEEEEeCCC-----cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLADG-----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
.+.|+..++||+|+||+||+|.++++ ..||||++...........|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45688899999999999999997532 4799999976555556678999999999999999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+.+|++.+.+.... ..+++..+.+++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999998887532 3489999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc--eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 438 VDVRKTN--VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 438 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+...... . +........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~---~~~~~i~~~--- 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----H---EVMKAINDG--- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H---HHHHHHHTT---
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----H---HHHHHHhcc---
Confidence 6543222 223456899999999999999999999999999999999976665432211 1 111111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.....+...+..+.+++.+||+.||++||||.||++.|+..
T Consensus 230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11222334457899999999999999999999999999763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=409.80 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=209.9
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeCC------CcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLAD------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
++..++|++.+.||+|+||+||+|++.. ...||+|++...........+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3455789999999999999999999642 2369999997655555667899999999988 89999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCC-------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKP-------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRD 413 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 413 (609)
.+..++||||+++|+|.++++.... ....+++..++.++.||++||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999975432 123589999999999999999999999 999999
Q ss_pred CCCCcEEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 007290 414 VKAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDF 491 (609)
Q Consensus 414 lkp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~ 491 (609)
|||+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3345668999999999999999999999999999999998 8999974
Q ss_pred CccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q 007290 492 SRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLE 561 (609)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 561 (609)
..... .+...+ .. ....+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 270 ~~~~~----~~~~~~---~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDA----NFYKLI---QN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSH----HHHHHH---HT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHH----HHHHHH---hc----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 33221 111111 11 1111223334568999999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=397.83 Aligned_cols=249 Identities=19% Similarity=0.301 Sum_probs=207.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999964 79999999986433 23457799999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999987652 389999999999999999999999 99999999999999999999999999999775432
Q ss_pred CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .............
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~~~~------ 235 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTPE------ 235 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSCC------
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCCC------
Confidence 2334557999999999999999999999999999999999999999643321 1111111111100
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112234568899999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=395.09 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=207.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+|+++ +|+.||+|++... ........+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 6899999998632 12334677899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..........
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~------- 220 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE------- 220 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC-------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-------
Confidence 2 234467999999999999999999999999999999999999999753321 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..++...+.++.+++.+||+.||++|||++|+++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0112234468899999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=411.58 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=209.1
Q ss_pred HHhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
+..++|++.+.||+|+||+||+|++. +|+.||+|+++....+.....+.+|+.++++++|||||++++++.++++.++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999975 68999999997655566677899999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
|||+++|+|.+++.... .+++..++.++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+.+
T Consensus 83 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999997643 38999999999999999999997 5 7999999999999999999999999999866
Q ss_pred ccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH-------h-
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL-------E- 510 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~- 510 (609)
... .....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.................... .
T Consensus 156 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 156 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 432 22346799999999999999999999999999999999999999975432211000000000000 0
Q ss_pred -------------hhcc----chhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 511 -------------REKR----LDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 511 -------------~~~~----~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... .................+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 00000000000001123467899999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=393.90 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=199.5
Q ss_pred CcccccCCceEEEEEeC---CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeecccC
Q 007290 290 NVLGQGGFGKVYRGVLA---DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPFMQN 365 (609)
Q Consensus 290 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 365 (609)
+.||+|+||+||+|.++ .++.||||+++... .+...+.|.+|++++++++|||||+++|+|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999864 35689999997533 344467899999999999999999999999654 57899999999
Q ss_pred chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCCce
Q 007290 366 LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKTNV 445 (609)
Q Consensus 366 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~~~ 445 (609)
|+|.++++... .+++..+.+++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997633 389999999999999999999999 99999999999999999999999999999775443322
Q ss_pred --eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhcccc
Q 007290 446 --TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRN 522 (609)
Q Consensus 446 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (609)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.........+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~-------- 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGER-------- 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--------HHHHHHHcCCC--------
Confidence 234568999999999999999999999999999999998 89999743221 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 523 LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 523 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus 229 --~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 --MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11223345688999999999999999999999998876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=399.28 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=204.6
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+..++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. .+..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 345789999999999999999999988889999999643 334578999999999999999999999985 45688999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|...+.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 91 Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 91 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999998887532 23489999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
..........||+.|+|||++....++.++|||||||++|||+||+.|+...... . +.........
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~---~~~~~i~~~~------- 231 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----R---EVLDQVERGY------- 231 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H---HHHHHHHTTC-------
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----H---HHHHHHHhcC-------
Confidence 4444445567999999999999999999999999999999999977665432211 1 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
........+.++.+++.+||+.||++||++++|+++|+..
T Consensus 232 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 232 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred ---CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 1122334456899999999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=395.48 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=205.4
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
+.|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 56899999999999999999975 6899999998653 345567899999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+++|+|.+++.+.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999999886532 3489999999999999999999999 99999999999999999999999999998654321
Q ss_pred CceeecccccccccCccccc-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 443 TNVTTQVRGTMGHIAPEYLS-----TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||......+ ... ....... .
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~~---~i~~~~~-~- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLL---KIAKSEP-P- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHH---HHHHSCC-C-
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHH---HHHcCCC-C-
Confidence 1223457999999999984 4568999999999999999999999997543211 111 1111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 ------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00112234568899999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=401.30 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=192.5
Q ss_pred HhcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
..+.|++.+.||+|+||+||+|+++ +|+.||||++...........+.+|++++++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999975 689999999975444444567889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~~~ 437 (609)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999753 3489999999999999999999999 999999999999994 578999999999986
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..........
T Consensus 160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~---- 225 (307)
T d1a06a_ 160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAE---- 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTC----
T ss_pred ccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccC----
Confidence 64322 234467999999999999999999999999999999999999999743321 1111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...........++++.+++.+||+.||++|||++|+++.
T Consensus 226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001111223445688999999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=394.05 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=199.9
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCC----CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLAD----GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
+..++|++.+.||+|+||+||+|++.. +..||||+++........+.|.+|++++++++|||||++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999999742 45799999876555555678999999999999999999999985 4678
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|+|.+++... ...+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999987653 23489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccc
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRL 515 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 515 (609)
..............||+.|+|||.+.+..++.++|||||||++|||+| |.+||......+ +.. .......
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----~~~---~i~~~~~- 227 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIG---RIENGER- 227 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH---HHHTTCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----HHH---HHHcCCC-
Confidence 776544444555678999999999999999999999999999999998 888987543321 111 1111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 516 DAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 516 ~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...+...+..+.+++.+||+.||++|||+.||++.|+.
T Consensus 228 ---------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11223345689999999999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=388.29 Aligned_cols=245 Identities=23% Similarity=0.393 Sum_probs=195.4
Q ss_pred CccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC----CCcceEEe
Q 007290 287 SEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT----PTERLLVY 360 (609)
Q Consensus 287 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 360 (609)
+..+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999975 68899999987533 33445678999999999999999999999854 34578999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCcEEeC-CCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPK--IIHRDVKAANVLLD-EDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfGl~~~ 437 (609)
||+++|+|.+++.... .+++..++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997643 389999999999999999999998 6 99999999999996 578999999999985
Q ss_pred eccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
... .......||+.|+|||++.+ .++.++|||||||++|||+||+.||....... ............ .
T Consensus 165 ~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~-~ 232 (270)
T d1t4ha_ 165 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP-A 232 (270)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC-G
T ss_pred ccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCCC-c
Confidence 432 22345679999999999865 69999999999999999999999996432111 111111111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.+....++++.+++.+||+.||++|||++|+++
T Consensus 233 --------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122356899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=394.27 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=204.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+|++. +|+.||||++... ......+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 7999999998642 12334577999999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999887643 389999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. ........||+.|+|||++.+..++.++||||+||++|||+||+.||...... .........
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~------- 225 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------LIFQKIIKL------- 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTT-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--------HHHHHHHcC-------
Confidence 32 22334567999999999999999999999999999999999999999753321 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ..++...+.++.+++.+||+.||++|||++|+++
T Consensus 226 --~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 --E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --C--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 0112233467899999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-49 Score=397.07 Aligned_cols=267 Identities=24% Similarity=0.391 Sum_probs=215.8
Q ss_pred HHHHHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeE
Q 007290 276 WRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGF 349 (609)
Q Consensus 276 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 349 (609)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++........+.|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667789999999999999999999964 4578999999765555556789999999999999999999999
Q ss_pred EeCCCcceEEeecccCchhhhhhhhcCC--------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 007290 350 CTTPTERLLVYPFMQNLSVAYRLREIKP--------------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKI 409 (609)
Q Consensus 350 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 409 (609)
+......+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999965321 223488999999999999999999999 99
Q ss_pred EecCCCCCcEEeCCCCcEEEcccccceeeccCC-CceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-C
Q 007290 410 IHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK-TNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-R 487 (609)
Q Consensus 410 vH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~-~ 487 (609)
+||||||+|||++.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+||. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664332 22334456899999999999999999999999999999999996 5
Q ss_pred CCCCCccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 488 AIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 488 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
||...... +.......... ...+...+.++.+|+.+||+.+|++||||.||+++|+++
T Consensus 242 p~~~~~~~--------e~~~~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHE--------EVIYYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHH--------HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHH--------HHHHHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66533211 11112111111 112223346789999999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=393.77 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=201.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
+.|+..+.||+|+||+||+|++. +|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999975 688999999875332 223467889999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|++...+... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999998766542 3489999999999999999999999 999999999999999999999999999986542
Q ss_pred CCCceeecccccccccCcccccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchh
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLST---GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDA 517 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 517 (609)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... +..........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~~--- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES--- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCC---
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCC---
Confidence 233569999999999864 46899999999999999999999999643211 11111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 518 IVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 518 ~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
........++.+.+++.+||+.||++|||+.|+++
T Consensus 232 ------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 ------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 01112233468999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=387.79 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=199.0
Q ss_pred HhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-CCcceEEe
Q 007290 282 ATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVY 360 (609)
Q Consensus 282 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 360 (609)
.-++|++.+.||+|+||+||+|.++ |+.||||+++.. ...+.|.+|++++++++||||++++|++.+ .+..++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3467888999999999999999995 789999999643 345789999999999999999999999855 45689999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+++|+|.+++.... ...+++..+++++.||+.||.|||++ +|+||||||+||+++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999997532 23479999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
. .....+|+.|+|||++.+..++.++|||||||++|||+| |++||....... ....+ ..
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-----~~~~i---~~-------- 215 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV---EK-------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHHH---TT--------
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHH---Hc--------
Confidence 2 223457899999999999999999999999999999998 687776433221 11111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
......+...+.++.+++.+||+.||++|||+.+++++|+.+
T Consensus 216 --~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 216 --GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222334456889999999999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=393.13 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=203.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCc----EEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGT----KVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLL 358 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 358 (609)
++|++.++||+|+||+||+|.+. +|+ +||+|+++........+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999975 343 69999987666666788999999999999999999999999865 5678
Q ss_pred EeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceee
Q 007290 359 VYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLV 438 (609)
Q Consensus 359 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~ 438 (609)
+++|+.+|+|.+.+... ...+++..+++++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 88999999999888763 34489999999999999999999999 9999999999999999999999999999877
Q ss_pred ccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 439 DVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 439 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||+.....+ +...+. ...+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----~~~~i~---~~~~-- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILE---KGER-- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----HHHHHH---HTCC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHH---cCCC--
Confidence 543332 2334568999999999999999999999999999999999 788887543221 111111 1111
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
...+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 232 --------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 112233456889999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=391.37 Aligned_cols=269 Identities=25% Similarity=0.356 Sum_probs=204.3
Q ss_pred CHHHHHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeE
Q 007290 275 SWRELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLI 347 (609)
Q Consensus 275 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 347 (609)
...++++..++|++.+.||+|+||+||+|.+. +++.||||+++........+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556666788999999999999999999963 35689999997655555567788888888776 689999999
Q ss_pred eEEeCC-CcceEEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 007290 348 GFCTTP-TERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDV 414 (609)
Q Consensus 348 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 414 (609)
+++..+ ...++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 988665 467899999999999999975321 123489999999999999999999999 9999999
Q ss_pred CCCcEEeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCC
Q 007290 415 KAANVLLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFS 492 (609)
Q Consensus 415 kp~NIll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~-~p~~~~ 492 (609)
||+|||+++++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||. +||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 334467999999999999999999999999999999999975 567543
Q ss_pred ccccccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 493 RLEEEDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.... .+.. ......+ ...+...+.++.+++.+||+.||++|||+.|++++|+.+
T Consensus 241 ~~~~----~~~~---~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 KIDE----EFCR---RLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSH----HHHH---HHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH----HHHH---HHhcCCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2211 1111 1111111 112223346789999999999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=380.24 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=206.4
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-----CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-----SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|++.+.||+|+||+||+|+++ +|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999975 79999999986432 122467899999999999999999999999999999
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC----cEEEccc
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF----EAVVGDF 432 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 432 (609)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997643 389999999999999999999999 999999999999998776 4999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +........
T Consensus 162 G~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~ 231 (293)
T d1jksa_ 162 GLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAV 231 (293)
T ss_dssp TTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHTT
T ss_pred hhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHHhc
Confidence 999876533 2233456899999999999999999999999999999999999999753321 111111111
Q ss_pred ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..........+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~-------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NY-------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000001123467889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-47 Score=392.90 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=207.3
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
-++|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 358999999999999999999975 6999999999643 23345778899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGl~~~~~ 439 (609)
|+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+.
T Consensus 104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999988642 23489999999999999999999999 999999999999996 46789999999999775
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +..........
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~----- 242 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDW----- 242 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC-----
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-----
Confidence 432 234467999999999999999999999999999999999999999744321 11111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+.++.+++.+||+.||++|||++|++++
T Consensus 243 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112234678999999999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=382.43 Aligned_cols=256 Identities=29% Similarity=0.379 Sum_probs=197.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC--CC--cEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA--DG--TKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTER 356 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 356 (609)
.++|++.+.||+|+||+||+|++. ++ ..||||++.... .....+.|.+|++++++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467899999999999999999864 22 378999986432 33445789999999999999999999999965 467
Q ss_pred eEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 357 LLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 357 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
++||||+++|++.+.+.... ..+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 89999999999998886532 3489999999999999999999999 99999999999999999999999999999
Q ss_pred eeccCCCce--eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 437 LVDVRKTNV--TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 437 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
......... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||...... +........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------~~~~~i~~~- 230 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKE- 230 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTS-
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------HHHHHHHhC-
Confidence 875443322 233567889999999999999999999999999999998 89998643321 111111111
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
....+.....+..+.+++.+||+.||++||||.||.+.|++
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11112223344689999999999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-47 Score=390.70 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=207.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999975 79999999986532 3345678899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC--CCCcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD--EDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGl~~~~~ 439 (609)
|+++|+|.+.+... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+.
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998877542 33489999999999999999999999 999999999999998 67899999999999876
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..........
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~------ 244 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCD------ 244 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCC------
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC------
Confidence 432 334457999999999999999999999999999999999999999743321 1111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...........+.++.+++.+||+.||++|||+.|++++
T Consensus 245 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 -WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111223345688999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=388.09 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=214.1
Q ss_pred HHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeC
Q 007290 280 QLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTT 352 (609)
Q Consensus 280 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 352 (609)
+...++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|+.+++++ +|||||++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 445678999999999999999999852 46789999998655555667899999999998 69999999999999
Q ss_pred CCcceEEeecccCchhhhhhhhcCC--------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKP--------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAAN 418 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N 418 (609)
....++||||+++|+|.++++.... ....+++..+.+++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999976432 233588999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEcccccceeeccCCC-ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcccc
Q 007290 419 VLLDEDFEAVVGDFGLAKLVDVRKT-NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTG-QRAIDFSRLEE 496 (609)
Q Consensus 419 Ill~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg-~~p~~~~~~~~ 496 (609)
|+++.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+||.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987754332 333456789999999999999999999999999999999995 54454322211
Q ss_pred ccchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 497 EDDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.+...+ ........+...+..+.+|+.+||+.||++||||.||+++|++
T Consensus 256 ----~~~~~i-------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 ----KFYKMI-------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ----HHHHHH-------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHH-------------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111 1111122223345689999999999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=387.51 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=215.7
Q ss_pred HHHHHhcCCCccCcccccCCceEEEEEeC------CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEe
Q 007290 278 ELQLATDNFSEKNVLGQGGFGKVYRGVLA------DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCT 351 (609)
Q Consensus 278 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 351 (609)
++++..++|++.+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++|||||++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45556688999999999999999999863 357899999976555555667899999999999999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcC------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIK------PGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF 425 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 425 (609)
..+..++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999986421 2223478899999999999999999999 999999999999999999
Q ss_pred cEEEcccccceeeccCCCce-eecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCccccccchhHH
Q 007290 426 EAVVGDFGLAKLVDVRKTNV-TTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQ-RAIDFSRLEEEDDVLLL 503 (609)
Q Consensus 426 ~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~-~p~~~~~~~~~~~~~~~ 503 (609)
++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||..... .
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~ 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------E 242 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------H
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 99999999998765433322 23346899999999999999999999999999999999985 66643221 1
Q ss_pred HHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 504 DHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
+.......... ...+...+..+.+++.+||+.+|++|||+++|+++|++.
T Consensus 243 ~~~~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 243 QVLRFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHhCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 12222221111 111223346899999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=386.34 Aligned_cols=249 Identities=22% Similarity=0.250 Sum_probs=207.1
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEE
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 359 (609)
-++|++.+.||+|+||+||+|+++ +|+.||||++.+.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999974 79999999996421 233467789999999999999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|..++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999988643 388899999999999999999999 99999999999999999999999999998654
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .......+||+.|+|||++.+..|+.++||||+||++|||+||++||...... ........ ..
T Consensus 157 ~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~-~~----- 221 (337)
T d1o6la_ 157 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILM-EE----- 221 (337)
T ss_dssp CT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-CC-----
T ss_pred cC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhc-CC-----
Confidence 32 22344567999999999999999999999999999999999999999754321 11111111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
..++...+.++.+++.+||+.||++||+ ++|+++
T Consensus 222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122234567899999999999999995 777765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=382.22 Aligned_cols=262 Identities=29% Similarity=0.396 Sum_probs=209.0
Q ss_pred HHhcCCCccCcccccCCceEEEEEeCC--------CcEEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEe
Q 007290 281 LATDNFSEKNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCT 351 (609)
Q Consensus 281 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 351 (609)
+..++|++.+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 456789999999999999999998632 3479999997655555667888999998887 7999999999999
Q ss_pred CCCcceEEeecccCchhhhhhhhcCC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 007290 352 TPTERLLVYPFMQNLSVAYRLREIKP------------GEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANV 419 (609)
Q Consensus 352 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI 419 (609)
++...++||||+++|+|.+++..... ....+++..+++++.|++.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999976432 234589999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEcccccceeeccCCCc-eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCccccc
Q 007290 420 LLDEDFEAVVGDFGLAKLVDVRKTN-VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVT-GQRAIDFSRLEEE 497 (609)
Q Consensus 420 ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~ellt-g~~p~~~~~~~~~ 497 (609)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |.+||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 9999999999999999877543322 2344578999999999999999999999999999999998 68887643321
Q ss_pred cchhHHHHHHHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 498 DDVLLLDHVKKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..........+ ...+...+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 245 ------~~~~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ------ELFKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ------HHHHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11111111111 112223446799999999999999999999999999763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=385.84 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=204.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCc--EEEEEEeccCCCCchHHHHHHHHHHHHhc-cCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGT--KVAVKRLTDFESPGGDAAFQREVEMISVA-VHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 359 (609)
++|++.+.||+|+||+||+|+++ +|. .||||++.........+.|.+|++++.++ +|||||+++|++...+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999975 344 57888887655555667899999999998 799999999999999999999
Q ss_pred eecccCchhhhhhhhc------------CCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcE
Q 007290 360 YPFMQNLSVAYRLREI------------KPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEA 427 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 427 (609)
|||+++|+|.++++.. ......+++..+.+++.||++||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999753 12345689999999999999999999999 99999999999999999999
Q ss_pred EEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCC-CCCCCccccccchhHHHHH
Q 007290 428 VVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR-AIDFSRLEEEDDVLLLDHV 506 (609)
Q Consensus 428 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~-p~~~~~~~~~~~~~~~~~~ 506 (609)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||+||.. ||...... +..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--------~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELY 236 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--------HHH
Confidence 999999998654222 1233468999999999999999999999999999999999765 56432211 111
Q ss_pred HHHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 507 KKLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 507 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
....... ....+...+.++.+++.+||+.||++||||+||++.|++.
T Consensus 237 ~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111 1122333456899999999999999999999999998774
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-47 Score=382.95 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=204.9
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++.+.||+|+||+||+|+++ +|+.||||+++.. ......+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6999999998642 12334678899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||++||+|...+.... .++...++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999887633 378888899999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~------- 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAE------- 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCC-------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCC-------
Confidence 2 23467999999999999999999999999999999999999999753321 1111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
..++...+.++.+++.+|++.||.+|| |++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 011223346789999999999999996 8888875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=380.97 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=202.4
Q ss_pred cCcccccCCceEEEEEeCCC----cEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeC-CCcceEEeecc
Q 007290 289 KNVLGQGGFGKVYRGVLADG----TKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-PTERLLVYPFM 363 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 363 (609)
.++||+|+||+||+|++.++ ..||||++.........++|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 36999999765566667889999999999999999999999865 55789999999
Q ss_pred cCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCCC
Q 007290 364 QNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRKT 443 (609)
Q Consensus 364 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~~ 443 (609)
++|+|.+++.... ..+++..+.+++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987533 3378888999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 444 N---VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 444 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||....... +.........+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCC-----
Confidence 2 2233568999999999999999999999999999999999888875322111 111111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
..+...+..+.+++.+||+.||++||+|.||++.|+++
T Consensus 254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222346789999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-46 Score=370.97 Aligned_cols=258 Identities=23% Similarity=0.278 Sum_probs=201.0
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCC--CchHHHHHHHHHHHHhccCCCcceeEeEEeCCCc----
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFES--PGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTE---- 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 355 (609)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 799999999975332 3345678999999999999999999999865443
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+++++|...+.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999887643 389999999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCC--ceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 436 KLVDVRKT--NVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 436 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--------HHHHHHHhcC
Confidence 76543222 2334567999999999999999999999999999999999999999753321 1111111111
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhc
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRP-AMSEVVRMLEG 562 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~ 562 (609)
... ........+..+.+++.+|++.||++|| |++++.+.|..
T Consensus 231 ~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 100 0011223346889999999999999999 89999888765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-46 Score=370.21 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=204.6
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCc--------hHHHHHHHHHHHHhcc-CCCcceeEeEEeCC
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPG--------GDAAFQREVEMISVAV-HRNLLRLIGFCTTP 353 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 353 (609)
++|++.+.||+|+||+||+|++. +|+.||||++....... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 78999999987533211 1246789999999997 99999999999999
Q ss_pred CcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccc
Q 007290 354 TERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFG 433 (609)
Q Consensus 354 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 433 (609)
+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997643 389999999999999999999999 99999999999999999999999999
Q ss_pred cceeeccCCCceeecccccccccCccccc------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHH
Q 007290 434 LAKLVDVRKTNVTTQVRGTMGHIAPEYLS------TGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVK 507 (609)
Q Consensus 434 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 507 (609)
+++...... ......||+.|+|||.+. ...++.++||||+||++|||+||+.||....... . ..
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----~---~~ 225 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----M---LR 225 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-----H---HH
Confidence 999875432 234467999999999885 3357899999999999999999999997543211 1 11
Q ss_pred HHhhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 508 KLEREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 508 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... +... .........++++.+++.+||+.||++|||++|+++
T Consensus 226 ~i~~-~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMS-GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHH-TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHh-CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 1100 111112244578999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=374.18 Aligned_cols=266 Identities=24% Similarity=0.339 Sum_probs=199.1
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHH--HHHhccCCCcceeEeEEeCCC----cce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVE--MISVAVHRNLLRLIGFCTTPT----ERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~~~----~~~ 357 (609)
++|.+.+.||+|+||+||+|++ +|+.||||++... ....+..|.+ .+.+++|||||++++++.+.+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5677889999999999999997 5899999998632 2344444444 456789999999999996543 478
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC-----NPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
+||||+++|+|.++++.. .+++..+.+++.|+|.||+|+|+.+ .++|+||||||+|||+++++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 999999999999999863 3899999999999999999999631 238999999999999999999999999
Q ss_pred ccceeeccCCCc---eeecccccccccCcccccCCC------CCcchhhHHHHHHHHHHHhCCCCCCCCccccccc----
Q 007290 433 GLAKLVDVRKTN---VTTQVRGTMGHIAPEYLSTGK------SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD---- 499 (609)
Q Consensus 433 Gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~---- 499 (609)
|+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+..........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999987543322 223467999999999986542 5779999999999999999998875422211100
Q ss_pred --hhHHHHHHHHhhhccchhhccccccCCC-CHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Q 007290 500 --VLLLDHVKKLEREKRLDAIVDRNLNKNY-NIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEGE 563 (609)
Q Consensus 500 --~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 563 (609)
.............+.. ++.+.... .......+.+++.+||+.||++|||+.||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0011111111111111 11111111 234557799999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.3e-46 Score=382.07 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=198.2
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHH---HHHHHhccCCCcceeEeEEeCCCcce
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQRE---VEMISVAVHRNLLRLIGFCTTPTERL 357 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 357 (609)
++|++.+.||+|+||+||+|++. +|+.||||++.... .......+.+| +++++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 69999999985311 11122334444 56666778999999999999999999
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999997643 378899999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccch
Q 007290 438 VDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLD 516 (609)
Q Consensus 438 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 516 (609)
+.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ...... .
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~-~------ 221 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM-T------ 221 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHH-S------
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHh-c------
Confidence 65432 334579999999999975 5689999999999999999999999975433211 011110 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 517 AIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 517 ~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
... ....+...+.++.+++.+||+.||++||| ++|+++
T Consensus 222 --~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 --LTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --SSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --ccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 000 01112234467899999999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-46 Score=381.99 Aligned_cols=245 Identities=21% Similarity=0.245 Sum_probs=205.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccC--CCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDF--ESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 360 (609)
++|++++.||+|+||+||+|+++ +|+.||||++... ......+.+.+|+++++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 7999999998632 12344577899999999999999999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeecc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDV 440 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~ 440 (609)
||+.+|+|...+.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997643 389999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhcc
Q 007290 441 RKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVD 520 (609)
Q Consensus 441 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 520 (609)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||...... ......... .
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~-~------ 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSG-K------ 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHC-C------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--------HHHHHHhcC-C------
Confidence 2 23457999999999999999999999999999999999999999743221 111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 007290 521 RNLNKNYNIQEVETMIQVALLCTQASPEDRP-----AMSEVVR 558 (609)
Q Consensus 521 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~ 558 (609)
...+...+.++.+++.+||+.||++|+ |++++++
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011223346789999999999999994 8888875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=375.71 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=198.8
Q ss_pred hcCCCccC-cccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHh-ccCCCcceeEeEEeC----CCc
Q 007290 283 TDNFSEKN-VLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISV-AVHRNLLRLIGFCTT----PTE 355 (609)
Q Consensus 283 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~ 355 (609)
.++|.+.+ .||+|+||+||+|++ .+|+.||||+++. ...+.+|++++.+ .+|||||++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 36788764 699999999999997 4789999999864 3567889998655 589999999998854 356
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC---CCcEEEccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE---DFEAVVGDF 432 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 432 (609)
.++|||||+||+|.+++... +...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 89999999999999999763 234599999999999999999999999 9999999999999985 567999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE 512 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 512 (609)
|+++...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||......... ....
T Consensus 159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-----~~~~----- 226 (335)
T d2ozaa1 159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMK----- 226 (335)
T ss_dssp TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-----HHHH-----
Confidence 9998765432 234567999999999999999999999999999999999999999643322110 0000
Q ss_pred ccchhhcccc--ccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 513 KRLDAIVDRN--LNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 513 ~~~~~~~~~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..+.... +........+.++.+++.+||+.||++|||+.|+++
T Consensus 227 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 ---TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111 111112345678999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=369.73 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=204.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
.++|++.+.||+|+||+||+|.++ +|+.||||+++.. ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999999999999975 6889999999643 2334568899999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCC--CcEEEcccccceeec
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDED--FEAVVGDFGLAKLVD 439 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGl~~~~~ 439 (609)
|+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999753 23489999999999999999999999 99999999999999854 589999999998764
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
.. .......||+.|+|||.+.+..++.++||||+||++|+|+||+.||...... +.......... .+
T Consensus 156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~---~~ 222 (321)
T d1tkia_ 156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEY---TF 222 (321)
T ss_dssp TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC---CC
T ss_pred cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC---CC
Confidence 32 2334456899999999999999999999999999999999999999754321 11111111100 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ....+.++.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0112457899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=378.52 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=202.7
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC--CCchHHHHHHHHHHHH-hccCCCcceeEeEEeCCCcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE--SPGGDAAFQREVEMIS-VAVHRNLLRLIGFCTTPTERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 359 (609)
++|++.+.||+|+||+||+|+++ +|+.||||+++... .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 68999999996421 2334556677777665 68999999999999999999999
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeec
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVD 439 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~ 439 (609)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998643 378899999999999999999999 99999999999999999999999999998664
Q ss_pred cCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhc
Q 007290 440 VRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIV 519 (609)
Q Consensus 440 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (609)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....... ..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~-~~----- 219 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRM-DN----- 219 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHH-CC-----
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHc-CC-----
Confidence 332 23344679999999999999999999999999999999999999997543211 1111111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 007290 520 DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMS-EVVR 558 (609)
Q Consensus 520 ~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 558 (609)
..++...+.++.+++.+||+.||++||++. ++++
T Consensus 220 -----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111223356789999999999999999985 6653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=368.12 Aligned_cols=258 Identities=24% Similarity=0.255 Sum_probs=195.3
Q ss_pred ccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC----chHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 288 EKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP----GGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 288 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
.+++||+|+||+||+|+++ +|+.||||+++..... ...+.+.+|+.++++++|||||++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 6999999998643221 1235688999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+.++++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 999887766643 34488889999999999999999999 99999999999999999999999999998664332
Q ss_pred CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccchhhccc
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLDAIVDR 521 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (609)
. ......||+.|+|||++... .++.++|||||||++|||+||+.||......+ ....+.............+.
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----QLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCTTTSSST
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-----HHHHHHHhcCCCChhhccch
Confidence 2 23345799999999998654 57999999999999999999999997543211 11111111000000000000
Q ss_pred -------cc--cCCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 522 -------NL--NKNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 522 -------~l--~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. .... ....+.++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 0000 1123468899999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=365.69 Aligned_cols=265 Identities=21% Similarity=0.288 Sum_probs=200.5
Q ss_pred cCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||+||+|++ .+|+.||||+++... .....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999997 479999999996432 23346789999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
|+.++.+...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9987655544333 223489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc--chhh
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR--LDAI 518 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 518 (609)
. .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||....... .+.........+.. ....
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH----HHHHHHHhcCCCchhhcccc
Confidence 2 2333457999999999877655 5899999999999999999999997543211 11111111100000 0000
Q ss_pred c-cccccCC-----------CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 519 V-DRNLNKN-----------YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 519 ~-~~~l~~~-----------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .+..... .....+.++.+++.+|++.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0000000 011234678999999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-45 Score=366.90 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=202.0
Q ss_pred cCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEeec
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYPF 362 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 362 (609)
++|++.+.||+|+||+||+|++++|+.||||++.... .....+.+.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999996432 233457899999999999999999999999999999999999
Q ss_pred ccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccCC
Q 007290 363 MQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRK 442 (609)
Q Consensus 363 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~~ 442 (609)
+.++.+...... ...++...++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 998887777654 23499999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh--c------
Q 007290 443 TNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE--K------ 513 (609)
Q Consensus 443 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~------ 513 (609)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... .+.......... .
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHHHHHhhCCCChhhccchh
Confidence 223344689999999998754 56999999999999999999999997543211 111111111000 0
Q ss_pred cchhh---c---cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 514 RLDAI---V---DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 514 ~~~~~---~---~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
..... . .+..........+..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0 000001112233467899999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=363.52 Aligned_cols=241 Identities=22% Similarity=0.356 Sum_probs=196.2
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCC-----chHHHHHHHHHHHHhcc--CCCcceeEeEEeCCC
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESP-----GGDAAFQREVEMISVAV--HRNLLRLIGFCTTPT 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 354 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++...... .....+.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367999999999999999999975 7999999998642211 11234678999999987 899999999999999
Q ss_pred cceEEeecccC-chhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-CCcEEEccc
Q 007290 355 ERLLVYPFMQN-LSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-DFEAVVGDF 432 (609)
Q Consensus 355 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 432 (609)
..++||||+.+ +++.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 67777776532 389999999999999999999999 9999999999999985 479999999
Q ss_pred ccceeeccCCCceeecccccccccCcccccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 433 GLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKS-SERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 433 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
|+++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... ...
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~ 218 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIR 218 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHH
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhh
Confidence 999875432 2344679999999999987765 6779999999999999999999963210 000
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.. ..+....+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 GQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 0011223467899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=367.38 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=197.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-C-CcEEEEEEeccCC-CCchHHHHHHHHHHHHhc---cCCCcceeEeEEeC----
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-D-GTKVAVKRLTDFE-SPGGDAAFQREVEMISVA---VHRNLLRLIGFCTT---- 352 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 352 (609)
.++|++.+.||+|+||+||+|++. + ++.||||+++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 5679999986422 223344566777777655 79999999998842
Q ss_pred -CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcc
Q 007290 353 -PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGD 431 (609)
Q Consensus 353 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 431 (609)
....+++|||+.++++....... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34578999999998876555432 33488999999999999999999999 999999999999999999999999
Q ss_pred cccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 432 FGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 432 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||....... .+.........
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhhCC
Confidence 9998865432 23345679999999999999999999999999999999999999997543211 11111111100
Q ss_pred hccc--------h-hhccc---cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 EKRL--------D-AIVDR---NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 ~~~~--------~-~~~~~---~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
+... . ..... .....+....+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0 00000 0001112233467889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-42 Score=348.19 Aligned_cols=259 Identities=15% Similarity=0.189 Sum_probs=204.5
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccC-CCcceeEeEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 468999999999999999999975 689999998865332 2456788899998875 89999999999999999999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCC-----CCcEEEcccccc
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDE-----DFEAVVGDFGLA 435 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl~ 435 (609)
||+ +++|.+.+.... ..++..++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 81 e~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 998 678888887533 3489999999999999999999999 9999999999999974 578999999999
Q ss_pred eeeccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHH
Q 007290 436 KLVDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKL 509 (609)
Q Consensus 436 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 509 (609)
+.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhc
Confidence 987543221 2334579999999999999999999999999999999999999997544332211 11111111
Q ss_pred hhhccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 510 EREKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 510 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
.......++ .. ..++++.+++..|++.+|++||+++.+.+.|++
T Consensus 232 ~~~~~~~~l-----~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 232 KQSTPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHSCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cCCCChHHh-----cC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111111111 11 123578999999999999999999999888766
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-43 Score=358.10 Aligned_cols=265 Identities=19% Similarity=0.278 Sum_probs=199.0
Q ss_pred hcCCCccCcccccCCceEEEEEe-CCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC----cce
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVL-ADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT----ERL 357 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 357 (609)
+++|++.+.||+|+||+||+|++ .+|+.||||++.........+.+.+|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999996 4799999999976554555678899999999999999999999986543 345
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 666778899999999752 389999999999999999999999 999999999999999999999999999987
Q ss_pred eccCCCc--eeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 438 VDVRKTN--VTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 438 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
....... ......||+.|+|||++.. ..++.++||||+||++|||+||+.||........ .............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~----~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGILGSPSQ 234 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH----HHHHhhhccCCCh
Confidence 6543222 2344679999999999854 5678999999999999999999999975432111 0000000000000
Q ss_pred c----------hhhc--cccccC----CCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 515 L----------DAIV--DRNLNK----NYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 515 ~----------~~~~--~~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
. .... .+.... ...+..+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 000000 0011223578899999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-43 Score=353.68 Aligned_cols=259 Identities=18% Similarity=0.201 Sum_probs=195.6
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeE-eEEeCCCcceEEe
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI-GFCTTPTERLLVY 360 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-~~~~~~~~~~lv~ 360 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ..++..|+++++.++|+|++..+ ++....+..++||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 357999999999999999999974 689999999865322 34578899999999877765554 5556777888999
Q ss_pred ecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeC---CCCcEEEccccccee
Q 007290 361 PFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLD---EDFEAVVGDFGLAKL 437 (609)
Q Consensus 361 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl~~~ 437 (609)
||+.+ ++...+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++ .+..+||+|||+++.
T Consensus 83 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELLGP-SLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECCCC-BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEcCC-chhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99965 555555432 23489999999999999999999999 999999999999986 455799999999998
Q ss_pred eccCCCc------eeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh
Q 007290 438 VDVRKTN------VTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER 511 (609)
Q Consensus 438 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 511 (609)
+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||............ ... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~~~-~~~~~ 233 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERI-SEKKM 233 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-HHH-HHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-HHh-hcccC
Confidence 7543321 233457999999999999999999999999999999999999999754432221111 000 00000
Q ss_pred hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q 007290 512 EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRMLEG 562 (609)
Q Consensus 512 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 562 (609)
...... + ....+.++.+++.+||+.+|++||++.++.+.|++
T Consensus 234 ~~~~~~-----~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 234 STPIEV-----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HSCHHH-----H----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CCChhH-----h----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 000000 1 11223678999999999999999999999988876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=351.75 Aligned_cols=265 Identities=24% Similarity=0.301 Sum_probs=196.9
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeC--------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTT-------- 352 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 352 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++.... .......+.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999974 79999999986432 33456778999999999999999999998855
Q ss_pred CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccc
Q 007290 353 PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDF 432 (609)
Q Consensus 353 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 432 (609)
....++||||+.++++...... ...++...++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 3457899999998887655443 23478889999999999999999999 9999999999999999999999999
Q ss_pred ccceeeccCCC---ceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHH
Q 007290 433 GLAKLVDVRKT---NVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKK 508 (609)
Q Consensus 433 Gl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 508 (609)
|+++....... .......||+.|+|||++.+. .++.++||||+||++|||+||+.||...... .....+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-----~~~~~i~~ 236 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQ 236 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-----HHHHHHHH
Confidence 99987653322 122335699999999998765 6899999999999999999999999743221 11111111
Q ss_pred Hhhhcc---chhhc--------cccccCCCC-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 509 LEREKR---LDAIV--------DRNLNKNYN-------IQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 509 ~~~~~~---~~~~~--------~~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...... ..... ......... ......+.+|+.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 110000 00000 000000000 1123567899999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-43 Score=358.67 Aligned_cols=259 Identities=24% Similarity=0.296 Sum_probs=193.5
Q ss_pred CCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------Ccce
Q 007290 285 NFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TERL 357 (609)
Q Consensus 285 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 357 (609)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5788899999999999999975 699999999975322 224799999999999999999988432 2368
Q ss_pred EEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccce
Q 007290 358 LVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAK 436 (609)
Q Consensus 358 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~ 436 (609)
+||||++++.+....+. ......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999987755544432 22344589999999999999999999999 999999999999999775 89999999998
Q ss_pred eeccCCCceeecccccccccCcccccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhh----
Q 007290 437 LVDVRKTNVTTQVRGTMGHIAPEYLST-GKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLER---- 511 (609)
Q Consensus 437 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 511 (609)
...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+.........
T Consensus 172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~----~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTRE 245 (350)
T ss_dssp ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCCCCHH
T ss_pred hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH----HHHHHHHHhCCChHH
Confidence 765432 2334579999999998765 568999999999999999999999997543211 11111110000
Q ss_pred ----------hccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 512 ----------EKRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 512 ----------~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
...........+........++++.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000111112334567899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=348.04 Aligned_cols=263 Identities=20% Similarity=0.234 Sum_probs=205.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCCcceEEee
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPTERLLVYP 361 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 361 (609)
++|++.+.||+|+||+||+|++. +|+.||||+++... .......+.+|+.+++.++||||+++++++......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 78999999996433 33456788999999999999999999999999999999999
Q ss_pred cccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccceeeccC
Q 007290 362 FMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVR 441 (609)
Q Consensus 362 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~~~~~ 441 (609)
++.++++...+... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999998887653 3378899999999999999999999 9999999999999999999999999999877543
Q ss_pred CCceeecccccccccCcccccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhccc-----
Q 007290 442 KTNVTTQVRGTMGHIAPEYLSTGK-SSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRL----- 515 (609)
Q Consensus 442 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 515 (609)
.. ......+++.|+|||.+.... ++.++||||+||++|||++|+.||...... ......+.........
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHHHCCCCTTTCTT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH----HHHHHHHHhhcCCCChhhhhh
Confidence 22 233445788999999987655 699999999999999999999997432211 1111111111111000
Q ss_pred -hhhc---------cccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 516 -DAIV---------DRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 516 -~~~~---------~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ............+..+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000011112334567899999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=355.25 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=203.8
Q ss_pred cCCCccCcccccCCceEEEEEeC----CCcEEEEEEeccCC---CCchHHHHHHHHHHHHhccC-CCcceeEeEEeCCCc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA----DGTKVAVKRLTDFE---SPGGDAAFQREVEMISVAVH-RNLLRLIGFCTTPTE 355 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 355 (609)
++|++.+.||+|+||+||+|+.. +|+.||||.++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 48899999986421 12234668899999999987 899999999999999
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.+++|||+.+|+|.+++..... ++......++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999986443 67788889999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG--KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 513 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 513 (609)
+.+............|++.|+|||.+.+. .++.++|||||||++|||+||+.||.......... ....... ..
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~----~i~~~~~-~~ 251 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA----EISRRIL-KS 251 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH----HHHHHHH-HC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHHhcc-cC
Confidence 88765555555566799999999999764 46889999999999999999999997654332211 1111110 00
Q ss_pred cchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 007290 514 RLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPA-----MSEVVR 558 (609)
Q Consensus 514 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~ 558 (609)
. ...+...+.++.+++.+||+.||++||| ++|+++
T Consensus 252 ~----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 E----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp C----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred C----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 1122334578999999999999999995 777764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=355.23 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=193.7
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCCC------
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTPT------ 354 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 354 (609)
.++|++++.||+|+||+||+|.+. +|+.||||+++... .....+.+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 69999999997533 2334567889999999999999999999997654
Q ss_pred cceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEccccc
Q 007290 355 ERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGL 434 (609)
Q Consensus 355 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 434 (609)
+.++||||+ +.+|....+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 468999999 5677776654 2389999999999999999999999 999999999999999999999999999
Q ss_pred ceeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhh-
Q 007290 435 AKLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLERE- 512 (609)
Q Consensus 435 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 512 (609)
++..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ +..........
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ----LKEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCC
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH----HHHHHhccCCCc
Confidence 9876432 2345799999999998764 578999999999999999999999975432110 10000000000
Q ss_pred ----------------ccchhhccccccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 513 ----------------KRLDAIVDRNLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 513 ----------------~~~~~~~~~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
..........+ .......+..+.+|+.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 01112334678899999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=351.87 Aligned_cols=259 Identities=19% Similarity=0.265 Sum_probs=197.1
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCC--CcceEE
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTP--TERLLV 359 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 359 (609)
++|++.+.||+|+||+||+|++. +|+.||||+++. ...+.+.+|+++++++. ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 68999999999999999999974 789999999864 23567899999999995 99999999998744 458899
Q ss_pred eecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCC-cEEEcccccceee
Q 007290 360 YPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDF-EAVVGDFGLAKLV 438 (609)
Q Consensus 360 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl~~~~ 438 (609)
|||+.+++|....+ .++...++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 99999999877643 288999999999999999999999 999999999999998654 6999999999876
Q ss_pred ccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHH---------HH
Q 007290 439 DVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHV---------KK 508 (609)
Q Consensus 439 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~---------~~ 508 (609)
.... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................. ..
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5332 23445689999999998765 479999999999999999999999975433211111110000 00
Q ss_pred Hhhh--ccchhhccc--------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 509 LERE--KRLDAIVDR--------NLNKNYNIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 509 ~~~~--~~~~~~~~~--------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
.... ......... ..........+.++.+|+.+|++.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000000 0011111234467899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=349.71 Aligned_cols=264 Identities=20% Similarity=0.226 Sum_probs=191.0
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC------Cc
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP------TE 355 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 355 (609)
++|++.++||+|+||+||+|++. +|+.||||++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 69999999997543 233446788999999999999999999998543 56
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.++||||+.++.+..... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 799999998776654422 278999999999999999999999 9999999999999999999999999998
Q ss_pred eeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHH------------
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLL------------ 503 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~------------ 503 (609)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..............
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 865432 233455789999999999999999999999999999999999999965432111000000
Q ss_pred --HHHHHH-hhhc-----cchhhccccccCC---CCHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 007290 504 --DHVKKL-EREK-----RLDAIVDRNLNKN---YNIQEVETMIQVALLCTQASPEDRPAMSEVVRM 559 (609)
Q Consensus 504 --~~~~~~-~~~~-----~~~~~~~~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 559 (609)
...... .... ............. .....+.++.+|+.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0000 0000010111110 123456789999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=342.21 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=194.8
Q ss_pred hcCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCC-CCchHHHHHHHHHHHHhccCCCcceeEeEEeCC-----Cc
Q 007290 283 TDNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFE-SPGGDAAFQREVEMISVAVHRNLLRLIGFCTTP-----TE 355 (609)
Q Consensus 283 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 355 (609)
.++|++.+.||+|+||+||+|++. +|+.||||++.... .....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999964 79999999997533 233456788999999999999999999998543 34
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEEEcccccc
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 435 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~ 435 (609)
.+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 5777888899999998864 2389999999999999999999999 9999999999999999999999999999
Q ss_pred eeeccCCCceeecccccccccCcccccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHHhhhcc
Q 007290 436 KLVDVRKTNVTTQVRGTMGHIAPEYLSTG-KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKR 514 (609)
Q Consensus 436 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 514 (609)
..... ......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||........ ...+........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-----~~~i~~~~~~~~ 239 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-----LKLILRLVGTPG 239 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCCCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCCC
Confidence 76542 23345689999999987665 468999999999999999999999975432111 111110000000
Q ss_pred c-----------hhhcccccc-CCC-----CHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 007290 515 L-----------DAIVDRNLN-KNY-----NIQEVETMIQVALLCTQASPEDRPAMSEVVR 558 (609)
Q Consensus 515 ~-----------~~~~~~~l~-~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 558 (609)
. ......... ... ....+..+.+|+.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 000000000 000 1123467889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-36 Score=315.03 Aligned_cols=265 Identities=19% Similarity=0.210 Sum_probs=188.8
Q ss_pred cCCCccCcccccCCceEEEEEeC-CCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-----------CCCcceeEeEEe
Q 007290 284 DNFSEKNVLGQGGFGKVYRGVLA-DGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-----------HRNLLRLIGFCT 351 (609)
Q Consensus 284 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 351 (609)
++|+++++||+|+||+||+|++. +|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 45999999999999999999974 7999999999642 223467788998888765 578999988875
Q ss_pred C--CCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCC---
Q 007290 352 T--PTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDF--- 425 (609)
Q Consensus 352 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~--- 425 (609)
. .....++++++..+......... .....+++..++.++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 4 34555666665544333332222 223457889999999999999999998 6 899999999999998654
Q ss_pred ---cEEEcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCccccccc--h
Q 007290 426 ---EAVVGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDD--V 500 (609)
Q Consensus 426 ---~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll~elltg~~p~~~~~~~~~~~--~ 500 (609)
.++++|||.+...... .....||+.|+|||.+.+..++.++||||+||++++|++|+.||.......... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999865432 234569999999999999999999999999999999999999997543221110 1
Q ss_pred hHHHHHHHHh--------hhccchhhccc-------------------cccCCCCHHHHHHHHHHHHhccCCCCCCCCCH
Q 007290 501 LLLDHVKKLE--------REKRLDAIVDR-------------------NLNKNYNIQEVETMIQVALLCTQASPEDRPAM 553 (609)
Q Consensus 501 ~~~~~~~~~~--------~~~~~~~~~~~-------------------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 553 (609)
.....+.... .........+. ..........+.++.+|+.+|++.||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1111111100 00000000000 00122356778899999999999999999999
Q ss_pred HHHHH
Q 007290 554 SEVVR 558 (609)
Q Consensus 554 ~evl~ 558 (609)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.93 E-value=5.2e-27 Score=236.83 Aligned_cols=172 Identities=31% Similarity=0.567 Sum_probs=155.6
Q ss_pred cCchhHHHHHHHHHhCCCCCCCcCCCCCCCCCCC--CcceeEEcCCC---CeEEEEecCCCccc--ccCccccCCCCCCE
Q 007290 22 LSDYQGDALFALRTSLRVPNNQLRDWNQNQVNPC--TWSNVICDNSN---NVASVTLSSMNFSG--TLSPRIGVLRTLST 94 (609)
Q Consensus 22 ~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~~~---~l~~L~L~~n~l~~--~~~~~~~~l~~L~~ 94 (609)
|.+.|++||++||+++.+|. .+.+|... .||| .|.||+|+..+ +|+.|+|++|+++| .+|+.+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 57789999999999999875 68999754 5999 59999998744 79999999999998 58899999999999
Q ss_pred EEccC-CCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCc
Q 007290 95 LTLKG-NGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNN 173 (609)
Q Consensus 95 L~l~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 173 (609)
|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|.+.+.+|..+.++++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 99999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCcccccCCc----ccCCCCCC
Q 007290 174 LSGQIPVHLFQIPK----YNFTGNNL 195 (609)
Q Consensus 174 l~~~ip~~l~~l~~----l~~~~n~~ 195 (609)
++|.+|..+.++.. +.+++|..
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccccccccccccccccccccccccc
Confidence 99999988776654 44555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.1e-23 Score=191.53 Aligned_cols=171 Identities=11% Similarity=0.051 Sum_probs=121.1
Q ss_pred CCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCC-------------c----hHHHHHHHHHHHHhccCCCcceeEe
Q 007290 286 FSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESP-------------G----GDAAFQREVEMISVAVHRNLLRLIG 348 (609)
Q Consensus 286 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------~----~~~~~~~E~~~l~~l~h~niv~l~~ 348 (609)
+.+.+.||+|+||+||+|...+|+.||||+++..... . .......|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999999889999999987531110 0 1123456888899999999998876
Q ss_pred EEeCCCcceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEeCCCCcEE
Q 007290 349 FCTTPTERLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHCNPKIIHRDVKAANVLLDEDFEAV 428 (609)
Q Consensus 349 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 428 (609)
+. ..+++|||+++..+.. ++......++.|++++++|||++ +|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence 54 3479999999865432 33344567899999999999999 99999999999999965 589
Q ss_pred EcccccceeeccCCCceeecccccccccCcccccCCCCCcchhhHHHHHHH
Q 007290 429 VGDFGLAKLVDVRKTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIML 479 (609)
Q Consensus 429 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~ll 479 (609)
|+|||++.....+....... .+... -.+.+ ...|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 99999997654322111000 00000 00111 35678899999986544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=4.8e-19 Score=164.43 Aligned_cols=123 Identities=27% Similarity=0.369 Sum_probs=98.9
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCccccc-CccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTL-SPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
|.|..|.|++. .+++.|+|++|.|++.+ +..|.++++|+.|+|++|++++..+..+..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 56888888642 26788888888887644 55678888888888888888877788888888888888888
Q ss_pred ccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCccccc
Q 007290 124 NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQ 177 (609)
Q Consensus 124 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 177 (609)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 888876677788888888888888888866667788888888888888888743
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.4e-17 Score=152.79 Aligned_cols=130 Identities=22% Similarity=0.326 Sum_probs=113.7
Q ss_pred EEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCC-CccccccccccccccccccccccCCccccCcccchhhhccc
Q 007290 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI-PEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQ 147 (609)
Q Consensus 69 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 147 (609)
+.++.++++++ .+|..+ .+++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 47899999999 778766 378999999999998655 56689999999999999999988899999999999999999
Q ss_pred CcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCCC
Q 007290 148 NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 148 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~~ 201 (609)
|+|++..|..|.++++|+.|+|++|+|++..|..| .+|..|++++|++.|++..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch
Confidence 99996667789999999999999999996556555 4667789999999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=2.1e-16 Score=154.31 Aligned_cols=133 Identities=27% Similarity=0.302 Sum_probs=91.0
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++|++++ .+..+..+++|+.|++++|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred cccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 34444444444442 23344444444444444444444344444555555666666666665555667788999999999
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccc---cCCcccCCCCCCCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLF---QIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~---~l~~l~~~~n~~~c~~~~ 201 (609)
+|+|++..+..+..+++|++|+|++|+|+ .+|..+. +|+.|+++||||.|+|.+
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 99999777788999999999999999999 8997665 556688999999999753
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.64 E-value=4.1e-17 Score=163.38 Aligned_cols=137 Identities=29% Similarity=0.498 Sum_probs=109.3
Q ss_pred CeEEEEecCCCcccccCccccCCCCC-CEEEccC-----------------------CCcCCCCCccccccccccccccc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTL-STLTLKG-----------------------NGITGEIPEELGNLSSLTSLDLD 122 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L-~~L~l~~-----------------------N~l~~~~p~~~~~l~~L~~L~L~ 122 (609)
+++.+++++|.+.|.+|..+..+..+ +.+++++ |.+.|.+|..+..+++|+.|+++
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~ 229 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45566666666666666555555443 4444444 44445566667778889999999
Q ss_pred cccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCCc--ccccCCcccCCCCCCCCCCC
Q 007290 123 NNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV--HLFQIPKYNFTGNNLNCGKT 200 (609)
Q Consensus 123 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~--~l~~l~~l~~~~n~~~c~~~ 200 (609)
+|.+++.+| .++.+++|+.|+|++|+|+|.+|..++++++|++|+|++|+|+|.+|. .+.+|..+++.+|+..||.|
T Consensus 230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999997655 689999999999999999999999999999999999999999999996 36788889999999999988
Q ss_pred CCCCC
Q 007290 201 LPHSC 205 (609)
Q Consensus 201 ~~~~c 205 (609)
+| +|
T Consensus 309 lp-~c 312 (313)
T d1ogqa_ 309 LP-AC 312 (313)
T ss_dssp SS-CC
T ss_pred CC-CC
Confidence 75 66
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.3e-16 Score=154.43 Aligned_cols=136 Identities=22% Similarity=0.255 Sum_probs=123.1
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 47999999999999888888999999999999999999766788999999999999999999888889999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCccc---ccCCcccCCCCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHL---FQIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l---~~l~~l~~~~n~~~c~~~~ 201 (609)
++|++++..|..|..+++|++|++++|.+++..|..| .+|..|++++|++.|+|+.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 9999998889999999999999999999997666555 4577789999999998763
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=1.1e-15 Score=130.39 Aligned_cols=102 Identities=25% Similarity=0.395 Sum_probs=90.3
Q ss_pred EEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccC
Q 007290 69 ASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQN 148 (609)
Q Consensus 69 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 148 (609)
+.|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|..++.+++|+.|++++|+|+ .+| .++++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 36899999998 455 4899999999999999999 78888999999999999999999 465 5999999999999999
Q ss_pred cCCCCcC--CCcCcccccccccCCCCcccc
Q 007290 149 NFSGTIP--DSLTTLSSLISIQLDSNNLSG 176 (609)
Q Consensus 149 ~l~~~~p--~~~~~l~~L~~L~l~~N~l~~ 176 (609)
+|+ .+| ..+..+++|+.|++++|+++.
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCCc
Confidence 999 454 468899999999999999983
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.5e-15 Score=133.54 Aligned_cols=120 Identities=18% Similarity=0.239 Sum_probs=100.0
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|+|+. ++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 3478999999999994 5666788999999999999999 665 489999999999999999955555567899999999
Q ss_pred cccCcCCCCcC--CCcCcccccccccCCCCcccccCCc----ccccCCccc
Q 007290 145 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIPV----HLFQIPKYN 189 (609)
Q Consensus 145 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ip~----~l~~l~~l~ 189 (609)
|++|+|+ .++ ..+..+++|++|++++|+++ ..|. .+..++.|.
T Consensus 94 L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 94 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 142 (162)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred ecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcC
Confidence 9999998 555 36788999999999999998 5663 355566554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=2e-14 Score=122.28 Aligned_cols=101 Identities=31% Similarity=0.422 Sum_probs=87.0
Q ss_pred CEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCC
Q 007290 93 STLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSN 172 (609)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 172 (609)
++|+|++|+|+ .+|. +.++++|++|+|++|+|+ .+|+.|+.+++|+.|++++|.|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 6764 999999999999999999 78889999999999999999999 566 4899999999999999
Q ss_pred cccccCC--ccc---ccCCcccCCCCCCCCCC
Q 007290 173 NLSGQIP--VHL---FQIPKYNFTGNNLNCGK 199 (609)
Q Consensus 173 ~l~~~ip--~~l---~~l~~l~~~~n~~~c~~ 199 (609)
+++ .+| ..+ .+|..|++++|+.....
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 998 454 334 45667889999875443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=3.9e-14 Score=137.89 Aligned_cols=128 Identities=24% Similarity=0.270 Sum_probs=96.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|++|+++ .++..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccc
Confidence 36899999999999777788999999999999999998 5664 678899999999999988 56778888888888888
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcc---cccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH---LFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~---l~~l~~l~~~~n~~~ 196 (609)
++|.+.+..+..+..+.+|+.|++++|.+++..+.. +.++..+++++|...
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 888887655566666667777777777666332322 234455566666543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.44 E-value=7.8e-14 Score=138.50 Aligned_cols=73 Identities=26% Similarity=0.345 Sum_probs=64.3
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN 124 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N 124 (609)
|.|++|.|++. .+++.|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 68999999762 46899999999999766678999999999999999999777888999999999999998
Q ss_pred ccc
Q 007290 125 RLV 127 (609)
Q Consensus 125 ~l~ 127 (609)
+|+
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 876
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.2e-13 Score=122.44 Aligned_cols=111 Identities=19% Similarity=0.149 Sum_probs=87.7
Q ss_pred CCCCCcceeEEcCCCCeEEEEecCCCcccccCccccCCCCCCEEEccCC-CcCCCCCccccccccccccccccccccccC
Q 007290 52 VNPCTWSNVICDNSNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGN-GITGEIPEELGNLSSLTSLDLDNNRLVGKI 130 (609)
Q Consensus 52 ~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 130 (609)
+.|+.+.+|+|. ++++. ..|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...
T Consensus 5 C~c~~~~~l~c~-----------~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~ 72 (156)
T d2ifga3 5 CCPHGSSGLRCT-----------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (156)
T ss_dssp SCCSSSSCEECC-----------SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred CCcCCCCeEEec-----------CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcc
Confidence 444456666665 34444 45677888999999999766 588555667999999999999999999777
Q ss_pred CccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCccc
Q 007290 131 PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 131 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
|..|..+++|++|+|++|+|+ .+|.......+|+.|+|++|++.
T Consensus 73 ~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp TTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 788999999999999999999 67666555557888888888885
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=7.8e-14 Score=123.75 Aligned_cols=112 Identities=22% Similarity=0.288 Sum_probs=95.3
Q ss_pred CCCCCCEEEccCCCcCCCCCccccccccccccccccc-cccccCCccccCcccchhhhcccCcCCCCcCCCcCccccccc
Q 007290 88 VLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNN-RLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLIS 166 (609)
Q Consensus 88 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 166 (609)
.....+.++.+++++. .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|.+|..+++|++
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 4455677999999999 78888999999999999766 588555678999999999999999999655788999999999
Q ss_pred ccCCCCcccccCCcc-cc--cCCcccCCCCCCCCCCCC
Q 007290 167 IQLDSNNLSGQIPVH-LF--QIPKYNFTGNNLNCGKTL 201 (609)
Q Consensus 167 L~l~~N~l~~~ip~~-l~--~l~~l~~~~n~~~c~~~~ 201 (609)
|+|++|+|+ .+|.. +. ++..|++++|++.|+|..
T Consensus 85 L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp EECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred eeccCCCCc-ccChhhhccccccccccCCCcccCCchH
Confidence 999999999 66643 32 667899999999998853
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=3.7e-14 Score=139.43 Aligned_cols=133 Identities=23% Similarity=0.285 Sum_probs=115.6
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.+++++|+|+++.+..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++..|..|.++++|+.|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 47899999999999887888999999999999999999888889999999999999999999999999999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCcc--cccCCcccCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVH--LFQIPKYNFTGNNLNCG 198 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~--l~~l~~l~~~~n~~~c~ 198 (609)
++|++.+..|..+..+++|++|+|++|++...-+.. ...+.++....+...|.
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred cccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 999999877788999999999999999998654421 12344555556666664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.39 E-value=2.4e-13 Score=134.90 Aligned_cols=128 Identities=23% Similarity=0.302 Sum_probs=112.7
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.+++++|++. .+|..+ +++|+.|++++|.+++..+..+.+++.++.|++++|.+++..+..|.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 47899999999988 455544 789999999999999999999999999999999999999888889999999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCCc-c---------cccCCcccCCCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPV-H---------LFQIPKYNFTGNNLNCG 198 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~-~---------l~~l~~l~~~~n~~~c~ 198 (609)
++|+|+ .+|..+..+++|++|+|++|+|+ .|+. . ..++..|++++|++.+.
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 999999 78999999999999999999999 5653 2 24577788999998764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=7.4e-14 Score=124.75 Aligned_cols=108 Identities=19% Similarity=0.256 Sum_probs=91.2
Q ss_pred ccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCC-CcCccc
Q 007290 84 PRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPD-SLTTLS 162 (609)
Q Consensus 84 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~ 162 (609)
+.+.++.+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++ .+|. .+..++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~ 87 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALP 87 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCcccccccc
Confidence 35678889999999999999 77877788999999999999999 564 5899999999999999999 5554 456899
Q ss_pred ccccccCCCCcccccCCc-----ccccCCcccCCCCCCC
Q 007290 163 SLISIQLDSNNLSGQIPV-----HLFQIPKYNFTGNNLN 196 (609)
Q Consensus 163 ~L~~L~l~~N~l~~~ip~-----~l~~l~~l~~~~n~~~ 196 (609)
+|+.|++++|+++ .++. .+.+|..|++++|+..
T Consensus 88 ~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 88 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccccceecccccc-ccccccccccccccchhhcCCCccc
Confidence 9999999999998 4542 3456777889999863
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.28 E-value=2.9e-12 Score=118.53 Aligned_cols=122 Identities=30% Similarity=0.472 Sum_probs=92.9
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++..| ++++++|++|++++|.+. .+|. +.++++|+.|++++|.+.. + ..+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-ccccccccccccccccccc-c-cccchhhhhHHhh
Confidence 3478888888888886443 788888888888888887 5553 7788888888888888773 2 3477888888888
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~ 195 (609)
+++|++. .+| .+..+++|+.|++++|++++ ++ ..+.+|+.|++++|+.
T Consensus 135 l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 135 LSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKV 184 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCC
T ss_pred hhhhhhc-ccc-cccccccccccccccccccC-CccccCCCCCCEEECCCCCC
Confidence 8888887 444 57788888888888888884 44 3456777788888864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=8.2e-12 Score=115.41 Aligned_cols=122 Identities=29% Similarity=0.494 Sum_probs=102.3
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|++++|++.. ++ .+..+++|++|+|++|+|++ ++. ++++++|++|++++|.+. .++ .++++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 489999999999984 33 58899999999999999995 443 999999999999999998 455 4899999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~ 196 (609)
++|.+.. + ..+..+++|+.|++++|++. .+| ..+.++..|++.+|...
T Consensus 114 ~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 114 FNNQITD-I-DPLKNLTNLNRLELSSNTIS-DISALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp CSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCGGGTTCTTCSEEECCSSCCC
T ss_pred ccccccc-c-cccchhhhhHHhhhhhhhhc-cccccccccccccccccccccc
Confidence 9999984 3 34788999999999999998 455 34457777888888653
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=4.5e-12 Score=129.40 Aligned_cols=122 Identities=27% Similarity=0.407 Sum_probs=57.3
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccC----------------
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKI---------------- 130 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~---------------- 130 (609)
+++.|++++|.++.. +.+..+++|+.|++++|.+++..| +..+++|+.|++++|++++..
T Consensus 220 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence 455555555555431 234444555555555555543221 444444444444444443211
Q ss_pred ----CccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCC
Q 007290 131 ----PPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNL 195 (609)
Q Consensus 131 ----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~ 195 (609)
...+..+++|+.|++++|++++. + .+..+++|+.|++++|+|+ .+| ..+.+|+.|++++|+.
T Consensus 296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~~l~~l~~L~~L~l~~N~l 363 (384)
T d2omza2 296 QLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVSSLANLTNINWLSAGHNQI 363 (384)
T ss_dssp CCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CChhHcCCCCCCEEECCCCcC
Confidence 11244455556666666666532 2 2555566666666666655 233 1222344455555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.21 E-value=5.5e-14 Score=130.10 Aligned_cols=109 Identities=23% Similarity=0.298 Sum_probs=82.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|+|+. ++ .+..+++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+ .++ .+.++++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccc
Confidence 3478888888888874 44 4778888888888888887 67765666678888888888888 343 477888888888
Q ss_pred cccCcCCCCcC--CCcCcccccccccCCCCcccccCC
Q 007290 145 LSQNNFSGTIP--DSLTTLSSLISIQLDSNNLSGQIP 179 (609)
Q Consensus 145 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~ip 179 (609)
|++|+|+ .++ ..+..+++|+.|+|++|++....+
T Consensus 122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 8888887 444 357788888888888888874444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=1.1e-11 Score=115.66 Aligned_cols=124 Identities=25% Similarity=0.400 Sum_probs=94.6
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhh
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLT 144 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 144 (609)
..+++.|+|++|.+++.. .++.+++|+.|++++|+|+ .+| .+.++++|+.|++++|.+. .+ ..+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-ccccccccccccc
Confidence 347888888888888643 3678888888888888888 465 4888888888888888877 33 3577888888888
Q ss_pred cccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCC
Q 007290 145 LSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 145 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~ 196 (609)
+++|.+++ +..+..+++|+.+++++|++++..| ..+.+|..|++++|...
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC
Confidence 88888873 2356778889999999999985333 34567777888888654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.20 E-value=6.7e-14 Score=129.50 Aligned_cols=111 Identities=22% Similarity=0.310 Sum_probs=94.3
Q ss_pred ccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCc
Q 007290 81 TLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTT 160 (609)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 160 (609)
.++..+..|++|++|+|++|+|+ .++ .+.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccc
Confidence 45677899999999999999999 666 4999999999999999999 68877777889999999999999 554 4788
Q ss_pred ccccccccCCCCcccccCC-----cccccCCcccCCCCCCCC
Q 007290 161 LSSLISIQLDSNNLSGQIP-----VHLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 161 l~~L~~L~l~~N~l~~~ip-----~~l~~l~~l~~~~n~~~c 197 (609)
+++|+.|++++|+++ .++ ..+.+|..|++++|+..+
T Consensus 114 l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 114 LVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccccccchhc-cccccccccCCCccceeecCCCcccc
Confidence 999999999999998 444 245567778899997543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.18 E-value=1.5e-11 Score=114.61 Aligned_cols=123 Identities=29% Similarity=0.426 Sum_probs=103.7
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTL 145 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 145 (609)
.+++.|++++|.++... .+..+++|++|+|++|+|++ ++. ++++++|++|+|++|+|+ .+| .+.++++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-ccc-cccCcccccccccccccc-ccc-ccccccccccccc
Confidence 37899999999998543 48889999999999999995 553 789999999999999999 466 5899999999999
Q ss_pred ccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCCCCC
Q 007290 146 SQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 146 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n~~~ 196 (609)
++|.+. .++ .+..+++|+.+++++|.+++..+ ..+.+|..+++++|...
T Consensus 120 ~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 120 EHNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp TTSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCC
T ss_pred cccccc-ccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence 999998 444 68899999999999999985332 34667888889988764
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=2e-10 Score=109.22 Aligned_cols=121 Identities=18% Similarity=0.305 Sum_probs=72.5
Q ss_pred CCcceeEEcCC----------CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCC-cccccccccccccccc
Q 007290 55 CTWSNVICDNS----------NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP-EELGNLSSLTSLDLDN 123 (609)
Q Consensus 55 c~w~gv~c~~~----------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L~~ 123 (609)
|....|.|.+. .++++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 55667777531 256677777777765555566677777777777776665443 3466667777766543
Q ss_pred -ccccccCCccccCcccchhhhcccCcCCCCcC-CCcCcccccccccCCCCccc
Q 007290 124 -NRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 124 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 175 (609)
|++....+..|.++++|+.|++++|++....+ ..+..+..|..+...++.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 55665555666777777777777776662211 12334455555555555555
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.99 E-value=4.5e-10 Score=105.70 Aligned_cols=125 Identities=24% Similarity=0.446 Sum_probs=90.0
Q ss_pred CCCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCC-------------
Q 007290 65 SNNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIP------------- 131 (609)
Q Consensus 65 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------- 131 (609)
..+++.|+|++|.+++..| +..+++|+.|++++|.++ .++ .+.++++|+.|++++|.+.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 4578888888888876543 778888888888888887 554 37778888888888777653211
Q ss_pred -------ccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCCCCCCC
Q 007290 132 -------PSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 132 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~~n~~~ 196 (609)
..+.++++|+.|++++|.+++.. .+.++++|+.|+|++|++++ +| ..+.+|..|++++|+..
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCC
Confidence 23455677888888888877432 37788888888888888884 55 34567777888888654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.98 E-value=3.4e-10 Score=115.07 Aligned_cols=122 Identities=26% Similarity=0.377 Sum_probs=80.1
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCC--------------------cccccccccccccccccc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIP--------------------EELGNLSSLTSLDLDNNR 125 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~ 125 (609)
.+++.|++++|.+++..+ +..+++|++|++++|.+++..| ..+..+++|+.|+|++|+
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 367777777777775443 6667777777777777764321 124455677777777777
Q ss_pred ccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC-cccccCCcccCCCC
Q 007290 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFTGN 193 (609)
Q Consensus 126 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~~n 193 (609)
|++. + .+..+++|+.|+|++|+|+ .+| .+.++++|++|++++|+|++..| ..+.+|+.|++++|
T Consensus 319 l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 7743 2 3677777777777777777 344 46777777777777777775444 33445566667666
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.89 E-value=7.1e-10 Score=104.31 Aligned_cols=119 Identities=27% Similarity=0.389 Sum_probs=85.2
Q ss_pred CCeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCC--------------------Ccccccccccccccccccc
Q 007290 66 NNVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEI--------------------PEELGNLSSLTSLDLDNNR 125 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------------------p~~~~~l~~L~~L~L~~N~ 125 (609)
.+++.+++++|.++. ++ .+..+++|+.|++++|.+.+.. ...+.++++|+.|++++|+
T Consensus 85 ~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 85 TKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 356677777776653 22 4566666666666666655321 1236678889999999999
Q ss_pred ccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccCCCCcccccCC--cccccCCcccCC
Q 007290 126 LVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIP--VHLFQIPKYNFT 191 (609)
Q Consensus 126 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip--~~l~~l~~l~~~ 191 (609)
+++. + .|+++++|+.|+|++|++++ +|. +.++++|++|+|++|++++ +| ..+.+|..|+++
T Consensus 163 ~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 163 VSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225 (227)
T ss_dssp CCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CGGGTTCTTCCEEEEE
T ss_pred cccc-h-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-CcccccCCCCCEEEee
Confidence 9843 2 48999999999999999994 553 8899999999999999994 55 334455555543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.87 E-value=2.3e-09 Score=107.14 Aligned_cols=114 Identities=29% Similarity=0.381 Sum_probs=91.9
Q ss_pred CeEEEEecCCCcccccCccccCCCCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcc
Q 007290 67 NVASVTLSSMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLS 146 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 146 (609)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 6889999999998 56753 678999999999999 888754 57889999999998 55532 1469999999
Q ss_pred cCcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCC
Q 007290 147 QNNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNL 195 (609)
Q Consensus 147 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~ 195 (609)
+|.++ .+|. ++.+++|+.|++++|.++ ..|.....+..+.+..+..
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQL 152 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCC
T ss_pred ccccc-cccc-hhhhccceeecccccccc-ccccccccccchhhccccc
Confidence 99999 7775 578999999999999998 5666666677666655443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=3.6e-08 Score=93.07 Aligned_cols=122 Identities=17% Similarity=0.205 Sum_probs=65.0
Q ss_pred CeEEEEec-CCCcccccCccccCCCCCCEEEccCCCcCCCCCc-cccccc-------------------------ccccc
Q 007290 67 NVASVTLS-SMNFSGTLSPRIGVLRTLSTLTLKGNGITGEIPE-ELGNLS-------------------------SLTSL 119 (609)
Q Consensus 67 ~l~~L~L~-~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~-------------------------~L~~L 119 (609)
++..|.+. .|++....+..|.++++|+.|++++|++....+. .+..+. .++.|
T Consensus 79 ~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L 158 (242)
T d1xwdc1 79 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 158 (242)
T ss_dssp TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred ccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceee
Confidence 55666554 4567666667777777888888877777632221 122233 34455
Q ss_pred ccccccccccCCccccCcccch-hhhcccCcCCCCcC-CCcCcccccccccCCCCcccccCC-cccccCCcccCC
Q 007290 120 DLDNNRLVGKIPPSLGNLKKLQ-FLTLSQNNFSGTIP-DSLTTLSSLISIQLDSNNLSGQIP-VHLFQIPKYNFT 191 (609)
Q Consensus 120 ~L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~ip-~~l~~l~~l~~~ 191 (609)
++++|+++ .++....+.++++ .+++++|+|+ .+| ..|.++++|++|+|++|+|+ .+| ..|.+++.|...
T Consensus 159 ~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 159 WLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR 230 (242)
T ss_dssp ECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEEESS
T ss_pred eccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcccccC
Confidence 55555555 2333333333333 2344555565 343 33556666666666666666 343 345555555433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=1.8e-09 Score=95.70 Aligned_cols=63 Identities=32% Similarity=0.391 Sum_probs=26.6
Q ss_pred cccccccccccccccccc--CCccccCcccchhhhcccCcCCCCcCC-CcCcccccccccCCCCccc
Q 007290 112 NLSSLTSLDLDNNRLVGK--IPPSLGNLKKLQFLTLSQNNFSGTIPD-SLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 112 ~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~ 175 (609)
++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+ .+++ ......+|+.|++++|+++
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcC
Confidence 444445555555544421 1122344445555555555544 2222 1112233455555555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.49 E-value=9.3e-08 Score=95.08 Aligned_cols=95 Identities=24% Similarity=0.339 Sum_probs=76.0
Q ss_pred CCCCEEEccCCCcCCCCCccccccccccccccccccccccCCccccCcccchhhhcccCcCCCCcCCCcCcccccccccC
Q 007290 90 RTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDNNRLVGKIPPSLGNLKKLQFLTLSQNNFSGTIPDSLTTLSSLISIQL 169 (609)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 169 (609)
.+|++|||++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 46899999999999 78864 468999999999999 788765 56888899999998 56532 146999999
Q ss_pred CCCcccccCCc--ccccCCcccCCCCCCCC
Q 007290 170 DSNNLSGQIPV--HLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 170 ~~N~l~~~ip~--~l~~l~~l~~~~n~~~c 197 (609)
++|.++ .+|. .+.+|..|++.+|....
T Consensus 106 ~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 106 SNNQLE-KLPELQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp CSSCCS-SCCCCTTCTTCCEEECCSSCCSC
T ss_pred cccccc-cccchhhhccceeeccccccccc
Confidence 999998 6774 34577778888876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=6.9e-07 Score=85.07 Aligned_cols=150 Identities=13% Similarity=0.092 Sum_probs=98.7
Q ss_pred HHHHHHhcCCCccCcccccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhcc-CCCcceeEeEEeCCCc
Q 007290 277 RELQLATDNFSEKNVLGQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAV-HRNLLRLIGFCTTPTE 355 (609)
Q Consensus 277 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 355 (609)
.++....+.|+..+..+.++.+.||+... ++..+++|+..... ......+.+|..++..+. +--+.+++.+...++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35555556777666555455578999875 46677888875422 122335677888877664 3335677888888888
Q ss_pred ceEEeecccCchhhhhhhhcCCCCCCccHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 007290 356 RLLVYPFMQNLSVAYRLREIKPGEPVLDWVTRKRVALGAARGLEYLHEHC------------------------------ 405 (609)
Q Consensus 356 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------ 405 (609)
.++||++++|.++....... .....++.++++.++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 89999999998775543210 012223444444444454321
Q ss_pred --------------------------CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 406 --------------------------NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 406 --------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12478999999999999877677999998864
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=7.7e-09 Score=91.46 Aligned_cols=91 Identities=23% Similarity=0.215 Sum_probs=69.0
Q ss_pred ccCccccCCCCCCEEEccCCCcCCC--CCccccccccccccccccccccccCCc-cccCcccchhhhcccCcCCCCcCCC
Q 007290 81 TLSPRIGVLRTLSTLTLKGNGITGE--IPEELGNLSSLTSLDLDNNRLVGKIPP-SLGNLKKLQFLTLSQNNFSGTIPDS 157 (609)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~ 157 (609)
.++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+ .+++ .+....+|+.|+|++|.++......
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~ 134 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQ 134 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccc
Confidence 4454556799999999999999953 2355778999999999999999 4544 3444567999999999998654432
Q ss_pred -------cCcccccccccCCCCcc
Q 007290 158 -------LTTLSSLISIQLDSNNL 174 (609)
Q Consensus 158 -------~~~l~~L~~L~l~~N~l 174 (609)
+..+|+|+.|| ++.+
T Consensus 135 ~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 135 STYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHHTTSTTCCEET--TEEC
T ss_pred hhHHHHHHHHCCCCCEEC--cCCC
Confidence 55688888886 4444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=2.8e-08 Score=96.48 Aligned_cols=57 Identities=25% Similarity=0.311 Sum_probs=29.9
Q ss_pred CeEEEEecCCCcccc-cCccccCCCCCCEEEccCCCcCCCCCcccccccccccccccc
Q 007290 67 NVASVTLSSMNFSGT-LSPRIGVLRTLSTLTLKGNGITGEIPEELGNLSSLTSLDLDN 123 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~ 123 (609)
+++.|+|+++.+++. +...+..+++|++|+|+++.+++..+..++.+++|++|+|++
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 455555555555432 233344555555555555555544445555555555555555
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=1.1e-08 Score=105.95 Aligned_cols=110 Identities=24% Similarity=0.351 Sum_probs=86.3
Q ss_pred CeEEEEecCCCccccc-CccccCCCCCCEEEccCCCcCC----CCCcccccccccccccccccccccc----CCcccc-C
Q 007290 67 NVASVTLSSMNFSGTL-SPRIGVLRTLSTLTLKGNGITG----EIPEELGNLSSLTSLDLDNNRLVGK----IPPSLG-N 136 (609)
Q Consensus 67 ~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~ 136 (609)
+|+.||++.|++++.. ..-+..+++|++|+|++|.|+. .++..+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998632 3445678999999999999883 3455677899999999999998621 222332 2
Q ss_pred cccchhhhcccCcCCCC----cCCCcCcccccccccCCCCcccc
Q 007290 137 LKKLQFLTLSQNNFSGT----IPDSLTTLSSLISIQLDSNNLSG 176 (609)
Q Consensus 137 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 176 (609)
..+|+.|+|++|+++.. ++..+..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35899999999999743 45667889999999999999874
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.19 E-value=4.2e-08 Score=97.95 Aligned_cols=131 Identities=20% Similarity=0.255 Sum_probs=86.0
Q ss_pred CeEEEEecCCCccc----ccCccccCCCCCCEEEccCCCcCCC-----CCcccccccccccccccccccccc----CCcc
Q 007290 67 NVASVTLSSMNFSG----TLSPRIGVLRTLSTLTLKGNGITGE-----IPEELGNLSSLTSLDLDNNRLVGK----IPPS 133 (609)
Q Consensus 67 ~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 133 (609)
.++.+++++|.+.. .+...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 45566666666542 2233345677888888888888632 334567788888899988887632 4456
Q ss_pred ccCcccchhhhcccCcCCCCcC----CCcC--cccccccccCCCCccccc----CCc----ccccCCcccCCCCCCCC
Q 007290 134 LGNLKKLQFLTLSQNNFSGTIP----DSLT--TLSSLISIQLDSNNLSGQ----IPV----HLFQIPKYNFTGNNLNC 197 (609)
Q Consensus 134 ~~~l~~L~~L~l~~N~l~~~~p----~~~~--~l~~L~~L~l~~N~l~~~----ip~----~l~~l~~l~~~~n~~~c 197 (609)
+..+++|++|+|++|.|++.-. ..+. ..+.|+.|++++|+++.. +.. ...+|+.|++++|.+..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 6778888889999888874311 1222 235688899999888632 122 23467788888887643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=4.8e-06 Score=78.54 Aligned_cols=143 Identities=15% Similarity=0.070 Sum_probs=85.3
Q ss_pred cccccCC-ceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCC--CcceeEeEEeCCCcceEEeecccCch
Q 007290 291 VLGQGGF-GKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR--NLLRLIGFCTTPTERLLVYPFMQNLS 367 (609)
Q Consensus 291 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gs 367 (609)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+... .+.+++++...++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3445554 57899998888889999765322 23467788887766533 35667888888888899999998865
Q ss_pred hhhhh-----------------hhcCCCCCCc--cHHHHHHHH--------------------HHHHHHHHHHHhcC---
Q 007290 368 VAYRL-----------------REIKPGEPVL--DWVTRKRVA--------------------LGAARGLEYLHEHC--- 405 (609)
Q Consensus 368 L~~~l-----------------~~~~~~~~~l--~~~~~~~i~--------------------~~ia~~L~~LH~~~--- 405 (609)
+.... +........+ .......-. ......+..+....
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred cccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 53211 1000000000 000000000 00112233332221
Q ss_pred -CCCeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 406 -NPKIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 406 -~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
.+.++|+|+.|.||+++.+..+.|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 22489999999999999887778999998863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.01 E-value=1.7e-07 Score=93.43 Aligned_cols=111 Identities=19% Similarity=0.246 Sum_probs=85.4
Q ss_pred CCeEEEEecCCCcccc-----cCccccCCCCCCEEEccCCCcCCC----CCccccccccccccccccccccccCCc----
Q 007290 66 NNVASVTLSSMNFSGT-----LSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGKIPP---- 132 (609)
Q Consensus 66 ~~l~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~---- 132 (609)
..++.|+|++|.+... +...+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|.|++.-..
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4799999999998742 445678899999999999998733 445677899999999999999854222
Q ss_pred cccC--cccchhhhcccCcCCCC----cCCCcC-cccccccccCCCCcccc
Q 007290 133 SLGN--LKKLQFLTLSQNNFSGT----IPDSLT-TLSSLISIQLDSNNLSG 176 (609)
Q Consensus 133 ~~~~--l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~ 176 (609)
.+.. .+.|+.|+|++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 3333 36799999999998732 233342 57789999999999973
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=1.6e-07 Score=96.82 Aligned_cols=107 Identities=21% Similarity=0.200 Sum_probs=64.4
Q ss_pred CCCCEEEccCCCcCCCCCcc----cccccccccccccccccccc----CCcccc-CcccchhhhcccCcCCCC----cCC
Q 007290 90 RTLSTLTLKGNGITGEIPEE----LGNLSSLTSLDLDNNRLVGK----IPPSLG-NLKKLQFLTLSQNNFSGT----IPD 156 (609)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~p~ 156 (609)
..|+.+++++|.++...... +...++|++|+|++|+|+.. ++..+. ..+.|++|+|++|+|+.. ++.
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 45677777777666432222 23345778888888877632 233332 355678888888877632 344
Q ss_pred CcCcccccccccCCCCcccccCCcc--------cccCCcccCCCCCCC
Q 007290 157 SLTTLSSLISIQLDSNNLSGQIPVH--------LFQIPKYNFTGNNLN 196 (609)
Q Consensus 157 ~~~~l~~L~~L~l~~N~l~~~ip~~--------l~~l~~l~~~~n~~~ 196 (609)
.+..+++|++|+|++|+|+...... -..|+.|++.+|.+.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 4556677888888888876432211 124666777777664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=2.6e-06 Score=82.18 Aligned_cols=131 Identities=18% Similarity=0.243 Sum_probs=94.7
Q ss_pred CCeEEEEecCC-Cccc-ccCccccC-CCCCCEEEccCC--CcCCC-CCccccccccccccccccc-cccccCCccccCcc
Q 007290 66 NNVASVTLSSM-NFSG-TLSPRIGV-LRTLSTLTLKGN--GITGE-IPEELGNLSSLTSLDLDNN-RLVGKIPPSLGNLK 138 (609)
Q Consensus 66 ~~l~~L~L~~n-~l~~-~~~~~~~~-l~~L~~L~l~~N--~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~ 138 (609)
.+++.|+|+++ +++. .+...+.. .++|+.|++++. .++.. +...+.++++|++|+|++| .+++.....+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 58999999985 4542 22233333 478999999974 44422 3333457899999999986 58877888899999
Q ss_pred cchhhhccc-CcCCCCcCCCcCcccccccccCCCCcccccCCcccccCCcccCCCCCCC
Q 007290 139 KLQFLTLSQ-NNFSGTIPDSLTTLSSLISIQLDSNNLSGQIPVHLFQIPKYNFTGNNLN 196 (609)
Q Consensus 139 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ip~~l~~l~~l~~~~n~~~ 196 (609)
+|++|+|++ +.+++.....++++++|+.|+++++--.+.++.....++.|.+..+++.
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~i~~~~ls 259 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFT 259 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSEESCCCSC
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccccccCccCC
Confidence 999999999 5788666677889999999999988323333333457888887655543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.65 E-value=2.4e-06 Score=75.28 Aligned_cols=109 Identities=15% Similarity=0.177 Sum_probs=72.8
Q ss_pred CCeEEEEecCC-Ccccc----cCccccCCCCCCEEEccCCCcCCC----CCcccccccccccccccccccccc----CCc
Q 007290 66 NNVASVTLSSM-NFSGT----LSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPP 132 (609)
Q Consensus 66 ~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 132 (609)
++++.|+|+++ .++.. +-..+...++|++|+|++|.|+.. +...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 47889999874 46532 334566778899999999988732 223445567889999999988732 223
Q ss_pred cccCcccchhhhcccCcCCCC-------cCCCcCcccccccccCCCCcc
Q 007290 133 SLGNLKKLQFLTLSQNNFSGT-------IPDSLTTLSSLISIQLDSNNL 174 (609)
Q Consensus 133 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 174 (609)
.+...++|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 456667888888888876521 223344456777787766644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.60 E-value=0.00014 Score=73.05 Aligned_cols=77 Identities=13% Similarity=0.100 Sum_probs=48.5
Q ss_pred cCcccccCCceEEEEEeCC-CcEEEEEEeccC------CCCchHHHHHHHHHHHHhcc-C-C-CcceeEeEEeCCCcceE
Q 007290 289 KNVLGQGGFGKVYRGVLAD-GTKVAVKRLTDF------ESPGGDAAFQREVEMISVAV-H-R-NLLRLIGFCTTPTERLL 358 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l 358 (609)
.+.||.|....||+....+ ++.|+||.-... ..+........|.+.++.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 678999965321 11222344566888877653 2 3 34455544 3456789
Q ss_pred EeecccCch
Q 007290 359 VYPFMQNLS 367 (609)
Q Consensus 359 v~e~~~~gs 367 (609)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.02 E-value=2.6e-05 Score=68.40 Aligned_cols=89 Identities=15% Similarity=0.193 Sum_probs=65.0
Q ss_pred cCCCCCCEEEccCC-CcCCC----CCcccccccccccccccccccccc----CCccccCcccchhhhcccCcCCCC----
Q 007290 87 GVLRTLSTLTLKGN-GITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPPSLGNLKKLQFLTLSQNNFSGT---- 153 (609)
Q Consensus 87 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---- 153 (609)
.+.++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999974 56532 233466778899999999998732 223455678899999999998842
Q ss_pred cCCCcCcccccccccCCCCccc
Q 007290 154 IPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 154 ~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
+-..+...++|++|+|++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 2234666788999999988765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.00 E-value=1.9e-05 Score=69.17 Aligned_cols=110 Identities=15% Similarity=0.229 Sum_probs=74.8
Q ss_pred CCeEEEEecC-CCccc----ccCccccCCCCCCEEEccCCCcCCC----CCcccccccccccccccccccccc----CCc
Q 007290 66 NNVASVTLSS-MNFSG----TLSPRIGVLRTLSTLTLKGNGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPP 132 (609)
Q Consensus 66 ~~l~~L~L~~-n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 132 (609)
..++.|+|++ ++++. .+-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4788899987 45653 2344566788899999999988743 223455678899999999888632 234
Q ss_pred cccCcccchh--hhcccCcCCC----CcCCCcCcccccccccCCCCccc
Q 007290 133 SLGNLKKLQF--LTLSQNNFSG----TIPDSLTTLSSLISIQLDSNNLS 175 (609)
Q Consensus 133 ~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 175 (609)
.+...++|+. |++++|.+.. .+...+...++|+.|+++.|...
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 5667788876 4445677753 23445667788888888777653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.87 E-value=0.0035 Score=60.62 Aligned_cols=137 Identities=13% Similarity=0.110 Sum_probs=77.6
Q ss_pred CceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc--ceeEe-----EEeCCCcceEEeecccCchhh
Q 007290 297 FGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL--LRLIG-----FCTTPTERLLVYPFMQNLSVA 369 (609)
Q Consensus 297 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 369 (609)
-..||++..++|..|++|..+... ...+++..|...+..+....+ +..+. ........+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 458999999999999999876432 235678889888877653322 11111 123344567788888764221
Q ss_pred h--------------hhhh----cC-CCCCCccHHH-------------------HHHHHHHHHHHHHHHHh----cCCC
Q 007290 370 Y--------------RLRE----IK-PGEPVLDWVT-------------------RKRVALGAARGLEYLHE----HCNP 407 (609)
Q Consensus 370 ~--------------~l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~----~~~~ 407 (609)
. .++. .. ......++.. +..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 1111 10 0111111111 11122222233333322 2244
Q ss_pred CeEecCCCCCcEEeCCCCcEEEccccccee
Q 007290 408 KIIHRDVKAANVLLDEDFEAVVGDFGLAKL 437 (609)
Q Consensus 408 ~ivH~Dlkp~NIll~~~~~~kl~DfGl~~~ 437 (609)
+++|+|+.+.||+++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.61 E-value=0.012 Score=56.37 Aligned_cols=159 Identities=12% Similarity=0.048 Sum_probs=80.1
Q ss_pred cCHHHHHHHhcCCCccCcc-----cccCCceEEEEEeCCCcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-----
Q 007290 274 YSWRELQLATDNFSEKNVL-----GQGGFGKVYRGVLADGTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL----- 343 (609)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni----- 343 (609)
.+-+|++....+|.+++.. ..|--.+.|+....+| .+++|+.....+ .+++..|++++..+...++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhcccccccc
Confidence 3456777777888775543 4566678999988655 589998864322 2344456666665543222
Q ss_pred ceeE-e--EEeCCCcceEEeecccCchhh--------------hhhhhcCCC-------CCCccHH--------------
Q 007290 344 LRLI-G--FCTTPTERLLVYPFMQNLSVA--------------YRLREIKPG-------EPVLDWV-------------- 385 (609)
Q Consensus 344 v~l~-~--~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~-------~~~l~~~-------------- 385 (609)
+... | +.........++.+..+.... ..++..... .....+.
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 0 111223344455555442111 111110000 0000000
Q ss_pred --HHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEeCCCCcEEEcccccce
Q 007290 386 --TRKRVALGAARGLEYLHE-HCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAK 436 (609)
Q Consensus 386 --~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl~~ 436 (609)
.....+..+...+...+. ....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011112222222222221 123489999999999999998877899999886
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.48 E-value=0.0069 Score=60.14 Aligned_cols=73 Identities=14% Similarity=0.219 Sum_probs=49.3
Q ss_pred cCcccccCCceEEEEEeCC--------CcEEEEEEeccCCCCchHHHHHHHHHHHHhccCCCc-ceeEeEEeCCCcceEE
Q 007290 289 KNVLGQGGFGKVYRGVLAD--------GTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNL-LRLIGFCTTPTERLLV 359 (609)
Q Consensus 289 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 359 (609)
++.|+.|-.-.+|++...+ .+.|.+++... ........+|..+++.+.-.++ .++++++. -..|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceE
Confidence 3578889999999998753 34577766542 2223456688888888764454 46777764 2678
Q ss_pred eecccCchh
Q 007290 360 YPFMQNLSV 368 (609)
Q Consensus 360 ~e~~~~gsL 368 (609)
+||++|.++
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.31 E-value=0.00035 Score=60.69 Aligned_cols=94 Identities=21% Similarity=0.214 Sum_probs=65.9
Q ss_pred cCccccCCCCCCEEEccC-CCcCCC----CCcccccccccccccccccccccc----CCccccCcccchhhhcccCcCCC
Q 007290 82 LSPRIGVLRTLSTLTLKG-NGITGE----IPEELGNLSSLTSLDLDNNRLVGK----IPPSLGNLKKLQFLTLSQNNFSG 152 (609)
Q Consensus 82 ~~~~~~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 152 (609)
+.....+.++|++|+|++ |.|+.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+..
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 333445678999999998 567532 233456788999999999998743 22345667899999999999873
Q ss_pred C----cCCCcCccccccc--ccCCCCccc
Q 007290 153 T----IPDSLTTLSSLIS--IQLDSNNLS 175 (609)
Q Consensus 153 ~----~p~~~~~l~~L~~--L~l~~N~l~ 175 (609)
. +-..+...++|+. |++++|.+.
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 3 2345667788886 455677775
|